[["index.html", "SCOPE &amp; STOP Hormones Analysis Overview", " SCOPE &amp; STOP Hormones Analysis 19 May 2023 Overview This page contains analysis results for SCOPE and STOP Hormones. Absorbance Concentrations: Standard curves "],["part-raw-data.html", "(PART*) Raw Data", " (PART*) Raw Data "],["standard-curves.html", "1 Standard Curves", " 1 Standard Curves This section contains standard curves fitted for Prolactin, HPL, and GH2. GH2 Plate 22 (28-2-22) omitted due to invalid standard curve. Inter-assay CV for Prolactin and HPL higher than recommended 15%. According to the protocols, the following methods were used for curve fitting: - Prolactin: Quadratic - HPL: 4-parameter Logistic - GH2: non-linear splines "],["prolactin.html", "1.1 Prolactin", " 1.1 Prolactin 1.1.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;Prolactin_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL Combined Abs standards only&quot;) std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates # samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;Prolactin_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL SCOPE and STOP combined Abs &quot;) samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates 1.1.1.1 Standard concentration by plate Click for more details Concentration 0 5 15 50 100 200 Assay 1 1 1 1 1 1 1 Assay 2 1 1 1 1 1 1 Assay 3 1 1 1 1 1 1 Assay 4 1 1 1 1 1 1 Assay 5 1 1 1 1 1 1 Assay 6 1 1 1 1 1 1 Assay 7 1 1 1 1 1 1 Assay 8 1 1 1 1 1 1 Assay 9 1 1 1 1 1 1 Assay 10 1 1 1 1 1 1 Assay 11 1 1 1 1 1 1 Assay 12 1 1 1 1 1 1 Assay 13 1 1 1 1 1 1 Assay 14 1 1 1 1 1 1 Assay 15 1 1 1 1 1 1 Assay 16 1 1 1 1 1 1 Assay 17 1 1 1 1 1 1 Assay 18 1 1 1 1 1 1 Assay 19 1 1 1 1 1 1 Assay 20 1 1 1 1 1 1 Assay 21 1 1 1 1 1 1 Assay 22 1 1 1 1 1 1 Assay 23 1 1 1 1 1 1 Assay 24 1 1 1 1 1 1 Assay 25 1 1 1 1 1 1 Assay 26 1 1 1 1 1 1 Assay 27 1 1 1 1 1 1 Assay 28 1 1 1 1 1 1 Assay 29 1 1 1 1 1 1 Assay 30 1 1 1 1 1 1 Assay 31 1 1 1 1 1 1 Assay 32 1 1 1 1 1 1 Assay 33 1 1 1 1 1 1 Assay 34 1 1 1 1 1 1 Assay 35 1 1 1 1 1 1 Assay 36 1 1 1 1 1 1 Assay 37 1 1 1 1 1 1 Assay 38 1 1 1 1 1 1 Assay 39 1 1 1 1 1 1 Assay 40 1 1 1 1 1 1 Assay 41 1 1 1 1 1 1 Assay 42 1 1 1 1 1 1 Assay 43 1 1 1 1 1 1 Assay 44 1 1 1 1 1 1 Assay 45 1 1 1 1 1 1 Assay 46 1 1 1 1 1 1 Assay 47 1 1 1 1 1 1 Assay 48 1 1 1 1 1 1 Assay 49 1 1 1 1 1 1 Assay 50 1 1 1 1 1 1 Assay 51 1 1 1 1 1 1 Assay 52 1 1 1 1 1 1 Assay 53 1 1 1 1 1 1 Assay 54 1 1 1 1 1 1 Assay 55 1 1 1 1 1 1 Assay 56 1 1 1 1 1 1 Assay 57 1 1 1 1 1 1 1.1.1.2 Samples by plate Click for more details Study SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 22 18 40 Assay 19 15 1 16 Assay 20 12 29 41 Assay 21 5 35 40 Assay 22 22 18 40 Assay 23 15 25 40 Assay 24 15 25 40 Assay 25 26 14 40 Assay 26 23 17 40 Assay 27 23 17 40 Assay 28 18 22 40 Assay 29 21 19 40 Assay 30 20 20 40 Assay 31 17 23 40 Assay 32 30 10 40 Assay 33 18 22 40 Assay 34 25 15 40 Assay 35 25 15 40 Assay 36 23 17 40 Assay 37 24 16 40 Assay 38 22 18 40 Assay 39 20 20 40 Assay 40 25 15 40 Assay 41 21 19 40 Assay 42 20 20 40 Assay 43 14 26 40 Assay 44 24 16 40 Assay 45 17 23 40 Assay 46 21 19 40 Assay 47 18 22 40 Assay 48 23 17 40 Assay 49 22 18 40 Assay 50 21 19 40 Assay 51 20 20 40 Assay 52 21 19 40 Assay 53 28 12 40 Assay 54 26 14 40 Assay 55 23 17 40 Assay 56 18 22 40 Assay 57 19 14 33 1.1.2 CV ## Inter-assay CV cv_dat &lt;- std_raw #cv_dat &lt;- std_raw[with(std_raw,get(conc_name)&lt;=50),] #cv_dat &lt;- std_raw[!std_raw$Assay%in%c(2,6,7,11,18,19),] cv_dat$Group &lt;- as.factor(with(cv_dat,get(conc_name))) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$&quot;Abs Ave&quot;,x$Group,mean,na.tm=T))) cv_mean_dat[cv_mean_dat&lt;0.0000001] &lt;- 0 cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_gps[is.nan(cv_gps)] &lt;- 0 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) cv_intra &lt;- mean(samp_cv) Inter-assay CV = 25.25% from 57 assays. Intra-assay CV = 3.85% from 2247 sample measurements. 1.1.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ poly(Conc,2,raw=T),data=std_ls[[k]])}) #fit quadratic #std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ Conc + I(Conc^2),data=std_ls[[k]])}) #fit model std_fit2 &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit splines Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 57 1.1.4 Session info Results generated on: 2023-05-19 18:25:43.59456 Click for more details sessionInfo() ## R version 4.2.3 (2023-03-15) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils ## [8] datasets methods base ## ## other attached packages: ## [1] widgetframe_0.3.1 fontawesome_0.5.1 doParallel_1.0.17 iterators_1.0.14 ## [5] foreach_1.5.2 plotly_4.10.1 investr_1.4.2 readxl_1.4.2 ## [9] htmlwidgets_1.6.2 kableExtra_1.3.4 knitr_1.42 rmarkdown_2.21 ## [13] ggplot2_3.4.2 devtools_2.4.5 usethis_2.1.6 pander_0.6.5 ## [17] magrittr_2.0.3 gridExtra_2.3 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] httr_1.4.5 tidyr_1.3.0 sass_0.4.5 pkgload_1.3.2 ## [5] jsonlite_1.8.4 viridisLite_0.4.1 bslib_0.4.2 shiny_1.7.4 ## [9] highr_0.10 cellranger_1.1.0 yaml_2.3.7 remotes_2.4.2 ## [13] sessioninfo_1.2.2 pillar_1.9.0 glue_1.6.2 digest_0.6.31 ## [17] promises_1.2.0.1 rvest_1.0.3 colorspace_2.1-0 htmltools_0.5.5 ## [21] httpuv_1.6.9 pkgconfig_2.0.3 bookdown_0.33 purrr_1.0.1 ## [25] xtable_1.8-4 scales_1.2.1 webshot_0.5.4 processx_3.8.1 ## [29] svglite_2.1.1 later_1.3.0 tibble_3.2.1 generics_0.1.3 ## [33] ellipsis_0.3.2 cachem_1.0.7 withr_2.5.0 lazyeval_0.2.2 ## [37] cli_3.6.1 crayon_1.5.2 mime_0.12 memoise_2.0.1 ## [41] evaluate_0.20 ps_1.7.5 fs_1.6.1 fansi_1.0.4 ## [45] xml2_1.3.3 pkgbuild_1.4.0 data.table_1.14.8 profvis_0.3.7 ## [49] tools_4.2.3 prettyunits_1.1.1 lifecycle_1.0.3 stringr_1.5.0 ## [53] munsell_0.5.0 callr_3.7.3 compiler_4.2.3 jquerylib_0.1.4 ## [57] systemfonts_1.0.4 rlang_1.1.0 rstudioapi_0.14 crosstalk_1.2.0 ## [61] miniUI_0.1.1.1 codetools_0.2-19 gtable_0.3.3 R6_2.5.1 ## [65] dplyr_1.1.2 fastmap_1.1.1 utf8_1.2.3 stringi_1.7.12 ## [69] Rcpp_1.0.10 vctrs_0.6.2 tidyselect_1.2.0 xfun_0.39 ## [73] urlchecker_1.0.1 "],["hpl.html", "1.2 HPL", " 1.2 HPL 1.2.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;HPL_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs standards&quot;) std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates #std_raw$Abs.ave &lt;- std_raw$&quot;Abs Ave&quot; std_qc &lt;- read.csv(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;HPL_QC.csv&quot;),header=T) #standards QC std_qc$Abs.ave &lt;- apply(std_qc[,c(&quot;Abs.1&quot;,&quot;Abs.2&quot;)],1,mean,na.rm=T) #average replicates # samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;HPL_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs samples&quot;) #samples samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates samp_raw$Abs.ave[samp_raw$Abs.ave&lt;0] &lt;- 0 #restrict to &gt;=0 Standard concentration by plate Click for more details Concentration St 0 St 1.25 St 10 St 20 St 5 Assay 1 1 1 1 1 1 Assay 2 1 1 1 1 1 Assay 3 1 1 1 1 1 Assay 4 1 1 1 1 1 Assay 5 1 1 1 1 1 Assay 6 1 1 1 1 1 Assay 7 1 1 1 1 1 Assay 8 1 1 1 1 1 Assay 9 1 1 1 1 1 Assay 10 1 1 1 1 1 Assay 11 1 1 1 1 1 Assay 12 1 1 1 1 1 Assay 13 1 1 1 1 1 Assay 14 1 1 1 1 1 Assay 15 1 1 1 1 1 Assay 16 1 1 1 1 1 Assay 17 1 1 1 1 1 Assay 18 1 1 1 1 1 Assay 19 1 1 1 1 1 Assay 20 1 1 1 1 1 Assay 21 1 1 1 1 1 Assay 22 1 1 1 1 1 Assay 23 1 1 1 1 1 Assay 24 1 1 1 1 1 Assay 25 1 1 1 1 1 Assay 26 1 1 1 1 1 Assay 27 1 1 1 1 1 Assay 28 1 1 1 1 1 Assay 29 1 1 1 1 1 Assay 30 1 1 1 1 1 Assay 31 1 1 1 1 1 Assay 32 1 1 1 1 1 Assay 33 1 1 1 1 1 Assay 34 1 1 1 1 1 Assay 35 1 1 1 1 1 Assay 36 1 1 1 1 1 Assay 37 1 1 1 1 1 Assay 38 1 1 1 1 1 Assay 39 1 1 1 1 1 Assay 40 1 1 1 1 1 Assay 41 1 1 1 1 1 Assay 42 1 1 1 1 1 Assay 43 1 1 1 1 1 Assay 44 1 1 1 1 1 Assay 45 1 1 1 1 1 Assay 46 1 1 1 1 1 Assay 47 1 1 1 1 1 Assay 48 1 1 1 1 1 Assay 49 1 1 1 1 1 Assay 50 1 1 1 1 1 Assay 51 1 1 1 1 1 Assay 52 1 1 1 1 1 Assay 53 1 1 1 1 1 Assay 54 1 1 1 1 1 Assay 55 1 1 1 1 1 Assay 56 1 1 1 1 1 Assay 57 1 1 1 1 1 Samples by plate Click for more details Concentration SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 23 18 41 Assay 19 12 0 12 Assay 20 27 13 40 Assay 21 22 18 40 Assay 22 22 18 40 Assay 23 15 25 40 Assay 24 15 25 40 Assay 25 26 14 40 Assay 26 23 17 40 Assay 27 23 17 40 Assay 28 18 22 40 Assay 29 21 19 40 Assay 30 20 20 40 Assay 31 17 23 40 Assay 32 30 10 40 Assay 33 18 22 40 Assay 34 25 15 40 Assay 35 25 15 40 Assay 36 23 17 40 Assay 37 24 16 40 Assay 38 22 18 40 Assay 39 20 20 40 Assay 40 25 15 40 Assay 41 21 19 40 Assay 42 20 20 40 Assay 43 14 26 40 Assay 44 24 16 40 Assay 45 17 23 40 Assay 46 21 19 40 Assay 47 18 22 40 Assay 48 23 17 40 Assay 49 22 18 40 Assay 50 21 19 40 Assay 51 20 20 40 Assay 52 21 19 40 Assay 53 28 12 40 Assay 54 26 14 40 Assay 55 23 17 40 Assay 56 18 22 40 Assay 57 19 14 33 1.2.2 CV ## Inter-assay CV cv_dat &lt;- std_qc cv_dat$Group &lt;- as.factor(with(cv_dat,Standard.conc..pg.ml.)) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$Abs.Ave,x$Group,mean,na.tm=T))) cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) cv_intra &lt;- mean(samp_cv) Inter-assay CV = 20% from 57 assays. Intra-assay CV = 7.81% from 2243 sample measurements. 1.2.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate fit.4PL &lt;- function(x,a,b,g,d){return(d + ((a-d)/(1+((x/g)^b))))} #f1 &lt;- nls(Abs.ave ~ d + ((a-d)/(1+((Conc/g)^b))),data=std_ls[[1]],start=list(a=-1,b=1,g=5,d=2)) #std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit splines std_fit &lt;- lapply(1:length(std_ls),function(k){ #fit 4PL start_ls &lt;- list(a=floor(min(std_ls[[k]][,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)])), b=1,g=5, d=ceiling(max(std_ls[[k]][,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)]))) fit &lt;- NULL try(fit &lt;- nls(Abs.ave ~ fit.4PL(Conc,a,b,g,d),data=std_ls[[k]],start=start_ls),silent=T) if(is.null(fit)){fit &lt;- nlsLM(Abs.ave ~ fit.4PL(Conc,a,b,g,d),data=std_ls[[k]],start=start_ls)} return(fit)}) Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 57 1.2.4 Session info Results generated on: 2023-05-19 18:25:43.632262 Click for more details sessionInfo() ## R version 4.2.3 (2023-03-15) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils ## [8] datasets methods base ## ## other attached packages: ## [1] minpack.lm_1.2-3 nlme_3.1-162 widgetframe_0.3.1 fontawesome_0.5.1 ## [5] doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 plotly_4.10.1 ## [9] investr_1.4.2 readxl_1.4.2 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [13] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.5 ## [17] usethis_2.1.6 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [21] nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] fs_1.6.1 webshot_0.5.4 httr_1.4.5 tools_4.2.3 ## [5] profvis_0.3.7 bslib_0.4.2 utf8_1.2.3 R6_2.5.1 ## [9] lazyeval_0.2.2 colorspace_2.1-0 urlchecker_1.0.1 withr_2.5.0 ## [13] tidyselect_1.2.0 prettyunits_1.1.1 processx_3.8.1 compiler_4.2.3 ## [17] cli_3.6.1 rvest_1.0.3 xml2_1.3.3 bookdown_0.33 ## [21] sass_0.4.5 scales_1.2.1 callr_3.7.3 systemfonts_1.0.4 ## [25] stringr_1.5.0 digest_0.6.31 svglite_2.1.1 pkgconfig_2.0.3 ## [29] htmltools_0.5.5 sessioninfo_1.2.2 fastmap_1.1.1 highr_0.10 ## [33] rlang_1.1.0 rstudioapi_0.14 shiny_1.7.4 jquerylib_0.1.4 ## [37] generics_0.1.3 jsonlite_1.8.4 crosstalk_1.2.0 dplyr_1.1.2 ## [41] Rcpp_1.0.10 munsell_0.5.0 fansi_1.0.4 lifecycle_1.0.3 ## [45] stringi_1.7.12 yaml_2.3.7 pkgbuild_1.4.0 promises_1.2.0.1 ## [49] crayon_1.5.2 lattice_0.21-8 miniUI_0.1.1.1 ps_1.7.5 ## [53] pillar_1.9.0 codetools_0.2-19 pkgload_1.3.2 glue_1.6.2 ## [57] evaluate_0.20 data.table_1.14.8 remotes_2.4.2 vctrs_0.6.2 ## [61] httpuv_1.6.9 cellranger_1.1.0 gtable_0.3.3 purrr_1.0.1 ## [65] tidyr_1.3.0 cachem_1.0.7 xfun_0.39 mime_0.12 ## [69] xtable_1.8-4 later_1.3.0 viridisLite_0.4.1 tibble_3.2.1 ## [73] memoise_2.0.1 ellipsis_0.3.2 "],["gh2.html", "1.3 GH2", " 1.3 GH2 1.3.1 Data # standards std_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;GH2_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs standards only&quot;) #standards std_raw$Abs.ave &lt;- apply(std_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates std_raw$Abs.ave[std_raw$Abs.ave&lt; 1e-10] &lt;- 0 ## samples samp_raw &lt;- read_excel(file.path(&quot;..&quot;,&quot;data&quot;,&quot;hormones&quot;,&quot;GH2_absorbance_combined_20220728.xlsx&quot;),sheet=&quot;SL combined Abs samples&quot;) #samples samp_raw$Abs.ave &lt;- apply(samp_raw[,c(&quot;Abs 1&quot;,&quot;Abs 2&quot;)],1,mean,na.rm=T) #average replicates Standard concentration by plate Click for more details Concentration 0 78.125 156.25 312.5 625 1250 2500 5000 Assay 1 1 1 1 1 1 1 1 1 Assay 2 1 1 1 1 1 1 1 1 Assay 3 1 1 1 1 1 1 1 1 Assay 4 1 1 1 1 1 1 1 1 Assay 5 1 1 1 1 1 1 1 1 Assay 6 1 1 1 1 1 1 1 1 Assay 7 1 1 1 1 1 1 1 1 Assay 8 1 1 1 1 1 1 1 1 Assay 9 1 1 1 1 1 1 1 1 Assay 10 1 1 1 1 1 1 1 1 Assay 11 1 1 1 1 1 1 1 1 Assay 12 1 1 1 1 1 1 1 1 Assay 13 1 1 1 1 1 1 1 1 Assay 14 1 1 1 1 1 1 1 1 Assay 15 1 1 1 1 1 1 1 1 Assay 16 1 1 1 1 1 1 1 1 Assay 17 1 1 1 1 1 1 1 1 Assay 18 1 1 1 1 1 1 1 1 Assay 19 1 1 1 1 1 1 1 1 Assay 20 1 1 1 1 1 1 1 1 Assay 21 1 1 1 1 1 1 1 1 Assay 22 1 1 1 1 1 1 1 1 Assay 23 1 1 1 1 1 1 1 1 Assay 24 1 1 1 1 1 1 1 1 Assay 25 1 1 1 1 1 1 1 1 Assay 26 1 1 1 1 1 1 1 1 Assay 27 1 1 1 1 1 1 1 1 Assay 28 1 1 1 1 1 1 1 1 Assay 29 1 1 1 1 1 1 1 1 Assay 30 1 1 1 1 1 1 1 1 Assay 31 1 1 1 1 1 1 1 1 Assay 32 1 1 1 1 1 1 1 1 Assay 33 1 1 1 1 1 1 1 1 Assay 34 1 1 1 1 1 1 1 1 Assay 35 1 1 1 1 1 1 1 1 Assay 36 1 1 1 1 1 1 1 1 Assay 37 1 1 1 1 1 1 1 1 Assay 38 1 1 1 1 1 1 1 1 Assay 39 1 1 1 1 1 1 1 1 Assay 40 1 1 1 1 1 1 1 1 Assay 41 1 1 1 1 1 1 1 1 Assay 42 1 1 1 1 1 1 1 1 Assay 43 1 1 1 1 1 1 1 1 Assay 44 1 1 1 1 1 1 1 1 Assay 45 1 1 1 1 1 1 1 1 Assay 46 1 1 1 1 1 1 1 1 Assay 47 1 1 1 1 1 1 1 1 Assay 48 1 1 1 1 1 1 1 1 Assay 49 1 1 1 1 1 1 1 1 Assay 50 1 1 1 1 1 1 1 1 Assay 51 1 1 1 1 1 1 1 1 Assay 52 1 1 1 1 1 1 1 1 Assay 53 1 1 1 1 1 1 1 1 Assay 54 1 1 1 1 1 1 1 1 Assay 55 1 1 1 1 1 1 1 1 Assay 56 1 1 1 1 1 1 1 1 Assay 57 1 1 1 1 1 1 1 1 Assay 58 1 1 1 1 1 1 1 1 Assay 59 1 1 1 1 1 1 1 1 Samples by plate Click for more details Concentration SCOPE STOP Total Assay 1 39 0 39 Assay 2 5 35 40 Assay 3 5 35 40 Assay 4 5 34 39 Assay 5 5 35 40 Assay 6 5 34 39 Assay 7 5 35 40 Assay 8 5 35 40 Assay 9 5 35 40 Assay 10 5 35 40 Assay 11 4 36 40 Assay 12 4 36 40 Assay 13 4 36 40 Assay 14 4 36 40 Assay 15 4 36 40 Assay 16 4 36 40 Assay 17 4 36 40 Assay 18 0 16 16 Assay 19 38 2 40 Assay 20 22 18 40 Assay 21 20 20 40 Assay 22 27 13 40 Assay 23 22 18 40 Assay 24 22 18 40 Assay 25 15 25 40 Assay 26 15 25 40 Assay 27 26 14 40 Assay 28 23 17 40 Assay 29 23 17 40 Assay 30 18 22 40 Assay 31 21 19 40 Assay 32 20 20 40 Assay 33 17 23 40 Assay 34 30 10 40 Assay 35 18 22 40 Assay 36 25 15 40 Assay 37 25 15 40 Assay 38 23 17 40 Assay 39 24 16 40 Assay 40 22 18 40 Assay 41 20 20 40 Assay 42 25 15 40 Assay 43 21 19 40 Assay 44 20 20 40 Assay 45 14 26 40 Assay 46 24 16 40 Assay 47 17 23 40 Assay 48 21 19 40 Assay 49 18 22 40 Assay 50 23 17 40 Assay 51 22 18 40 Assay 52 21 19 40 Assay 53 20 20 40 Assay 54 21 19 40 Assay 55 28 12 40 Assay 56 26 14 40 Assay 57 23 17 40 Assay 58 18 22 40 Assay 59 19 14 33 1.3.2 CV ## Inter-assay CV cv_dat &lt;- std_raw[!std_raw$Assay%in%exc_plate,] cv_dat &lt;- std_raw cv_dat$Group &lt;- as.factor(with(cv_dat,get(conc_name))) assay_ls &lt;- split(cv_dat,cv_dat$Assay) cv_mean_dat &lt;- Reduce(rbind,lapply(assay_ls,function(x) tapply(x$&quot;Abs Ave&quot;,x$Group,mean,na.tm=T))) cv_mean &lt;- apply(cv_mean_dat,2,mean,na.rm=T) cv_sd &lt;- apply(cv_mean_dat,2,sd,na.rm=T) cv_gps &lt;- (cv_sd/cv_mean)*100 cv_gps[is.nan(cv_gps)] &lt;- 0 cv_inter &lt;- mean(cv_gps,na.rm=T) ## Intra-assay CV samp_cv &lt;- unlist(lapply(1:nrow(samp_raw),function(x){ tmp_dat &lt;- data.frame(samp_raw[x,]) tmp_mean &lt;- mean(as.numeric(tmp_dat[5:6])) tmp_sd &lt;- sd(as.numeric(tmp_dat[5:6])) return((tmp_sd/tmp_mean)*100)})) samp_cv[is.infinite(samp_cv)|samp_cv&lt;0] &lt;- NA cv_intra &lt;- mean(samp_cv,na.rm=T) Inter-assay CV = 15.24% from 59 assays. Intra-assay CV = 3.78% from 2326 sample measurements. Plate 22 (28-2-22) omitted due to invalid standard curve. 1.3.3 Standard curves std_ls &lt;- split(std_raw,std_raw$Assay) #split data by plate std_fit &lt;- lapply(1:length(std_ls),function(k){lm(Abs.ave ~ ns(Conc,df=3),data=std_ls[[k]])}) #fit model Plate 1 - 10 Plate 11 - 20 Plate 21 - 30 Plate 31 - 40 Plate 41 - 50 Plate 51 - 59 1.3.4 Session info Results generated on: 2023-05-19 18:25:43.677666 Click for more details sessionInfo() ## R version 4.2.3 (2023-03-15) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=C ## [9] LC_ADDRESS=C LC_TELEPHONE=C ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=C ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils ## [8] datasets methods base ## ## other attached packages: ## [1] minpack.lm_1.2-3 nlme_3.1-162 widgetframe_0.3.1 fontawesome_0.5.1 ## [5] doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 plotly_4.10.1 ## [9] investr_1.4.2 readxl_1.4.2 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [13] knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 devtools_2.4.5 ## [17] usethis_2.1.6 pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 ## [21] nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] fs_1.6.1 webshot_0.5.4 httr_1.4.5 tools_4.2.3 ## [5] profvis_0.3.7 bslib_0.4.2 utf8_1.2.3 R6_2.5.1 ## [9] lazyeval_0.2.2 colorspace_2.1-0 urlchecker_1.0.1 withr_2.5.0 ## [13] tidyselect_1.2.0 prettyunits_1.1.1 processx_3.8.1 compiler_4.2.3 ## [17] cli_3.6.1 rvest_1.0.3 xml2_1.3.3 bookdown_0.33 ## [21] sass_0.4.5 scales_1.2.1 callr_3.7.3 systemfonts_1.0.4 ## [25] stringr_1.5.0 digest_0.6.31 svglite_2.1.1 pkgconfig_2.0.3 ## [29] htmltools_0.5.5 sessioninfo_1.2.2 fastmap_1.1.1 highr_0.10 ## [33] rlang_1.1.0 rstudioapi_0.14 shiny_1.7.4 jquerylib_0.1.4 ## [37] generics_0.1.3 jsonlite_1.8.4 crosstalk_1.2.0 dplyr_1.1.2 ## [41] Rcpp_1.0.10 munsell_0.5.0 fansi_1.0.4 lifecycle_1.0.3 ## [45] stringi_1.7.12 yaml_2.3.7 pkgbuild_1.4.0 promises_1.2.0.1 ## [49] crayon_1.5.2 lattice_0.21-8 miniUI_0.1.1.1 ps_1.7.5 ## [53] pillar_1.9.0 codetools_0.2-19 pkgload_1.3.2 glue_1.6.2 ## [57] evaluate_0.20 data.table_1.14.8 remotes_2.4.2 vctrs_0.6.2 ## [61] httpuv_1.6.9 cellranger_1.1.0 gtable_0.3.3 purrr_1.0.1 ## [65] tidyr_1.3.0 cachem_1.0.7 xfun_0.39 mime_0.12 ## [69] xtable_1.8-4 later_1.3.0 viridisLite_0.4.1 tibble_3.2.1 ## [73] memoise_2.0.1 ellipsis_0.3.2 "],["plate-effect.html", "2 Plate Effect", " 2 Plate Effect This section explores the Plate effect on hormone levels. Outcomes: Prolactin, hPL, GH2 (all outcomes log-transformed) Independent variables: Plate + Study, BMI, GA at sampling Model fitted: LME model       log(hormones) ~ Plate + Study + BMI + GA at sampling       Random intercepts for Study ID There is evidence of a Plate effect and it will be adjusted for (as a random effect) in the analyses. "],["prolactin-1.html", "2.1 Prolactin", " 2.1 Prolactin Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 199.66141 1 &lt;0.0001 *** Assay.Prolactin 3242.32129 56 &lt;0.0001 *** Study 0.39792 1 0.5 ns BMI 20.34960 1 &lt;0.0001 *** GA_samp 243.34574 1 &lt;0.0001 *** 2.1.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 2.7029744 0.1912911 2699.476 14.1301595 &lt;0.0001 *** Assay.Prolactin1 0.1212429 0.1059894 2432.003 1.1439154 0.3 ns Assay.Prolactin2 -0.1778566 0.1164062 2644.382 -1.5278971 0.1 ns Assay.Prolactin3 0.0276810 0.1298168 2712.887 0.2132314 0.8 ns Assay.Prolactin4 0.6684824 0.1336746 2711.326 5.0008192 &lt;0.0001 *** Assay.Prolactin5 -2.7409455 0.1179895 2243.227 -23.2304142 &lt;0.0001 *** Assay.Prolactin6 0.6409714 0.1270956 2623.257 5.0432216 &lt;0.0001 *** Assay.Prolactin7 -0.1247035 0.1242381 2559.986 -1.0037455 0.3 ns Assay.Prolactin8 -0.0314571 0.1266782 2528.487 -0.2483227 0.8 ns Assay.Prolactin9 -0.0105195 0.1232303 2503.349 -0.0853644 0.9 ns Assay.Prolactin10 0.1684885 0.1273688 2629.966 1.3228396 0.2 ns Assay.Prolactin11 -0.1515120 0.1276569 2639.532 -1.1868684 0.2 ns Assay.Prolactin12 0.0851213 0.1324984 2702.232 0.6424328 0.5 ns Assay.Prolactin13 0.1201180 0.1242124 2510.966 0.9670369 0.3 ns Assay.Prolactin14 0.3695932 0.1201204 2438.010 3.0768571 0.002 ** Assay.Prolactin15 0.0363681 0.1199989 2386.639 0.3030705 0.8 ns Assay.Prolactin16 -0.1975497 0.1205968 2441.830 -1.6381006 0.1 ns Assay.Prolactin17 0.2384564 0.1186976 2352.060 2.0089403 0.04 * Assay.Prolactin18 -0.0096860 0.1191918 2397.717 -0.0812641 0.9 ns Assay.Prolactin19 -0.2778632 0.1327844 1795.499 -2.0925896 0.04 * Assay.Prolactin20 1.3669180 0.1168697 2375.834 11.6960823 &lt;0.0001 *** Assay.Prolactin21 0.2718832 0.1032018 2404.313 2.6344795 0.008 ** Assay.Prolactin22 -0.0736811 0.1147746 2665.747 -0.6419630 0.5 ns Assay.Prolactin23 0.6455957 0.1278116 2602.500 5.0511524 &lt;0.0001 *** Assay.Prolactin24 0.4746078 0.1293510 2658.915 3.6691463 0.0002 *** Assay.Prolactin25 0.2473075 0.1337241 2702.103 1.8493859 0.06 ns Assay.Prolactin26 -0.4426617 0.1308254 2707.453 -3.3836078 0.0007 *** Assay.Prolactin27 0.0793262 0.1311297 2706.948 0.6049448 0.5 ns Assay.Prolactin28 -0.0203714 0.1311472 2707.661 -0.1553320 0.9 ns Assay.Prolactin29 0.5754633 0.1308084 2698.094 4.3992841 &lt;0.0001 *** Assay.Prolactin30 0.1374354 0.1336598 2708.164 1.0282479 0.3 ns Assay.Prolactin31 0.7510783 0.1292684 2677.630 5.8102225 &lt;0.0001 *** Assay.Prolactin32 0.2829795 0.1298106 2693.328 2.1799418 0.03 * Assay.Prolactin33 0.2428402 0.1314159 2709.509 1.8478750 0.06 ns Assay.Prolactin34 -0.0032740 0.1281654 2623.648 -0.0255454 1.0 ns Assay.Prolactin35 0.0472200 0.1252984 2583.389 0.3768603 0.7 ns Assay.Prolactin36 -0.0709905 0.1336269 2702.845 -0.5312586 0.6 ns Assay.Prolactin37 -0.0405481 0.1316884 2710.312 -0.3079096 0.8 ns Assay.Prolactin38 0.2676561 0.1297542 2680.044 2.0627940 0.04 * Assay.Prolactin39 -0.1316890 0.1319063 2703.547 -0.9983530 0.3 ns Assay.Prolactin40 0.0215482 0.1290479 2701.244 0.1669785 0.9 ns Assay.Prolactin41 0.1862089 0.1337114 2703.047 1.3926175 0.2 ns Assay.Prolactin42 0.2115212 0.1270103 2640.916 1.6653859 0.10 ns Assay.Prolactin43 0.3240612 0.1332052 2712.017 2.4327970 0.02 * Assay.Prolactin44 0.0393886 0.1289286 2653.485 0.3055073 0.8 ns Assay.Prolactin45 0.1143590 0.1313129 2704.973 0.8708894 0.4 ns Assay.Prolactin46 0.0123467 0.1283756 2631.277 0.0961764 0.9 ns Assay.Prolactin47 -0.2727913 0.1324885 2711.041 -2.0589807 0.04 * Assay.Prolactin48 0.0159011 0.1312939 2699.744 0.1211109 0.9 ns Assay.Prolactin49 0.2076152 0.1333566 2710.643 1.5568428 0.1 ns Assay.Prolactin50 0.1781638 0.1281007 2644.721 1.3908105 0.2 ns Assay.Prolactin51 0.2760667 0.1314998 2708.357 2.0993701 0.04 * Assay.Prolactin52 -0.0623079 0.1305366 2691.379 -0.4773213 0.6 ns Assay.Prolactin54 0.2941893 0.1280834 2674.690 2.2968568 0.02 * Assay.Prolactin55 0.2087797 0.1280497 2674.447 1.6304584 0.1 ns Assay.Prolactin56 0.2677806 0.1346602 2684.107 1.9885660 0.05 ns Assay.Prolactin57 1.2168334 0.1401107 2695.656 8.6848013 &lt;0.0001 *** StudySTOP 0.0301960 0.0478687 2710.543 0.6308090 0.5 ns BMI -0.0089192 0.0019772 2628.076 -4.5110530 &lt;0.0001 *** GA_samp 0.1511183 0.0096874 2707.712 15.5995430 &lt;0.0001 *** 2.1.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Male Female Plate 1 (n=206) 0 (0.0) 206 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 206 (100.0) 0 (0.0) 92 (44.7) 114 (55.3) Plate 2 (n=86) 0 (0.0) 8 (9.3) 78 (90.7) 0 (0.0) 0 (0.0) 86 (100.0) 0 (0.0) 63 (73.3) 23 (26.7) Plate 3 (n=49) 0 (0.0) 5 (10.2) 44 (89.8) 0 (0.0) 0 (0.0) 49 (100.0) 0 (0.0) 29 (59.2) 20 (40.8) Plate 4 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 23 (53.5) 20 (46.5) Plate 5 (n=45) 0 (0.0) 5 (11.1) 40 (88.9) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 25 (55.6) 20 (44.4) Plate 6 (n=45) 0 (0.0) 5 (11.1) 40 (88.9) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 16 (35.6) 29 (64.4) Plate 7 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 34 (70.8) 14 (29.2) Plate 8 (n=40) 0 (0.0) 5 (12.5) 35 (87.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 9 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 27 (56.2) 21 (43.8) Plate 10 (n=44) 0 (0.0) 6 (13.6) 38 (86.4) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 11 (n=44) 0 (0.0) 4 (9.1) 40 (90.9) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 14 (31.8) 30 (68.2) Plate 12 (n=41) 0 (0.0) 4 (9.8) 37 (90.2) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 18 (43.9) 23 (56.1) Plate 13 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 23 (50.0) 23 (50.0) Plate 14 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 26 (52.0) 24 (48.0) Plate 15 (n=48) 0 (0.0) 4 (8.3) 44 (91.7) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 30 (62.5) 18 (37.5) Plate 16 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 1 (2.0) 26 (52.0) 23 (46.0) Plate 17 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 15 (30.0) 35 (70.0) Plate 18 (n=51) 0 (0.0) 27 (52.9) 24 (47.1) 0 (0.0) 17 (33.3) 34 (66.7) 0 (0.0) 24 (47.1) 27 (52.9) Plate 19 (n=24) 0 (0.0) 23 (95.8) 1 (4.2) 0 (0.0) 14 (58.3) 10 (41.7) 0 (0.0) 7 (29.2) 17 (70.8) Plate 20 (n=53) 0 (0.0) 15 (28.3) 38 (71.7) 0 (0.0) 0 (0.0) 53 (100.0) 0 (0.0) 34 (64.2) 19 (35.8) Plate 21 (n=130) 0 (0.0) 29 (22.3) 101 (77.7) 0 (0.0) 0 (0.0) 130 (100.0) 0 (0.0) 56 (43.1) 74 (56.9) Plate 22 (n=112) 0 (0.0) 44 (39.3) 68 (60.7) 0 (0.0) 0 (0.0) 112 (100.0) 0 (0.0) 72 (64.3) 40 (35.7) Plate 23 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 24 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 25 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 26 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 27 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 28 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 29 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 30 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 31 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 25 (62.5) 15 (37.5) Plate 32 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 33 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 34 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 35 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 36 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 37 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 38 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 39 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 40 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 41 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 42 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 43 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 44 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 45 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 46 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 23 (57.5) 16 (40.0) Plate 47 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 48 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 49 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 28 (60.9) 18 (39.1) Plate 50 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 51 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 53 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 54 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 22 (51.2) 21 (48.8) Plate 55 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 28 (65.1) 15 (34.9) Plate 56 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 57 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 17 (51.5) 13 (39.4) Plate Total (n=2776) 0 (0.0) 1201 (43.3) 1575 (56.7) 0 (0.0) 31 (1.1) 2745 (98.9) 5 (0.2) 1418 (51.1) 1353 (48.7) "],["hpl-1.html", "2.2 HPL", " 2.2 HPL Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 89.04744 1 &lt;0.0001 *** Assay.HPL 738.44227 56 &lt;0.0001 *** Study 12.65682 1 0.0004 *** BMI 281.91493 1 &lt;0.0001 *** GA_samp 3001.83025 1 &lt;0.0001 *** 2.2.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 0.9918178 0.1051045 2533.466 9.4364953 &lt;0.0001 *** Assay.HPL1 0.0921711 0.0606656 2625.550 1.5193305 0.1 ns Assay.HPL2 0.2305057 0.0664929 2693.257 3.4666206 0.0005 *** Assay.HPL3 0.0324389 0.0715481 2652.110 0.4533860 0.7 ns Assay.HPL4 0.0768561 0.0735279 2622.508 1.0452644 0.3 ns Assay.HPL5 0.1891226 0.0678734 2497.891 2.7864029 0.005 ** Assay.HPL6 0.2354691 0.0716632 2692.436 3.2857748 0.001 ** Assay.HPL7 -0.0648563 0.0703540 2693.768 -0.9218564 0.4 ns Assay.HPL8 0.2909962 0.0722893 2693.732 4.0254407 &lt;0.0001 *** Assay.HPL9 0.0574963 0.0703906 2690.741 0.8168175 0.4 ns Assay.HPL10 0.0977651 0.0719626 2689.477 1.3585548 0.2 ns Assay.HPL11 0.1245978 0.0718970 2684.512 1.7330032 0.08 ns Assay.HPL12 0.2577725 0.0734449 2646.439 3.5097395 0.0005 *** Assay.HPL13 0.3311287 0.0709268 2692.442 4.6685975 &lt;0.0001 *** Assay.HPL14 0.1470589 0.0691096 2677.509 2.1279094 0.03 * Assay.HPL15 0.1324150 0.0693577 2673.204 1.9091614 0.06 ns Assay.HPL16 0.2984871 0.0693148 2677.391 4.3062555 &lt;0.0001 *** Assay.HPL17 -0.0358695 0.0686740 2651.758 -0.5223152 0.6 ns Assay.HPL18 0.0544943 0.0644116 2626.621 0.8460317 0.4 ns Assay.HPL19 0.2686786 0.0990292 2143.426 2.7131257 0.007 ** Assay.HPL20 -0.2121390 0.0631995 2582.169 -3.3566574 0.0008 *** Assay.HPL21 -0.1312074 0.0586272 2671.829 -2.2379947 0.03 * Assay.HPL22 -0.0543114 0.0643441 2617.564 -0.8440767 0.4 ns Assay.HPL23 0.7437893 0.0723670 2692.466 10.2780225 &lt;0.0001 *** Assay.HPL24 0.0334058 0.0726732 2681.475 0.4596709 0.6 ns Assay.HPL25 0.6560953 0.0738694 2604.776 8.8818215 &lt;0.0001 *** Assay.HPL26 0.0799927 0.0740999 2660.203 1.0795247 0.3 ns Assay.HPL27 0.1095021 0.0728614 2653.404 1.5028829 0.1 ns Assay.HPL28 0.0196264 0.0728741 2653.324 0.2693193 0.8 ns Assay.HPL29 0.1805839 0.0728864 2659.331 2.4776074 0.01 * Assay.HPL30 -0.0553226 0.0734201 2586.721 -0.7535075 0.5 ns Assay.HPL31 0.1580722 0.0724168 2677.426 2.1828106 0.03 * Assay.HPL32 0.3118338 0.0724805 2669.127 4.3023152 &lt;0.0001 *** Assay.HPL33 0.1090237 0.0729327 2649.276 1.4948532 0.1 ns Assay.HPL34 0.1072198 0.0723386 2688.378 1.4821926 0.1 ns Assay.HPL35 -0.1816678 0.0711618 2693.932 -2.5528833 0.01 * Assay.HPL36 0.0570492 0.0733728 2604.436 0.7775243 0.4 ns Assay.HPL37 0.1132805 0.0730191 2643.142 1.5513835 0.1 ns Assay.HPL38 0.3106045 0.0726500 2674.769 4.2753557 &lt;0.0001 *** Assay.HPL39 0.1459116 0.0729377 2653.643 2.0004958 0.05 ns Assay.HPL40 0.0566781 0.0718851 2661.086 0.7884536 0.4 ns Assay.HPL41 0.1994536 0.0734263 2605.205 2.7163791 0.007 ** Assay.HPL42 -0.0677224 0.0715788 2687.222 -0.9461240 0.3 ns Assay.HPL43 0.2401154 0.0736095 2602.954 3.2620161 0.001 ** Assay.HPL44 0.1141842 0.0724814 2682.267 1.5753580 0.1 ns Assay.HPL45 0.1800752 0.0730007 2653.527 2.4667617 0.01 * Assay.HPL46 0.1009820 0.0725317 2681.930 1.3922466 0.2 ns Assay.HPL47 0.2556517 0.0734007 2635.412 3.4829610 0.0005 *** Assay.HPL48 0.1066926 0.0730994 2653.596 1.4595558 0.1 ns Assay.HPL49 -0.0254198 0.0733466 2592.945 -0.3465716 0.7 ns Assay.HPL50 0.1892451 0.0721640 2687.798 2.6224304 0.009 ** Assay.HPL51 0.1394344 0.0731642 2634.829 1.9057741 0.06 ns Assay.HPL52 0.1119099 0.0728747 2665.948 1.5356468 0.1 ns Assay.HPL54 0.3039624 0.0717702 2675.625 4.2352185 &lt;0.0001 *** Assay.HPL55 0.2546358 0.0717667 2676.413 3.5481031 0.0004 *** Assay.HPL56 0.0147899 0.0736068 2584.311 0.2009311 0.8 ns Assay.HPL57 0.0507690 0.0768536 2607.965 0.6605935 0.5 ns StudySTOP 0.0926816 0.0260514 2576.298 3.5576422 0.0004 *** BMI -0.0178690 0.0010642 2367.090 -16.7903227 &lt;0.0001 *** GA_samp 0.2925421 0.0053394 2549.329 54.7889611 &lt;0.0001 *** 2.2.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Male Female Plate 1 (n=106) 0 (0.0) 106 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 106 (100.0) 0 (0.0) 46 (43.4) 60 (56.6) Plate 2 (n=86) 0 (0.0) 8 (9.3) 78 (90.7) 0 (0.0) 0 (0.0) 86 (100.0) 0 (0.0) 63 (73.3) 23 (26.7) Plate 3 (n=48) 0 (0.0) 5 (10.4) 43 (89.6) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 28 (58.3) 20 (41.7) Plate 4 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 23 (53.5) 20 (46.5) Plate 5 (n=81) 0 (0.0) 8 (9.9) 73 (90.1) 0 (0.0) 0 (0.0) 81 (100.0) 0 (0.0) 47 (58.0) 34 (42.0) Plate 6 (n=44) 0 (0.0) 5 (11.4) 39 (88.6) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 15 (34.1) 29 (65.9) Plate 7 (n=47) 0 (0.0) 6 (12.8) 41 (87.2) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 32 (68.1) 15 (31.9) Plate 8 (n=41) 0 (0.0) 6 (14.6) 35 (85.4) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 19 (46.3) 22 (53.7) Plate 9 (n=48) 0 (0.0) 8 (16.7) 40 (83.3) 0 (0.0) 0 (0.0) 48 (100.0) 0 (0.0) 27 (56.2) 21 (43.8) Plate 10 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 20 (46.5) 23 (53.5) Plate 11 (n=44) 0 (0.0) 4 (9.1) 40 (90.9) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 14 (31.8) 30 (68.2) Plate 12 (n=42) 0 (0.0) 5 (11.9) 37 (88.1) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 19 (45.2) 23 (54.8) Plate 13 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 23 (50.0) 23 (50.0) Plate 14 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 0 (0.0) 26 (52.0) 24 (48.0) Plate 15 (n=49) 0 (0.0) 5 (10.2) 44 (89.8) 0 (0.0) 0 (0.0) 49 (100.0) 0 (0.0) 30 (61.2) 19 (38.8) Plate 16 (n=50) 0 (0.0) 4 (8.0) 46 (92.0) 0 (0.0) 0 (0.0) 50 (100.0) 1 (2.0) 26 (52.0) 23 (46.0) Plate 17 (n=51) 0 (0.0) 4 (7.8) 47 (92.2) 0 (0.0) 0 (0.0) 51 (100.0) 0 (0.0) 15 (29.4) 36 (70.6) Plate 18 (n=71) 0 (0.0) 46 (64.8) 25 (35.2) 0 (0.0) 14 (19.7) 57 (80.3) 0 (0.0) 25 (35.2) 46 (64.8) Plate 19 (n=13) 0 (0.0) 13 (100.0) 0 (0.0) 0 (0.0) 13 (100.0) 0 (0.0) 0 (0.0) 4 (30.8) 9 (69.2) Plate 20 (n=72) 0 (0.0) 50 (69.4) 22 (30.6) 0 (0.0) 0 (0.0) 72 (100.0) 0 (0.0) 42 (58.3) 30 (41.7) Plate 21 (n=162) 0 (0.0) 78 (48.1) 84 (51.9) 0 (0.0) 0 (0.0) 162 (100.0) 0 (0.0) 74 (45.7) 88 (54.3) Plate 22 (n=112) 0 (0.0) 44 (39.3) 68 (60.7) 0 (0.0) 0 (0.0) 112 (100.0) 0 (0.0) 72 (64.3) 40 (35.7) Plate 23 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 24 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 25 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 26 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 27 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 28 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 29 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 30 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 31 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 25 (62.5) 15 (37.5) Plate 32 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 33 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 34 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 35 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 36 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 37 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 38 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 39 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 40 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 41 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 42 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 43 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 44 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 45 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 46 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 23 (57.5) 16 (40.0) Plate 47 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 48 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 49 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 28 (60.9) 18 (39.1) Plate 50 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 51 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 53 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 54 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 22 (51.2) 21 (48.8) Plate 55 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 28 (65.1) 15 (34.9) Plate 56 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 57 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 17 (51.5) 13 (39.4) Plate Total (n=2772) 0 (0.0) 1197 (43.2) 1575 (56.8) 0 (0.0) 27 (1.0) 2745 (99.0) 5 (0.2) 1416 (51.1) 1351 (48.7) "],["gh2-1.html", "2.3 GH2", " 2.3 GH2 Plate 22 omitted due to invalid standard curve. Type III Sum of Squares Chisq Df Pr(&gt;Chisq) (Intercept) 212.579351 1 &lt;0.0001 *** Assay.GH2 228.193477 57 &lt;0.0001 *** Study 4.354346 1 0.04 * BMI 109.759740 1 &lt;0.0001 *** GA_samp 1154.337251 1 &lt;0.0001 *** 2.3.1 Model summary Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) -2.0852748 0.1430220 2582.496 -14.5801012 &lt;0.0001 *** Assay.GH21 -0.0791846 0.0837897 2525.783 -0.9450398 0.3 ns Assay.GH22 0.1754518 0.0903899 2634.047 1.9410538 0.05 ns Assay.GH23 0.2868065 0.0986797 2611.877 2.9064371 0.004 ** Assay.GH24 -0.0048460 0.1050752 2438.502 -0.0461189 1.0 ns Assay.GH25 0.1980649 0.0943090 2610.141 2.1001708 0.04 * Assay.GH26 0.2803362 0.0976512 2634.714 2.8707907 0.004 ** Assay.GH27 0.0989152 0.0950059 2602.154 1.0411480 0.3 ns Assay.GH28 -0.0810342 0.0973165 2610.799 -0.8326878 0.4 ns Assay.GH29 0.0634070 0.0945526 2587.036 0.6706003 0.5 ns Assay.GH210 -0.1162066 0.0994339 2636.863 -1.1686820 0.2 ns Assay.GH211 -0.1601729 0.0975028 2635.430 -1.6427510 0.1 ns Assay.GH212 -0.0603924 0.1011241 2609.689 -0.5972102 0.6 ns Assay.GH213 0.1146427 0.0958679 2610.351 1.1958399 0.2 ns Assay.GH214 0.2642879 0.0932988 2565.499 2.8327037 0.005 ** Assay.GH215 0.1451245 0.0937086 2575.083 1.5486792 0.1 ns Assay.GH216 0.1255673 0.0931174 2556.264 1.3484842 0.2 ns Assay.GH217 0.3126568 0.0924637 2539.728 3.3814022 0.0007 *** Assay.GH218 0.3073315 0.1247045 2637.952 2.4644781 0.01 * Assay.GH219 0.0798359 0.0908369 2308.265 0.8788927 0.4 ns Assay.GH220 -0.0715429 0.0892041 2582.031 -0.8020143 0.4 ns Assay.GH221 0.1159995 0.0818348 2553.780 1.4174827 0.2 ns Assay.GH223 0.1156668 0.0814530 2562.999 1.4200437 0.2 ns Assay.GH224 -0.0715429 0.0892041 2582.031 -0.8020143 0.4 ns Assay.GH225 0.3472763 0.0978500 2627.980 3.5490665 0.0004 *** Assay.GH226 0.0567823 0.0990734 2639.989 0.5731334 0.6 ns Assay.GH227 0.0386721 0.1019304 2567.883 0.3793975 0.7 ns Assay.GH228 0.0803651 0.1012572 2594.081 0.7936724 0.4 ns Assay.GH229 0.0381013 0.1005929 2630.209 0.3787673 0.7 ns Assay.GH230 -0.1241027 0.1001082 2626.523 -1.2396856 0.2 ns Assay.GH231 -0.0019059 0.0999963 2631.126 -0.0190602 1.0 ns Assay.GH232 0.2835346 0.1018710 2571.564 2.7832699 0.005 ** Assay.GH233 -0.0613889 0.1005350 2618.603 -0.6106217 0.5 ns Assay.GH234 0.0560195 0.1009235 2612.151 0.5550687 0.6 ns Assay.GH235 -0.0076636 0.0989012 2638.810 -0.0774879 0.9 ns Assay.GH236 0.2298988 0.0997097 2639.804 2.3056812 0.02 * Assay.GH237 0.1735538 0.0961543 2619.356 1.8049509 0.07 ns Assay.GH238 -0.0645211 0.1017993 2566.048 -0.6338064 0.5 ns Assay.GH239 -0.0706903 0.1007704 2613.399 -0.7014987 0.5 ns Assay.GH240 0.0480588 0.0993875 2638.649 0.4835499 0.6 ns Assay.GH241 -0.0688661 0.0987487 2639.995 -0.6973873 0.5 ns Assay.GH242 -0.0583906 0.0987406 2633.463 -0.5913532 0.6 ns Assay.GH243 -0.1163097 0.1017559 2568.225 -1.1430258 0.3 ns Assay.GH244 0.1624526 0.0972865 2637.584 1.6698366 0.10 ns Assay.GH245 0.2267436 0.1012045 2596.831 2.2404505 0.03 * Assay.GH246 -0.0126099 0.0989556 2639.895 -0.1274296 0.9 ns Assay.GH247 -0.0684904 0.1001997 2628.590 -0.6835389 0.5 ns Assay.GH248 0.0704647 0.0985888 2636.871 0.7147330 0.5 ns Assay.GH249 0.1156909 0.1011720 2614.499 1.1435066 0.3 ns Assay.GH250 0.0953516 0.1005831 2629.596 0.9479887 0.3 ns Assay.GH251 0.1946719 0.1015888 2587.762 1.9162727 0.06 ns Assay.GH252 -0.0969296 0.0997871 2634.971 -0.9713637 0.3 ns Assay.GH254 -0.0028326 0.0997500 2635.834 -0.0283965 1.0 ns Assay.GH255 -0.0164475 0.0987908 2638.169 -0.1664878 0.9 ns Assay.GH256 0.0426585 0.0980730 2639.719 0.4349666 0.7 ns Assay.GH257 0.2281709 0.0978808 2639.943 2.3311089 0.02 * Assay.GH258 0.0975326 0.1022645 2535.274 0.9537292 0.3 ns Assay.GH259 0.1453408 0.1081603 2495.146 1.3437527 0.2 ns StudySTOP -0.0754529 0.0361588 2632.840 -2.0867070 0.04 * BMI -0.0155536 0.0014846 2542.218 -10.4766283 &lt;0.0001 *** GA_samp 0.2526113 0.0074351 2610.748 33.9755390 &lt;0.0001 *** 2.3.2 Sample descriptives Study Timepoint Fetal sex Missing SCOPE STOP Missing 12wks 15wks Missing Male Female Plate 1 (n=91) 0 (0.0) 91 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 91 (100.0) 0 (0.0) 38 (41.8) 53 (58.2) Plate 2 (n=70) 0 (0.0) 8 (11.4) 62 (88.6) 0 (0.0) 0 (0.0) 70 (100.0) 0 (0.0) 49 (70.0) 21 (30.0) Plate 3 (n=47) 0 (0.0) 5 (10.6) 42 (89.4) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 29 (61.7) 18 (38.3) Plate 4 (n=42) 0 (0.0) 5 (11.9) 37 (88.1) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 23 (54.8) 19 (45.2) Plate 5 (n=79) 0 (0.0) 8 (10.1) 71 (89.9) 0 (0.0) 0 (0.0) 79 (100.0) 0 (0.0) 47 (59.5) 32 (40.5) Plate 6 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 16 (37.2) 27 (62.8) Plate 7 (n=45) 0 (0.0) 6 (13.3) 39 (86.7) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 30 (66.7) 15 (33.3) Plate 8 (n=41) 0 (0.0) 6 (14.6) 35 (85.4) 0 (0.0) 0 (0.0) 41 (100.0) 0 (0.0) 19 (46.3) 22 (53.7) Plate 9 (n=46) 0 (0.0) 8 (17.4) 38 (82.6) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 25 (54.3) 21 (45.7) Plate 10 (n=44) 0 (0.0) 6 (13.6) 38 (86.4) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 20 (45.5) 24 (54.5) Plate 11 (n=43) 0 (0.0) 4 (9.3) 39 (90.7) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 14 (32.6) 29 (67.4) Plate 12 (n=43) 0 (0.0) 5 (11.6) 38 (88.4) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 19 (44.2) 24 (55.8) Plate 13 (n=45) 0 (0.0) 4 (8.9) 41 (91.1) 0 (0.0) 0 (0.0) 45 (100.0) 0 (0.0) 24 (53.3) 21 (46.7) Plate 14 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 15 (n=47) 0 (0.0) 5 (10.6) 42 (89.4) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 28 (59.6) 19 (40.4) Plate 16 (n=46) 0 (0.0) 4 (8.7) 42 (91.3) 0 (0.0) 0 (0.0) 46 (100.0) 1 (2.2) 24 (52.2) 21 (45.7) Plate 17 (n=47) 0 (0.0) 4 (8.5) 43 (91.5) 0 (0.0) 0 (0.0) 47 (100.0) 0 (0.0) 15 (31.9) 32 (68.1) Plate 18 (n=20) 0 (0.0) 0 (0.0) 20 (100.0) 0 (0.0) 0 (0.0) 20 (100.0) 0 (0.0) 11 (55.0) 9 (45.0) Plate 19 (n=48) 0 (0.0) 43 (89.6) 5 (10.4) 0 (0.0) 35 (72.9) 13 (27.1) 0 (0.0) 21 (43.8) 27 (56.2) Plate 20 (n=64) 0 (0.0) 22 (34.4) 42 (65.6) 0 (0.0) 0 (0.0) 64 (100.0) 0 (0.0) 43 (67.2) 21 (32.8) Plate 21 (n=109) 0 (0.0) 55 (50.5) 54 (49.5) 0 (0.0) 0 (0.0) 109 (100.0) 0 (0.0) 44 (40.4) 65 (59.6) Plate 22 (n=72) 0 (0.0) 50 (69.4) 22 (30.6) 0 (0.0) 0 (0.0) 72 (100.0) 0 (0.0) 39 (54.2) 33 (45.8) Plate 23 (n=115) 0 (0.0) 61 (53.0) 54 (47.0) 0 (0.0) 0 (0.0) 115 (100.0) 0 (0.0) 50 (43.5) 65 (56.5) Plate 24 (n=64) 0 (0.0) 22 (34.4) 42 (65.6) 0 (0.0) 0 (0.0) 64 (100.0) 0 (0.0) 43 (67.2) 21 (32.8) Plate 25 (n=42) 0 (0.0) 15 (35.7) 27 (64.3) 0 (0.0) 0 (0.0) 42 (100.0) 0 (0.0) 21 (50.0) 21 (50.0) Plate 26 (n=40) 0 (0.0) 15 (37.5) 25 (62.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 28 (70.0) 12 (30.0) Plate 27 (n=40) 0 (0.0) 26 (65.0) 14 (35.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 28 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 29 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 30 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 31 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 32 (n=46) 0 (0.0) 26 (56.5) 20 (43.5) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 22 (47.8) 24 (52.2) Plate 33 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 25 (62.5) 15 (37.5) Plate 34 (n=40) 0 (0.0) 30 (75.0) 10 (25.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 35 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 23 (57.5) 17 (42.5) Plate 36 (n=40) 0 (0.0) 25 (62.5) 15 (37.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 37 (n=44) 0 (0.0) 29 (65.9) 15 (34.1) 0 (0.0) 0 (0.0) 44 (100.0) 0 (0.0) 24 (54.5) 20 (45.5) Plate 38 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 17 (42.5) 23 (57.5) Plate 39 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 21 (52.5) 19 (47.5) Plate 40 (n=40) 0 (0.0) 22 (55.0) 18 (45.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 41 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 42 (n=43) 0 (0.0) 28 (65.1) 15 (34.9) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 43 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 12 (30.0) 28 (70.0) Plate 44 (n=43) 0 (0.0) 23 (53.5) 20 (46.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 17 (39.5) 26 (60.5) Plate 45 (n=40) 0 (0.0) 14 (35.0) 26 (65.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 46 (n=40) 0 (0.0) 24 (60.0) 16 (40.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 19 (47.5) 21 (52.5) Plate 47 (n=40) 0 (0.0) 17 (42.5) 23 (57.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 48 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 1 (2.5) 23 (57.5) 16 (40.0) Plate 49 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 50 (n=40) 0 (0.0) 23 (57.5) 17 (42.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 24 (60.0) 16 (40.0) Plate 51 (n=46) 0 (0.0) 28 (60.9) 18 (39.1) 0 (0.0) 0 (0.0) 46 (100.0) 0 (0.0) 28 (60.9) 18 (39.1) Plate 52 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 13 (32.5) 27 (67.5) Plate 53 (n=40) 0 (0.0) 20 (50.0) 20 (50.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 54 (n=40) 0 (0.0) 21 (52.5) 19 (47.5) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 18 (45.0) 22 (55.0) Plate 55 (n=40) 0 (0.0) 28 (70.0) 12 (30.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 22 (55.0) 18 (45.0) Plate 56 (n=43) 0 (0.0) 29 (67.4) 14 (32.6) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 22 (51.2) 21 (48.8) Plate 57 (n=43) 0 (0.0) 26 (60.5) 17 (39.5) 0 (0.0) 0 (0.0) 43 (100.0) 0 (0.0) 28 (65.1) 15 (34.9) Plate 58 (n=40) 0 (0.0) 18 (45.0) 22 (55.0) 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 20 (50.0) 20 (50.0) Plate 59 (n=33) 0 (0.0) 19 (57.6) 14 (42.4) 0 (0.0) 0 (0.0) 33 (100.0) 3 (9.1) 17 (51.5) 13 (39.4) Plate Total (n=2780) 0 (0.0) 1205 (43.3) 1575 (56.7) 0 (0.0) 35 (1.3) 2745 (98.7) 5 (0.2) 1419 (51.0) 1356 (48.8) "],["session-info-3.html", "2.4 Session info", " 2.4 Session info Results generated on: 2023-05-19 18:25:48.985357 Click for more details sessionInfo() ## R version 4.3.0 (2023-04-21) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] grid stats graphics grDevices utils datasets methods ## [8] base ## ## other attached packages: ## [1] xlsx_0.6.5 plotly_4.10.1 geepack_1.3.9 lmerTest_3.1-3 ## [5] lme4_1.1-33 Matrix_1.5-1 ggpubr_0.6.0 emmeans_1.8.5 ## [9] car_3.1-2 carData_3.0-5 readxl_1.4.2 Hmisc_4.6-0 ## [13] Formula_1.2-4 survival_3.5-3 lattice_0.21-8 fontawesome_0.5.1 ## [17] htmlwidgets_1.6.2 kableExtra_1.3.4 knitr_1.42 rmarkdown_2.21 ## [21] ggplot2_3.4.2 devtools_2.4.3 usethis_2.1.5 pander_0.6.5 ## [25] magrittr_2.0.3 gridExtra_2.3 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.0 png_0.1-7 ## [7] systemfonts_1.0.4 callr_3.7.3 vctrs_0.6.2 ## [10] rvest_1.0.3 stringr_1.5.0 pkgconfig_2.0.3 ## [13] crayon_1.5.2 fastmap_1.1.1 backports_1.4.1 ## [16] ellipsis_0.3.2 labeling_0.4.2 utf8_1.2.3 ## [19] sessioninfo_1.2.2 nloptr_2.0.0 ps_1.7.5 ## [22] purrr_1.0.1 xfun_0.39 cachem_1.0.8 ## [25] jsonlite_1.8.4 highr_0.10 xlsxjars_0.6.1 ## [28] jpeg_0.1-9 broom_1.0.4 prettyunits_1.1.1 ## [31] cluster_2.1.4 R6_2.5.1 bslib_0.4.2 ## [34] stringi_1.7.12 RColorBrewer_1.1-3 boot_1.3-28 ## [37] pkgload_1.3.2 rpart_4.1.19 numDeriv_2016.8-1.1 ## [40] jquerylib_0.1.4 cellranger_1.1.0 estimability_1.4.1 ## [43] Rcpp_1.0.10 bookdown_0.34 zoo_1.8-9 ## [46] base64enc_0.1-3 splines_4.3.0 nnet_7.3-18 ## [49] tidyselect_1.2.0 rstudioapi_0.14 abind_1.4-5 ## [52] yaml_2.3.7 codetools_0.2-19 processx_3.8.1 ## [55] pkgbuild_1.4.0 tibble_3.2.1 withr_2.5.0 ## [58] coda_0.19-4 evaluate_0.21 foreign_0.8-82 ## [61] rJava_1.0-6 xml2_1.3.3 pillar_1.9.0 ## [64] checkmate_2.0.0 generics_0.1.3 munsell_0.5.0 ## [67] scales_1.2.1 minqa_1.2.4 xtable_1.8-4 ## [70] glue_1.6.2 lazyeval_0.2.2 tools_4.3.0 ## [73] data.table_1.14.8 webshot_0.5.4 ggsignif_0.6.4 ## [76] fs_1.6.2 mvtnorm_1.1-3 tidyr_1.3.0 ## [79] latticeExtra_0.6-29 colorspace_2.1-0 nlme_3.1-162 ## [82] htmlTable_2.4.0 cli_3.6.1 fansi_1.0.4 ## [85] viridisLite_0.4.2 svglite_2.1.0 dplyr_1.1.2 ## [88] gtable_0.3.3 rstatix_0.7.2 sass_0.4.6 ## [91] digest_0.6.31 TH.data_1.1-0 farver_2.1.1 ## [94] memoise_2.0.1 htmltools_0.5.5 lifecycle_1.0.3 ## [97] httr_1.4.2 MASS_7.3-59 "],["part-association-with-factors.html", "(PART*) Association with Factors", " (PART*) Association with Factors "],["descriptives.html", "3 Descriptives", " 3 Descriptives Descriptives on raw data. Tables in this page are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value PRL (ng/ml): Mean (SD) 187.6 (190.2) 105.4 (113.5) 138.9 (154.9) &lt;0.0001 hPL (μg/ml): Mean (SD) 183.6 (55.5) 74.1 (49.8) 119.3 (75.1) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.7 (2.8) 1.9 (1.6) 3.1 (2.6) &lt;0.0001 Insulin (uU/L): Mean (SD) 24.9 (28.9) 18.7 (26.3) 21.2 (27.6) &lt;0.0001 HOMA-IR: Mean (SD) 6.5 (8.4) 4.2 (7.2) 5.1 (7.8) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.5 (0.8) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 "],["by-study.html", "3.1 By Study", " 3.1 By Study 3.1.1 Demographics Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 26.0 (22.0-29.0) 25.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.02 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1140 (97.9) 1252 (96.3) 2392 (97.1) &gt;=35 24 (2.1) 48 (3.7) 72 (2.9) Maternal BMI: Median (IQ range) 25.6 (22.2-30.8) 26.3 (22.7-31.8) 25.9 (22.5-31.3) 0.006 Maternal BMI (category): N(%) 0.02 Missing 0 (0.0) 1 (0.1) 1 (0.0) &lt;20 122 (10.5) 95 (7.3) 217 (8.8) &gt;=20 to &lt;25 398 (34.2) 442 (34.0) 840 (34.1) &gt;=25 to &lt;30 322 (27.7) 361 (27.8) 683 (27.7) &gt;=30 to &lt;40 267 (22.9) 315 (24.2) 582 (23.6) &gt;=40 55 (4.7) 86 (6.6) 141 (5.7) SEI: Median (IQ range) 25.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-34.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 1067 (91.7) 1073 (82.5) 2140 (86.9) Maori 5 (0.4) 2 (0.2) 7 (0.3) Pacific Islander 1 (0.1) 4 (0.3) 5 (0.2) South East and Far East 42 (3.6) 66 (5.1) 108 (4.4) Indian 4 (0.3) 60 (4.6) 64 (2.6) African 4 (0.3) 23 (1.8) 27 (1.1) Middle-eastern 6 (0.5) 25 (1.9) 31 (1.3) Hispanic 0 (0.0) 5 (0.4) 5 (0.2) Aboriginal 23 (2.0) 24 (1.8) 47 (1.9) China and Japan 0 (0.0) 16 (1.2) 16 (0.6) Other 12 (1.0) 2 (0.2) 14 (0.6) Smoking: N(%) &lt;0.0001 Missing 0 (0.0) 7 (0.5) 7 (0.3) No 886 (76.1) 1077 (82.8) 1963 (79.7) Yes 278 (23.9) 216 (16.6) 494 (20.0) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 152 (11.7) 152 (6.2) None 251 (21.6) 97 (7.5) 348 (14.1) &lt;800 611 (52.5) 271 (20.8) 882 (35.8) &gt;=800 302 (25.9) 780 (60.0) 1082 (43.9) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 152 (11.7) 152 (6.2) None 251 (21.6) 97 (7.5) 348 (14.1) &lt;=400 116 (10.0) 15 (1.2) 131 (5.3) &gt;400 to &lt;800 495 (42.5) 256 (19.7) 751 (30.5) &gt;=800 302 (25.9) 780 (60.0) 1082 (43.9) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 16 (1.2) 16 (0.6) &lt;1-3x/month 117 (10.1) 95 (7.3) 212 (8.6) 1-6x/week 454 (39.0) 388 (29.8) 842 (34.2) &gt;=1-&lt;3x/day 410 (35.2) 639 (49.2) 1049 (42.6) &gt;=3x/day 183 (15.7) 162 (12.5) 345 (14.0) Leafy vege (1st trim): N(%) 0.004 Missing 0 (0.0) 17 (1.3) 17 (0.7) &lt;1-3x/month 113 (9.7) 143 (11.0) 256 (10.4) 1-2x/week 265 (22.8) 291 (22.4) 556 (22.6) 3-6x/week 474 (40.7) 440 (33.8) 914 (37.1) &gt;=1x/day 312 (26.8) 409 (31.5) 721 (29.3) Fast food (1st trim): N(%) &lt;0.0001 Missing 233 (20.0) 176 (13.5) 409 (16.6) Never 16 (1.4) 58 (4.5) 74 (3.0) &gt;0-&lt;2x/week 109 (9.4) 216 (16.6) 325 (13.2) &gt;=2-&lt;4x/week 479 (41.2) 501 (38.5) 980 (39.8) &gt;=4x/week 327 (28.1) 349 (26.8) 676 (27.4) Vigorous exercise: N(%) 0.45 Missing 3 (0.3) 12 (0.9) 15 (0.6) Never 755 (64.9) 809 (62.2) 1564 (63.5) Once a week 290 (24.9) 318 (24.5) 608 (24.7) 2-3/wk 87 (7.5) 119 (9.2) 206 (8.4) 4-6/wk 14 (1.2) 22 (1.7) 36 (1.5) Daily 12 (1.0) 18 (1.4) 30 (1.2) More than once a day 3 (0.3) 2 (0.2) 5 (0.2) Moderate exercise: N(%) 0.46 Missing 3 (0.3) 14 (1.1) 17 (0.7) Never 500 (43.0) 516 (39.7) 1016 (41.2) Once a week 302 (25.9) 334 (25.7) 636 (25.8) 2-3/wk 231 (19.8) 286 (22.0) 517 (21.0) 4-6/wk 53 (4.6) 64 (4.9) 117 (4.7) Daily 67 (5.8) 71 (5.5) 138 (5.6) More than once a day 8 (0.7) 15 (1.2) 23 (0.9) Recreational walking: N(%) 0.08 Missing 3 (0.3) 14 (1.1) 17 (0.7) Never 266 (22.9) 272 (20.9) 538 (21.8) Once a week 363 (31.2) 464 (35.7) 827 (33.6) 2-3/wk 309 (26.5) 313 (24.1) 622 (25.2) 4-6/wk 84 (7.2) 95 (7.3) 179 (7.3) Daily 113 (9.7) 126 (9.7) 239 (9.7) More than once a day 26 (2.2) 16 (1.2) 42 (1.7) Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.8) 40.5 (36.3-45.3) 39.1 (33.3-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.2) &lt;0.0001 B12 concentration (pM): Median (IQ range) 245.5 (195.0-309.0) 278.0 (218.0-356.0) 262.0 (206.0-337.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 143.1 (102.9-208.5) 152.6 (114.8-222.1) 148.8 (108.7-217.2) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.5 (24.1) 69.3 (25.5) 64.9 (25.2) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 603.3 (437.9-895.6) 628.1 (461.3-920.6) 620.6 (448.9-901.5) 0.05 Vitamin D: Median (IQ range) 57.6 (42.1-76.0) 61.0 (46.0-77.0) 59.6 (44.0-76.2) 0.009 UIC (ug/L): Median (IQ range) 107.2 (66.4-163.3) 202.5 (125.5-331.4) 159.3 (92.8-269.0) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.5) 0.14 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.4) 1.0 (0.7-1.4) 0.08 Haemoglobin (g/L): Mean (SD) 129.2 (9.3) 131.5 (9.6) 130.4 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 3.1.2 MetS Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value MetS: N(%) &lt;0.0001 Missing 11 (0.9) 92 (7.1) 103 (4.2) No 952 (81.8) 1100 (84.6) 2052 (83.3) Yes 201 (17.3) 108 (8.3) 309 (12.5) : Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-98.0) 82.0 (75.0-94.0) 85.0 (76.5-96.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.6 (0.8) 5.0 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.8) 1.1 (0.9-1.4) 1.2 (1.0-1.6) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.5 (0.8) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.1 (0.8) 2.5 (0.7) 2.7 (0.8) &lt;0.0001 : Mean (SD) 109.3 (10.3) 115.9 (10.6) 112.7 (11.0) &lt;0.0001 : Mean (SD) 64.5 (8.0) 70.7 (8.7) 67.7 (9.0) &lt;0.0001 : Mean (SD) 79.4 (7.8) 85.8 (8.4) 82.7 (8.7) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 3 (0.3) 28 (2.2) 31 (1.3) &lt;80 cm 307 (26.4) 528 (40.6) 835 (33.9) &gt;=80 cm 854 (73.4) 744 (57.2) 1598 (64.9) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 15 (1.2) 15 (0.6) &lt;1.7 mmol/L 828 (71.1) 1108 (85.2) 1936 (78.6) &gt;=1.7 mmol/L 336 (28.9) 177 (13.6) 513 (20.8) MetS criteria: HDL: N(%) 0.001 Missing 0 (0.0) 15 (1.2) 15 (0.6) &gt;=1.3 mmol/L 1036 (89.0) 1085 (83.5) 2121 (86.1) &lt;1.3 mmol/L 128 (11.0) 200 (15.4) 328 (13.3) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 10 (0.9) 15 (1.2) 25 (1.0) &lt;5.6 mmol/L 661 (56.8) 1184 (91.1) 1845 (74.9) &gt;=5.6 mmol/L 493 (42.4) 101 (7.8) 594 (24.1) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;130 mmHg 1127 (96.8) 1112 (85.5) 2239 (90.9) &gt;=130 mmHg 37 (3.2) 132 (10.2) 169 (6.9) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 56 (4.3) 56 (2.3) &lt;85 mmHg 1156 (99.3) 1169 (89.9) 2325 (94.4) &gt;=85 mmHg 8 (0.7) 75 (5.8) 83 (3.4) : Mean (SD) 0.0 (0.2) 0.1 (0.3) 0.1 (0.3) &lt;0.0001 CRP (mg/L): Median (IQ range) 4.9 (2.5-9.1) 3.4 (1.4-6.6) 4.0 (1.9-7.6) &lt;0.0001 3.1.3 Outcomes Characteristic SCOPE (n=1164) STOP (n=1300) Total (n=2464) P-value Birthweight (g): Median (IQ range) 3390.0 (3050.0-3730.0) 3390.0 (3039.0-3704.5) 3390.0 (3045.0-3720.0) 0.78 : Median (IQ range) 44.5 (20.8-71.0) 46.2 (23.3-73.6) 45.2 (22.0-72.4) 0.10 Baby sex: N(%) 0.18 Missing 6 (0.5) 17 (1.3) 23 (0.9) Male 567 (48.7) 664 (51.1) 1231 (50.0) Female 591 (50.8) 619 (47.6) 1210 (49.1) Mode of delivery: N(%) 0.02 Missing 6 (0.5) 16 (1.2) 22 (0.9) Unassisted vaginal 617 (53.0) 643 (49.5) 1260 (51.1) Operative vaginal 186 (16.0) 268 (20.6) 454 (18.4) Pre-labour LSCS 77 (6.6) 89 (6.8) 166 (6.7) LSCS in labour 278 (23.9) 284 (21.8) 562 (22.8) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) Induction of Labour: N(%) &lt;0.0001 Missing 7 (0.6) 0 (0.0) 7 (0.3) No 804 (69.1) 663 (51.0) 1467 (59.5) Yes 353 (30.3) 637 (49.0) 990 (40.2) PE vs Uncomplicated: N(%) 0.59 Missing 467 (40.1) 469 (36.1) 936 (38.0) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 93 (8.0) 120 (9.2) 213 (8.6) SPTB vs Uncomplicated: N(%) 0.14 Missing 491 (42.2) 528 (40.6) 1019 (41.4) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 69 (5.9) 61 (4.7) 130 (5.3) SGA vs Uncomplicted: N(%) 0.65 Missing 419 (36.0) 435 (33.5) 854 (34.7) No 604 (51.9) 710 (54.6) 1314 (53.3) Yes 141 (12.1) 155 (11.9) 296 (12.0) GDM vs Uncomplicated: N(%) &lt;0.0001 Missing 502 (43.1) 391 (30.1) 893 (36.2) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 58 (5.0) 198 (15.2) 256 (10.4) GHT vs Uncomplicated: N(%) 0.001 Missing 442 (38.0) 505 (38.8) 947 (38.4) No 604 (51.9) 711 (54.7) 1315 (53.4) Yes 118 (10.1) 84 (6.5) 202 (8.2) PE vs non-PE: N(%) 0.27 Missing 5 (0.4) 20 (1.5) 25 (1.0) No 1066 (91.6) 1160 (89.2) 2226 (90.3) Yes 93 (8.0) 120 (9.2) 213 (8.6) SPTB vs non-SPTB: N(%) 0.22 Missing 5 (0.4) 16 (1.2) 21 (0.9) No 1090 (93.6) 1223 (94.1) 2313 (93.9) Yes 69 (5.9) 61 (4.7) 130 (5.3) SGA vs non-SGA: N(%) 0.99 Missing 6 (0.5) 17 (1.3) 23 (0.9) No 1017 (87.4) 1128 (86.8) 2145 (87.1) Yes 141 (12.1) 155 (11.9) 296 (12.0) GDM vs non-GDM: N(%) &lt;0.0001 Missing 33 (2.8) 54 (4.2) 87 (3.5) No 1073 (92.2) 1048 (80.6) 2121 (86.1) Yes 58 (5.0) 198 (15.2) 256 (10.4) GHT vs non-GHT: N(%) 0.002 Missing 6 (0.5) 20 (1.5) 26 (1.1) No 1040 (89.3) 1196 (92.0) 2236 (90.7) Yes 118 (10.1) 84 (6.5) 202 (8.2) "],["folate-vs-fa-supplement.html", "3.2 Folate vs FA supplement", " 3.2 Folate vs FA supplement 3.2.1 FA supp (3 categories) Characteristic None (n=348) &lt;800 (n=882) &gt;=800 (n=1082) Total (n=2312) P-value Serum folate concentration (nM): Median (IQ range) 29.5 (20.4-36.4) 38.4 (32.2-43.8) 41.2 (36.9-56.8) 39.3 (33.3-44.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.7 (1.2) 4.7 (1.0) 4.7 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 246.0 (192.0-302.5) 254.0 (200.0-326.8) 275.0 (217.0-355.0) 262.0 (205.0-337.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.2 (24.2) 63.1 (25.7) 68.5 (24.8) 65.1 (25.3) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 117.0 (78.4-165.1) 150.8 (112.0-219.6) 158.8 (117.9-237.3) 149.8 (109.0-218.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 478.0 (331.8-675.2) 628.6 (471.7-924.4) 653.3 (481.0-1012.1) 619.3 (447.8-913.0) &lt;0.0001 Vitamin D: Median (IQ range) 52.6 (39.3-69.0) 58.0 (42.5-75.7) 63.5 (47.9-79.0) 60.0 (44.0-76.7) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=251) &lt;800 (n=611) &gt;=800 (n=302) Total (n=1164) P-value Serum folate concentration (nM): Median (IQ range) 25.6 (17.5-33.3) 37.3 (30.2-43.2) 40.0 (34.8-48.7) 36.0 (28.2-42.8) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (179.0-291.0) 250.0 (198.0-319.0) 249.5 (198.8-310.2) 245.5 (195.0-309.0) 0.002 Active B12 concentration (pM): Mean (SD) 55.9 (22.2) 60.0 (24.3) 65.4 (24.6) 60.5 (24.1) 0.002 Folate:B12 ratio: Median (IQ range) 108.4 (72.7-157.7) 143.2 (108.4-208.8) 167.7 (119.7-253.8) 143.1 (102.9-208.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (332.7-708.0) 632.8 (476.9-923.9) 650.8 (489.9-1074.3) 603.3 (437.9-895.6) &lt;0.0001 Vitamin D: Median (IQ range) 51.7 (38.9-68.5) 55.3 (40.2-74.2) 67.7 (50.9-83.4) 57.6 (42.1-76.0) &lt;0.0001 Click here for table within STOP Characteristic None (n=97) &lt;800 (n=271) &gt;=800 (n=780) Total (n=1148) P-value Serum folate concentration (nM): Median (IQ range) 36.6 (30.5-41.2) 40.4 (35.5-54.4) 41.5 (37.6-58.0) 40.9 (36.7-54.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.3 (1.4) 5.1 (1.3) 4.8 (1.0) 4.9 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 279.0 (217.0-339.0) 266.0 (205.0-345.0) 282.0 (226.0-370.0) 279.0 (220.0-361.5) 0.007 Active B12 concentration (pM): Mean (SD) 74.2 (25.3) 70.8 (27.8) 69.8 (24.8) 70.4 (25.6) 0.55 Folate:B12 ratio: Median (IQ range) 132.7 (101.4-193.7) 166.7 (121.1-234.6) 155.4 (116.7-227.8) 154.9 (116.2-227.9) 0.003 Folate:Active B12 ratio: Median (IQ range) 518.7 (336.7-647.2) 622.1 (460.9-916.9) 658.3 (472.2-979.9) 627.4 (460.1-939.8) 0.001 Vitamin D: Median (IQ range) 57.0 (43.0-69.5) 64.0 (48.0-80.0) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.04 3.2.2 FA supp (4 categories) Characteristic None (n=348) &lt;=400 (n=131) &gt;400 to &lt;800 (n=751) &gt;=800 (n=1082) Total (n=2312) P-value Serum folate concentration (nM): Median (IQ range) 29.5 (20.4-36.4) 36.3 (28.6-42.7) 38.8 (33.0-44.0) 41.2 (36.9-56.8) 39.3 (33.3-44.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.6 (1.0) 4.7 (1.2) 4.7 (1.0) 4.7 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 246.0 (192.0-302.5) 260.0 (200.8-347.5) 254.0 (200.0-322.0) 275.0 (217.0-355.0) 262.0 (205.0-337.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.2 (24.2) 62.3 (27.2) 63.2 (25.5) 68.5 (24.8) 65.1 (25.3) 0.0002 Folate:B12 ratio: Median (IQ range) 117.0 (78.4-165.1) 135.4 (106.9-185.3) 154.9 (113.5-225.5) 158.8 (117.9-237.3) 149.8 (109.0-218.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 478.0 (331.8-675.2) 540.9 (429.0-882.4) 638.0 (476.3-938.6) 653.3 (481.0-1012.1) 619.3 (447.8-913.0) &lt;0.0001 Vitamin D: Median (IQ range) 52.6 (39.3-69.0) 50.1 (37.1-69.1) 58.9 (43.7-77.0) 63.5 (47.9-79.0) 60.0 (44.0-76.7) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=251) &lt;=400 (n=116) &gt;400 to &lt;800 (n=495) &gt;=800 (n=302) Total (n=1164) P-value Serum folate concentration (nM): Median (IQ range) 25.6 (17.5-33.3) 35.5 (27.8-41.6) 37.5 (30.9-43.5) 40.0 (34.8-48.7) 36.0 (28.2-42.8) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (179.0-291.0) 251.0 (201.0-339.0) 248.5 (198.0-311.5) 249.5 (198.8-310.2) 245.5 (195.0-309.0) 0.002 Active B12 concentration (pM): Mean (SD) 55.9 (22.2) 62.1 (28.3) 59.6 (23.4) 65.4 (24.6) 60.5 (24.1) 0.005 Folate:B12 ratio: Median (IQ range) 108.4 (72.7-157.7) 132.4 (105.5-179.9) 146.7 (111.8-219.3) 167.7 (119.7-253.8) 143.1 (102.9-208.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (332.7-708.0) 537.9 (410.4-891.6) 641.2 (484.9-967.9) 650.8 (489.9-1074.3) 603.3 (437.9-895.6) &lt;0.0001 Vitamin D: Median (IQ range) 51.7 (38.9-68.5) 49.0 (35.5-65.2) 56.6 (41.6-75.6) 67.7 (50.9-83.4) 57.6 (42.1-76.0) &lt;0.0001 Click here for table within STOP Characteristic None (n=97) &lt;=400 (n=15) &gt;400 to &lt;800 (n=256) &gt;=800 (n=780) Total (n=1148) P-value Serum folate concentration (nM): Median (IQ range) 36.6 (30.5-41.2) 43.0 (39.8-57.2) 40.1 (35.5-49.5) 41.5 (37.6-58.0) 40.9 (36.7-54.3) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.3 (1.4) 5.0 (0.9) 5.1 (1.3) 4.8 (1.0) 4.9 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 279.0 (217.0-339.0) 276.0 (203.5-360.5) 265.0 (205.8-343.2) 282.0 (226.0-370.0) 279.0 (220.0-361.5) 0.02 Active B12 concentration (pM): Mean (SD) 74.2 (25.3) 63.7 (17.7) 71.2 (28.3) 69.8 (24.8) 70.4 (25.6) 0.62 Folate:B12 ratio: Median (IQ range) 132.7 (101.4-193.7) 180.2 (141.2-214.2) 166.1 (119.0-236.7) 155.4 (116.7-227.8) 154.9 (116.2-227.9) 0.007 Folate:Active B12 ratio: Median (IQ range) 518.7 (336.7-647.2) 794.6 (550.8-848.5) 620.0 (455.9-931.1) 658.3 (472.2-979.9) 627.4 (460.1-939.8) 0.003 Vitamin D: Median (IQ range) 57.0 (43.0-69.5) 68.0 (53.5-94.0) 63.0 (48.0-79.8) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.06 "],["fa-supp-3-categories-1.html", "4 FA supp: 3 categories", " 4 FA supp: 3 categories Characteristic None (n=341) &lt;800 (n=872) &gt;=800 (n=1067) Total (n=2280) P-value Prolactin: Median (IQ range) 132.0 (81.5-215.5) 117.9 (72.2-183.5) 82.1 (51.0-137.3) 100.4 (58.8-166.0) &lt;0.0001 HPL: Median (IQ range) 158.4 (106.8-201.2) 153.0 (78.1-195.9) 73.4 (43.9-137.4) 113.0 (55.1-179.2) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.3-5.2) 3.3 (1.8-4.7) 1.7 (1.0-3.3) 2.6 (1.3-4.2) &lt;0.0001 LME for duplicated or repeated measures shown on next page. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod)}) ## Warning in checkConv(attr(opt, &quot;derivs&quot;), opt$par, ctrl = control$checkConv, : ## Model failed to converge with max|grad| = 0.00274069 (tol = 0.002, component 1) mod_em &lt;- foreach(ind1=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} mod_em2 &lt;- foreach(ind2=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-2.html", "4.1 Prolactin", " 4.1 Prolactin cat(&quot;\\n&lt;b&gt;Model summary&lt;/b&gt;\\n&quot;) Model summary mod_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Var Effect P (Intercept) 14.57 (10.03, 21.16) &lt;0.0001 folate_cat2&lt;800 1.01 (0.90, 1.12) 0.91 folate_cat2&gt;=800 1.07 (0.95, 1.21) 0.29 StudySTOP 1.16 (0.97, 1.39) 0.10 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.97 (0.80, 1.17) 0.73 folate_cat2&gt;=800:StudySTOP 0.77 (0.64, 0.93) 0.007 cat(&quot;\\n&lt;b&gt;Estimated marginal means&lt;/b&gt;\\n&quot;) Estimated marginal means mod_em_est[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 97.37 8.20 138.81 82.44 115.01 &lt;800 SCOPE 97.96 7.54 97.46 84.09 114.12 &gt;=800 SCOPE 104.03 8.54 125.69 88.43 122.38 None STOP 113.04 10.81 226.18 93.62 136.48 &lt;800 STOP 110.07 8.78 112.16 93.99 128.91 &gt;=800 STOP 93.49 6.84 79.86 80.82 108.14 if(!any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=lower.CL,ymax=upper.CL,group=Study,color=Study))} if(any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=asymp.LCL,ymax=asymp.UCL,group=Study,color=Study))} p1 &lt;- p1 + geom_pointrange(size=0.7,position=position_dodge(width=0.2)) + geom_errorbar(width=0.08,linewidth=1,position=position_dodge(width=0.2))+ scale_y_continuous(limits=c(0,NA),expand=expansion(mult=c(0,0.1))) + labs(title=&quot;Estimated marginal means (95% CI)&quot;,x=dat_labels[fvarc],y=dat_labels[varc]) + theme_bw() + theme(axis.title=element_text(size=16,face=&quot;bold&quot;),axis.text=element_text(color=&quot;black&quot;,size=14), plot.title=element_text(face=&quot;bold&quot;,color=&quot;black&quot;,size=14), panel.grid.major.x=element_blank(), legend.position=&quot;bottom&quot;,legend.title=element_text(size=15,face=&quot;bold&quot;),legend.text=element_text(size=14)) print(p1) cat(&quot;\\n\\n\\n&lt;br /&gt;&lt;b&gt;Post-hoc comparisons&lt;/b&gt;&lt;br /&gt;\\n&quot;) Post-hoc comparisons mod_em_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.01 (0.89, 1.14) 1.0 &gt;=800 / None Study: SCOPE 1.07 (0.92, 1.24) 0.5 &gt;=800 / &lt;800 Study: SCOPE 1.06 (0.94, 1.20) 0.5 &lt;800 / None Study: STOP 0.97 (0.81, 1.17) 0.9 &gt;=800 / None Study: STOP 0.83 (0.70, 0.98) 0.02 &gt;=800 / &lt;800 Study: STOP 0.85 (0.76, 0.95) 0.002 STOP / SCOPE Folic acid supplement (μg): None 1.16 (0.97, 1.39) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.12 (0.98, 1.28) 0.09 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.90 (0.79, 1.03) 0.1 "],["hpl-2.html", "4.2 HPL", " 4.2 HPL Model summary Var Effect P (Intercept) 1.98 (1.62, 2.41) &lt;0.0001 folate_cat2&lt;800 0.98 (0.93, 1.04) 0.60 folate_cat2&gt;=800 0.99 (0.93, 1.06) 0.85 StudySTOP 1.13 (1.03, 1.25) 0.01 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.98 (0.89, 1.09) 0.71 folate_cat2&gt;=800:StudySTOP 0.96 (0.87, 1.06) 0.43 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 93.46 3.18 398.87 87.42 99.93 &lt;800 SCOPE 92.01 2.60 202.09 87.03 97.28 &gt;=800 SCOPE 92.87 2.98 323.74 87.18 98.92 None STOP 105.80 4.49 799.43 97.34 115.00 &lt;800 STOP 102.18 3.20 293.39 96.07 108.67 &gt;=800 STOP 100.92 2.60 141.12 95.91 106.20 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.98 (0.92, 1.06) 0.9 &gt;=800 / None Study: SCOPE 0.99 (0.92, 1.08) 1.0 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.95, 1.08) 0.9 &lt;800 / None Study: STOP 0.97 (0.87, 1.07) 0.7 &gt;=800 / None Study: STOP 0.95 (0.87, 1.05) 0.5 &gt;=800 / &lt;800 Study: STOP 0.99 (0.93, 1.05) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.13 (1.03, 1.25) 0.01 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.11 (1.03, 1.19) 0.005 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.09 (1.01, 1.17) 0.02 "],["gh2-2.html", "4.3 GH2", " 4.3 GH2 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.11) &lt;0.0001 folate_cat2&lt;800 0.99 (0.91, 1.07) 0.71 folate_cat2&gt;=800 1.04 (0.95, 1.14) 0.37 StudySTOP 1.11 (0.97, 1.26) 0.14 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.86 (0.75, 0.99) 0.04 folate_cat2&gt;=800:StudySTOP 0.82 (0.72, 0.95) 0.007 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2.44 0.10 1139.06 2.26 2.64 &lt;800 SCOPE 2.40 0.07 579.26 2.26 2.55 &gt;=800 SCOPE 2.54 0.10 972.81 2.36 2.74 None STOP 2.70 0.14 1729.12 2.43 3.00 &lt;800 STOP 2.30 0.08 873.62 2.14 2.46 &gt;=800 STOP 2.31 0.06 348.38 2.20 2.44 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.99 (0.90, 1.08) 0.9 &gt;=800 / None Study: SCOPE 1.04 (0.93, 1.16) 0.6 &gt;=800 / &lt;800 Study: SCOPE 1.06 (0.97, 1.16) 0.3 &lt;800 / None Study: STOP 0.85 (0.74, 0.98) 0.02 &gt;=800 / None Study: STOP 0.86 (0.76, 0.97) 0.01 &gt;=800 / &lt;800 Study: STOP 1.01 (0.93, 1.09) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.11 (0.97, 1.26) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.96 (0.87, 1.05) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.91 (0.83, 1.00) 0.06 "],["insulin.html", "4.4 Insulin", " 4.4 Insulin Model summary Var Effect P (Intercept) 11.61 (7.07, 19.05) &lt;0.0001 folate_cat2&lt;800 0.96 (0.82, 1.14) 0.67 folate_cat2&gt;=800 0.97 (0.81, 1.17) 0.75 StudySTOP 0.80 (0.62, 1.03) 0.08 GA_samp 1.02 (0.99, 1.05) 0.21 folate_cat2&lt;800:StudySTOP 1.09 (0.83, 1.44) 0.54 folate_cat2&gt;=800:StudySTOP 1.02 (0.77, 1.34) 0.90 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 15.09 1.13 Inf 13.03 17.49 &lt;800 SCOPE 14.56 0.88 Inf 12.93 16.39 &gt;=800 SCOPE 14.64 1.09 Inf 12.65 16.95 None STOP 12.04 1.21 Inf 9.89 14.66 &lt;800 STOP 12.66 0.81 Inf 11.17 14.35 &gt;=800 STOP 11.90 0.54 Inf 10.89 13.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.96 (0.79, 1.17) 0.9 &gt;=800 / None Study: SCOPE 0.97 (0.78, 1.21) 0.9 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.83, 1.22) 1.0 &lt;800 / None Study: STOP 1.05 (0.80, 1.37) 0.9 &gt;=800 / None Study: STOP 0.99 (0.77, 1.26) 1.0 &gt;=800 / &lt;800 Study: STOP 0.94 (0.81, 1.10) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.80 (0.62, 1.03) 0.08 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.87 (0.72, 1.06) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.81 (0.67, 0.99) 0.04 "],["homa-ir.html", "4.5 HOMA-IR", " 4.5 HOMA-IR Model summary Var Effect P (Intercept) 2.97 (1.76, 5.01) &lt;0.0001 folate_cat2&lt;800 0.97 (0.81, 1.15) 0.70 folate_cat2&gt;=800 0.97 (0.80, 1.19) 0.80 StudySTOP 0.69 (0.52, 0.90) 0.007 GA_samp 1.02 (0.98, 1.05) 0.34 folate_cat2&lt;800:StudySTOP 1.09 (0.81, 1.46) 0.58 folate_cat2&gt;=800:StudySTOP 1.01 (0.75, 1.36) 0.93 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 3.66 0.29 Inf 3.13 4.28 &lt;800 SCOPE 3.54 0.23 Inf 3.12 4.01 &gt;=800 SCOPE 3.57 0.29 Inf 3.05 4.18 None STOP 2.52 0.27 Inf 2.04 3.11 &lt;800 STOP 2.65 0.18 Inf 2.32 3.03 &gt;=800 STOP 2.49 0.12 Inf 2.27 2.74 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.97 (0.78, 1.19) 0.9 &gt;=800 / None Study: SCOPE 0.97 (0.77, 1.24) 1.0 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.82, 1.24) 1.0 &lt;800 / None Study: STOP 1.05 (0.79, 1.40) 0.9 &gt;=800 / None Study: STOP 0.99 (0.76, 1.28) 1.0 &gt;=800 / &lt;800 Study: STOP 0.94 (0.80, 1.11) 0.6 STOP / SCOPE Folic acid supplement (μg): None 0.69 (0.52, 0.90) 0.007 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.75 (0.61, 0.92) 0.006 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.70 (0.57, 0.86) 0.0007 "],["glucose.html", "4.6 Glucose", " 4.6 Glucose Model summary Var Effect P (Intercept) 5.50 (4.96, 6.11) &lt;0.0001 folate_cat2&lt;800 1.04 (1.00, 1.08) 0.03 folate_cat2&gt;=800 1.03 (1.00, 1.08) 0.09 StudySTOP 0.90 (0.85, 0.94) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.47 folate_cat2&lt;800:StudySTOP 0.95 (0.90, 1.01) 0.11 folate_cat2&gt;=800:StudySTOP 0.96 (0.91, 1.01) 0.08 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.33 0.08 Inf 5.17 5.49 &lt;800 SCOPE 5.55 0.07 Inf 5.42 5.69 &gt;=800 SCOPE 5.52 0.08 Inf 5.35 5.68 None STOP 4.78 0.08 Inf 4.62 4.95 &lt;800 STOP 4.76 0.08 Inf 4.61 4.91 &gt;=800 STOP 4.73 0.04 Inf 4.65 4.81 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.04 (1.00, 1.09) 0.08 &gt;=800 / None Study: SCOPE 1.03 (0.99, 1.08) 0.2 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.95, 1.04) 0.9 &lt;800 / None Study: STOP 0.99 (0.94, 1.05) 1.0 &gt;=800 / None Study: STOP 0.99 (0.95, 1.03) 0.8 &gt;=800 / &lt;800 Study: STOP 0.99 (0.96, 1.03) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.90 (0.85, 0.94) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.86 (0.82, 0.89) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.83, 0.89) &lt;0.0001 "],["fa-supp-4-categories-1.html", "5 FA supp: 4 categories", " 5 FA supp: 4 categories Characteristic None (n=341) &lt;=400 (n=131) &gt;400 to &lt;800 (n=741) &gt;=800 (n=1067) Total (n=2280) P-value Prolactin: Median (IQ range) 132.0 (81.5-215.5) 128.5 (84.7-209.4) 112.4 (70.9-178.5) 82.1 (51.0-137.3) 100.4 (58.8-166.0) &lt;0.0001 HPL: Median (IQ range) 158.4 (106.8-201.2) 171.8 (128.8-205.8) 145.8 (71.1-195.0) 73.4 (43.9-137.4) 113.0 (55.1-179.2) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.3-5.2) 4.0 (3.0-5.7) 3.2 (1.6-4.5) 1.7 (1.0-3.3) 2.6 (1.3-4.2) &lt;0.0001 Insulin: Mean (SD) 22.6 (28.9) 26.2 (31.7) 22.9 (29.0) 19.8 (25.7) 21.5 (27.6) 0.03 HOMA.IR: Mean (SD) 5.6 (8.5) 7.0 (10.0) 5.6 (7.8) 4.7 (7.6) 5.3 (8.0) 0.009 GLUC3_mmol.L: Mean (SD) 5.2 (0.8) 5.4 (0.9) 5.3 (0.8) 5.0 (0.8) 5.1 (0.8) &lt;0.0001 LME or GEE for duplicated or repeated measures. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-3.html", "5.1 Prolactin", " 5.1 Prolactin Model summary Var Effect P (Intercept) 14.58 (10.03, 21.18) &lt;0.0001 folate_cat3&lt;=400 1.05 (0.90, 1.22) 0.55 folate_cat3&gt;400 to &lt;800 0.99 (0.89, 1.11) 0.93 folate_cat3&gt;=800 1.07 (0.95, 1.21) 0.29 StudySTOP 1.16 (0.97, 1.39) 0.10 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.93 (0.63, 1.37) 0.71 folate_cat3&gt;400 to &lt;800:StudySTOP 0.98 (0.81, 1.18) 0.83 folate_cat3&gt;=800:StudySTOP 0.77 (0.64, 0.93) 0.008 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 97.41 8.21 138.89 82.47 115.07 &lt;=400 SCOPE 102.11 9.81 228.75 84.49 123.39 &gt;400 to &lt;800 SCOPE 96.90 7.60 105.10 82.94 113.21 &gt;=800 SCOPE 104.05 8.54 125.72 88.45 122.42 None STOP 113.02 10.81 226.16 93.61 136.47 &lt;=400 STOP 110.03 20.16 1395.91 76.81 157.61 &gt;400 to &lt;800 STOP 110.05 8.83 114.63 93.88 129.00 &gt;=800 STOP 93.51 6.84 79.88 80.83 108.17 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.05 (0.86, 1.28) 0.9 &gt;400 to &lt;800 / None Study: SCOPE 0.99 (0.86, 1.15) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.95 (0.79, 1.14) 0.9 &gt;=800 / None Study: SCOPE 1.07 (0.91, 1.25) 0.7 &gt;=800 / &lt;=400 Study: SCOPE 1.02 (0.84, 1.24) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.07 (0.93, 1.23) 0.6 &lt;=400 / None Study: STOP 0.97 (0.61, 1.55) 1.0 &gt;400 to &lt;800 / None Study: STOP 0.97 (0.79, 1.19) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.00 (0.64, 1.56) 1.0 &gt;=800 / None Study: STOP 0.83 (0.69, 1.00) 0.04 &gt;=800 / &lt;=400 Study: STOP 0.85 (0.55, 1.32) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.85 (0.75, 0.96) 0.004 STOP / SCOPE Folic acid supplement (μg): None 1.16 (0.97, 1.39) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.08 (0.74, 1.56) 0.7 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.14 (0.99, 1.30) 0.07 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.90 (0.79, 1.03) 0.1 "],["hpl-3.html", "5.2 HPL", " 5.2 HPL Model summary Var Effect P (Intercept) 1.96 (1.61, 2.38) &lt;0.0001 folate_cat3&lt;=400 1.00 (0.92, 1.08) 0.96 folate_cat3&gt;400 to &lt;800 0.98 (0.92, 1.04) 0.53 folate_cat3&gt;=800 0.99 (0.93, 1.06) 0.85 StudySTOP 1.13 (1.03, 1.25) 0.01 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.12 (0.91, 1.38) 0.29 folate_cat3&gt;400 to &lt;800:StudySTOP 0.98 (0.88, 1.08) 0.65 folate_cat3&gt;=800:StudySTOP 0.96 (0.87, 1.06) 0.43 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 93.34 3.18 396.02 87.29 99.80 &lt;=400 SCOPE 93.16 3.88 728.11 85.85 101.10 &gt;400 to &lt;800 SCOPE 91.54 2.70 236.62 86.37 97.02 &gt;=800 SCOPE 92.76 2.98 321.53 87.07 98.82 None STOP 105.93 4.50 793.17 97.45 115.14 &lt;=400 STOP 118.38 11.13 1946.09 98.45 142.35 &gt;400 to &lt;800 STOP 101.36 3.21 304.17 95.23 107.89 &gt;=800 STOP 101.02 2.61 140.54 95.99 106.32 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.00 (0.89, 1.11) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.98 (0.91, 1.06) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.98 (0.89, 1.09) 1.0 &gt;=800 / None Study: SCOPE 0.99 (0.91, 1.08) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.00 (0.90, 1.11) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.94, 1.09) 1.0 &lt;=400 / None Study: STOP 1.12 (0.87, 1.44) 0.7 &gt;400 to &lt;800 / None Study: STOP 0.96 (0.86, 1.07) 0.7 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.86 (0.67, 1.09) 0.3 &gt;=800 / None Study: STOP 0.95 (0.86, 1.06) 0.6 &gt;=800 / &lt;=400 Study: STOP 0.85 (0.67, 1.08) 0.3 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.00 (0.93, 1.07) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.13 (1.03, 1.25) 0.01 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.27 (1.04, 1.55) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.11 (1.03, 1.19) 0.008 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.09 (1.01, 1.17) 0.02 "],["gh2-3.html", "5.3 GH2", " 5.3 GH2 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.11) &lt;0.0001 folate_cat3&lt;=400 1.05 (0.94, 1.18) 0.40 folate_cat3&gt;400 to &lt;800 0.97 (0.89, 1.05) 0.44 folate_cat3&gt;=800 1.04 (0.95, 1.14) 0.38 StudySTOP 1.10 (0.97, 1.26) 0.15 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.73 (0.55, 0.97) 0.03 folate_cat3&gt;400 to &lt;800:StudySTOP 0.89 (0.77, 1.02) 0.10 folate_cat3&gt;=800:StudySTOP 0.82 (0.72, 0.95) 0.007 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2.44 0.10 1145.85 2.26 2.64 &lt;=400 SCOPE 2.56 0.13 1565.76 2.32 2.84 &gt;400 to &lt;800 SCOPE 2.36 0.08 718.38 2.22 2.52 &gt;=800 SCOPE 2.54 0.10 978.28 2.36 2.74 None STOP 2.69 0.14 1731.02 2.43 2.99 &lt;=400 STOP 2.06 0.26 1920.91 1.61 2.64 &gt;400 to &lt;800 STOP 2.31 0.08 921.32 2.15 2.48 &gt;=800 STOP 2.31 0.06 352.18 2.20 2.43 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.05 (0.90, 1.22) 0.8 &gt;400 to &lt;800 / None Study: SCOPE 0.97 (0.87, 1.08) 0.9 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.92 (0.80, 1.06) 0.4 &gt;=800 / None Study: SCOPE 1.04 (0.92, 1.17) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 0.99 (0.86, 1.15) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.08 (0.97, 1.19) 0.3 &lt;=400 / None Study: STOP 0.76 (0.54, 1.08) 0.2 &gt;400 to &lt;800 / None Study: STOP 0.86 (0.74, 1.00) 0.05 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.12 (0.81, 1.56) 0.8 &gt;=800 / None Study: STOP 0.86 (0.75, 0.99) 0.03 &gt;=800 / &lt;=400 Study: STOP 1.12 (0.81, 1.55) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.00 (0.91, 1.10) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.10 (0.97, 1.26) 0.2 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.80 (0.61, 1.06) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.98 (0.88, 1.08) 0.6 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.91 (0.83, 1.00) 0.05 "],["insulin-1.html", "5.4 Insulin", " 5.4 Insulin Model summary Var Effect P (Intercept) 11.73 (7.14, 19.26) &lt;0.0001 folate_cat3&lt;=400 0.95 (0.73, 1.25) 0.73 folate_cat3&gt;400 to &lt;800 0.97 (0.82, 1.15) 0.70 folate_cat3&gt;=800 0.97 (0.81, 1.17) 0.75 StudySTOP 0.80 (0.62, 1.03) 0.08 GA_samp 1.02 (0.99, 1.05) 0.23 folate_cat3&lt;=400:StudySTOP 0.94 (0.52, 1.71) 0.85 folate_cat3&gt;400 to &lt;800:StudySTOP 1.10 (0.83, 1.45) 0.52 folate_cat3&gt;=800:StudySTOP 1.02 (0.77, 1.34) 0.90 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 15.12 1.13 Inf 13.05 17.51 &lt;=400 SCOPE 14.42 1.79 Inf 11.31 18.39 &gt;400 to &lt;800 SCOPE 14.62 0.94 Inf 12.89 16.58 &gt;=800 SCOPE 14.66 1.10 Inf 12.67 16.98 None STOP 12.03 1.21 Inf 9.88 14.65 &lt;=400 STOP 10.83 2.77 Inf 6.57 17.87 &gt;400 to &lt;800 STOP 12.77 0.83 Inf 11.24 14.50 &gt;=800 STOP 11.88 0.54 Inf 10.87 12.99 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.95 (0.67, 1.35) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.97 (0.78, 1.21) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.01 (0.73, 1.42) 1.0 &gt;=800 / None Study: SCOPE 0.97 (0.76, 1.24) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.02 (0.72, 1.44) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.80, 1.25) 1.0 &lt;=400 / None Study: STOP 0.90 (0.45, 1.81) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.06 (0.79, 1.43) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.18 (0.61, 2.29) 0.9 &gt;=800 / None Study: STOP 0.99 (0.75, 1.29) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.10 (0.57, 2.11) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.93 (0.78, 1.10) 0.7 STOP / SCOPE Folic acid supplement (μg): None 0.80 (0.62, 1.03) 0.08 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.75 (0.43, 1.32) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.87 (0.72, 1.07) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.81 (0.67, 0.98) 0.03 "],["homa-ir-1.html", "5.5 HOMA-IR", " 5.5 HOMA-IR Model summary Var Effect P (Intercept) 3.00 (1.78, 5.07) &lt;0.0001 folate_cat3&lt;=400 0.96 (0.72, 1.28) 0.78 folate_cat3&gt;400 to &lt;800 0.97 (0.81, 1.16) 0.72 folate_cat3&gt;=800 0.97 (0.80, 1.19) 0.80 StudySTOP 0.69 (0.52, 0.90) 0.007 GA_samp 1.02 (0.98, 1.05) 0.37 folate_cat3&lt;=400:StudySTOP 0.93 (0.50, 1.75) 0.83 folate_cat3&gt;400 to &lt;800:StudySTOP 1.10 (0.81, 1.48) 0.55 folate_cat3&gt;=800:StudySTOP 1.01 (0.75, 1.36) 0.93 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 3.67 0.29 Inf 3.13 4.29 &lt;=400 SCOPE 3.52 0.47 Inf 2.72 4.56 &gt;400 to &lt;800 SCOPE 3.55 0.24 Inf 3.10 4.05 &gt;=800 SCOPE 3.57 0.29 Inf 3.05 4.18 None STOP 2.52 0.27 Inf 2.04 3.11 &lt;=400 STOP 2.26 0.61 Inf 1.33 3.83 &gt;400 to &lt;800 STOP 2.67 0.18 Inf 2.34 3.06 &gt;=800 STOP 2.49 0.12 Inf 2.27 2.73 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.96 (0.66, 1.40) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.97 (0.76, 1.22) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 1.01 (0.71, 1.44) 1.0 &gt;=800 / None Study: SCOPE 0.97 (0.75, 1.27) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 1.02 (0.70, 1.48) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.79, 1.28) 1.0 &lt;=400 / None Study: STOP 0.90 (0.43, 1.87) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.06 (0.77, 1.45) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.18 (0.59, 2.38) 0.9 &gt;=800 / None Study: STOP 0.99 (0.74, 1.32) 1.0 &gt;=800 / &lt;=400 Study: STOP 1.10 (0.55, 2.19) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.93 (0.78, 1.12) 0.7 STOP / SCOPE Folic acid supplement (μg): None 0.69 (0.52, 0.90) 0.007 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.64 (0.35, 1.17) 0.1 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.75 (0.61, 0.93) 0.009 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.70 (0.57, 0.86) 0.0006 "],["glucose-1.html", "5.6 Glucose", " 5.6 Glucose Model summary Var Effect P (Intercept) 5.44 (4.93, 6.01) &lt;0.0001 folate_cat3&lt;=400 1.09 (0.99, 1.20) 0.07 folate_cat3&gt;400 to &lt;800 1.03 (1.00, 1.06) 0.09 folate_cat3&gt;=800 1.04 (1.00, 1.08) 0.09 StudySTOP 0.90 (0.86, 0.94) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.59 folate_cat3&lt;=400:StudySTOP 1.07 (0.84, 1.35) 0.59 folate_cat3&gt;400 to &lt;800:StudySTOP 0.96 (0.91, 1.00) 0.06 folate_cat3&gt;=800:StudySTOP 0.96 (0.91, 1.01) 0.09 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 5.32 0.08 Inf 5.16 5.48 &lt;=400 SCOPE 5.81 0.26 Inf 5.32 6.34 &gt;400 to &lt;800 SCOPE 5.47 0.06 Inf 5.36 5.59 &gt;=800 SCOPE 5.51 0.08 Inf 5.35 5.67 None STOP 4.79 0.08 Inf 4.63 4.95 &lt;=400 STOP 5.57 0.61 Inf 4.50 6.91 &gt;400 to &lt;800 STOP 4.70 0.05 Inf 4.61 4.80 &gt;=800 STOP 4.73 0.04 Inf 4.66 4.81 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.09 (0.96, 1.24) 0.3 &gt;400 to &lt;800 / None Study: SCOPE 1.03 (0.99, 1.07) 0.3 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.94 (0.83, 1.06) 0.6 &gt;=800 / None Study: SCOPE 1.04 (0.98, 1.09) 0.3 &gt;=800 / &lt;=400 Study: SCOPE 0.95 (0.84, 1.08) 0.7 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.96, 1.05) 1.0 &lt;=400 / None Study: STOP 1.16 (0.88, 1.55) 0.5 &gt;400 to &lt;800 / None Study: STOP 0.98 (0.94, 1.03) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.84 (0.64, 1.12) 0.4 &gt;=800 / None Study: STOP 0.99 (0.95, 1.03) 0.9 &gt;=800 / &lt;=400 Study: STOP 0.85 (0.64, 1.12) 0.4 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.01 (0.98, 1.03) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.90 (0.86, 0.94) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.96 (0.76, 1.21) 0.7 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.86 (0.83, 0.89) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.86 (0.83, 0.89) &lt;0.0001 "],["age-groups.html", "6 Age groups", " 6 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=2329) &gt;=35 yrs (n=96) Total (n=2425) P-value PRL (ng/ml): Median (IQ range) 99.2 (58.5-164.2) 79.2 (47.7-132.5) 98.4 (58.1-163.5) 0.03 hPL (μg/ml): Median (IQ range) 108.1 (54.5-177.0) 76.7 (37.2-143.4) 106.2 (54.1-176.4) 0.003 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.2) 1.9 (1.1-3.4) 2.5 (1.2-4.2) 0.07 Insulin (uU/L): Median (IQ range) 11.6 (6.4-24.8) 12.1 (8.0-20.9) 11.7 (6.5-24.6) 0.73 HOMA-IR: Median (IQ range) 2.6 (1.4-5.7) 2.7 (1.7-4.5) 2.6 (1.4-5.6) 0.74 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.6) 5.0 (4.6-5.4) 5.0 (4.6-5.5) 0.34 Within SCOPE Characteristic &lt;35 yrs (n=1126) &gt;=35 yrs (n=31) Total (n=1157) P-value PRL (ng/ml): Median (IQ range) 139.8 (92.0-222.0) 129.7 (79.3-223.8) 139.8 (91.8-222.1) 0.66 hPL (μg/ml): Median (IQ range) 179.8 (147.9-215.7) 160.1 (130.8-208.1) 179.6 (147.5-215.5) 0.13 GH2 (ng/ml): Median (IQ range) 4.2 (3.1-5.7) 3.8 (3.3-6.1) 4.2 (3.1-5.7) 0.77 Insulin (uU/L): Median (IQ range) 14.5 (6.7-31.8) 19.5 (10.2-37.2) 14.5 (6.8-31.8) 0.19 HOMA-IR: Median (IQ range) 3.4 (1.6-7.8) 4.8 (2.7-10.8) 3.4 (1.6-7.8) 0.10 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.2-5.9) 5.4 (5.0-5.8) 0.28 Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.7) 41.1 (34.6-57.9) 36.1 (28.3-42.8) 0.01 B12 concentration (pM): Median (IQ range) 245.0 (194.0-309.0) 255.0 (212.0-364.0) 245.0 (195.0-310.0) 0.24 Folate:B12 ratio: Median (IQ range) 143.0 (102.3-208.9) 164.5 (121.3-204.5) 143.7 (103.3-208.9) 0.16 Active B12 concentration (pM): Median (IQ range) 57.0 (43.0-73.5) 52.0 (39.0-94.0) 57.0 (43.0-74.0) 0.65 Folate:Active B12 ratio: Median (IQ range) 603.3 (438.7-893.4) 685.4 (405.0-904.2) 606.9 (438.3-898.4) 0.67 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.6 (4.0-5.0) 4.4 (3.8-5.1) 0.41 Within STOP Characteristic &lt;35 yrs (n=1203) &gt;=35 yrs (n=65) Total (n=1268) P-value PRL (ng/ml): Median (IQ range) 75.4 (49.0-118.7) 64.9 (43.4-110.8) 74.6 (48.5-118.7) 0.29 hPL (μg/ml): Median (IQ range) 60.3 (40.3-92.2) 59.1 (31.5-90.1) 60.2 (40.1-92.1) 0.38 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.5 (1.0-2.5) 1.4 (0.9-2.4) 0.66 Insulin (uU/L): Median (IQ range) 10.4 (6.3-20.9) 11.7 (7.1-16.0) 10.4 (6.3-20.7) 0.93 HOMA-IR: Median (IQ range) 2.1 (1.2-4.5) 2.3 (1.4-3.2) 2.2 (1.3-4.4) 0.94 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.8 (4.4-5.0) 4.7 (4.4-5.1) 0.93 Serum folate concentration (nM): Median (IQ range) 40.3 (36.1-45.1) 43.7 (39.8-80.1) 40.5 (36.2-45.3) 0.0003 B12 concentration (pM): Median (IQ range) 279.0 (220.0-356.0) 273.0 (204.0-376.5) 278.5 (218.8-357.0) 0.83 Folate:B12 ratio: Median (IQ range) 151.5 (114.3-218.3) 194.2 (126.5-297.3) 152.4 (114.8-220.6) 0.009 Active B12 concentration (pM): Median (IQ range) 65.0 (50.0-86.0) 67.5 (54.0-96.0) 65.0 (50.0-87.0) 0.64 Folate:Active B12 ratio: Median (IQ range) 626.2 (460.9-883.7) 771.8 (493.6-1019.2) 627.0 (461.1-913.0) 0.21 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.9 (4.5-5.5) 4.8 (4.2-5.6) 0.48 Red cell folate (nmol/L): Median (IQ range) 1477.5 (1216.0-1785.2) 1592.0 (1327.0-1792.0) 1492.0 (1223.0-1788.0) 0.03 mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod1)}) #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) #mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { if(!any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)} return(em1)} mod_em2 &lt;- foreach(ind2=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { if(!any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)} return(em2)} names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-4.html", "6.1 Prolactin", " 6.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 14.92 (10.50, 21.20) &lt;0.0001 Age_gp&gt;=35 yrs 0.93 (0.72, 1.20) 0.57 StudySTOP 0.99 (0.90, 1.10) 0.92 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.00 (0.73, 1.35) 0.97 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 102.63 7.52 79.19 88.71 118.74 &gt;=35 yrs SCOPE 95.27 13.94 921.16 71.49 126.96 &lt;35 yrs STOP 102.09 7.36 74.24 88.44 117.86 &gt;=35 yrs STOP 94.30 10.07 336.17 76.44 116.34 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.93 (0.72, 1.20) 0.6 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.92 (0.78, 1.09) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.99 (0.90, 1.10) 0.9 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.99 (0.73, 1.35) 0.9 "],["hpl-4.html", "6.2 HPL", " 6.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.84 (1.54, 2.21) &lt;0.0001 Age_gp&gt;=35 yrs 0.94 (0.82, 1.08) 0.42 StudySTOP 1.12 (1.06, 1.19) &lt;0.0001 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.94 (0.80, 1.10) 0.43 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 95.25 2.42 132.84 90.58 100.15 &gt;=35 yrs SCOPE 90.00 6.51 1821.01 78.10 103.71 &lt;35 yrs STOP 106.97 2.63 116.00 101.89 112.31 &gt;=35 yrs STOP 94.71 4.66 1144.38 85.99 104.31 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.94 (0.82, 1.08) 0.4 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.89 (0.81, 0.97) 0.007 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.12 (1.06, 1.19) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.05 (0.89, 1.24) 0.5 "],["gh2-4.html", "6.3 GH2", " 6.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 Age_gp&gt;=35 yrs 1.02 (0.84, 1.24) 0.85 StudySTOP 0.99 (0.91, 1.07) 0.74 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.00 (0.80, 1.26) 0.98 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 2.50 0.07 343.87 2.38 2.64 &gt;=35 yrs SCOPE 2.55 0.26 2229.49 2.10 3.10 &lt;35 yrs STOP 2.47 0.06 274.45 2.36 2.59 &gt;=35 yrs STOP 2.52 0.16 2038.49 2.23 2.86 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.02 (0.84, 1.24) 0.9 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.02 (0.90, 1.15) 0.7 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.99 (0.91, 1.07) 0.7 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.99 (0.78, 1.25) 0.9 "],["insulin-2.html", "6.4 Insulin", " 6.4 Insulin GEE for repeated measures. Model summary Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 14.64 0.71 Inf 13.31 16.10 &gt;=35 yrs SCOPE 19.75 3.11 Inf 14.50 26.90 &lt;35 yrs STOP 11.97 0.44 Inf 11.14 12.87 &gt;=35 yrs STOP 11.57 1.16 Inf 9.50 14.09 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.35 (0.99, 1.84) 0.06 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.97 (0.79, 1.18) 0.7 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.82 (0.71, 0.95) 0.006 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.59 (0.40, 0.85) 0.005 "],["homa-ir-2.html", "6.5 HOMA-IR", " 6.5 HOMA-IR GEE for repeated measures. Model summary Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 3.55 0.18 Inf 3.21 3.93 &gt;=35 yrs SCOPE 5.14 0.86 Inf 3.70 7.14 &lt;35 yrs STOP 2.51 0.10 Inf 2.32 2.71 &gt;=35 yrs STOP 2.43 0.26 Inf 1.97 2.98 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.45 (1.04, 2.01) 0.03 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.97 (0.78, 1.19) 0.8 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.71 (0.61, 0.82) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.47 (0.32, 0.70) 0.0002 "],["glucose-2.html", "6.6 Glucose", " 6.6 Glucose GEE for repeated measures. Model summary Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 5.48 0.05 Inf 5.39 5.58 &gt;=35 yrs SCOPE 5.67 0.17 Inf 5.35 6.02 &lt;35 yrs STOP 4.74 0.04 Inf 4.67 4.81 &gt;=35 yrs STOP 4.72 0.05 Inf 4.61 4.82 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.03 (0.97, 1.10) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.00 (0.97, 1.02) 0.7 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.86 (0.84, 0.89) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.83 (0.78, 0.89) &lt;0.0001 "],["bmi-groups.html", "7 BMI groups", " 7 BMI groups Descriptives with univariate P-values. Characteristic Underweight (n=63) Normal (n=975) Overweight (n=672) Obese (n=715) Total (n=2425) P-value PRL (ng/ml): Median (IQ range) 104.2 (52.4-216.8) 105.8 (62.8-172.4) 102.1 (59.4-172.6) 85.7 (50.7-145.5) 98.4 (58.1-163.5) &lt;0.0001 hPL (μg/ml): Median (IQ range) 155.5 (87.4-215.8) 125.8 (61.0-197.4) 108.7 (55.5-170.0) 74.1 (41.9-146.5) 106.2 (54.1-176.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.3 (2.3-6.2) 3.0 (1.3-4.8) 2.5 (1.2-4.0) 2.1 (1.0-3.3) 2.5 (1.2-4.2) &lt;0.0001 Insulin (uU/L): Median (IQ range) 6.2 (4.4-12.5) 7.9 (4.7-17.3) 11.8 (7.0-25.5) 17.6 (10.6-34.5) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 1.5 (0.9-3.1) 1.7 (1.0-3.9) 2.6 (1.5-5.7) 3.8 (2.3-8.2) 2.6 (1.4-5.6) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.9 (4.4-5.4) 5.0 (4.6-5.4) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.0009 Within SCOPE Characteristic Underweight (n=36) Normal (n=479) Overweight (n=321) Obese (n=321) Total (n=1157) P-value PRL (ng/ml): Median (IQ range) 182.4 (98.9-303.2) 142.3 (96.6-221.9) 146.5 (97.3-234.1) 128.7 (79.0-199.9) 139.8 (91.8-222.1) 0.005 hPL (μg/ml): Median (IQ range) 198.4 (166.8-249.6) 198.9 (169.0-227.6) 171.0 (148.0-208.2) 155.3 (127.7-184.2) 179.6 (147.5-215.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 5.1 (4.3-6.6) 4.7 (3.5-6.5) 4.0 (3.1-5.4) 3.4 (2.6-4.3) 4.2 (3.1-5.7) &lt;0.0001 Insulin (uU/L): Median (IQ range) 8.8 (4.8-18.1) 9.6 (5.1-24.3) 17.9 (9.1-38.3) 20.4 (10.9-39.8) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 1.8 (1.2-4.2) 2.2 (1.2-5.9) 4.4 (2.0-8.6) 4.7 (2.5-9.8) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.8-5.8) 5.3 (5.0-5.7) 5.5 (5.0-5.9) 5.4 (5.0-6.0) 5.4 (5.0-5.8) 0.03 Serum folate concentration (nM): Median (IQ range) 29.3 (22.8-38.0) 36.3 (29.1-43.4) 36.2 (29.6-41.2) 36.1 (26.8-43.2) 36.1 (28.3-42.8) 0.08 B12 concentration (pM): Median (IQ range) 269.0 (208.0-329.0) 254.0 (196.0-323.5) 243.5 (199.8-309.0) 231.0 (185.0-291.0) 245.0 (195.0-310.0) 0.005 Folate:B12 ratio: Median (IQ range) 113.8 (74.6-181.7) 141.7 (102.3-206.1) 144.8 (107.0-200.9) 148.3 (103.5-217.0) 143.7 (103.3-208.9) 0.21 Active B12 concentration (pM): Median (IQ range) 52.0 (40.0-71.0) 54.0 (42.0-71.0) 57.0 (43.5-72.0) 62.0 (46.0-77.0) 57.0 (43.0-74.0) 0.05 Folate:Active B12 ratio: Median (IQ range) 609.3 (427.4-805.2) 651.8 (454.0-973.3) 618.9 (465.8-897.8) 539.1 (399.4-818.9) 606.9 (438.3-898.4) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.2-5.3) 4.5 (3.9-5.3) 4.3 (3.7-4.8) 4.4 (3.8-5.0) 4.4 (3.8-5.1) 0.008 Within STOP Characteristic Underweight (n=27) Normal (n=496) Overweight (n=351) Obese (n=394) Total (n=1268) P-value PRL (ng/ml): Median (IQ range) 80.1 (41.3-103.4) 78.8 (51.5-125.2) 76.5 (51.7-115.3) 68.2 (44.3-112.8) 74.6 (48.5-118.7) 0.03 hPL (μg/ml): Median (IQ range) 86.3 (51.8-125.0) 66.6 (45.7-105.4) 62.4 (42.1-97.9) 49.8 (33.4-71.7) 60.2 (40.1-92.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.9 (1.4-3.8) 1.5 (1.0-2.5) 1.4 (0.8-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.0001 Insulin (uU/L): Median (IQ range) 4.8 (4.4-11.7) 7.4 (4.3-13.6) 9.7 (6.6-17.7) 16.2 (10.4-30.9) 10.4 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.0 (0.8-2.5) 1.5 (0.9-2.9) 2.0 (1.3-4.0) 3.5 (2.2-6.9) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.4 (4.2-4.9) 4.7 (4.3-5.0) 4.7 (4.4-5.1) 4.8 (4.5-5.2) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 35.4 (29.6-41.6) 40.9 (36.9-54.0) 40.5 (36.3-46.0) 39.9 (35.6-45.2) 40.5 (36.2-45.3) 0.0008 B12 concentration (pM): Median (IQ range) 345.0 (230.5-391.0) 293.0 (228.0-374.0) 282.0 (215.0-355.0) 264.0 (209.0-329.0) 278.5 (218.8-357.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 108.9 (70.3-158.9) 152.3 (110.0-222.4) 148.0 (115.8-218.3) 162.5 (118.1-230.1) 152.4 (114.8-220.6) 0.001 Active B12 concentration (pM): Median (IQ range) 50.0 (42.0-50.5) 65.5 (48.8-84.0) 62.0 (47.0-86.0) 70.0 (53.0-88.2) 65.0 (50.0-87.0) 0.05 Folate:Active B12 ratio: Median (IQ range) 752.6 (636.0-850.5) 637.7 (486.5-947.5) 670.2 (455.9-940.0) 575.0 (444.5-833.1) 627.0 (461.1-913.0) 0.12 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.6-5.8) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 4.8 (4.2-5.6) 0.37 Red cell folate (nmol/L): Median (IQ range) 1276.0 (1054.5-1458.5) 1466.0 (1212.8-1764.2) 1503.0 (1216.0-1792.0) 1512.0 (1275.0-1792.0) 1492.0 (1223.0-1788.0) 0.02 "],["prolactin-5.html", "7.1 Prolactin", " 7.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 18.51 (12.09, 28.34) &lt;0.0001 BMI_gp3Normal 0.84 (0.65, 1.08) 0.17 BMI_gp3Overweight 0.88 (0.68, 1.13) 0.31 BMI_gp3Obese 0.72 (0.56, 0.93) 0.01 StudySTOP 0.84 (0.59, 1.20) 0.35 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.19 (0.83, 1.70) 0.34 BMI_gp3Overweight:StudySTOP 1.15 (0.80, 1.66) 0.44 BMI_gp3Obese:StudySTOP 1.19 (0.83, 1.72) 0.34 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 125.79 17.83 860.14 95.24 166.13 Normal SCOPE 105.51 8.13 99.06 90.56 122.94 Overweight SCOPE 110.19 8.86 117.09 93.98 129.20 Obese SCOPE 90.90 7.38 122.01 77.40 106.75 Underweight STOP 105.78 15.36 914.20 79.56 140.65 Normal STOP 105.54 7.90 88.55 90.96 122.47 Overweight STOP 106.95 8.27 100.40 91.75 124.68 Obese STOP 91.22 7.05 100.23 78.25 106.34 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.84 (0.60, 1.16) 0.5 Overweight / Underweight Study: SCOPE 0.88 (0.63, 1.22) 0.7 Overweight / Normal Study: SCOPE 1.04 (0.91, 1.20) 0.8 Obese / Underweight Study: SCOPE 0.72 (0.52, 1.01) 0.06 Obese / Normal Study: SCOPE 0.86 (0.75, 0.99) 0.03 Obese / Overweight Study: SCOPE 0.82 (0.71, 0.96) 0.005 Normal / Underweight Study: STOP 1.00 (0.71, 1.40) 1.0 Overweight / Underweight Study: STOP 1.01 (0.72, 1.42) 1.0 Overweight / Normal Study: STOP 1.01 (0.90, 1.14) 1.0 Obese / Underweight Study: STOP 0.86 (0.61, 1.21) 0.7 Obese / Normal Study: STOP 0.86 (0.77, 0.97) 0.007 Obese / Overweight Study: STOP 0.85 (0.75, 0.97) 0.006 STOP / SCOPE Maternal BMI: Underweight 0.84 (0.59, 1.21) 0.3 STOP / SCOPE Maternal BMI: Normal 1.00 (0.89, 1.13) 1.0 STOP / SCOPE Maternal BMI: Overweight 0.97 (0.85, 1.11) 0.7 STOP / SCOPE Maternal BMI: Obese 1.00 (0.87, 1.15) 1.0 "],["hpl-5.html", "7.2 HPL", " 7.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.03 (1.64, 2.51) &lt;0.0001 BMI_gp3Normal 1.03 (0.90, 1.17) 0.67 BMI_gp3Overweight 0.96 (0.84, 1.09) 0.50 BMI_gp3Obese 0.81 (0.71, 0.93) 0.002 StudySTOP 1.38 (1.15, 1.66) 0.0007 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.81 (0.68, 0.98) 0.03 BMI_gp3Overweight:StudySTOP 0.80 (0.66, 0.97) 0.02 BMI_gp3Obese:StudySTOP 0.76 (0.63, 0.92) 0.004 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 102.28 6.96 1900.44 89.50 116.88 Normal SCOPE 105.18 2.95 206.77 99.53 111.16 Overweight SCOPE 97.72 2.95 274.01 92.07 103.71 Obese SCOPE 83.18 2.53 280.38 78.33 88.32 Underweight STOP 141.07 9.76 1912.03 123.17 161.56 Normal STOP 117.87 3.12 166.21 111.86 124.20 Overweight STOP 108.07 3.06 212.67 102.20 114.27 Obese STOP 87.13 2.48 211.72 82.38 92.16 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.03 (0.87, 1.22) 1.0 Overweight / Underweight Study: SCOPE 0.96 (0.80, 1.14) 0.9 Overweight / Normal Study: SCOPE 0.93 (0.87, 1.00) 0.03 Obese / Underweight Study: SCOPE 0.81 (0.68, 0.97) 0.01 Obese / Normal Study: SCOPE 0.79 (0.74, 0.85) &lt;0.0001 Obese / Overweight Study: SCOPE 0.85 (0.79, 0.92) &lt;0.0001 Normal / Underweight Study: STOP 0.84 (0.70, 0.99) 0.04 Overweight / Underweight Study: STOP 0.77 (0.64, 0.91) 0.0005 Overweight / Normal Study: STOP 0.92 (0.86, 0.97) 0.002 Obese / Underweight Study: STOP 0.62 (0.52, 0.74) &lt;0.0001 Obese / Normal Study: STOP 0.74 (0.70, 0.79) &lt;0.0001 Obese / Overweight Study: STOP 0.81 (0.76, 0.86) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.38 (1.15, 1.66) 0.0007 STOP / SCOPE Maternal BMI: Normal 1.12 (1.05, 1.19) 0.0004 STOP / SCOPE Maternal BMI: Overweight 1.11 (1.03, 1.19) 0.005 STOP / SCOPE Maternal BMI: Obese 1.05 (0.98, 1.12) 0.2 "],["gh2-5.html", "7.3 GH2", " 7.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.09 (0.07, 0.12) &lt;0.0001 BMI_gp3Normal 0.97 (0.81, 1.17) 0.77 BMI_gp3Overweight 0.84 (0.70, 1.01) 0.07 BMI_gp3Obese 0.69 (0.57, 0.82) &lt;0.0001 StudySTOP 1.45 (1.11, 1.88) 0.006 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.64 (0.49, 0.83) 0.0007 BMI_gp3Overweight:StudySTOP 0.65 (0.50, 0.85) 0.001 BMI_gp3Obese:StudySTOP 0.78 (0.60, 1.02) 0.07 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 2.96 0.27 2243.04 2.47 3.55 Normal SCOPE 2.88 0.09 640.97 2.71 3.07 Overweight SCOPE 2.49 0.09 895.17 2.33 2.68 Obese SCOPE 2.03 0.07 886.20 1.89 2.18 Underweight STOP 4.28 0.41 2234.26 3.55 5.16 Normal STOP 2.65 0.08 503.43 2.50 2.80 Overweight STOP 2.35 0.08 678.19 2.20 2.50 Obese STOP 2.29 0.07 576.78 2.15 2.44 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.97 (0.77, 1.24) 1.0 Overweight / Underweight Study: SCOPE 0.84 (0.66, 1.08) 0.3 Overweight / Normal Study: SCOPE 0.87 (0.78, 0.96) 0.0009 Obese / Underweight Study: SCOPE 0.69 (0.54, 0.87) 0.0004 Obese / Normal Study: SCOPE 0.70 (0.64, 0.78) &lt;0.0001 Obese / Overweight Study: SCOPE 0.81 (0.73, 0.91) &lt;0.0001 Normal / Underweight Study: STOP 0.62 (0.48, 0.79) &lt;0.0001 Overweight / Underweight Study: STOP 0.55 (0.43, 0.70) &lt;0.0001 Overweight / Normal Study: STOP 0.89 (0.81, 0.97) 0.002 Obese / Underweight Study: STOP 0.54 (0.42, 0.69) &lt;0.0001 Obese / Normal Study: STOP 0.87 (0.80, 0.94) &lt;0.0001 Obese / Overweight Study: STOP 0.98 (0.89, 1.07) 0.9 STOP / SCOPE Maternal BMI: Underweight 1.45 (1.11, 1.88) 0.006 STOP / SCOPE Maternal BMI: Normal 0.92 (0.84, 1.00) 0.06 STOP / SCOPE Maternal BMI: Overweight 0.94 (0.85, 1.04) 0.2 STOP / SCOPE Maternal BMI: Obese 1.13 (1.02, 1.25) 0.02 "],["insulin-3.html", "7.4 Insulin", " 7.4 Insulin GEE for repeated measures. Model summary Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 9.01 1.72 Inf 6.20 13.09 Normal SCOPE 10.77 0.67 Inf 9.53 12.17 Overweight SCOPE 16.44 1.11 Inf 14.39 18.77 Obese SCOPE 21.77 1.47 Inf 19.07 24.85 Underweight STOP 7.36 1.10 Inf 5.50 9.86 Normal STOP 8.65 0.41 Inf 7.88 9.49 Overweight STOP 11.72 0.60 Inf 10.61 12.94 Obese STOP 19.54 0.98 Inf 17.71 21.55 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.20 (0.73, 1.97) 0.8 Overweight / Underweight Study: SCOPE 1.82 (1.10, 3.03) 0.01 Overweight / Normal Study: SCOPE 1.53 (1.24, 1.88) &lt;0.0001 Obese / Underweight Study: SCOPE 2.42 (1.46, 4.00) &lt;0.0001 Obese / Normal Study: SCOPE 2.02 (1.65, 2.48) &lt;0.0001 Obese / Overweight Study: SCOPE 1.32 (1.07, 1.64) 0.005 Normal / Underweight Study: STOP 1.17 (0.80, 1.73) 0.7 Overweight / Underweight Study: STOP 1.59 (1.08, 2.35) 0.01 Overweight / Normal Study: STOP 1.36 (1.17, 1.57) &lt;0.0001 Obese / Underweight Study: STOP 2.65 (1.79, 3.92) &lt;0.0001 Obese / Normal Study: STOP 2.26 (1.95, 2.62) &lt;0.0001 Obese / Overweight Study: STOP 1.67 (1.43, 1.95) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.82 (0.50, 1.33) 0.4 STOP / SCOPE Maternal BMI: Normal 0.80 (0.67, 0.96) 0.01 STOP / SCOPE Maternal BMI: Overweight 0.71 (0.59, 0.86) 0.0003 STOP / SCOPE Maternal BMI: Obese 0.90 (0.75, 1.08) 0.3 "],["homa-ir-3.html", "7.5 HOMA-IR", " 7.5 HOMA-IR GEE for repeated measures. Model summary Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 2.12 0.40 Inf 1.47 3.08 Normal SCOPE 2.60 0.17 Inf 2.29 2.96 Overweight SCOPE 3.99 0.29 Inf 3.45 4.60 Obese SCOPE 5.33 0.39 Inf 4.62 6.16 Underweight STOP 1.47 0.22 Inf 1.10 1.98 Normal STOP 1.78 0.09 Inf 1.61 1.96 Overweight STOP 2.45 0.13 Inf 2.20 2.72 Obese STOP 4.22 0.23 Inf 3.80 4.69 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.23 (0.74, 2.01) 0.7 Overweight / Underweight Study: SCOPE 1.88 (1.13, 3.11) 0.008 Overweight / Normal Study: SCOPE 1.53 (1.22, 1.91) &lt;0.0001 Obese / Underweight Study: SCOPE 2.51 (1.52, 4.15) &lt;0.0001 Obese / Normal Study: SCOPE 2.05 (1.64, 2.55) &lt;0.0001 Obese / Overweight Study: SCOPE 1.34 (1.06, 1.69) 0.008 Normal / Underweight Study: STOP 1.21 (0.82, 1.79) 0.6 Overweight / Underweight Study: STOP 1.66 (1.12, 2.47) 0.006 Overweight / Normal Study: STOP 1.37 (1.17, 1.61) &lt;0.0001 Obese / Underweight Study: STOP 2.87 (1.93, 4.27) &lt;0.0001 Obese / Normal Study: STOP 2.37 (2.03, 2.78) &lt;0.0001 Obese / Overweight Study: STOP 1.73 (1.46, 2.04) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.69 (0.43, 1.12) 0.1 STOP / SCOPE Maternal BMI: Normal 0.68 (0.57, 0.82) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.61 (0.50, 0.75) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.79 (0.65, 0.97) 0.02 "],["glucose-3.html", "7.6 Glucose", " 7.6 Glucose GEE for repeated measures. Model summary Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 5.24 0.12 Inf 5.01 5.48 Normal SCOPE 5.41 0.06 Inf 5.29 5.53 Overweight SCOPE 5.62 0.12 Inf 5.38 5.86 Obese SCOPE 5.48 0.07 Inf 5.34 5.62 Underweight STOP 4.51 0.08 Inf 4.34 4.68 Normal STOP 4.67 0.05 Inf 4.58 4.76 Overweight STOP 4.74 0.06 Inf 4.62 4.86 Obese STOP 4.84 0.05 Inf 4.74 4.94 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.03 (0.97, 1.10) 0.5 Overweight / Underweight Study: SCOPE 1.07 (0.99, 1.16) 0.1 Overweight / Normal Study: SCOPE 1.04 (0.97, 1.11) 0.5 Obese / Underweight Study: SCOPE 1.05 (0.98, 1.11) 0.3 Obese / Normal Study: SCOPE 1.01 (0.97, 1.05) 0.8 Obese / Overweight Study: SCOPE 0.98 (0.91, 1.04) 0.8 Normal / Underweight Study: STOP 1.04 (0.99, 1.09) 0.3 Overweight / Underweight Study: STOP 1.05 (0.99, 1.11) 0.10 Overweight / Normal Study: STOP 1.01 (0.98, 1.05) 0.8 Obese / Underweight Study: STOP 1.07 (1.02, 1.13) 0.003 Obese / Normal Study: STOP 1.04 (1.00, 1.07) 0.03 Obese / Overweight Study: STOP 1.02 (0.98, 1.06) 0.5 STOP / SCOPE Maternal BMI: Underweight 0.86 (0.81, 0.91) &lt;0.0001 STOP / SCOPE Maternal BMI: Normal 0.86 (0.83, 0.89) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.84 (0.80, 0.88) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.88 (0.85, 0.92) &lt;0.0001 "],["age-bmi-groups.html", "8 Age &amp; BMI groups", " 8 Age &amp; BMI groups Descriptives with univariate P-values. Characteristic &lt;35 yrs, non-obese (n=1657) &lt;35 yrs, obese (n=672) &gt;=35 yrs, non-obese (n=53) &gt;=35 yrs, obese (n=43) Total (n=2425) P-value PRL (ng/ml): Median (IQ range) 104.2 (61.8-174.8) 88.8 (52.2-146.2) 93.9 (67.3-178.7) 54.6 (40.6-110.3) 98.4 (58.1-163.5) &lt;0.0001 hPL (μg/ml): Median (IQ range) 122.7 (59.5-187.9) 76.2 (43.5-148.3) 90.4 (59.1-160.1) 41.7 (26.5-98.8) 106.2 (54.1-176.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.8 (1.3-4.5) 2.1 (1.1-3.3) 2.2 (1.1-4.5) 1.7 (1.0-2.8) 2.5 (1.2-4.2) &lt;0.0001 Insulin (uU/L): Median (IQ range) 9.4 (5.3-21.4) 18.1 (10.6-35.3) 9.2 (5.3-17.7) 12.9 (10.3-24.0) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.2-4.8) 3.9 (2.3-8.3) 2.0 (1.1-4.0) 2.8 (2.2-5.4) 2.6 (1.4-5.6) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.7) 5.1 (4.6-5.4) 4.8 (4.5-5.2) 5.0 (4.6-5.5) 0.0005 Within SCOPE Characteristic &lt;35 yrs, non-obese (n=815) &lt;35 yrs, obese (n=311) &gt;=35 yrs, non-obese (n=21) &gt;=35 yrs, obese (n=10) Total (n=1157) P-value PRL (ng/ml): Median (IQ range) 145.6 (97.1-225.0) 130.4 (79.7-205.3) 199.6 (98.1-334.1) 69.8 (36.8-121.3) 139.8 (91.8-222.1) 0.0007 hPL (μg/ml): Median (IQ range) 190.0 (157.0-222.9) 155.3 (127.9-183.8) 161.9 (136.3-202.0) 158.4 (78.6-204.8) 179.6 (147.5-215.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.5 (3.4-6.1) 3.4 (2.6-4.3) 4.1 (3.4-6.1) 3.8 (2.4-5.0) 4.2 (3.1-5.7) &lt;0.0001 Insulin (uU/L): Median (IQ range) 12.6 (5.9-29.5) 20.4 (10.6-39.1) 14.2 (8.6-25.3) 36.5 (16.0-53.5) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 3.0 (1.4-7.3) 4.7 (2.5-9.3) 3.9 (2.1-6.9) 8.8 (4.0-15.8) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.4 (4.9-5.8) 5.4 (5.0-6.0) 5.5 (5.2-5.8) 5.5 (5.1-5.9) 5.4 (5.0-5.8) 0.31 Serum folate concentration (nM): Median (IQ range) 36.0 (28.6-42.4) 36.0 (26.3-43.1) 42.1 (36.3-74.5) 37.1 (32.3-42.6) 36.1 (28.3-42.8) 0.06 B12 concentration (pM): Median (IQ range) 250.0 (198.0-317.0) 232.0 (185.0-292.0) 305.0 (239.8-367.0) 219.5 (197.0-249.0) 245.0 (195.0-310.0) 0.002 Folate:B12 ratio: Median (IQ range) 142.3 (102.0-204.3) 145.7 (102.8-218.6) 157.4 (117.5-207.7) 174.2 (140.7-200.8) 143.7 (103.3-208.9) 0.35 Active B12 concentration (pM): Median (IQ range) 55.0 (42.0-71.0) 61.5 (46.2-77.0) 48.0 (43.5-98.5) 67.0 (39.0-93.0) 57.0 (43.0-74.0) 0.07 Folate:Active B12 ratio: Median (IQ range) 630.8 (455.8-929.4) 539.3 (400.5-817.1) 804.5 (646.0-977.4) 420.3 (400.0-817.9) 606.9 (438.3-898.4) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.4 (3.8-5.0) 4.6 (4.1-5.1) 4.5 (3.9-4.9) 4.4 (3.8-5.1) 0.72 Within STOP Characteristic &lt;35 yrs, non-obese (n=842) &lt;35 yrs, obese (n=361) &gt;=35 yrs, non-obese (n=32) &gt;=35 yrs, obese (n=33) Total (n=1268) P-value PRL (ng/ml): Median (IQ range) 77.4 (50.7-120.2) 69.3 (45.6-113.1) 82.3 (50.7-110.8) 53.2 (40.6-107.8) 74.6 (48.5-118.7) 0.03 hPL (μg/ml): Median (IQ range) 65.4 (44.1-101.3) 50.4 (34.5-71.5) 67.2 (51.1-100.0) 37.9 (24.6-82.1) 60.2 (40.1-92.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.5 (1.0-2.4) 1.5 (1.0-2.4) 1.4 (0.9-2.4) 0.03 Insulin (uU/L): Median (IQ range) 8.2 (4.9-15.4) 16.8 (10.5-32.0) 8.0 (4.4-14.8) 12.4 (9.8-20.6) 10.4 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.7 (1.0-3.2) 3.7 (2.2-7.4) 1.7 (0.9-2.9) 2.6 (2.1-4.3) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.2) 4.8 (4.4-5.1) 4.7 (4.5-5.0) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.2) 39.6 (35.5-44.7) 44.2 (40.6-71.5) 42.9 (37.5-93.9) 40.5 (36.2-45.3) 0.0007 B12 concentration (pM): Median (IQ range) 288.0 (225.8-367.5) 262.0 (209.0-322.0) 263.0 (200.0-329.0) 300.5 (204.5-387.5) 278.5 (218.8-357.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 148.6 (109.9-217.3) 161.1 (118.1-221.7) 174.3 (128.3-354.5) 199.8 (114.5-286.9) 152.4 (114.8-220.6) 0.01 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-83.8) 70.0 (53.0-89.0) 63.5 (50.2-99.0) 72.0 (54.8-80.2) 65.0 (50.0-87.0) 0.20 Folate:Active B12 ratio: Median (IQ range) 654.8 (474.4-937.1) 569.5 (441.6-812.2) 779.9 (441.0-1019.2) 751.2 (586.3-1025.3) 627.0 (461.1-913.0) 0.04 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 4.9 (4.2-6.0) 4.8 (4.5-5.2) 4.8 (4.2-5.6) 0.84 Red cell folate (nmol/L): Median (IQ range) 1464.0 (1209.0-1778.0) 1501.0 (1276.0-1792.0) 1572.0 (1344.0-1792.0) 1631.0 (1314.0-1792.0) 1492.0 (1223.0-1788.0) 0.10 "],["prolactin-6.html", "8.1 Prolactin", " 8.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 15.77 (11.12, 22.37) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.86 (0.78, 0.95) 0.003 Age_BMI_gp&gt;=35 yrs, non-obese 1.26 (0.91, 1.75) 0.17 Age_BMI_gp&gt;=35 yrs, obese 0.53 (0.36, 0.79) 0.002 StudySTOP 0.99 (0.89, 1.10) 0.84 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.00 (0.88, 1.14) 0.97 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.77 (0.51, 1.14) 0.19 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.49 (0.94, 2.35) 0.09 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 107.65 7.96 84.34 92.93 124.71 &lt;35 yrs, obese SCOPE 92.62 7.57 124.70 78.79 108.87 &gt;=35 yrs, non-obese SCOPE 135.50 24.45 1438.23 95.11 193.04 &gt;=35 yrs, obese SCOPE 57.31 12.18 1486.80 37.77 86.94 &lt;35 yrs, non-obese STOP 106.44 7.72 77.97 92.13 122.97 &lt;35 yrs, obese STOP 91.79 7.15 103.37 78.64 107.12 &gt;=35 yrs, non-obese STOP 102.73 13.55 697.94 79.29 133.11 &gt;=35 yrs, obese STOP 84.29 11.33 737.10 64.74 109.75 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.86 (0.76, 0.98) 0.01 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.26 (0.82, 1.94) 0.5 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.46 (0.94, 2.28) 0.1 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.53 (0.32, 0.90) 0.01 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.62 (0.36, 1.05) 0.09 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.42 (0.22, 0.83) 0.006 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.86 (0.77, 0.96) 0.003 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.97 (0.72, 1.30) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.12 (0.83, 1.51) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.79 (0.58, 1.07) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.92 (0.67, 1.25) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.82 (0.54, 1.24) 0.6 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.99 (0.89, 1.10) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.99 (0.86, 1.14) 0.9 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.76 (0.51, 1.14) 0.2 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.47 (0.93, 2.33) 0.1 "],["hpl-6.html", "8.2 HPL", " 8.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.02 (1.69, 2.40) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.82 (0.78, 0.86) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.97 (0.81, 1.15) 0.71 Age_BMI_gp&gt;=35 yrs, obese 0.80 (0.66, 0.97) 0.03 StudySTOP 1.12 (1.06, 1.19) &lt;0.0001 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.95 (0.89, 1.01) 0.12 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.05 (0.85, 1.29) 0.68 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.80 (0.64, 1.01) 0.06 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 101.95 2.61 149.93 96.91 107.24 &lt;35 yrs, obese SCOPE 83.24 2.57 299.45 78.33 88.45 &gt;=35 yrs, non-obese SCOPE 98.63 8.93 2152.02 82.58 117.81 &gt;=35 yrs, obese SCOPE 81.47 8.27 1415.38 66.75 99.43 &lt;35 yrs, non-obese STOP 114.46 2.82 127.16 109.02 120.17 &lt;35 yrs, obese STOP 88.72 2.57 230.34 83.80 93.93 &gt;=35 yrs, non-obese STOP 115.75 7.18 1702.74 102.48 130.73 &gt;=35 yrs, obese STOP 73.19 4.70 1799.69 64.52 83.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.82 (0.76, 0.87) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 0.97 (0.77, 1.22) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.18 (0.94, 1.50) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.80 (0.62, 1.03) 0.1 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 0.98 (0.75, 1.27) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.83 (0.59, 1.16) 0.5 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.78 (0.73, 0.82) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 1.01 (0.87, 1.18) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.30 (1.11, 1.53) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.64 (0.55, 0.75) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.82 (0.70, 0.97) 0.01 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.63 (0.51, 0.78) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 1.12 (1.06, 1.19) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.07 (0.99, 1.15) 0.09 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 1.17 (0.95, 1.45) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.90 (0.71, 1.13) 0.4 "],["gh2-6.html", "8.3 GH2", " 8.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.74 (0.69, 0.80) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.07 (0.84, 1.37) 0.58 Age_BMI_gp&gt;=35 yrs, obese 0.77 (0.57, 1.04) 0.09 StudySTOP 0.94 (0.87, 1.01) 0.10 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.21 (1.10, 1.32) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.99 (0.73, 1.34) 0.96 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.18 (0.84, 1.66) 0.35 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE 2.72 0.08 424.97 2.58 2.87 &lt;35 yrs, obese SCOPE 2.03 0.07 972.09 1.88 2.18 &gt;=35 yrs, non-obese SCOPE 2.92 0.37 2237.15 2.28 3.75 &gt;=35 yrs, obese SCOPE 2.11 0.32 1928.04 1.56 2.84 &lt;35 yrs, non-obese STOP 2.55 0.06 340.39 2.42 2.68 &lt;35 yrs, obese STOP 2.29 0.08 652.27 2.15 2.44 &gt;=35 yrs, non-obese STOP 2.71 0.23 2219.41 2.29 3.21 &gt;=35 yrs, obese STOP 2.33 0.20 2211.87 1.96 2.76 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.74 (0.68, 0.82) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.07 (0.77, 1.49) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.44 (1.03, 2.01) 0.02 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 0.77 (0.52, 1.15) 0.3 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.04 (0.70, 1.55) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 0.72 (0.43, 1.20) 0.3 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.90 (0.83, 0.97) 0.004 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 1.06 (0.85, 1.33) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 1.18 (0.94, 1.48) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 0.91 (0.73, 1.14) 0.7 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 1.01 (0.81, 1.27) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 0.86 (0.63, 1.16) 0.6 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.94 (0.87, 1.01) 0.1 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 1.13 (1.02, 1.25) 0.02 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.93 (0.69, 1.26) 0.6 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 1.10 (0.78, 1.56) 0.6 "],["insulin-4.html", "8.4 Insulin", " 8.4 Insulin GEE for repeated measures. Model summary Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 12.58 0.65 Inf 11.37 13.91 &lt;35 yrs, obese SCOPE 21.53 1.49 Inf 18.80 24.67 &gt;=35 yrs, non-obese SCOPE 14.67 2.66 Inf 10.29 20.92 &gt;=35 yrs, obese SCOPE 29.01 5.82 Inf 19.58 42.98 &lt;35 yrs, non-obese STOP 9.72 0.39 Inf 8.99 10.52 &lt;35 yrs, obese STOP 20.02 1.05 Inf 18.06 22.19 &gt;=35 yrs, non-obese STOP 9.15 1.44 Inf 6.72 12.47 &gt;=35 yrs, obese STOP 14.70 1.57 Inf 11.92 18.13 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.71 (1.42, 2.06) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.17 (0.73, 1.87) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 0.68 (0.42, 1.11) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 2.31 (1.37, 3.88) 0.0002 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.35 (0.79, 2.29) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.98 (1.00, 3.92) 0.05 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 2.06 (1.79, 2.37) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.94 (0.63, 1.41) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.46 (0.30, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.51 (1.14, 2.00) 0.0008 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.73 (0.55, 0.98) 0.03 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.61 (0.99, 2.60) 0.06 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.77 (0.66, 0.90) 0.0009 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.93 (0.77, 1.12) 0.5 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.62 (0.39, 1.01) 0.05 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.51 (0.32, 0.80) 0.003 "],["homa-ir-4.html", "8.5 HOMA-IR", " 8.5 HOMA-IR GEE for repeated measures. Model summary Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 3.04 0.17 Inf 2.73 3.38 &lt;35 yrs, obese SCOPE 5.27 0.40 Inf 4.54 6.10 &gt;=35 yrs, non-obese SCOPE 3.82 0.75 Inf 2.60 5.62 &gt;=35 yrs, obese SCOPE 7.34 1.61 Inf 4.78 11.27 &lt;35 yrs, non-obese STOP 2.01 0.08 Inf 1.85 2.18 &lt;35 yrs, obese STOP 4.34 0.24 Inf 3.88 4.84 &gt;=35 yrs, non-obese STOP 1.92 0.32 Inf 1.38 2.67 &gt;=35 yrs, obese STOP 3.08 0.34 Inf 2.48 3.84 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.73 (1.42, 2.12) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.26 (0.76, 2.09) 0.7 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 0.73 (0.43, 1.23) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 2.41 (1.37, 4.26) 0.0004 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.39 (0.78, 2.49) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.92 (0.91, 4.05) 0.1 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 2.16 (1.86, 2.51) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 0.96 (0.62, 1.47) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.44 (0.28, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.53 (1.15, 2.05) 0.0010 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.71 (0.52, 0.97) 0.02 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.60 (0.96, 2.67) 0.08 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.66 (0.56, 0.78) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.82 (0.67, 1.01) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.50 (0.30, 0.84) 0.009 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.42 (0.26, 0.68) 0.0005 "],["glucose-4.html", "8.6 Glucose", " 8.6 Glucose GEE for repeated measures. Model summary Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs, non-obese SCOPE 5.49 0.06 Inf 5.37 5.61 &lt;35 yrs, obese SCOPE 5.46 0.07 Inf 5.32 5.60 &gt;=35 yrs, non-obese SCOPE 5.53 0.11 Inf 5.32 5.75 &gt;=35 yrs, obese SCOPE 5.84 0.33 Inf 5.23 6.52 &lt;35 yrs, non-obese STOP 4.69 0.04 Inf 4.61 4.77 &lt;35 yrs, obese STOP 4.85 0.06 Inf 4.74 4.96 &gt;=35 yrs, non-obese STOP 4.73 0.07 Inf 4.60 4.85 &gt;=35 yrs, obese STOP 4.71 0.08 Inf 4.57 4.86 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.00 (0.95, 1.04) 1.0 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: SCOPE 1.01 (0.95, 1.07) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: SCOPE 1.01 (0.96, 1.07) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: SCOPE 1.06 (0.92, 1.23) 0.7 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: SCOPE 1.07 (0.92, 1.24) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: SCOPE 1.06 (0.91, 1.23) 0.8 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.03 (1.00, 1.07) 0.06 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) Study: STOP 1.01 (0.97, 1.05) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese Study: STOP 0.97 (0.93, 1.02) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) Study: STOP 1.00 (0.96, 1.05) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese Study: STOP 0.97 (0.93, 1.02) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) Study: STOP 1.00 (0.95, 1.05) 1.0 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, non-obese 0.86 (0.83, 0.88) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35 yrs, obese 0.89 (0.86, 0.92) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, non-obese 0.85 (0.81, 0.90) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35 yrs, obese 0.81 (0.72, 0.90) 0.0002 "],["mets-1.html", "9 MetS", " 9 MetS Descriptives with univariate P-values. Characteristic No MetS (n=2036) MetS (n=308) Total (n=2344) P-value PRL (ng/ml): Median (IQ range) 96.2 (57.8-158.3) 109.2 (58.5-183.4) 97.6 (57.8-161.6) 0.06 hPL (μg/ml): Median (IQ range) 102.1 (54.1-176.8) 124.7 (53.2-172.6) 105.2 (54.0-176.0) 0.64 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 2.7 (1.5-4.2) 2.5 (1.2-4.2) 0.11 Insulin (uU/L): Median (IQ range) 10.5 (6.1-21.3) 31.0 (15.4-53.5) 11.7 (6.5-24.6) &lt;0.0001 HOMA-IR: Median (IQ range) 2.3 (1.3-4.8) 7.6 (3.5-14.5) 2.6 (1.4-5.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.4) 5.8 (5.3-6.2) 5.0 (4.6-5.6) &lt;0.0001 Within SCOPE Characteristic No MetS (n=946) MetS (n=200) Total (n=1146) P-value PRL (ng/ml): Median (IQ range) 137.8 (90.4-223.7) 145.2 (93.5-214.1) 139.7 (91.4-222.3) 0.61 hPL (μg/ml): Median (IQ range) 181.6 (150.3-217.9) 165.5 (132.2-202.1) 179.7 (147.1-215.6) 0.0007 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.8) 3.7 (2.7-5.3) 4.2 (3.1-5.7) 0.005 Insulin (uU/L): Median (IQ range) 12.3 (6.2-25.8) 35.7 (17.9-60.1) 14.5 (6.8-31.8) &lt;0.0001 HOMA-IR: Median (IQ range) 2.9 (1.4-6.2) 8.9 (4.4-16.6) 3.4 (1.6-7.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.7) 5.9 (5.6-6.4) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.1 (28.3-42.9) 36.2 (28.4-42.5) 36.1 (28.4-42.8) 0.73 B12 concentration (pM): Median (IQ range) 250.0 (196.0-316.0) 230.0 (190.5-291.0) 245.0 (195.0-310.0) 0.002 Folate:B12 ratio: Median (IQ range) 142.5 (101.5-205.9) 152.3 (114.1-212.8) 144.1 (103.5-209.0) 0.20 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.5) 59.0 (46.0-78.0) 57.0 (43.0-74.0) 0.16 Folate:Active B12 ratio: Median (IQ range) 618.5 (450.9-923.7) 553.8 (406.5-771.1) 608.2 (438.8-900.5) 0.04 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.01 Within STOP Characteristic No MetS (n=1090) MetS (n=108) Total (n=1198) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.5-115.2) 69.6 (44.4-111.5) 73.7 (48.3-114.4) 0.42 hPL (μg/ml): Median (IQ range) 60.3 (40.8-90.2) 49.9 (34.0-69.9) 59.2 (39.7-89.0) 0.0005 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.3 (0.9-2.1) 1.4 (0.9-2.3) 0.38 Insulin (uU/L): Median (IQ range) 9.6 (5.9-18.3) 24.4 (13.9-46.9) 10.5 (6.3-20.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.2-3.9) 5.9 (3.0-12.2) 2.2 (1.3-4.4) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 5.4 (4.8-5.8) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.6 (36.3-46.8) 39.3 (34.6-44.5) 40.4 (36.2-45.3) 0.02 B12 concentration (pM): Median (IQ range) 281.0 (220.0-363.0) 261.0 (200.5-324.5) 278.0 (218.0-357.0) 0.006 Folate:B12 ratio: Median (IQ range) 151.8 (114.3-222.5) 156.3 (119.4-206.1) 152.2 (114.8-221.9) 0.56 Active B12 concentration (pM): Median (IQ range) 65.0 (50.0-85.8) 66.0 (54.0-88.0) 66.0 (50.0-86.5) 0.66 Folate:Active B12 ratio: Median (IQ range) 630.6 (461.5-920.9) 550.7 (447.9-726.8) 626.0 (461.0-885.0) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.2-5.6) 0.88 Red cell folate (nmol/L): Median (IQ range) 1479.0 (1216.0-1778.0) 1496.0 (1273.8-1792.0) 1483.0 (1220.5-1782.8) 0.44 "],["prolactin-7.html", "9.1 Prolactin", " 9.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 16.80 (11.63, 24.26) &lt;0.0001 metab.C1MetS 1.00 (0.89, 1.12) 0.97 StudySTOP 0.96 (0.86, 1.07) 0.43 GA_samp 1.15 (1.12, 1.17) &lt;0.0001 metab.C1MetS:StudySTOP 1.01 (0.85, 1.20) 0.89 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 104.09 7.72 83.20 89.81 120.64 MetS SCOPE 103.84 9.08 158.76 87.37 123.42 No MetS STOP 99.50 7.25 77.46 86.06 115.03 MetS STOP 100.51 9.51 214.03 83.41 121.12 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.00 (0.89, 1.12) 1.0 MetS / No MetS Study: STOP 1.01 (0.89, 1.15) 0.9 STOP / SCOPE MetS: No MetS 0.96 (0.86, 1.07) 0.4 STOP / SCOPE MetS: MetS 0.97 (0.80, 1.17) 0.7 "],["hpl-7.html", "9.2 HPL", " 9.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.05 (1.70, 2.47) &lt;0.0001 metab.C1MetS 0.90 (0.85, 0.95) 0.0004 StudySTOP 1.09 (1.03, 1.16) 0.003 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.93 (0.85, 1.02) 0.13 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 98.36 2.53 142.85 93.48 103.50 MetS SCOPE 88.47 3.11 447.11 82.57 94.80 No MetS STOP 107.50 2.68 124.22 102.33 112.93 MetS STOP 90.18 3.67 702.25 83.26 97.69 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.85, 0.95) 0.0004 MetS / No MetS Study: STOP 0.84 (0.78, 0.90) &lt;0.0001 STOP / SCOPE MetS: No MetS 1.09 (1.03, 1.16) 0.003 STOP / SCOPE MetS: MetS 1.02 (0.92, 1.12) 0.7 "],["gh2-7.html", "9.3 GH2", " 9.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 metab.C1MetS 0.87 (0.80, 0.95) 0.001 StudySTOP 0.96 (0.88, 1.04) 0.30 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 metab.C1MetS:StudySTOP 1.12 (0.98, 1.27) 0.09 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 2.58 0.07 381.38 2.44 2.72 MetS SCOPE 2.25 0.10 1348.37 2.06 2.45 No MetS STOP 2.47 0.06 311.35 2.35 2.60 MetS STOP 2.41 0.13 1620.36 2.17 2.67 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.87 (0.80, 0.95) 0.001 MetS / No MetS Study: STOP 0.97 (0.88, 1.07) 0.6 STOP / SCOPE MetS: No MetS 0.96 (0.88, 1.04) 0.3 STOP / SCOPE MetS: MetS 1.07 (0.93, 1.23) 0.3 "],["insulin-5.html", "9.4 Insulin", " 9.4 Insulin GEE for repeated measures. Model summary Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 12.50 0.62 Inf 11.33 13.78 MetS SCOPE 31.68 2.37 Inf 27.36 36.68 No MetS STOP 11.06 0.42 Inf 10.28 11.91 MetS STOP 26.54 2.48 Inf 22.10 31.88 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.53 (2.18, 2.94) &lt;0.0001 MetS / No MetS Study: STOP 2.40 (2.00, 2.88) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.89 (0.76, 1.03) 0.1 STOP / SCOPE MetS: MetS 0.84 (0.65, 1.07) 0.2 "],["homa-ir-5.html", "9.5 HOMA-IR", " 9.5 HOMA-IR GEE for repeated measures. Model summary Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 2.96 0.16 Inf 2.67 3.29 MetS SCOPE 8.43 0.68 Inf 7.19 9.88 No MetS STOP 2.30 0.09 Inf 2.13 2.49 MetS STOP 6.35 0.65 Inf 5.19 7.75 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.84 (2.42, 3.35) &lt;0.0001 MetS / No MetS Study: STOP 2.76 (2.26, 3.37) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.78 (0.66, 0.91) 0.002 STOP / SCOPE MetS: MetS 0.75 (0.58, 0.99) 0.04 "],["glucose-5.html", "9.6 Glucose", " 9.6 Glucose GEE for repeated measures. Model summary Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.34 0.05 Inf 5.25 5.44 MetS SCOPE 6.10 0.15 Inf 5.81 6.41 No MetS STOP 4.69 0.03 Inf 4.63 4.76 MetS STOP 5.38 0.09 Inf 5.20 5.56 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.14 (1.08, 1.21) &lt;0.0001 MetS / No MetS Study: STOP 1.15 (1.11, 1.18) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.88 (0.85, 0.90) &lt;0.0001 STOP / SCOPE MetS: MetS 0.88 (0.83, 0.93) &lt;0.0001 "],["birthweight-centile.html", "10 Birthweight centile", " 10 Birthweight centile Descriptives with univariate P-values. Characteristic &lt;=90th centile (n=2165) &gt;90th centile (n=232) Total (n=2397) P-value PRL (ng/ml): Median (IQ range) 97.8 (57.7-160.3) 106.5 (64.1-191.5) 98.5 (58.1-163.6) 0.05 hPL (μg/ml): Median (IQ range) 108.0 (54.1-175.8) 95.2 (55.2-185.1) 106.5 (54.2-176.4) 0.61 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.2) 2.2 (1.1-4.1) 2.5 (1.2-4.2) 0.33 Insulin (uU/L): Median (IQ range) 11.6 (6.5-24.4) 12.8 (6.3-27.9) 11.7 (6.5-24.6) 0.65 HOMA-IR: Median (IQ range) 2.6 (1.4-5.5) 2.8 (1.3-6.3) 2.6 (1.4-5.6) 0.62 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.0 (4.6-5.6) 5.0 (4.6-5.5) 0.62 Within SCOPE Characteristic &lt;=90th centile (n=1048) &gt;90th centile (n=103) Total (n=1151) P-value PRL (ng/ml): Median (IQ range) 137.9 (89.3-221.6) 177.5 (118.9-229.5) 139.9 (91.7-222.2) 0.02 hPL (μg/ml): Median (IQ range) 177.2 (147.1-212.9) 203.1 (149.7-239.2) 179.4 (147.5-215.5) 0.01 GH2 (ng/ml): Median (IQ range) 4.1 (3.1-5.7) 4.5 (3.1-5.6) 4.2 (3.1-5.7) 0.74 Insulin (uU/L): Median (IQ range) 14.1 (6.8-30.1) 20.9 (7.0-39.8) 14.6 (6.8-31.9) 0.14 HOMA-IR: Median (IQ range) 3.3 (1.6-7.5) 5.0 (1.6-9.9) 3.5 (1.6-7.8) 0.13 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.0-5.9) 5.4 (5.0-5.8) 0.29 Serum folate concentration (nM): Median (IQ range) 36.0 (28.2-42.8) 38.0 (30.3-42.8) 36.1 (28.3-42.8) 0.36 B12 concentration (pM): Median (IQ range) 243.0 (193.0-305.0) 255.5 (203.8-330.2) 245.0 (195.0-309.0) 0.09 Folate:B12 ratio: Median (IQ range) 143.7 (104.4-208.7) 146.8 (99.1-211.0) 144.6 (103.5-208.8) 0.84 Active B12 concentration (pM): Median (IQ range) 56.0 (43.0-73.0) 66.0 (49.0-81.0) 57.0 (43.0-74.0) 0.11 Folate:Active B12 ratio: Median (IQ range) 608.8 (435.2-901.0) 556.2 (455.8-871.4) 606.9 (438.3-898.4) 0.95 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.7) 4.4 (3.8-5.1) 0.09 Within STOP Characteristic &lt;=90th centile (n=1117) &gt;90th centile (n=129) Total (n=1246) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.5-118.1) 83.1 (51.8-141.3) 74.6 (48.5-118.7) 0.19 hPL (μg/ml): Median (IQ range) 60.3 (39.3-93.2) 60.9 (46.0-88.0) 60.3 (40.1-92.3) 0.30 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-2.2) 1.4 (0.9-2.4) 0.85 Insulin (uU/L): Median (IQ range) 10.4 (6.3-20.8) 10.4 (5.6-19.7) 10.4 (6.3-20.8) 0.78 HOMA-IR: Median (IQ range) 2.2 (1.2-4.4) 2.0 (1.3-4.3) 2.2 (1.3-4.4) 0.92 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.7 (4.5-5.1) 4.7 (4.4-5.1) 0.49 Serum folate concentration (nM): Median (IQ range) 40.4 (36.1-45.7) 40.9 (36.8-45.0) 40.5 (36.2-45.3) 0.52 B12 concentration (pM): Median (IQ range) 278.5 (216.8-356.0) 276.0 (231.0-363.5) 278.0 (218.0-356.0) 0.71 Folate:B12 ratio: Median (IQ range) 152.7 (114.8-222.8) 153.2 (116.2-212.1) 152.7 (114.9-221.7) 0.62 Active B12 concentration (pM): Median (IQ range) 64.5 (49.8-86.2) 70.0 (51.5-87.5) 65.0 (50.0-87.0) 0.25 Folate:Active B12 ratio: Median (IQ range) 630.7 (464.9-921.5) 615.5 (446.0-843.8) 628.0 (461.0-914.4) 0.44 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.7 (4.2-5.3) 4.8 (4.2-5.6) 0.08 Red cell folate (nmol/L): Median (IQ range) 1483.0 (1215.0-1781.0) 1508.0 (1236.0-1792.0) 1490.0 (1221.5-1786.0) 0.33 "],["prolactin-8.html", "10.1 Prolactin", " 10.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 14.49 (10.19, 20.59) &lt;0.0001 BW_gp&gt;90th centile 1.23 (1.05, 1.43) 0.009 StudySTOP 1.00 (0.90, 1.11) 1.00 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.91 (0.75, 1.11) 0.36 Estimated marginal means BW_gp Study response SE df lower.CL upper.CL &lt;=90th centile SCOPE 100.67 7.38 79.95 87.00 116.47 &gt;90th centile SCOPE 123.42 12.56 284.50 101.01 150.81 &lt;=90th centile STOP 100.68 7.26 74.78 87.21 116.22 &gt;90th centile STOP 112.77 10.15 178.48 94.43 134.68 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.23 (1.05, 1.43) 0.009 &gt;90th centile / &lt;=90th centile Study: STOP 1.12 (1.00, 1.26) 0.06 STOP / SCOPE : &lt;=90th centile 1.00 (0.90, 1.11) 1.0 STOP / SCOPE : &gt;90th centile 0.91 (0.74, 1.12) 0.4 "],["hpl-8.html", "10.2 HPL", " 10.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.82 (1.52, 2.18) &lt;0.0001 BW_gp&gt;90th centile 1.11 (1.02, 1.20) 0.01 StudySTOP 1.12 (1.05, 1.18) 0.0002 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.03 (0.93, 1.14) 0.59 Estimated marginal means BW_gp Study response SE df lower.CL upper.CL &lt;=90th centile SCOPE 94.38 2.42 134.20 89.72 99.29 &gt;90th centile SCOPE 104.86 4.76 929.04 95.92 114.64 &lt;=90th centile STOP 105.24 2.61 116.61 100.20 110.53 &gt;90th centile STOP 120.27 4.66 594.72 111.45 129.78 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.11 (1.02, 1.20) 0.01 &gt;90th centile / &lt;=90th centile Study: STOP 1.14 (1.07, 1.22) &lt;0.0001 STOP / SCOPE : &lt;=90th centile 1.12 (1.05, 1.18) 0.0002 STOP / SCOPE : &gt;90th centile 1.15 (1.03, 1.28) 0.01 "],["gh2-8.html", "10.3 GH2", " 10.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 BW_gp&gt;90th centile 1.03 (0.92, 1.15) 0.63 StudySTOP 0.99 (0.91, 1.06) 0.72 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.98 (0.85, 1.14) 0.82 Estimated marginal means BW_gp Study response SE df lower.CL upper.CL &lt;=90th centile SCOPE 2.51 0.07 358.17 2.38 2.64 &gt;90th centile SCOPE 2.58 0.15 1942.61 2.30 2.90 &lt;=90th centile STOP 2.47 0.06 285.10 2.36 2.60 &gt;90th centile STOP 2.50 0.12 1613.67 2.28 2.75 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.03 (0.92, 1.15) 0.6 &gt;90th centile / &lt;=90th centile Study: STOP 1.01 (0.92, 1.11) 0.8 STOP / SCOPE : &lt;=90th centile 0.99 (0.91, 1.06) 0.7 STOP / SCOPE : &gt;90th centile 0.97 (0.83, 1.13) 0.7 "],["insulin-6.html", "10.4 Insulin", " 10.4 Insulin GEE for repeated measures. Model summary Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 14.67 0.72 Inf 13.32 16.16 &gt;90th centile SCOPE 16.56 2.07 Inf 12.97 21.16 &lt;=90th centile STOP 11.90 0.44 Inf 11.07 12.80 &gt;90th centile STOP 11.94 1.04 Inf 10.07 14.16 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.13 (0.88, 1.45) 0.3 &gt;90th centile / &lt;=90th centile Study: STOP 1.00 (0.85, 1.19) 1.0 STOP / SCOPE : &lt;=90th centile 0.81 (0.70, 0.94) 0.005 STOP / SCOPE : &gt;90th centile 0.72 (0.53, 0.98) 0.04 "],["homa-ir-6.html", "10.5 HOMA-IR", " 10.5 HOMA-IR GEE for repeated measures. Model summary Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 3.56 0.19 Inf 3.21 3.94 &gt;90th centile SCOPE 4.09 0.53 Inf 3.16 5.28 &lt;=90th centile STOP 2.49 0.10 Inf 2.31 2.69 &gt;90th centile STOP 2.52 0.23 Inf 2.11 3.01 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.15 (0.89, 1.49) 0.3 &gt;90th centile / &lt;=90th centile Study: STOP 1.01 (0.85, 1.21) 0.9 STOP / SCOPE : &lt;=90th centile 0.70 (0.60, 0.82) &lt;0.0001 STOP / SCOPE : &gt;90th centile 0.62 (0.45, 0.85) 0.003 "],["glucose-6.html", "10.6 Glucose", " 10.6 Glucose GEE for repeated measures. Model summary Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 5.46 0.05 Inf 5.36 5.56 &gt;90th centile SCOPE 5.72 0.14 Inf 5.46 5.99 &lt;=90th centile STOP 4.72 0.03 Inf 4.65 4.79 &gt;90th centile STOP 4.90 0.13 Inf 4.66 5.15 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.05 (1.00, 1.10) 0.06 &gt;90th centile / &lt;=90th centile Study: STOP 1.04 (0.99, 1.09) 0.2 STOP / SCOPE : &lt;=90th centile 0.86 (0.84, 0.89) &lt;0.0001 STOP / SCOPE : &gt;90th centile 0.86 (0.80, 0.92) &lt;0.0001 "],["hormone-models.html", "11 Hormone Models", " 11 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 33 0 15wks 891 1276 "],["raw-plots.html", "11.1 Raw plots", " 11.1 Raw plots "],["scope-vs-stop.html", "11.2 SCOPE vs STOP", " 11.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Fit GEE models for Insulin, HOMA-IR and Glucose. Outcomes: Prolactin, hPL, GH2, Insulin, HOMA-IR, Glucose (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Random intercepts for Study ID and Plate 11.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 11.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 11.2.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 11.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 11.2.5 Comparisons Hormone Contrast Ratio of Geometric means (95% CI) P-value Prolactin STOP / SCOPE 1.23 (0.89, 1.69) 0.2 Prolactin STOP / SCOPE 0.95 (0.84, 1.07) 0.4 HPL STOP / SCOPE 0.55 (0.46, 0.65) &lt;0.0001 HPL STOP / SCOPE 1.29 (1.21, 1.38) &lt;0.0001 GH2 STOP / SCOPE 0.55 (0.44, 0.70) &lt;0.0001 GH2 STOP / SCOPE 1.12 (1.02, 1.22) 0.01 Insulin STOP / SCOPE 0.56 (0.35, 0.90) 0.02 Insulin STOP / SCOPE 0.88 (0.74, 1.04) 0.1 HOMA.IR STOP / SCOPE 0.47 (0.29, 0.76) 0.002 HOMA.IR STOP / SCOPE 0.76 (0.64, 0.91) 0.003 GLUC3_mmol.L STOP / SCOPE 0.88 (0.78, 1.00) 0.05 GLUC3_mmol.L STOP / SCOPE 0.86 (0.83, 0.89) &lt;0.0001 11.2.6 Plots for GA "],["session-info-4.html", "12 Session info", " 12 Session info Results generated on: 2023-05-19 18:26:18.750781 Click for more details sessionInfo() ## R version 4.2.3 (2023-03-15) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3 ## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## attached base packages: ## [1] parallel grid stats graphics grDevices utils datasets ## [8] methods base ## ## other attached packages: ## [1] ggpubr_0.6.0 car_3.1-2 carData_3.0-5 xlsx_0.6.5 ## [5] geepack_1.3.9 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] emmeans_1.8.5 lmerTest_3.1-3 lme4_1.1-32 Matrix_1.5-4 ## [13] readxl_1.4.2 Hmisc_5.0-1 fontawesome_0.5.1 htmlwidgets_1.6.2 ## [17] kableExtra_1.3.4 knitr_1.42 rmarkdown_2.21 ggplot2_3.4.2 ## [21] devtools_2.4.5 usethis_2.1.6 pander_0.6.5 magrittr_2.0.3 ## [25] gridExtra_2.3 nvimcom_0.9-75 ## ## loaded via a namespace (and not attached): ## [1] TH.data_1.1-2 minqa_1.2.5 colorspace_2.1-0 ## [4] ggsignif_0.6.4 ellipsis_0.3.2 estimability_1.4.1 ## [7] htmlTable_2.4.1 base64enc_0.1-3 fs_1.6.1 ## [10] rstudioapi_0.14 farver_2.1.1 remotes_2.4.2 ## [13] fansi_1.0.4 mvtnorm_1.1-3 xml2_1.3.3 ## [16] codetools_0.2-19 splines_4.2.3 cachem_1.0.7 ## [19] pkgload_1.3.2 Formula_1.2-5 jsonlite_1.8.4 ## [22] nloptr_2.0.3 rJava_1.0-6 broom_1.0.4 ## [25] cluster_2.1.4 shiny_1.7.4 compiler_4.2.3 ## [28] httr_1.4.5 backports_1.4.1 fastmap_1.1.1 ## [31] cli_3.6.1 later_1.3.0 htmltools_0.5.5 ## [34] prettyunits_1.1.1 tools_4.2.3 coda_0.19-4 ## [37] gtable_0.3.3 glue_1.6.2 dplyr_1.1.2 ## [40] Rcpp_1.0.10 cellranger_1.1.0 jquerylib_0.1.4 ## [43] vctrs_0.6.2 svglite_2.1.1 nlme_3.1-162 ## [46] xfun_0.39 stringr_1.5.0 xlsxjars_0.6.1 ## [49] ps_1.7.5 rvest_1.0.3 mime_0.12 ## [52] miniUI_0.1.1.1 lifecycle_1.0.3 rstatix_0.7.2 ## [55] MASS_7.3-58.3 zoo_1.8-12 scales_1.2.1 ## [58] promises_1.2.0.1 sandwich_3.0-2 yaml_2.3.7 ## [61] memoise_2.0.1 sass_0.4.5 rpart_4.1.19 ## [64] stringi_1.7.12 highr_0.10 checkmate_2.1.0 ## [67] boot_1.3-28.1 pkgbuild_1.4.0 rlang_1.1.0 ## [70] pkgconfig_2.0.3 systemfonts_1.0.4 evaluate_0.20 ## [73] lattice_0.21-8 purrr_1.0.1 labeling_0.4.2 ## [76] processx_3.8.1 tidyselect_1.2.0 bookdown_0.33 ## [79] R6_2.5.1 generics_0.1.3 profvis_0.3.7 ## [82] multcomp_1.4-23 mgcv_1.8-42 pillar_1.9.0 ## [85] foreign_0.8-84 withr_2.5.0 abind_1.4-5 ## [88] survival_3.5-5 nnet_7.3-18 tibble_3.2.1 ## [91] crayon_1.5.2 utf8_1.2.3 urlchecker_1.0.1 ## [94] data.table_1.14.8 callr_3.7.3 digest_0.6.31 ## [97] webshot_0.5.4 xtable_1.8-4 tidyr_1.3.0 ## [100] httpuv_1.6.9 numDeriv_2016.8-1.1 munsell_0.5.0 ## [103] viridisLite_0.4.1 bslib_0.4.2 sessioninfo_1.2.2 "],["part-uncomplicated-pregnancies.html", "(PART*) Uncomplicated Pregnancies", " (PART*) Uncomplicated Pregnancies "],["descriptives-1.html", "13 Descriptives", " 13 Descriptives Descriptives on raw data. Tables in this section are descriptives on raw data. They have not been adjusted for GA at sampling. Model results with adjustments are in the next section. Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value PRL (ng/ml): Mean (SD) 184.4 (193.4) 101.3 (112.3) 134.1 (155.0) &lt;0.0001 hPL (μg/ml): Mean (SD) 188.4 (57.8) 76.7 (50.5) 121.4 (76.6) &lt;0.0001 GH2 (ng/ml): Mean (SD) 4.6 (2.0) 1.9 (1.5) 3.0 (2.2) &lt;0.0001 Insulin (uU/L): Mean (SD) 21.8 (23.0) 15.4 (18.2) 18.0 (20.5) &lt;0.0001 HOMA-IR: Mean (SD) 5.6 (6.8) 3.4 (4.3) 4.3 (5.5) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 "],["by-study-1.html", "13.1 By Study", " 13.1 By Study 13.1.1 Demographics Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 25.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 694 (97.6) 1285 (97.7) &gt;=35 13 (2.2) 17 (2.4) 30 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 25.3 (22.4-29.5) 25.2 (22.2-29.4) 0.27 Maternal BMI (category): N(%) 0.41 Missing 0 (0.0) 1 (0.1) 1 (0.1) &lt;20 64 (10.6) 55 (7.7) 119 (9.0) &gt;=20 to &lt;25 228 (37.7) 278 (39.1) 506 (38.5) &gt;=25 to &lt;30 176 (29.1) 212 (29.8) 388 (29.5) &gt;=30 to &lt;40 117 (19.4) 136 (19.1) 253 (19.2) &gt;=40 19 (3.1) 29 (4.1) 48 (3.7) SEI: Median (IQ range) 24.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-36.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 555 (91.9) 595 (83.7) 1150 (87.5) Maori 3 (0.5) 0 (0.0) 3 (0.2) Pacific Islander 0 (0.0) 3 (0.4) 3 (0.2) South East and Far East 25 (4.1) 30 (4.2) 55 (4.2) Indian 2 (0.3) 27 (3.8) 29 (2.2) African 3 (0.5) 11 (1.5) 14 (1.1) Middle-eastern 4 (0.7) 18 (2.5) 22 (1.7) Hispanic 0 (0.0) 2 (0.3) 2 (0.2) Aboriginal 9 (1.5) 13 (1.8) 22 (1.7) China and Japan 0 (0.0) 10 (1.4) 10 (0.8) Other 3 (0.5) 2 (0.3) 5 (0.4) Smoking: N(%) 0.002 Missing 0 (0.0) 6 (0.8) 6 (0.5) No 476 (78.8) 602 (84.7) 1078 (82.0) Yes 128 (21.2) 103 (14.5) 231 (17.6) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;800 335 (55.5) 134 (18.8) 469 (35.7) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;=400 66 (10.9) 7 (1.0) 73 (5.6) &gt;400 to &lt;800 269 (44.5) 127 (17.9) 396 (30.1) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 58 (9.6) 47 (6.6) 105 (8.0) 1-6x/week 222 (36.8) 203 (28.6) 425 (32.3) &gt;=1-&lt;3x/day 221 (36.6) 349 (49.1) 570 (43.3) &gt;=3x/day 103 (17.1) 101 (14.2) 204 (15.5) Leafy vege (1st trim): N(%) 0.52 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 60 (9.9) 73 (10.3) 133 (10.1) 1-2x/week 144 (23.8) 159 (22.4) 303 (23.0) 3-6x/week 220 (36.4) 235 (33.1) 455 (34.6) &gt;=1x/day 180 (29.8) 233 (32.8) 413 (31.4) Fast food (1st trim): N(%) 0.001 Missing 114 (18.9) 93 (13.1) 207 (15.7) Never 12 (2.0) 30 (4.2) 42 (3.2) &gt;0-&lt;2x/week 62 (10.3) 118 (16.6) 180 (13.7) &gt;=2-&lt;4x/week 249 (41.2) 261 (36.7) 510 (38.8) &gt;=4x/week 167 (27.6) 209 (29.4) 376 (28.6) Vigorous exercise: N(%) 0.71 Missing 3 (0.5) 5 (0.7) 8 (0.6) Never 390 (64.6) 439 (61.7) 829 (63.0) Once a week 148 (24.5) 179 (25.2) 327 (24.9) 2-3/wk 50 (8.3) 63 (8.9) 113 (8.6) 4-6/wk 7 (1.2) 12 (1.7) 19 (1.4) Daily 6 (1.0) 12 (1.7) 18 (1.4) More than once a day 0 (0.0) 1 (0.1) 1 (0.1) Moderate exercise: N(%) 0.17 Missing 3 (0.5) 7 (1.0) 10 (0.8) Never 248 (41.1) 266 (37.4) 514 (39.1) Once a week 146 (24.2) 173 (24.3) 319 (24.3) 2-3/wk 134 (22.2) 156 (21.9) 290 (22.1) 4-6/wk 36 (6.0) 49 (6.9) 85 (6.5) Daily 35 (5.8) 48 (6.8) 83 (6.3) More than once a day 2 (0.3) 12 (1.7) 14 (1.1) Recreational walking: N(%) 0.24 Missing 3 (0.5) 8 (1.1) 11 (0.8) Never 147 (24.3) 158 (22.2) 305 (23.2) Once a week 187 (31.0) 233 (32.8) 420 (31.9) 2-3/wk 161 (26.7) 170 (23.9) 331 (25.2) 4-6/wk 44 (7.3) 53 (7.5) 97 (7.4) Daily 52 (8.6) 83 (11.7) 135 (10.3) More than once a day 10 (1.7) 6 (0.8) 16 (1.2) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.5 (36.4-45.2) 39.2 (33.8-44.2) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 277.5 (219.0-355.0) 262.0 (206.0-339.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 155.9 (115.7-222.4) 150.5 (109.3-217.2) 0.0006 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 66.7 (24.7) 62.9 (24.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 670.7 (493.5-950.5) 634.4 (480.9-941.9) 0.05 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 61.0 (45.0-76.0) 59.3 (43.0-76.0) 0.02 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 199.0 (127.1-320.1) 156.1 (93.2-257.5) &lt;0.0001 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.6) 0.26 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.07 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.8 (9.7) 129.7 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 13.1.2 MetS Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 51 (7.2) 54 (4.1) No 525 (86.9) 624 (87.8) 1149 (87.4) Yes 76 (12.6) 36 (5.1) 112 (8.5) : Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 81.0 (74.0-89.0) 83.0 (76.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 4.6 (0.8) 5.0 (0.9) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.1 (0.9-1.4) 1.2 (0.9-1.5) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.7 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.7) 2.4 (0.7) 2.7 (0.8) &lt;0.0001 : Mean (SD) 107.8 (9.3) 113.9 (9.7) 111.0 (10.0) &lt;0.0001 : Mean (SD) 63.4 (7.5) 69.4 (8.2) 66.6 (8.4) &lt;0.0001 : Mean (SD) 78.2 (7.1) 84.2 (7.7) 81.4 (8.0) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;80 cm 168 (27.8) 329 (46.3) 497 (37.8) &gt;=80 cm 436 (72.2) 371 (52.2) 807 (61.4) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 10 (1.4) 10 (0.8) &lt;1.7 mmol/L 468 (77.5) 627 (88.2) 1095 (83.3) &gt;=1.7 mmol/L 136 (22.5) 74 (10.4) 210 (16.0) MetS criteria: HDL: N(%) 0.003 Missing 0 (0.0) 10 (1.4) 10 (0.8) &gt;=1.3 mmol/L 554 (91.7) 606 (85.2) 1160 (88.2) &lt;1.3 mmol/L 50 (8.3) 95 (13.4) 145 (11.0) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 3 (0.5) 10 (1.4) 13 (1.0) &lt;5.6 mmol/L 341 (56.5) 648 (91.1) 989 (75.2) &gt;=5.6 mmol/L 260 (43.0) 53 (7.5) 313 (23.8) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130 mmHg 596 (98.7) 634 (89.2) 1230 (93.5) &gt;=130 mmHg 8 (1.3) 44 (6.2) 52 (4.0) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;85 mmHg 602 (99.7) 654 (92.0) 1256 (95.5) &gt;=85 mmHg 2 (0.3) 24 (3.4) 26 (2.0) : Mean (SD) 0.0 (0.1) 0.1 (0.3) 0.1 (0.2) &lt;0.0001 CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 3.1 (1.3-6.0) 3.6 (1.7-6.9) &lt;0.0001 13.1.3 Outcomes Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 40.0 (39.1-40.9) 40.1 (39.3-40.9) 0.010 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3506.0 (3250.0-3786.0) 3526.0 (3270.0-3810.0) 0.03 : Mean (SD) 54.2 (25.1) 53.3 (26.1) 53.7 (25.7) 0.52 Baby sex: N(%) 0.53 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 291 (48.2) 356 (50.1) 647 (49.2) Female 313 (51.8) 355 (49.9) 668 (50.8) Mode of delivery: N(%) 0.14 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 361 (59.8) 382 (53.7) 743 (56.5) Operative vaginal 103 (17.1) 147 (20.7) 250 (19.0) Pre-labour LSCS 24 (4.0) 35 (4.9) 59 (4.5) LSCS in labour 116 (19.2) 147 (20.7) 263 (20.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) Induction of Labour: N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 470 (77.8) 415 (58.4) 885 (67.3) Yes 134 (22.2) 296 (41.6) 430 (32.7) "],["folate-vs-fa-supplement-1.html", "14 Folate vs FA supplement", " 14 Folate vs FA supplement 14.0.1 FA supp (3 categories) Characteristic None (n=171) &lt;800 (n=469) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 38.7 (32.2-44.2) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 254.5 (199.2-336.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 59.8 (23.4) 66.9 (25.0) 62.9 (24.5) 0.0004 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 151.4 (111.3-225.3) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 637.9 (482.6-1013.6) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.0008 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 57.0 (40.8-76.0) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=122) &lt;800 (n=335) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 37.8 (30.1-43.9) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 252.0 (196.8-327.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.005 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 59.0 (22.8) 65.1 (26.7) 58.8 (23.4) 0.0007 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 143.7 (107.5-210.1) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 618.7 (486.6-988.8) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.03 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 53.6 (38.6-75.0) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Click here for table within STOP Characteristic None (n=49) &lt;800 (n=134) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 39.8 (35.5-44.6) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.002 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 260.5 (205.0-347.2) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.06 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 62.3 (25.0) 67.6 (24.4) 67.4 (25.0) 0.04 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 171.1 (119.0-245.9) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.50 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 758.2 (480.3-1110.3) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.07 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 63.5 (49.2-79.8) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 14.0.2 FA supp (4 categories) Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 36.5 (29.7-42.0) 39.0 (32.7-44.4) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.8 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 255.0 (193.8-338.5) 254.5 (200.0-332.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 56.7 (21.6) 60.4 (23.7) 66.9 (25.0) 62.9 (24.5) 0.0009 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 141.7 (108.7-186.1) 152.4 (111.9-234.0) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 563.0 (487.9-894.8) 649.1 (483.2-1041.9) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.001 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 49.0 (35.7-69.0) 58.8 (42.1-76.4) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Click here for table within SCOPE Characteristic None (n=122) &lt;=400 (n=66) &gt;400 to &lt;800 (n=269) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 35.6 (28.9-41.6) 38.4 (30.4-44.2) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 251.0 (192.5-338.0) 252.0 (198.0-318.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.01 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 55.3 (21.3) 59.9 (23.2) 65.1 (26.7) 58.8 (23.4) 0.001 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 131.6 (107.4-184.5) 146.9 (107.8-228.4) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 563.0 (507.4-920.2) 629.2 (483.2-997.7) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.06 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 47.1 (35.5-62.8) 55.6 (40.0-75.8) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Click here for table within STOP Characteristic None (n=49) &lt;=400 (n=7) &gt;400 to &lt;800 (n=127) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 42.1 (36.6-56.3) 39.8 (35.4-44.5) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.006 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.1 (1.1) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 261.0 (203.5-315.5) 260.0 (205.0-346.5) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.12 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 68.0 (23.3) 61.8 (25.3) 67.6 (24.4) 67.4 (25.0) 0.09 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 180.2 (165.0-201.9) 168.0 (116.3-248.2) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.52 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 550.8 (476.6-682.4) 805.2 (504.9-1155.7) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.08 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 76.0 (63.5-104.0) 63.0 (49.0-78.5) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 "],["folate.html", "14.1 Folate", " 14.1 Folate 14.1.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0918622 0.0940957 32.858714 &lt;0.0001 *** folate_cat2&lt;800 0.4044411 0.0532352 7.597252 &lt;0.0001 *** folate_cat2&gt;=800 0.4779058 0.0612912 7.797297 &lt;0.0001 *** StudySTOP 0.4876934 0.0824564 5.914563 &lt;0.0001 *** f1_age 0.0132802 0.0029572 4.490775 &lt;0.0001 *** BMI -0.0056414 0.0023590 -2.391397 0.02 * folate_cat2&lt;800:StudySTOP -0.3899550 0.0960217 -4.061112 &lt;0.0001 *** folate_cat2&gt;=800:StudySTOP -0.3603296 0.0943408 -3.819446 0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.50 (1.29, 1.74) &lt;0.0001 SCOPE: &gt;=800/None 1.61 (1.36, 1.91) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.08 (0.94, 1.23) 1 STOP: &lt;800/None 1.01 (0.81, 1.27) 1 STOP: &gt;=800/None 1.12 (0.92, 1.37) 0.9 STOP: &gt;=800/&lt;800 1.11 (0.97, 1.26) 0.3 None: STOP/SCOPE 1.63 (1.30, 2.05) &lt;0.0001 &lt;800: STOP/SCOPE 1.10 (0.96, 1.27) 0.5 &gt;=800: STOP/SCOPE 1.14 (1.00, 1.29) 0.05 P-value adjustment: bonferroni method for 9 tests 14.1.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0905284 0.0940717 32.852890 &lt;0.0001 *** folate_cat3&lt;=400 0.3173159 0.0767843 4.132562 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4255637 0.0548854 7.753682 &lt;0.0001 *** folate_cat3&gt;=800 0.4775237 0.0612737 7.793285 &lt;0.0001 *** StudySTOP 0.4873285 0.0824325 5.911846 &lt;0.0001 *** f1_age 0.0134131 0.0029575 4.535215 &lt;0.0001 *** BMI -0.0057020 0.0023587 -2.417392 0.02 * folate_cat3&lt;=400:StudySTOP -0.2254040 0.2062415 -1.092913 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4155745 0.0974396 -4.264946 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3600711 0.0943133 -3.817818 0.0001 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.37 (1.09, 1.72) 0.0006 SCOPE: &gt;400 to &lt;800/None 1.53 (1.30, 1.80) &lt;0.0001 SCOPE: &gt;=800/None 1.61 (1.34, 1.93) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.17 (0.94, 1.46) 0.5 SCOPE: &gt;=800/&gt;400 to &lt;800 1.05 (0.91, 1.22) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.90 (0.73, 1.10) 1 STOP: &lt;=400/None 1.10 (0.62, 1.93) 1 STOP: &gt;400 to &lt;800/None 1.01 (0.80, 1.28) 1 STOP: &gt;=800/None 1.12 (0.91, 1.39) 1 STOP: &gt;=800/&lt;=400 1.03 (0.60, 1.75) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.96, 1.28) 0.4 STOP: &lt;=400/&gt;400 to &lt;800 1.09 (0.63, 1.87) 1 None: STOP/SCOPE 1.63 (1.28, 2.08) &lt;0.0001 &lt;=400: STOP/SCOPE 1.30 (0.74, 2.28) 1 &gt;400 to &lt;800: STOP/SCOPE 1.07 (0.92, 1.26) 1 &gt;=800: STOP/SCOPE 1.14 (0.99, 1.30) 0.10 P-value adjustment: bonferroni method for 16 tests "],["b12.html", "14.2 B12", " 14.2 B12 14.2.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4221270 0.0745587 72.7228994 &lt;0.0001 *** folate_cat2&lt;800 0.1122967 0.0421820 2.6621912 0.008 ** folate_cat2&gt;=800 0.1217016 0.0485654 2.5059308 0.01 * StudySTOP 0.1714030 0.0653361 2.6234043 0.009 ** f1_age 0.0106478 0.0023432 4.5440955 &lt;0.0001 *** BMI -0.0098606 0.0018692 -5.2752170 &lt;0.0001 *** folate_cat2&lt;800:StudySTOP -0.1600879 0.0760849 -2.1040696 0.04 * folate_cat2&gt;=800:StudySTOP -0.0702722 0.0747530 -0.9400586 0.35 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.12 (1.00, 1.26) 0.07 SCOPE: &gt;=800/None 1.13 (0.99, 1.29) 0.1 SCOPE: &gt;=800/&lt;800 1.01 (0.91, 1.12) 1 STOP: &lt;800/None 0.95 (0.80, 1.14) 1 STOP: &gt;=800/None 1.05 (0.90, 1.23) 1 STOP: &gt;=800/&lt;800 1.10 (1.00, 1.23) 0.07 None: STOP/SCOPE 1.19 (0.99, 1.42) 0.08 &lt;800: STOP/SCOPE 1.01 (0.91, 1.13) 1 &gt;=800: STOP/SCOPE 1.11 (1.00, 1.22) 0.05 P-value adjustment: bonferroni method for 9 tests 14.2.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4221799 0.0746248 72.6592525 &lt;0.0001 *** folate_cat3&lt;=400 0.1116077 0.0609111 1.8323054 0.07 ns folate_cat3&gt;400 to &lt;800 0.1124641 0.0435392 2.5830535 0.010 ** folate_cat3&gt;=800 0.1216999 0.0486069 2.5037563 0.01 * StudySTOP 0.1713993 0.0653917 2.6211177 0.009 ** f1_age 0.0106483 0.0023461 4.5386395 &lt;0.0001 *** BMI -0.0098630 0.0018711 -5.2711581 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.1894511 0.1636063 -1.1579699 0.25 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1585432 0.0772964 -2.0511079 0.04 * folate_cat3&gt;=800:StudySTOP -0.0702675 0.0748164 -0.9391987 0.35 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.12 (0.93, 1.34) 1 SCOPE: &gt;400 to &lt;800/None 1.12 (0.98, 1.27) 0.2 SCOPE: &gt;=800/None 1.13 (0.98, 1.30) 0.2 SCOPE: &gt;=800/&lt;=400 1.01 (0.85, 1.20) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.01 (0.90, 1.14) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 1.00 (0.85, 1.17) 1 STOP: &lt;=400/None 0.93 (0.59, 1.45) 1 STOP: &gt;400 to &lt;800/None 0.95 (0.79, 1.15) 1 STOP: &gt;=800/None 1.05 (0.89, 1.25) 1 STOP: &gt;=800/&lt;=400 1.14 (0.75, 1.74) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.10 (0.98, 1.24) 0.2 STOP: &lt;=400/&gt;400 to &lt;800 0.97 (0.63, 1.49) 1 None: STOP/SCOPE 1.19 (0.98, 1.44) 0.1 &lt;=400: STOP/SCOPE 0.98 (0.63, 1.53) 1 &gt;400 to &lt;800: STOP/SCOPE 1.01 (0.89, 1.15) 1 &gt;=800: STOP/SCOPE 1.11 (0.99, 1.23) 0.09 P-value adjustment: bonferroni method for 16 tests "],["homocysteine.html", "14.3 Homocysteine", " 14.3 Homocysteine 14.3.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5756808 0.0444031 35.4858518 &lt;0.0001 *** folate_cat2&lt;800 -0.1151020 0.0251167 -4.5826830 &lt;0.0001 *** folate_cat2&gt;=800 -0.1623759 0.0289179 -5.6150683 &lt;0.0001 *** StudySTOP 0.0302406 0.0389037 0.7773193 0.44 ns f1_age 0.0005980 0.0013961 0.4283576 0.67 ns BMI 0.0002349 0.0011148 0.2106636 0.83 ns folate_cat2&lt;800:StudySTOP 0.1285288 0.0453036 2.8370549 0.005 ** folate_cat2&gt;=800:StudySTOP 0.0856836 0.0445148 1.9248354 0.05 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 0.89 (0.83, 0.96) &lt;0.0001 SCOPE: &gt;=800/None 0.85 (0.78, 0.92) &lt;0.0001 SCOPE: &gt;=800/&lt;800 0.95 (0.89, 1.02) 0.4 STOP: &lt;800/None 1.01 (0.91, 1.13) 1 STOP: &gt;=800/None 0.93 (0.84, 1.02) 0.2 STOP: &gt;=800/&lt;800 0.91 (0.86, 0.97) 0.0005 None: STOP/SCOPE 1.03 (0.93, 1.15) 1 &lt;800: STOP/SCOPE 1.17 (1.10, 1.25) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.06, 1.19) &lt;0.0001 P-value adjustment: bonferroni method for 9 tests 14.3.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5755699 0.0444379 35.4555061 &lt;0.0001 *** folate_cat3&lt;=400 -0.1268829 0.0362651 -3.4987635 0.0005 *** folate_cat3&gt;400 to &lt;800 -0.1122455 0.0259222 -4.3300917 &lt;0.0001 *** folate_cat3&gt;=800 -0.1624262 0.0289397 -5.6125727 &lt;0.0001 *** StudySTOP 0.0301903 0.0389329 0.7754434 0.44 ns f1_age 0.0006154 0.0013977 0.4402927 0.66 ns BMI 0.0002245 0.0011159 0.2012125 0.84 ns folate_cat3&lt;=400:StudySTOP 0.1173646 0.0974071 1.2048878 0.23 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.1269687 0.0460204 2.7589678 0.006 ** folate_cat3&gt;=800:StudySTOP 0.0857212 0.0445481 1.9242383 0.05 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 0.88 (0.79, 0.98) 0.008 SCOPE: &gt;400 to &lt;800/None 0.89 (0.83, 0.97) 0.0003 SCOPE: &gt;=800/None 0.85 (0.78, 0.93) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 0.97 (0.87, 1.07) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.95 (0.89, 1.02) 0.6 SCOPE: &lt;=400/&gt;400 to &lt;800 0.99 (0.90, 1.08) 1 STOP: &lt;=400/None 0.99 (0.76, 1.29) 1 STOP: &gt;400 to &lt;800/None 1.01 (0.91, 1.14) 1 STOP: &gt;=800/None 0.93 (0.84, 1.02) 0.4 STOP: &gt;=800/&lt;=400 0.94 (0.73, 1.20) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.91 (0.85, 0.98) 0.001 STOP: &lt;=400/&gt;400 to &lt;800 0.98 (0.75, 1.26) 1 None: STOP/SCOPE 1.03 (0.92, 1.16) 1 &lt;=400: STOP/SCOPE 1.16 (0.89, 1.51) 1 &gt;400 to &lt;800: STOP/SCOPE 1.17 (1.09, 1.26) &lt;0.0001 &gt;=800: STOP/SCOPE 1.12 (1.05, 1.20) &lt;0.0001 P-value adjustment: bonferroni method for 16 tests "],["active-b12.html", "14.4 Active B12", " 14.4 Active B12 14.4.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6122690 0.1028613 35.117846 &lt;0.0001 *** folate_cat2&lt;800 0.1367106 0.0555196 2.462387 0.01 * folate_cat2&gt;=800 0.2164003 0.0633348 3.416767 0.0007 *** StudySTOP 0.4286753 0.0919347 4.662825 &lt;0.0001 *** f1_age 0.0076438 0.0033803 2.261274 0.02 * BMI 0.0029555 0.0026004 1.136572 0.26 ns folate_cat2&lt;800:StudySTOP -0.4092640 0.1100691 -3.718247 0.0002 *** folate_cat2&gt;=800:StudySTOP -0.3901251 0.1049792 -3.716212 0.0002 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.15 (0.98, 1.34) 0.1 SCOPE: &gt;=800/None 1.24 (1.04, 1.48) 0.006 SCOPE: &gt;=800/&lt;800 1.08 (0.94, 1.25) 1 STOP: &lt;800/None 0.76 (0.58, 0.99) 0.04 STOP: &gt;=800/None 0.84 (0.67, 1.06) 0.4 STOP: &gt;=800/&lt;800 1.10 (0.94, 1.30) 0.8 None: STOP/SCOPE 1.54 (1.19, 1.98) &lt;0.0001 &lt;800: STOP/SCOPE 1.02 (0.86, 1.21) 1 &gt;=800: STOP/SCOPE 1.04 (0.90, 1.20) 1 P-value adjustment: bonferroni method for 9 tests 14.4.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6107066 0.1029489 35.0727978 &lt;0.0001 *** folate_cat3&lt;=400 0.0765721 0.0837526 0.9142653 0.36 ns folate_cat3&gt;400 to &lt;800 0.1509771 0.0574959 2.6258750 0.009 ** folate_cat3&gt;=800 0.2164867 0.0633662 3.4164408 0.0007 *** StudySTOP 0.4288045 0.0919802 4.6619199 &lt;0.0001 *** f1_age 0.0076339 0.0033820 2.2571861 0.02 * BMI 0.0030216 0.0026033 1.1606941 0.25 ns folate_cat3&lt;=400:StudySTOP -0.2189817 0.2258022 -0.9697942 0.33 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4336678 0.1120755 -3.8694268 0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3903496 0.1050317 -3.7164949 0.0002 *** Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.08 (0.84, 1.38) 1 SCOPE: &gt;400 to &lt;800/None 1.16 (0.98, 1.38) 0.1 SCOPE: &gt;=800/None 1.24 (1.03, 1.50) 0.01 SCOPE: &gt;=800/&lt;=400 1.15 (0.90, 1.47) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.07 (0.91, 1.26) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.93 (0.74, 1.17) 1 STOP: &lt;=400/None 0.87 (0.47, 1.62) 1 STOP: &gt;400 to &lt;800/None 0.75 (0.57, 1.00) 0.06 STOP: &gt;=800/None 0.84 (0.65, 1.08) 0.6 STOP: &gt;=800/&lt;=400 0.97 (0.54, 1.73) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.11 (0.93, 1.33) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.15 (0.63, 2.09) 1 None: STOP/SCOPE 1.54 (1.17, 2.02) &lt;0.0001 &lt;=400: STOP/SCOPE 1.23 (0.67, 2.28) 1 &gt;400 to &lt;800: STOP/SCOPE 1.00 (0.82, 1.20) 1 &gt;=800: STOP/SCOPE 1.04 (0.89, 1.21) 1 P-value adjustment: bonferroni method for 16 tests "],["folateb12.html", "14.5 Folate:B12", " 14.5 Folate:B12 14.5.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5774904 0.1135284 40.3202170 &lt;0.0001 *** folate_cat2&lt;800 0.2921444 0.0642294 4.5484542 &lt;0.0001 *** folate_cat2&gt;=800 0.3562042 0.0739492 4.8168797 &lt;0.0001 *** StudySTOP 0.3162904 0.0994854 3.1792654 0.002 ** f1_age 0.0026324 0.0035680 0.7377927 0.46 ns BMI 0.0042192 0.0028462 1.4823900 0.14 ns folate_cat2&lt;800:StudySTOP -0.2298671 0.1158523 -1.9841398 0.05 * folate_cat2&gt;=800:StudySTOP -0.2900574 0.1138242 -2.5482928 0.01 * Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.34 (1.12, 1.60) &lt;0.0001 SCOPE: &gt;=800/None 1.43 (1.16, 1.75) &lt;0.0001 SCOPE: &gt;=800/&lt;800 1.07 (0.91, 1.26) 1 STOP: &lt;800/None 1.06 (0.81, 1.39) 1 STOP: &gt;=800/None 1.07 (0.84, 1.36) 1 STOP: &gt;=800/&lt;800 1.00 (0.86, 1.18) 1 None: STOP/SCOPE 1.37 (1.04, 1.81) 0.01 &lt;800: STOP/SCOPE 1.09 (0.92, 1.29) 1 &gt;=800: STOP/SCOPE 1.03 (0.88, 1.20) 1 P-value adjustment: bonferroni method for 9 tests 14.5.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5761038 0.1135359 40.3053372 &lt;0.0001 *** folate_cat3&lt;=400 0.2057082 0.0926716 2.2197548 0.03 * folate_cat3&gt;400 to &lt;800 0.3130996 0.0662416 4.7266319 &lt;0.0001 *** folate_cat3&gt;=800 0.3558238 0.0739518 4.8115659 &lt;0.0001 *** StudySTOP 0.3159292 0.0994885 3.1755350 0.002 ** f1_age 0.0027648 0.0035695 0.7745620 0.44 ns BMI 0.0041610 0.0028468 1.4616578 0.14 ns folate_cat3&lt;=400:StudySTOP -0.0359529 0.2489145 -0.1444386 0.89 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2570313 0.1176006 -2.1856289 0.03 * folate_cat3&gt;=800:StudySTOP -0.2898036 0.1138275 -2.5459896 0.01 * Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.23 (0.93, 1.62) 0.4 SCOPE: &gt;400 to &lt;800/None 1.37 (1.12, 1.66) &lt;0.0001 SCOPE: &gt;=800/None 1.43 (1.15, 1.78) &lt;0.0001 SCOPE: &gt;=800/&lt;=400 1.16 (0.89, 1.51) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 1.04 (0.87, 1.25) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.90 (0.70, 1.15) 1 STOP: &lt;=400/None 1.19 (0.60, 2.35) 1 STOP: &gt;400 to &lt;800/None 1.06 (0.79, 1.41) 1 STOP: &gt;=800/None 1.07 (0.83, 1.38) 1 STOP: &gt;=800/&lt;=400 0.90 (0.47, 1.72) 1 STOP: &gt;=800/&gt;400 to &lt;800 1.01 (0.85, 1.20) 1 STOP: &lt;=400/&gt;400 to &lt;800 1.12 (0.58, 2.16) 1 None: STOP/SCOPE 1.37 (1.02, 1.84) 0.02 &lt;=400: STOP/SCOPE 1.32 (0.67, 2.60) 1 &gt;400 to &lt;800: STOP/SCOPE 1.06 (0.88, 1.28) 1 &gt;=800: STOP/SCOPE 1.03 (0.87, 1.21) 1 P-value adjustment: bonferroni method for 16 tests "],["folateactive-b12.html", "14.6 Folate:Active B12", " 14.6 Folate:Active B12 14.6.1 FA supp (3 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5761805 0.1554473 42.3048944 &lt;0.0001 *** folate_cat2&lt;800 0.2297706 0.0839029 2.7385302 0.006 ** folate_cat2&gt;=800 0.2003714 0.0957136 2.0934487 0.04 * StudySTOP 0.0302250 0.1389345 0.2175484 0.83 ns f1_age 0.0001884 0.0051084 0.0368818 0.97 ns BMI -0.0097795 0.0039298 -2.4885510 0.01 * folate_cat2&lt;800:StudySTOP 0.0872974 0.1663398 0.5248135 0.60 ns folate_cat2&gt;=800:StudySTOP 0.0707165 0.1586479 0.4457452 0.66 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;800/None 1.26 (1.00, 1.59) 0.06 SCOPE: &gt;=800/None 1.22 (0.94, 1.59) 0.3 SCOPE: &gt;=800/&lt;800 0.97 (0.78, 1.21) 1 STOP: &lt;800/None 1.37 (0.92, 2.05) 0.2 STOP: &gt;=800/None 1.31 (0.92, 1.87) 0.3 STOP: &gt;=800/&lt;800 0.96 (0.75, 1.22) 1 None: STOP/SCOPE 1.03 (0.70, 1.52) 1 &lt;800: STOP/SCOPE 1.12 (0.87, 1.45) 1 &gt;=800: STOP/SCOPE 1.11 (0.89, 1.37) 1 P-value adjustment: bonferroni method for 9 tests 14.6.2 FA supp (4 categories) Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5810099 0.1555581 42.3058016 &lt;0.0001 *** folate_cat3&lt;=400 0.1714131 0.1265520 1.3544877 0.18 ns folate_cat3&gt;400 to &lt;800 0.2435284 0.0868776 2.8031201 0.005 ** folate_cat3&gt;=800 0.2002737 0.0957477 2.0916821 0.04 * StudySTOP 0.0299622 0.1389842 0.2155798 0.83 ns f1_age 0.0001536 0.0051103 0.0300603 0.98 ns BMI -0.0099293 0.0039336 -2.5241999 0.01 * folate_cat3&lt;=400:StudySTOP -0.1628045 0.3411921 -0.4771638 0.63 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0977125 0.1693485 0.5769909 0.56 ns folate_cat3&gt;=800:StudySTOP 0.0712919 0.1587051 0.4492099 0.65 ns Contrast Ratio of Geometric means (95% CI) P-value SCOPE: &lt;=400/None 1.19 (0.82, 1.73) 1 SCOPE: &gt;400 to &lt;800/None 1.28 (0.99, 1.65) 0.08 SCOPE: &gt;=800/None 1.22 (0.92, 1.62) 0.6 SCOPE: &gt;=800/&lt;=400 1.03 (0.71, 1.49) 1 SCOPE: &gt;=800/&gt;400 to &lt;800 0.96 (0.75, 1.22) 1 SCOPE: &lt;=400/&gt;400 to &lt;800 0.93 (0.66, 1.32) 1 STOP: &lt;=400/None 1.01 (0.39, 2.58) 1 STOP: &gt;400 to &lt;800/None 1.41 (0.91, 2.17) 0.3 STOP: &gt;=800/None 1.31 (0.90, 1.91) 0.5 STOP: &gt;=800/&lt;=400 1.30 (0.54, 3.13) 1 STOP: &gt;=800/&gt;400 to &lt;800 0.93 (0.71, 1.22) 1 STOP: &lt;=400/&gt;400 to &lt;800 0.72 (0.29, 1.77) 1 None: STOP/SCOPE 1.03 (0.68, 1.56) 1 &lt;=400: STOP/SCOPE 0.88 (0.35, 2.21) 1 &gt;400 to &lt;800: STOP/SCOPE 1.14 (0.85, 1.52) 1 &gt;=800: STOP/SCOPE 1.11 (0.88, 1.39) 1 P-value adjustment: bonferroni method for 16 tests "],["fa-supp-3-categories-9.html", "15 FA supp: 3 categories", " 15 FA supp: 3 categories Characteristic None (n=171) &lt;800 (n=469) &gt;=800 (n=588) Total (n=1228) P-value Prolactin: Median (IQ range) 120.7 (74.1-194.3) 120.0 (79.1-184.2) 76.5 (49.8-130.4) 98.4 (59.2-160.6) &lt;0.0001 HPL: Median (IQ range) 155.9 (95.6-206.4) 157.2 (91.4-202.8) 71.3 (44.7-134.7) 114.2 (55.9-181.1) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.0-5.0) 3.5 (2.2-4.9) 1.7 (1.0-3.2) 2.6 (1.3-4.2) &lt;0.0001 LME for duplicated or repeated measures shown on next page. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat2&quot; mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod1)}) mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) mod_sum &lt;- lapply(mod_ls,extract.ci.mod,rc=2,eff.exp=T) #model summary mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) names(mod_sum) &lt;- names(mod_em_sum) &lt;- names(mod_em_est) &lt;- names(mod_ls) "],["prolactin-9.html", "15.1 Prolactin", " 15.1 Prolactin cat(&quot;\\n&lt;b&gt;Model summary&lt;/b&gt;\\n&quot;) Model summary mod_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Var Effect P (Intercept) 12.47 (7.75, 20.06) &lt;0.0001 folate_cat2&lt;800 1.02 (0.88, 1.18) 0.83 folate_cat2&gt;=800 1.14 (0.96, 1.35) 0.13 StudySTOP 1.24 (0.97, 1.59) 0.09 GA_samp 1.17 (1.13, 1.20) &lt;0.0001 folate_cat2&lt;800:StudySTOP 1.00 (0.77, 1.29) 0.98 folate_cat2&gt;=800:StudySTOP 0.68 (0.53, 0.89) 0.004 cat(&quot;\\n&lt;b&gt;Estimated marginal means&lt;/b&gt;\\n&quot;) Estimated marginal means mod_em_est[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 94.59 9.53 203.66 77.55 115.38 &lt;800 SCOPE 96.14 8.39 119.20 80.89 114.27 &gt;=800 SCOPE 107.83 10.39 173.62 89.16 130.41 None STOP 117.45 13.94 354.82 93.00 148.33 &lt;800 STOP 119.07 11.01 148.52 99.19 142.93 &gt;=800 STOP 91.38 7.43 90.74 77.75 107.41 if(!any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=lower.CL,ymax=upper.CL,group=Study,color=Study))} if(any(class(mod_ls[[varc]])%in%&quot;gee&quot;)){ p1 &lt;- ggplot(mod_em_est[[varc]], aes(x=get(names(mod_em_est[[varc]])[1]),y=response, ymin=asymp.LCL,ymax=asymp.UCL,group=Study,color=Study))} p1 &lt;- p1 + geom_pointrange(size=0.7,position=position_dodge(width=0.2)) + geom_errorbar(width=0.08,size=1,position=position_dodge(width=0.2))+ scale_y_continuous(limits=c(0,NA),expand=expansion(mult=c(0,0.1))) + labs(title=&quot;Estimated marginal means (95% CI)&quot;,x=dat_labels[fvarc],y=dat_labels[varc]) + theme_bw() + theme(axis.title=element_text(size=16,face=&quot;bold&quot;),axis.text=element_text(color=&quot;black&quot;,size=14), plot.title=element_text(face=&quot;bold&quot;,color=&quot;black&quot;,size=14), panel.grid.major.x=element_blank(), legend.position=&quot;bottom&quot;,legend.title=element_text(size=15,face=&quot;bold&quot;),legend.text=element_text(size=14)) print(p1) cat(&quot;\\n\\n\\n&lt;br /&gt;&lt;b&gt;Post-hoc comparisons&lt;/b&gt;&lt;br /&gt;\\n&quot;) Post-hoc comparisons mod_em_sum[[varc]] %&gt;% kbl() %&gt;% kable_classic(full_width=F,font_size=16,position=&quot;left&quot;) Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.02 (0.85, 1.21) 1.0 &gt;=800 / None Study: SCOPE 1.14 (0.93, 1.40) 0.3 &gt;=800 / &lt;800 Study: SCOPE 1.12 (0.95, 1.33) 0.2 &lt;800 / None Study: STOP 1.01 (0.79, 1.31) 1.0 &gt;=800 / None Study: STOP 0.78 (0.61, 0.99) 0.03 &gt;=800 / &lt;800 Study: STOP 0.77 (0.66, 0.89) 0.0001 STOP / SCOPE Folic acid supplement (μg): None 1.24 (0.97, 1.59) 0.09 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.24 (1.04, 1.48) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.85 (0.71, 1.01) 0.07 "],["hpl-9.html", "15.2 HPL", " 15.2 HPL Model summary Var Effect P (Intercept) 1.96 (1.53, 2.51) &lt;0.0001 folate_cat2&lt;800 0.99 (0.91, 1.07) 0.78 folate_cat2&gt;=800 0.98 (0.90, 1.07) 0.68 StudySTOP 1.16 (1.02, 1.32) 0.03 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.97 (0.85, 1.12) 0.71 folate_cat2&gt;=800:StudySTOP 0.99 (0.86, 1.14) 0.88 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 94.35 4.03 570.38 86.76 102.60 &lt;800 SCOPE 93.31 3.10 278.76 87.41 99.61 &gt;=800 SCOPE 92.57 3.68 474.46 85.61 100.10 None STOP 109.41 6.00 873.71 98.25 121.84 &lt;800 STOP 105.38 4.01 416.20 97.78 113.58 &gt;=800 STOP 106.22 3.14 178.20 100.21 112.60 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.99 (0.90, 1.09) 1.0 &gt;=800 / None Study: SCOPE 0.98 (0.88, 1.09) 0.9 &gt;=800 / &lt;800 Study: SCOPE 0.99 (0.91, 1.08) 1.0 &lt;800 / None Study: STOP 0.96 (0.84, 1.10) 0.8 &gt;=800 / None Study: STOP 0.97 (0.86, 1.10) 0.8 &gt;=800 / &lt;800 Study: STOP 1.01 (0.93, 1.09) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.16 (1.02, 1.32) 0.03 STOP / SCOPE Folic acid supplement (μg): &lt;800 1.13 (1.03, 1.24) 0.01 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.15 (1.05, 1.26) 0.004 "],["gh2-9.html", "15.3 GH2", " 15.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 folate_cat2&lt;800 1.04 (0.94, 1.16) 0.41 folate_cat2&gt;=800 1.05 (0.93, 1.19) 0.39 StudySTOP 1.16 (0.97, 1.39) 0.09 GA_samp 1.30 (1.28, 1.33) &lt;0.0001 folate_cat2&lt;800:StudySTOP 0.83 (0.69, 1.01) 0.06 folate_cat2&gt;=800:StudySTOP 0.83 (0.69, 1.00) 0.05 Estimated marginal means folate_cat2 Study response SE df lower.CL upper.CL None SCOPE 2.32 0.12 923.22 2.09 2.57 &lt;800 SCOPE 2.42 0.09 554.23 2.24 2.61 &gt;=800 SCOPE 2.44 0.12 839.00 2.22 2.69 None STOP 2.69 0.19 1046.47 2.34 3.09 &lt;800 STOP 2.35 0.11 739.24 2.15 2.56 &gt;=800 STOP 2.35 0.08 318.25 2.21 2.50 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 1.04 (0.92, 1.18) 0.7 &gt;=800 / None Study: SCOPE 1.05 (0.91, 1.22) 0.7 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.90, 1.14) 1.0 &lt;800 / None Study: STOP 0.87 (0.72, 1.05) 0.2 &gt;=800 / None Study: STOP 0.87 (0.74, 1.03) 0.1 &gt;=800 / &lt;800 Study: STOP 1.00 (0.90, 1.11) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.16 (0.97, 1.39) 0.10 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.97 (0.86, 1.10) 0.6 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.96 (0.85, 1.09) 0.5 "],["insulin-7.html", "15.4 Insulin", " 15.4 Insulin Model summary Var Effect P (Intercept) 18.22 (9.81, 33.84) &lt;0.0001 folate_cat2&lt;800 0.76 (0.61, 0.93) 0.009 folate_cat2&gt;=800 0.76 (0.59, 0.98) 0.03 StudySTOP 0.48 (0.35, 0.66) &lt;0.0001 GA_samp 1.00 (0.96, 1.04) 0.90 folate_cat2&lt;800:StudySTOP 1.64 (1.17, 2.31) 0.004 folate_cat2&gt;=800:StudySTOP 1.58 (1.12, 2.23) 0.010 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 17.63 1.67 Inf 14.64 21.22 &lt;800 SCOPE 13.33 1.03 Inf 11.47 15.50 &gt;=800 SCOPE 13.41 1.39 Inf 10.94 16.44 None STOP 8.47 1.01 Inf 6.72 10.69 &lt;800 STOP 10.52 0.85 Inf 8.98 12.32 &gt;=800 STOP 10.17 0.57 Inf 9.11 11.36 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.76 (0.59, 0.97) 0.03 &gt;=800 / None Study: SCOPE 0.76 (0.57, 1.02) 0.08 &gt;=800 / &lt;800 Study: SCOPE 1.01 (0.77, 1.31) 1.0 &lt;800 / None Study: STOP 1.24 (0.90, 1.71) 0.3 &gt;=800 / None Study: STOP 1.20 (0.90, 1.60) 0.3 &gt;=800 / &lt;800 Study: STOP 0.97 (0.80, 1.18) 0.9 STOP / SCOPE Folic acid supplement (μg): None 0.48 (0.35, 0.66) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.79 (0.62, 1.01) 0.06 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.76 (0.58, 0.98) 0.04 "],["homa-ir-7.html", "15.5 HOMA-IR", " 15.5 HOMA-IR Model summary Var Effect P (Intercept) 4.69 (2.45, 8.95) &lt;0.0001 folate_cat2&lt;800 0.75 (0.60, 0.94) 0.01 folate_cat2&gt;=800 0.74 (0.57, 0.97) 0.03 StudySTOP 0.41 (0.29, 0.57) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.76 folate_cat2&lt;800:StudySTOP 1.64 (1.14, 2.36) 0.008 folate_cat2&gt;=800:StudySTOP 1.62 (1.11, 2.34) 0.01 Estimated marginal means folate_cat2 Study response SE df asymp.LCL asymp.UCL None SCOPE 4.31 0.44 Inf 3.53 5.27 &lt;800 SCOPE 3.23 0.26 Inf 2.75 3.78 &gt;=800 SCOPE 3.21 0.36 Inf 2.58 4.00 None STOP 1.77 0.22 Inf 1.38 2.26 &lt;800 STOP 2.16 0.19 Inf 1.83 2.56 &gt;=800 STOP 2.12 0.12 Inf 1.89 2.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;800 / None Study: SCOPE 0.75 (0.57, 0.98) 0.03 &gt;=800 / None Study: SCOPE 0.74 (0.54, 1.03) 0.08 &gt;=800 / &lt;800 Study: SCOPE 1.00 (0.75, 1.32) 1.0 &lt;800 / None Study: STOP 1.23 (0.87, 1.72) 0.3 &gt;=800 / None Study: STOP 1.20 (0.89, 1.64) 0.3 &gt;=800 / &lt;800 Study: STOP 0.98 (0.80, 1.21) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.41 (0.29, 0.57) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;800 0.67 (0.52, 0.87) 0.002 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.66 (0.50, 0.87) 0.003 "],["fa-supp-4-categories-9.html", "16 FA supp: 4 categories", " 16 FA supp: 4 categories Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Prolactin: Median (IQ range) 120.7 (74.1-194.3) 134.9 (95.6-200.4) 118.8 (76.3-178.8) 76.5 (49.8-130.4) 98.4 (59.2-160.6) &lt;0.0001 HPL: Median (IQ range) 155.9 (95.6-206.4) 175.7 (143.2-201.1) 154.3 (81.7-202.7) 71.3 (44.7-134.7) 114.2 (55.9-181.1) &lt;0.0001 GH2: Median (IQ range) 3.6 (2.0-5.0) 4.0 (3.2-5.9) 3.3 (2.1-4.6) 1.7 (1.0-3.2) 2.6 (1.3-4.2) &lt;0.0001 Insulin: Mean (SD) 19.0 (18.2) 25.6 (34.9) 18.2 (18.3) 16.7 (20.1) 18.0 (20.5) 0.01 HOMA.IR: Mean (SD) 4.7 (5.0) 6.8 (10.4) 4.4 (5.1) 3.9 (5.2) 4.3 (5.6) 0.002 GLUC3_mmol.L: Mean (SD) 5.3 (0.8) 5.4 (0.8) 5.2 (0.7) 4.9 (0.7) 5.1 (0.8) &lt;0.0001 LME or GEE for duplicated or repeated measures. LME models used for Prolactin, hPL and Gh2 with Study ID as a random effect in the analyses. GEEs used for Insulin and HOMA-IR due to failed distributional assumption even after data transformation. fvarc &lt;- &quot;folate_cat3&quot; "],["prolactin-10.html", "16.1 Prolactin", " 16.1 Prolactin Model summary Var Effect P (Intercept) 12.27 (7.62, 19.75) &lt;0.0001 folate_cat3&lt;=400 1.04 (0.84, 1.28) 0.74 folate_cat3&gt;400 to &lt;800 1.01 (0.87, 1.18) 0.87 folate_cat3&gt;=800 1.14 (0.96, 1.35) 0.13 StudySTOP 1.25 (0.97, 1.59) 0.08 GA_samp 1.17 (1.13, 1.20) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.35 (0.79, 2.33) 0.28 folate_cat3&gt;400 to &lt;800:StudySTOP 0.98 (0.76, 1.28) 0.91 folate_cat3&gt;=800:StudySTOP 0.68 (0.53, 0.88) 0.004 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 94.38 9.51 204.08 77.37 115.13 &lt;=400 SCOPE 97.84 11.45 334.03 77.72 123.16 &gt;400 to &lt;800 SCOPE 95.56 8.53 130.73 80.08 114.02 &gt;=800 SCOPE 107.66 10.37 173.73 89.02 130.20 None STOP 117.53 13.94 354.88 93.07 148.41 &lt;=400 STOP 164.98 41.65 998.33 100.52 270.77 &gt;400 to &lt;800 STOP 117.16 10.91 152.99 97.47 140.82 &gt;=800 STOP 91.46 7.44 90.76 77.82 107.49 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.04 (0.79, 1.37) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 1.01 (0.83, 1.24) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.98 (0.76, 1.25) 1.0 &gt;=800 / None Study: SCOPE 1.14 (0.91, 1.43) 0.4 &gt;=800 / &lt;=400 Study: SCOPE 1.10 (0.84, 1.44) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.13 (0.93, 1.36) 0.4 &lt;=400 / None Study: STOP 1.40 (0.72, 2.73) 0.6 &gt;400 to &lt;800 / None Study: STOP 1.00 (0.75, 1.32) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.71 (0.38, 1.34) 0.5 &gt;=800 / None Study: STOP 0.78 (0.60, 1.01) 0.06 &gt;=800 / &lt;=400 Study: STOP 0.55 (0.30, 1.04) 0.07 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.78 (0.66, 0.92) 0.0009 STOP / SCOPE Folic acid supplement (μg): None 1.25 (0.97, 1.59) 0.08 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.69 (1.00, 2.83) 0.05 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.23 (1.02, 1.47) 0.03 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.85 (0.71, 1.01) 0.07 "],["hpl-10.html", "16.2 HPL", " 16.2 HPL Model summary Var Effect P (Intercept) 1.94 (1.51, 2.49) &lt;0.0001 folate_cat3&lt;=400 1.00 (0.90, 1.12) 0.96 folate_cat3&gt;400 to &lt;800 0.99 (0.91, 1.07) 0.73 folate_cat3&gt;=800 0.98 (0.90, 1.07) 0.69 StudySTOP 1.16 (1.02, 1.32) 0.02 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 1.18 (0.88, 1.57) 0.27 folate_cat3&gt;400 to &lt;800:StudySTOP 0.97 (0.84, 1.11) 0.63 folate_cat3&gt;=800:StudySTOP 0.99 (0.86, 1.14) 0.88 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 94.18 4.02 565.40 86.60 102.42 &lt;=400 SCOPE 94.48 5.00 810.00 85.16 104.82 &gt;400 to &lt;800 SCOPE 92.86 3.24 325.60 86.70 99.45 &gt;=800 SCOPE 92.44 3.68 470.37 85.48 99.97 None STOP 109.48 6.00 868.96 98.31 121.92 &lt;=400 STOP 129.24 16.62 942.41 100.41 166.34 &gt;400 to &lt;800 STOP 104.29 4.03 430.60 96.65 112.52 &gt;=800 STOP 106.32 3.15 177.05 100.29 112.72 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.00 (0.87, 1.16) 1.0 &gt;400 to &lt;800 / None Study: SCOPE 0.99 (0.89, 1.10) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.98 (0.86, 1.12) 1.0 &gt;=800 / None Study: SCOPE 0.98 (0.87, 1.11) 1.0 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.85, 1.13) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.90, 1.10) 1.0 &lt;=400 / None Study: STOP 1.18 (0.83, 1.67) 0.6 &gt;400 to &lt;800 / None Study: STOP 0.95 (0.82, 1.11) 0.8 &gt;400 to &lt;800 / &lt;=400 Study: STOP 0.81 (0.58, 1.13) 0.3 &gt;=800 / None Study: STOP 0.97 (0.85, 1.11) 0.9 &gt;=800 / &lt;=400 Study: STOP 0.82 (0.59, 1.14) 0.4 &gt;=800 / &gt;400 to &lt;800 Study: STOP 1.02 (0.93, 1.12) 0.9 STOP / SCOPE Folic acid supplement (μg): None 1.16 (1.02, 1.33) 0.02 STOP / SCOPE Folic acid supplement (μg): &lt;=400 1.37 (1.04, 1.80) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 1.12 (1.02, 1.24) 0.02 STOP / SCOPE Folic acid supplement (μg): &gt;=800 1.15 (1.05, 1.26) 0.003 "],["gh2-10.html", "16.3 GH2", " 16.3 GH2 Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 folate_cat3&lt;=400 1.10 (0.95, 1.28) 0.20 folate_cat3&gt;400 to &lt;800 1.03 (0.92, 1.15) 0.61 folate_cat3&gt;=800 1.05 (0.93, 1.19) 0.40 StudySTOP 1.16 (0.97, 1.38) 0.10 GA_samp 1.30 (1.28, 1.33) &lt;0.0001 folate_cat3&lt;=400:StudySTOP 0.67 (0.46, 0.99) 0.05 folate_cat3&gt;400 to &lt;800:StudySTOP 0.86 (0.71, 1.03) 0.11 folate_cat3&gt;=800:StudySTOP 0.83 (0.69, 1.00) 0.05 Estimated marginal means folate_cat3 Study response SE df lower.CL upper.CL None SCOPE 2.32 0.12 921.92 2.09 2.57 &lt;=400 SCOPE 2.56 0.17 993.64 2.25 2.91 &gt;400 to &lt;800 SCOPE 2.39 0.10 654.15 2.20 2.58 &gt;=800 SCOPE 2.44 0.12 837.96 2.22 2.69 None STOP 2.69 0.19 1044.77 2.34 3.09 &lt;=400 STOP 2.00 0.35 963.93 1.42 2.81 &gt;400 to &lt;800 STOP 2.37 0.11 761.87 2.16 2.59 &gt;=800 STOP 2.35 0.08 319.11 2.21 2.50 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 1.10 (0.91, 1.34) 0.6 &gt;400 to &lt;800 / None Study: SCOPE 1.03 (0.89, 1.19) 1.0 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.93 (0.78, 1.11) 0.7 &gt;=800 / None Study: SCOPE 1.05 (0.90, 1.24) 0.8 &gt;=800 / &lt;=400 Study: SCOPE 0.96 (0.79, 1.16) 0.9 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.02 (0.90, 1.17) 1.0 &lt;=400 / None Study: STOP 0.74 (0.46, 1.20) 0.4 &gt;400 to &lt;800 / None Study: STOP 0.88 (0.72, 1.08) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.19 (0.75, 1.87) 0.8 &gt;=800 / None Study: STOP 0.87 (0.72, 1.05) 0.2 &gt;=800 / &lt;=400 Study: STOP 1.18 (0.75, 1.84) 0.8 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.99 (0.88, 1.12) 1.0 STOP / SCOPE Folic acid supplement (μg): None 1.16 (0.97, 1.39) 0.1 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.78 (0.54, 1.13) 0.2 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.99 (0.87, 1.13) 0.9 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.96 (0.85, 1.09) 0.5 "],["insulin-8.html", "16.4 Insulin", " 16.4 Insulin Model summary Var Effect P (Intercept) 18.35 (9.88, 34.06) &lt;0.0001 folate_cat3&lt;=400 0.77 (0.54, 1.11) 0.16 folate_cat3&gt;400 to &lt;800 0.75 (0.61, 0.93) 0.01 folate_cat3&gt;=800 0.76 (0.59, 0.98) 0.03 StudySTOP 0.48 (0.35, 0.66) &lt;0.0001 GA_samp 1.00 (0.96, 1.04) 0.88 folate_cat3&lt;=400:StudySTOP 1.39 (0.58, 3.35) 0.47 folate_cat3&gt;400 to &lt;800:StudySTOP 1.66 (1.18, 2.35) 0.004 folate_cat3&gt;=800:StudySTOP 1.58 (1.12, 2.23) 0.010 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 17.64 1.67 Inf 14.65 21.24 &lt;=400 SCOPE 13.63 2.30 Inf 9.79 18.98 &gt;400 to &lt;800 SCOPE 13.28 1.07 Inf 11.34 15.54 &gt;=800 SCOPE 13.42 1.40 Inf 10.95 16.46 None STOP 8.47 1.00 Inf 6.71 10.69 &lt;=400 STOP 9.08 3.60 Inf 4.18 19.74 &gt;400 to &lt;800 STOP 10.60 0.86 Inf 9.03 12.43 &gt;=800 STOP 10.16 0.57 Inf 9.10 11.35 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.77 (0.48, 1.24) 0.5 &gt;400 to &lt;800 / None Study: SCOPE 0.75 (0.57, 1.00) 0.05 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.97 (0.62, 1.53) 1.0 &gt;=800 / None Study: SCOPE 0.76 (0.55, 1.05) 0.1 &gt;=800 / &lt;=400 Study: SCOPE 0.98 (0.61, 1.59) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.01 (0.75, 1.36) 1.0 &lt;=400 / None Study: STOP 1.07 (0.37, 3.08) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.25 (0.88, 1.78) 0.4 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.17 (0.42, 3.26) 1.0 &gt;=800 / None Study: STOP 1.20 (0.88, 1.64) 0.4 &gt;=800 / &lt;=400 Study: STOP 1.12 (0.41, 3.09) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.96 (0.77, 1.19) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.48 (0.35, 0.66) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.67 (0.28, 1.57) 0.4 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.80 (0.62, 1.02) 0.07 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.76 (0.58, 0.98) 0.04 "],["homa-ir-8.html", "16.5 HOMA-IR", " 16.5 HOMA-IR Model summary Var Effect P (Intercept) 4.70 (2.46, 8.97) &lt;0.0001 folate_cat3&lt;=400 0.75 (0.51, 1.10) 0.14 folate_cat3&gt;400 to &lt;800 0.75 (0.59, 0.94) 0.01 folate_cat3&gt;=800 0.74 (0.57, 0.97) 0.03 StudySTOP 0.41 (0.29, 0.57) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.76 folate_cat3&lt;=400:StudySTOP 1.52 (0.57, 4.04) 0.40 folate_cat3&gt;400 to &lt;800:StudySTOP 1.65 (1.14, 2.38) 0.008 folate_cat3&gt;=800:StudySTOP 1.62 (1.11, 2.34) 0.01 Estimated marginal means folate_cat3 Study response SE df asymp.LCL asymp.UCL None SCOPE 4.32 0.44 Inf 3.53 5.27 &lt;=400 SCOPE 3.24 0.58 Inf 2.28 4.61 &gt;400 to &lt;800 SCOPE 3.23 0.27 Inf 2.73 3.81 &gt;=800 SCOPE 3.21 0.36 Inf 2.58 4.00 None STOP 1.76 0.22 Inf 1.38 2.26 &lt;=400 STOP 2.01 0.90 Inf 0.84 4.82 &gt;400 to &lt;800 STOP 2.17 0.19 Inf 1.83 2.57 &gt;=800 STOP 2.12 0.12 Inf 1.89 2.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;=400 / None Study: SCOPE 0.75 (0.46, 1.24) 0.5 &gt;400 to &lt;800 / None Study: SCOPE 0.75 (0.55, 1.01) 0.07 &gt;400 to &lt;800 / &lt;=400 Study: SCOPE 0.99 (0.62, 1.61) 1.0 &gt;=800 / None Study: SCOPE 0.74 (0.52, 1.06) 0.1 &gt;=800 / &lt;=400 Study: SCOPE 0.99 (0.59, 1.65) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: SCOPE 1.00 (0.72, 1.37) 1.0 &lt;=400 / None Study: STOP 1.14 (0.35, 3.72) 1.0 &gt;400 to &lt;800 / None Study: STOP 1.23 (0.85, 1.79) 0.5 &gt;400 to &lt;800 / &lt;=400 Study: STOP 1.08 (0.34, 3.43) 1.0 &gt;=800 / None Study: STOP 1.20 (0.86, 1.68) 0.5 &gt;=800 / &lt;=400 Study: STOP 1.06 (0.34, 3.31) 1.0 &gt;=800 / &gt;400 to &lt;800 Study: STOP 0.98 (0.78, 1.23) 1.0 STOP / SCOPE Folic acid supplement (μg): None 0.41 (0.29, 0.57) &lt;0.0001 STOP / SCOPE Folic acid supplement (μg): &lt;=400 0.62 (0.24, 1.61) 0.3 STOP / SCOPE Folic acid supplement (μg): &gt;400 to &lt;800 0.67 (0.52, 0.87) 0.003 STOP / SCOPE Folic acid supplement (μg): &gt;=800 0.66 (0.50, 0.87) 0.003 "],["age-groups-1.html", "17 Age groups", " 17 Age groups Descriptives with univariate P-values. Characteristic &lt;35 yrs (n=1270) &gt;=35 yrs (n=45) Total (n=1315) P-value PRL (ng/ml): Median (IQ range) 97.6 (59.0-158.9) 74.6 (43.8-99.7) 96.8 (58.3-157.1) 0.01 hPL (μg/ml): Median (IQ range) 108.9 (54.6-179.9) 81.6 (43.8-136.1) 108.1 (54.6-179.4) 0.08 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.1) 2.1 (1.4-3.4) 2.5 (1.2-4.1) 0.54 Insulin (uU/L): Median (IQ range) 10.8 (6.0-21.9) 10.3 (6.3-16.8) 10.8 (6.1-21.7) 0.69 HOMA-IR: Median (IQ range) 2.4 (1.3-5.1) 2.5 (1.3-3.7) 2.4 (1.3-5.0) 0.68 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 4.9 (4.5-5.3) 5.0 (4.6-5.5) 0.22 Within SCOPE Characteristic &lt;35 yrs (n=587) &gt;=35 yrs (n=17) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 140.1 (95.6-215.5) 101.2 (74.7-174.9) 139.9 (94.7-215.5) 0.20 hPL (μg/ml): Median (IQ range) 183.5 (151.1-220.8) 168.6 (123.6-206.2) 183.5 (149.9-220.6) 0.17 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.6) 3.8 (3.1-5.6) 4.2 (3.2-5.6) 0.70 Insulin (uU/L): Median (IQ range) 14.4 (6.5-29.1) 19.5 (10.0-35.6) 14.4 (6.5-29.1) 0.37 HOMA-IR: Median (IQ range) 3.3 (1.5-7.2) 4.5 (2.5-9.7) 3.3 (1.5-7.2) 0.28 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.2-5.8) 5.4 (5.0-5.8) 0.66 Serum folate concentration (nM): Median (IQ range) 36.5 (28.3-43.0) 34.6 (32.1-42.2) 36.4 (28.5-43.0) 1.00 B12 concentration (pM): Median (IQ range) 248.0 (195.0-316.0) 255.0 (218.0-331.8) 248.0 (195.5-316.0) 0.69 Folate:B12 ratio: Median (IQ range) 143.0 (103.0-210.0) 133.8 (117.5-192.9) 142.6 (104.0-207.4) 0.93 Active B12 concentration (pM): Median (IQ range) 54.0 (42.5-72.0) 55.5 (48.0-78.8) 54.0 (43.0-72.0) 0.51 Folate:Active B12 ratio: Median (IQ range) 617.5 (462.2-951.7) 500.8 (390.1-718.5) 617.0 (458.5-931.9) 0.21 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.2 (3.9-4.6) 4.4 (3.8-5.0) 0.67 Within STOP Characteristic &lt;35 yrs (n=683) &gt;=35 yrs (n=28) Total (n=711) P-value PRL (ng/ml): Median (IQ range) 73.2 (49.2-114.9) 52.6 (38.2-90.3) 72.9 (48.6-113.6) 0.08 hPL (μg/ml): Median (IQ range) 62.2 (41.7-96.7) 68.1 (39.3-83.4) 62.4 (41.4-96.2) 0.91 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.6 (1.1-2.2) 1.4 (0.9-2.4) 0.53 Insulin (uU/L): Median (IQ range) 9.3 (5.7-17.3) 8.5 (4.7-13.9) 9.3 (5.6-17.0) 0.34 HOMA-IR: Median (IQ range) 1.9 (1.1-3.8) 1.8 (1.0-2.8) 1.9 (1.1-3.7) 0.28 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.1) 4.5 (4.4-4.9) 4.7 (4.4-5.1) 0.14 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-44.9) 44.0 (41.2-97.7) 40.5 (36.4-45.2) 0.001 B12 concentration (pM): Median (IQ range) 277.5 (218.8-354.2) 283.5 (228.5-363.0) 277.5 (219.0-355.0) 0.81 Folate:B12 ratio: Median (IQ range) 155.5 (114.9-219.5) 172.7 (132.5-316.0) 155.9 (115.7-222.4) 0.06 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 57.0 (54.5-83.5) 63.0 (48.0-80.0) 0.82 Folate:Active B12 ratio: Median (IQ range) 670.5 (493.5-950.0) 747.4 (505.0-965.5) 670.7 (493.5-950.5) 0.86 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.8 (4.4-5.8) 4.8 (4.3-5.6) 0.40 Red cell folate (nmol/L): Median (IQ range) 1435.0 (1202.0-1760.0) 1592.0 (1443.5-1743.0) 1446.5 (1204.8-1755.5) 0.15 mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod1 &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod1 &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(mod1)}) #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)}) #mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { if(!any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind1]])%in%&quot;gee&quot;)){ em1 &lt;- emmeans(mod_ls[[ind1]],as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study&quot;)),type=&quot;response&quot;)} return(em1)} mod_em2 &lt;- foreach(ind2=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { if(!any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;,data=dat_run)} if(any(class(mod_ls[[ind2]])%in%&quot;gee&quot;)){ em2 &lt;- emmeans(mod_ls[[ind2]],as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)} return(em2)} names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts mod_em_sum &lt;- mapply(function(x,y){ x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; return(rbind(x,y))}, mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-11.html", "17.1 Prolactin", " 17.1 Prolactin LME for repeated measures. Model summary Var Effect P (Intercept) 12.50 (8.08, 19.33) &lt;0.0001 Age_gp&gt;=35 yrs 0.84 (0.59, 1.20) 0.35 StudySTOP 1.02 (0.89, 1.17) 0.80 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.86 (0.56, 1.34) 0.52 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 100.60 8.19 96.10 85.59 118.25 &gt;=35 yrs SCOPE 84.92 16.47 1008.64 58.04 124.26 &lt;35 yrs STOP 102.35 8.03 83.18 87.56 119.65 &gt;=35 yrs STOP 74.69 11.15 686.34 55.72 100.12 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.84 (0.59, 1.20) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.73 (0.56, 0.94) 0.02 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.02 (0.89, 1.17) 0.8 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.88 (0.56, 1.38) 0.6 "],["hpl-11.html", "17.2 HPL", " 17.2 HPL LME for repeated measures. Model summary Var Effect P (Intercept) 1.93 (1.55, 2.42) &lt;0.0001 Age_gp&gt;=35 yrs 0.90 (0.74, 1.08) 0.24 StudySTOP 1.14 (1.06, 1.22) 0.0003 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.10 (0.88, 1.39) 0.39 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 94.98 2.73 171.25 89.74 100.52 &gt;=35 yrs SCOPE 85.10 8.15 1153.13 70.52 102.70 &lt;35 yrs STOP 108.11 2.88 125.44 102.55 113.98 &gt;=35 yrs STOP 107.04 7.74 1130.93 92.88 123.36 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.90 (0.75, 1.08) 0.2 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.99 (0.86, 1.14) 0.9 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.14 (1.06, 1.22) 0.0003 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.26 (1.00, 1.59) 0.05 "],["gh2-11.html", "17.3 GH2", " 17.3 GH2 LME for repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Age_gp&gt;=35 yrs 0.96 (0.75, 1.24) 0.78 StudySTOP 1.03 (0.93, 1.13) 0.58 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.04 (0.76, 1.42) 0.79 Estimated marginal means Age_gp Study response SE df lower.CL upper.CL &lt;35 yrs SCOPE 2.39 0.08 384.28 2.25 2.55 &gt;=35 yrs SCOPE 2.31 0.30 1227.37 1.79 2.98 &lt;35 yrs STOP 2.46 0.07 242.06 2.32 2.60 &gt;=35 yrs STOP 2.47 0.23 1224.31 2.05 2.98 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 0.96 (0.75, 1.24) 0.8 &gt;=35 yrs / &lt;35 yrs Study: STOP 1.01 (0.84, 1.21) 0.9 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 1.03 (0.93, 1.13) 0.6 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 1.07 (0.78, 1.47) 0.7 "],["insulin-9.html", "17.4 Insulin", " 17.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 15.26 (8.64, 26.97) &lt;0.0001 Age_gp&gt;=35 yrs 1.26 (0.82, 1.94) 0.29 StudySTOP 0.73 (0.61, 0.88) 0.0008 GA_samp 0.99 (0.96, 1.03) 0.76 Age_gp&gt;=35 yrs:StudySTOP 0.64 (0.38, 1.08) 0.09 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 14.17 0.89 Inf 12.52 16.04 &gt;=35 yrs SCOPE 17.86 3.90 Inf 11.64 27.40 &lt;35 yrs STOP 10.34 0.47 Inf 9.45 11.31 &gt;=35 yrs STOP 8.34 1.23 Inf 6.24 11.15 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.26 (0.82, 1.94) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.81 (0.60, 1.08) 0.2 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.73 (0.61, 0.88) 0.0008 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.47 (0.28, 0.79) 0.004 "],["homa-ir-9.html", "17.5 HOMA-IR", " 17.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.79 (2.09, 6.87) &lt;0.0001 Age_gp&gt;=35 yrs 1.34 (0.84, 2.13) 0.22 StudySTOP 0.63 (0.52, 0.77) &lt;0.0001 GA_samp 0.99 (0.96, 1.03) 0.68 Age_gp&gt;=35 yrs:StudySTOP 0.59 (0.34, 1.03) 0.06 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 3.42 0.23 Inf 3.00 3.89 &gt;=35 yrs SCOPE 4.57 1.08 Inf 2.88 7.26 &lt;35 yrs STOP 2.16 0.10 Inf 1.97 2.37 &gt;=35 yrs STOP 1.70 0.27 Inf 1.24 2.32 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.34 (0.84, 2.13) 0.2 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.79 (0.57, 1.08) 0.1 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.63 (0.52, 0.77) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.37 (0.21, 0.66) 0.0006 "],["glucose-7.html", "17.6 Glucose", " 17.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.54 (4.97, 6.17) &lt;0.0001 Age_gp&gt;=35 yrs 1.06 (0.95, 1.17) 0.30 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.62 Age_gp&gt;=35 yrs:StudySTOP 0.93 (0.83, 1.04) 0.19 Estimated marginal means Age_gp Study response SE df asymp.LCL asymp.UCL &lt;35 yrs SCOPE 5.41 0.07 Inf 5.29 5.54 &gt;=35 yrs SCOPE 5.71 0.29 Inf 5.16 6.32 &lt;35 yrs STOP 4.72 0.04 Inf 4.64 4.80 &gt;=35 yrs STOP 4.64 0.08 Inf 4.48 4.80 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs Study: SCOPE 1.06 (0.95, 1.17) 0.3 &gt;=35 yrs / &lt;35 yrs Study: STOP 0.98 (0.95, 1.02) 0.3 STOP / SCOPE Maternal age (yrs): &lt;35 yrs 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE Maternal age (yrs): &gt;=35 yrs 0.81 (0.73, 0.90) 0.0001 "],["bmi-groups-1.html", "18 BMI groups", " 18 BMI groups Descriptives with univariate P-values. Characteristic Underweight (n=32) Normal (n=593) Overweight (n=388) Obese (n=301) Total (n=1314) P-value PRL (ng/ml): Median (IQ range) 103.1 (78.8-182.4) 103.2 (64.2-160.3) 97.3 (56.9-164.2) 80.6 (48.1-131.6) 96.8 (58.3-157.1) 0.0003 hPL (μg/ml): Median (IQ range) 144.8 (88.1-242.9) 121.0 (61.1-195.3) 109.6 (54.2-172.4) 75.7 (41.7-145.4) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.1 (1.5-5.9) 2.9 (1.3-4.7) 2.5 (1.2-3.9) 2.2 (1.0-3.3) 2.5 (1.2-4.1) &lt;0.0001 Insulin (uU/L): Median (IQ range) 6.1 (4.4-12.4) 7.7 (4.6-16.6) 11.6 (6.8-23.3) 15.4 (9.6-31.6) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.4 (0.9-2.8) 1.7 (1.0-3.7) 2.6 (1.4-5.4) 3.6 (2.1-7.0) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.4-5.3) 5.0 (4.6-5.4) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.02 Within SCOPE Characteristic Underweight (n=16) Normal (n=276) Overweight (n=176) Obese (n=136) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 187.3 (146.2-325.0) 142.3 (97.1-212.7) 139.1 (97.5-222.1) 130.4 (82.4-194.3) 139.9 (94.7-215.5) 0.10 hPL (μg/ml): Median (IQ range) 262.2 (219.0-278.0) 197.4 (170.3-230.2) 172.9 (150.5-210.5) 153.3 (130.2-181.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 6.2 (4.6-6.5) 4.7 (3.5-6.5) 4.0 (3.2-5.2) 3.4 (2.6-4.4) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/L): Median (IQ range) 9.0 (6.0-11.4) 10.6 (5.2-22.4) 17.7 (9.0-29.6) 20.3 (9.7-36.3) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.4-2.4) 2.5 (1.2-5.7) 4.0 (2.0-7.5) 4.7 (2.3-9.3) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.2 (4.8-5.8) 5.4 (5.0-5.7) 5.5 (5.0-6.0) 5.4 (5.1-5.9) 5.4 (5.0-5.8) 0.18 Serum folate concentration (nM): Median (IQ range) 29.2 (24.9-36.1) 37.0 (29.7-43.8) 37.0 (29.7-41.2) 35.2 (24.8-43.0) 36.4 (28.5-43.0) 0.07 B12 concentration (pM): Median (IQ range) 288.0 (252.0-355.0) 256.0 (198.5-324.0) 248.5 (198.2-311.2) 227.0 (181.0-285.0) 248.0 (195.5-316.0) 0.005 Folate:B12 ratio: Median (IQ range) 105.6 (74.6-117.3) 142.5 (104.6-204.3) 144.2 (106.8-208.7) 143.0 (103.5-210.0) 142.6 (104.0-207.4) 0.24 Active B12 concentration (pM): Median (IQ range) 63.5 (53.5-78.0) 53.0 (41.0-72.0) 54.0 (43.0-70.2) 60.5 (43.8-72.2) 54.0 (43.0-72.0) 0.36 Folate:Active B12 ratio: Median (IQ range) 491.8 (337.4-589.7) 641.2 (465.6-1042.9) 638.0 (491.8-953.1) 537.6 (404.5-693.9) 617.0 (458.5-931.9) 0.009 Homocysteine concentration (μM): Median (IQ range) 4.5 (4.2-5.3) 4.4 (3.9-5.0) 4.2 (3.8-4.9) 4.4 (3.8-5.0) 4.4 (3.8-5.0) 0.24 Within STOP Characteristic Underweight (n=16) Normal (n=317) Overweight (n=212) Obese (n=165) Total (n=710) P-value PRL (ng/ml): Median (IQ range) 91.6 (47.1-99.5) 78.8 (53.8-120.4) 72.9 (49.1-115.1) 62.1 (40.3-99.3) 72.9 (48.6-113.6) 0.003 hPL (μg/ml): Median (IQ range) 90.3 (64.3-140.4) 67.3 (45.7-101.5) 61.0 (42.3-97.2) 50.5 (34.5-73.3) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (1.4-3.5) 1.5 (1.0-2.4) 1.5 (0.8-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.03 Insulin (uU/L): Median (IQ range) 4.8 (4.3-14.1) 7.2 (4.2-12.8) 9.6 (6.5-16.1) 14.8 (9.5-26.4) 9.3 (5.6-17.0) &lt;0.0001 HOMA-IR: Median (IQ range) 1.0 (0.8-2.9) 1.5 (0.8-2.9) 1.9 (1.2-3.6) 3.3 (2.0-5.9) 1.9 (1.1-3.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.5 (4.3-4.9) 4.7 (4.4-5.0) 4.7 (4.4-5.0) 4.8 (4.5-5.3) 4.7 (4.4-5.1) 0.01 Serum folate concentration (nM): Median (IQ range) 35.0 (29.9-40.4) 40.8 (37.0-52.4) 40.4 (36.2-45.1) 40.5 (35.8-45.2) 40.5 (36.4-45.3) 0.008 B12 concentration (pM): Median (IQ range) 349.5 (240.0-494.2) 288.0 (227.0-369.0) 275.5 (213.2-338.8) 260.5 (217.2-333.0) 278.0 (219.0-355.0) 0.03 Folate:B12 ratio: Median (IQ range) 98.0 (68.5-159.2) 154.8 (114.8-227.6) 151.2 (120.5-215.2) 168.3 (118.0-233.7) 155.8 (115.6-222.5) 0.03 Active B12 concentration (pM): Median (IQ range) 50.0 (48.0-82.0) 63.0 (46.0-79.0) 63.0 (49.0-82.2) 62.0 (51.5-76.0) 63.0 (48.0-80.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 602.0 (490.9-735.8) 693.8 (534.1-990.9) 675.3 (461.4-944.2) 644.4 (517.4-898.6) 670.9 (493.7-951.1) 0.59 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.7-5.7) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 4.8 (4.3-5.6) 0.15 Red cell folate (nmol/L): Median (IQ range) 1305.5 (1058.0-1585.0) 1445.0 (1212.0-1744.5) 1469.0 (1208.5-1785.5) 1433.0 (1189.0-1737.0) 1446.5 (1204.8-1755.5) 0.55 "],["prolactin-12.html", "18.1 Prolactin", " 18.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 16.42 (9.16, 29.44) &lt;0.0001 BMI_gp3Normal 0.80 (0.54, 1.17) 0.25 BMI_gp3Overweight 0.83 (0.56, 1.23) 0.36 BMI_gp3Obese 0.70 (0.47, 1.05) 0.09 StudySTOP 0.75 (0.46, 1.25) 0.27 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.37 (0.83, 2.26) 0.21 BMI_gp3Overweight:StudySTOP 1.28 (0.78, 2.12) 0.33 BMI_gp3Obese:StudySTOP 1.22 (0.73, 2.04) 0.45 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 128.74 26.71 1081.39 85.69 193.43 Normal SCOPE 102.79 8.91 127.14 86.59 122.02 Overweight SCOPE 107.19 9.83 157.84 89.43 128.49 Obese SCOPE 90.72 9.06 214.48 74.51 110.46 Underweight STOP 97.08 16.92 917.23 68.95 136.68 Normal STOP 106.44 8.69 101.42 90.52 125.15 Overweight STOP 103.61 8.93 124.58 87.36 122.89 Obese STOP 83.45 7.81 165.19 69.37 100.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.80 (0.48, 1.32) 0.7 Overweight / Underweight Study: SCOPE 0.83 (0.50, 1.39) 0.8 Overweight / Normal Study: SCOPE 1.04 (0.88, 1.24) 0.9 Obese / Underweight Study: SCOPE 0.70 (0.42, 1.19) 0.3 Obese / Normal Study: SCOPE 0.88 (0.72, 1.08) 0.4 Obese / Overweight Study: SCOPE 0.85 (0.68, 1.05) 0.2 Normal / Underweight Study: STOP 1.10 (0.72, 1.67) 0.9 Overweight / Underweight Study: STOP 1.07 (0.70, 1.63) 1.0 Overweight / Normal Study: STOP 0.97 (0.84, 1.13) 1.0 Obese / Underweight Study: STOP 0.86 (0.56, 1.32) 0.8 Obese / Normal Study: STOP 0.78 (0.66, 0.93) 0.002 Obese / Overweight Study: STOP 0.81 (0.67, 0.96) 0.01 STOP / SCOPE Maternal BMI: Underweight 0.75 (0.46, 1.25) 0.3 STOP / SCOPE Maternal BMI: Normal 1.04 (0.89, 1.21) 0.7 STOP / SCOPE Maternal BMI: Overweight 0.97 (0.81, 1.15) 0.7 STOP / SCOPE Maternal BMI: Obese 0.92 (0.75, 1.13) 0.4 "],["hpl-12.html", "18.2 HPL", " 18.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.23 (1.66, 3.00) &lt;0.0001 BMI_gp3Normal 0.98 (0.80, 1.19) 0.81 BMI_gp3Overweight 0.91 (0.75, 1.12) 0.38 BMI_gp3Obese 0.78 (0.63, 0.96) 0.02 StudySTOP 1.33 (1.02, 1.71) 0.03 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.83 (0.64, 1.07) 0.15 BMI_gp3Overweight:StudySTOP 0.84 (0.65, 1.09) 0.19 BMI_gp3Obese:StudySTOP 0.82 (0.63, 1.06) 0.13 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 105.75 10.87 1207.24 86.44 129.37 Normal SCOPE 103.21 3.23 328.15 97.04 109.77 Overweight SCOPE 96.64 3.36 442.16 90.26 103.48 Obese SCOPE 82.45 3.17 534.39 76.46 88.91 Underweight STOP 140.15 11.60 1157.89 119.14 164.88 Normal STOP 113.44 3.15 219.07 107.40 119.82 Overweight STOP 107.55 3.34 301.92 101.18 114.33 Obese STOP 89.09 3.20 364.00 83.01 95.61 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 0.98 (0.75, 1.27) 1.0 Overweight / Underweight Study: SCOPE 0.91 (0.70, 1.19) 0.8 Overweight / Normal Study: SCOPE 0.94 (0.86, 1.02) 0.2 Obese / Underweight Study: SCOPE 0.78 (0.60, 1.02) 0.08 Obese / Normal Study: SCOPE 0.80 (0.72, 0.88) &lt;0.0001 Obese / Overweight Study: SCOPE 0.85 (0.77, 0.95) 0.0009 Normal / Underweight Study: STOP 0.81 (0.65, 1.00) 0.05 Overweight / Underweight Study: STOP 0.77 (0.62, 0.95) 0.009 Overweight / Normal Study: STOP 0.95 (0.88, 1.02) 0.3 Obese / Underweight Study: STOP 0.64 (0.51, 0.79) &lt;0.0001 Obese / Normal Study: STOP 0.79 (0.72, 0.86) &lt;0.0001 Obese / Overweight Study: STOP 0.83 (0.76, 0.91) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 1.33 (1.02, 1.72) 0.03 STOP / SCOPE Maternal BMI: Normal 1.10 (1.02, 1.19) 0.02 STOP / SCOPE Maternal BMI: Overweight 1.11 (1.02, 1.22) 0.02 STOP / SCOPE Maternal BMI: Obese 1.08 (0.98, 1.20) 0.1 "],["gh2-12.html", "18.3 GH2", " 18.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.04, 0.10) &lt;0.0001 BMI_gp3Normal 1.06 (0.81, 1.39) 0.67 BMI_gp3Overweight 0.94 (0.71, 1.23) 0.64 BMI_gp3Obese 0.79 (0.60, 1.04) 0.10 StudySTOP 1.49 (1.04, 2.12) 0.03 GA_samp 1.31 (1.29, 1.34) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.64 (0.45, 0.91) 0.01 BMI_gp3Overweight:StudySTOP 0.69 (0.48, 0.98) 0.04 BMI_gp3Obese:StudySTOP 0.76 (0.53, 1.10) 0.14 Estimated marginal means BMI_gp3 Study response SE df lower.CL upper.CL Underweight SCOPE 2.52 0.35 1235.72 1.92 3.30 Normal SCOPE 2.67 0.10 614.70 2.47 2.88 Overweight SCOPE 2.35 0.10 786.29 2.16 2.57 Obese SCOPE 1.99 0.10 857.06 1.80 2.19 Underweight STOP 3.74 0.43 1233.39 2.98 4.68 Normal STOP 2.53 0.08 453.27 2.37 2.70 Overweight STOP 2.40 0.09 562.47 2.22 2.58 Obese STOP 2.25 0.10 459.22 2.06 2.45 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.06 (0.74, 1.52) 1.0 Overweight / Underweight Study: SCOPE 0.94 (0.65, 1.34) 1.0 Overweight / Normal Study: SCOPE 0.88 (0.78, 1.00) 0.04 Obese / Underweight Study: SCOPE 0.79 (0.55, 1.14) 0.4 Obese / Normal Study: SCOPE 0.74 (0.65, 0.86) &lt;0.0001 Obese / Overweight Study: SCOPE 0.84 (0.73, 0.98) 0.02 Normal / Underweight Study: STOP 0.68 (0.50, 0.91) 0.004 Overweight / Underweight Study: STOP 0.64 (0.47, 0.87) 0.0009 Overweight / Normal Study: STOP 0.95 (0.85, 1.05) 0.6 Obese / Underweight Study: STOP 0.60 (0.44, 0.82) 0.0001 Obese / Normal Study: STOP 0.89 (0.79, 1.00) 0.06 Obese / Overweight Study: STOP 0.94 (0.83, 1.06) 0.5 STOP / SCOPE Maternal BMI: Underweight 1.49 (1.04, 2.12) 0.03 STOP / SCOPE Maternal BMI: Normal 0.95 (0.85, 1.05) 0.3 STOP / SCOPE Maternal BMI: Overweight 1.02 (0.90, 1.15) 0.8 STOP / SCOPE Maternal BMI: Obese 1.13 (0.98, 1.30) 0.08 "],["insulin-10.html", "18.4 Insulin", " 18.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 8.46 (4.06, 17.62) &lt;0.0001 BMI_gp3Normal 1.35 (0.83, 2.19) 0.22 BMI_gp3Overweight 1.77 (1.09, 2.87) 0.02 BMI_gp3Obese 2.35 (1.44, 3.83) 0.0007 StudySTOP 0.87 (0.47, 1.64) 0.68 GA_samp 1.00 (0.97, 1.04) 0.95 BMI_gp3Normal:StudySTOP 0.80 (0.43, 1.50) 0.48 BMI_gp3Overweight:StudySTOP 0.81 (0.43, 1.52) 0.51 BMI_gp3Obese:StudySTOP 0.95 (0.50, 1.79) 0.86 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 8.57 2.07 Inf 5.35 13.75 Normal SCOPE 11.58 0.96 Inf 9.84 13.64 Overweight SCOPE 15.14 1.29 Inf 12.81 17.90 Obese SCOPE 20.12 1.92 Inf 16.69 24.25 Underweight STOP 7.50 1.51 Inf 5.05 11.13 Normal STOP 8.09 0.48 Inf 7.20 9.08 Overweight STOP 10.72 0.64 Inf 9.54 12.06 Obese STOP 16.64 1.14 Inf 14.55 19.03 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.35 (0.72, 2.54) 0.6 Overweight / Underweight Study: SCOPE 1.77 (0.93, 3.34) 0.10 Overweight / Normal Study: SCOPE 1.31 (1.00, 1.71) 0.05 Obese / Underweight Study: SCOPE 2.35 (1.23, 4.46) 0.004 Obese / Normal Study: SCOPE 1.74 (1.30, 2.31) &lt;0.0001 Obese / Overweight Study: SCOPE 1.33 (0.99, 1.78) 0.06 Normal / Underweight Study: STOP 1.08 (0.64, 1.82) 1.0 Overweight / Underweight Study: STOP 1.43 (0.84, 2.42) 0.3 Overweight / Normal Study: STOP 1.33 (1.11, 1.59) 0.0003 Obese / Underweight Study: STOP 2.22 (1.30, 3.79) 0.0008 Obese / Normal Study: STOP 2.06 (1.68, 2.52) &lt;0.0001 Obese / Overweight Study: STOP 1.55 (1.26, 1.91) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.87 (0.47, 1.64) 0.7 STOP / SCOPE Maternal BMI: Normal 0.70 (0.56, 0.88) 0.002 STOP / SCOPE Maternal BMI: Overweight 0.71 (0.56, 0.89) 0.003 STOP / SCOPE Maternal BMI: Obese 0.83 (0.64, 1.06) 0.1 "],["homa-ir-10.html", "18.5 HOMA-IR", " 18.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 1.99 (0.94, 4.19) 0.07 BMI_gp3Normal 1.41 (0.88, 2.26) 0.15 BMI_gp3Overweight 1.86 (1.16, 3.00) 0.01 BMI_gp3Obese 2.50 (1.54, 4.05) 0.0002 StudySTOP 0.77 (0.42, 1.43) 0.41 GA_samp 1.00 (0.96, 1.04) 0.97 BMI_gp3Normal:StudySTOP 0.78 (0.42, 1.45) 0.43 BMI_gp3Overweight:StudySTOP 0.79 (0.42, 1.47) 0.45 BMI_gp3Obese:StudySTOP 0.95 (0.50, 1.79) 0.87 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 1.97 0.46 Inf 1.24 3.12 Normal SCOPE 2.78 0.24 Inf 2.34 3.30 Overweight SCOPE 3.67 0.34 Inf 3.06 4.40 Obese SCOPE 4.92 0.51 Inf 4.02 6.02 Underweight STOP 1.52 0.31 Inf 1.02 2.26 Normal STOP 1.67 0.10 Inf 1.48 1.88 Overweight STOP 2.23 0.14 Inf 1.97 2.52 Obese STOP 3.61 0.26 Inf 3.13 4.16 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.41 (0.76, 2.62) 0.5 Overweight / Underweight Study: SCOPE 1.86 (1.00, 3.49) 0.05 Overweight / Normal Study: SCOPE 1.32 (0.99, 1.77) 0.06 Obese / Underweight Study: SCOPE 2.50 (1.33, 4.71) 0.001 Obese / Normal Study: SCOPE 1.77 (1.30, 2.41) &lt;0.0001 Obese / Overweight Study: SCOPE 1.34 (0.97, 1.85) 0.09 Normal / Underweight Study: STOP 1.10 (0.65, 1.86) 1.0 Overweight / Underweight Study: STOP 1.46 (0.86, 2.49) 0.3 Overweight / Normal Study: STOP 1.34 (1.11, 1.61) 0.0005 Obese / Underweight Study: STOP 2.37 (1.38, 4.07) 0.0002 Obese / Normal Study: STOP 2.16 (1.75, 2.68) &lt;0.0001 Obese / Overweight Study: STOP 1.62 (1.30, 2.02) &lt;0.0001 STOP / SCOPE Maternal BMI: Underweight 0.77 (0.42, 1.43) 0.4 STOP / SCOPE Maternal BMI: Normal 0.60 (0.47, 0.76) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.61 (0.48, 0.77) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.73 (0.56, 0.96) 0.02 "],["glucose-8.html", "18.6 Glucose", " 18.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.19 (4.58, 5.89) &lt;0.0001 BMI_gp3Normal 1.05 (0.98, 1.13) 0.17 BMI_gp3Overweight 1.06 (0.98, 1.15) 0.15 BMI_gp3Obese 1.07 (0.99, 1.15) 0.09 StudySTOP 0.89 (0.82, 0.98) 0.01 GA_samp 1.00 (0.99, 1.01) 0.73 BMI_gp3Normal:StudySTOP 0.97 (0.89, 1.06) 0.49 BMI_gp3Overweight:StudySTOP 0.97 (0.88, 1.08) 0.62 BMI_gp3Obese:StudySTOP 0.99 (0.90, 1.09) 0.79 Estimated marginal means BMI_gp3 Study response SE df asymp.LCL asymp.UCL Underweight SCOPE 5.11 0.19 Inf 4.76 5.49 Normal SCOPE 5.38 0.07 Inf 5.24 5.53 Overweight SCOPE 5.43 0.12 Inf 5.20 5.68 Obese SCOPE 5.47 0.10 Inf 5.28 5.66 Underweight STOP 4.57 0.11 Inf 4.35 4.80 Normal STOP 4.66 0.06 Inf 4.55 4.77 Overweight STOP 4.73 0.08 Inf 4.57 4.90 Obese STOP 4.82 0.08 Inf 4.66 4.99 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value Normal / Underweight Study: SCOPE 1.05 (0.96, 1.16) 0.5 Overweight / Underweight Study: SCOPE 1.06 (0.95, 1.18) 0.5 Overweight / Normal Study: SCOPE 1.01 (0.95, 1.07) 1.0 Obese / Underweight Study: SCOPE 1.07 (0.97, 1.18) 0.3 Obese / Normal Study: SCOPE 1.02 (0.97, 1.07) 0.9 Obese / Overweight Study: SCOPE 1.01 (0.94, 1.08) 1.0 Normal / Underweight Study: STOP 1.02 (0.95, 1.09) 0.9 Overweight / Underweight Study: STOP 1.04 (0.96, 1.12) 0.7 Overweight / Normal Study: STOP 1.02 (0.96, 1.07) 0.9 Obese / Underweight Study: STOP 1.05 (0.98, 1.14) 0.3 Obese / Normal Study: STOP 1.03 (0.98, 1.09) 0.4 Obese / Overweight Study: STOP 1.02 (0.95, 1.09) 0.9 STOP / SCOPE Maternal BMI: Underweight 0.89 (0.82, 0.98) 0.01 STOP / SCOPE Maternal BMI: Normal 0.87 (0.83, 0.90) &lt;0.0001 STOP / SCOPE Maternal BMI: Overweight 0.87 (0.82, 0.92) &lt;0.0001 STOP / SCOPE Maternal BMI: Obese 0.88 (0.84, 0.93) &lt;0.0001 "],["age-bmi-groups-1.html", "19 Age &amp; BMI groups", " 19 Age &amp; BMI groups Descriptives with univariate P-values. Characteristic &lt;35y, non-obese (n=984) &lt;35y, obese (n=285) &gt;=35y, non-obese (n=29) &gt;=35y, obese (n=16) Total (n=1314) P-value PRL (ng/ml): Median (IQ range) 102.6 (62.6-164.4) 81.7 (49.5-132.4) 79.2 (52.1-95.7) 45.1 (32.3-103.1) 96.8 (58.3-157.1) &lt;0.0001 hPL (μg/ml): Median (IQ range) 120.8 (58.4-189.2) 73.8 (43.5-145.4) 81.8 (58.5-136.1) 81.2 (33.9-129.1) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.4) 2.2 (1.0-3.3) 2.1 (1.2-3.7) 2.1 (1.6-3.0) 2.5 (1.2-4.1) 0.0004 Insulin (uU/L): Median (IQ range) 9.3 (5.2-19.2) 16.1 (9.7-31.6) 8.5 (4.6-16.8) 11.6 (8.8-23.2) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.1-4.4) 3.6 (2.2-7.0) 2.1 (0.9-3.7) 2.6 (1.7-5.2) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.6) 4.9 (4.5-5.4) 4.7 (4.5-5.2) 5.0 (4.6-5.5) 0.02 Within SCOPE Characteristic &lt;35y, non-obese (n=457) &lt;35y, obese (n=130) &gt;=35y, non-obese (n=11) &gt;=35y, obese (n=6) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 142.7 (100.7-221.2) 131.3 (82.8-196.2) 134.9 (82.4-210.6) 85.0 (45.7-124.5) 139.9 (94.7-215.5) 0.12 hPL (μg/ml): Median (IQ range) 192.3 (157.8-226.8) 153.3 (130.7-180.3) 168.6 (136.6-202.0) 160.7 (98.5-202.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.4 (3.4-6.0) 3.4 (2.6-4.4) 3.8 (3.4-4.7) 4.5 (2.7-6.9) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/L): Median (IQ range) 13.4 (5.8-25.7) 20.1 (9.7-34.8) 11.3 (8.1-20.2) 50.4 (39.0-53.5) 14.4 (6.5-29.1) 0.0007 HOMA-IR: Median (IQ range) 3.1 (1.3-6.4) 4.6 (2.3-9.0) 2.7 (2.1-4.8) 14.0 (10.0-15.8) 3.3 (1.5-7.2) 0.001 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.1-5.9) 5.4 (5.2-5.7) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.91 Serum folate concentration (nM): Median (IQ range) 36.8 (29.2-43.0) 35.5 (24.8-43.2) 37.6 (33.9-43.0) 32.7 (31.3-36.9) 36.4 (28.5-43.0) 0.57 B12 concentration (pM): Median (IQ range) 252.5 (199.0-318.8) 227.0 (182.0-287.5) 289.0 (245.2-345.2) 227.5 (181.2-249.0) 248.0 (195.5-316.0) 0.02 Folate:B12 ratio: Median (IQ range) 142.8 (103.4-207.5) 143.0 (103.1-215.4) 124.3 (115.6-165.0) 153.9 (126.0-192.9) 142.6 (104.0-207.4) 0.97 Active B12 concentration (pM): Median (IQ range) 53.5 (42.0-72.0) 60.0 (43.5-71.0) 48.0 (48.0-53.5) 74.0 (52.0-93.0) 54.0 (43.0-72.0) 0.45 Folate:Active B12 ratio: Median (IQ range) 634.3 (471.2-1019.0) 546.7 (436.3-698.7) 685.4 (633.4-794.8) 400.0 (360.2-420.3) 617.0 (458.5-931.9) 0.01 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-5.0) 4.4 (3.8-5.0) 4.2 (3.9-4.5) 4.3 (3.9-4.6) 4.4 (3.8-5.0) 0.98 Within STOP Characteristic &lt;35y, non-obese (n=527) &lt;35y, obese (n=155) &gt;=35y, non-obese (n=18) &gt;=35y, obese (n=10) Total (n=710) P-value PRL (ng/ml): Median (IQ range) 76.3 (52.4-119.1) 62.9 (40.9-99.3) 72.9 (50.0-90.3) 41.2 (32.3-60.9) 72.9 (48.6-113.6) 0.001 hPL (μg/ml): Median (IQ range) 66.5 (44.4-101.1) 50.5 (34.5-71.7) 68.1 (49.4-83.4) 60.2 (33.9-90.7) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.6 (1.1-2.1) 1.6 (1.3-2.4) 1.4 (0.9-2.4) 0.10 Insulin (uU/L): Median (IQ range) 8.1 (4.8-14.6) 15.2 (9.9-27.4) 6.7 (4.1-15.4) 9.2 (8.4-12.4) 9.3 (5.6-17.0) &lt;0.0001 HOMA-IR: Median (IQ range) 1.7 (1.0-3.1) 3.5 (2.1-6.0) 1.1 (0.8-2.9) 1.9 (1.7-2.6) 1.9 (1.1-3.7) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.3) 4.6 (4.3-4.9) 4.5 (4.4-4.7) 4.7 (4.4-5.1) 0.002 Serum folate concentration (nM): Median (IQ range) 40.4 (36.5-45.0) 40.0 (35.4-44.9) 44.5 (40.3-78.6) 43.6 (42.1-99.6) 40.5 (36.4-45.3) 0.007 B12 concentration (pM): Median (IQ range) 284.5 (221.5-361.2) 260.0 (218.0-330.0) 272.0 (239.0-363.0) 295.0 (205.0-363.0) 278.0 (219.0-355.0) 0.20 Folate:B12 ratio: Median (IQ range) 152.6 (114.8-219.0) 166.7 (116.5-224.1) 168.2 (127.9-316.8) 241.6 (144.4-313.7) 155.8 (115.6-222.5) 0.22 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-80.5) 62.0 (51.5-76.0) 68.0 (55.0-100.0) 56.0 (53.2-59.5) 63.0 (48.0-80.0) 0.72 Folate:Active B12 ratio: Median (IQ range) 691.9 (487.2-959.9) 630.9 (513.8-898.6) 527.9 (444.1-965.5) 756.4 (713.9-1092.8) 670.9 (493.7-951.1) 0.71 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.5) 4.9 (4.3-5.7) 4.8 (4.4-6.1) 4.9 (4.7-5.3) 4.8 (4.3-5.6) 0.68 Red cell folate (nmol/L): Median (IQ range) 1445.0 (1205.8-1760.5) 1388.0 (1182.0-1744.0) 1592.0 (1361.0-1751.0) 1592.5 (1529.2-1667.0) 1446.5 (1204.8-1755.5) 0.50 "],["prolactin-13.html", "19.1 Prolactin", " 19.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 13.14 (8.50, 20.31) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.87 (0.75, 1.01) 0.08 Age_BMI_gp&gt;=35y, non-obese 0.97 (0.60, 1.55) 0.89 Age_BMI_gp&gt;=35y, obese 0.64 (0.38, 1.10) 0.11 StudySTOP 1.01 (0.88, 1.16) 0.86 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 0.91 (0.76, 1.10) 0.34 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.77 (0.44, 1.36) 0.37 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.85 (0.42, 1.71) 0.65 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35y, non-obese SCOPE 105.03 8.65 104.00 89.20 123.66 &lt;35y, obese SCOPE 91.83 9.26 221.14 75.28 112.03 &gt;=35y, non-obese SCOPE 101.48 25.28 1153.69 62.25 165.44 &gt;=35y, obese SCOPE 67.58 18.97 1190.07 38.97 117.21 &lt;35y, non-obese STOP 106.38 8.35 86.53 91.01 124.35 &lt;35y, obese STOP 84.85 7.99 168.51 70.46 102.18 &gt;=35y, non-obese STOP 79.47 13.68 895.15 56.69 111.42 &gt;=35y, obese STOP 58.22 13.91 1136.28 36.44 93.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.87 (0.72, 1.06) 0.3 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.97 (0.52, 1.79) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.11 (0.58, 2.09) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.64 (0.32, 1.30) 0.4 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 0.74 (0.36, 1.50) 0.7 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.67 (0.26, 1.69) 0.7 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.80 (0.68, 0.94) 0.002 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.75 (0.50, 1.12) 0.3 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.94 (0.62, 1.43) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.55 (0.30, 0.99) 0.04 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.69 (0.38, 1.25) 0.4 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.73 (0.36, 1.48) 0.7 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.01 (0.88, 1.16) 0.9 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.92 (0.75, 1.14) 0.5 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.78 (0.44, 1.38) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.86 (0.43, 1.74) 0.7 "],["hpl-13.html", "19.2 HPL", " 19.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.08 (1.67, 2.59) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.83 (0.77, 0.89) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 1.00 (0.78, 1.28) 0.98 Age_BMI_gp&gt;=35y, obese 0.71 (0.55, 0.92) 0.01 StudySTOP 1.12 (1.04, 1.20) 0.002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 0.97 (0.88, 1.07) 0.57 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 1.03 (0.76, 1.38) 0.86 Age_BMI_gp&gt;=35y, obese:StudySTOP 1.03 (0.72, 1.45) 0.88 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35y, non-obese SCOPE 100.30 2.83 220.85 94.87 106.04 &lt;35y, obese SCOPE 82.94 3.27 555.32 76.76 89.61 &gt;=35y, non-obese SCOPE 100.62 12.80 1204.80 78.40 129.14 &gt;=35y, obese SCOPE 71.31 9.48 930.08 54.93 92.58 &lt;35y, non-obese STOP 112.04 2.84 148.51 106.57 117.80 &lt;35y, obese STOP 90.14 3.31 383.81 83.86 96.90 &gt;=35y, non-obese STOP 115.43 9.67 1189.99 97.94 136.05 &gt;=35y, obese STOP 81.78 9.74 1199.46 64.73 103.32 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.83 (0.75, 0.91) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.00 (0.72, 1.39) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.21 (0.87, 1.69) 0.4 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.71 (0.51, 1.00) 0.05 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 0.86 (0.61, 1.22) 0.7 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.71 (0.44, 1.13) 0.2 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.80 (0.74, 0.88) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.03 (0.83, 1.27) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.28 (1.03, 1.59) 0.02 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.73 (0.54, 0.99) 0.04 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.91 (0.67, 1.23) 0.8 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.71 (0.49, 1.02) 0.07 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 1.12 (1.04, 1.20) 0.002 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.09 (0.98, 1.21) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 1.15 (0.85, 1.55) 0.4 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 1.15 (0.81, 1.63) 0.4 "],["gh2-13.html", "19.3 GH2", " 19.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 Age_BMI_gp&lt;35y, obese 0.78 (0.70, 0.86) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 0.95 (0.69, 1.32) 0.78 Age_BMI_gp&gt;=35y, obese 0.85 (0.58, 1.25) 0.41 StudySTOP 0.99 (0.90, 1.09) 0.80 GA_samp 1.31 (1.29, 1.34) &lt;0.0001 Age_BMI_gp&lt;35y, obese:StudySTOP 1.16 (1.02, 1.33) 0.03 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 1.07 (0.72, 1.59) 0.73 Age_BMI_gp&gt;=35y, obese:StudySTOP 1.02 (0.62, 1.68) 0.93 Estimated marginal means Age_BMI_gp Study response SE df lower.CL upper.CL &lt;35y, non-obese SCOPE 2.54 0.09 442.31 2.37 2.71 &lt;35y, obese SCOPE 1.97 0.10 894.28 1.78 2.19 &gt;=35y, non-obese SCOPE 2.42 0.41 1231.79 1.74 3.36 &gt;=35y, obese SCOPE 2.16 0.42 1195.00 1.48 3.17 &lt;35y, non-obese STOP 2.50 0.07 299.95 2.37 2.65 &lt;35y, obese STOP 2.27 0.10 491.56 2.07 2.48 &gt;=35y, non-obese STOP 2.56 0.29 1210.81 2.05 3.19 &gt;=35y, obese STOP 2.18 0.36 1164.32 1.58 3.02 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.78 (0.68, 0.89) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.95 (0.62, 1.47) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.22 (0.78, 1.91) 0.6 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 0.85 (0.52, 1.41) 0.8 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.10 (0.66, 1.82) 1.0 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 0.90 (0.46, 1.72) 1.0 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 0.90 (0.81, 1.01) 0.1 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 1.02 (0.77, 1.36) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 1.13 (0.84, 1.52) 0.7 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.87 (0.57, 1.34) 0.8 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.96 (0.62, 1.49) 1.0 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.85 (0.51, 1.42) 0.9 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.99 (0.90, 1.09) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 1.15 (0.99, 1.32) 0.06 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 1.06 (0.71, 1.58) 0.8 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 1.01 (0.61, 1.67) 1.0 "],["insulin-11.html", "19.4 Insulin", " 19.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 12.74 (7.23, 22.42) &lt;0.0001 Age_BMI_gp&lt;35y, obese 1.55 (1.27, 1.89) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 0.96 (0.65, 1.41) 0.82 Age_BMI_gp&gt;=35y, obese 2.30 (1.22, 4.34) 0.010 StudySTOP 0.71 (0.58, 0.86) 0.0005 GA_samp 1.00 (0.96, 1.04) 0.99 Age_BMI_gp&lt;35y, obese:StudySTOP 1.22 (0.95, 1.57) 0.11 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.90 (0.50, 1.59) 0.71 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.47 (0.24, 0.92) 0.03 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 12.78 0.86 Inf 11.21 14.58 &lt;35y, obese SCOPE 19.77 1.93 Inf 16.32 23.95 &gt;=35y, non-obese SCOPE 12.22 2.38 Inf 8.34 17.89 &gt;=35y, obese SCOPE 29.44 9.47 Inf 15.67 55.30 &lt;35y, non-obese STOP 9.04 0.45 Inf 8.20 9.96 &lt;35y, obese STOP 17.09 1.22 Inf 14.86 19.66 &gt;=35y, non-obese STOP 7.75 1.69 Inf 5.06 11.87 &gt;=35y, obese STOP 9.81 0.95 Inf 8.12 11.85 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.55 (1.19, 2.01) 0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 0.96 (0.58, 1.59) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 0.62 (0.36, 1.06) 0.10 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.30 (1.01, 5.28) 0.05 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.49 (0.64, 3.48) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 2.41 (0.93, 6.25) 0.08 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.89 (1.56, 2.29) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.86 (0.49, 1.50) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.45 (0.25, 0.81) 0.002 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 1.09 (0.83, 1.42) 0.9 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.57 (0.42, 0.78) &lt;0.0001 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.27 (0.69, 2.32) 0.7 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.71 (0.58, 0.86) 0.0005 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.86 (0.67, 1.12) 0.3 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.63 (0.35, 1.14) 0.1 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.33 (0.17, 0.65) 0.001 "],["homa-ir-11.html", "19.5 HOMA-IR", " 19.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.13 (1.74, 5.65) 0.0001 Age_BMI_gp&lt;35y, obese 1.57 (1.26, 1.95) &lt;0.0001 Age_BMI_gp&gt;=35y, non-obese 1.00 (0.65, 1.52) 0.99 Age_BMI_gp&gt;=35y, obese 2.52 (1.26, 5.06) 0.009 StudySTOP 0.61 (0.50, 0.75) &lt;0.0001 GA_samp 1.00 (0.96, 1.04) 0.94 Age_BMI_gp&lt;35y, obese:StudySTOP 1.27 (0.97, 1.66) 0.08 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.85 (0.46, 1.59) 0.61 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.42 (0.20, 0.87) 0.02 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 3.07 0.22 Inf 2.67 3.53 &lt;35y, obese SCOPE 4.82 0.51 Inf 3.91 5.92 &gt;=35y, non-obese SCOPE 3.06 0.65 Inf 2.02 4.63 &gt;=35y, obese SCOPE 7.74 2.74 Inf 3.87 15.49 &lt;35y, non-obese STOP 1.87 0.10 Inf 1.69 2.07 &lt;35y, obese STOP 3.72 0.28 Inf 3.21 4.32 &gt;=35y, non-obese STOP 1.59 0.38 Inf 1.00 2.52 &gt;=35y, obese STOP 1.99 0.19 Inf 1.65 2.39 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.57 (1.18, 2.09) 0.0003 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.00 (0.57, 1.73) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 0.64 (0.35, 1.14) 0.2 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 2.52 (1.01, 6.28) 0.05 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.61 (0.63, 4.09) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 2.53 (0.89, 7.20) 0.1 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.99 (1.63, 2.44) &lt;0.0001 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.85 (0.46, 1.56) 0.9 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.43 (0.23, 0.80) 0.003 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 1.06 (0.82, 1.38) 0.9 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.53 (0.39, 0.72) &lt;0.0001 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 1.25 (0.65, 2.39) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.61 (0.50, 0.75) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.77 (0.59, 1.02) 0.07 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.52 (0.28, 0.98) 0.04 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.26 (0.12, 0.53) 0.0002 "],["glucose-9.html", "19.6 Glucose", " 19.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.48 (4.93, 6.10) &lt;0.0001 Age_BMI_gp&lt;35y, obese 1.01 (0.97, 1.05) 0.68 Age_BMI_gp&gt;=35y, non-obese 1.01 (0.95, 1.07) 0.82 Age_BMI_gp&gt;=35y, obese 1.12 (0.94, 1.34) 0.20 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.74 Age_BMI_gp&lt;35y, obese:StudySTOP 1.02 (0.97, 1.08) 0.45 Age_BMI_gp&gt;=35y, non-obese:StudySTOP 0.99 (0.92, 1.07) 0.75 Age_BMI_gp&gt;=35y, obese:StudySTOP 0.87 (0.72, 1.04) 0.12 Estimated marginal means Age_BMI_gp Study response SE df asymp.LCL asymp.UCL &lt;35y, non-obese SCOPE 5.40 0.07 Inf 5.26 5.54 &lt;35y, obese SCOPE 5.44 0.10 Inf 5.25 5.63 &gt;=35y, non-obese SCOPE 5.43 0.17 Inf 5.12 5.77 &gt;=35y, obese SCOPE 6.05 0.54 Inf 5.08 7.21 &lt;35y, non-obese STOP 4.69 0.05 Inf 4.59 4.79 &lt;35y, obese STOP 4.83 0.09 Inf 4.66 5.00 &gt;=35y, non-obese STOP 4.67 0.10 Inf 4.48 4.86 &gt;=35y, obese STOP 4.55 0.09 Inf 4.39 4.73 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &lt;35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.01 (0.96, 1.06) 1.0 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: SCOPE 1.01 (0.93, 1.09) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: SCOPE 1.00 (0.92, 1.09) 1.0 &gt;=35y, obese / (&lt;35y, non-obese) Study: SCOPE 1.12 (0.89, 1.41) 0.6 &gt;=35y, obese / &lt;35y, obese Study: SCOPE 1.11 (0.88, 1.40) 0.6 &gt;=35y, obese / (&gt;=35y, non-obese) Study: SCOPE 1.11 (0.88, 1.42) 0.7 &lt;35y, obese / (&lt;35y, non-obese) Study: STOP 1.03 (0.98, 1.09) 0.5 (&gt;=35y, non-obese) / (&lt;35y, non-obese) Study: STOP 0.99 (0.94, 1.05) 1.0 (&gt;=35y, non-obese) / &lt;35y, obese Study: STOP 0.97 (0.90, 1.03) 0.6 &gt;=35y, obese / (&lt;35y, non-obese) Study: STOP 0.97 (0.92, 1.03) 0.5 &gt;=35y, obese / &lt;35y, obese Study: STOP 0.94 (0.88, 1.01) 0.1 &gt;=35y, obese / (&gt;=35y, non-obese) Study: STOP 0.98 (0.91, 1.05) 0.8 STOP / SCOPE Maternal age, BMI: &lt;35y, non-obese 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &lt;35y, obese 0.89 (0.84, 0.93) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35y, non-obese 0.86 (0.80, 0.92) &lt;0.0001 STOP / SCOPE Maternal age, BMI: &gt;=35y, obese 0.75 (0.63, 0.90) 0.002 "],["mets-3.html", "20 MetS", " 20 MetS Descriptives with univariate P-values. Characteristic No MetS (n=1149) MetS (n=112) Total (n=1261) P-value PRL (ng/ml): Median (IQ range) 95.2 (57.7-150.3) 107.5 (66.8-182.2) 96.3 (58.2-154.4) 0.11 hPL (μg/ml): Median (IQ range) 100.5 (54.0-179.2) 143.6 (59.4-179.6) 105.2 (54.1-179.5) 0.21 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 3.0 (1.6-4.6) 2.5 (1.2-4.1) 0.07 Insulin (uU/L): Median (IQ range) 9.9 (5.7-19.6) 28.0 (14.4-51.6) 10.8 (6.1-21.9) &lt;0.0001 HOMA-IR: Median (IQ range) 2.1 (1.2-4.5) 7.4 (3.6-14.1) 2.4 (1.3-5.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.4) 5.8 (5.6-6.2) 5.0 (4.6-5.5) &lt;0.0001 Within SCOPE Characteristic No MetS (n=525) MetS (n=76) Total (n=601) P-value PRL (ng/ml): Median (IQ range) 138.1 (92.3-218.7) 154.1 (105.0-204.0) 139.7 (94.2-215.5) 0.50 hPL (μg/ml): Median (IQ range) 185.1 (151.8-222.3) 169.0 (146.8-201.1) 183.5 (149.7-220.6) 0.04 GH2 (ng/ml): Median (IQ range) 4.2 (3.3-5.7) 4.1 (2.8-5.4) 4.2 (3.2-5.6) 0.29 Insulin (uU/L): Median (IQ range) 12.5 (6.1-24.7) 33.9 (20.3-60.0) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 2.8 (1.4-5.8) 8.9 (4.7-15.9) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.8) 5.9 (5.6-6.2) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.8 (28.2-43.2) 35.2 (30.3-42.5) 36.5 (28.6-43.0) 0.76 B12 concentration (pM): Median (IQ range) 252.0 (198.2-320.5) 223.0 (173.5-291.5) 249.5 (196.0-316.0) 0.006 Folate:B12 ratio: Median (IQ range) 141.0 (101.6-203.1) 154.1 (118.2-216.4) 142.6 (104.3-208.3) 0.18 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 51.0 (43.5-68.0) 54.0 (42.8-72.0) 0.65 Folate:Active B12 ratio: Median (IQ range) 615.9 (456.2-973.2) 620.0 (505.1-746.5) 617.2 (461.4-935.8) 0.80 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.8-4.7) 4.4 (3.8-4.9) 0.44 Within STOP Characteristic No MetS (n=624) MetS (n=36) Total (n=660) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.5-112.3) 65.1 (46.2-98.4) 72.6 (48.4-111.3) 0.28 hPL (μg/ml): Median (IQ range) 60.9 (41.3-91.0) 50.6 (34.5-71.3) 60.5 (41.1-90.6) 0.07 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.5 (0.8-2.0) 1.4 (0.9-2.3) 0.37 Insulin (uU/L): Median (IQ range) 9.1 (5.5-16.2) 16.5 (10.9-37.2) 9.2 (5.7-17.1) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.1-3.5) 4.5 (2.8-8.6) 1.9 (1.1-3.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 5.6 (4.9-5.8) 4.7 (4.4-5.1) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.1) 40.3 (37.2-45.0) 40.5 (36.3-45.1) 0.85 B12 concentration (pM): Median (IQ range) 279.5 (220.2-356.0) 247.0 (201.0-335.5) 278.0 (219.0-356.0) 0.13 Folate:B12 ratio: Median (IQ range) 153.6 (114.8-223.8) 172.4 (143.0-203.7) 155.4 (115.6-222.8) 0.27 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-81.0) 62.0 (56.0-74.0) 63.0 (49.0-81.0) 0.84 Folate:Active B12 ratio: Median (IQ range) 670.5 (487.1-941.9) 633.9 (493.7-726.8) 667.9 (488.1-936.8) 0.63 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.5) 4.8 (4.3-5.6) 0.91 Red cell folate (nmol/L): Median (IQ range) 1446.0 (1206.0-1751.0) 1469.5 (1207.5-1784.8) 1446.5 (1206.0-1753.8) 0.66 "],["prolactin-14.html", "20.1 Prolactin", " 20.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 12.78 (8.12, 20.14) &lt;0.0001 metab.C1MetS 1.04 (0.87, 1.24) 0.68 StudySTOP 1.01 (0.87, 1.16) 0.90 GA_samp 1.17 (1.13, 1.20) &lt;0.0001 metab.C1MetS:StudySTOP 0.90 (0.69, 1.19) 0.47 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 100.46 8.29 100.88 85.28 118.33 MetS SCOPE 104.27 11.83 322.41 83.41 130.35 No MetS STOP 101.36 8.07 87.36 86.53 118.73 MetS STOP 95.21 12.31 474.86 73.85 122.76 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.04 (0.87, 1.24) 0.7 MetS / No MetS Study: STOP 0.94 (0.76, 1.16) 0.6 STOP / SCOPE MetS: No MetS 1.01 (0.87, 1.16) 0.9 STOP / SCOPE MetS: MetS 0.91 (0.68, 1.22) 0.5 "],["hpl-14.html", "20.2 HPL", " 20.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 2.13 (1.70, 2.65) &lt;0.0001 metab.C1MetS 0.90 (0.83, 0.99) 0.02 StudySTOP 1.11 (1.04, 1.20) 0.003 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.97 (0.85, 1.12) 0.68 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 97.42 2.82 173.52 92.02 103.14 MetS SCOPE 88.07 4.24 759.47 80.12 96.80 No MetS STOP 108.61 2.94 131.77 102.96 114.58 MetS STOP 95.39 5.65 974.18 84.91 107.16 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.83, 0.99) 0.02 MetS / No MetS Study: STOP 0.88 (0.79, 0.98) 0.02 STOP / SCOPE MetS: No MetS 1.11 (1.04, 1.20) 0.003 STOP / SCOPE MetS: MetS 1.08 (0.94, 1.25) 0.3 "],["gh2-14.html", "20.3 GH2", " 20.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.05, 0.09) &lt;0.0001 metab.C1MetS 0.90 (0.80, 1.03) 0.12 StudySTOP 1.01 (0.91, 1.11) 0.87 GA_samp 1.31 (1.29, 1.34) &lt;0.0001 metab.C1MetS:StudySTOP 1.10 (0.90, 1.34) 0.35 Estimated marginal means metab.C1 Study response SE df lower.CL upper.CL No MetS SCOPE 2.44 0.08 405.19 2.29 2.61 MetS SCOPE 2.21 0.14 1126.55 1.94 2.51 No MetS STOP 2.46 0.07 272.09 2.32 2.61 MetS STOP 2.45 0.20 1133.90 2.09 2.86 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 0.90 (0.80, 1.03) 0.1 MetS / No MetS Study: STOP 0.99 (0.85, 1.16) 0.9 STOP / SCOPE MetS: No MetS 1.01 (0.91, 1.11) 0.9 STOP / SCOPE MetS: MetS 1.11 (0.90, 1.37) 0.3 "],["insulin-12.html", "20.4 Insulin", " 20.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 12.83 (7.08, 23.24) &lt;0.0001 metab.C1MetS 2.51 (2.00, 3.14) &lt;0.0001 StudySTOP 0.79 (0.65, 0.96) 0.02 GA_samp 1.00 (0.96, 1.04) 0.96 metab.C1MetS:StudySTOP 0.78 (0.54, 1.13) 0.19 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 12.65 0.84 Inf 11.11 14.41 MetS SCOPE 31.73 3.51 Inf 25.54 39.43 No MetS STOP 9.99 0.48 Inf 9.09 10.98 MetS STOP 19.59 2.87 Inf 14.69 26.11 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.51 (2.00, 3.14) &lt;0.0001 MetS / No MetS Study: STOP 1.96 (1.46, 2.62) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.79 (0.65, 0.96) 0.02 STOP / SCOPE MetS: MetS 0.62 (0.43, 0.89) 0.01 "],["homa-ir-12.html", "20.5 HOMA-IR", " 20.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.09 (1.67, 5.71) 0.0003 metab.C1MetS 2.85 (2.24, 3.63) &lt;0.0001 StudySTOP 0.69 (0.56, 0.85) 0.0004 GA_samp 1.00 (0.96, 1.04) 0.91 metab.C1MetS:StudySTOP 0.80 (0.53, 1.20) 0.28 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 3.00 0.21 Inf 2.62 3.44 MetS SCOPE 8.54 1.02 Inf 6.76 10.79 No MetS STOP 2.08 0.10 Inf 1.88 2.29 MetS STOP 4.72 0.76 Inf 3.44 6.48 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 2.85 (2.24, 3.63) &lt;0.0001 MetS / No MetS Study: STOP 2.28 (1.65, 3.14) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.69 (0.56, 0.85) 0.0004 STOP / SCOPE MetS: MetS 0.55 (0.37, 0.83) 0.004 "],["glucose-10.html", "20.6 Glucose", " 20.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.35 (4.79, 5.98) &lt;0.0001 metab.C1MetS 1.12 (1.09, 1.16) &lt;0.0001 StudySTOP 0.88 (0.85, 0.91) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.95 metab.C1MetS:StudySTOP 1.04 (0.97, 1.11) 0.27 Estimated marginal means metab.C1 Study response SE df asymp.LCL asymp.UCL No MetS SCOPE 5.33 0.07 Inf 5.20 5.47 MetS SCOPE 6.00 0.10 Inf 5.81 6.19 No MetS STOP 4.68 0.04 Inf 4.60 4.76 MetS STOP 5.46 0.15 Inf 5.17 5.77 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value MetS / No MetS Study: SCOPE 1.12 (1.09, 1.16) &lt;0.0001 MetS / No MetS Study: STOP 1.17 (1.10, 1.23) &lt;0.0001 STOP / SCOPE MetS: No MetS 0.88 (0.85, 0.91) &lt;0.0001 STOP / SCOPE MetS: MetS 0.91 (0.85, 0.97) 0.006 "],["birthweight-centile-1.html", "21 Birthweight centile", " 21 Birthweight centile Descriptives with univariate P-values. Characteristic &lt;=90th centile (n=1175) &gt;90th centile (n=135) Total (n=1310) P-value PRL (ng/ml): Median (IQ range) 97.0 (57.9-155.7) 96.1 (62.2-159.9) 96.9 (58.2-157.3) 0.89 hPL (μg/ml): Median (IQ range) 111.1 (54.6-179.0) 93.2 (54.6-184.1) 108.1 (54.6-179.7) 0.90 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.1) 2.0 (1.1-4.1) 2.5 (1.2-4.1) 0.31 Insulin (uU/L): Median (IQ range) 10.7 (6.1-21.4) 11.1 (5.8-22.7) 10.8 (6.0-21.7) 0.67 HOMA-IR: Median (IQ range) 2.4 (1.3-5.0) 2.6 (1.3-5.2) 2.4 (1.3-5.0) 0.54 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.6-5.6) 5.0 (4.6-5.5) 0.31 Within SCOPE Characteristic &lt;=90th centile (n=549) &gt;90th centile (n=55) Total (n=604) P-value PRL (ng/ml): Median (IQ range) 139.1 (92.8-215.5) 156.5 (106.3-223.3) 139.9 (94.7-215.5) 0.30 hPL (μg/ml): Median (IQ range) 181.5 (148.0-217.8) 206.6 (159.9-259.2) 183.5 (149.9-220.6) 0.02 GH2 (ng/ml): Median (IQ range) 4.1 (3.2-5.6) 4.6 (3.5-6.0) 4.2 (3.2-5.6) 0.36 Insulin (uU/L): Median (IQ range) 14.1 (6.4-27.4) 19.8 (7.2-39.0) 14.4 (6.5-29.1) 0.14 HOMA-IR: Median (IQ range) 3.2 (1.5-6.8) 4.8 (1.8-9.4) 3.3 (1.5-7.2) 0.10 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.07 Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.2) 37.7 (26.5-42.4) 36.4 (28.5-43.0) 0.72 B12 concentration (pM): Median (IQ range) 249.0 (195.0-313.0) 245.0 (202.0-325.0) 248.0 (195.5-316.0) 0.71 Folate:B12 ratio: Median (IQ range) 142.8 (105.2-207.8) 141.1 (96.2-202.9) 142.6 (104.0-207.4) 0.64 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-71.2) 56.0 (44.5-76.5) 54.0 (43.0-72.0) 0.41 Folate:Active B12 ratio: Median (IQ range) 617.2 (449.7-946.3) 575.0 (478.4-872.4) 617.0 (458.5-931.9) 0.88 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-5.0) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.62 Within STOP Characteristic &lt;=90th centile (n=626) &gt;90th centile (n=80) Total (n=706) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.7-114.6) 68.7 (47.2-104.7) 72.9 (48.6-113.5) 0.68 hPL (μg/ml): Median (IQ range) 63.5 (41.0-98.8) 58.5 (48.5-86.7) 62.4 (41.4-96.7) 0.98 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-1.9) 1.4 (0.9-2.4) 0.33 Insulin (uU/L): Median (IQ range) 9.3 (5.7-17.0) 8.3 (5.3-16.9) 9.2 (5.6-17.0) 0.74 HOMA-IR: Median (IQ range) 1.9 (1.1-3.7) 1.9 (1.1-3.9) 1.9 (1.1-3.7) 0.90 Glucose (mmol/L): Median (IQ range) 4.7 (4.4-5.0) 4.8 (4.5-5.1) 4.7 (4.4-5.1) 0.25 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-45.3) 41.3 (37.2-44.8) 40.5 (36.4-45.3) 0.52 B12 concentration (pM): Median (IQ range) 277.0 (217.0-353.8) 285.0 (231.0-366.0) 277.0 (219.0-355.0) 0.48 Folate:B12 ratio: Median (IQ range) 155.8 (116.3-225.5) 163.4 (114.6-216.1) 155.9 (115.6-222.8) 0.51 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 68.0 (51.0-88.8) 63.0 (48.0-80.0) 0.25 Folate:Active B12 ratio: Median (IQ range) 670.9 (502.6-964.3) 646.1 (460.7-853.3) 670.5 (493.5-950.0) 0.38 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.4-5.5) 4.8 (4.3-5.6) 0.89 Red cell folate (nmol/L): Median (IQ range) 1454.0 (1206.5-1761.0) 1383.5 (1187.0-1704.0) 1447.0 (1205.0-1754.0) 0.42 "],["prolactin-15.html", "21.1 Prolactin", " 21.1 Prolactin LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 11.82 (7.62, 18.34) &lt;0.0001 BW_gp&gt;90th centile 1.18 (0.97, 1.44) 0.10 StudySTOP 1.02 (0.89, 1.17) 0.74 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.95 (0.74, 1.21) 0.67 Estimated marginal means BW_gp Study response SE df lower.CL upper.CL &lt;=90th centile SCOPE 98.14 8.03 98.14 83.43 115.46 &gt;90th centile SCOPE 115.87 14.14 406.73 91.15 147.28 &lt;=90th centile STOP 100.41 7.90 84.09 85.86 117.43 &gt;90th centile STOP 112.33 11.82 250.40 91.30 138.21 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.18 (0.97, 1.44) 0.10 &gt;90th centile / &lt;=90th centile Study: STOP 1.12 (0.96, 1.30) 0.1 STOP / SCOPE : &lt;=90th centile 1.02 (0.89, 1.17) 0.7 STOP / SCOPE : &gt;90th centile 0.97 (0.74, 1.26) 0.8 "],["hpl-15.html", "21.2 HPL", " 21.2 HPL LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 1.84 (1.47, 2.30) &lt;0.0001 BW_gp&gt;90th centile 1.14 (1.03, 1.26) 0.01 StudySTOP 1.15 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.01 (0.88, 1.15) 0.92 Estimated marginal means BW_gp Study response SE df lower.CL upper.CL &lt;=90th centile SCOPE 93.26 2.70 176.89 88.08 98.75 &gt;90th centile SCOPE 106.51 5.86 899.06 95.60 118.66 &lt;=90th centile STOP 106.93 2.86 127.18 101.42 112.75 &gt;90th centile STOP 122.98 5.63 680.10 112.41 134.53 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.14 (1.03, 1.26) 0.01 &gt;90th centile / &lt;=90th centile Study: STOP 1.15 (1.06, 1.25) 0.0006 STOP / SCOPE : &lt;=90th centile 1.15 (1.07, 1.23) 0.0002 STOP / SCOPE : &gt;90th centile 1.15 (1.01, 1.33) 0.04 "],["gh2-15.html", "21.3 GH2", " 21.3 GH2 LME for duplicated or repeated measures. Model summary Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 BW_gp&gt;90th centile 1.06 (0.92, 1.22) 0.43 StudySTOP 1.03 (0.94, 1.13) 0.55 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.00 (0.84, 1.20) 0.98 Estimated marginal means BW_gp Study response SE df lower.CL upper.CL &lt;=90th centile SCOPE 2.38 0.08 403.13 2.23 2.54 &gt;90th centile SCOPE 2.52 0.18 1172.83 2.18 2.91 &lt;=90th centile STOP 2.45 0.07 247.11 2.31 2.59 &gt;90th centile STOP 2.60 0.15 1052.85 2.31 2.92 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.06 (0.92, 1.22) 0.4 &gt;90th centile / &lt;=90th centile Study: STOP 1.06 (0.95, 1.19) 0.3 STOP / SCOPE : &lt;=90th centile 1.03 (0.94, 1.13) 0.6 STOP / SCOPE : &gt;90th centile 1.03 (0.85, 1.25) 0.8 "],["insulin-13.html", "21.4 Insulin", " 21.4 Insulin GEE for repeated measures. Model summary Var Effect P (Intercept) 15.27 (8.60, 27.11) &lt;0.0001 BW_gp&gt;90th centile 1.16 (0.83, 1.62) 0.38 StudySTOP 0.73 (0.61, 0.88) 0.0009 GA_samp 0.99 (0.96, 1.03) 0.74 BW_gp&gt;90th centile:StudySTOP 0.82 (0.56, 1.21) 0.33 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 14.08 0.90 Inf 12.41 15.97 &gt;90th centile SCOPE 16.35 2.72 Inf 11.80 22.67 &lt;=90th centile STOP 10.30 0.47 Inf 9.41 11.27 &gt;90th centile STOP 9.87 1.00 Inf 8.09 12.04 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.16 (0.83, 1.62) 0.4 &gt;90th centile / &lt;=90th centile Study: STOP 0.96 (0.79, 1.17) 0.7 STOP / SCOPE : &lt;=90th centile 0.73 (0.61, 0.88) 0.0009 STOP / SCOPE : &gt;90th centile 0.60 (0.41, 0.90) 0.01 "],["homa-ir-13.html", "21.5 HOMA-IR", " 21.5 HOMA-IR GEE for repeated measures. Model summary Var Effect P (Intercept) 3.78 (2.08, 6.88) &lt;0.0001 BW_gp&gt;90th centile 1.20 (0.85, 1.70) 0.30 StudySTOP 0.63 (0.52, 0.77) &lt;0.0001 GA_samp 0.99 (0.95, 1.03) 0.67 BW_gp&gt;90th centile:StudySTOP 0.81 (0.54, 1.21) 0.31 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 3.39 0.23 Inf 2.96 3.87 &gt;90th centile SCOPE 4.07 0.71 Inf 2.89 5.72 &lt;=90th centile STOP 2.15 0.10 Inf 1.96 2.36 &gt;90th centile STOP 2.09 0.22 Inf 1.70 2.58 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.20 (0.85, 1.70) 0.3 &gt;90th centile / &lt;=90th centile Study: STOP 0.97 (0.79, 1.20) 0.8 STOP / SCOPE : &lt;=90th centile 0.63 (0.52, 0.77) &lt;0.0001 STOP / SCOPE : &gt;90th centile 0.51 (0.34, 0.78) 0.002 "],["glucose-11.html", "21.6 Glucose", " 21.6 Glucose GEE for repeated measures. Model summary Var Effect P (Intercept) 5.44 (4.89, 6.06) &lt;0.0001 BW_gp&gt;90th centile 1.07 (1.00, 1.13) 0.04 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.80 BW_gp&gt;90th centile:StudySTOP 1.00 (0.91, 1.10) 0.99 Estimated marginal means BW_gp Study response SE df asymp.LCL asymp.UCL &lt;=90th centile SCOPE 5.38 0.06 Inf 5.26 5.51 &gt;90th centile SCOPE 5.73 0.17 Inf 5.40 6.08 &lt;=90th centile STOP 4.69 0.04 Inf 4.61 4.76 &gt;90th centile STOP 5.00 0.19 Inf 4.64 5.38 Post-hoc comparisons Contrast Subgroup Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile Study: SCOPE 1.07 (1.00, 1.13) 0.04 &gt;90th centile / &lt;=90th centile Study: STOP 1.07 (0.99, 1.15) 0.10 STOP / SCOPE : &lt;=90th centile 0.87 (0.84, 0.90) &lt;0.0001 STOP / SCOPE : &gt;90th centile 0.87 (0.79, 0.96) 0.006 "],["hormone-models-1.html", "22 Hormone Models", " 22 Hormone Models Number of samples per timepoint SCOPE STOP 12wks 22 0 15wks 465 684 "],["raw-plots-1.html", "22.1 Raw plots", " 22.1 Raw plots "],["scope-vs-stop-1.html", "22.2 SCOPE vs STOP", " 22.2 SCOPE vs STOP Fit LME models for Prolactin, HPL and GH2. Fit GEE models for Insulin and HOMA-IR. Outcomes: Prolactin, hPL, GH2, Insulin, HOMA-IR (all outcomes log-transformed) Independent variables: Study, GA at sampling Model fitted: LME model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       LME only: Random intercepts for Study ID and Plate       GEE only: Independence correlation structure 22.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 8.706512 1 0.003 ** Study 2.244395 1 0.1 ns GA_samp 30.790407 1 &lt;0.0001 *** Study:GA_samp 2.221336 1 0.1 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 46.94900 1 &lt;0.0001 *** Study 21.66283 1 &lt;0.0001 *** GA_samp 94.21469 1 &lt;0.0001 *** Study:GA_samp 25.95307 1 &lt;0.0001 *** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 12.13572 1 0.0005 *** Study 16.86104 1 &lt;0.0001 *** GA_samp 53.71079 1 &lt;0.0001 *** Study:GA_samp 17.66908 1 &lt;0.0001 *** Insulin model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 6.440 6.440 0.01 * 3 GA_samp 1 Inf 3.036 3.036 0.08 ns 2 Study:GA_samp 1 Inf 4.677 4.677 0.03 * HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Study 1 Inf 7.472 7.472 0.006 ** 3 GA_samp 1 Inf 3.420 3.420 0.06 ns 2 Study:GA_samp 1 Inf 4.874 4.874 0.03 * 22.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 5.60 (1.78, 17.59) 0.003 StudySTOP 2.48 (0.76, 8.13) 0.13 GA_samp 1.23 (1.14, 1.32) &lt;0.0001 StudySTOP:GA_samp 0.94 (0.87, 1.02) 0.14 HPL Var Effect P (Intercept) 8.51 (4.57, 15.74) &lt;0.0001 StudySTOP 0.22 (0.12, 0.42) &lt;0.0001 GA_samp 1.22 (1.17, 1.27) &lt;0.0001 StudySTOP:GA_samp 1.12 (1.07, 1.16) &lt;0.0001 GH2 Var Effect P (Intercept) 0.27 (0.12, 0.57) 0.0005 StudySTOP 0.19 (0.09, 0.44) &lt;0.0001 GA_samp 1.20 (1.14, 1.26) &lt;0.0001 StudySTOP:GA_samp 1.12 (1.06, 1.18) &lt;0.0001 Insulin Var Effect P (Intercept) 74.21 (15.57, 353.77) &lt;0.0001 StudySTOP 0.12 (0.02, 0.62) 0.01 GA_samp 0.90 (0.81, 0.99) 0.04 StudySTOP:GA_samp 1.13 (1.01, 1.25) 0.03 HOMA.IR Var Effect P (Intercept) 20.36 (4.01, 103.37) 0.0003 StudySTOP 0.09 (0.02, 0.51) 0.006 GA_samp 0.89 (0.80, 0.99) 0.03 StudySTOP:GA_samp 1.13 (1.01, 1.27) 0.03 22.2.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.2.4 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Prolactin Study GA_samp response SE df lower.CL upper.CL SCOPE 10 44.67877 9.814452 700.78387 29.02665 68.77105 STOP 10 60.90187 4.719146 75.98848 52.19222 71.06496 SCOPE 16 155.26985 12.172577 79.04067 132.83688 181.49120 STOP 16 147.84441 14.560660 190.02837 121.74071 179.54527 HPL Study GA_samp response SE df lower.CL upper.CL SCOPE 10 60.06118 6.820203 1019.8755 48.06417 75.05269 STOP 10 39.61791 1.056218 118.9886 37.58074 41.76552 SCOPE 16 194.04839 5.267210 124.4580 183.89857 204.75841 STOP 16 247.31102 10.223451 514.9155 228.02015 268.23393 GH2 Study GA_samp response SE df lower.CL upper.CL SCOPE 10 1.600762 0.2219984 415.1058 1.218806 2.102418 STOP 10 0.948957 0.0264773 228.1998 0.898194 1.002589 SCOPE 16 4.703807 0.1319952 206.8337 4.450646 4.971368 STOP 16 5.462550 0.2820075 941.3979 4.936226 6.044993 Insulin Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 25.31505 7.1937998 Inf 14.504141 44.18404 STOP 10 10.17569 0.4433112 Inf 9.342878 11.08274 SCOPE 16 13.27781 0.7140309 Inf 11.949565 14.75370 STOP 16 10.90728 1.0191172 Inf 9.082069 13.09930 HOMA.IR Study GA_samp response SE df asymp.LCL asymp.UCL SCOPE 10 6.371755 1.8874508 Inf 3.565455 11.386841 STOP 10 2.137866 0.0979181 Inf 1.954312 2.338660 SCOPE 16 3.173325 0.1800916 Inf 2.839275 3.546678 STOP 16 2.273611 0.2215450 Inf 1.878337 2.752067 22.2.5 Comparisons Hormone Contrast GA_samp Ratio of Geometric means (95% CI) P-value Prolactin STOP / SCOPE 10 1.36 (0.90, 2.07) 0.1 Prolactin STOP / SCOPE 16 0.95 (0.81, 1.11) 0.5 HPL STOP / SCOPE 10 0.66 (0.53, 0.83) 0.0003 HPL STOP / SCOPE 16 1.27 (1.17, 1.38) &lt;0.0001 GH2 STOP / SCOPE 10 0.59 (0.45, 0.78) 0.0002 GH2 STOP / SCOPE 16 1.16 (1.04, 1.30) 0.007 Insulin STOP / SCOPE 10 0.40 (0.23, 0.71) 0.002 Insulin STOP / SCOPE 16 0.82 (0.67, 1.01) 0.07 HOMA.IR STOP / SCOPE 10 0.34 (0.19, 0.60) 0.0003 HOMA.IR STOP / SCOPE 16 0.72 (0.57, 0.89) 0.003 GLUC3_mmol.L STOP / SCOPE 10 0.89 (0.79, 1.00) 0.05 GLUC3_mmol.L STOP / SCOPE 16 0.87 (0.84, 0.90) &lt;0.0001 22.2.6 Barplots by Study Barplots in this section may be misleading due to involvement of Study by GA interaction. 22.2.7 Plots for GA "],["folate-1.html", "22.3 Folate", " 22.3 Folate 22.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 129.2308225 1 &lt;0.0001 *** Folate 2.0006170 1 0.2 ns Study 0.5519894 1 0.5 ns GA_samp 130.9134873 1 &lt;0.0001 *** Folate:Study 2.1143312 1 0.1 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 32.2090781 1 &lt;0.0001 *** Folate 0.1917908 1 0.7 ns Study 8.1357120 1 0.004 ** GA_samp 1633.8508884 1 &lt;0.0001 *** Folate:Study 0.0205584 1 0.9 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 329.3390138 1 &lt;0.0001 *** Folate 0.4074204 1 0.5 ns Study 1.3523959 1 0.2 ns GA_samp 806.7098807 1 &lt;0.0001 *** Folate:Study 1.0842100 1 0.3 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 8.298 8.298 0.004 ** 3 Study 1 Inf 11.103 11.103 0.0009 *** 4 GA_samp 1 Inf 0.126 0.126 0.7 ns 2 Folate:Study 1 Inf 1.122 1.122 0.3 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Folate 1 Inf 8.507 8.507 0.004 ** 3 Study 1 Inf 19.086 19.086 &lt;0.0001 *** 4 GA_samp 1 Inf 0.220 0.220 0.6 ns 2 Folate:Study 1 Inf 1.183 1.183 0.3 ns 22.3.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 12.75 (8.19, 19.85) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.69 StudySTOP 1.02 (0.89, 1.16) 0.83 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 HPL Var Effect P (Intercept) 1.94 (1.54, 2.43) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.59 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.72 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 22.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 96.09899 7.960411 98.27683 81.53238 113.2681 STOP 97.55176 7.573900 76.26709 83.57620 113.8643 HPL Study response SE df lower.CL upper.CL SCOPE 89.84074 2.661650 198.9858 84.74246 95.24575 STOP 102.82324 2.707566 125.3168 97.60199 108.32379 GH2 Study response SE df lower.CL upper.CL SCOPE 2.275956 0.0762282 422.9521 2.130948 2.430831 STOP 2.346964 0.0646647 228.4676 2.222945 2.477901 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.58196 0.9172011 Inf 12.890676 16.49515 STOP 10.49963 0.4816931 Inf 9.596731 11.48748 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.525574 0.2354573 Inf 3.093014 4.018628 STOP 2.195501 0.1052510 Inf 1.998608 2.411792 22.3.4 Comparisons Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.7 Prolactin Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.7 HPL Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.6 HPL Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.6 GH2 Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.7 GH2 Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.7 Insulin Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.006 Insulin Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.006 HOMA.IR Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 0.006 HOMA.IR Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 0.006 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE 1.00 (1.00, 1.00) 1.0 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP 1.00 (1.00, 1.00) 1.0 22.3.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.3.6 Plots "],["b12-1.html", "22.4 B12", " 22.4 B12 22.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 113.7952111 1 &lt;0.0001 *** B12 0.0039381 1 0.9 ns Study 0.1835478 1 0.7 ns GA_samp 132.0512503 1 &lt;0.0001 *** B12:Study 0.4161577 1 0.5 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 24.428879 1 &lt;0.0001 *** B12 1.133261 1 0.3 ns Study 3.998083 1 0.05 ns GA_samp 1648.072726 1 &lt;0.0001 *** B12:Study 0.017806 1 0.9 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 336.340208 1 &lt;0.0001 *** B12 6.624419 1 0.01 * Study 1.872150 1 0.2 ns GA_samp 815.254269 1 &lt;0.0001 *** B12:Study 1.840691 1 0.2 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 4.297 4.297 0.04 * 3 Study 1 Inf 7.878 7.878 0.005 ** 4 GA_samp 1 Inf 0.122 0.122 0.7 ns 2 B12:Study 1 Inf 1.131 1.131 0.3 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 B12 1 Inf 3.806 3.806 0.05 ns 3 Study 1 Inf 11.788 11.788 0.0006 *** 4 GA_samp 1 Inf 0.209 0.209 0.6 ns 2 B12:Study 1 Inf 1.079 1.079 0.3 ns 22.4.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 12.05 (7.69, 18.87) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.41 StudySTOP 1.01 (0.88, 1.16) 0.87 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 HPL Var Effect P (Intercept) 1.81 (1.44, 2.28) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.04 StudySTOP 1.14 (1.06, 1.22) 0.0003 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 0.06 (0.04, 0.08) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.01 StudySTOP 1.02 (0.93, 1.12) 0.66 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 22.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 96.44883 7.995409 99.12550 81.82049 113.6925 STOP 97.57641 7.549111 75.59233 83.64104 113.8335 HPL Study response SE df lower.CL upper.CL SCOPE 90.37671 2.679268 203.5448 85.24545 95.81683 STOP 102.98997 2.685378 122.8965 97.80923 108.44512 GH2 Study response SE df lower.CL upper.CL SCOPE 2.305636 0.0778216 439.4523 2.157650 2.463772 STOP 2.354790 0.0639321 215.9014 2.232091 2.484234 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.15732 0.8882227 Inf 12.519214 16.00976 STOP 10.17033 0.4597934 Inf 9.307926 11.11264 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.420104 0.2279209 Inf 3.001332 3.897308 STOP 2.123460 0.1003240 Inf 1.935658 2.329483 22.4.4 Comparisons Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin B12363.5 / B12263.5 SCOPE 1.01 (0.98, 1.05) 0.4 Prolactin B12363.5 / B12263.5 STOP 1.01 (0.98, 1.05) 0.4 HPL B12363.5 / B12263.5 SCOPE 1.02 (1.00, 1.04) 0.04 HPL B12363.5 / B12263.5 STOP 1.02 (1.00, 1.04) 0.04 GH2 B12363.5 / B12263.5 SCOPE 1.03 (1.01, 1.05) 0.01 GH2 B12363.5 / B12263.5 STOP 1.03 (1.01, 1.05) 0.01 Insulin B12363.5 / B12263.5 SCOPE 0.95 (0.91, 1.00) 0.04 Insulin B12363.5 / B12263.5 STOP 0.95 (0.91, 1.00) 0.04 HOMA.IR B12363.5 / B12263.5 SCOPE 0.95 (0.90, 1.00) 0.06 HOMA.IR B12363.5 / B12263.5 STOP 0.95 (0.90, 1.00) 0.06 GLUC3_mmol.L B12363.5 / B12263.5 SCOPE 0.99 (0.99, 1.00) 0.10 GLUC3_mmol.L B12363.5 / B12263.5 STOP 0.99 (0.99, 1.00) 0.10 22.4.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 96.12350 7.947519 98.09299 81.57799 113.2625 STOP 97.24727 7.516907 75.33670 83.36971 113.4349 HPL Study response SE df lower.CL upper.CL SCOPE 89.98138 2.651712 199.1091 84.90137 95.36534 STOP 102.53947 2.668252 121.9775 97.39112 107.95996 GH2 Study response SE df lower.CL upper.CL SCOPE 2.288290 0.0764347 425.0011 2.142879 2.443569 STOP 2.337074 0.0633250 215.3192 2.215533 2.465284 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.33738 0.8943328 Inf 12.687433 16.20189 STOP 10.29968 0.4592552 Inf 9.437771 11.24031 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.463888 0.2293611 Inf 3.042297 3.943901 STOP 2.150644 0.1002700 Inf 1.962830 2.356429 22.4.6 Comparisons (50 unit increase) Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin B12313.5 / B12263.5 SCOPE 1.01 (0.99, 1.02) 0.4 Prolactin B12313.5 / B12263.5 STOP 1.01 (0.99, 1.02) 0.4 HPL B12313.5 / B12263.5 SCOPE 1.01 (1.00, 1.02) 0.04 HPL B12313.5 / B12263.5 STOP 1.01 (1.00, 1.02) 0.04 GH2 B12313.5 / B12263.5 SCOPE 1.02 (1.00, 1.03) 0.01 GH2 B12313.5 / B12263.5 STOP 1.02 (1.00, 1.03) 0.01 Insulin B12313.5 / B12263.5 SCOPE 0.98 (0.95, 1.00) 0.04 Insulin B12313.5 / B12263.5 STOP 0.98 (0.95, 1.00) 0.04 HOMA.IR B12313.5 / B12263.5 SCOPE 0.97 (0.95, 1.00) 0.06 HOMA.IR B12313.5 / B12263.5 STOP 0.97 (0.95, 1.00) 0.06 GLUC3_mmol.L B12313.5 / B12263.5 SCOPE 1.00 (0.99, 1.00) 0.10 GLUC3_mmol.L B12313.5 / B12263.5 STOP 1.00 (0.99, 1.00) 0.10 22.4.7 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.4.8 Plots "],["folateb12-1.html", "22.5 Folate:B12", " 22.5 Folate:B12 22.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 131.619724 1 &lt;0.0001 *** folate_B12 2.967510 1 0.08 ns Study 1.329267 1 0.2 ns GA_samp 131.577880 1 &lt;0.0001 *** folate_B12:Study 5.013235 1 0.03 * HPL Chisq Df Pr(&gt;Chisq) (Intercept) 32.3040552 1 &lt;0.0001 *** folate_B12 0.1638235 1 0.7 ns Study 9.3893442 1 0.002 ** GA_samp 1638.1363304 1 &lt;0.0001 *** folate_B12:Study 0.0023293 1 1.0 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 320.4006010 1 &lt;0.0001 *** folate_B12 1.3497714 1 0.2 ns Study 0.1266652 1 0.7 ns GA_samp 807.9421439 1 &lt;0.0001 *** folate_B12:Study 0.0677801 1 0.8 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.333 0.333 0.6 ns 3 Study 1 Inf 9.600 9.600 0.002 ** 4 GA_samp 1 Inf 0.076 0.076 0.8 ns 2 folate_B12:Study 1 Inf 0.120 0.120 0.7 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 folate_B12 1 Inf 0.406 0.406 0.5 ns 3 Study 1 Inf 17.721 17.721 &lt;0.0001 *** 4 GA_samp 1 Inf 0.153 0.153 0.7 ns 2 folate_B12:Study 1 Inf 0.217 0.217 0.6 ns 22.5.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 13.46 (8.64, 20.98) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.09 StudySTOP 0.91 (0.77, 1.07) 0.25 GA_samp 1.17 (1.14, 1.20) &lt;0.0001 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.03 HPL Var Effect P (Intercept) 1.94 (1.55, 2.43) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.49 StudySTOP 1.14 (1.07, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 0.06 (0.05, 0.08) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.13 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 22.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 95.45434 7.892902 97.94519 81.00864 112.4760 STOP 97.32665 7.524037 75.24338 83.43580 113.5301 HPL Study response SE df lower.CL upper.CL SCOPE 89.70666 2.649346 197.6966 84.63129 95.08641 STOP 102.63004 2.679109 121.6350 97.46103 108.07320 GH2 Study response SE df lower.CL upper.CL SCOPE 2.271708 0.0758594 419.5700 2.127385 2.425823 STOP 2.342068 0.0635849 214.5217 2.220031 2.470813 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.41229 0.9070753 Inf 12.739738 16.30443 STOP 10.28088 0.4603074 Inf 9.417142 11.22383 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.481303 0.2322185 Inf 3.05466 3.967535 STOP 2.146647 0.1004986 Inf 1.95844 2.352940 22.5.4 Comparisons Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin folate_B12247.58 / folate_B12147.58 SCOPE 0.96 (0.93, 1.01) 0.09 Prolactin folate_B12247.58 / folate_B12147.58 STOP 1.02 (0.99, 1.06) 0.2 HPL folate_B12247.58 / folate_B12147.58 SCOPE 1.00 (0.98, 1.01) 0.5 HPL folate_B12247.58 / folate_B12147.58 STOP 1.00 (0.98, 1.01) 0.5 GH2 folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.97, 1.00) 0.1 GH2 folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.97, 1.00) 0.1 Insulin folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.96, 1.02) 0.6 Insulin folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.96, 1.02) 0.6 HOMA.IR folate_B12247.58 / folate_B12147.58 SCOPE 0.99 (0.96, 1.02) 0.6 HOMA.IR folate_B12247.58 / folate_B12147.58 STOP 0.99 (0.96, 1.02) 0.6 GLUC3_mmol.L folate_B12247.58 / folate_B12147.58 SCOPE 1.00 (0.99, 1.01) 0.6 GLUC3_mmol.L folate_B12247.58 / folate_B12147.58 STOP 1.00 (0.99, 1.01) 0.6 22.5.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.5.6 Plots "],["active-b12-1.html", "22.6 Active B12", " 22.6 Active B12 22.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 67.4457733 1 &lt;0.0001 *** Active.B12 0.1176992 1 0.7 ns Study 0.1615703 1 0.7 ns GA_samp 58.6983233 1 &lt;0.0001 *** Active.B12:Study 0.0319285 1 0.9 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 6.1178575 1 0.01 * Active.B12 0.0010379 1 1.0 ns Study 3.0037869 1 0.08 ns GA_samp 832.2474984 1 &lt;0.0001 *** Active.B12:Study 0.0508695 1 0.8 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 193.194888 1 &lt;0.0001 *** Active.B12 1.660906 1 0.2 ns Study 2.898371 1 0.09 ns GA_samp 463.652179 1 &lt;0.0001 *** Active.B12:Study 2.181948 1 0.1 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 0.122 0.122 0.7 ns 3 Study 1 Inf 2.404 2.404 0.1 ns 4 GA_samp 1 Inf 0.098 0.098 0.8 ns 2 Active.B12:Study 1 Inf 0.008 0.008 0.9 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Active.B12 1 Inf 0.136 0.136 0.7 ns 3 Study 1 Inf 4.369 4.369 0.04 * 4 GA_samp 1 Inf 0.177 0.177 0.7 ns 2 Active.B12:Study 1 Inf 0.023 0.023 0.9 ns 22.6.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 14.66 (7.87, 27.29) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.75 StudySTOP 0.91 (0.76, 1.10) 0.34 GA_samp 1.16 (1.11, 1.20) &lt;0.0001 HPL Var Effect P (Intercept) 1.53 (1.09, 2.15) 0.01 Active.B12 1.00 (1.00, 1.00) 0.75 StudySTOP 1.19 (1.08, 1.32) 0.0008 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 GH2 Var Effect P (Intercept) 0.05 (0.03, 0.07) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.81 StudySTOP 1.06 (0.93, 1.20) 0.39 GA_samp 1.33 (1.30, 1.37) &lt;0.0001 22.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 104.01066 9.626059 123.0482 86.59997 124.9217 STOP 94.94685 8.209625 94.7514 79.97034 112.7281 HPL Study response SE df lower.CL upper.CL SCOPE 90.59169 3.245454 284.9368 84.42361 97.21041 STOP 107.89007 3.445517 187.3029 101.30274 114.90575 GH2 Study response SE df lower.CL upper.CL SCOPE 2.293938 0.0981028 340.3339 2.108867 2.495250 STOP 2.425388 0.0895900 225.3341 2.255119 2.608513 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.72221 1.1449052 Inf 12.640885 17.14623 STOP 10.51991 0.6520471 Inf 9.316497 11.87877 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.563678 0.2995429 Inf 3.022395 4.201900 STOP 2.196609 0.1440558 Inf 1.931657 2.497902 22.6.4 Comparisons Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin Active.B1270 / Active.B1260 SCOPE 1.00 (0.98, 1.03) 0.7 Prolactin Active.B1270 / Active.B1260 STOP 1.00 (0.98, 1.03) 0.7 HPL Active.B1270 / Active.B1260 SCOPE 1.00 (0.99, 1.01) 0.7 HPL Active.B1270 / Active.B1260 STOP 1.00 (0.99, 1.01) 0.7 GH2 Active.B1270 / Active.B1260 SCOPE 1.00 (0.99, 1.02) 0.8 GH2 Active.B1270 / Active.B1260 STOP 1.00 (0.99, 1.02) 0.8 Insulin Active.B1270 / Active.B1260 SCOPE 0.99 (0.96, 1.03) 0.7 Insulin Active.B1270 / Active.B1260 STOP 0.99 (0.96, 1.03) 0.7 HOMA.IR Active.B1270 / Active.B1260 SCOPE 0.99 (0.96, 1.03) 0.7 HOMA.IR Active.B1270 / Active.B1260 STOP 0.99 (0.96, 1.03) 0.7 GLUC3_mmol.L Active.B1270 / Active.B1260 SCOPE 1.01 (1.00, 1.01) 0.2 GLUC3_mmol.L Active.B1270 / Active.B1260 STOP 1.01 (1.00, 1.01) 0.2 22.6.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.6.6 Plots "],["folateactive-b12-1.html", "22.7 Folate:Active B12", " 22.7 Folate:Active B12 22.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 81.653013 1 &lt;0.0001 *** folate_Active.B12 2.405026 1 0.1 ns Study 5.359313 1 0.02 * GA_samp 60.136224 1 &lt;0.0001 *** folate_Active.B12:Study 7.831834 1 0.005 ** HPL Chisq Df Pr(&gt;Chisq) (Intercept) 6.7473777 1 0.009 ** folate_Active.B12 0.4492223 1 0.5 ns Study 16.2494864 1 &lt;0.0001 *** GA_samp 843.1941108 1 &lt;0.0001 *** folate_Active.B12:Study 4.5843424 1 0.03 * GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 198.6866206 1 &lt;0.0001 *** folate_Active.B12 1.0610568 1 0.3 ns Study 0.0121323 1 0.9 ns GA_samp 468.3134903 1 &lt;0.0001 *** folate_Active.B12:Study 2.2694976 1 0.1 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 1.589 1.589 0.2 ns 3 Study 1 Inf 8.527 8.527 0.003 ** 4 GA_samp 1 Inf 0.097 0.097 0.8 ns 2 folate_Active.B12:Study 1 Inf 1.432 1.432 0.2 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 folate_Active.B12 1 Inf 1.851 1.851 0.2 ns 3 Study 1 Inf 14.060 14.060 0.0002 *** 4 GA_samp 1 Inf 0.177 0.177 0.7 ns 2 folate_Active.B12:Study 1 Inf 1.383 1.383 0.2 ns 22.7.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 15.95 (8.75, 29.04) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.12 StudySTOP 0.77 (0.62, 0.96) 0.02 GA_samp 1.16 (1.12, 1.20) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.005 HPL Var Effect P (Intercept) 1.54 (1.11, 2.14) 0.010 folate_Active.B12 1.00 (1.00, 1.00) 0.50 StudySTOP 1.28 (1.13, 1.44) &lt;0.0001 GA_samp 1.36 (1.33, 1.38) &lt;0.0001 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.03 GH2 Var Effect P (Intercept) 0.05 (0.03, 0.07) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 1.00 StudySTOP 1.06 (0.93, 1.20) 0.39 GA_samp 1.33 (1.30, 1.37) &lt;0.0001 22.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 103.52216 9.549322 122.42134 86.24441 124.2612 STOP 95.26028 8.213629 94.46877 80.27242 113.0465 HPL Study response SE df lower.CL upper.CL SCOPE 90.58383 3.249700 278.4913 84.4074 97.21223 STOP 107.75515 3.455875 184.7057 101.1483 114.79353 GH2 Study response SE df lower.CL upper.CL SCOPE 2.292618 0.0978943 337.6858 2.107924 2.493496 STOP 2.425090 0.0895859 225.4901 2.254830 2.608207 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.69993 1.1456949 Inf 12.617509 17.12604 STOP 10.50458 0.6474221 Inf 9.309302 11.85333 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.557729 0.2993955 Inf 3.016764 4.195701 STOP 2.192979 0.1431559 Inf 1.929606 2.492300 22.7.4 Comparisons Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.96 (0.92, 1.01) 0.1 Prolactin folate_Active.B121144.86 / folate_Active.B12644.86 STOP 1.06 (1.01, 1.12) 0.02 HPL folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 1.01 (0.98, 1.04) 0.5 HPL folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.94, 1.00) 0.02 GH2 folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 1.00 (0.98, 1.02) 1.0 GH2 folate_Active.B121144.86 / folate_Active.B12644.86 STOP 1.00 (0.98, 1.02) 1.0 Insulin folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.97 (0.93, 1.01) 0.2 Insulin folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.93, 1.01) 0.2 HOMA.IR folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.97 (0.93, 1.01) 0.1 HOMA.IR folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.97 (0.93, 1.01) 0.1 GLUC3_mmol.L folate_Active.B121144.86 / folate_Active.B12644.86 SCOPE 0.99 (0.99, 1.00) 0.004 GLUC3_mmol.L folate_Active.B121144.86 / folate_Active.B12644.86 STOP 0.99 (0.99, 1.00) 0.004 22.7.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.7.6 Plots "],["homocysteine-1.html", "22.8 Homocysteine", " 22.8 Homocysteine 22.8.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 117.9823128 1 &lt;0.0001 *** Homocysteine 2.2161224 1 0.1 ns Study 0.0338807 1 0.9 ns GA_samp 122.0902307 1 &lt;0.0001 *** Homocysteine:Study 0.0959458 1 0.8 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 31.1427141 1 &lt;0.0001 *** Homocysteine 0.6346316 1 0.4 ns Study 3.0978882 1 0.08 ns GA_samp 1551.6084962 1 &lt;0.0001 *** Homocysteine:Study 0.0725759 1 0.8 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 239.2035022 1 &lt;0.0001 *** Homocysteine 1.5409841 1 0.2 ns Study 0.8917925 1 0.3 ns GA_samp 785.9602453 1 &lt;0.0001 *** Homocysteine:Study 1.7161585 1 0.2 ns Insulin model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.759 0.759 0.4 ns 3 Study 1 Inf 1.868 1.868 0.2 ns 4 GA_samp 1 Inf 0.138 0.138 0.7 ns 2 Homocysteine:Study 1 Inf 0.001 0.001 1.0 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value 1 Homocysteine 1 Inf 0.548 0.548 0.5 ns 3 Study 1 Inf 3.470 3.470 0.06 ns 4 GA_samp 1 Inf 0.210 0.210 0.6 ns 2 Homocysteine:Study 1 Inf 0.000 0.000 1.0 ns 22.8.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 15.39 (9.51, 24.91) &lt;0.0001 Homocysteine 0.97 (0.94, 1.00) 0.05 StudySTOP 1.02 (0.89, 1.16) 0.81 GA_samp 1.16 (1.13, 1.20) &lt;0.0001 HPL Var Effect P (Intercept) 2.09 (1.63, 2.68) &lt;0.0001 Homocysteine 0.99 (0.97, 1.00) 0.12 StudySTOP 1.14 (1.06, 1.23) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 GH2 Var Effect P (Intercept) 0.06 (0.04, 0.09) &lt;0.0001 Homocysteine 1.00 (0.97, 1.02) 0.71 StudySTOP 1.03 (0.94, 1.13) 0.52 GA_samp 1.32 (1.29, 1.34) &lt;0.0001 22.8.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. Prolactin Study response SE df lower.CL upper.CL SCOPE 95.14832 7.872904 98.14826 80.74033 112.1274 STOP 96.72139 7.493736 75.86991 82.89050 112.8601 HPL Study response SE df lower.CL upper.CL SCOPE 89.48048 2.648455 200.4057 84.40755 94.8583 STOP 102.27292 2.682151 124.6366 97.09987 107.7216 GH2 Study response SE df lower.CL upper.CL SCOPE 2.271353 0.0762138 421.7530 2.126380 2.426210 STOP 2.342118 0.0643205 222.2644 2.218731 2.472366 Insulin Study response SE df asymp.LCL asymp.UCL SCOPE 14.32849 0.9049166 Inf 12.660262 16.21653 STOP 10.23459 0.4633987 Inf 9.365476 11.18435 HOMA.IR Study response SE df asymp.LCL asymp.UCL SCOPE 3.462311 0.2324445 Inf 3.035429 3.949226 STOP 2.138542 0.1012539 Inf 1.949018 2.346496 22.8.4 Comparisons Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin Homocysteine5.6 / Homocysteine4.6 SCOPE 0.97 (0.94, 1.00) 0.05 Prolactin Homocysteine5.6 / Homocysteine4.6 STOP 0.97 (0.94, 1.00) 0.05 HPL Homocysteine5.6 / Homocysteine4.6 SCOPE 0.99 (0.97, 1.00) 0.1 HPL Homocysteine5.6 / Homocysteine4.6 STOP 0.99 (0.97, 1.00) 0.1 GH2 Homocysteine5.6 / Homocysteine4.6 SCOPE 1.00 (0.97, 1.02) 0.7 GH2 Homocysteine5.6 / Homocysteine4.6 STOP 1.00 (0.97, 1.02) 0.7 Insulin Homocysteine5.6 / Homocysteine4.6 SCOPE 0.98 (0.93, 1.03) 0.4 Insulin Homocysteine5.6 / Homocysteine4.6 STOP 0.98 (0.93, 1.03) 0.4 HOMA.IR Homocysteine5.6 / Homocysteine4.6 SCOPE 0.98 (0.93, 1.03) 0.4 HOMA.IR Homocysteine5.6 / Homocysteine4.6 STOP 0.98 (0.93, 1.03) 0.4 GLUC3_mmol.L Homocysteine5.6 / Homocysteine4.6 SCOPE 1.00 (0.99, 1.01) 0.7 GLUC3_mmol.L Homocysteine5.6 / Homocysteine4.6 STOP 1.00 (0.99, 1.01) 0.7 22.8.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.8.6 Plots "],["red-cell-folate.html", "22.9 Red cell folate", " 22.9 Red cell folate 22.9.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 43.64894 1 &lt;0.0001 *** ns(rcfolate, 3) 5.76169 3 0.1 ns GA_samp 70.48397 1 &lt;0.0001 *** HPL Chisq Df Pr(&gt;Chisq) (Intercept) 10.1918551 1 0.001 ** ns(rcfolate, 3) 0.1840576 3 1.0 ns GA_samp 1109.0784596 1 &lt;0.0001 *** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 94.062933 1 &lt;0.0001 *** ns(rcfolate, 3) 6.776213 3 0.08 ns GA_samp 558.762160 1 &lt;0.0001 *** Insulin model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.363 0.363 0.5 ns GA_samp 1 Inf 0.389 0.389 0.5 ns HOMA.IR model term df1 df2 F.ratio Chisq p.value rcfolate 1 Inf 0.345 0.345 0.6 ns GA_samp 1 Inf 0.266 0.266 0.6 ns 22.9.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 17.37 (7.46, 40.43) &lt;0.0001 ns(rcfolate, 3)1 0.80 (0.49, 1.32) 0.39 ns(rcfolate, 3)2 0.89 (0.18, 4.41) 0.89 ns(rcfolate, 3)3 1.01 (0.80, 1.27) 0.92 GA_samp 1.15 (1.11, 1.18) &lt;0.0001 HPL Var Effect P (Intercept) 2.13 (1.34, 3.40) 0.001 ns(rcfolate, 3)1 0.95 (0.72, 1.25) 0.72 ns(rcfolate, 3)2 0.87 (0.36, 2.10) 0.75 ns(rcfolate, 3)3 0.99 (0.87, 1.12) 0.86 GA_samp 1.35 (1.33, 1.37) &lt;0.0001 GH2 Var Effect P (Intercept) 0.04 (0.02, 0.08) &lt;0.0001 ns(rcfolate, 3)1 0.93 (0.64, 1.37) 0.73 ns(rcfolate, 3)2 1.52 (0.44, 5.27) 0.51 ns(rcfolate, 3)3 0.90 (0.75, 1.07) 0.24 GA_samp 1.35 (1.32, 1.38) &lt;0.0001 22.9.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR 22.9.4 Plots "],["session-info-5.html", "23 Session info", " 23 Session info Results generated on: 2023-05-19 18:28:51.248856 Click for more details sessionInfo() ## R version 4.3.0 (2023-04-21) ## Platform: x86_64-pc-linux-gnu (64-bit) ## Running under: Ubuntu 22.04.2 LTS ## ## Matrix products: default ## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 ## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0 ## ## locale: ## [1] LC_CTYPE=en_AU.UTF-8 LC_NUMERIC=C ## [3] LC_TIME=en_AU.UTF-8 LC_COLLATE=en_AU.UTF-8 ## [5] LC_MONETARY=en_AU.UTF-8 LC_MESSAGES=en_AU.UTF-8 ## [7] LC_PAPER=en_AU.UTF-8 LC_NAME=en_AU.UTF-8 ## [9] LC_ADDRESS=en_AU.UTF-8 LC_TELEPHONE=en_AU.UTF-8 ## [11] LC_MEASUREMENT=en_AU.UTF-8 LC_IDENTIFICATION=en_AU.UTF-8 ## ## time zone: Australia/Adelaide ## tzcode source: system (glibc) ## ## attached base packages: ## [1] parallel splines grid stats graphics grDevices utils ## [8] datasets methods base ## ## other attached packages: ## [1] ggpubr_0.6.0 car_3.1-2 carData_3.0-5 xlsx_0.6.5 ## [5] geepack_1.3.9 doParallel_1.0.17 iterators_1.0.14 foreach_1.5.2 ## [9] emmeans_1.8.5 lmerTest_3.1-3 lme4_1.1-33 Matrix_1.5-1 ## [13] readxl_1.4.2 fontawesome_0.5.1 htmlwidgets_1.6.2 kableExtra_1.3.4 ## [17] knitr_1.42 rmarkdown_2.21 devtools_2.4.3 usethis_2.1.5 ## [21] pander_0.6.5 magrittr_2.0.3 gridExtra_2.3 Hmisc_4.6-0 ## [25] ggplot2_3.4.2 Formula_1.2-4 survival_3.5-3 lattice_0.21-8 ## ## loaded via a namespace (and not attached): ## [1] remotes_2.4.2 sandwich_3.0-1 rlang_1.1.1 ## [4] multcomp_1.4-18 compiler_4.3.0 mgcv_1.8-42 ## [7] png_0.1-7 systemfonts_1.0.4 callr_3.7.3 ## [10] vctrs_0.6.2 rvest_1.0.3 stringr_1.5.0 ## [13] pkgconfig_2.0.3 crayon_1.5.2 fastmap_1.1.1 ## [16] backports_1.4.1 ellipsis_0.3.2 labeling_0.4.2 ## [19] utf8_1.2.3 sessioninfo_1.2.2 ps_1.7.5 ## [22] nloptr_2.0.0 purrr_1.0.1 xfun_0.39 ## [25] cachem_1.0.8 jsonlite_1.8.4 highr_0.10 ## [28] xlsxjars_0.6.1 jpeg_0.1-9 broom_1.0.4 ## [31] prettyunits_1.1.1 cluster_2.1.4 R6_2.5.1 ## [34] bslib_0.4.2 stringi_1.7.12 RColorBrewer_1.1-3 ## [37] boot_1.3-28 pkgload_1.3.2 rpart_4.1.19 ## [40] jquerylib_0.1.4 cellranger_1.1.0 numDeriv_2016.8-1.1 ## [43] estimability_1.4.1 Rcpp_1.0.10 bookdown_0.34 ## [46] zoo_1.8-9 base64enc_0.1-3 nnet_7.3-18 ## [49] tidyselect_1.2.0 abind_1.4-5 rstudioapi_0.14 ## [52] yaml_2.3.7 codetools_0.2-19 processx_3.8.1 ## [55] pkgbuild_1.4.0 tibble_3.2.1 withr_2.5.0 ## [58] coda_0.19-4 evaluate_0.21 foreign_0.8-82 ## [61] rJava_1.0-6 xml2_1.3.3 pillar_1.9.0 ## [64] checkmate_2.0.0 generics_0.1.3 munsell_0.5.0 ## [67] scales_1.2.1 minqa_1.2.4 xtable_1.8-4 ## [70] glue_1.6.2 tools_4.3.0 data.table_1.14.8 ## [73] ggsignif_0.6.4 webshot_0.5.4 fs_1.6.2 ## [76] mvtnorm_1.1-3 tidyr_1.3.0 latticeExtra_0.6-29 ## [79] colorspace_2.1-0 nlme_3.1-162 htmlTable_2.4.0 ## [82] cli_3.6.1 fansi_1.0.4 viridisLite_0.4.2 ## [85] svglite_2.1.0 dplyr_1.1.2 gtable_0.3.3 ## [88] rstatix_0.7.2 sass_0.4.6 digest_0.6.31 ## [91] pbkrtest_0.5.2 TH.data_1.1-0 farver_2.1.1 ## [94] memoise_2.0.1 htmltools_0.5.5 lifecycle_1.0.3 ## [97] httr_1.4.2 MASS_7.3-59 "],["part-gdm-vs-uncomplicated.html", "(PART*) GDM vs Uncomplicated", " (PART*) GDM vs Uncomplicated "],["descriptives-2.html", "24 Descriptives", " 24 Descriptives Results in this section are from univariate analyses. Characteristic Uncomplicated (n=1292) GDM (n=251) Total (n=1543) P-value PRL (ng/ml): Mean (SD) 134.1 (155.0) 101.1 (94.7) 128.7 (147.3) &lt;0.0001 hPL (μg/ml): Mean (SD) 121.4 (76.6) 76.2 (52.6) 114.2 (75.1) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.0 (2.2) 1.9 (1.4) 2.8 (2.1) &lt;0.0001 "],["within-scope.html", "24.1 Within SCOPE", " 24.1 Within SCOPE 24.1.1 Demographics Characteristic Uncomplicated (n=604) GDM (n=58) Total (n=662) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 28.0 (25.0-32.0) 23.0 (20.0-27.0) &lt;0.0001 Maternal age (yrs): N(%) 0.38 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 56 (96.6) 647 (97.7) &gt;=35 13 (2.2) 2 (3.4) 15 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 30.6 (25.4-36.3) 25.3 (22.2-30.1) &lt;0.0001 Maternal BMI (category): N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 64 (10.6) 1 (1.7) 65 (9.8) &gt;=20 to &lt;25 228 (37.7) 13 (22.4) 241 (36.4) &gt;=25 to &lt;30 176 (29.1) 13 (22.4) 189 (28.5) &gt;=30 to &lt;40 117 (19.4) 24 (41.4) 141 (21.3) &gt;=40 19 (3.1) 7 (12.1) 26 (3.9) SEI: Median (IQ range) 24.0 (20.0-30.0) 27.0 (20.2-34.0) 24.0 (20.0-33.0) 0.15 Ethnicity: N(%) 0.36 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 555 (91.9) 51 (87.9) 606 (91.5) Maori 3 (0.5) 0 (0.0) 3 (0.5) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 25 (4.1) 4 (6.9) 29 (4.4) Indian 2 (0.3) 1 (1.7) 3 (0.5) African 3 (0.5) 0 (0.0) 3 (0.5) Middle-eastern 4 (0.7) 0 (0.0) 4 (0.6) Hispanic 0 (0.0) 0 (0.0) 0 (0.0) Aboriginal 9 (1.5) 1 (1.7) 10 (1.5) China and Japan 0 (0.0) 0 (0.0) 0 (0.0) Other 3 (0.5) 1 (1.7) 4 (0.6) Smoking: N(%) 0.25 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 476 (78.8) 50 (86.2) 526 (79.5) Yes 128 (21.2) 8 (13.8) 136 (20.5) Folic acid supplement (μg): N(%) 0.07 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 122 (20.2) 9 (15.5) 131 (19.8) &lt;800 335 (55.5) 27 (46.6) 362 (54.7) &gt;=800 147 (24.3) 22 (37.9) 169 (25.5) Folic acid supplement (μg): N(%) 0.15 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 122 (20.2) 9 (15.5) 131 (19.8) &lt;=400 66 (10.9) 6 (10.3) 72 (10.9) &gt;400 to &lt;800 269 (44.5) 21 (36.2) 290 (43.8) &gt;=800 147 (24.3) 22 (37.9) 169 (25.5) Fruit (1st trim): N(%) 0.03 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 58 (9.6) 3 (5.2) 61 (9.2) 1-6x/week 222 (36.8) 19 (32.8) 241 (36.4) &gt;=1-&lt;3x/day 221 (36.6) 32 (55.2) 253 (38.2) &gt;=3x/day 103 (17.1) 4 (6.9) 107 (16.2) Leafy vege (1st trim): N(%) 0.07 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 60 (9.9) 3 (5.2) 63 (9.5) 1-2x/week 144 (23.8) 13 (22.4) 157 (23.7) 3-6x/week 220 (36.4) 31 (53.4) 251 (37.9) &gt;=1x/day 180 (29.8) 11 (19.0) 191 (28.9) Fast food (1st trim): N(%) 1.00 Missing 114 (18.9) 9 (15.5) 123 (18.6) Never 12 (2.0) 1 (1.7) 13 (2.0) &gt;0-&lt;2x/week 62 (10.3) 6 (10.3) 68 (10.3) &gt;=2-&lt;4x/week 249 (41.2) 25 (43.1) 274 (41.4) &gt;=4x/week 167 (27.6) 17 (29.3) 184 (27.8) Vigorous exercise: N(%) 0.30 Missing 3 (0.5) 0 (0.0) 3 (0.5) Never 390 (64.6) 38 (65.5) 428 (64.7) Once a week 148 (24.5) 19 (32.8) 167 (25.2) 2-3/wk 50 (8.3) 1 (1.7) 51 (7.7) 4-6/wk 7 (1.2) 0 (0.0) 7 (1.1) Daily 6 (1.0) 0 (0.0) 6 (0.9) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) Moderate exercise: N(%) 0.41 Missing 3 (0.5) 0 (0.0) 3 (0.5) Never 248 (41.1) 30 (51.7) 278 (42.0) Once a week 146 (24.2) 16 (27.6) 162 (24.5) 2-3/wk 134 (22.2) 8 (13.8) 142 (21.5) 4-6/wk 36 (6.0) 1 (1.7) 37 (5.6) Daily 35 (5.8) 3 (5.2) 38 (5.7) More than once a day 2 (0.3) 0 (0.0) 2 (0.3) Recreational walking: N(%) 0.64 Missing 3 (0.5) 0 (0.0) 3 (0.5) Never 147 (24.3) 9 (15.5) 156 (23.6) Once a week 187 (31.0) 21 (36.2) 208 (31.4) 2-3/wk 161 (26.7) 17 (29.3) 178 (26.9) 4-6/wk 44 (7.3) 5 (8.6) 49 (7.4) Daily 52 (8.6) 6 (10.3) 58 (8.8) More than once a day 10 (1.7) 0 (0.0) 10 (1.5) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.1 (32.0-43.8) 36.8 (29.1-43.4) 0.09 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 4.1 (0.9) 4.5 (1.1) 0.002 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 253.5 (194.2-333.0) 249.0 (195.0-316.5) 0.80 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 158.9 (116.5-210.2) 143.2 (105.3-208.5) 0.29 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 72.7 (26.4) 59.9 (23.9) 0.01 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 553.8 (424.7-660.3) 612.3 (452.1-926.2) 0.20 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 55.8 (44.6-72.0) 56.3 (40.7-75.8) 0.99 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 132.7 (68.3-167.0) 111.1 (66.6-164.5) 0.62 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 1.0 (0.7-1.6) 0.59 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 0.9 (0.5-1.4) 1.1 (0.7-1.5) 0.09 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.9 (9.4) 128.5 (9.2) 0.04 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.04 24.1.2 MetS Characteristic Uncomplicated (n=604) GDM (n=58) Total (n=662) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 1 (1.7) 4 (0.6) No 525 (86.9) 29 (50.0) 554 (83.7) Yes 76 (12.6) 28 (48.3) 104 (15.7) : Median (IQ range) 1.0 (0.0-1.0) 2.0 (1.0-2.0) 1.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 97.0 (87.0-109.0) 86.0 (79.0-97.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 5.5 (0.9) 5.4 (0.9) 0.38 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.8 (1.6-2.4) 1.4 (1.1-1.7) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.6 (0.3) 1.8 (0.4) 0.003 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 6.0 (1.1) 5.5 (0.8) 0.0004 LDL (mmol/L): Mean (SD) 3.0 (0.7) 3.0 (0.8) 3.0 (0.7) 0.64 : Mean (SD) 107.8 (9.3) 112.9 (12.0) 108.2 (9.7) 0.002 : Mean (SD) 63.4 (7.5) 68.6 (8.9) 63.9 (7.8) &lt;0.0001 : Mean (SD) 78.2 (7.1) 83.4 (8.9) 78.7 (7.4) &lt;0.0001 MetS criteria: Waist circumference: N(%) 0.04 Missing 0 (0.0) 1 (1.7) 1 (0.2) &lt;80 cm 168 (27.8) 8 (13.8) 176 (26.6) &gt;=80 cm 436 (72.2) 49 (84.5) 485 (73.3) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1.7 mmol/L 468 (77.5) 23 (39.7) 491 (74.2) &gt;=1.7 mmol/L 136 (22.5) 35 (60.3) 171 (25.8) MetS criteria: HDL: N(%) 0.04 Missing 0 (0.0) 0 (0.0) 0 (0.0) &gt;=1.3 mmol/L 554 (91.7) 48 (82.8) 602 (90.9) &lt;1.3 mmol/L 50 (8.3) 10 (17.2) 60 (9.1) MetS criteria: Glucose: N(%) 0.0005 Missing 3 (0.5) 1 (1.7) 4 (0.6) &lt;5.6 mmol/L 341 (56.5) 18 (31.0) 359 (54.2) &gt;=5.6 mmol/L 260 (43.0) 39 (67.2) 299 (45.2) MetS criteria: sBP: N(%) 0.02 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;130 mmHg 596 (98.7) 54 (93.1) 650 (98.2) &gt;=130 mmHg 8 (1.3) 4 (6.9) 12 (1.8) MetS criteria: dBP: N(%) 0.04 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;85 mmHg 602 (99.7) 56 (96.6) 658 (99.4) &gt;=85 mmHg 2 (0.3) 2 (3.4) 4 (0.6) : Mean (SD) 0.0 (0.1) 0.1 (0.3) 0.0 (0.1) 0.06 CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 7.8 (4.4-12.5) 4.5 (2.4-8.0) &lt;0.0001 24.1.3 Outcomes Characteristic Uncomplicated (n=604) GDM (n=58) Total (n=662) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 38.9 (38.1-40.0) 40.1 (39.2-41.0) &lt;0.0001 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3260.0 (2825.0-3728.8) 3530.0 (3264.2-3825.0) 0.0002 : Mean (SD) 54.2 (25.1) 47.6 (31.9) 53.6 (25.8) 0.13 Baby sex: N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 291 (48.2) 27 (46.6) 318 (48.0) Female 313 (51.8) 31 (53.4) 344 (52.0) Mode of delivery: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 361 (59.8) 19 (32.8) 380 (57.4) Operative vaginal 103 (17.1) 7 (12.1) 110 (16.6) Pre-labour LSCS 24 (4.0) 10 (17.2) 34 (5.1) LSCS in labour 116 (19.2) 22 (37.9) 138 (20.8) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["within-stop.html", "24.2 Within STOP", " 24.2 Within STOP 24.2.1 Demographics Characteristic Uncomplicated (n=711) GDM (n=198) Total (n=909) P-value Maternal age (yrs): Median (IQ range) 25.0 (22.0-29.0) 28.0 (24.0-31.0) 26.0 (22.0-29.0) &lt;0.0001 Maternal age (yrs): N(%) 0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 694 (97.6) 181 (91.4) 875 (96.3) &gt;=35 17 (2.4) 17 (8.6) 34 (3.7) Maternal BMI: Median (IQ range) 25.3 (22.4-29.5) 30.9 (24.6-37.6) 26.0 (22.6-31.3) &lt;0.0001 Maternal BMI (category): N(%) &lt;0.0001 Missing 1 (0.1) 0 (0.0) 1 (0.1) &lt;20 55 (7.7) 8 (4.0) 63 (6.9) &gt;=20 to &lt;25 278 (39.1) 47 (23.7) 325 (35.8) &gt;=25 to &lt;30 212 (29.8) 40 (20.2) 252 (27.7) &gt;=30 to &lt;40 136 (19.1) 68 (34.3) 204 (22.4) &gt;=40 29 (4.1) 35 (17.7) 64 (7.0) SEI: Median (IQ range) 29.0 (22.0-45.0) 28.5 (20.0-45.0) 29.0 (21.0-45.0) 0.94 Ethnicity: N(%) 0.0010 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 595 (83.7) 141 (71.2) 736 (81.0) Maori 0 (0.0) 1 (0.5) 1 (0.1) Pacific Islander 3 (0.4) 0 (0.0) 3 (0.3) South East and Far East 30 (4.2) 24 (12.1) 54 (5.9) Indian 27 (3.8) 17 (8.6) 44 (4.8) African 11 (1.5) 5 (2.5) 16 (1.8) Middle-eastern 18 (2.5) 4 (2.0) 22 (2.4) Hispanic 2 (0.3) 1 (0.5) 3 (0.3) Aboriginal 13 (1.8) 3 (1.5) 16 (1.8) China and Japan 10 (1.4) 2 (1.0) 12 (1.3) Other 2 (0.3) 0 (0.0) 2 (0.2) Smoking: N(%) 0.34 Missing 6 (0.8) 0 (0.0) 6 (0.7) No 602 (84.7) 163 (82.3) 765 (84.2) Yes 103 (14.5) 35 (17.7) 138 (15.2) Folic acid supplement (μg): N(%) 0.63 Missing 87 (12.2) 21 (10.6) 108 (11.9) None 49 (6.9) 13 (6.6) 62 (6.8) &lt;800 134 (18.8) 44 (22.2) 178 (19.6) &gt;=800 441 (62.0) 120 (60.6) 561 (61.7) Folic acid supplement (μg): N(%) 0.71 Missing 87 (12.2) 21 (10.6) 108 (11.9) None 49 (6.9) 13 (6.6) 62 (6.8) &lt;=400 7 (1.0) 3 (1.5) 10 (1.1) &gt;400 to &lt;800 127 (17.9) 41 (20.7) 168 (18.5) &gt;=800 441 (62.0) 120 (60.6) 561 (61.7) Fruit (1st trim): N(%) 0.14 Missing 11 (1.5) 3 (1.5) 14 (1.5) &lt;1-3x/month 47 (6.6) 16 (8.1) 63 (6.9) 1-6x/week 203 (28.6) 66 (33.3) 269 (29.6) &gt;=1-&lt;3x/day 349 (49.1) 96 (48.5) 445 (49.0) &gt;=3x/day 101 (14.2) 17 (8.6) 118 (13.0) Leafy vege (1st trim): N(%) 0.79 Missing 11 (1.5) 4 (2.0) 15 (1.7) &lt;1-3x/month 73 (10.3) 21 (10.6) 94 (10.3) 1-2x/week 159 (22.4) 42 (21.2) 201 (22.1) 3-6x/week 235 (33.1) 72 (36.4) 307 (33.8) &gt;=1x/day 233 (32.8) 59 (29.8) 292 (32.1) Fast food (1st trim): N(%) 0.22 Missing 93 (13.1) 24 (12.1) 117 (12.9) Never 30 (4.2) 11 (5.6) 41 (4.5) &gt;0-&lt;2x/week 118 (16.6) 34 (17.2) 152 (16.7) &gt;=2-&lt;4x/week 261 (36.7) 84 (42.4) 345 (38.0) &gt;=4x/week 209 (29.4) 45 (22.7) 254 (27.9) Vigorous exercise: N(%) 0.99 Missing 5 (0.7) 3 (1.5) 8 (0.9) Never 439 (61.7) 124 (62.6) 563 (61.9) Once a week 179 (25.2) 48 (24.2) 227 (25.0) 2-3/wk 63 (8.9) 16 (8.1) 79 (8.7) 4-6/wk 12 (1.7) 4 (2.0) 16 (1.8) Daily 12 (1.7) 3 (1.5) 15 (1.7) More than once a day 1 (0.1) 0 (0.0) 1 (0.1) Moderate exercise: N(%) 0.006 Missing 7 (1.0) 4 (2.0) 11 (1.2) Never 266 (37.4) 87 (43.9) 353 (38.8) Once a week 173 (24.3) 54 (27.3) 227 (25.0) 2-3/wk 156 (21.9) 42 (21.2) 198 (21.8) 4-6/wk 49 (6.9) 3 (1.5) 52 (5.7) Daily 48 (6.8) 6 (3.0) 54 (5.9) More than once a day 12 (1.7) 2 (1.0) 14 (1.5) Recreational walking: N(%) 0.15 Missing 8 (1.1) 3 (1.5) 11 (1.2) Never 158 (22.2) 33 (16.7) 191 (21.0) Once a week 233 (32.8) 81 (40.9) 314 (34.5) 2-3/wk 170 (23.9) 49 (24.7) 219 (24.1) 4-6/wk 53 (7.5) 12 (6.1) 65 (7.2) Daily 83 (11.7) 17 (8.6) 100 (11.0) More than once a day 6 (0.8) 3 (1.5) 9 (1.0) Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.2) 40.1 (35.5-45.2) 40.5 (36.3-45.2) 0.41 Homocysteine concentration (μM): Mean (SD) 5.0 (1.1) 4.8 (1.0) 4.9 (1.1) 0.03 B12 concentration (pM): Median (IQ range) 277.5 (219.0-355.0) 273.0 (217.5-348.5) 276.0 (219.0-354.0) 0.54 Folate:B12 ratio: Median (IQ range) 155.9 (115.7-222.4) 148.0 (112.4-225.9) 153.9 (115.0-222.5) 0.43 Active B12 concentration (pM): Mean (SD) 66.7 (24.7) 76.6 (26.1) 69.0 (25.3) 0.0007 Folate:Active B12 ratio: Median (IQ range) 670.7 (493.5-950.5) 531.9 (417.3-788.4) 634.4 (475.9-919.4) 0.0004 Vitamin D: Median (IQ range) 61.0 (45.0-76.0) 60.0 (44.5-77.5) 61.0 (45.0-76.0) 0.49 UIC (ug/L): Median (IQ range) 199.0 (127.1-320.1) 220.6 (139.0-344.1) 205.2 (127.6-324.8) 0.11 HCG (MoM): Median (IQ range) 1.0 (0.7-1.5) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.00 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.3) 1.0 (0.7-1.4) 0.26 Haemoglobin (g/L): Mean (SD) 130.8 (9.7) 132.2 (10.0) 131.1 (9.8) 0.09 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.02 Red cell folate (nmol/L): Mean (SD) 1417.2 (325.0) 1492.9 (307.2) 1433.8 (322.5) 0.004 24.2.2 MetS Characteristic Uncomplicated (n=711) GDM (n=198) Total (n=909) P-value MetS: N(%) &lt;0.0001 Missing 51 (7.2) 14 (7.1) 65 (7.2) No 624 (87.8) 144 (72.7) 768 (84.5) Yes 36 (5.1) 40 (20.2) 76 (8.4) : Median (IQ range) 0.0 (0.0-1.0) 0.0 (0.0-1.5) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 81.0 (74.0-89.0) 91.0 (78.0-107.5) 82.0 (75.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 4.6 (0.8) 4.7 (0.9) 4.6 (0.8) 0.27 Triglyceride (mmol/L): Median (IQ range) 1.1 (0.9-1.4) 1.2 (0.9-1.6) 1.1 (0.9-1.4) 0.001 HDL (mmol/L): Mean (SD) 1.7 (0.3) 1.5 (0.3) 1.6 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 4.8 (0.7) 4.9 (0.8) 4.8 (0.7) 0.008 LDL (mmol/L): Mean (SD) 2.4 (0.7) 2.6 (0.7) 2.5 (0.7) 0.001 : Mean (SD) 113.9 (9.7) 118.8 (11.6) 115.0 (10.3) &lt;0.0001 : Mean (SD) 69.4 (8.2) 73.5 (9.9) 70.3 (8.7) &lt;0.0001 : Mean (SD) 84.2 (7.7) 88.6 (9.6) 85.2 (8.3) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 11 (1.5) 3 (1.5) 14 (1.5) &lt;80 cm 329 (46.3) 54 (27.3) 383 (42.1) &gt;=80 cm 371 (52.2) 141 (71.2) 512 (56.3) MetS criteria: Triglyceride: N(%) 0.0002 Missing 10 (1.4) 1 (0.5) 11 (1.2) &lt;1.7 mmol/L 627 (88.2) 156 (78.8) 783 (86.1) &gt;=1.7 mmol/L 74 (10.4) 41 (20.7) 115 (12.7) MetS criteria: HDL: N(%) 0.02 Missing 10 (1.4) 1 (0.5) 11 (1.2) &gt;=1.3 mmol/L 606 (85.2) 156 (78.8) 762 (83.8) &lt;1.3 mmol/L 95 (13.4) 41 (20.7) 136 (15.0) MetS criteria: Glucose: N(%) 0.09 Missing 10 (1.4) 1 (0.5) 11 (1.2) &lt;5.6 mmol/L 648 (91.1) 174 (87.9) 822 (90.4) &gt;=5.6 mmol/L 53 (7.5) 23 (11.6) 76 (8.4) MetS criteria: sBP: N(%) &lt;0.0001 Missing 33 (4.6) 11 (5.6) 44 (4.8) &lt;130 mmHg 634 (89.2) 155 (78.3) 789 (86.8) &gt;=130 mmHg 44 (6.2) 32 (16.2) 76 (8.4) MetS criteria: dBP: N(%) &lt;0.0001 Missing 33 (4.6) 11 (5.6) 44 (4.8) &lt;85 mmHg 654 (92.0) 162 (81.8) 816 (89.8) &gt;=85 mmHg 24 (3.4) 25 (12.6) 49 (5.4) : Mean (SD) 0.1 (0.3) 0.2 (0.4) 0.1 (0.3) &lt;0.0001 CRP (mg/L): Median (IQ range) 3.1 (1.3-6.0) 3.9 (2.1-8.1) 3.3 (1.4-6.5) 0.001 24.2.3 Outcomes Characteristic Uncomplicated (n=711) GDM (n=198) Total (n=909) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (39.1-40.9) 38.9 (38.1-39.7) 39.9 (38.9-40.6) &lt;0.0001 Birthweight (g): Median (IQ range) 3506.0 (3250.0-3786.0) 3350.0 (3020.0-3645.0) 3467.0 (3220.0-3761.5) &lt;0.0001 : Mean (SD) 53.3 (26.1) 52.5 (30.3) 53.1 (27.1) 0.75 Baby sex: N(%) 1.00 Missing 0 (0.0) 1 (0.5) 1 (0.1) Male 356 (50.1) 98 (49.5) 454 (49.9) Female 355 (49.9) 99 (50.0) 454 (49.9) Mode of delivery: N(%) 0.01 Missing 0 (0.0) 1 (0.5) 1 (0.1) Unassisted vaginal 382 (53.7) 91 (46.0) 473 (52.0) Operative vaginal 147 (20.7) 34 (17.2) 181 (19.9) Pre-labour LSCS 35 (4.9) 19 (9.6) 54 (5.9) LSCS in labour 147 (20.7) 53 (26.8) 200 (22.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-gdm.html", "24.3 SCOPE vs STOP (GDM)", " 24.3 SCOPE vs STOP (GDM) 24.3.1 Demographics Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Maternal age (yrs): Median (IQ range) 28.0 (25.0-32.0) 28.0 (24.0-31.0) 28.0 (24.0-32.0) 0.95 Maternal age (yrs): N(%) 0.26 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 56 (96.6) 181 (91.4) 237 (92.6) &gt;=35 2 (3.4) 17 (8.6) 19 (7.4) Maternal BMI: Median (IQ range) 30.6 (25.4-36.3) 30.9 (24.6-37.6) 30.6 (24.6-37.3) 0.85 Maternal BMI (category): N(%) 0.74 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 1 (1.7) 8 (4.0) 9 (3.5) &gt;=20 to &lt;25 13 (22.4) 47 (23.7) 60 (23.4) &gt;=25 to &lt;30 13 (22.4) 40 (20.2) 53 (20.7) &gt;=30 to &lt;40 24 (41.4) 68 (34.3) 92 (35.9) &gt;=40 7 (12.1) 35 (17.7) 42 (16.4) SEI: Median (IQ range) 27.0 (20.2-34.0) 28.5 (20.0-45.0) 28.0 (20.0-45.0) 0.19 Ethnicity: N(%) 0.19 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 51 (87.9) 141 (71.2) 192 (75.0) Maori 0 (0.0) 1 (0.5) 1 (0.4) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 4 (6.9) 24 (12.1) 28 (10.9) Indian 1 (1.7) 17 (8.6) 18 (7.0) African 0 (0.0) 5 (2.5) 5 (2.0) Middle-eastern 0 (0.0) 4 (2.0) 4 (1.6) Hispanic 0 (0.0) 1 (0.5) 1 (0.4) Aboriginal 1 (1.7) 3 (1.5) 4 (1.6) China and Japan 0 (0.0) 2 (1.0) 2 (0.8) Other 1 (1.7) 0 (0.0) 1 (0.4) Smoking: N(%) 0.62 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 50 (86.2) 163 (82.3) 213 (83.2) Yes 8 (13.8) 35 (17.7) 43 (16.8) Folic acid supplement (μg): N(%) 0.0003 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;800 27 (46.6) 44 (22.2) 71 (27.7) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Folic acid supplement (μg): N(%) 0.0010 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;=400 6 (10.3) 3 (1.5) 9 (3.5) &gt;400 to &lt;800 21 (36.2) 41 (20.7) 62 (24.2) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) Fruit (1st trim): N(%) 0.87 Missing 0 (0.0) 3 (1.5) 3 (1.2) &lt;1-3x/month 3 (5.2) 16 (8.1) 19 (7.4) 1-6x/week 19 (32.8) 66 (33.3) 85 (33.2) &gt;=1-&lt;3x/day 32 (55.2) 96 (48.5) 128 (50.0) &gt;=3x/day 4 (6.9) 17 (8.6) 21 (8.2) Leafy vege (1st trim): N(%) 0.10 Missing 0 (0.0) 4 (2.0) 4 (1.6) &lt;1-3x/month 3 (5.2) 21 (10.6) 24 (9.4) 1-2x/week 13 (22.4) 42 (21.2) 55 (21.5) 3-6x/week 31 (53.4) 72 (36.4) 103 (40.2) &gt;=1x/day 11 (19.0) 59 (29.8) 70 (27.3) Fast food (1st trim): N(%) 0.36 Missing 9 (15.5) 24 (12.1) 33 (12.9) Never 1 (1.7) 11 (5.6) 12 (4.7) &gt;0-&lt;2x/week 6 (10.3) 34 (17.2) 40 (15.6) &gt;=2-&lt;4x/week 25 (43.1) 84 (42.4) 109 (42.6) &gt;=4x/week 17 (29.3) 45 (22.7) 62 (24.2) Vigorous exercise: N(%) 0.24 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 38 (65.5) 124 (62.6) 162 (63.3) Once a week 19 (32.8) 48 (24.2) 67 (26.2) 2-3/wk 1 (1.7) 16 (8.1) 17 (6.6) 4-6/wk 0 (0.0) 4 (2.0) 4 (1.6) Daily 0 (0.0) 3 (1.5) 3 (1.2) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) Moderate exercise: N(%) 0.67 Missing 0 (0.0) 4 (2.0) 4 (1.6) Never 30 (51.7) 87 (43.9) 117 (45.7) Once a week 16 (27.6) 54 (27.3) 70 (27.3) 2-3/wk 8 (13.8) 42 (21.2) 50 (19.5) 4-6/wk 1 (1.7) 3 (1.5) 4 (1.6) Daily 3 (5.2) 6 (3.0) 9 (3.5) More than once a day 0 (0.0) 2 (1.0) 2 (0.8) Recreational walking: N(%) 0.88 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 9 (15.5) 33 (16.7) 42 (16.4) Once a week 21 (36.2) 81 (40.9) 102 (39.8) 2-3/wk 17 (29.3) 49 (24.7) 66 (25.8) 4-6/wk 5 (8.6) 12 (6.1) 17 (6.6) Daily 6 (10.3) 17 (8.6) 23 (9.0) More than once a day 0 (0.0) 3 (1.5) 3 (1.2) Serum folate concentration (nM): Median (IQ range) 40.1 (32.0-43.8) 40.1 (35.5-45.2) 40.1 (35.0-44.8) 0.26 Homocysteine concentration (μM): Mean (SD) 4.1 (0.9) 4.8 (1.0) 4.7 (1.0) &lt;0.0001 B12 concentration (pM): Median (IQ range) 253.5 (194.2-333.0) 273.0 (217.5-348.5) 270.0 (215.0-345.5) 0.16 Folate:B12 ratio: Median (IQ range) 158.9 (116.5-210.2) 148.0 (112.4-225.9) 149.3 (113.3-220.0) 0.79 Active B12 concentration (pM): Mean (SD) 72.7 (26.4) 76.6 (26.1) 75.7 (26.1) 0.48 Folate:Active B12 ratio: Median (IQ range) 553.8 (424.7-660.3) 531.9 (417.3-788.4) 536.7 (418.1-784.2) 0.97 Vitamin D: Median (IQ range) 55.8 (44.6-72.0) 60.0 (44.5-77.5) 59.0 (44.3-75.1) 0.52 UIC (ug/L): Median (IQ range) 132.7 (68.3-167.0) 220.6 (139.0-344.1) 206.4 (124.8-323.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 0.92 PAPP-A (MoM): Median (IQ range) 0.9 (0.5-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.53 Haemoglobin (g/L): Mean (SD) 130.9 (9.4) 132.2 (10.0) 131.9 (9.8) 0.38 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.07 24.3.2 MetS Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value MetS: N(%) 0.0001 Missing 1 (1.7) 14 (7.1) 15 (5.9) No 29 (50.0) 144 (72.7) 173 (67.6) Yes 28 (48.3) 40 (20.2) 68 (26.6) : Median (IQ range) 2.0 (1.0-2.0) 0.0 (0.0-1.5) 1.0 (0.0-2.0) &lt;0.0001 Waist (cm): Median (IQ range) 97.0 (87.0-109.0) 91.0 (78.0-107.5) 93.0 (80.0-108.0) 0.03 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.7 (0.9) 4.9 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.8 (1.6-2.4) 1.2 (0.9-1.6) 1.3 (1.0-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) 0.09 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.8) 2.6 (0.7) 2.7 (0.7) 0.004 : Mean (SD) 112.9 (12.0) 118.8 (11.6) 117.4 (11.9) 0.001 : Mean (SD) 68.6 (8.9) 73.5 (9.9) 72.3 (9.9) 0.0005 : Mean (SD) 83.4 (8.9) 88.6 (9.6) 87.4 (9.7) 0.0002 MetS criteria: Waist circumference: N(%) 0.05 Missing 1 (1.7) 3 (1.5) 4 (1.6) &lt;80 cm 8 (13.8) 54 (27.3) 62 (24.2) &gt;=80 cm 49 (84.5) 141 (71.2) 190 (74.2) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 1 (0.5) 1 (0.4) &lt;1.7 mmol/L 23 (39.7) 156 (78.8) 179 (69.9) &gt;=1.7 mmol/L 35 (60.3) 41 (20.7) 76 (29.7) MetS criteria: HDL: N(%) 0.68 Missing 0 (0.0) 1 (0.5) 1 (0.4) &gt;=1.3 mmol/L 48 (82.8) 156 (78.8) 204 (79.7) &lt;1.3 mmol/L 10 (17.2) 41 (20.7) 51 (19.9) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 1 (1.7) 1 (0.5) 2 (0.8) &lt;5.6 mmol/L 18 (31.0) 174 (87.9) 192 (75.0) &gt;=5.6 mmol/L 39 (67.2) 23 (11.6) 62 (24.2) MetS criteria: sBP: N(%) 0.06 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130 mmHg 54 (93.1) 155 (78.3) 209 (81.6) &gt;=130 mmHg 4 (6.9) 32 (16.2) 36 (14.1) MetS criteria: dBP: N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;85 mmHg 56 (96.6) 162 (81.8) 218 (85.2) &gt;=85 mmHg 2 (3.4) 25 (12.6) 27 (10.5) : Mean (SD) 0.1 (0.3) 0.2 (0.4) 0.2 (0.4) 0.005 CRP (mg/L): Median (IQ range) 7.8 (4.4-12.5) 3.9 (2.1-8.1) 4.5 (2.4-9.1) &lt;0.0001 24.3.3 Outcomes Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Gestational age at birth (weeks): Median (IQ range) 38.9 (38.1-40.0) 38.9 (38.1-39.7) 38.9 (38.1-39.9) 0.91 Birthweight (g): Median (IQ range) 3260.0 (2825.0-3728.8) 3350.0 (3020.0-3645.0) 3330.0 (2990.5-3650.0) 0.61 : Mean (SD) 47.6 (31.9) 52.5 (30.3) 51.4 (30.7) 0.30 Baby sex: N(%) 0.78 Missing 0 (0.0) 1 (0.5) 1 (0.4) Male 27 (46.6) 98 (49.5) 125 (48.8) Female 31 (53.4) 99 (50.0) 130 (50.8) Mode of delivery: N(%) 0.08 Missing 0 (0.0) 1 (0.5) 1 (0.4) Unassisted vaginal 19 (32.8) 91 (46.0) 110 (43.0) Operative vaginal 7 (12.1) 34 (17.2) 41 (16.0) Pre-labour LSCS 10 (17.2) 19 (9.6) 29 (11.3) LSCS in labour 22 (37.9) 53 (26.8) 75 (29.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-uncomplicated.html", "24.4 SCOPE vs STOP (Uncomplicated)", " 24.4 SCOPE vs STOP (Uncomplicated) 24.4.1 Demographics Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-26.0) 25.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.92 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 591 (97.8) 694 (97.6) 1285 (97.7) &gt;=35 13 (2.2) 17 (2.4) 30 (2.3) Maternal BMI: Median (IQ range) 25.1 (22.0-29.1) 25.3 (22.4-29.5) 25.2 (22.2-29.4) 0.27 Maternal BMI (category): N(%) 0.41 Missing 0 (0.0) 1 (0.1) 1 (0.1) &lt;20 64 (10.6) 55 (7.7) 119 (9.0) &gt;=20 to &lt;25 228 (37.7) 278 (39.1) 506 (38.5) &gt;=25 to &lt;30 176 (29.1) 212 (29.8) 388 (29.5) &gt;=30 to &lt;40 117 (19.4) 136 (19.1) 253 (19.2) &gt;=40 19 (3.1) 29 (4.1) 48 (3.7) SEI: Median (IQ range) 24.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-36.0) &lt;0.0001 Ethnicity: N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 555 (91.9) 595 (83.7) 1150 (87.5) Maori 3 (0.5) 0 (0.0) 3 (0.2) Pacific Islander 0 (0.0) 3 (0.4) 3 (0.2) South East and Far East 25 (4.1) 30 (4.2) 55 (4.2) Indian 2 (0.3) 27 (3.8) 29 (2.2) African 3 (0.5) 11 (1.5) 14 (1.1) Middle-eastern 4 (0.7) 18 (2.5) 22 (1.7) Hispanic 0 (0.0) 2 (0.3) 2 (0.2) Aboriginal 9 (1.5) 13 (1.8) 22 (1.7) China and Japan 0 (0.0) 10 (1.4) 10 (0.8) Other 3 (0.5) 2 (0.3) 5 (0.4) Smoking: N(%) 0.002 Missing 0 (0.0) 6 (0.8) 6 (0.5) No 476 (78.8) 602 (84.7) 1078 (82.0) Yes 128 (21.2) 103 (14.5) 231 (17.6) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;800 335 (55.5) 134 (18.8) 469 (35.7) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Folic acid supplement (μg): N(%) &lt;0.0001 Missing 0 (0.0) 87 (12.2) 87 (6.6) None 122 (20.2) 49 (6.9) 171 (13.0) &lt;=400 66 (10.9) 7 (1.0) 73 (5.6) &gt;400 to &lt;800 269 (44.5) 127 (17.9) 396 (30.1) &gt;=800 147 (24.3) 441 (62.0) 588 (44.7) Fruit (1st trim): N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 58 (9.6) 47 (6.6) 105 (8.0) 1-6x/week 222 (36.8) 203 (28.6) 425 (32.3) &gt;=1-&lt;3x/day 221 (36.6) 349 (49.1) 570 (43.3) &gt;=3x/day 103 (17.1) 101 (14.2) 204 (15.5) Leafy vege (1st trim): N(%) 0.52 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;1-3x/month 60 (9.9) 73 (10.3) 133 (10.1) 1-2x/week 144 (23.8) 159 (22.4) 303 (23.0) 3-6x/week 220 (36.4) 235 (33.1) 455 (34.6) &gt;=1x/day 180 (29.8) 233 (32.8) 413 (31.4) Fast food (1st trim): N(%) 0.001 Missing 114 (18.9) 93 (13.1) 207 (15.7) Never 12 (2.0) 30 (4.2) 42 (3.2) &gt;0-&lt;2x/week 62 (10.3) 118 (16.6) 180 (13.7) &gt;=2-&lt;4x/week 249 (41.2) 261 (36.7) 510 (38.8) &gt;=4x/week 167 (27.6) 209 (29.4) 376 (28.6) Vigorous exercise: N(%) 0.73 Missing 3 (0.5) 5 (0.7) 8 (0.6) Never 390 (64.6) 439 (61.7) 829 (63.0) Once a week 148 (24.5) 179 (25.2) 327 (24.9) 2-3/wk 50 (8.3) 63 (8.9) 113 (8.6) 4-6/wk 7 (1.2) 12 (1.7) 19 (1.4) Daily 6 (1.0) 12 (1.7) 18 (1.4) More than once a day 0 (0.0) 1 (0.1) 1 (0.1) Moderate exercise: N(%) 0.16 Missing 3 (0.5) 7 (1.0) 10 (0.8) Never 248 (41.1) 266 (37.4) 514 (39.1) Once a week 146 (24.2) 173 (24.3) 319 (24.3) 2-3/wk 134 (22.2) 156 (21.9) 290 (22.1) 4-6/wk 36 (6.0) 49 (6.9) 85 (6.5) Daily 35 (5.8) 48 (6.8) 83 (6.3) More than once a day 2 (0.3) 12 (1.7) 14 (1.1) Recreational walking: N(%) 0.24 Missing 3 (0.5) 8 (1.1) 11 (0.8) Never 147 (24.3) 158 (22.2) 305 (23.2) Once a week 187 (31.0) 233 (32.8) 420 (31.9) 2-3/wk 161 (26.7) 170 (23.9) 331 (25.2) 4-6/wk 44 (7.3) 53 (7.5) 97 (7.4) Daily 52 (8.6) 83 (11.7) 135 (10.3) More than once a day 10 (1.7) 6 (0.8) 16 (1.2) Serum folate concentration (nM): Median (IQ range) 36.4 (28.5-43.0) 40.5 (36.4-45.2) 39.2 (33.8-44.2) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.1) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 248.0 (195.5-316.0) 277.5 (219.0-355.0) 262.0 (206.0-339.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.6 (104.0-207.4) 155.9 (115.7-222.4) 150.5 (109.3-217.2) 0.0006 Active B12 concentration (pM): Mean (SD) 58.8 (23.4) 66.7 (24.7) 62.9 (24.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 617.0 (458.5-931.9) 670.7 (493.5-950.5) 634.4 (480.9-941.9) 0.05 Vitamin D: Median (IQ range) 56.3 (40.2-76.1) 61.0 (45.0-76.0) 59.3 (43.0-76.0) 0.02 UIC (ug/L): Median (IQ range) 109.8 (66.5-164.3) 199.0 (127.1-320.1) 156.1 (93.2-257.5) &lt;0.0001 HCG (MoM): Median (IQ range) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 1.0 (0.7-1.6) 0.26 PAPP-A (MoM): Median (IQ range) 1.1 (0.8-1.5) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.07 Haemoglobin (g/L): Mean (SD) 128.3 (9.1) 130.8 (9.7) 129.7 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 24.4.2 MetS Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value MetS: N(%) &lt;0.0001 Missing 3 (0.5) 51 (7.2) 54 (4.1) No 525 (86.9) 624 (87.8) 1149 (87.4) Yes 76 (12.6) 36 (5.1) 112 (8.5) : Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 86.0 (79.0-95.0) 81.0 (74.0-89.0) 83.0 (76.0-93.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.4 (0.9) 4.6 (0.8) 5.0 (0.9) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.3 (1.1-1.6) 1.1 (0.9-1.4) 1.2 (0.9-1.5) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.8 (0.4) 1.7 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.7) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.7) 2.4 (0.7) 2.7 (0.8) &lt;0.0001 : Mean (SD) 107.8 (9.3) 113.9 (9.7) 111.0 (10.0) &lt;0.0001 : Mean (SD) 63.4 (7.5) 69.4 (8.2) 66.6 (8.4) &lt;0.0001 : Mean (SD) 78.2 (7.1) 84.2 (7.7) 81.4 (8.0) &lt;0.0001 MetS criteria: Waist circumference: N(%) &lt;0.0001 Missing 0 (0.0) 11 (1.5) 11 (0.8) &lt;80 cm 168 (27.8) 329 (46.3) 497 (37.8) &gt;=80 cm 436 (72.2) 371 (52.2) 807 (61.4) MetS criteria: Triglyceride: N(%) &lt;0.0001 Missing 0 (0.0) 10 (1.4) 10 (0.8) &lt;1.7 mmol/L 468 (77.5) 627 (88.2) 1095 (83.3) &gt;=1.7 mmol/L 136 (22.5) 74 (10.4) 210 (16.0) MetS criteria: HDL: N(%) 0.003 Missing 0 (0.0) 10 (1.4) 10 (0.8) &gt;=1.3 mmol/L 554 (91.7) 606 (85.2) 1160 (88.2) &lt;1.3 mmol/L 50 (8.3) 95 (13.4) 145 (11.0) MetS criteria: Glucose: N(%) &lt;0.0001 Missing 3 (0.5) 10 (1.4) 13 (1.0) &lt;5.6 mmol/L 341 (56.5) 648 (91.1) 989 (75.2) &gt;=5.6 mmol/L 260 (43.0) 53 (7.5) 313 (23.8) MetS criteria: sBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;130 mmHg 596 (98.7) 634 (89.2) 1230 (93.5) &gt;=130 mmHg 8 (1.3) 44 (6.2) 52 (4.0) MetS criteria: dBP: N(%) &lt;0.0001 Missing 0 (0.0) 33 (4.6) 33 (2.5) &lt;85 mmHg 602 (99.7) 654 (92.0) 1256 (95.5) &gt;=85 mmHg 2 (0.3) 24 (3.4) 26 (2.0) : Mean (SD) 0.0 (0.1) 0.1 (0.3) 0.1 (0.2) &lt;0.0001 CRP (mg/L): Median (IQ range) 4.3 (2.3-7.7) 3.1 (1.3-6.0) 3.6 (1.7-6.9) &lt;0.0001 24.4.3 Outcomes Characteristic SCOPE (n=604) STOP (n=711) Total (n=1315) P-value Gestational age at birth (weeks): Median (IQ range) 40.3 (39.4-41.0) 40.0 (39.1-40.9) 40.1 (39.3-40.9) 0.010 Birthweight (g): Median (IQ range) 3542.5 (3290.0-3825.0) 3506.0 (3250.0-3786.0) 3526.0 (3270.0-3810.0) 0.03 : Mean (SD) 54.2 (25.1) 53.3 (26.1) 53.7 (25.7) 0.52 Baby sex: N(%) 0.53 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 291 (48.2) 356 (50.1) 647 (49.2) Female 313 (51.8) 355 (49.9) 668 (50.8) Mode of delivery: N(%) 0.15 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 361 (59.8) 382 (53.7) 743 (56.5) Operative vaginal 103 (17.1) 147 (20.7) 250 (19.0) Pre-labour LSCS 24 (4.0) 35 (4.9) 59 (4.5) LSCS in labour 116 (19.2) 147 (20.7) 263 (20.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["folate-vs-fa-supplement-2.html", "25 Folate vs FA supplement", " 25 Folate vs FA supplement Within Uncomplicated Characteristic None (n=171) &lt;=400 (n=73) &gt;400 to &lt;800 (n=396) &gt;=800 (n=588) Total (n=1228) P-value Serum folate concentration (nM): Median (IQ range) 32.0 (22.2-38.5) 36.5 (29.7-42.0) 39.0 (32.7-44.4) 41.0 (36.8-53.1) 39.3 (33.9-44.5) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.8 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 237.5 (192.0-296.2) 255.0 (193.8-338.5) 254.5 (200.0-332.2) 274.0 (220.0-356.0) 262.0 (206.0-339.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 57.6 (23.6) 56.7 (21.6) 60.4 (23.7) 66.9 (25.0) 62.9 (24.5) 0.0009 Folate:B12 ratio: Median (IQ range) 128.3 (84.6-179.5) 141.7 (108.7-186.1) 152.4 (111.9-234.0) 157.4 (118.1-229.3) 151.1 (109.5-218.6) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 588.8 (368.3-815.2) 563.0 (487.9-894.8) 649.1 (483.2-1041.9) 682.0 (500.0-1010.9) 634.6 (477.1-964.6) 0.001 Vitamin D: Median (IQ range) 52.1 (39.0-66.0) 49.0 (35.7-69.0) 58.8 (42.1-76.4) 64.0 (46.5-78.0) 60.0 (43.0-76.4) &lt;0.0001 Within GDM Characteristic None (n=22) &lt;=400 (n=9) &gt;400 to &lt;800 (n=62) &gt;=800 (n=142) Total (n=235) P-value Serum folate concentration (nM): Median (IQ range) 30.4 (26.5-40.2) 41.3 (36.3-54.4) 39.8 (33.8-44.0) 41.2 (37.9-58.0) 40.7 (35.9-45.2) 0.0002 Homocysteine concentration (μM): Mean (SD) 4.6 (1.0) 4.1 (0.9) 4.6 (1.0) 4.6 (0.9) 4.6 (1.0) 0.43 B12 concentration (pM): Median (IQ range) 260.5 (175.2-314.0) 268.0 (222.0-292.0) 268.5 (218.0-303.5) 278.0 (220.0-353.0) 271.5 (216.8-345.8) 0.55 Active B12 concentration (pM): Mean (SD) 65.2 (22.4) 80.3 (35.3) 84.4 (26.1) 74.1 (24.1) 76.4 (25.5) 0.09 Folate:B12 ratio: Median (IQ range) 123.5 (80.3-170.6) 162.4 (135.4-220.6) 153.1 (112.8-215.4) 160.1 (117.5-256.9) 150.7 (116.1-227.3) 0.10 Folate:Active B12 ratio: Median (IQ range) 510.1 (409.2-591.5) 715.7 (399.3-826.4) 524.9 (427.0-593.3) 565.1 (429.3-895.6) 539.5 (424.7-784.2) 0.30 Vitamin D: Median (IQ range) 45.4 (29.4-69.3) 68.6 (44.3-74.0) 57.6 (45.2-72.7) 61.0 (46.8-76.5) 59.0 (44.5-75.2) 0.23 Click here for table within SCOPE Within Uncomplicated Characteristic None (n=122) &lt;=400 (n=66) &gt;400 to &lt;800 (n=269) &gt;=800 (n=147) Total (n=604) P-value Serum folate concentration (nM): Median (IQ range) 27.1 (18.5-34.3) 35.6 (28.9-41.6) 38.4 (30.4-44.2) 39.3 (34.8-44.2) 36.4 (28.5-43.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.1) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 217.5 (189.0-280.5) 251.0 (192.5-338.0) 252.0 (198.0-318.0) 260.0 (208.0-315.5) 248.0 (195.5-316.0) 0.01 Active B12 concentration (pM): Mean (SD) 50.8 (17.7) 55.3 (21.3) 59.9 (23.2) 65.1 (26.7) 58.8 (23.4) 0.001 Folate:B12 ratio: Median (IQ range) 117.7 (80.2-162.5) 131.6 (107.4-184.5) 146.9 (107.8-228.4) 156.5 (115.7-238.9) 142.6 (104.0-207.4) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 591.3 (368.3-822.3) 563.0 (507.4-920.2) 629.2 (483.2-997.7) 636.2 (487.4-1099.7) 617.0 (458.5-931.9) 0.06 Vitamin D: Median (IQ range) 51.8 (36.1-65.7) 47.1 (35.5-62.8) 55.6 (40.0-75.8) 67.6 (49.5-83.4) 56.3 (40.2-76.1) &lt;0.0001 Within GDM Characteristic None (n=9) &lt;=400 (n=6) &gt;400 to &lt;800 (n=21) &gt;=800 (n=22) Total (n=58) P-value Serum folate concentration (nM): Median (IQ range) 26.7 (21.7-29.6) 36.8 (32.7-40.3) 41.5 (32.6-43.7) 42.5 (38.4-65.4) 40.1 (32.0-43.8) 0.002 Homocysteine concentration (μM): Mean (SD) 4.3 (1.1) 3.7 (0.7) 4.2 (0.9) 4.1 (0.8) 4.1 (0.9) 0.52 B12 concentration (pM): Median (IQ range) 200.5 (171.8-265.5) 280.0 (259.8-348.2) 271.5 (228.5-333.0) 237.5 (192.0-342.8) 253.5 (194.2-333.0) 0.25 Active B12 concentration (pM): Mean (SD) 66.6 (22.5) 102.7 (39.7) 68.4 (21.1) 71.7 (27.1) 72.7 (26.4) 0.22 Folate:B12 ratio: Median (IQ range) 125.3 (68.1-178.3) 138.4 (125.8-157.2) 144.0 (111.7-170.7) 210.6 (147.3-391.7) 158.9 (116.5-210.2) 0.03 Folate:Active B12 ratio: Median (IQ range) 447.5 (321.0-553.6) 320.2 (289.2-478.5) 558.4 (516.5-660.3) 674.9 (540.9-1118.7) 553.8 (424.7-660.3) 0.12 Vitamin D: Median (IQ range) 45.4 (29.8-79.0) 56.5 (33.3-70.7) 51.7 (45.9-68.3) 65.5 (51.4-75.2) 55.8 (44.6-72.0) 0.27 Click here for table within STOP Within Uncomplicated Characteristic None (n=49) &lt;=400 (n=7) &gt;400 to &lt;800 (n=127) &gt;=800 (n=441) Total (n=624) P-value Serum folate concentration (nM): Median (IQ range) 38.9 (34.3-43.2) 42.1 (36.6-56.3) 39.8 (35.4-44.5) 41.3 (37.3-55.2) 40.8 (36.7-53.4) 0.006 Homocysteine concentration (μM): Mean (SD) 5.2 (1.4) 5.1 (1.1) 5.3 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 277.5 (219.2-316.5) 261.0 (203.5-315.5) 260.0 (205.0-346.5) 281.0 (231.0-370.0) 277.0 (220.0-359.0) 0.12 Active B12 concentration (pM): Mean (SD) 77.5 (27.4) 68.0 (23.3) 61.8 (25.3) 67.6 (24.4) 67.4 (25.0) 0.09 Folate:B12 ratio: Median (IQ range) 137.7 (109.8-211.8) 180.2 (165.0-201.9) 168.0 (116.3-248.2) 158.1 (118.6-222.1) 159.5 (118.0-226.7) 0.52 Folate:Active B12 ratio: Median (IQ range) 573.6 (378.4-724.3) 550.8 (476.6-682.4) 805.2 (504.9-1155.7) 692.5 (512.4-977.9) 682.9 (493.5-981.1) 0.08 Vitamin D: Median (IQ range) 56.5 (41.2-68.2) 76.0 (63.5-104.0) 63.0 (49.0-78.5) 63.0 (45.2-77.0) 63.0 (46.0-77.0) 0.07 Within GDM Characteristic None (n=13) &lt;=400 (n=3) &gt;400 to &lt;800 (n=41) &gt;=800 (n=120) Total (n=177) P-value Serum folate concentration (nM): Median (IQ range) 35.6 (30.1-42.0) 54.4 (49.5-57.2) 39.4 (34.6-44.5) 41.1 (37.5-56.3) 40.7 (36.1-53.6) 0.02 Homocysteine concentration (μM): Mean (SD) 4.7 (0.9) 4.9 (0.8) 4.8 (1.1) 4.7 (0.9) 4.7 (1.0) 0.96 B12 concentration (pM): Median (IQ range) 279.0 (243.8-381.5) 182.0 (181.0-227.0) 268.5 (218.0-284.2) 285.0 (224.0-358.5) 275.5 (221.2-348.8) 0.20 Active B12 concentration (pM): Mean (SD) 63.4 (24.8) 58.0 (6.2) 90.2 (25.6) 74.5 (23.8) 77.6 (25.2) 0.01 Folate:B12 ratio: Median (IQ range) 123.5 (102.6-144.2) 244.5 (232.5-273.4) 162.0 (116.1-254.6) 150.2 (116.3-228.4) 150.6 (116.1-231.2) 0.09 Folate:Active B12 ratio: Median (IQ range) 633.8 (487.5-645.7) 836.9 (815.8-984.5) 512.7 (419.6-590.5) 542.1 (424.7-838.0) 534.2 (427.0-788.4) 0.13 Vitamin D: Median (IQ range) 45.0 (29.0-54.8) 89.0 (77.0-107.5) 59.0 (45.0-79.0) 60.5 (46.0-77.5) 60.0 (44.8-78.0) 0.07 "],["folate-2.html", "25.1 Folate", " 25.1 Folate 25.1.1 FA supp (4 categories) 25.1.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.1399572 0.0855977 36.6827453 &lt;0.0001 *** folate_cat3&lt;=400 0.3208489 0.0761262 4.2146996 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4278112 0.0544222 7.8609650 &lt;0.0001 *** folate_cat3&gt;=800 0.4835980 0.0606742 7.9704096 &lt;0.0001 *** GDM_newGDM -0.0397839 0.1721949 -0.2310397 0.82 ns StudySTOP 0.4921357 0.0816951 6.0240567 &lt;0.0001 *** f1_age 0.0112472 0.0026639 4.2220630 &lt;0.0001 *** BMI -0.0057626 0.0020148 -2.8601916 0.004 ** folate_cat3&lt;=400:StudySTOP -0.2268403 0.2045541 -1.1089498 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4154404 0.0966373 -4.2989640 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3624643 0.0935050 -3.8764160 0.0001 *** GDM_newGDM:StudySTOP -0.1610481 0.2292030 -0.7026438 0.48 ns folate_cat3&lt;=400:GDM_newGDM 0.0538187 0.2649672 0.2031146 0.84 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.0774336 0.2104068 0.3680183 0.71 ns folate_cat3&gt;=800:GDM_newGDM 0.2060160 0.2085974 0.9876249 0.32 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.2222605 0.4449148 0.4995575 0.62 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP 0.1121351 0.2730231 0.4107164 0.68 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.0024625 0.2623842 -0.0093852 0.99 ns 25.1.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 26.20464 1.202445 1365 23.94885 28.67290 &lt;=400 Uncomplicated SCOPE 36.11778 2.212519 1365 32.02813 40.72965 &gt;400 to &lt;800 Uncomplicated SCOPE 40.19520 1.235041 1365 37.84399 42.69249 &gt;=800 Uncomplicated SCOPE 42.50129 1.694192 1365 39.30441 45.95819 None GDM SCOPE 25.18258 4.184828 1365 18.17701 34.88816 &lt;=400 GDM SCOPE 36.62826 7.034441 1365 25.13034 53.38685 &gt;400 to &lt;800 GDM SCOPE 41.73739 4.907584 1365 33.13982 52.56546 &gt;=800 GDM SCOPE 50.18753 5.598147 1365 40.32410 62.46360 None Uncomplicated STOP 42.86571 2.909471 1365 37.52185 48.97064 &lt;=400 Uncomplicated STOP 47.09095 8.354940 1365 33.24927 66.69493 &gt;400 to &lt;800 Uncomplicated STOP 43.39928 1.839161 1365 39.93729 47.16138 &gt;=800 Uncomplicated STOP 48.38578 1.092631 1365 46.28914 50.57738 None GDM STOP 35.06629 4.757825 1365 26.87172 45.75980 &lt;=400 GDM STOP 50.77114 13.801248 1365 29.78704 86.53794 &gt;400 to &lt;800 GDM STOP 42.91321 3.235427 1365 37.01331 49.75354 &gt;=800 GDM STOP 48.51764 2.153078 1365 44.47257 52.93064 25.1.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.05 (0.89, 1.22) 0.6 GDM / Uncomplicated STOP 0.97 (0.80, 1.16) 0.7 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.27 (1.14, 1.42) &lt;0.0001 STOP / SCOPE GDM 1.18 (0.95, 1.46) 0.1 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.23 (0.95, 1.60) 0.2 &gt;400 to &lt;800 / None Uncomplicated 1.25 (1.10, 1.41) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.01 (0.79, 1.30) 1.0 &gt;=800 / None Uncomplicated 1.35 (1.20, 1.53) &lt;0.0001 &gt;=800 / &lt;=400 Uncomplicated 1.10 (0.86, 1.41) 0.8 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.09 (0.99, 1.19) 0.08 &lt;=400 / None GDM 1.45 (0.87, 2.42) 0.2 &gt;400 to &lt;800 / None GDM 1.42 (1.03, 1.98) 0.03 &gt;400 to &lt;800 / &lt;=400 GDM 0.98 (0.62, 1.56) 1.0 &gt;=800 / None GDM 1.66 (1.21, 2.28) 0.0002 &gt;=800 / &lt;=400 GDM 1.14 (0.73, 1.80) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.17 (0.92, 1.48) 0.3 "],["b12-2.html", "25.2 B12", " 25.2 B12 25.2.1 FA supp (4 categories) 25.2.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4116552 0.0697337 77.6046002 &lt;0.0001 *** folate_cat3&lt;=400 0.1120120 0.0620416 1.8054332 0.07 ns folate_cat3&gt;400 to &lt;800 0.1126241 0.0443532 2.5392534 0.01 * folate_cat3&gt;=800 0.1220442 0.0494484 2.4681099 0.01 * GDM_newGDM 0.0044797 0.1403359 0.0319213 0.97 ns StudySTOP 0.1721404 0.0665802 2.5854604 0.010 ** f1_age 0.0105511 0.0021709 4.8602930 &lt;0.0001 *** BMI -0.0093831 0.0016412 -5.7171869 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.1900321 0.1667084 -1.1399074 0.25 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1590529 0.0787579 -2.0195174 0.04 * folate_cat3&gt;=800:StudySTOP -0.0712129 0.0762051 -0.9344900 0.35 ns GDM_newGDM:StudySTOP 0.0374712 0.1867968 0.2005987 0.84 ns folate_cat3&lt;=400:GDM_newGDM 0.1084600 0.2159441 0.5022598 0.62 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.1056298 0.1714782 0.6159955 0.54 ns folate_cat3&gt;=800:GDM_newGDM -0.1997495 0.1700035 -1.1749724 0.24 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP -0.3352256 0.3625985 -0.9245089 0.36 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP -0.1461003 0.2225095 -0.6566023 0.51 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP 0.1628004 0.2138174 0.7613993 0.45 ns 25.2.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 226.2103 8.459507 1366 210.2094 243.4292 &lt;=400 Uncomplicated SCOPE 253.0222 12.631972 1366 229.4168 279.0564 &gt;400 to &lt;800 Uncomplicated SCOPE 253.1771 6.339766 1366 241.0409 265.9244 &gt;=800 Uncomplicated SCOPE 255.5733 8.302739 1366 239.7940 272.3910 None GDM SCOPE 227.2260 30.774075 1366 174.2105 296.3750 &lt;=400 GDM SCOPE 283.2747 44.337362 1366 208.3828 385.0823 &gt;400 to &lt;800 GDM SCOPE 282.6470 27.085473 1366 234.2088 341.1031 &gt;=800 GDM SCOPE 210.2379 19.112046 1366 175.8986 251.2810 None Uncomplicated STOP 268.7027 14.863538 1366 241.0712 299.5014 &lt;=400 Uncomplicated STOP 248.5355 35.937115 1366 187.1541 330.0483 &gt;400 to &lt;800 Uncomplicated STOP 256.5124 8.859134 1366 239.7090 274.4936 &gt;=800 Uncomplicated STOP 282.7143 5.202929 1366 272.6898 293.1074 None GDM STOP 280.2148 30.985543 1366 225.5712 348.0957 &lt;=400 GDM STOP 206.5972 45.769284 1366 133.7775 319.0552 &gt;400 to &lt;800 GDM STOP 256.8924 15.784764 1366 227.7208 289.8009 &gt;=800 GDM STOP 284.1320 10.228097 1366 264.7596 304.9219 25.2.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.01 (0.89, 1.14) 0.9 GDM / Uncomplicated STOP 0.97 (0.83, 1.12) 0.7 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.07 (0.98, 1.17) 0.1 STOP / SCOPE GDM 1.03 (0.86, 1.22) 0.8 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.02 (0.82, 1.26) 1.0 &gt;400 to &lt;800 / None Uncomplicated 1.03 (0.93, 1.14) 0.8 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.02 (0.83, 1.25) 1.0 &gt;=800 / None Uncomplicated 1.09 (0.99, 1.20) 0.1 &gt;=800 / &lt;=400 Uncomplicated 1.07 (0.88, 1.31) 0.8 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.05 (0.98, 1.13) 0.2 &lt;=400 / None GDM 0.96 (0.63, 1.45) 1.0 &gt;400 to &lt;800 / None GDM 1.07 (0.82, 1.40) 0.9 &gt;400 to &lt;800 / &lt;=400 GDM 1.11 (0.76, 1.63) 0.9 &gt;=800 / None GDM 0.97 (0.75, 1.25) 1.0 &gt;=800 / &lt;=400 GDM 1.01 (0.70, 1.46) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.91 (0.75, 1.10) 0.6 "],["homocysteine-2.html", "25.3 Homocysteine", " 25.3 Homocysteine 25.3.1 FA supp (4 categories) 25.3.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5903682 0.0401107 39.6495138 &lt;0.0001 *** folate_cat3&lt;=400 -0.1267169 0.0356823 -3.5512578 0.0004 *** folate_cat3&gt;400 to &lt;800 -0.1120650 0.0255091 -4.3931472 &lt;0.0001 *** folate_cat3&gt;=800 -0.1618704 0.0284397 -5.6917114 &lt;0.0001 *** GDM_newGDM -0.1555095 0.0807119 -1.9267223 0.05 ns StudySTOP 0.0302688 0.0382927 0.7904602 0.43 ns f1_age 0.0003975 0.0012492 0.3181905 0.75 ns BMI -0.0001537 0.0009451 -0.1626695 0.87 ns folate_cat3&lt;=400:StudySTOP 0.1176184 0.0958795 1.2267310 0.22 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.1273798 0.0452963 2.8121475 0.005 ** folate_cat3&gt;=800:StudySTOP 0.0861223 0.0438326 1.9648008 0.05 * GDM_newGDM:StudySTOP 0.0614192 0.1074330 0.5716978 0.57 ns folate_cat3&lt;=400:GDM_newGDM -0.0267895 0.1241967 -0.2157024 0.83 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.0958406 0.0986228 0.9717896 0.33 ns folate_cat3&gt;=800:GDM_newGDM 0.1055810 0.0977747 1.0798393 0.28 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.0758389 0.2085424 0.3636619 0.72 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP -0.0982402 0.1279726 -0.7676657 0.44 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.0322823 0.1229762 -0.2625089 0.79 ns 25.3.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 4.934164 0.1061282 1364 4.730303 5.146811 &lt;=400 Uncomplicated SCOPE 4.346914 0.1248138 1364 4.108835 4.598789 &gt;400 to &lt;800 Uncomplicated SCOPE 4.411074 0.0635298 1364 4.288191 4.537478 &gt;=800 Uncomplicated SCOPE 4.196760 0.0784123 1364 4.045723 4.353436 None GDM SCOPE 4.223541 0.3289847 1364 3.625059 4.920829 &lt;=400 GDM SCOPE 3.622511 0.3260914 1364 3.036114 4.322164 &gt;400 to &lt;800 GDM SCOPE 4.155569 0.2290313 1364 3.729713 4.630049 &gt;=800 GDM SCOPE 3.992367 0.2087343 1364 3.603191 4.423578 None Uncomplicated STOP 5.085799 0.1617990 1364 4.778098 5.413314 &lt;=400 Uncomplicated STOP 5.039735 0.4191122 1364 4.281122 5.932774 &gt;400 to &lt;800 Uncomplicated STOP 5.164286 0.1025783 1364 4.966928 5.369486 &gt;=800 Uncomplicated STOP 4.714788 0.0500265 1364 4.617665 4.813954 None GDM STOP 4.629097 0.2943973 1364 4.086149 5.244189 &lt;=400 GDM STOP 4.817777 0.6138537 1364 3.752279 6.185834 &gt;400 to &lt;800 GDM STOP 4.689270 0.1657206 1364 4.375188 5.025899 &gt;=800 GDM STOP 4.617772 0.0956053 1364 4.433980 4.809183 25.3.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 0.89 (0.83, 0.96) 0.003 GDM / Uncomplicated STOP 0.94 (0.86, 1.02) 0.1 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.12 (1.07, 1.18) &lt;0.0001 STOP / SCOPE GDM 1.17 (1.06, 1.30) 0.002 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 0.93 (0.83, 1.06) 0.5 &gt;400 to &lt;800 / None Uncomplicated 0.95 (0.90, 1.01) 0.1 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.02 (0.91, 1.15) 1.0 &gt;=800 / None Uncomplicated 0.89 (0.84, 0.94) &lt;0.0001 &gt;=800 / &lt;=400 Uncomplicated 0.95 (0.85, 1.07) 0.7 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 0.93 (0.89, 0.97) &lt;0.0001 &lt;=400 / None GDM 0.94 (0.74, 1.20) 0.9 &gt;400 to &lt;800 / None GDM 1.00 (0.86, 1.16) 1.0 &gt;400 to &lt;800 / &lt;=400 GDM 1.06 (0.85, 1.31) 0.9 &gt;=800 / None GDM 0.97 (0.84, 1.13) 1.0 &gt;=800 / &lt;=400 GDM 1.03 (0.83, 1.27) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.97 (0.87, 1.09) 0.9 "],["active-b12-2.html", "25.4 Active B12", " 25.4 Active B12 25.4.1 FA supp (4 categories) 25.4.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.6233607 0.0937463 38.6506907 &lt;0.0001 *** folate_cat3&lt;=400 0.0766874 0.0825455 0.9290314 0.35 ns folate_cat3&gt;400 to &lt;800 0.1511533 0.0566633 2.6675710 0.008 ** folate_cat3&gt;=800 0.2172425 0.0623839 3.4823484 0.0005 *** GDM_newGDM 0.2765502 0.1518351 1.8213850 0.07 ns StudySTOP 0.4289330 0.0906163 4.7335061 &lt;0.0001 *** f1_age 0.0071521 0.0030595 2.3376384 0.02 * BMI 0.0029547 0.0022062 1.3392607 0.18 ns folate_cat3&lt;=400:StudySTOP -0.2181906 0.2225446 -0.9804356 0.33 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.4324177 0.1103958 -3.9169775 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3895496 0.1034255 -3.7664740 0.0002 *** GDM_newGDM:StudySTOP -0.5422062 0.2421764 -2.2388890 0.03 * folate_cat3&lt;=400:GDM_newGDM 0.3072266 0.2769116 1.1094753 0.27 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM -0.1724478 0.2011184 -0.8574437 0.39 ns folate_cat3&gt;=800:GDM_newGDM -0.2463271 0.1998625 -1.2324827 0.22 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP -0.2266852 0.4442534 -0.5102610 0.61 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP 0.8406211 0.2913885 2.8848813 0.004 ** folate_cat3&gt;=800:GDM_newGDM:StudySTOP 0.5925950 0.2813713 2.1060964 0.04 * 25.4.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 48.60880 2.249452 714 44.38715 53.23197 &lt;=400 Uncomplicated SCOPE 52.48314 3.621908 714 45.83296 60.09824 &gt;400 to &lt;800 Uncomplicated SCOPE 56.54054 1.920890 714 52.89229 60.44042 &gt;=800 Uncomplicated SCOPE 60.40350 2.550434 714 55.59818 65.62414 None GDM SCOPE 64.09426 9.283304 714 48.23066 85.17557 &lt;=400 GDM SCOPE 94.09160 20.798071 714 60.96509 145.21802 &gt;400 to &lt;800 GDM SCOPE 62.74383 8.038391 714 48.79043 80.68772 &gt;=800 GDM SCOPE 62.25695 7.682712 714 48.86168 79.32449 None Uncomplicated STOP 74.64456 5.855827 714 63.98946 87.07387 &lt;=400 Uncomplicated STOP 64.79538 12.403687 714 44.49622 94.35502 &gt;400 to &lt;800 Uncomplicated STOP 56.34385 2.993251 714 50.76331 62.53788 &gt;=800 Uncomplicated STOP 62.82986 1.652831 714 59.66725 66.16011 None GDM STOP 57.23020 9.828922 714 40.84967 80.17924 &lt;=400 GDM STOP 53.84555 11.961786 714 34.81243 83.28471 &gt;400 to &lt;800 GDM STOP 84.26702 6.512383 714 72.40404 98.07368 &gt;=800 GDM STOP 68.10445 3.467001 714 61.62681 75.26295 25.4.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.28 (1.09, 1.51) 0.003 GDM / Uncomplicated STOP 1.01 (0.84, 1.21) 0.9 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.18 (1.05, 1.33) 0.005 STOP / SCOPE GDM 0.93 (0.75, 1.15) 0.5 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 0.97 (0.73, 1.29) 1.0 &gt;400 to &lt;800 / None Uncomplicated 0.94 (0.81, 1.08) 0.6 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 0.97 (0.74, 1.27) 1.0 &gt;=800 / None Uncomplicated 1.02 (0.89, 1.17) 1.0 &gt;=800 / &lt;=400 Uncomplicated 1.06 (0.81, 1.38) 1.0 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.09 (0.98, 1.21) 0.1 &lt;=400 / None GDM 1.18 (0.72, 1.93) 0.8 &gt;400 to &lt;800 / None GDM 1.20 (0.85, 1.70) 0.5 &gt;400 to &lt;800 / &lt;=400 GDM 1.02 (0.65, 1.60) 1.0 &gt;=800 / None GDM 1.08 (0.77, 1.50) 0.9 &gt;=800 / &lt;=400 GDM 0.91 (0.59, 1.41) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.90 (0.69, 1.16) 0.7 "],["folateb12-2.html", "25.5 Folate:B12", " 25.5 Folate:B12 25.5.1 FA supp (4 categories) 25.5.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.6335377 0.1052659 44.0174748 &lt;0.0001 *** folate_cat3&lt;=400 0.2088131 0.0936180 2.2304788 0.03 * folate_cat3&gt;400 to &lt;800 0.3151588 0.0669271 4.7089865 &lt;0.0001 *** folate_cat3&gt;=800 0.3614655 0.0746156 4.8443694 &lt;0.0001 *** GDM_newGDM -0.0445885 0.2117610 -0.2105603 0.83 ns StudySTOP 0.3199886 0.1004665 3.1850268 0.001 ** f1_age 0.0007311 0.0032760 0.2231551 0.82 ns BMI 0.0036867 0.0024777 1.4879379 0.14 ns folate_cat3&lt;=400:StudySTOP -0.0368547 0.2515556 -0.1465073 0.88 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2564593 0.1188422 -2.1579825 0.03 * folate_cat3&gt;=800:StudySTOP -0.2913260 0.1149901 -2.5334872 0.01 * GDM_newGDM:StudySTOP -0.1986224 0.2818682 -0.7046642 0.48 ns folate_cat3&lt;=400:GDM_newGDM -0.0547758 0.3258501 -0.1681011 0.87 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM -0.0282800 0.2587530 -0.1092933 0.91 ns folate_cat3&gt;=800:GDM_newGDM 0.4055958 0.2565279 1.5810985 0.11 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.5572382 0.5471451 1.0184468 0.31 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP 0.2581876 0.3357570 0.7689716 0.44 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.1691998 0.3226735 -0.5243683 0.60 ns 25.5.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 115.8641 6.538249 1365 103.72242 129.4271 &lt;=400 Uncomplicated SCOPE 142.7694 10.755408 1365 123.15550 165.5071 &gt;400 to &lt;800 Uncomplicated SCOPE 158.7891 6.000030 1365 147.44444 171.0066 &gt;=800 Uncomplicated SCOPE 166.3150 8.153002 1365 151.06615 183.1030 None GDM SCOPE 110.8114 22.645785 1365 74.21224 165.4600 &lt;=400 GDM SCOPE 129.2653 30.529578 1365 81.33335 205.4448 &gt;400 to &lt;800 GDM SCOPE 147.6299 21.347269 1365 111.16839 196.0501 &gt;=800 GDM SCOPE 238.6244 32.733242 1365 182.32569 312.3071 None Uncomplicated STOP 159.5579 13.318273 1365 135.45825 187.9451 &lt;=400 Uncomplicated STOP 189.4954 41.345700 1365 123.51270 290.7273 &gt;400 to &lt;800 Uncomplicated STOP 169.2042 8.818076 1365 152.76057 187.4178 &gt;=800 Uncomplicated STOP 171.1510 4.752923 1365 162.07656 180.7334 None GDM STOP 125.1103 20.875526 1365 90.18578 173.5593 &lt;=400 GDM STOP 245.5785 82.095130 1365 127.46388 473.1441 &gt;400 to &lt;800 GDM STOP 166.9681 15.481028 1365 139.20068 200.2745 &gt;=800 GDM STOP 169.9886 9.276955 1365 152.73025 189.1971 25.5.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 1.04 (0.86, 1.26) 0.7 GDM / Uncomplicated STOP 1.00 (0.80, 1.25) 1.0 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.19 (1.04, 1.36) 0.009 STOP / SCOPE GDM 1.15 (0.88, 1.49) 0.3 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.21 (0.88, 1.67) 0.4 &gt;400 to &lt;800 / None Uncomplicated 1.21 (1.03, 1.40) 0.009 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.00 (0.73, 1.36) 1.0 &gt;=800 / None Uncomplicated 1.24 (1.07, 1.44) 0.001 &gt;=800 / &lt;=400 Uncomplicated 1.03 (0.76, 1.39) 1.0 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 1.03 (0.92, 1.15) 0.9 &lt;=400 / None GDM 1.51 (0.81, 2.83) 0.3 &gt;400 to &lt;800 / None GDM 1.33 (0.89, 2.00) 0.3 &gt;400 to &lt;800 / &lt;=400 GDM 0.88 (0.50, 1.56) 0.9 &gt;=800 / None GDM 1.71 (1.16, 2.52) 0.002 &gt;=800 / &lt;=400 GDM 1.13 (0.65, 1.97) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.28 (0.96, 1.71) 0.1 "],["folateactive-b12-2.html", "25.6 Folate:Active B12", " 25.6 Folate:Active B12 25.6.1 FA supp (4 categories) 25.6.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.5433082 0.1434489 45.6142102 &lt;0.0001 *** folate_cat3&lt;=400 0.1712593 0.1262044 1.3570002 0.18 ns folate_cat3&gt;400 to &lt;800 0.2432297 0.0866328 2.8075940 0.005 ** folate_cat3&gt;=800 0.1988297 0.0953792 2.0846235 0.04 * GDM_newGDM -0.3402459 0.2321425 -1.4656770 0.14 ns StudySTOP 0.0302317 0.1385442 0.2182095 0.83 ns f1_age 0.0012772 0.0046780 0.2730187 0.78 ns BMI -0.0094699 0.0033778 -2.8036160 0.005 ** folate_cat3&lt;=400:StudySTOP -0.1645965 0.3402498 -0.4837521 0.63 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0939664 0.1687858 0.5567202 0.58 ns folate_cat3&gt;=800:StudySTOP 0.0683435 0.1581294 0.4321996 0.67 ns GDM_newGDM:StudySTOP 0.3203723 0.3702667 0.8652474 0.39 ns folate_cat3&lt;=400:GDM_newGDM -0.2036292 0.4233719 -0.4809701 0.63 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM 0.3233856 0.3074920 1.0516879 0.29 ns folate_cat3&gt;=800:GDM_newGDM 0.5511296 0.3055733 1.8035920 0.07 ns folate_cat3&lt;=400:GDM_newGDM:StudySTOP 0.7429180 0.6792218 1.0937782 0.27 ns folate_cat3&gt;400 to &lt;800:GDM_newGDM:StudySTOP -0.7568308 0.4455080 -1.6988042 0.09 ns folate_cat3&gt;=800:GDM_newGDM:StudySTOP -0.5901214 0.4302630 -1.3715364 0.17 ns 25.6.3 Estimated Marginal Means folate_cat3 GDM_new Study response SE df lower.CL upper.CL None Uncomplicated SCOPE 550.3577 38.93965 713 478.9799 632.3723 &lt;=400 Uncomplicated SCOPE 653.1637 68.91670 713 530.9544 803.5018 &gt;400 to &lt;800 Uncomplicated SCOPE 701.9051 36.46014 713 633.8521 777.2645 &gt;=800 Uncomplicated SCOPE 671.4222 43.34609 713 591.4933 762.1519 None GDM SCOPE 391.6320 86.72432 713 253.5506 604.9112 &lt;=400 GDM SCOPE 379.1579 128.13661 713 195.2841 736.1617 &gt;400 to &lt;800 GDM SCOPE 690.1700 135.18736 713 469.8325 1013.8392 &gt;=800 GDM SCOPE 829.0511 156.42210 713 572.4095 1200.7587 None Uncomplicated STOP 567.2500 68.03864 713 448.2330 717.8691 &lt;=400 Uncomplicated STOP 571.0421 167.13133 713 321.4525 1014.4240 &gt;400 to &lt;800 Uncomplicated STOP 794.7251 64.55022 713 677.5822 932.1202 &gt;=800 Uncomplicated STOP 740.9797 29.80313 713 684.7180 801.8644 None GDM STOP 556.0880 146.01823 713 332.0886 931.1788 &lt;=400 GDM STOP 959.9471 326.04485 713 492.7721 1870.0295 &gt;400 to &lt;800 GDM STOP 505.0601 59.67734 713 400.4931 636.9292 &gt;=800 GDM STOP 698.6206 54.89786 713 598.7422 815.1600 25.6.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / Uncomplicated SCOPE 0.84 (0.65, 1.08) 0.2 GDM / Uncomplicated STOP 1.00 (0.75, 1.32) 1.0 Contrast GDM_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE Uncomplicated 1.03 (0.86, 1.23) 0.7 STOP / SCOPE GDM 1.22 (0.88, 1.69) 0.2 Contrast GDM_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None Uncomplicated 1.09 (0.71, 1.69) 1.0 &gt;400 to &lt;800 / None Uncomplicated 1.34 (1.08, 1.66) 0.003 &gt;400 to &lt;800 / &lt;=400 Uncomplicated 1.22 (0.80, 1.86) 0.6 &gt;=800 / None Uncomplicated 1.26 (1.03, 1.55) 0.02 &gt;=800 / &lt;=400 Uncomplicated 1.15 (0.76, 1.74) 0.8 &gt;=800 / &gt;400 to &lt;800 Uncomplicated 0.94 (0.81, 1.11) 0.8 &lt;=400 / None GDM 1.29 (0.61, 2.76) 0.8 &gt;400 to &lt;800 / None GDM 1.27 (0.75, 2.15) 0.7 &gt;400 to &lt;800 / &lt;=400 GDM 0.98 (0.49, 1.94) 1.0 &gt;=800 / None GDM 1.63 (0.98, 2.72) 0.07 &gt;=800 / &lt;=400 GDM 1.26 (0.65, 2.46) 0.8 &gt;=800 / &gt;400 to &lt;800 GDM 1.29 (0.87, 1.91) 0.3 "],["age-groups-2.html", "26 Age groups", " 26 Age groups Descriptives with univariate P-values. Within Uncomplicated Characteristic &lt;35 yrs (n=1251) &gt;=35 yrs (n=41) Total (n=1292) P-value PRL (ng/ml): Median (IQ range) 97.6 (59.0-158.9) 74.6 (43.8-99.7) 96.8 (58.3-157.1) 0.01 hPL (μg/ml): Median (IQ range) 108.9 (54.6-179.9) 81.6 (43.8-136.1) 108.1 (54.6-179.4) 0.08 GH2 (ng/ml): Median (IQ range) 2.5 (1.2-4.1) 2.1 (1.4-3.4) 2.5 (1.2-4.1) 0.54 Insulin (uU/L): Median (IQ range) 10.8 (6.0-21.9) 10.3 (6.3-16.8) 10.8 (6.1-21.7) 0.69 HOMA-IR: Median (IQ range) 2.4 (1.3-5.1) 2.5 (1.3-3.7) 2.4 (1.3-5.0) 0.68 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 4.9 (4.5-5.4) 5.0 (4.6-5.5) 0.38 Within GDM Characteristic &lt;35 yrs (n=226) &gt;=35 yrs (n=25) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 76.7 (45.6-121.8) 59.4 (42.7-110.7) 73.3 (45.3-120.9) 0.31 hPL (μg/ml): Median (IQ range) 66.2 (41.0-99.9) 35.4 (24.5-66.5) 61.4 (37.6-98.5) 0.006 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.2 (1.0-1.8) 1.5 (1.0-2.6) 0.41 Insulin (uU/L): Median (IQ range) 17.7 (9.2-42.2) 13.0 (9.9-23.8) 17.3 (9.4-40.4) 0.37 HOMA-IR: Median (IQ range) 3.9 (1.9-9.6) 3.0 (2.2-5.9) 3.8 (1.9-9.1) 0.43 Glucose (mmol/L): Median (IQ range) 5.0 (4.5-5.6) 4.9 (4.6-5.3) 4.9 (4.5-5.6) 0.66 Click here for table within SCOPE Within Uncomplicated Characteristic &lt;35 yrs (n=582) &gt;=35 yrs (n=16) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 140.1 (95.6-215.5) 101.2 (74.7-174.9) 139.9 (94.7-215.5) 0.20 hPL (μg/ml): Median (IQ range) 183.5 (151.1-220.8) 168.6 (123.6-206.2) 183.5 (149.9-220.6) 0.17 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.6) 3.8 (3.1-5.6) 4.2 (3.2-5.6) 0.70 Insulin (uU/L): Median (IQ range) 14.4 (6.5-29.1) 19.5 (10.0-35.6) 14.4 (6.5-29.1) 0.37 HOMA-IR: Median (IQ range) 3.3 (1.5-7.2) 4.5 (2.5-9.7) 3.3 (1.5-7.2) 0.28 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.2-5.8) 5.4 (5.0-5.8) 0.60 Serum folate concentration (nM): Median (IQ range) 36.7 (28.5-43.1) 35.0 (31.9-42.9) 36.6 (28.6-43.1) 0.96 B12 concentration (pM): Median (IQ range) 248.0 (195.0-316.0) 255.0 (216.0-338.0) 248.0 (195.0-316.0) 0.75 Folate:B12 ratio: Median (IQ range) 143.1 (103.4-210.5) 138.1 (116.9-200.6) 143.0 (104.5-208.8) 0.95 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 52.0 (48.0-83.5) 54.0 (42.5-72.0) 0.54 Folate:Active B12 ratio: Median (IQ range) 618.0 (464.9-963.5) 420.3 (380.1-751.7) 617.5 (461.2-937.5) 0.20 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.9-4.6) 4.4 (3.8-4.9) 0.92 Within GDM Characteristic &lt;35 yrs (n=56) &gt;=35 yrs (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 92.0 (66.0-164.6) 25.7 (14.6-36.7) 92.0 (62.0-147.2) 0.01 hPL (μg/ml): Median (IQ range) 106.6 (91.4-134.3) 36.0 (36.0-36.0) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.2) 1.8 (1.8-1.8) 2.7 (1.6-4.2) 0.69 Insulin (uU/L): Median (IQ range) 34.0 (16.6-52.7) 52.7 (35.0-70.4) 34.0 (16.6-55.4) 0.64 HOMA-IR: Median (IQ range) 8.1 (3.6-14.0) 13.7 (9.1-18.4) 8.1 (3.6-17.4) 0.70 Glucose (mmol/L): Median (IQ range) 5.8 (5.2-6.7) 5.8 (5.8-5.9) 5.8 (5.2-6.6) 0.93 Serum folate concentration (nM): Median (IQ range) 38.8 (31.7-43.8) 86.0 (63.5-108.6) 40.1 (32.0-43.8) 0.23 B12 concentration (pM): Median (IQ range) 254.5 (194.8-335.0) 205.0 (200.0-210.0) 253.5 (194.2-333.0) 0.31 Folate:B12 ratio: Median (IQ range) 152.8 (114.2-196.8) 410.0 (309.9-510.1) 158.9 (116.5-210.2) 0.11 Active B12 concentration (pM): Median (IQ range) 68.0 (55.0-85.5) 67.5 (50.8-84.2) 68.0 (55.0-86.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 553.8 (431.4-648.6) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) 0.65 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 4.1 (3.5-4.7) 3.9 (3.6-4.6) 0.94 Click here for table within STOP Within Uncomplicated Characteristic &lt;35 yrs (n=669) &gt;=35 yrs (n=25) Total (n=694) P-value PRL (ng/ml): Median (IQ range) 73.2 (49.2-114.9) 52.6 (38.2-90.3) 72.9 (48.6-113.6) 0.08 hPL (μg/ml): Median (IQ range) 62.2 (41.7-96.7) 68.1 (39.3-83.4) 62.4 (41.4-96.2) 0.91 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.6 (1.1-2.2) 1.4 (0.9-2.4) 0.53 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-44.9) 44.8 (41.2-99.7) 40.5 (36.4-45.2) 0.0010 B12 concentration (pM): Median (IQ range) 279.0 (220.5-355.0) 267.5 (220.2-370.5) 279.0 (220.5-356.0) 0.96 Folate:B12 ratio: Median (IQ range) 153.9 (114.8-219.0) 175.4 (140.1-335.7) 155.4 (115.1-222.2) 0.03 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.2) 61.5 (54.2-91.2) 63.0 (48.0-80.8) 0.71 Folate:Active B12 ratio: Median (IQ range) 670.3 (492.7-949.5) 689.4 (493.6-1059.1) 670.3 (491.4-950.5) 0.93 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.8) 4.8 (4.3-5.6) 0.30 Within GDM Characteristic &lt;35 yrs (n=170) &gt;=35 yrs (n=23) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 73.0 (42.6-114.0) 62.6 (43.5-114.4) 68.8 (42.6-114.0) 0.83 hPL (μg/ml): Median (IQ range) 59.4 (37.8-85.3) 34.8 (24.4-67.2) 57.0 (35.8-84.1) 0.03 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.1 (1.0-2.0) 1.3 (0.9-2.2) 0.67 Serum folate concentration (nM): Median (IQ range) 39.7 (35.0-44.5) 43.7 (39.1-64.9) 40.2 (35.4-45.1) 0.04 B12 concentration (pM): Median (IQ range) 272.0 (220.5-346.5) 298.0 (190.5-381.5) 273.5 (216.8-352.0) 0.90 Folate:B12 ratio: Median (IQ range) 147.7 (112.4-206.3) 169.4 (97.5-284.9) 148.0 (111.3-220.6) 0.56 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-91.0) 74.0 (62.0-78.0) 74.5 (56.2-90.2) 0.77 Folate:Active B12 ratio: Median (IQ range) 521.2 (419.2-757.8) 836.9 (594.2-1038.7) 531.9 (419.6-786.4) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.7 (4.0-5.4) 4.8 (4.5-5.2) 4.8 (4.0-5.3) 0.91 mod_ls &lt;- lapply(c(hormone_var,insulin_var),function(x){ if(x%in%hormone_var){ #LME for hormones mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,preg_out,&quot;+&quot;,fvarc,&quot;*Study +&quot;,preg_out,&quot;*Study +&quot;,preg_out,&quot;*&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run)))} if(x%in%insulin_var){ #GEE for insulin dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,fvarc,preg_out,x)]) dat_tmp &lt;- dat_tmp[with(dat_tmp,order(Study,Study.ID)),] mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,preg_out,&quot;+&quot;,fvarc,&quot;*Study +&quot;,preg_out,&quot;*Study +&quot;,preg_out,&quot;*&quot;,fvarc,&quot;*Study + GA_samp + Study&quot;)) mod &lt;- NULL try(mod &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;))),silent=T) if(is.null(mod)){ mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,preg_out,&quot;+&quot;,fvarc,&quot;*Study +&quot;,preg_out,&quot;*Study + GA_samp + Study&quot;)) mod &lt;- eval(bquote(geeglm(.(mod_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))}} return(mod)}) em2_eq &lt;- as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study*&quot;,preg_out)) em2_eq_o &lt;- as.formula(paste0(&quot;revpairwise~Study*&quot;,preg_out)) em2_eq_c &lt;- as.formula(paste0(&quot;~&quot;,fvarc,&quot;*Study*&quot;,preg_out)) ##mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study*&quot;,preg_out)),type=&quot;response&quot;)}) ##mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) ##names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- hormone_var #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,em2_eq,type=&quot;response&quot;)}) #mod_em_o &lt;- lapply(mod_ls,function(x){emmeans(x,em2_eq_o,type=&quot;response&quot;)}) #mod_em_c &lt;- lapply(mod_ls,function(x){emmeans(x,em2_eq_c,type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind1]],em2_eq,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} mod_em_o &lt;- foreach(ind2=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind2]],em2_eq_o,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} mod_em_c &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind3]],em2_eq_c,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} names(mod_em) &lt;- names(mod_em_o) &lt;- names(mod_em_c) &lt;- c(hormone_var,insulin_var) #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;)) %dopar% { extract.ci.mod(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- c(hormone_var,insulin_var) mod_em_est &lt;- lapply(mod_em,function(x){ #estimated means dtmp &lt;- round_df(data.frame(x$emmeans),2) names(dtmp)[(ncol(dtmp)-1):ncol(dtmp)] &lt;- c(&quot;lower.CL&quot;,&quot;upper.CL&quot;) return(dtmp)}) mod_em2 &lt;- lapply(mod_em,function(x) return(emmeans.sum(x))) #Post-hoc: within gps names(mod_em) &lt;- names(mod_em_o) &lt;- names(mod_em_c) &lt;- names(mod_sum) &lt;- names(mod_em_est) &lt;- names(mod_em2) &lt;- c(hormone_var,insulin_var) fit_em_contrasts &lt;- lapply(mod_em_c,function(x){ contrast_dat &lt;- data.frame(x) contrast_dat$Group &lt;- with(contrast_dat,paste(Study,get(preg_out),sep=&quot;.&quot;)) contrast_dat$Group &lt;- paste(contrast_dat$Group,1:2,sep=&quot;.&quot;) contrast_mat &lt;- diag(nrow(contrast_dat)) rownames(contrast_mat) &lt;- colnames(contrast_mat) &lt;- contrast_dat$Group contrast_ls &lt;- list( &quot;STOP/SCOPE (Overall)&quot;= ((contrast_mat[4,]-contrast_mat[3,])+(contrast_mat[8,]-contrast_mat[7,]))- ((contrast_mat[2,]-contrast_mat[1,])+(contrast_mat[6,]-contrast_mat[5,])), &quot;STOP/SCOPE (Control)&quot;= (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.1&quot;),]), &quot;STOP/SCOPE (Cases)&quot;= (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.1&quot;),]), &quot;Cases/Control (SCOPE)&quot;= (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.1&quot;),]), &quot;Cases/Control (STOP)&quot;= (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.1&quot;),])) names(contrast_ls) &lt;- c(&quot;SCOPE/SCOPE (Overall)&quot;,paste0(&quot;STOP/SCOPE (&quot;,preg_out_label,&quot;)&quot;), paste0(preg_out_label[2],&quot;/&quot;,preg_out_label[1],&quot; (&quot;,c(&quot;SCOPE&quot;,&quot;STOP&quot;),&quot;)&quot;)) contrast_out &lt;- contrast(x,method=contrast_ls) return(contrast_out)}) mod_em2_c &lt;- lapply(fit_em_contrasts,function(x){ #tmp1 &lt;- data.frame(confint(x)$contrasts) tmp1 &lt;- data.frame(confint(x)) #tmp2 &lt;- cbind(tmp1,&quot;p.value&quot;=data.frame(x$contrasts)$p.value) tmp2 &lt;- cbind(tmp1,&quot;p.value&quot;=data.frame(x)$p.value) tmp2$&quot;&quot; &lt;- p_val_ast(tmp2$p.value) tmp2$p.value &lt;- round_p_vec(tmp2$p.value,rc=3) return(tmp2)}) names(mod_em2_c) &lt;- c(hormone_var,insulin_var) #mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts #mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts #mod_em_sum &lt;- mapply(function(x,y){ # x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) # y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) # names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; # return(rbind(x,y))}, # mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-16.html", "26.1 Prolactin", " 26.1 Prolactin LME for repeated measures. 26.1.1 Model summary Var Effect P (Intercept) 13.80 (9.30, 20.49) &lt;0.0001 Age_gp&gt;=35 yrs 0.84 (0.59, 1.20) 0.33 GDM_newGDM 0.96 (0.78, 1.19) 0.73 StudySTOP 0.99 (0.87, 1.12) 0.82 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.91 (0.58, 1.42) 0.68 GDM_newGDM:StudySTOP 1.10 (0.87, 1.39) 0.41 Age_gp&gt;=35 yrs:GDM_newGDM 0.57 (0.25, 1.32) 0.19 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 2.18 (0.87, 5.47) 0.10 26.1.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 95.85 7.74 102.70 81.65 112.50 &gt;=35 yrs SCOPE Uncomplicated 80.30 15.71 1190.90 54.70 117.86 &lt;35 yrs STOP Uncomplicated 94.44 7.08 76.41 81.35 109.65 &gt;=35 yrs STOP Uncomplicated 71.98 10.71 774.58 53.75 96.40 &lt;35 yrs SCOPE GDM 92.32 11.75 491.62 71.90 118.55 &gt;=35 yrs SCOPE GDM 44.15 16.91 577.40 20.80 93.70 &lt;35 yrs STOP GDM 100.29 8.94 147.81 84.09 119.62 &gt;=35 yrs STOP GDM 95.06 14.40 795.34 70.61 127.99 ## Warning: Using `size` aesthetic for lines was deprecated in ggplot2 3.4.0. ## ℹ Please use `linewidth` instead. ## This warning is displayed once every 8 hours. ## Call `lifecycle::last_lifecycle_warnings()` to see where this warning was generated. 26.1.3 Post-hoc comparisons 26.1.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE 0.84 (0.58, 1.20) 0.3 &gt;=35 yrs / &lt;35 yrs STOP 0.76 (0.59, 0.99) 0.04 &gt;=35 yrs / &lt;35 yrs SCOPE 0.48 (0.22, 1.03) 0.06 &gt;=35 yrs / &lt;35 yrs STOP 0.95 (0.72, 1.25) 0.7 26.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.8033017 0.8492204 838.1331 0.7155440 4.544650 0.211 ns STOP/SCOPE (Uncomplicated) 0.9097827 0.2062110 1431.2352 0.5832321 1.419169 0.677 ns STOP/SCOPE (GDM) 1.9821235 0.8176655 637.3703 0.8817085 4.455910 0.098 ns GDM/Uncomplicated (SCOPE) 0.5708094 0.2452270 721.7561 0.2455782 1.326760 0.192 ns GDM/Uncomplicated (STOP) 1.2436098 0.2404574 1407.1881 0.8510575 1.817228 0.260 ns "],["hpl-16.html", "26.2 HPL", " 26.2 HPL LME for repeated measures. 26.2.1 Model summary Var Effect P (Intercept) 1.92 (1.57, 2.36) &lt;0.0001 Age_gp&gt;=35 yrs 0.89 (0.74, 1.08) 0.24 GDM_newGDM 0.93 (0.84, 1.03) 0.18 StudySTOP 1.14 (1.06, 1.22) 0.0002 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.12 (0.88, 1.41) 0.36 GDM_newGDM:StudySTOP 1.09 (0.97, 1.23) 0.13 Age_gp&gt;=35 yrs:GDM_newGDM 1.02 (0.66, 1.59) 0.92 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 0.70 (0.43, 1.13) 0.15 26.2.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 86.97 2.54 189.21 82.10 92.12 &gt;=35 yrs SCOPE Uncomplicated 77.57 7.63 1440.36 63.97 94.08 &lt;35 yrs STOP Uncomplicated 98.96 2.51 107.96 94.11 104.05 &gt;=35 yrs STOP Uncomplicated 98.65 7.25 1356.95 85.41 113.94 &lt;35 yrs SCOPE GDM 80.99 4.51 679.61 72.60 90.34 &gt;=35 yrs SCOPE GDM 73.91 14.63 474.34 50.10 109.05 &lt;35 yrs STOP GDM 100.88 3.66 343.33 93.93 108.34 &gt;=35 yrs STOP GDM 71.87 5.36 1294.42 62.09 83.19 26.2.3 Post-hoc comparisons 26.2.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE 0.89 (0.74, 1.08) 0.2 &gt;=35 yrs / &lt;35 yrs STOP 1.00 (0.87, 1.15) 1.0 &gt;=35 yrs / &lt;35 yrs SCOPE 0.91 (0.61, 1.36) 0.7 &gt;=35 yrs / &lt;35 yrs STOP 0.71 (0.61, 0.83) &lt;0.0001 26.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8724134 0.2156989 720.6900 0.5369253 1.4175252 0.581 ns STOP/SCOPE (Uncomplicated) 1.1175774 0.1343859 1419.0147 0.8827452 1.4148808 0.355 ns STOP/SCOPE (GDM) 0.7806291 0.1683624 543.2569 0.5110361 1.1924435 0.251 ns GDM/Uncomplicated (SCOPE) 1.0231517 0.2293448 594.4515 0.6587938 1.5890245 0.919 ns GDM/Uncomplicated (STOP) 0.7146726 0.0742161 1391.4911 0.5829564 0.8761495 0.001 ** "],["gh2-16.html", "26.3 GH2", " 26.3 GH2 LME for repeated measures. 26.3.1 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 Age_gp&gt;=35 yrs 0.95 (0.74, 1.23) 0.70 GDM_newGDM 0.90 (0.78, 1.05) 0.19 StudySTOP 0.98 (0.90, 1.07) 0.68 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.07 (0.78, 1.46) 0.69 GDM_newGDM:StudySTOP 1.13 (0.95, 1.34) 0.16 Age_gp&gt;=35 yrs:GDM_newGDM 0.85 (0.44, 1.65) 0.64 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 1.29 (0.63, 2.65) 0.48 26.3.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 2.26 0.07 450.31 2.11 2.41 &gt;=35 yrs SCOPE Uncomplicated 2.15 0.28 1415.94 1.66 2.77 &lt;35 yrs STOP Uncomplicated 2.21 0.06 214.88 2.10 2.33 &gt;=35 yrs STOP Uncomplicated 2.25 0.22 1484.42 1.86 2.72 &lt;35 yrs SCOPE GDM 2.04 0.16 1108.15 1.75 2.37 &gt;=35 yrs SCOPE GDM 1.65 0.50 802.72 0.91 3.01 &lt;35 yrs STOP GDM 2.26 0.10 539.32 2.08 2.45 &gt;=35 yrs STOP GDM 2.53 0.25 1426.51 2.07 3.08 26.3.3 Post-hoc comparisons 26.3.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE 0.95 (0.74, 1.23) 0.7 &gt;=35 yrs / &lt;35 yrs STOP 1.01 (0.84, 1.23) 0.9 &gt;=35 yrs / &lt;35 yrs SCOPE 0.81 (0.44, 1.50) 0.5 &gt;=35 yrs / &lt;35 yrs STOP 1.12 (0.91, 1.37) 0.3 26.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.4698123 0.5391396 1057.3628 0.7156095 3.018893 0.294 ns STOP/SCOPE (Uncomplicated) 1.0666101 0.1728880 1461.3444 0.7761026 1.465859 0.691 ns STOP/SCOPE (GDM) 1.3780222 0.4533225 880.2743 0.7225273 2.628198 0.330 ns GDM/Uncomplicated (SCOPE) 0.8535475 0.2885458 963.1589 0.4396560 1.657076 0.640 ns GDM/Uncomplicated (STOP) 1.1027530 0.1570264 1466.3815 0.8340102 1.458093 0.492 ns "],["insulin-14.html", "26.4 Insulin", " 26.4 Insulin GEE for repeated measures. 26.4.1 Model summary Var Effect P (Intercept) 12.92 (7.66, 21.81) &lt;0.0001 Age_gp&gt;=35 yrs 1.26 (0.82, 1.93) 0.29 GDM_newGDM 2.19 (1.59, 3.01) &lt;0.0001 StudySTOP 0.76 (0.64, 0.91) 0.002 GA_samp 1.01 (0.97, 1.04) 0.76 Age_gp&gt;=35 yrs:StudySTOP 0.64 (0.38, 1.07) 0.09 GDM_newGDM:StudySTOP 0.81 (0.56, 1.15) 0.24 Age_gp&gt;=35 yrs:GDM_newGDM 1.07 (0.51, 2.27) 0.85 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 0.97 (0.41, 2.32) 0.95 26.4.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 13.82 0.87 Inf 12.22 15.63 &gt;=35 yrs SCOPE Uncomplicated 17.42 3.79 Inf 11.38 26.68 &lt;35 yrs STOP Uncomplicated 10.52 0.44 Inf 9.69 11.42 &gt;=35 yrs STOP Uncomplicated 8.46 1.24 Inf 6.35 11.28 &lt;35 yrs SCOPE GDM 30.24 4.90 Inf 22.02 41.53 &gt;=35 yrs SCOPE GDM 40.93 11.26 Inf 23.87 70.18 &lt;35 yrs STOP GDM 18.56 1.52 Inf 15.81 21.79 &gt;=35 yrs STOP GDM 15.61 2.38 Inf 11.58 21.05 26.4.3 Post-hoc comparisons 26.4.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE 1.26 (0.82, 1.93) 0.3 &gt;=35 yrs / &lt;35 yrs STOP 0.80 (0.60, 1.08) 0.1 &gt;=35 yrs / &lt;35 yrs SCOPE 1.35 (0.73, 2.51) 0.3 &gt;=35 yrs / &lt;35 yrs STOP 0.84 (0.61, 1.17) 0.3 26.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.3967798 0.1759183 Inf 0.1664012 0.9461122 0.037 * STOP/SCOPE (Uncomplicated) 0.6383914 0.1686954 Inf 0.3803263 1.0715630 0.089 ns STOP/SCOPE (GDM) 0.6215306 0.2211962 Inf 0.3094061 1.2485220 0.181 ns GDM/Uncomplicated (SCOPE) 1.0737975 0.4109668 Inf 0.5071637 2.2735090 0.852 ns GDM/Uncomplicated (STOP) 1.0454370 0.2346315 Inf 0.6733787 1.6230667 0.843 ns "],["homa-ir-14.html", "26.5 HOMA-IR", " 26.5 HOMA-IR GEE for repeated measures. 26.5.1 Model summary Var Effect P (Intercept) 3.30 (1.90, 5.72) &lt;0.0001 Age_gp&gt;=35 yrs 1.34 (0.84, 2.13) 0.22 GDM_newGDM 2.38 (1.67, 3.40) &lt;0.0001 StudySTOP 0.66 (0.55, 0.79) &lt;0.0001 GA_samp 1.00 (0.97, 1.04) 0.95 Age_gp&gt;=35 yrs:StudySTOP 0.59 (0.33, 1.03) 0.06 GDM_newGDM:StudySTOP 0.77 (0.51, 1.14) 0.19 Age_gp&gt;=35 yrs:GDM_newGDM 0.98 (0.44, 2.18) 0.97 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 1.09 (0.43, 2.72) 0.86 26.5.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 3.35 0.22 Inf 2.94 3.81 &gt;=35 yrs SCOPE Uncomplicated 4.48 1.05 Inf 2.82 7.10 &lt;35 yrs STOP Uncomplicated 2.19 0.10 Inf 2.01 2.39 &gt;=35 yrs STOP Uncomplicated 1.72 0.27 Inf 1.26 2.35 &lt;35 yrs SCOPE GDM 7.98 1.44 Inf 5.60 11.35 &gt;=35 yrs SCOPE GDM 10.51 2.95 Inf 6.06 18.23 &lt;35 yrs STOP GDM 4.00 0.35 Inf 3.37 4.76 &gt;=35 yrs STOP GDM 3.36 0.52 Inf 2.49 4.55 26.5.3 Post-hoc comparisons 26.5.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE 1.34 (0.84, 2.13) 0.2 &gt;=35 yrs / &lt;35 yrs STOP 0.78 (0.57, 1.08) 0.1 &gt;=35 yrs / &lt;35 yrs SCOPE 1.32 (0.69, 2.51) 0.4 &gt;=35 yrs / &lt;35 yrs STOP 0.84 (0.60, 1.18) 0.3 26.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.3739222 0.1750465 Inf 0.1493836 0.9359647 0.036 * STOP/SCOPE (Uncomplicated) 0.5863093 0.1675235 Inf 0.3349012 1.0264476 0.062 ns STOP/SCOPE (GDM) 0.6377559 0.2364667 Inf 0.3083519 1.3190535 0.225 ns GDM/Uncomplicated (SCOPE) 0.9842875 0.3987915 Inf 0.4448886 2.1776731 0.969 ns GDM/Uncomplicated (STOP) 1.0706554 0.2520065 Inf 0.6749901 1.6982517 0.772 ns "],["glucose-12.html", "26.6 Glucose", " 26.6 Glucose GEE for repeated measures. 26.6.1 Model summary Var Effect P (Intercept) 5.59 (5.00, 6.25) &lt;0.0001 Age_gp&gt;=35 yrs 1.06 (0.95, 1.17) 0.30 GDM_newGDM 1.11 (1.00, 1.24) 0.06 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.00) 0.52 Age_gp&gt;=35 yrs:StudySTOP 0.93 (0.84, 1.04) 0.20 GDM_newGDM:StudySTOP 0.93 (0.83, 1.04) 0.23 Age_gp&gt;=35 yrs:GDM_newGDM 0.91 (0.79, 1.06) 0.23 Age_gp&gt;=35 yrs:GDM_newGDM:StudySTOP 1.09 (0.93, 1.28) 0.27 26.6.2 Estimated marginal means Age_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE Uncomplicated 5.42 0.07 Inf 5.29 5.55 &gt;=35 yrs SCOPE Uncomplicated 5.72 0.30 Inf 5.17 6.33 &lt;35 yrs STOP Uncomplicated 4.72 0.04 Inf 4.63 4.80 &gt;=35 yrs STOP Uncomplicated 4.63 0.08 Inf 4.48 4.80 &lt;35 yrs SCOPE GDM 6.02 0.32 Inf 5.44 6.67 &gt;=35 yrs SCOPE GDM 5.81 0.06 Inf 5.69 5.94 &lt;35 yrs STOP GDM 4.89 0.07 Inf 4.75 5.03 &gt;=35 yrs STOP GDM 4.79 0.09 Inf 4.62 4.97 26.6.3 Post-hoc comparisons 26.6.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE 1.06 (0.95, 1.17) 0.3 &gt;=35 yrs / &lt;35 yrs STOP 0.98 (0.95, 1.02) 0.3 &gt;=35 yrs / &lt;35 yrs SCOPE 0.96 (0.87, 1.07) 0.5 &gt;=35 yrs / &lt;35 yrs STOP 0.98 (0.94, 1.02) 0.4 26.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9468606 0.0758078 Inf 0.8093511 1.107733 0.495 ns STOP/SCOPE (Uncomplicated) 0.9308189 0.0515651 Inf 0.8350466 1.037575 0.196 ns STOP/SCOPE (GDM) 1.0172340 0.0591792 Inf 0.9076133 1.140095 0.769 ns GDM/Uncomplicated (SCOPE) 0.9138292 0.0688681 Inf 0.7883457 1.059286 0.232 ns GDM/Uncomplicated (STOP) 0.9986671 0.0283507 Inf 0.9446183 1.055808 0.963 ns "],["bmi-groups-2.html", "27 BMI groups", " 27 BMI groups Descriptives with univariate P-values. Within Uncomplicated Characteristic Underweight (n=32) Normal (n=580) Overweight (n=382) Obese (n=298) Total (n=1292) P-value PRL (ng/ml): Median (IQ range) 103.1 (78.8-182.4) 103.2 (64.2-160.3) 97.3 (56.9-164.2) 80.6 (48.1-131.6) 96.8 (58.3-157.1) 0.0003 hPL (μg/ml): Median (IQ range) 144.8 (88.1-242.9) 121.0 (61.1-195.3) 109.6 (54.2-172.4) 75.7 (41.7-145.4) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.1 (1.5-5.9) 2.9 (1.3-4.7) 2.5 (1.2-3.9) 2.2 (1.0-3.3) 2.5 (1.2-4.1) &lt;0.0001 Insulin (uU/L): Median (IQ range) 6.1 (4.4-12.4) 7.7 (4.6-16.6) 11.6 (6.8-23.3) 15.4 (9.6-31.6) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 1.4 (0.9-2.8) 1.7 (1.0-3.7) 2.6 (1.4-5.4) 3.6 (2.1-7.0) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.4-5.3) 5.0 (4.6-5.4) 5.0 (4.6-5.6) 5.1 (4.7-5.6) 5.0 (4.6-5.5) 0.02 Within GDM Characteristic Underweight (n=3) Normal (n=65) Overweight (n=51) Obese (n=132) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 92.0 (51.9-158.9) 77.0 (35.9-111.0) 66.0 (45.0-108.6) 73.3 (45.3-120.9) 0.03 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 87.0 (53.6-115.5) 79.6 (45.6-99.8) 50.2 (34.6-76.8) 61.4 (37.6-98.5) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.1-2.9) 1.4 (0.9-2.9) 1.3 (1.0-2.3) 1.5 (1.0-2.6) 0.34 Insulin (uU/L): Median (IQ range) 4.5 (3.7-6.8) 11.1 (5.7-30.9) 12.6 (8.5-20.1) 24.6 (13.4-47.1) 17.3 (9.4-40.4) &lt;0.0001 HOMA-IR: Median (IQ range) 0.8 (0.7-1.2) 2.2 (1.2-7.3) 2.7 (1.7-4.4) 5.5 (2.8-11.2) 3.8 (1.9-9.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.1 (4.0-4.5) 4.9 (4.4-5.2) 4.8 (4.6-5.6) 5.1 (4.6-5.8) 4.9 (4.5-5.6) 0.02 Click here for table within SCOPE Within Uncomplicated Characteristic Underweight (n=16) Normal (n=272) Overweight (n=175) Obese (n=135) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 187.3 (146.2-325.0) 142.3 (97.1-212.7) 139.1 (97.5-222.1) 130.4 (82.4-194.3) 139.9 (94.7-215.5) 0.10 hPL (μg/ml): Median (IQ range) 262.2 (219.0-278.0) 197.4 (170.3-230.2) 172.9 (150.5-210.5) 153.3 (130.2-181.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 6.2 (4.6-6.5) 4.7 (3.5-6.5) 4.0 (3.2-5.2) 3.4 (2.6-4.4) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/L): Median (IQ range) 9.0 (6.0-11.4) 10.6 (5.2-22.4) 17.7 (9.0-29.6) 20.3 (9.7-36.3) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 1.9 (1.4-2.4) 2.5 (1.2-5.7) 4.0 (2.0-7.5) 4.7 (2.3-9.3) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.2 (4.8-5.8) 5.3 (5.0-5.7) 5.5 (5.0-6.0) 5.4 (5.1-5.9) 5.4 (5.0-5.8) 0.15 Serum folate concentration (nM): Median (IQ range) 29.2 (24.9-36.1) 37.5 (29.7-43.8) 37.2 (30.1-41.2) 35.4 (24.8-43.1) 36.6 (28.6-43.1) 0.06 B12 concentration (pM): Median (IQ range) 288.0 (252.0-355.0) 256.0 (198.0-325.0) 249.0 (199.0-312.0) 226.0 (180.2-286.2) 248.0 (195.0-316.0) 0.005 Folate:B12 ratio: Median (IQ range) 105.6 (74.6-117.3) 146.9 (104.6-208.2) 144.7 (107.1-208.8) 143.3 (103.3-211.0) 143.0 (104.5-208.8) 0.23 Active B12 concentration (pM): Median (IQ range) 63.5 (53.5-78.0) 53.0 (41.0-72.5) 54.0 (43.0-70.5) 60.0 (43.5-72.5) 54.0 (42.5-72.0) 0.39 Folate:Active B12 ratio: Median (IQ range) 491.8 (337.4-589.7) 642.4 (464.2-1054.8) 643.8 (496.6-965.2) 537.9 (403.0-698.7) 617.5 (461.2-937.5) 0.010 Homocysteine concentration (μM): Median (IQ range) 4.5 (4.2-5.3) 4.4 (3.9-5.0) 4.2 (3.8-4.9) 4.4 (3.8-5.0) 4.4 (3.8-4.9) 0.20 Within GDM Characteristic Underweight (n=0) Normal (n=14) Overweight (n=13) Obese (n=31) Total (n=58) P-value PRL (ng/ml): Median (IQ range) NA (NA-NA) 119.0 (86.9-144.9) 133.7 (87.4-214.9) 66.0 (55.9-111.0) 92.0 (62.0-147.2) – hPL (μg/ml): Median (IQ range) NA (NA-NA) 106.6 (100.2-178.0) 98.8 (91.4-114.2) 106.6 (80.8-133.7) 106.2 (85.6-134.2) – GH2 (ng/ml): Median (IQ range) NA (NA-NA) 2.6 (1.9-3.9) 4.2 (3.2-5.6) 1.9 (1.5-3.0) 2.7 (1.6-4.2) – Insulin (uU/L): Median (IQ range) NA (NA-NA) 25.1 (8.8-38.2) 17.1 (16.6-62.4) 41.4 (24.5-76.7) 34.0 (16.6-55.4) – HOMA-IR: Median (IQ range) NA (NA-NA) 6.0 (2.0-11.1) 4.3 (3.5-18.6) 10.0 (4.9-20.1) 8.1 (3.6-17.4) – Glucose (mmol/L): Median (IQ range) NA (NA-NA) 5.3 (5.1-6.4) 5.9 (5.6-6.4) 5.9 (5.6-6.7) 5.8 (5.2-6.6) – Serum folate concentration (nM): Median (IQ range) NA (NA-NA) 43.6 (39.0-44.6) 36.9 (31.7-45.9) 39.6 (31.5-43.0) 40.1 (32.0-43.8) – B12 concentration (pM): Median (IQ range) NA (NA-NA) 289.0 (170.5-372.5) 263.5 (224.2-309.8) 240.0 (192.0-301.0) 253.5 (194.2-333.0) – Folate:B12 ratio: Median (IQ range) NA (NA-NA) 155.4 (114.2-232.5) 145.1 (121.9-190.5) 169.4 (118.7-199.0) 158.9 (116.5-210.2) – Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 83.5 (66.2-99.2) 58.5 (54.5-77.0) 77.0 (53.0-85.0) 68.0 (55.0-86.0) – Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 553.9 (377.4-674.3) 535.8 (321.6-763.8) 553.8 (516.5-577.4) 553.8 (424.7-660.3) – Homocysteine concentration (μM): Median (IQ range) NA (NA-NA) 4.3 (3.9-5.1) 4.0 (3.5-4.6) 3.7 (3.5-4.3) 3.9 (3.6-4.6) – Click here for table within STOP Within Uncomplicated Characteristic Underweight (n=16) Normal (n=308) Overweight (n=207) Obese (n=163) Total (n=694) P-value PRL (ng/ml): Median (IQ range) 91.6 (47.1-99.5) 78.8 (53.8-120.4) 72.9 (49.1-115.1) 62.1 (40.3-99.3) 72.9 (48.6-113.6) 0.003 hPL (μg/ml): Median (IQ range) 90.3 (64.3-140.4) 67.3 (45.7-101.5) 61.0 (42.3-97.2) 50.5 (34.5-73.3) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (1.4-3.5) 1.5 (1.0-2.4) 1.5 (0.8-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.03 Serum folate concentration (nM): Median (IQ range) 35.0 (29.9-40.4) 40.8 (37.0-52.4) 40.4 (36.3-45.0) 40.5 (35.7-46.9) 40.5 (36.4-45.2) 0.008 B12 concentration (pM): Median (IQ range) 349.5 (240.0-494.2) 288.0 (228.0-369.0) 276.0 (214.5-339.0) 260.5 (217.8-335.2) 279.0 (220.5-356.0) 0.03 Folate:B12 ratio: Median (IQ range) 98.0 (68.5-159.2) 154.8 (114.8-225.9) 149.5 (120.1-215.2) 168.3 (117.6-233.6) 155.4 (115.1-222.2) 0.03 Active B12 concentration (pM): Median (IQ range) 50.0 (48.0-82.0) 63.0 (46.0-79.0) 63.0 (49.0-83.0) 62.0 (51.0-76.0) 63.0 (48.0-80.8) 0.78 Folate:Active B12 ratio: Median (IQ range) 602.0 (490.9-735.8) 693.3 (532.0-964.9) 670.9 (460.9-951.1) 644.4 (520.0-929.8) 670.3 (491.4-950.5) 0.67 Homocysteine concentration (μM): Median (IQ range) 5.3 (4.7-5.7) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 4.8 (4.3-5.6) 0.15 Within GDM Characteristic Underweight (n=3) Normal (n=51) Overweight (n=38) Obese (n=101) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 86.0 (50.3-158.9) 68.8 (33.6-110.6) 66.6 (43.3-107.8) 68.8 (42.6-114.0) 0.07 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 69.0 (51.5-110.6) 68.0 (40.0-94.5) 47.1 (32.5-66.9) 57.0 (35.8-84.1) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.1-2.2) 1.2 (0.8-2.5) 1.3 (0.9-2.2) 1.3 (0.9-2.2) 0.25 Serum folate concentration (nM): Median (IQ range) 42.7 (41.5-42.9) 41.3 (36.8-54.0) 40.7 (36.7-56.8) 39.2 (34.4-43.8) 40.2 (35.4-45.1) 0.24 B12 concentration (pM): Median (IQ range) 345.0 (307.0-492.5) 292.0 (237.0-348.8) 257.0 (189.0-360.0) 269.5 (215.4-338.0) 273.5 (216.8-352.0) 0.23 Folate:B12 ratio: Median (IQ range) 117.1 (91.9-138.7) 136.4 (109.7-197.4) 164.8 (114.1-265.0) 149.2 (111.7-217.8) 148.0 (111.3-220.6) 0.57 Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 68.0 (55.0-79.0) 67.0 (48.0-95.8) 78.0 (61.0-91.0) 74.5 (56.2-90.2) Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 521.2 (457.3-770.2) 785.3 (497.1-883.3) 512.7 (410.8-645.7) 531.9 (419.6-786.4) Homocysteine concentration (μM): Median (IQ range) 4.5 (4.0-4.5) 4.7 (4.0-5.4) 4.8 (4.0-5.7) 4.8 (4.0-5.2) 4.8 (4.0-5.3) 0.65 (Intercept) BMI_gp3Normal BMI_gp3Overweight BMI_gp3Obese GDM_newGDM 39 1 1 0 0 0 40 1 1 0 0 0 41 1 0 1 0 0 42 1 0 1 0 1 46 1 0 1 0 0 47 1 1 0 0 0 StudySTOP GA_samp BMI_gp3Normal:StudySTOP BMI_gp3Overweight:StudySTOP 39 0 15.00 0 0 40 0 15.00 0 0 41 0 16.00 0 0 42 0 14.43 0 0 46 0 14.86 0 0 47 0 13.71 0 0 BMI_gp3Obese:StudySTOP GDM_newGDM:StudySTOP BMI_gp3Normal:GDM_newGDM 39 0 0 0 40 0 0 0 41 0 0 0 42 0 0 0 46 0 0 0 47 0 0 0 BMI_gp3Overweight:GDM_newGDM BMI_gp3Obese:GDM_newGDM 39 0 0 40 0 0 41 0 0 42 1 0 46 0 0 47 0 0 BMI_gp3Normal:GDM_newGDM:StudySTOP BMI_gp3Overweight:GDM_newGDM:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 BMI_gp3Obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 (Intercept) BMI_gp3Normal BMI_gp3Overweight BMI_gp3Obese GDM_newGDM 39 1 1 0 0 0 40 1 1 0 0 0 41 1 0 1 0 0 42 1 0 1 0 1 46 1 0 1 0 0 47 1 1 0 0 0 StudySTOP GA_samp BMI_gp3Normal:StudySTOP BMI_gp3Overweight:StudySTOP 39 0 15.00 0 0 40 0 15.00 0 0 41 0 16.00 0 0 42 0 14.43 0 0 46 0 14.86 0 0 47 0 13.71 0 0 BMI_gp3Obese:StudySTOP GDM_newGDM:StudySTOP BMI_gp3Normal:GDM_newGDM 39 0 0 0 40 0 0 0 41 0 0 0 42 0 0 0 46 0 0 0 47 0 0 0 BMI_gp3Overweight:GDM_newGDM BMI_gp3Obese:GDM_newGDM 39 0 0 40 0 0 41 0 0 42 1 0 46 0 0 47 0 0 BMI_gp3Normal:GDM_newGDM:StudySTOP BMI_gp3Overweight:GDM_newGDM:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 BMI_gp3Obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 (Intercept) BMI_gp3Normal BMI_gp3Overweight BMI_gp3Obese GDM_newGDM 39 1 1 0 0 0 40 1 1 0 0 0 41 1 0 1 0 0 42 1 0 1 0 1 43 1 0 1 0 1 44 1 0 1 0 1 StudySTOP GA_samp BMI_gp3Normal:StudySTOP BMI_gp3Overweight:StudySTOP 39 0 15.00 0 0 40 0 15.00 0 0 41 0 16.00 0 0 42 0 14.43 0 0 43 0 14.43 0 0 44 0 14.43 0 0 BMI_gp3Obese:StudySTOP GDM_newGDM:StudySTOP BMI_gp3Normal:GDM_newGDM 39 0 0 0 40 0 0 0 41 0 0 0 42 0 0 0 43 0 0 0 44 0 0 0 BMI_gp3Overweight:GDM_newGDM BMI_gp3Obese:GDM_newGDM 39 0 0 40 0 0 41 0 0 42 1 0 43 1 0 44 1 0 BMI_gp3Normal:GDM_newGDM:StudySTOP BMI_gp3Overweight:GDM_newGDM:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 43 0 0 44 0 0 BMI_gp3Obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 43 0 44 0 "],["prolactin-17.html", "27.1 Prolactin", " 27.1 Prolactin LME for repeated measures. 27.1.1 Model summary Var Effect P (Intercept) 18.47 (10.62, 32.11) &lt;0.0001 BMI_gp3Normal 0.80 (0.54, 1.18) 0.27 BMI_gp3Overweight 0.82 (0.55, 1.21) 0.32 BMI_gp3Obese 0.69 (0.46, 1.04) 0.08 GDM_newGDM 0.56 (0.24, 1.32) 0.19 StudySTOP 0.73 (0.44, 1.20) 0.22 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.35 (0.82, 2.24) 0.24 BMI_gp3Overweight:StudySTOP 1.31 (0.79, 2.19) 0.30 BMI_gp3Obese:StudySTOP 1.24 (0.74, 2.08) 0.42 GDM_newGDM:StudySTOP 1.45 (1.05, 2.02) 0.03 BMI_gp3Normal:GDM_newGDM 1.71 (0.67, 4.34) 0.26 BMI_gp3Overweight:GDM_newGDM 2.30 (0.89, 5.89) 0.09 BMI_gp3Obese:GDM_newGDM 1.38 (0.62, 3.09) 0.43 BMI_gp3Normal:GDM_newGDM:StudySTOP 0.86 (0.50, 1.48) 0.59 BMI_gp3Overweight:GDM_newGDM:StudySTOP 0.51 (0.29, 0.90) 0.02 27.1.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 124.06 26.05 1281.02 82.17 187.29 Normal SCOPE Uncomplicated 99.36 8.58 137.02 83.77 117.86 Overweight SCOPE Uncomplicated 101.34 9.27 170.66 84.60 121.39 Obese SCOPE Uncomplicated 85.91 8.51 228.46 70.68 104.42 Underweight STOP Uncomplicated 90.10 15.75 1059.44 63.94 126.96 Normal STOP Uncomplicated 97.55 7.66 95.27 83.47 114.01 Overweight STOP Uncomplicated 96.75 8.05 118.95 82.05 114.08 Obese STOP Uncomplicated 77.25 6.98 158.72 64.62 92.34 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 95.01 19.80 936.62 63.11 143.02 Overweight SCOPE GDM 130.34 27.64 1268.69 85.98 197.59 Obese SCOPE GDM 66.37 10.16 714.25 49.15 89.64 Underweight STOP GDM 73.30 27.76 1434.82 34.87 154.07 Normal STOP GDM 116.71 13.43 377.07 93.08 146.34 Overweight STOP GDM 92.90 11.64 494.58 72.62 118.83 Obese STOP GDM 86.74 8.53 217.91 71.46 105.28 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 27.1.3 Post-hoc comparisons 27.1.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE 0.80 (0.48, 1.34) 0.7 Overweight / Underweight SCOPE 0.82 (0.49, 1.37) 0.7 Overweight / Normal SCOPE 1.02 (0.86, 1.22) 1.0 Obese / Underweight SCOPE 0.69 (0.41, 1.18) 0.3 Obese / Normal SCOPE 0.86 (0.70, 1.06) 0.3 Obese / Overweight SCOPE 0.85 (0.68, 1.05) 0.2 Normal / Underweight STOP 1.08 (0.71, 1.65) 1.0 Overweight / Underweight STOP 1.07 (0.70, 1.65) 1.0 Overweight / Normal STOP 0.99 (0.85, 1.15) 1.0 Obese / Underweight STOP 0.86 (0.55, 1.33) 0.8 Obese / Normal STOP 0.79 (0.66, 0.94) 0.004 Obese / Overweight STOP 0.80 (0.67, 0.95) 0.007 Normal / Underweight SCOPE NA (NA, NA) Overweight / Underweight SCOPE NA (NA, NA) Overweight / Normal SCOPE 1.37 (0.68, 2.79) 0.7 Obese / Underweight SCOPE NA (NA, NA) Obese / Normal SCOPE 0.70 (0.38, 1.28) 0.4 Obese / Overweight SCOPE 0.51 (0.28, 0.93) 0.02 Normal / Underweight STOP 1.59 (0.60, 4.25) 0.6 Overweight / Underweight STOP 1.27 (0.47, 3.40) 0.9 Overweight / Normal STOP 0.80 (0.57, 1.12) 0.3 Obese / Underweight STOP 1.18 (0.45, 3.11) 1.0 Obese / Normal STOP 0.74 (0.56, 0.98) 0.03 Obese / Overweight STOP 0.93 (0.69, 1.26) 0.9 27.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.7804428 0.2197400 1426.505 0.4492363 1.355836 0.379 ns STOP/SCOPE (Uncomplicated) 1.3518183 0.3501843 1424.535 0.8132606 2.247020 0.245 ns STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/Uncomplicated (SCOPE) NA NA NA NA NA NA GDM/Uncomplicated (STOP) 1.4705950 0.6108418 1390.375 0.6510600 3.321736 0.353 ns "],["hpl-17.html", "27.2 HPL", " 27.2 HPL LME for repeated measures. 27.2.1 Model summary Var Effect P (Intercept) 2.23 (1.68, 2.97) &lt;0.0001 BMI_gp3Normal 0.97 (0.79, 1.20) 0.81 BMI_gp3Overweight 0.91 (0.74, 1.12) 0.39 BMI_gp3Obese 0.78 (0.63, 0.96) 0.02 GDM_newGDM 1.07 (0.68, 1.66) 0.77 StudySTOP 1.33 (1.02, 1.72) 0.04 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.83 (0.64, 1.08) 0.16 BMI_gp3Overweight:StudySTOP 0.84 (0.64, 1.09) 0.19 BMI_gp3Obese:StudySTOP 0.81 (0.62, 1.06) 0.13 GDM_newGDM:StudySTOP 1.00 (0.85, 1.18) 0.98 BMI_gp3Normal:GDM_newGDM 0.85 (0.52, 1.37) 0.50 BMI_gp3Overweight:GDM_newGDM 0.87 (0.54, 1.41) 0.58 BMI_gp3Obese:GDM_newGDM 0.90 (0.59, 1.37) 0.62 BMI_gp3Normal:GDM_newGDM:StudySTOP 1.23 (0.94, 1.60) 0.14 BMI_gp3Overweight:GDM_newGDM:StudySTOP 1.10 (0.84, 1.44) 0.50 27.2.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 97.10 10.23 1459.51 78.97 119.38 Normal SCOPE Uncomplicated 94.65 3.06 351.25 88.82 100.85 Overweight SCOPE Uncomplicated 88.65 3.18 481.96 82.62 95.12 Obese SCOPE Uncomplicated 75.75 2.99 603.55 70.10 81.85 Underweight STOP Uncomplicated 128.70 10.90 1394.98 109.00 151.96 Normal STOP Uncomplicated 103.87 2.82 195.95 98.45 109.58 Overweight STOP Uncomplicated 98.38 3.01 285.94 92.63 104.49 Obese STOP Uncomplicated 81.64 2.90 366.51 76.13 87.55 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 85.51 8.40 645.73 70.52 103.70 Overweight SCOPE GDM 82.71 7.52 940.81 69.19 98.87 Obese SCOPE GDM 72.76 5.00 655.21 63.57 83.27 Underweight STOP GDM 137.13 26.82 1421.34 93.44 201.25 Normal STOP GDM 114.76 5.92 956.92 103.72 126.98 Overweight STOP GDM 100.63 5.90 1162.87 89.70 112.89 Obese STOP GDM 78.28 3.21 577.27 72.23 84.84 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 27.2.3 Post-hoc comparisons 27.2.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE 0.97 (0.74, 1.28) 1.0 Overweight / Underweight SCOPE 0.91 (0.70, 1.20) 0.8 Overweight / Normal SCOPE 0.94 (0.85, 1.03) 0.3 Obese / Underweight SCOPE 0.78 (0.59, 1.03) 0.10 Obese / Normal SCOPE 0.80 (0.72, 0.89) &lt;0.0001 Obese / Overweight SCOPE 0.85 (0.77, 0.95) 0.001 Normal / Underweight STOP 0.81 (0.65, 1.00) 0.06 Overweight / Underweight STOP 0.76 (0.61, 0.95) 0.010 Overweight / Normal STOP 0.95 (0.88, 1.02) 0.3 Obese / Underweight STOP 0.63 (0.51, 0.79) &lt;0.0001 Obese / Normal STOP 0.79 (0.72, 0.86) &lt;0.0001 Obese / Overweight STOP 0.83 (0.76, 0.91) &lt;0.0001 Normal / Underweight SCOPE NA (NA, NA) Overweight / Underweight SCOPE NA (NA, NA) Overweight / Normal SCOPE 0.97 (0.69, 1.35) 1.0 Obese / Underweight SCOPE NA (NA, NA) Obese / Normal SCOPE 0.85 (0.63, 1.14) 0.5 Obese / Overweight SCOPE 0.88 (0.67, 1.16) 0.6 Normal / Underweight STOP 0.84 (0.50, 1.40) 0.8 Overweight / Underweight STOP 0.73 (0.44, 1.23) 0.4 Overweight / Normal STOP 0.88 (0.73, 1.05) 0.2 Obese / Underweight STOP 0.57 (0.34, 0.95) 0.02 Obese / Normal STOP 0.68 (0.59, 0.79) &lt;0.0001 Obese / Overweight STOP 0.78 (0.66, 0.92) 0.0004 27.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9013170 0.1318169 1427.718 0.6765258 1.200800 0.478 ns STOP/SCOPE (Uncomplicated) 0.8279005 0.1116091 1424.218 0.6355215 1.078515 0.161 ns STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/Uncomplicated (SCOPE) NA NA NA NA NA NA GDM/Uncomplicated (STOP) 1.0369922 0.2249165 1394.778 0.6776343 1.586922 0.867 ns "],["gh2-17.html", "27.3 GH2", " 27.3 GH2 LME for repeated measures. 27.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.12) &lt;0.0001 BMI_gp3Normal 1.04 (0.79, 1.38) 0.78 BMI_gp3Overweight 0.92 (0.69, 1.22) 0.55 BMI_gp3Obese 0.77 (0.58, 1.02) 0.07 GDM_newGDM 0.63 (0.34, 1.18) 0.15 StudySTOP 1.41 (0.98, 2.02) 0.07 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.64 (0.45, 0.92) 0.02 BMI_gp3Overweight:StudySTOP 0.69 (0.48, 1.00) 0.05 BMI_gp3Obese:StudySTOP 0.78 (0.53, 1.13) 0.18 GDM_newGDM:StudySTOP 1.24 (0.98, 1.58) 0.08 BMI_gp3Normal:GDM_newGDM 1.50 (0.75, 2.99) 0.25 BMI_gp3Overweight:GDM_newGDM 1.84 (0.93, 3.64) 0.08 BMI_gp3Obese:GDM_newGDM 1.35 (0.75, 2.44) 0.32 BMI_gp3Normal:GDM_newGDM:StudySTOP 0.95 (0.64, 1.43) 0.82 BMI_gp3Overweight:GDM_newGDM:StudySTOP 0.65 (0.44, 0.96) 0.03 27.3.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 2.42 0.35 1487.90 1.83 3.21 Normal SCOPE Uncomplicated 2.52 0.10 701.12 2.33 2.73 Overweight SCOPE Uncomplicated 2.22 0.10 903.12 2.03 2.43 Obese SCOPE Uncomplicated 1.86 0.10 1038.75 1.68 2.06 Underweight STOP Uncomplicated 3.41 0.40 1479.55 2.71 4.29 Normal STOP Uncomplicated 2.27 0.07 453.93 2.13 2.42 Overweight STOP Uncomplicated 2.17 0.08 612.00 2.02 2.33 Obese STOP Uncomplicated 2.03 0.09 528.47 1.87 2.22 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 2.40 0.36 1102.60 1.78 3.23 Overweight SCOPE GDM 2.60 0.35 1280.20 1.99 3.39 Obese SCOPE GDM 1.60 0.16 953.27 1.31 1.95 Underweight STOP GDM 2.69 0.73 1376.28 1.57 4.60 Normal STOP GDM 2.57 0.17 1215.58 2.25 2.93 Overweight STOP GDM 2.05 0.16 1324.58 1.76 2.38 Obese STOP GDM 2.17 0.11 795.49 1.96 2.40 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 27.3.3 Post-hoc comparisons 27.3.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE 1.04 (0.72, 1.50) 1.0 Overweight / Underweight SCOPE 0.92 (0.63, 1.33) 0.9 Overweight / Normal SCOPE 0.88 (0.78, 1.00) 0.05 Obese / Underweight SCOPE 0.77 (0.53, 1.12) 0.3 Obese / Normal SCOPE 0.74 (0.64, 0.85) &lt;0.0001 Obese / Overweight SCOPE 0.84 (0.72, 0.98) 0.02 Normal / Underweight STOP 0.67 (0.49, 0.90) 0.004 Overweight / Underweight STOP 0.64 (0.47, 0.87) 0.0010 Overweight / Normal STOP 0.95 (0.86, 1.06) 0.7 Obese / Underweight STOP 0.60 (0.44, 0.82) 0.0001 Obese / Normal STOP 0.89 (0.79, 1.01) 0.09 Obese / Overweight STOP 0.94 (0.82, 1.07) 0.6 Normal / Underweight SCOPE NA (NA, NA) Overweight / Underweight SCOPE NA (NA, NA) Overweight / Normal SCOPE 1.08 (0.65, 1.81) 1.0 Obese / Underweight SCOPE NA (NA, NA) Obese / Normal SCOPE 0.67 (0.42, 1.05) 0.1 Obese / Overweight SCOPE 0.62 (0.40, 0.94) 0.02 Normal / Underweight STOP 0.95 (0.47, 1.96) 1.0 Overweight / Underweight STOP 0.76 (0.37, 1.57) 0.8 Overweight / Normal STOP 0.80 (0.62, 1.02) 0.09 Obese / Underweight STOP 0.81 (0.40, 1.64) 0.9 Obese / Normal STOP 0.84 (0.69, 1.03) 0.1 Obese / Overweight STOP 1.06 (0.85, 1.32) 0.9 27.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.1327493 0.2280461 1488.513 0.7631848 1.681272 0.536 ns STOP/SCOPE (Uncomplicated) 0.6397739 0.1190934 1482.053 0.4440650 0.921736 0.017 * STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/Uncomplicated (SCOPE) NA NA NA NA NA NA GDM/Uncomplicated (STOP) 1.4329362 0.4352380 1393.517 0.7896949 2.600126 0.236 ns "],["insulin-15.html", "27.4 Insulin", " 27.4 Insulin GEE for repeated measures. 27.4.1 Model summary Var Effect P (Intercept) 7.09 (3.53, 14.27) &lt;0.0001 BMI_gp3Normal 1.33 (0.82, 2.16) 0.24 BMI_gp3Overweight 1.77 (1.09, 2.87) 0.02 BMI_gp3Obese 2.49 (1.53, 4.06) 0.0002 GDM_newGDM 1.88 (1.46, 2.42) &lt;0.0001 StudySTOP 0.81 (0.44, 1.49) 0.50 GA_samp 1.01 (0.98, 1.05) 0.48 BMI_gp3Normal:StudySTOP 0.92 (0.50, 1.70) 0.80 BMI_gp3Overweight:StudySTOP 0.90 (0.49, 1.65) 0.73 BMI_gp3Obese:StudySTOP 1.03 (0.55, 1.90) 0.94 GDM_newGDM:StudySTOP 0.77 (0.57, 1.03) 0.08 27.4.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 8.28 1.99 Inf 5.17 13.27 Normal SCOPE Uncomplicated 11.05 0.90 Inf 9.41 12.97 Overweight SCOPE Uncomplicated 14.67 1.22 Inf 12.47 17.27 Obese SCOPE Uncomplicated 20.66 1.87 Inf 17.30 24.66 Underweight STOP Uncomplicated 6.73 1.26 Inf 4.67 9.70 Normal STOP Uncomplicated 8.29 0.44 Inf 7.47 9.21 Overweight STOP Uncomplicated 10.70 0.60 Inf 9.59 11.94 Obese STOP Uncomplicated 17.21 1.08 Inf 15.23 19.46 Underweight SCOPE GDM 15.56 4.24 Inf 9.11 26.56 Normal SCOPE GDM 20.76 3.02 Inf 15.60 27.61 Overweight SCOPE GDM 27.56 3.97 Inf 20.78 36.54 Obese SCOPE GDM 38.80 4.95 Inf 30.21 49.83 Underweight STOP GDM 9.74 1.92 Inf 6.61 14.34 Normal STOP GDM 12.00 1.04 Inf 10.12 14.23 Overweight STOP GDM 15.48 1.37 Inf 13.02 18.40 Obese STOP GDM 24.90 1.92 Inf 21.41 28.96 27.4.3 Post-hoc comparisons 27.4.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE 1.33 (0.71, 2.51) 0.6 Overweight / Underweight SCOPE 1.77 (0.94, 3.34) 0.09 Overweight / Normal SCOPE 1.33 (1.02, 1.72) 0.03 Obese / Underweight SCOPE 2.49 (1.32, 4.72) 0.001 Obese / Normal SCOPE 1.87 (1.43, 2.44) &lt;0.0001 Obese / Overweight SCOPE 1.41 (1.07, 1.85) 0.006 Normal / Underweight STOP 1.23 (0.76, 2.00) 0.7 Overweight / Underweight STOP 1.59 (0.98, 2.59) 0.07 Overweight / Normal STOP 1.29 (1.09, 1.53) 0.0007 Obese / Underweight STOP 2.56 (1.56, 4.18) &lt;0.0001 Obese / Normal STOP 2.08 (1.73, 2.49) &lt;0.0001 Obese / Overweight STOP 1.61 (1.33, 1.94) &lt;0.0001 Normal / Underweight SCOPE 1.33 (0.71, 2.51) 0.6 Overweight / Underweight SCOPE 1.77 (0.94, 3.34) 0.09 Overweight / Normal SCOPE 1.33 (1.02, 1.72) 0.03 Obese / Underweight SCOPE 2.49 (1.32, 4.72) 0.001 Obese / Normal SCOPE 1.87 (1.43, 2.44) &lt;0.0001 Obese / Overweight SCOPE 1.41 (1.07, 1.85) 0.006 Normal / Underweight STOP 1.23 (0.76, 2.00) 0.7 Overweight / Underweight STOP 1.59 (0.98, 2.59) 0.07 Overweight / Normal STOP 1.29 (1.09, 1.53) 0.0007 Obese / Underweight STOP 2.56 (1.56, 4.18) &lt;0.0001 Obese / Normal STOP 2.08 (1.73, 2.49) &lt;0.0001 Obese / Overweight STOP 1.61 (1.33, 1.94) &lt;0.0001 27.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.3777576 0.4618989 Inf 0.714174 2.657918 0.339 ns STOP/SCOPE (Uncomplicated) 0.9236378 0.2863924 Inf 0.503002 1.696031 0.798 ns STOP/SCOPE (GDM) 0.9236378 0.2863924 Inf 0.503002 1.696031 0.798 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.000000 1.000000 NA "],["homa-ir-15.html", "27.5 HOMA-IR", " 27.5 HOMA-IR GEE for repeated measures. 27.5.1 Model summary Var Effect P (Intercept) 1.71 (0.84, 3.49) 0.14 BMI_gp3Normal 1.39 (0.87, 2.23) 0.17 BMI_gp3Overweight 1.87 (1.16, 3.00) 0.010 BMI_gp3Obese 2.65 (1.64, 4.27) &lt;0.0001 GDM_newGDM 2.04 (1.52, 2.73) &lt;0.0001 StudySTOP 0.70 (0.39, 1.28) 0.25 GA_samp 1.01 (0.97, 1.04) 0.63 BMI_gp3Normal:StudySTOP 0.91 (0.50, 1.66) 0.76 BMI_gp3Overweight:StudySTOP 0.88 (0.48, 1.62) 0.69 BMI_gp3Obese:StudySTOP 1.05 (0.57, 1.94) 0.88 GDM_newGDM:StudySTOP 0.72 (0.52, 1.01) 0.06 27.5.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 1.91 0.45 Inf 1.21 3.03 Normal SCOPE Uncomplicated 2.66 0.23 Inf 2.25 3.16 Overweight SCOPE Uncomplicated 3.57 0.32 Inf 2.99 4.27 Obese SCOPE Uncomplicated 5.06 0.50 Inf 4.17 6.14 Underweight STOP Uncomplicated 1.35 0.25 Inf 0.93 1.95 Normal STOP Uncomplicated 1.71 0.09 Inf 1.53 1.90 Overweight STOP Uncomplicated 2.22 0.13 Inf 1.97 2.49 Obese STOP Uncomplicated 3.74 0.25 Inf 3.28 4.26 Underweight SCOPE GDM 3.90 1.08 Inf 2.26 6.71 Normal SCOPE GDM 5.43 0.89 Inf 3.93 7.49 Overweight SCOPE GDM 7.28 1.20 Inf 5.27 10.05 Obese SCOPE GDM 10.31 1.50 Inf 7.75 13.72 Underweight STOP GDM 1.99 0.40 Inf 1.34 2.94 Normal STOP GDM 2.52 0.23 Inf 2.10 3.01 Overweight STOP GDM 3.27 0.31 Inf 2.72 3.94 Obese STOP GDM 5.51 0.46 Inf 4.68 6.49 27.5.3 Post-hoc comparisons 27.5.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE 1.39 (0.75, 2.58) 0.5 Overweight / Underweight SCOPE 1.87 (1.00, 3.48) 0.05 Overweight / Normal SCOPE 1.34 (1.01, 1.78) 0.04 Obese / Underweight SCOPE 2.65 (1.41, 4.96) 0.0004 Obese / Normal SCOPE 1.90 (1.42, 2.54) &lt;0.0001 Obese / Overweight SCOPE 1.42 (1.05, 1.91) 0.01 Normal / Underweight STOP 1.27 (0.78, 2.07) 0.6 Overweight / Underweight STOP 1.65 (1.00, 2.70) 0.05 Overweight / Normal STOP 1.30 (1.09, 1.56) 0.001 Obese / Underweight STOP 2.78 (1.69, 4.57) &lt;0.0001 Obese / Normal STOP 2.19 (1.81, 2.65) &lt;0.0001 Obese / Overweight STOP 1.68 (1.38, 2.06) &lt;0.0001 Normal / Underweight SCOPE 1.39 (0.75, 2.58) 0.5 Overweight / Underweight SCOPE 1.87 (1.00, 3.48) 0.05 Overweight / Normal SCOPE 1.34 (1.01, 1.78) 0.04 Obese / Underweight SCOPE 2.65 (1.41, 4.96) 0.0004 Obese / Normal SCOPE 1.90 (1.42, 2.54) &lt;0.0001 Obese / Overweight SCOPE 1.42 (1.05, 1.91) 0.01 Normal / Underweight STOP 1.27 (0.78, 2.07) 0.6 Overweight / Underweight STOP 1.65 (1.00, 2.70) 0.05 Overweight / Normal STOP 1.30 (1.09, 1.56) 0.001 Obese / Underweight STOP 2.78 (1.69, 4.57) &lt;0.0001 Obese / Normal STOP 2.19 (1.81, 2.65) &lt;0.0001 Obese / Overweight STOP 1.68 (1.38, 2.06) &lt;0.0001 27.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.3526010 0.4564660 Inf 0.6980915 2.620759 0.371 ns STOP/SCOPE (Uncomplicated) 0.9106654 0.2797197 Inf 0.4987743 1.662699 0.761 ns STOP/SCOPE (GDM) 0.9106654 0.2797197 Inf 0.4987743 1.662699 0.761 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["glucose-13.html", "27.6 Glucose", " 27.6 Glucose GEE for repeated measures. 27.6.1 Model summary Var Effect P (Intercept) 5.24 (4.60, 5.97) &lt;0.0001 BMI_gp3Normal 1.05 (0.98, 1.14) 0.16 BMI_gp3Overweight 1.08 (0.99, 1.18) 0.08 BMI_gp3Obese 1.04 (0.96, 1.13) 0.29 GDM_newGDM 1.11 (1.00, 1.23) 0.05 StudySTOP 0.88 (0.81, 0.96) 0.005 GA_samp 1.00 (0.99, 1.01) 0.62 BMI_gp3Normal:StudySTOP 0.98 (0.90, 1.07) 0.66 BMI_gp3Overweight:StudySTOP 0.97 (0.87, 1.07) 0.52 BMI_gp3Obese:StudySTOP 1.03 (0.93, 1.13) 0.60 GDM_newGDM:StudySTOP 0.93 (0.83, 1.03) 0.16 27.6.2 Estimated marginal means BMI_gp3 Study GDM_new response SE df lower.CL upper.CL Underweight SCOPE Uncomplicated 5.12 0.19 Inf 4.77 5.50 Normal SCOPE Uncomplicated 5.40 0.09 Inf 5.23 5.58 Overweight SCOPE Uncomplicated 5.53 0.14 Inf 5.27 5.81 Obese SCOPE Uncomplicated 5.35 0.12 Inf 5.11 5.59 Underweight STOP Uncomplicated 4.51 0.11 Inf 4.30 4.73 Normal STOP Uncomplicated 4.66 0.05 Inf 4.56 4.77 Overweight STOP Uncomplicated 4.71 0.08 Inf 4.56 4.87 Obese STOP Uncomplicated 4.83 0.07 Inf 4.69 4.98 Underweight SCOPE GDM 5.68 0.35 Inf 5.04 6.40 Normal SCOPE GDM 5.99 0.29 Inf 5.46 6.58 Overweight SCOPE GDM 6.14 0.37 Inf 5.45 6.92 Obese SCOPE GDM 5.93 0.27 Inf 5.42 6.48 Underweight STOP GDM 4.63 0.13 Inf 4.39 4.89 Normal STOP GDM 4.79 0.08 Inf 4.63 4.96 Overweight STOP GDM 4.84 0.09 Inf 4.67 5.02 Obese STOP GDM 4.96 0.08 Inf 4.81 5.12 27.6.3 Post-hoc comparisons 27.6.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE 1.05 (0.96, 1.16) 0.5 Overweight / Underweight SCOPE 1.08 (0.97, 1.21) 0.3 Overweight / Normal SCOPE 1.02 (0.95, 1.11) 0.9 Obese / Underweight SCOPE 1.04 (0.94, 1.16) 0.7 Obese / Normal SCOPE 0.99 (0.93, 1.05) 1.0 Obese / Overweight SCOPE 0.97 (0.88, 1.06) 0.8 Normal / Underweight STOP 1.03 (0.97, 1.10) 0.6 Overweight / Underweight STOP 1.05 (0.97, 1.12) 0.4 Overweight / Normal STOP 1.01 (0.96, 1.06) 0.9 Obese / Underweight STOP 1.07 (1.00, 1.15) 0.06 Obese / Normal STOP 1.04 (0.99, 1.08) 0.2 Obese / Overweight STOP 1.02 (0.97, 1.08) 0.6 Normal / Underweight SCOPE 1.05 (0.96, 1.16) 0.5 Overweight / Underweight SCOPE 1.08 (0.97, 1.21) 0.3 Overweight / Normal SCOPE 1.02 (0.95, 1.11) 0.9 Obese / Underweight SCOPE 1.04 (0.94, 1.16) 0.7 Obese / Normal SCOPE 0.99 (0.93, 1.05) 1.0 Obese / Overweight SCOPE 0.97 (0.88, 1.06) 0.8 Normal / Underweight STOP 1.03 (0.97, 1.10) 0.6 Overweight / Underweight STOP 1.05 (0.97, 1.12) 0.4 Overweight / Normal STOP 1.01 (0.96, 1.06) 0.9 Obese / Underweight STOP 1.07 (1.00, 1.15) 0.06 Obese / Normal STOP 1.04 (0.99, 1.08) 0.2 Obese / Overweight STOP 1.02 (0.97, 1.08) 0.6 27.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9078294 0.0553357 Inf 0.8056014 1.023030 0.113 ns STOP/SCOPE (Uncomplicated) 0.9800936 0.0445386 Inf 0.8965742 1.071393 0.658 ns STOP/SCOPE (GDM) 0.9800936 0.0445386 Inf 0.8965742 1.071393 0.658 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["age-bmi-groups-2.html", "28 Age &amp; BMI groups", " 28 Age &amp; BMI groups Descriptives with univariate P-values. Within Uncomplicated Characteristic &lt;35 yrs, non-obese (n=968) &lt;35 yrs, obese (n=283) &gt;=35 yrs, non-obese (n=26) &gt;=35 yrs, obese (n=15) Total (n=1292) P-value PRL (ng/ml): Median (IQ range) 102.6 (62.6-164.4) 81.7 (49.5-132.4) 79.2 (52.1-95.7) 45.1 (32.3-103.1) 96.8 (58.3-157.1) &lt;0.0001 hPL (μg/ml): Median (IQ range) 120.8 (58.4-189.2) 73.8 (43.5-145.4) 81.8 (58.5-136.1) 81.2 (33.9-129.1) 108.1 (54.6-179.4) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.4) 2.2 (1.0-3.3) 2.1 (1.2-3.7) 2.1 (1.6-3.0) 2.5 (1.2-4.1) 0.0004 Insulin (uU/L): Median (IQ range) 9.3 (5.2-19.2) 16.1 (9.7-31.6) 8.5 (4.6-16.8) 11.6 (8.8-23.2) 10.8 (6.1-21.7) &lt;0.0001 HOMA-IR: Median (IQ range) 2.0 (1.1-4.4) 3.6 (2.2-7.0) 2.1 (0.9-3.7) 2.6 (1.7-5.2) 2.4 (1.3-5.0) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.7-5.6) 5.0 (4.4-5.4) 4.7 (4.5-5.2) 5.0 (4.6-5.5) 0.02 Within GDM Characteristic &lt;35 yrs, non-obese (n=110) &lt;35 yrs, obese (n=116) &gt;=35 yrs, non-obese (n=9) &gt;=35 yrs, obese (n=16) Total (n=251) P-value PRL (ng/ml): Median (IQ range) 81.4 (43.4-131.9) 73.3 (46.7-113.2) 110.7 (89.5-156.8) 51.4 (41.1-62.6) 73.3 (45.3-120.9) 0.08 hPL (μg/ml): Median (IQ range) 83.2 (51.0-108.8) 55.7 (37.4-79.9) 68.1 (47.9-126.8) 25.8 (19.4-35.7) 61.4 (37.6-98.5) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.7 (1.0-2.9) 1.3 (1.0-2.3) 1.2 (1.0-2.2) 1.3 (1.0-1.8) 1.5 (1.0-2.6) 0.47 Insulin (uU/L): Median (IQ range) 11.9 (6.6-30.3) 26.6 (15.7-50.8) 9.4 (7.8-13.3) 16.9 (12.5-27.9) 17.3 (9.4-40.4) &lt;0.0001 HOMA-IR: Median (IQ range) 2.4 (1.4-6.4) 5.9 (3.3-12.1) 2.0 (1.4-3.0) 3.9 (2.5-6.8) 3.8 (1.9-9.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.4) 5.1 (4.6-5.8) 4.8 (4.5-5.2) 5.0 (4.8-5.4) 4.9 (4.5-5.6) 0.05 Click here for table within SCOPE Within Uncomplicated Characteristic &lt;35 yrs, non-obese (n=453) &lt;35 yrs, obese (n=129) &gt;=35 yrs, non-obese (n=10) &gt;=35 yrs, obese (n=6) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 142.7 (100.7-221.2) 131.3 (82.8-196.2) 134.9 (82.4-210.6) 85.0 (45.7-124.5) 139.9 (94.7-215.5) 0.12 hPL (μg/ml): Median (IQ range) 192.3 (157.8-226.8) 153.3 (130.7-180.3) 168.6 (136.6-202.0) 160.7 (98.5-202.5) 183.5 (149.9-220.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.4 (3.4-6.0) 3.4 (2.6-4.4) 3.8 (3.4-4.7) 4.5 (2.7-6.9) 4.2 (3.2-5.6) &lt;0.0001 Insulin (uU/L): Median (IQ range) 13.4 (5.8-25.7) 20.1 (9.7-34.8) 11.3 (8.1-20.2) 50.4 (39.0-53.5) 14.4 (6.5-29.1) 0.0007 HOMA-IR: Median (IQ range) 3.1 (1.3-6.4) 4.6 (2.3-9.0) 2.7 (2.1-4.8) 14.0 (10.0-15.8) 3.3 (1.5-7.2) 0.001 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.4 (5.1-5.9) 5.4 (5.2-5.8) 5.5 (5.1-6.1) 5.4 (5.0-5.8) 0.90 Serum folate concentration (nM): Median (IQ range) 37.0 (29.3-43.1) 35.5 (24.7-43.3) 40.3 (34.0-43.1) 32.7 (31.3-36.9) 36.6 (28.6-43.1) 0.52 B12 concentration (pM): Median (IQ range) 253.5 (199.0-320.5) 226.0 (181.5-288.8) 313.0 (235.5-352.5) 227.5 (181.2-249.0) 248.0 (195.0-316.0) 0.01 Folate:B12 ratio: Median (IQ range) 143.1 (104.6-208.7) 143.3 (102.9-216.0) 119.2 (114.4-177.6) 153.9 (126.0-192.9) 143.0 (104.5-208.8) 0.97 Active B12 concentration (pM): Median (IQ range) 53.5 (42.0-72.0) 60.0 (43.2-71.0) 48.0 (48.0-48.0) 74.0 (52.0-93.0) 54.0 (42.5-72.0) 0.43 Folate:Active B12 ratio: Median (IQ range) 638.6 (472.9-1019.3) 548.7 (449.2-703.5) 794.8 (740.1-849.5) 400.0 (360.2-420.3) 617.5 (461.2-937.5) 0.01 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-4.9) 4.4 (3.8-5.0) 4.3 (4.0-4.6) 4.3 (3.9-4.6) 4.4 (3.8-4.9) 1.00 Within GDM Characteristic &lt;35 yrs, non-obese (n=27) &lt;35 yrs, obese (n=29) &gt;=35 yrs, non-obese (n=0) &gt;=35 yrs, obese (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 119.0 (87.4-179.1) 79.6 (59.7-120.5) NA (NA-NA) 25.7 (14.6-36.7) 92.0 (62.0-147.2) – hPL (μg/ml): Median (IQ range) 105.8 (91.4-170.8) 113.3 (90.4-133.9) NA (NA-NA) 36.0 (36.0-36.0) 106.2 (85.6-134.2) – GH2 (ng/ml): Median (IQ range) 3.3 (2.6-4.5) 2.0 (1.5-3.1) NA (NA-NA) 1.8 (1.8-1.8) 2.7 (1.6-4.2) – Insulin (uU/L): Median (IQ range) 17.1 (11.5-39.8) 41.4 (27.2-67.4) NA (NA-NA) 52.7 (35.0-70.4) 34.0 (16.6-55.4) – HOMA-IR: Median (IQ range) 4.3 (3.1-11.4) 10.0 (5.6-17.4) NA (NA-NA) 13.7 (9.1-18.4) 8.1 (3.6-17.4) – Glucose (mmol/L): Median (IQ range) 5.6 (5.1-6.4) 6.0 (5.6-6.7) NA (NA-NA) 5.8 (5.8-5.9) 5.8 (5.2-6.6) – Serum folate concentration (nM): Median (IQ range) 41.3 (34.2-44.6) 38.0 (31.1-42.9) NA (NA-NA) 86.0 (63.5-108.6) 40.1 (32.0-43.8) – B12 concentration (pM): Median (IQ range) 268.0 (212.5-350.0) 245.0 (192.0-314.0) NA (NA-NA) 205.0 (200.0-210.0) 253.5 (194.2-333.0) – Folate:B12 ratio: Median (IQ range) 150.3 (114.2-232.5) 167.7 (115.9-185.4) NA (NA-NA) 410.0 (309.9-510.1) 158.9 (116.5-210.2) – Active B12 concentration (pM): Median (IQ range) 63.0 (56.5-99.2) 77.0 (54.0-82.5) NA (NA-NA) 67.5 (50.8-84.2) 68.0 (55.0-86.0) – Folate:Active B12 ratio: Median (IQ range) 540.4 (321.6-674.3) 553.8 (524.6-575.9) NA (NA-NA) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) – Homocysteine concentration (μM): Median (IQ range) 4.2 (3.8-4.8) 3.7 (3.5-4.2) NA (NA-NA) 4.1 (3.5-4.7) 3.9 (3.6-4.6) – Click here for table within STOP Within Uncomplicated Characteristic &lt;35 yrs, non-obese (n=515) &lt;35 yrs, obese (n=154) &gt;=35 yrs, non-obese (n=16) &gt;=35 yrs, obese (n=9) Total (n=694) P-value PRL (ng/ml): Median (IQ range) 76.3 (52.4-119.1) 62.9 (40.9-99.3) 72.9 (50.0-90.3) 41.2 (32.3-60.9) 72.9 (48.6-113.6) 0.001 hPL (μg/ml): Median (IQ range) 66.5 (44.4-101.1) 50.5 (34.5-71.7) 68.1 (49.4-83.4) 60.2 (33.9-90.7) 62.4 (41.4-96.2) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.4) 1.2 (0.8-2.2) 1.6 (1.1-2.1) 1.6 (1.3-2.4) 1.4 (0.9-2.4) 0.10 Serum folate concentration (nM): Median (IQ range) 40.4 (36.5-44.8) 40.0 (35.4-44.9) 44.8 (41.0-83.9) 67.8 (41.9-101.1) 40.5 (36.4-45.2) 0.006 B12 concentration (pM): Median (IQ range) 285.0 (223.5-362.0) 260.5 (218.0-331.0) 267.5 (235.5-370.5) 274.5 (191.2-381.8) 279.0 (220.5-356.0) 0.20 Folate:B12 ratio: Median (IQ range) 152.2 (114.8-218.8) 166.1 (116.2-223.3) 171.2 (128.5-335.7) 247.5 (164.3-392.4) 155.4 (115.1-222.2) 0.12 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-81.0) 62.0 (51.2-76.0) 68.0 (55.0-100.0) 55.0 (51.5-61.0) 63.0 (48.0-80.8) 0.76 Folate:Active B12 ratio: Median (IQ range) 686.8 (485.9-954.7) 637.7 (516.0-914.2) 527.9 (444.1-965.5) 765.5 (689.4-1420.2) 670.3 (491.4-950.5) 0.76 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.5) 4.9 (4.3-5.7) 5.2 (4.5-6.1) 4.9 (4.6-5.4) 4.8 (4.3-5.6) 0.55 Within GDM Characteristic &lt;35 yrs, non-obese (n=83) &lt;35 yrs, obese (n=87) &gt;=35 yrs, non-obese (n=9) &gt;=35 yrs, obese (n=14) Total (n=193) P-value PRL (ng/ml): Median (IQ range) 73.7 (41.0-122.2) 73.0 (44.0-111.6) 110.7 (89.5-156.8) 52.3 (42.3-65.6) 68.8 (42.6-114.0) 0.27 hPL (μg/ml): Median (IQ range) 69.4 (46.6-106.0) 50.2 (36.2-72.4) 68.1 (47.9-126.8) 25.0 (18.5-34.8) 57.0 (35.8-84.1) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.6 (0.9-2.2) 1.3 (0.9-2.2) 1.2 (1.0-2.2) 1.1 (1.0-1.8) 1.3 (0.9-2.2) 0.74 Serum folate concentration (nM): Median (IQ range) 40.7 (36.2-47.4) 38.9 (34.3-43.1) 44.2 (41.0-64.4) 41.0 (35.9-64.4) 40.2 (35.4-45.1) 0.03 B12 concentration (pM): Median (IQ range) 285.0 (231.0-360.0) 266.0 (216.4-306.0) 194.0 (148.0-319.0) 330.0 (222.2-388.5) 273.5 (216.8-352.0) 0.05 Folate:B12 ratio: Median (IQ range) 143.3 (106.3-212.0) 150.2 (116.7-204.1) 197.4 (136.4-447.2) 127.1 (91.8-262.1) 148.0 (111.3-220.6) 0.29 Active B12 concentration (pM): Median (IQ range) 68.5 (55.0-89.0) 78.0 (58.0-91.0) 62.0 (49.0-65.0) 77.0 (75.5-84.2) 74.5 (56.2-90.2) 0.47 Folate:Active B12 ratio: Median (IQ range) 573.3 (461.9-838.0) 505.4 (407.4-633.8) 836.9 (781.6-1038.7) 755.0 (548.3-1065.0) 531.9 (419.6-786.4) 0.09 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.0-5.5) 4.8 (4.0-5.3) 4.9 (4.1-5.3) 4.8 (4.5-4.9) 4.8 (4.0-5.3) 0.99 (Intercept) Age_BMI_gp&lt;35 yrs, obese Age_BMI_gp&gt;=35 yrs, non-obese 39 1 0 0 40 1 0 0 41 1 0 0 42 1 0 0 46 1 0 0 47 1 0 0 Age_BMI_gp&gt;=35 yrs, obese GDM_newGDM StudySTOP GA_samp 39 0 0 0 15.00 40 0 0 0 15.00 41 0 0 0 16.00 42 0 1 0 14.43 46 0 0 0 14.86 47 0 0 0 13.71 Age_BMI_gp&lt;35 yrs, obese:StudySTOP Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP GDM_newGDM:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 39 0 40 0 41 0 42 0 46 0 47 0 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 (Intercept) Age_BMI_gp&lt;35 yrs, obese Age_BMI_gp&gt;=35 yrs, non-obese 39 1 0 0 40 1 0 0 41 1 0 0 42 1 0 0 46 1 0 0 47 1 0 0 Age_BMI_gp&gt;=35 yrs, obese GDM_newGDM StudySTOP GA_samp 39 0 0 0 15.00 40 0 0 0 15.00 41 0 0 0 16.00 42 0 1 0 14.43 46 0 0 0 14.86 47 0 0 0 13.71 Age_BMI_gp&lt;35 yrs, obese:StudySTOP Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP GDM_newGDM:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 39 0 0 40 0 0 41 0 0 42 0 0 46 0 0 47 0 0 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 39 0 40 0 41 0 42 0 46 0 47 0 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 46 0 47 0 (Intercept) Age_BMI_gp&lt;35 yrs, obese Age_BMI_gp&gt;=35 yrs, non-obese 39 1 0 0 40 1 0 0 41 1 0 0 42 1 0 0 43 1 0 0 44 1 0 0 Age_BMI_gp&gt;=35 yrs, obese GDM_newGDM StudySTOP GA_samp 39 0 0 0 15.00 40 0 0 0 15.00 41 0 0 0 16.00 42 0 1 0 14.43 43 0 1 0 14.43 44 0 1 0 14.43 Age_BMI_gp&lt;35 yrs, obese:StudySTOP Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 43 0 0 44 0 0 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP GDM_newGDM:StudySTOP 39 0 0 40 0 0 41 0 0 42 0 0 43 0 0 44 0 0 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 39 0 0 40 0 0 41 0 0 42 0 0 43 0 0 44 0 0 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 39 0 40 0 41 0 42 0 43 0 44 0 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 43 0 44 0 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 43 0 44 0 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 39 0 40 0 41 0 42 0 43 0 44 0 "],["prolactin-18.html", "28.1 Prolactin", " 28.1 Prolactin LME for repeated measures. 28.1.1 Model summary Var Effect P (Intercept) 14.76 (9.96, 21.88) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.87 (0.75, 1.00) 0.06 Age_BMI_gp&gt;=35 yrs, non-obese 1.00 (0.63, 1.61) 1.00 Age_BMI_gp&gt;=35 yrs, obese 0.61 (0.35, 1.04) 0.07 GDM_newGDM 1.10 (0.82, 1.46) 0.53 StudySTOP 0.97 (0.86, 1.11) 0.70 GA_samp 1.16 (1.13, 1.19) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.92 (0.77, 1.12) 0.41 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.77 (0.44, 1.36) 0.37 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.97 (0.48, 1.96) 0.94 GDM_newGDM:StudySTOP 0.96 (0.70, 1.32) 0.79 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM 0.73 (0.49, 1.11) 0.14 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 1.55 (0.92, 2.61) 0.10 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 0.63 (0.25, 1.62) 0.34 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 1.47 (0.92, 2.35) 0.10 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 1.90 (0.63, 5.73) 0.25 28.1.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 100.58 8.23 111.44 85.52 118.29 &lt;35 yrs, obese SCOPE Uncomplicated 87.12 8.72 236.95 71.54 106.10 &gt;=35 yrs, non-obese SCOPE Uncomplicated 100.72 25.24 1329.03 61.61 164.66 &gt;=35 yrs, obese SCOPE Uncomplicated 60.86 17.27 1438.69 34.88 106.19 &lt;35 yrs, non-obese STOP Uncomplicated 98.02 7.36 79.92 84.41 113.83 &lt;35 yrs, obese STOP Uncomplicated 78.47 7.13 162.64 65.58 93.90 &gt;=35 yrs, non-obese STOP Uncomplicated 75.85 13.07 1038.23 54.10 106.36 &gt;=35 yrs, obese STOP Uncomplicated 57.66 13.78 1358.05 36.08 92.15 &lt;35 yrs, non-obese SCOPE GDM 110.24 17.48 852.13 80.76 150.49 &lt;35 yrs, obese SCOPE GDM 70.15 11.27 795.11 51.17 96.15 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 42.20 15.96 548.60 20.08 88.69 &lt;35 yrs, non-obese STOP GDM 102.97 10.44 244.27 84.32 125.73 &lt;35 yrs, obese STOP GDM 89.23 9.01 240.90 73.13 108.87 &gt;=35 yrs, non-obese STOP GDM 123.39 26.63 1252.79 80.80 188.42 &gt;=35 yrs, obese STOP GDM 72.97 13.68 1141.69 50.51 105.42 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 28.1.3 Post-hoc comparisons 28.1.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.87 (0.71, 1.05) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 1.00 (0.54, 1.86) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 1.16 (0.61, 2.20) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.61 (0.30, 1.23) 0.3 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 0.70 (0.34, 1.44) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 0.60 (0.24, 1.55) 0.5 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.80 (0.68, 0.94) 0.003 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.77 (0.51, 1.17) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.97 (0.63, 1.48) 1.0 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.59 (0.32, 1.07) 0.10 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.73 (0.40, 1.34) 0.5 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 0.76 (0.37, 1.55) 0.8 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.64 (0.39, 1.05) 0.09 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.38 (0.14, 1.06) 0.07 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 0.60 (0.22, 1.67) 0.6 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.87 (0.68, 1.11) 0.4 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 1.20 (0.69, 2.08) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 1.38 (0.80, 2.40) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.71 (0.44, 1.14) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.82 (0.51, 1.31) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 0.59 (0.30, 1.17) 0.2 28.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.6623506 0.3079152 1426.749 0.2660990 1.648666 0.376 ns STOP/SCOPE (Uncomplicated) 0.9241665 0.0890523 1408.484 0.7649944 1.116457 0.413 ns STOP/SCOPE (GDM) 1.3619455 0.2941015 1241.372 0.8915999 2.080412 0.153 ns GDM/Uncomplicated (SCOPE) 0.7345357 0.1538749 1198.389 0.4869875 1.107919 0.141 ns GDM/Uncomplicated (STOP) 1.0824864 0.1244474 1409.912 0.8639338 1.356327 0.491 ns "],["hpl-18.html", "28.2 HPL", " 28.2 HPL LME for repeated measures. 28.2.1 Model summary Var Effect P (Intercept) 2.11 (1.73, 2.57) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.83 (0.77, 0.89) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.98 (0.76, 1.26) 0.87 Age_BMI_gp&gt;=35 yrs, obese 0.72 (0.56, 0.94) 0.02 GDM_newGDM 0.91 (0.80, 1.04) 0.17 StudySTOP 1.11 (1.04, 1.19) 0.002 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.98 (0.89, 1.07) 0.61 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.06 (0.79, 1.43) 0.71 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.02 (0.72, 1.46) 0.90 GDM_newGDM:StudySTOP 1.21 (1.04, 1.40) 0.02 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM 1.05 (0.87, 1.28) 0.60 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 0.82 (0.62, 1.07) 0.14 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 1.17 (0.73, 1.87) 0.52 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 0.87 (0.70, 1.10) 0.25 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 0.56 (0.32, 0.98) 0.04 28.2.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 92.17 2.67 234.61 87.06 97.59 &lt;35 yrs, obese SCOPE Uncomplicated 76.29 3.07 622.35 70.50 82.56 &gt;=35 yrs, non-obese SCOPE Uncomplicated 90.22 11.63 1430.69 70.06 116.18 &gt;=35 yrs, obese SCOPE Uncomplicated 66.77 9.08 1233.43 51.14 87.18 &lt;35 yrs, non-obese STOP Uncomplicated 102.37 2.50 125.98 97.54 107.44 &lt;35 yrs, obese STOP Uncomplicated 82.64 2.99 384.58 76.97 88.73 &gt;=35 yrs, non-obese STOP Uncomplicated 106.05 8.97 1437.11 89.83 125.20 &gt;=35 yrs, obese STOP Uncomplicated 75.89 9.17 1445.02 59.88 96.18 &lt;35 yrs, non-obese SCOPE GDM 83.86 5.80 778.40 73.21 96.06 &lt;35 yrs, obese SCOPE GDM 73.15 5.29 678.56 63.47 84.31 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 71.10 13.54 452.43 48.90 103.37 &lt;35 yrs, non-obese STOP GDM 112.25 4.86 665.32 103.10 122.22 &lt;35 yrs, obese STOP GDM 83.48 3.59 653.02 76.72 90.84 &gt;=35 yrs, non-obese STOP GDM 94.88 10.15 1223.16 76.92 117.04 &gt;=35 yrs, obese STOP GDM 54.64 5.07 1435.02 45.54 65.55 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 28.2.3 Post-hoc comparisons 28.2.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.83 (0.75, 0.91) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 0.98 (0.70, 1.36) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 1.18 (0.84, 1.66) 0.6 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.72 (0.51, 1.03) 0.08 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 0.88 (0.61, 1.25) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 0.74 (0.46, 1.19) 0.4 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.81 (0.74, 0.88) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 1.04 (0.84, 1.28) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 1.28 (1.03, 1.60) 0.02 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.74 (0.54, 1.01) 0.06 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.92 (0.67, 1.26) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 0.72 (0.49, 1.04) 0.09 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.87 (0.69, 1.11) 0.5 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.85 (0.51, 1.42) 0.8 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 0.97 (0.58, 1.63) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.74 (0.65, 0.85) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.85 (0.64, 1.12) 0.4 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 1.14 (0.85, 1.51) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.49 (0.38, 0.62) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.65 (0.51, 0.84) &lt;0.0001 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 0.58 (0.40, 0.82) 0.0004 28.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.7926550 0.1892968 1411.0593 0.4961708 1.266302 0.331 ns STOP/SCOPE (Uncomplicated) 0.9753258 0.0481629 1380.9412 0.8852774 1.074534 0.613 ns STOP/SCOPE (GDM) 0.8525700 0.0899444 856.0971 0.6931110 1.048714 0.131 ns GDM/Uncomplicated (SCOPE) 1.0538514 0.1059063 733.1645 0.8651608 1.283695 0.602 ns GDM/Uncomplicated (STOP) 0.9212122 0.0560185 1440.8980 0.8176266 1.037921 0.177 ns "],["gh2-18.html", "28.3 GH2", " 28.3 GH2 LME for repeated measures. 28.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.11) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.77 (0.70, 0.86) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.94 (0.68, 1.30) 0.71 Age_BMI_gp&gt;=35 yrs, obese 0.84 (0.57, 1.25) 0.40 GDM_newGDM 1.04 (0.85, 1.28) 0.69 StudySTOP 0.94 (0.86, 1.03) 0.20 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.17 (1.03, 1.34) 0.02 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.09 (0.73, 1.62) 0.67 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 1.06 (0.63, 1.76) 0.84 GDM_newGDM:StudySTOP 0.99 (0.79, 1.24) 0.91 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM 0.83 (0.61, 1.11) 0.21 Age_BMI_gp&gt;=35 yrs, non-obese:GDM_newGDM 1.11 (0.75, 1.62) 0.61 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM 0.77 (0.37, 1.61) 0.49 Age_BMI_gp&lt;35 yrs, obese:GDM_newGDM:StudySTOP 1.23 (0.88, 1.73) 0.23 Age_BMI_gp&gt;=35 yrs, obese:GDM_newGDM:StudySTOP 1.50 (0.65, 3.51) 0.35 28.3.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 2.40 0.08 508.78 2.24 2.57 &lt;35 yrs, obese SCOPE Uncomplicated 1.85 0.10 1086.33 1.67 2.06 &gt;=35 yrs, non-obese SCOPE Uncomplicated 2.25 0.38 1327.35 1.62 3.12 &gt;=35 yrs, obese SCOPE Uncomplicated 2.03 0.40 1464.96 1.37 2.99 &lt;35 yrs, non-obese STOP Uncomplicated 2.26 0.06 278.45 2.14 2.38 &lt;35 yrs, obese STOP Uncomplicated 2.05 0.09 570.40 1.88 2.24 &gt;=35 yrs, non-obese STOP Uncomplicated 2.31 0.26 1479.53 1.85 2.90 &gt;=35 yrs, obese STOP Uncomplicated 2.01 0.34 1388.55 1.44 2.80 &lt;35 yrs, non-obese SCOPE GDM 2.50 0.26 1388.47 2.04 3.06 &lt;35 yrs, obese SCOPE GDM 1.59 0.17 969.19 1.29 1.97 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 1.63 0.49 793.88 0.90 2.95 &lt;35 yrs, non-obese STOP GDM 2.32 0.13 946.17 2.08 2.59 &lt;35 yrs, obese STOP GDM 2.14 0.12 914.45 1.92 2.38 &gt;=35 yrs, non-obese STOP GDM 2.63 0.40 1488.56 1.95 3.55 &gt;=35 yrs, obese STOP GDM 2.41 0.31 1386.86 1.87 3.10 ## Warning: Removed 1 rows containing missing values (`geom_pointrange()`). 28.3.3 Post-hoc comparisons 28.3.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.77 (0.67, 0.89) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 0.94 (0.61, 1.44) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 1.21 (0.78, 1.89) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.84 (0.51, 1.41) 0.8 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.09 (0.65, 1.84) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 0.90 (0.46, 1.75) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.91 (0.81, 1.02) 0.1 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 1.03 (0.76, 1.38) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 1.13 (0.83, 1.54) 0.7 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.89 (0.58, 1.38) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.98 (0.63, 1.53) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 0.87 (0.52, 1.46) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.64 (0.44, 0.92) 0.010 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.65 (0.29, 1.48) 0.5 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.02 (0.45, 2.33) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 0.92 (0.77, 1.11) 0.7 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 1.13 (0.75, 1.71) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 1.23 (0.82, 1.85) 0.6 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.04 (0.73, 1.47) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 1.12 (0.79, 1.59) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 0.91 (0.55, 1.52) 1.0 28.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.1147321 0.3718226 1465.062 0.5794483 2.144502 0.745 ns STOP/SCOPE (Uncomplicated) 1.1740137 0.0810988 1463.692 1.0252387 1.344378 0.020 * STOP/SCOPE (GDM) 1.4462095 0.2303471 1341.423 1.0581139 1.976651 0.021 * GDM/Uncomplicated (SCOPE) 0.8250411 0.1266625 1280.320 0.6104825 1.115008 0.211 ns GDM/Uncomplicated (STOP) 1.0163274 0.0851217 1491.086 0.8623509 1.197797 0.847 ns "],["insulin-16.html", "28.4 Insulin", " 28.4 Insulin GEE for repeated measures. 28.4.1 Model summary Var Effect P (Intercept) 10.73 (6.38, 18.03) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 1.66 (1.38, 2.00) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.97 (0.66, 1.42) 0.88 Age_BMI_gp&gt;=35 yrs, obese 2.05 (1.26, 3.34) 0.004 GDM_newGDM 1.89 (1.45, 2.47) &lt;0.0001 StudySTOP 0.74 (0.62, 0.89) 0.001 GA_samp 1.01 (0.98, 1.04) 0.53 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.17 (0.93, 1.47) 0.18 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.89 (0.54, 1.48) 0.66 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.63 (0.36, 1.08) 0.09 GDM_newGDM:StudySTOP 0.78 (0.58, 1.06) 0.12 28.4.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 12.31 0.81 Inf 10.81 14.01 &lt;35 yrs, obese SCOPE Uncomplicated 20.39 1.89 Inf 17.00 24.46 &gt;=35 yrs, non-obese SCOPE Uncomplicated 11.94 2.30 Inf 8.18 17.42 &gt;=35 yrs, obese SCOPE Uncomplicated 25.23 6.30 Inf 15.47 41.15 &lt;35 yrs, non-obese STOP Uncomplicated 9.11 0.40 Inf 8.35 9.93 &lt;35 yrs, obese STOP Uncomplicated 17.64 1.14 Inf 15.54 20.02 &gt;=35 yrs, non-obese STOP Uncomplicated 7.89 1.32 Inf 5.68 10.96 &gt;=35 yrs, obese STOP Uncomplicated 11.69 1.46 Inf 9.16 14.92 &lt;35 yrs, non-obese SCOPE GDM 23.27 3.33 Inf 17.57 30.81 &lt;35 yrs, obese SCOPE GDM 38.55 5.31 Inf 29.44 50.50 &gt;=35 yrs, non-obese SCOPE GDM 22.57 5.33 Inf 14.20 35.86 &gt;=35 yrs, obese SCOPE GDM 47.71 12.07 Inf 29.06 78.32 &lt;35 yrs, non-obese STOP GDM 13.48 1.12 Inf 11.45 15.87 &lt;35 yrs, obese STOP GDM 26.10 2.13 Inf 22.25 30.62 &gt;=35 yrs, non-obese STOP GDM 11.68 2.00 Inf 8.35 16.34 &gt;=35 yrs, obese STOP GDM 17.30 2.13 Inf 13.59 22.02 28.4.3 Post-hoc comparisons 28.4.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 1.66 (1.30, 2.11) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 0.97 (0.59, 1.60) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 0.59 (0.34, 0.99) 0.05 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 2.05 (1.08, 3.89) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.24 (0.65, 2.37) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 2.11 (0.95, 4.69) 0.07 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.94 (1.63, 2.30) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.87 (0.56, 1.33) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.45 (0.29, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.28 (0.93, 1.77) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.66 (0.48, 0.92) 0.008 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 1.48 (0.89, 2.47) 0.2 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 1.66 (1.30, 2.11) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 0.97 (0.59, 1.60) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 0.59 (0.34, 0.99) 0.05 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 2.05 (1.08, 3.89) 0.02 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.24 (0.65, 2.37) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 2.11 (0.95, 4.69) 0.07 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.94 (1.63, 2.30) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.87 (0.56, 1.33) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.45 (0.29, 0.69) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.28 (0.93, 1.77) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.66 (0.48, 0.92) 0.008 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 1.48 (0.89, 2.47) 0.2 28.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9761825 0.3734941 Inf 0.4611641 2.066363 0.950 ns STOP/SCOPE (Uncomplicated) 1.1686509 0.1354989 Inf 0.9310918 1.466821 0.179 ns STOP/SCOPE (GDM) 1.1686509 0.1354989 Inf 0.9310918 1.466821 0.179 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["homa-ir-16.html", "28.5 HOMA-IR", " 28.5 HOMA-IR GEE for repeated measures. 28.5.1 Model summary Var Effect P (Intercept) 2.71 (1.57, 4.68) 0.0004 Age_BMI_gp&lt;35 yrs, obese 1.68 (1.37, 2.06) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.01 (0.67, 1.53) 0.96 Age_BMI_gp&gt;=35 yrs, obese 2.13 (1.24, 3.68) 0.006 GDM_newGDM 2.05 (1.51, 2.79) &lt;0.0001 StudySTOP 0.63 (0.52, 0.77) &lt;0.0001 GA_samp 1.01 (0.97, 1.04) 0.69 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.22 (0.95, 1.56) 0.12 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.86 (0.50, 1.47) 0.57 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.61 (0.33, 1.11) 0.11 GDM_newGDM:StudySTOP 0.74 (0.52, 1.04) 0.08 28.5.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 2.97 0.21 Inf 2.59 3.41 &lt;35 yrs, obese SCOPE Uncomplicated 4.99 0.50 Inf 4.09 6.08 &gt;=35 yrs, non-obese SCOPE Uncomplicated 3.00 0.63 Inf 1.99 4.53 &gt;=35 yrs, obese SCOPE Uncomplicated 6.34 1.77 Inf 3.68 10.95 &lt;35 yrs, non-obese STOP Uncomplicated 1.88 0.09 Inf 1.71 2.06 &lt;35 yrs, obese STOP Uncomplicated 3.84 0.26 Inf 3.35 4.39 &gt;=35 yrs, non-obese STOP Uncomplicated 1.62 0.29 Inf 1.14 2.30 &gt;=35 yrs, obese STOP Uncomplicated 2.44 0.31 Inf 1.90 3.14 &lt;35 yrs, non-obese SCOPE GDM 6.10 0.99 Inf 4.44 8.38 &lt;35 yrs, obese SCOPE GDM 10.23 1.60 Inf 7.52 13.91 &gt;=35 yrs, non-obese SCOPE GDM 6.16 1.61 Inf 3.69 10.28 &gt;=35 yrs, obese SCOPE GDM 13.02 3.67 Inf 7.49 22.63 &lt;35 yrs, non-obese STOP GDM 2.84 0.25 Inf 2.38 3.38 &lt;35 yrs, obese STOP GDM 5.80 0.52 Inf 4.87 6.91 &gt;=35 yrs, non-obese STOP GDM 2.45 0.44 Inf 1.72 3.50 &gt;=35 yrs, obese STOP GDM 3.69 0.46 Inf 2.89 4.72 28.5.3 Post-hoc comparisons 28.5.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 1.68 (1.29, 2.19) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 1.01 (0.58, 1.75) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 0.60 (0.34, 1.07) 0.1 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 2.13 (1.04, 4.36) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.27 (0.62, 2.62) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 2.11 (0.87, 5.11) 0.1 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 2.04 (1.70, 2.45) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.86 (0.55, 1.36) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.42 (0.27, 0.67) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.30 (0.94, 1.81) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.64 (0.45, 0.90) 0.004 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 1.51 (0.88, 2.57) 0.2 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 1.68 (1.29, 2.19) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 1.01 (0.58, 1.75) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 0.60 (0.34, 1.07) 0.1 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 2.13 (1.04, 4.36) 0.03 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.27 (0.62, 2.62) 0.8 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 2.11 (0.87, 5.11) 0.1 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 2.04 (1.70, 2.45) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.86 (0.55, 1.36) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.42 (0.27, 0.67) &lt;0.0001 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.30 (0.94, 1.81) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.64 (0.45, 0.90) 0.004 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 1.51 (0.88, 2.57) 0.2 28.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9270661 0.3862837 Inf 0.4096734 2.097895 0.856 ns STOP/SCOPE (Uncomplicated) 1.2187621 0.1532544 Inf 0.9525412 1.559388 0.116 ns STOP/SCOPE (GDM) 1.2187621 0.1532544 Inf 0.9525412 1.559388 0.116 ns GDM/Uncomplicated (SCOPE) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.0000000 0.0000000 Inf 1.0000000 1.000000 NA "],["glucose-14.html", "28.6 Glucose", " 28.6 Glucose GEE for repeated measures. 28.6.1 Model summary Var Effect P (Intercept) 5.57 (4.99, 6.21) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.98 (0.93, 1.03) 0.36 Age_BMI_gp&gt;=35 yrs, non-obese 1.00 (0.94, 1.06) 0.95 Age_BMI_gp&gt;=35 yrs, obese 1.05 (0.91, 1.22) 0.50 GDM_newGDM 1.11 (1.00, 1.24) 0.05 StudySTOP 0.86 (0.83, 0.89) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.65 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.06 (1.00, 1.13) 0.07 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.99 (0.93, 1.07) 0.87 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.95 (0.81, 1.10) 0.49 GDM_newGDM:StudySTOP 0.93 (0.83, 1.03) 0.17 28.6.2 Estimated marginal means Age_BMI_gp Study GDM_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE Uncomplicated 5.45 0.08 Inf 5.31 5.60 &lt;35 yrs, obese SCOPE Uncomplicated 5.32 0.12 Inf 5.08 5.57 &gt;=35 yrs, non-obese SCOPE Uncomplicated 5.44 0.17 Inf 5.12 5.78 &gt;=35 yrs, obese SCOPE Uncomplicated 5.73 0.42 Inf 4.96 6.62 &lt;35 yrs, non-obese STOP Uncomplicated 4.68 0.05 Inf 4.59 4.78 &lt;35 yrs, obese STOP Uncomplicated 4.84 0.08 Inf 4.69 4.99 &gt;=35 yrs, non-obese STOP Uncomplicated 4.64 0.08 Inf 4.50 4.80 &gt;=35 yrs, obese STOP Uncomplicated 4.66 0.10 Inf 4.47 4.87 &lt;35 yrs, non-obese SCOPE GDM 6.06 0.33 Inf 5.45 6.74 &lt;35 yrs, obese SCOPE GDM 5.92 0.28 Inf 5.39 6.49 &gt;=35 yrs, non-obese SCOPE GDM 6.05 0.36 Inf 5.38 6.80 &gt;=35 yrs, obese SCOPE GDM 6.37 0.48 Inf 5.50 7.38 &lt;35 yrs, non-obese STOP GDM 4.82 0.08 Inf 4.67 4.97 &lt;35 yrs, obese STOP GDM 4.98 0.08 Inf 4.82 5.15 &gt;=35 yrs, non-obese STOP GDM 4.78 0.09 Inf 4.61 4.96 &gt;=35 yrs, obese STOP GDM 4.80 0.10 Inf 4.60 5.01 28.6.3 Post-hoc comparisons 28.6.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.98 (0.91, 1.04) 0.8 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 1.00 (0.92, 1.08) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 1.02 (0.93, 1.12) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 1.05 (0.87, 1.27) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.08 (0.89, 1.30) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 1.05 (0.86, 1.29) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.03 (0.99, 1.08) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.99 (0.95, 1.04) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.96 (0.91, 1.01) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.00 (0.94, 1.05) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.96 (0.91, 1.02) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 1.00 (0.94, 1.07) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 0.98 (0.91, 1.04) 0.8 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE 1.00 (0.92, 1.08) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE 1.02 (0.93, 1.12) 0.9 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE 1.05 (0.87, 1.27) 0.9 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE 1.08 (0.89, 1.30) 0.7 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE 1.05 (0.86, 1.29) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.03 (0.99, 1.08) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP 0.99 (0.95, 1.04) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP 0.96 (0.91, 1.01) 0.2 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP 1.00 (0.94, 1.05) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP 0.96 (0.91, 1.02) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP 1.00 (0.94, 1.07) 1.0 28.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.048150 0.0902902 Inf 0.8853170 1.240932 0.585 ns STOP/SCOPE (Uncomplicated) 1.059262 0.0335696 Inf 0.9954682 1.127143 0.069 ns STOP/SCOPE (GDM) 1.059262 0.0335696 Inf 0.9954682 1.127143 0.069 ns GDM/Uncomplicated (SCOPE) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA GDM/Uncomplicated (STOP) 1.000000 0.0000000 Inf 1.0000000 1.000000 NA "],["mets-8.html", "29 MetS", " 29 MetS Descriptives with univariate P-values. Within Uncomplicated Characteristic No MetS (n=1140) MetS (n=111) Total (n=1251) P-value PRL (ng/ml): Median (IQ range) 95.2 (57.7-150.3) 107.5 (66.8-182.2) 96.3 (58.2-154.4) 0.11 hPL (μg/ml): Median (IQ range) 100.5 (54.0-179.2) 143.6 (59.4-179.6) 105.2 (54.1-179.5) 0.21 GH2 (ng/ml): Median (IQ range) 2.4 (1.2-4.1) 3.0 (1.6-4.6) 2.5 (1.2-4.1) 0.07 Insulin (uU/L): Median (IQ range) 9.9 (5.7-19.6) 28.0 (14.4-51.6) 10.8 (6.1-21.9) &lt;0.0001 HOMA-IR: Median (IQ range) 2.1 (1.2-4.5) 7.4 (3.6-14.1) 2.4 (1.3-5.1) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.9 (4.6-5.4) 5.8 (5.5-6.2) 5.0 (4.6-5.5) &lt;0.0001 Within GDM Characteristic No MetS (n=172) MetS (n=68) Total (n=240) P-value PRL (ng/ml): Median (IQ range) 73.6 (47.5-122.7) 64.1 (41.6-110.2) 71.9 (44.4-114.1) 0.19 hPL (μg/ml): Median (IQ range) 64.3 (37.8-100.2) 55.7 (37.4-79.8) 60.2 (37.4-91.8) 0.22 GH2 (ng/ml): Median (IQ range) 1.4 (1.0-2.5) 1.5 (1.0-2.4) 1.4 (1.0-2.4) 0.97 Insulin (uU/L): Median (IQ range) 13.4 (7.7-30.2) 34.0 (17.6-58.7) 17.1 (9.4-38.5) &lt;0.0001 HOMA-IR: Median (IQ range) 3.0 (1.5-6.9) 8.3 (4.4-17.1) 3.8 (1.9-8.8) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 4.8 (4.5-5.2) 5.8 (5.1-6.4) 5.0 (4.5-5.6) &lt;0.0001 Click here for table within SCOPE Within Uncomplicated Characteristic No MetS (n=520) MetS (n=75) Total (n=595) P-value PRL (ng/ml): Median (IQ range) 138.1 (92.3-218.7) 154.1 (105.0-204.0) 139.7 (94.2-215.5) 0.50 hPL (μg/ml): Median (IQ range) 185.1 (151.8-222.3) 169.0 (146.8-201.1) 183.5 (149.7-220.6) 0.04 GH2 (ng/ml): Median (IQ range) 4.2 (3.3-5.7) 4.1 (2.8-5.4) 4.2 (3.2-5.6) 0.29 Insulin (uU/L): Median (IQ range) 12.5 (6.1-24.7) 33.9 (20.3-60.0) 14.4 (6.5-29.1) &lt;0.0001 HOMA-IR: Median (IQ range) 2.8 (1.4-5.8) 8.9 (4.7-15.9) 3.3 (1.5-7.2) &lt;0.0001 Glucose (mmol/L): Median (IQ range) 5.3 (4.9-5.7) 5.9 (5.6-6.2) 5.4 (5.0-5.8) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 36.9 (28.3-43.4) 35.2 (30.2-42.5) 36.8 (28.8-43.2) 0.75 B12 concentration (pM): Median (IQ range) 253.0 (198.0-322.0) 220.0 (173.0-293.0) 248.5 (196.0-316.8) 0.005 Folate:B12 ratio: Median (IQ range) 141.6 (101.7-205.3) 155.1 (118.5-217.2) 143.0 (104.6-209.7) 0.18 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-73.0) 51.0 (43.5-68.0) 54.0 (42.0-72.2) 0.65 Folate:Active B12 ratio: Median (IQ range) 617.0 (460.8-986.7) 620.0 (505.1-746.5) 618.0 (462.5-946.3) 0.75 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.3 (3.8-4.6) 4.4 (3.8-4.9) 0.39 Within GDM Characteristic No MetS (n=29) MetS (n=28) Total (n=57) P-value PRL (ng/ml): Median (IQ range) 119.0 (74.7-180.2) 73.7 (54.6-101.6) 92.0 (62.0-147.2) 0.09 hPL (μg/ml): Median (IQ range) 117.2 (105.8-161.5) 96.2 (77.6-113.5) 106.2 (85.6-134.2) 0.08 GH2 (ng/ml): Median (IQ range) 3.0 (1.6-4.4) 2.0 (1.6-3.1) 2.7 (1.6-4.2) 0.49 Insulin (uU/L): Median (IQ range) 19.6 (12.1-43.2) 39.9 (17.6-82.7) 31.9 (16.6-51.0) 0.15 HOMA-IR: Median (IQ range) 5.1 (3.1-11.4) 9.8 (4.4-23.2) 8.1 (3.6-17.4) 0.15 Glucose (mmol/L): Median (IQ range) 5.5 (5.0-6.3) 6.1 (5.8-6.7) 5.8 (5.2-6.6) 0.01 Serum folate concentration (nM): Median (IQ range) 39.7 (31.7-44.0) 39.6 (31.9-42.3) 39.6 (31.9-43.8) 0.90 B12 concentration (pM): Median (IQ range) 274.0 (196.2-341.5) 240.0 (193.5-296.5) 254.0 (193.5-334.0) 0.39 Folate:B12 ratio: Median (IQ range) 152.8 (112.5-184.8) 167.7 (121.8-210.6) 155.4 (115.4-210.6) 0.59 Active B12 concentration (pM): Median (IQ range) 85.0 (58.0-99.5) 60.0 (53.0-79.0) 66.5 (54.5-89.2) 0.28 Folate:Active B12 ratio: Median (IQ range) 516.5 (418.5-688.3) 560.9 (424.7-636.8) 546.6 (419.7-674.3) 0.61 Homocysteine concentration (μM): Median (IQ range) 4.1 (3.8-4.7) 3.7 (3.5-4.1) 3.9 (3.6-4.6) 0.10 Click here for table within STOP Within Uncomplicated Characteristic No MetS (n=620) MetS (n=36) Total (n=656) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.5-112.3) 65.1 (46.2-98.4) 72.6 (48.4-111.3) 0.28 hPL (μg/ml): Median (IQ range) 60.9 (41.3-91.0) 50.6 (34.5-71.3) 60.5 (41.1-90.6) 0.07 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.5 (0.8-2.0) 1.4 (0.9-2.3) 0.37 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.1) 40.3 (37.2-45.0) 40.5 (36.3-45.1) 0.85 B12 concentration (pM): Median (IQ range) 279.5 (220.8-356.8) 247.0 (201.0-335.5) 278.0 (219.5-356.0) 0.13 Folate:B12 ratio: Median (IQ range) 153.6 (114.8-224.2) 172.4 (143.0-203.7) 155.4 (115.3-222.9) 0.27 Active B12 concentration (pM): Median (IQ range) 63.0 (48.8-81.0) 62.0 (56.0-74.0) 63.0 (49.0-81.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 670.3 (486.7-943.6) 633.9 (493.7-726.8) 666.1 (487.3-939.1) 0.64 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.3-5.6) 4.9 (4.5-5.5) 4.8 (4.3-5.6) 0.92 Within GDM Characteristic No MetS (n=143) MetS (n=40) Total (n=183) P-value PRL (ng/ml): Median (IQ range) 70.4 (43.4-111.5) 56.2 (38.6-110.4) 68.4 (42.3-111.0) 0.21 hPL (μg/ml): Median (IQ range) 59.4 (35.3-85.7) 50.0 (36.2-65.0) 55.6 (35.3-83.0) 0.06 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.1) 1.2 (0.8-2.0) 1.3 (0.9-2.1) 0.39 Serum folate concentration (nM): Median (IQ range) 40.7 (36.0-54.0) 37.2 (33.8-41.7) 40.0 (35.1-45.2) 0.02 B12 concentration (pM): Median (IQ range) 278.0 (217.0-359.2) 264.0 (207.0-306.0) 275.0 (216.0-353.0) 0.23 Folate:B12 ratio: Median (IQ range) 147.4 (109.7-228.7) 149.8 (114.6-211.8) 147.7 (111.7-223.1) 0.98 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-88.0) 73.0 (57.5-92.2) 75.0 (56.0-91.0) 0.99 Folate:Active B12 ratio: Median (IQ range) 531.9 (419.9-818.0) 551.8 (417.2-693.7) 534.2 (419.9-798.9) 0.77 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.8 (4.1-5.2) 4.8 (4.0-5.3) 0.92 "],["prolactin-19.html", "29.1 Prolactin", " 29.1 Prolactin LME for repeated measures. 29.1.1 Model summary Var Effect P (Intercept) 15.21 (10.06, 23.00) &lt;0.0001 metab.C1MetS 1.03 (0.86, 1.23) 0.78 GDM_newGDM 1.11 (0.84, 1.46) 0.47 StudySTOP 0.96 (0.84, 1.10) 0.54 GA_samp 1.15 (1.13, 1.18) &lt;0.0001 metab.C1MetS:StudySTOP 0.90 (0.68, 1.19) 0.46 GDM_newGDM:StudySTOP 0.97 (0.73, 1.31) 0.86 metab.C1MetS:GDM_newGDM 0.65 (0.43, 0.98) 0.04 metab.C1MetS:GDM_newGDM:StudySTOP 1.52 (0.91, 2.55) 0.11 29.1.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 96.45 7.94 109.25 81.93 113.54 MetS SCOPE Uncomplicated 98.98 11.27 359.48 79.12 123.81 No MetS STOP Uncomplicated 92.45 7.00 78.65 79.52 107.48 MetS STOP Uncomplicated 85.56 10.94 512.96 66.55 110.00 No MetS SCOPE GDM 106.63 16.45 788.06 78.76 144.35 MetS SCOPE GDM 70.78 11.48 759.63 51.48 97.30 No MetS STOP GDM 99.58 9.16 164.77 83.03 119.42 MetS STOP GDM 90.70 11.60 507.78 70.55 116.60 29.1.3 Post-hoc comparisons 29.1.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE 1.03 (0.86, 1.23) 0.8 MetS / No MetS STOP 0.93 (0.75, 1.14) 0.5 MetS / No MetS SCOPE 0.66 (0.46, 0.97) 0.03 MetS / No MetS STOP 0.91 (0.73, 1.14) 0.4 29.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.2374301 0.3264023 1264.204 0.7375312 2.0761606 0.419 ns STOP/SCOPE (Uncomplicated) 0.9018147 0.1271878 1381.642 0.6838525 1.1892472 0.464 ns STOP/SCOPE (GDM) 1.3721557 0.3062313 1190.378 0.8856107 2.1260032 0.157 ns GDM/Uncomplicated (SCOPE) 0.6468335 0.1370211 1176.512 0.4268681 0.9801471 0.040 * GDM/Uncomplicated (STOP) 0.9841892 0.1551743 1371.595 0.7223597 1.3409225 0.920 ns "],["hpl-19.html", "29.2 HPL", " 29.2 HPL LME for repeated measures. 29.2.1 Model summary Var Effect P (Intercept) 2.05 (1.67, 2.53) &lt;0.0001 metab.C1MetS 0.91 (0.83, 0.99) 0.04 GDM_newGDM 0.96 (0.84, 1.09) 0.51 StudySTOP 1.12 (1.05, 1.20) 0.001 GA_samp 1.33 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.97 (0.84, 1.12) 0.68 GDM_newGDM:StudySTOP 1.05 (0.91, 1.21) 0.49 metab.C1MetS:GDM_newGDM 1.04 (0.85, 1.27) 0.73 metab.C1MetS:GDM_newGDM:StudySTOP 0.96 (0.74, 1.25) 0.77 29.2.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 87.90 2.62 203.33 82.88 93.23 MetS SCOPE Uncomplicated 79.66 4.00 912.87 72.18 87.92 No MetS STOP Uncomplicated 98.62 2.53 113.34 93.74 103.76 MetS STOP Uncomplicated 86.69 5.27 1153.56 76.93 97.68 No MetS SCOPE GDM 84.15 5.75 826.16 73.59 96.22 MetS SCOPE GDM 79.05 5.87 704.63 68.33 91.46 No MetS STOP GDM 99.30 3.73 385.45 92.23 106.92 MetS STOP GDM 87.01 5.23 1107.51 77.33 97.89 29.2.3 Post-hoc comparisons 29.2.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE 0.91 (0.83, 0.99) 0.04 MetS / No MetS STOP 0.88 (0.78, 0.98) 0.03 MetS / No MetS SCOPE 0.94 (0.78, 1.13) 0.5 MetS / No MetS STOP 0.88 (0.78, 0.99) 0.03 29.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9047120 0.1203686 1095.0285 0.6968443 1.174586 0.452 ns STOP/SCOPE (Uncomplicated) 0.9699470 0.0719962 1378.6476 0.8385141 1.121981 0.681 ns STOP/SCOPE (GDM) 0.9327437 0.1032235 919.9378 0.7506522 1.159007 0.529 ns GDM/Uncomplicated (SCOPE) 1.0366034 0.1074394 835.1597 0.8457876 1.270469 0.729 ns GDM/Uncomplicated (STOP) 0.9968435 0.0836478 1379.8101 0.8455468 1.175212 0.970 ns "],["gh2-19.html", "29.3 GH2", " 29.3 GH2 LME for repeated measures. 29.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 metab.C1MetS 0.90 (0.79, 1.02) 0.10 GDM_newGDM 1.03 (0.85, 1.26) 0.75 StudySTOP 0.96 (0.88, 1.06) 0.43 GA_samp 1.30 (1.27, 1.32) &lt;0.0001 metab.C1MetS:StudySTOP 1.10 (0.90, 1.35) 0.35 GDM_newGDM:StudySTOP 1.01 (0.82, 1.25) 0.95 metab.C1MetS:GDM_newGDM 0.76 (0.56, 1.04) 0.08 metab.C1MetS:GDM_newGDM:StudySTOP 1.30 (0.88, 1.90) 0.18 29.3.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 2.28 0.08 478.04 2.13 2.44 MetS SCOPE Uncomplicated 2.05 0.14 1340.37 1.79 2.33 No MetS STOP Uncomplicated 2.20 0.06 232.82 2.08 2.32 MetS STOP Uncomplicated 2.17 0.18 1372.17 1.85 2.54 No MetS SCOPE GDM 2.36 0.24 1313.97 1.94 2.87 MetS SCOPE GDM 1.61 0.18 1057.92 1.30 2.00 No MetS STOP GDM 2.29 0.10 603.84 2.09 2.50 MetS STOP GDM 2.23 0.18 1292.03 1.91 2.62 29.3.3 Post-hoc comparisons 29.3.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE 0.90 (0.79, 1.02) 0.10 MetS / No MetS STOP 0.99 (0.84, 1.16) 0.9 MetS / No MetS SCOPE 0.68 (0.52, 0.90) 0.008 MetS / No MetS STOP 0.98 (0.83, 1.16) 0.8 29.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.5755532 0.3083808 1343.816 1.0731945 2.313064 0.020 * STOP/SCOPE (Uncomplicated) 1.1017095 0.1141060 1431.468 0.8991497 1.349902 0.350 ns STOP/SCOPE (GDM) 1.4300987 0.2375745 1271.659 1.0323473 1.981099 0.031 * GDM/Uncomplicated (SCOPE) 0.7619268 0.1195626 1256.150 0.5600318 1.036606 0.083 ns GDM/Uncomplicated (STOP) 0.9890361 0.1157988 1430.538 0.7860804 1.244392 0.925 ns "],["insulin-17.html", "29.4 Insulin", " 29.4 Insulin GEE for repeated measures. 29.4.1 Model summary Var Effect P (Intercept) 10.91 (6.36, 18.69) &lt;0.0001 metab.C1MetS 2.51 (2.01, 3.14) &lt;0.0001 GDM_newGDM 1.74 (1.14, 2.66) 0.01 StudySTOP 0.82 (0.69, 0.99) 0.04 GA_samp 1.01 (0.98, 1.04) 0.59 metab.C1MetS:StudySTOP 0.78 (0.54, 1.13) 0.19 GDM_newGDM:StudySTOP 0.85 (0.54, 1.34) 0.49 metab.C1MetS:GDM_newGDM 0.79 (0.46, 1.38) 0.41 metab.C1MetS:GDM_newGDM:StudySTOP 1.40 (0.70, 2.83) 0.34 29.4.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 12.33 0.81 Inf 10.85 14.02 MetS SCOPE Uncomplicated 30.94 3.41 Inf 24.92 38.41 No MetS STOP Uncomplicated 10.15 0.44 Inf 9.32 11.06 MetS STOP Uncomplicated 19.92 2.91 Inf 14.97 26.52 No MetS SCOPE GDM 21.47 4.58 Inf 14.13 32.63 MetS SCOPE GDM 42.76 6.66 Inf 31.52 58.02 No MetS STOP GDM 15.08 1.24 Inf 12.83 17.71 MetS STOP GDM 32.98 4.83 Inf 24.74 43.96 29.4.3 Post-hoc comparisons 29.4.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE 2.51 (2.01, 3.14) &lt;0.0001 MetS / No MetS STOP 1.96 (1.47, 2.63) &lt;0.0001 MetS / No MetS SCOPE 1.99 (1.20, 3.30) 0.007 MetS / No MetS STOP 2.19 (1.59, 3.00) &lt;0.0001 29.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.8588782 0.3068673 Inf 0.4263901 1.730040 0.670 ns STOP/SCOPE (Uncomplicated) 0.7821066 0.1466311 Inf 0.5416026 1.129409 0.190 ns STOP/SCOPE (GDM) 1.0981601 0.3342823 Inf 0.6047252 1.994221 0.758 ns GDM/Uncomplicated (SCOPE) 0.7939556 0.2237288 Inf 0.4570208 1.379293 0.413 ns GDM/Uncomplicated (STOP) 1.1147973 0.2453719 Inf 0.7241735 1.716126 0.621 ns "],["homa-ir-17.html", "29.5 HOMA-IR", " 29.5 HOMA-IR GEE for repeated measures. 29.5.1 Model summary Var Effect P (Intercept) 2.63 (1.50, 4.60) 0.0007 metab.C1MetS 2.85 (2.24, 3.63) &lt;0.0001 GDM_newGDM 1.92 (1.20, 3.07) 0.007 StudySTOP 0.72 (0.60, 0.87) 0.0008 GA_samp 1.01 (0.97, 1.04) 0.65 metab.C1MetS:StudySTOP 0.80 (0.54, 1.20) 0.28 GDM_newGDM:StudySTOP 0.79 (0.48, 1.30) 0.35 metab.C1MetS:GDM_newGDM 0.72 (0.39, 1.34) 0.30 metab.C1MetS:GDM_newGDM:StudySTOP 1.53 (0.70, 3.35) 0.29 29.5.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 2.93 0.20 Inf 2.56 3.35 MetS SCOPE Uncomplicated 8.33 0.99 Inf 6.60 10.52 No MetS STOP Uncomplicated 2.11 0.10 Inf 1.93 2.31 MetS STOP Uncomplicated 4.81 0.77 Inf 3.51 6.59 No MetS SCOPE GDM 5.61 1.33 Inf 3.52 8.92 MetS SCOPE GDM 11.50 2.04 Inf 8.12 16.30 No MetS STOP GDM 3.18 0.28 Inf 2.68 3.77 MetS STOP GDM 7.99 1.32 Inf 5.77 11.05 29.5.3 Post-hoc comparisons 29.5.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE 2.85 (2.24, 3.63) &lt;0.0001 MetS / No MetS STOP 2.28 (1.65, 3.14) &lt;0.0001 MetS / No MetS SCOPE 2.05 (1.16, 3.63) 0.01 MetS / No MetS STOP 2.51 (1.76, 3.58) &lt;0.0001 29.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9799646 0.3910973 Inf 0.4482307 2.142492 0.960 ns STOP/SCOPE (Uncomplicated) 0.7998569 0.1640606 Inf 0.5350819 1.195651 0.276 ns STOP/SCOPE (GDM) 1.2251749 0.4197975 Inf 0.6259504 2.398039 0.553 ns GDM/Uncomplicated (SCOPE) 0.7201415 0.2275098 Inf 0.3877064 1.337620 0.299 ns GDM/Uncomplicated (STOP) 1.1030713 0.2696007 Inf 0.6832225 1.780922 0.688 ns "],["glucose-15.html", "29.6 Glucose", " 29.6 Glucose GEE for repeated measures. 29.6.1 Model summary Var Effect P (Intercept) 5.31 (4.76, 5.93) &lt;0.0001 metab.C1MetS 1.12 (1.09, 1.16) &lt;0.0001 GDM_newGDM 1.07 (0.97, 1.18) 0.20 StudySTOP 0.88 (0.85, 0.91) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.96 metab.C1MetS:StudySTOP 1.04 (0.97, 1.11) 0.27 GDM_newGDM:StudySTOP 0.96 (0.87, 1.07) 0.46 metab.C1MetS:GDM_newGDM 0.99 (0.81, 1.21) 0.95 metab.C1MetS:GDM_newGDM:StudySTOP 0.97 (0.78, 1.20) 0.79 29.6.2 Estimated marginal means metab.C1 Study GDM_new response SE df lower.CL upper.CL No MetS SCOPE Uncomplicated 5.33 0.07 Inf 5.20 5.46 MetS SCOPE Uncomplicated 5.99 0.10 Inf 5.80 6.19 No MetS STOP Uncomplicated 4.69 0.04 Inf 4.61 4.77 MetS STOP Uncomplicated 5.46 0.15 Inf 5.17 5.77 No MetS SCOPE GDM 5.70 0.29 Inf 5.16 6.29 MetS SCOPE GDM 6.36 0.53 Inf 5.41 7.48 No MetS STOP GDM 4.81 0.07 Inf 4.68 4.95 MetS STOP GDM 5.42 0.16 Inf 5.12 5.74 29.6.3 Post-hoc comparisons 29.6.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE 1.12 (1.09, 1.16) &lt;0.0001 MetS / No MetS STOP 1.17 (1.10, 1.23) &lt;0.0001 MetS / No MetS SCOPE 1.12 (0.92, 1.36) 0.3 MetS / No MetS STOP 1.13 (1.06, 1.20) 0.0001 29.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.0458155 0.1136258 Inf 0.8452277 1.294007 0.680 ns STOP/SCOPE (Uncomplicated) 1.0373786 0.0342887 Inf 0.9723046 1.106808 0.267 ns STOP/SCOPE (GDM) 1.0081329 0.1045116 Inf 0.8227636 1.235266 0.938 ns GDM/Uncomplicated (SCOPE) 0.9932065 0.1003173 Inf 0.8148266 1.210637 0.946 ns GDM/Uncomplicated (STOP) 0.9652060 0.0401921 Inf 0.8895598 1.047285 0.395 ns "],["birthweight-centile-2.html", "30 Birthweight centile", " 30 Birthweight centile Descriptives with univariate P-values. Within Uncomplicated Characteristic &lt;=90th centile (n=1159) &gt;90th centile (n=130) Total (n=1289) P-value PRL (ng/ml): Median (IQ range) 97.0 (57.9-155.7) 96.1 (62.2-159.9) 96.9 (58.2-157.3) 0.89 hPL (μg/ml): Median (IQ range) 111.1 (54.6-179.0) 93.2 (54.6-184.1) 108.1 (54.6-179.7) 0.90 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.1) 2.0 (1.1-4.1) 2.5 (1.2-4.1) 0.31 Insulin (uU/L): Median (IQ range) 10.7 (6.1-21.4) 11.1 (5.8-22.7) 10.8 (6.0-21.7) 0.67 HOMA-IR: Median (IQ range) 2.4 (1.3-5.0) 2.6 (1.3-5.2) 2.4 (1.3-5.0) 0.54 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.5) 5.1 (4.6-5.6) 5.0 (4.6-5.5) 0.28 Within GDM Characteristic &lt;=90th centile (n=219) &gt;90th centile (n=30) Total (n=249) P-value PRL (ng/ml): Median (IQ range) 67.2 (43.9-113.0) 101.2 (82.0-181.8) 73.6 (45.6-121.8) 0.001 hPL (μg/ml): Median (IQ range) 61.3 (38.1-98.8) 67.2 (34.2-86.3) 61.4 (37.4-98.0) 0.93 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.6) 1.3 (1.0-2.7) 1.5 (1.0-2.6) 0.97 Insulin (uU/L): Median (IQ range) 17.6 (9.6-39.0) 16.8 (8.0-47.2) 17.6 (9.5-40.5) 0.98 HOMA-IR: Median (IQ range) 3.9 (2.0-8.9) 3.3 (1.8-10.2) 3.8 (1.9-9.2) 0.90 Glucose (mmol/L): Median (IQ range) 5.0 (4.6-5.6) 4.9 (4.5-5.4) 5.0 (4.5-5.6) 0.31 Click here for table within SCOPE Within Uncomplicated Characteristic &lt;=90th centile (n=544) &gt;90th centile (n=54) Total (n=598) P-value PRL (ng/ml): Median (IQ range) 139.1 (92.8-215.5) 156.5 (106.3-223.3) 139.9 (94.7-215.5) 0.30 hPL (μg/ml): Median (IQ range) 181.5 (148.0-217.8) 206.6 (159.9-259.2) 183.5 (149.9-220.6) 0.02 GH2 (ng/ml): Median (IQ range) 4.1 (3.2-5.6) 4.6 (3.5-6.0) 4.2 (3.2-5.6) 0.36 Insulin (uU/L): Median (IQ range) 14.1 (6.4-27.4) 19.8 (7.2-39.0) 14.4 (6.5-29.1) 0.14 HOMA-IR: Median (IQ range) 3.2 (1.5-6.8) 4.8 (1.8-9.4) 3.3 (1.5-7.2) 0.10 Glucose (mmol/L): Median (IQ range) 5.4 (5.0-5.8) 5.5 (5.1-6.0) 5.4 (5.0-5.8) 0.09 Serum folate concentration (nM): Median (IQ range) 36.5 (28.6-43.4) 38.0 (28.3-42.4) 36.6 (28.6-43.1) 0.86 B12 concentration (pM): Median (IQ range) 248.0 (195.0-315.0) 244.5 (201.8-325.2) 248.0 (195.0-316.0) 0.72 Folate:B12 ratio: Median (IQ range) 143.0 (105.1-208.8) 147.5 (100.7-204.7) 143.0 (104.5-208.8) 0.79 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-72.0) 56.0 (44.5-76.5) 54.0 (42.5-72.0) 0.41 Folate:Active B12 ratio: Median (IQ range) 618.0 (452.1-963.5) 575.0 (478.4-872.4) 617.5 (461.2-937.5) 0.91 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.9-4.9) 4.3 (3.7-4.9) 4.4 (3.8-4.9) 0.65 Within GDM Characteristic &lt;=90th centile (n=50) &gt;90th centile (n=8) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 87.6 (59.0-138.5) 114.4 (93.1-148.1) 92.0 (62.0-147.2) 0.58 hPL (μg/ml): Median (IQ range) 105.8 (86.1-152.6) 107.3 (95.5-119.5) 106.2 (85.6-134.2) 1.00 GH2 (ng/ml): Median (IQ range) 2.7 (1.6-4.0) 3.4 (2.3-4.3) 2.7 (1.6-4.2) 0.81 Insulin (uU/L): Median (IQ range) 31.9 (16.6-54.1) 39.9 (21.0-58.3) 34.0 (16.6-55.4) 0.84 HOMA-IR: Median (IQ range) 7.4 (3.7-16.1) 10.1 (5.4-14.6) 8.1 (3.6-17.4) 0.82 Glucose (mmol/L): Median (IQ range) 5.9 (5.2-6.6) 5.6 (5.4-6.0) 5.8 (5.2-6.6) 0.50 Serum folate concentration (nM): Median (IQ range) 39.6 (32.2-43.8) 41.4 (32.1-43.7) 40.1 (32.0-43.8) 0.93 B12 concentration (pM): Median (IQ range) 245.0 (192.0-332.0) 257.0 (245.0-324.5) 253.5 (194.2-333.0) 0.29 Folate:B12 ratio: Median (IQ range) 167.7 (118.7-211.5) 122.6 (114.2-155.7) 158.9 (116.5-210.2) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (53.0-81.5) 85.0 (77.0-104.0) 68.0 (55.0-86.0) 0.14 Folate:Active B12 ratio: Median (IQ range) 559.7 (436.8-674.3) 438.2 (424.7-516.5) 553.8 (424.7-660.3) 0.32 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 3.8 (3.7-4.2) 3.9 (3.6-4.6) 0.66 Click here for table within STOP Within Uncomplicated Characteristic &lt;=90th centile (n=615) &gt;90th centile (n=76) Total (n=691) P-value PRL (ng/ml): Median (IQ range) 73.0 (48.7-114.6) 68.7 (47.2-104.7) 72.9 (48.6-113.5) 0.68 hPL (μg/ml): Median (IQ range) 63.5 (41.0-98.8) 58.5 (48.5-86.7) 62.4 (41.4-96.7) 0.98 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (0.9-1.9) 1.4 (0.9-2.4) 0.33 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-45.3) 41.3 (37.2-44.8) 40.5 (36.4-45.2) 0.53 B12 concentration (pM): Median (IQ range) 277.0 (217.0-354.0) 286.0 (233.0-374.0) 278.5 (220.8-355.2) 0.24 Folate:B12 ratio: Median (IQ range) 155.4 (116.2-224.2) 160.8 (109.9-210.6) 155.5 (115.1-222.4) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (48.0-80.0) 68.5 (52.2-90.2) 63.0 (48.0-81.0) 0.18 Folate:Active B12 ratio: Median (IQ range) 670.5 (502.6-964.3) 646.1 (459.1-843.8) 670.2 (490.7-948.9) 0.32 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.4-5.5) 4.8 (4.3-5.6) 0.96 Within GDM Characteristic &lt;=90th centile (n=169) &gt;90th centile (n=22) Total (n=191) P-value PRL (ng/ml): Median (IQ range) 64.1 (42.3-111.0) 99.2 (82.6-186.0) 70.4 (43.2-114.3) 0.002 hPL (μg/ml): Median (IQ range) 57.0 (36.2-83.8) 56.7 (33.7-81.4) 57.0 (35.5-83.8) 0.85 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.2) 1.3 (0.9-1.9) 1.3 (0.9-2.2) 0.80 Serum folate concentration (nM): Median (IQ range) 39.9 (35.1-44.7) 43.1 (38.3-63.6) 40.2 (35.5-45.2) 0.08 B12 concentration (pM): Median (IQ range) 275.5 (216.8-356.5) 269.5 (198.0-297.2) 273.5 (215.9-353.0) 0.34 Folate:B12 ratio: Median (IQ range) 145.9 (107.6-218.0) 162.5 (130.5-251.1) 148.0 (111.6-221.1) 0.12 Active B12 concentration (pM): Median (IQ range) 74.5 (56.0-88.0) 77.0 (68.8-96.2) 74.5 (56.0-88.8) 0.43 Folate:Active B12 ratio: Median (IQ range) 539.3 (419.9-784.7) 531.8 (431.4-817.4) 531.9 (419.8-790.5) 0.98 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.3) 4.5 (3.8-4.8) 4.7 (4.0-5.3) 0.06 "],["prolactin-20.html", "30.1 Prolactin", " 30.1 Prolactin LME for repeated measures. 30.1.1 Model summary Var Effect P (Intercept) 12.94 (8.70, 19.24) &lt;0.0001 BW_gp&gt;90th centile 1.18 (0.97, 1.45) 0.09 GDM_newGDM 0.92 (0.74, 1.14) 0.43 StudySTOP 1.00 (0.88, 1.13) 0.97 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.93 (0.72, 1.19) 0.56 GDM_newGDM:StudySTOP 1.13 (0.89, 1.44) 0.30 BW_gp&gt;90th centile:GDM_newGDM 1.15 (0.60, 2.19) 0.67 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 1.16 (0.57, 2.38) 0.68 30.1.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 93.18 7.55 105.00 79.35 109.43 &gt;90th centile SCOPE Uncomplicated 110.42 13.51 458.37 86.82 140.43 &lt;=90th centile STOP Uncomplicated 92.99 6.98 77.66 80.08 107.98 &gt;90th centile STOP Uncomplicated 102.36 10.47 251.92 83.69 125.20 &lt;=90th centile SCOPE GDM 85.31 10.98 507.83 66.25 109.85 &gt;90th centile SCOPE GDM 116.21 35.53 1039.60 63.79 211.72 &lt;=90th centile STOP GDM 96.44 8.60 149.35 80.86 115.04 &gt;90th centile STOP GDM 141.86 21.51 804.69 105.34 191.05 30.1.3 Post-hoc comparisons 30.1.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE 1.18 (0.97, 1.45) 0.09 &gt;90th centile / &lt;=90th centile STOP 1.10 (0.95, 1.28) 0.2 &gt;90th centile / &lt;=90th centile SCOPE 1.36 (0.74, 2.51) 0.3 &gt;90th centile / &lt;=90th centile STOP 1.47 (1.12, 1.94) 0.006 30.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.0031710 0.3668862 1118.284 0.4894753 2.055981 0.993 ns STOP/SCOPE (Uncomplicated) 0.9290065 0.1186387 1401.109 0.7231396 1.193481 0.564 ns STOP/SCOPE (GDM) 1.0798320 0.3701594 1071.725 0.5511121 2.115789 0.823 ns GDM/Uncomplicated (SCOPE) 1.1495773 0.3775124 1052.036 0.6035151 2.189718 0.671 ns GDM/Uncomplicated (STOP) 1.3362128 0.2139029 1409.313 0.9761059 1.829171 0.070 ns "],["hpl-20.html", "30.2 HPL", " 30.2 HPL LME for repeated measures. 30.2.1 Model summary Var Effect P (Intercept) 1.85 (1.51, 2.27) &lt;0.0001 BW_gp&gt;90th centile 1.15 (1.03, 1.28) 0.01 GDM_newGDM 0.91 (0.82, 1.01) 0.08 StudySTOP 1.14 (1.07, 1.22) 0.0001 GA_samp 1.34 (1.32, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.00 (0.88, 1.15) 0.97 GDM_newGDM:StudySTOP 1.08 (0.96, 1.22) 0.20 BW_gp&gt;90th centile:GDM_newGDM 1.21 (0.88, 1.67) 0.24 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 0.74 (0.52, 1.07) 0.11 30.2.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 85.47 2.52 198.46 80.64 90.58 &gt;90th centile SCOPE Uncomplicated 98.07 5.58 1063.99 87.71 109.64 &lt;=90th centile STOP Uncomplicated 97.71 2.49 111.79 92.90 102.78 &gt;90th centile STOP Uncomplicated 112.40 5.14 756.69 102.74 122.96 &lt;=90th centile SCOPE GDM 77.80 4.41 671.88 69.61 86.95 &gt;90th centile SCOPE GDM 108.15 15.94 578.84 80.97 144.45 &lt;=90th centile STOP GDM 96.28 3.49 346.45 89.65 103.40 &gt;90th centile STOP GDM 99.81 7.67 1372.55 85.84 116.06 30.2.3 Post-hoc comparisons 30.2.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE 1.15 (1.03, 1.28) 0.01 &gt;90th centile / &lt;=90th centile STOP 1.15 (1.06, 1.25) 0.0009 &gt;90th centile / &lt;=90th centile SCOPE 1.39 (1.03, 1.88) 0.03 &gt;90th centile / &lt;=90th centile STOP 1.04 (0.89, 1.21) 0.6 30.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.7476478 0.1381842 773.5571 0.5201480 1.074650 0.116 ns STOP/SCOPE (Uncomplicated) 1.0024878 0.0686687 1375.6882 0.8764394 1.146664 0.971 ns STOP/SCOPE (GDM) 0.7457924 0.1281386 693.8980 0.5322466 1.045016 0.088 ns GDM/Uncomplicated (SCOPE) 1.2115322 0.1970244 633.1960 0.8803268 1.667347 0.238 ns GDM/Uncomplicated (STOP) 0.9013092 0.0795092 1409.0366 0.7580891 1.071587 0.239 ns "],["gh2-20.html", "30.3 GH2", " 30.3 GH2 LME for repeated measures. 30.3.1 Model summary Var Effect P (Intercept) 0.07 (0.06, 0.10) &lt;0.0001 BW_gp&gt;90th centile 1.07 (0.92, 1.23) 0.39 GDM_newGDM 0.89 (0.76, 1.04) 0.13 StudySTOP 0.98 (0.90, 1.08) 0.71 GA_samp 1.30 (1.28, 1.32) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.99 (0.82, 1.19) 0.91 GDM_newGDM:StudySTOP 1.18 (0.99, 1.40) 0.06 BW_gp&gt;90th centile:GDM_newGDM 1.06 (0.66, 1.70) 0.82 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 0.85 (0.50, 1.44) 0.54 30.3.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 2.24 0.08 471.07 2.10 2.40 &gt;90th centile SCOPE Uncomplicated 2.39 0.18 1396.84 2.06 2.77 &lt;=90th centile STOP Uncomplicated 2.21 0.06 223.72 2.09 2.32 &gt;90th centile STOP Uncomplicated 2.33 0.14 1243.02 2.07 2.61 &lt;=90th centile SCOPE GDM 1.99 0.16 1135.89 1.70 2.33 &gt;90th centile SCOPE GDM 2.24 0.49 844.40 1.46 3.44 &lt;=90th centile STOP GDM 2.31 0.10 542.15 2.12 2.51 &gt;90th centile STOP GDM 2.18 0.22 1464.87 1.79 2.65 30.3.3 Post-hoc comparisons 30.3.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE 1.07 (0.92, 1.23) 0.4 &gt;90th centile / &lt;=90th centile STOP 1.05 (0.94, 1.18) 0.4 &gt;90th centile / &lt;=90th centile SCOPE 1.12 (0.72, 1.77) 0.6 &gt;90th centile / &lt;=90th centile STOP 0.94 (0.77, 1.16) 0.6 30.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8300292 0.2242689 1055.9174 0.4884723 1.410415 0.491 ns STOP/SCOPE (Uncomplicated) 0.9898510 0.0934756 1471.6718 0.8224723 1.191293 0.914 ns STOP/SCOPE (GDM) 0.8385396 0.2123336 987.7004 0.5101751 1.378250 0.487 ns GDM/Uncomplicated (SCOPE) 1.0558885 0.2550816 943.8044 0.6572350 1.696350 0.822 ns GDM/Uncomplicated (STOP) 0.8944823 0.1069154 1471.3225 0.7075316 1.130831 0.351 ns "],["insulin-18.html", "30.4 Insulin", " 30.4 Insulin GEE for repeated measures. 30.4.1 Model summary Var Effect P (Intercept) 13.06 (7.73, 22.08) &lt;0.0001 BW_gp&gt;90th centile 1.16 (0.83, 1.62) 0.37 GDM_newGDM 2.43 (1.79, 3.30) &lt;0.0001 StudySTOP 0.76 (0.64, 0.91) 0.002 GA_samp 1.00 (0.97, 1.04) 0.82 BW_gp&gt;90th centile:StudySTOP 0.83 (0.56, 1.22) 0.34 GDM_newGDM:StudySTOP 0.71 (0.50, 1.00) 0.05 BW_gp&gt;90th centile:GDM_newGDM 0.46 (0.19, 1.11) 0.09 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 2.60 (0.93, 7.27) 0.07 30.4.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 13.75 0.88 Inf 12.14 15.58 &gt;90th centile SCOPE Uncomplicated 15.98 2.66 Inf 11.53 22.16 &lt;=90th centile STOP Uncomplicated 10.46 0.44 Inf 9.63 11.37 &gt;90th centile STOP Uncomplicated 10.07 1.00 Inf 8.30 12.23 &lt;=90th centile SCOPE GDM 33.42 5.13 Inf 24.74 45.16 &gt;90th centile SCOPE GDM 17.83 7.03 Inf 8.24 38.61 &lt;=90th centile STOP GDM 18.01 1.42 Inf 15.44 21.01 &gt;90th centile STOP GDM 20.66 4.93 Inf 12.93 32.99 30.4.3 Post-hoc comparisons 30.4.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE 1.16 (0.83, 1.62) 0.4 &gt;90th centile / &lt;=90th centile STOP 0.96 (0.79, 1.17) 0.7 &gt;90th centile / &lt;=90th centile SCOPE 0.53 (0.23, 1.21) 0.1 &gt;90th centile / &lt;=90th centile STOP 1.15 (0.71, 1.86) 0.6 30.4.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.7812368 0.9360468 Inf 0.6359339 4.989205 0.272 ns STOP/SCOPE (Uncomplicated) 0.8284024 0.1626572 Inf 0.5637773 1.217237 0.338 ns STOP/SCOPE (GDM) 2.1502072 1.0480854 Inf 0.8271328 5.589660 0.116 ns GDM/Uncomplicated (SCOPE) 0.4590172 0.2077239 Inf 0.1890714 1.114377 0.085 ns GDM/Uncomplicated (STOP) 1.1914284 0.3181725 Inf 0.7059167 2.010863 0.512 ns "],["homa-ir-18.html", "30.5 HOMA-IR", " 30.5 HOMA-IR GEE for repeated measures. 30.5.1 Model summary Var Effect P (Intercept) 3.31 (1.90, 5.76) &lt;0.0001 BW_gp&gt;90th centile 1.20 (0.85, 1.70) 0.30 GDM_newGDM 2.64 (1.86, 3.75) &lt;0.0001 StudySTOP 0.66 (0.54, 0.79) &lt;0.0001 GA_samp 1.00 (0.97, 1.04) 0.99 BW_gp&gt;90th centile:StudySTOP 0.81 (0.54, 1.22) 0.32 GDM_newGDM:StudySTOP 0.68 (0.46, 1.01) 0.05 BW_gp&gt;90th centile:GDM_newGDM 0.47 (0.19, 1.14) 0.10 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 2.41 (0.84, 6.87) 0.10 30.5.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 3.32 0.23 Inf 2.91 3.79 &gt;90th centile SCOPE Uncomplicated 3.99 0.70 Inf 2.84 5.62 &lt;=90th centile STOP Uncomplicated 2.18 0.10 Inf 2.00 2.38 &gt;90th centile STOP Uncomplicated 2.13 0.22 Inf 1.73 2.62 &lt;=90th centile SCOPE GDM 8.76 1.55 Inf 6.19 12.39 &gt;90th centile SCOPE GDM 4.90 1.89 Inf 2.30 10.45 &lt;=90th centile STOP GDM 3.91 0.33 Inf 3.31 4.62 &gt;90th centile STOP GDM 4.28 1.05 Inf 2.65 6.92 30.5.3 Post-hoc comparisons 30.5.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE 1.20 (0.85, 1.70) 0.3 &gt;90th centile / &lt;=90th centile STOP 0.98 (0.79, 1.20) 0.8 &gt;90th centile / &lt;=90th centile SCOPE 0.56 (0.24, 1.28) 0.2 &gt;90th centile / &lt;=90th centile STOP 1.09 (0.66, 1.81) 0.7 30.5.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 1.5935500 0.8527789 Inf 0.5582776 4.548636 0.384 ns STOP/SCOPE (Uncomplicated) 0.8138401 0.1679260 Inf 0.5431303 1.219478 0.318 ns STOP/SCOPE (GDM) 1.9580629 0.9669252 Inf 0.7438556 5.154240 0.174 ns GDM/Uncomplicated (SCOPE) 0.4654494 0.2133441 Inf 0.1895459 1.142959 0.095 ns GDM/Uncomplicated (STOP) 1.1198505 0.3091731 Inf 0.6518635 1.923815 0.682 ns "],["glucose-16.html", "30.6 Glucose", " 30.6 Glucose GEE for repeated measures. 30.6.1 Model summary Var Effect P (Intercept) 5.51 (4.93, 6.16) &lt;0.0001 BW_gp&gt;90th centile 1.07 (1.00, 1.13) 0.04 GDM_newGDM 1.12 (0.99, 1.26) 0.06 StudySTOP 0.87 (0.84, 0.90) &lt;0.0001 GA_samp 1.00 (0.99, 1.01) 0.65 BW_gp&gt;90th centile:StudySTOP 1.00 (0.91, 1.10) 1.00 GDM_newGDM:StudySTOP 0.94 (0.83, 1.06) 0.31 BW_gp&gt;90th centile:GDM_newGDM 0.91 (0.78, 1.06) 0.21 BW_gp&gt;90th centile:GDM_newGDM:StudySTOP 0.98 (0.83, 1.17) 0.86 30.6.2 Estimated marginal means BW_gp Study GDM_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE Uncomplicated 5.39 0.07 Inf 5.26 5.52 &gt;90th centile SCOPE Uncomplicated 5.74 0.17 Inf 5.41 6.10 &lt;=90th centile STOP Uncomplicated 4.68 0.04 Inf 4.61 4.76 &gt;90th centile STOP Uncomplicated 4.99 0.19 Inf 4.63 5.38 &lt;=90th centile SCOPE GDM 6.03 0.34 Inf 5.40 6.72 &gt;90th centile SCOPE GDM 5.82 0.24 Inf 5.37 6.31 &lt;=90th centile STOP GDM 4.92 0.07 Inf 4.78 5.06 &gt;90th centile STOP GDM 4.68 0.09 Inf 4.50 4.86 30.6.3 Post-hoc comparisons 30.6.3.1 Within Groups Contrast Study Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE 1.07 (1.00, 1.13) 0.04 &gt;90th centile / &lt;=90th centile STOP 1.07 (0.99, 1.15) 0.10 &gt;90th centile / &lt;=90th centile SCOPE 0.97 (0.84, 1.11) 0.6 &gt;90th centile / &lt;=90th centile STOP 0.95 (0.91, 0.99) 0.02 30.6.3.2 Between Groups contrast ratio SE df asymp.LCL asymp.UCL p.value SCOPE/SCOPE (Overall) 0.9847103 0.0885723 Inf 0.8255529 1.1745513 0.864 ns STOP/SCOPE (Uncomplicated) 1.0002131 0.0492606 Inf 0.9081776 1.1015756 0.997 ns STOP/SCOPE (GDM) 0.9845004 0.0735805 Inf 0.8503507 1.1398134 0.834 ns GDM/Uncomplicated (SCOPE) 0.9066157 0.0703320 Inf 0.7787357 1.0554954 0.206 ns GDM/Uncomplicated (STOP) 0.8923733 0.0395243 Inf 0.8181743 0.9733013 0.010 * "],["hormone-models-2.html", "31 Hormone Models ", " 31 Hormone Models "],["scope-vs-stop-2.html", "31.1 SCOPE vs STOP", " 31.1 SCOPE vs STOP - Outcomes: Prolactin, hPL, GH2, Insulin, HOME-IR, glucose (all outcomes log-transformed) - Independent variables: Study, GDM_new, BMI, Ethnicity (Caucasian/non-Caucasian), smoking (yes/no), GA at sampling - Model fitted: LME or GEE model       log(hormones) ~ Study + GA at sampling + Study:GA at sampling       Random intercepts for Study ID and Plate #outc_ls &lt;- c(&quot;Prolactin&quot;,&quot;HPL&quot;,&quot;GH2&quot;) outc_ls &lt;- c(hormone_var,insulin_var) outc2 &lt;- preg_out # fit LME fit_ls &lt;- lapply(outc_ls,function(outc){ if(outc%in%hormone_var){ #LME for hormones fit_eq &lt;- as.formula(paste0(&quot;log(&quot;,outc,&quot;)~ Study + &quot;,outc2,&quot; + BMI + Ethnicity_cauc + f10c_any_cig_1st_vst + GA_samp + Study*&quot;,outc2,&quot; + (1|Study.ID) + (1|Assay.&quot;,outc,&quot;)&quot;)) fit &lt;- eval(bquote(lmer(.(fit_eq),data=dat_run)))} if(outc%in%insulin_var){ #GEE for insulin fit_eq &lt;- as.formula(paste0(&quot;log(&quot;,outc,&quot;)~ Study + &quot;,outc2,&quot;+BMI+Ethnicity_cauc+f10c_any_cig_1st_vst+GA_samp+Study*&quot;,outc2)) dat_tmp &lt;- na.omit(dat_run[with(dat_run,order(Study,Study.ID)),c(&quot;Study&quot;,&quot;Study.ID&quot;,&quot;GA_samp&quot;,&quot;BMI&quot;,&quot;Ethnicity_cauc&quot;,&quot;f10c_any_cig_1st_vst&quot;,outc,outc2)]) fit &lt;- eval(bquote(geeglm(.(fit_eq),data=dat_tmp,id=Study.ID,corstr=&quot;independence&quot;)))} return(fit)}) names(fit_ls) &lt;- outc_ls # Type III SS anova_ls &lt;- lapply(fit_ls,function(fit){ if(!any(class(fit)%in%&quot;gee&quot;)){return(Anova(fit,type=&quot;III&quot;))} if(any(class(fit)%in%&quot;gee&quot;)){return(joint_tests(fit,cov.reduce=symmint(0)))}}) 31.1.1 Model Summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.1.2 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.1.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.1.4 Results 31.1.4.1 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling, BMI, ethnicity and smoking. em_eq &lt;- as.formula(paste0(&quot;pairwise~Study*&quot;,outc2)) #fit_em &lt;- lapply(fit_ls,function(x){emmeans(x,em_eq,type=&quot;response&quot;)}) fit_em &lt;- foreach(ind2=1:length(fit_ls),.packages=c(&quot;foreach&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;,&quot;geepack&quot;,&quot;emmeans&quot;)) %dopar% { emmeans(fit_ls[[ind2]],em_eq,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} names(fit_em) &lt;- names(fit_ls) fit_em_contrasts &lt;- lapply(fit_em,function(x){ contrast_dat &lt;- data.frame(x$emmeans) contrast_dat$Group &lt;- with(contrast_dat,paste(Study,get(outc2),sep=&quot;.&quot;)) contrast_mat &lt;- diag(nrow(contrast_dat)) rownames(contrast_mat) &lt;- colnames(contrast_mat) &lt;- contrast_dat$Group contrast_ls &lt;- list( &quot;STOP/SCOPE (Uncomplicated)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1]),], &quot;STOP/SCOPE (Cases)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2]),], &quot;Cases/Uncomplicated (SCOPE)&quot;=contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1]),], &quot;Cases/Uncomplicated (STOP)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1]),]) names(contrast_ls) &lt;- c(&quot;STOP/SCOPE (Uncomplicated)&quot;,paste0(&quot;STOP/SCOPE (&quot;,outc2,&quot;)&quot;), paste0(outc2,&quot;/Uncomplicated (SCOPE)&quot;),paste0(outc2,&quot;/Uncomplicated (STOP)&quot;)) contrast_out &lt;- contrast(x$emmeans,method=contrast_ls) return(contrast_out)}) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.1.5 Comparisons Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.1.5.1 Barplots 31.1.6 Comparisons by Timepoint Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.1.6.1 Barplots by Timepoint 31.1.6.2 Plots for GA "],["folate-3.html", "31.2 Folate", " 31.2 Folate 31.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.2.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling, BMI, ethnicity and smoking. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.2.4 Comparisons 31.2.4.1 Within Groups Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin Folate40.2 / Folate39.2 SCOPE 0.999 (0.997, 1.000) 0.1 Prolactin Folate40.2 / Folate39.2 STOP 1.000 (0.999, 1.002) 0.6 Prolactin Folate40.2 / Folate39.2 SCOPE 0.999 (0.996, 1.002) 0.5 Prolactin Folate40.2 / Folate39.2 STOP 1.001 (0.999, 1.003) 0.4 HPL Folate40.2 / Folate39.2 SCOPE 1.000 (0.999, 1.001) 0.5 HPL Folate40.2 / Folate39.2 STOP 1.000 (0.999, 1.001) 0.9 HPL Folate40.2 / Folate39.2 SCOPE 1.000 (0.999, 1.002) 0.7 HPL Folate40.2 / Folate39.2 STOP 1.001 (0.999, 1.002) 0.3 GH2 Folate40.2 / Folate39.2 SCOPE 1.000 (0.999, 1.002) 0.6 GH2 Folate40.2 / Folate39.2 STOP 1.000 (0.999, 1.001) 0.5 GH2 Folate40.2 / Folate39.2 SCOPE 1.000 (0.998, 1.003) 0.7 GH2 Folate40.2 / Folate39.2 STOP 1.000 (0.998, 1.001) 0.7 Insulin Folate40.2 / Folate39.2 SCOPE 0.997 (0.995, 1.000) 0.02 Insulin Folate40.2 / Folate39.2 STOP 0.999 (0.997, 1.000) 0.1 Insulin Folate40.2 / Folate39.2 SCOPE 0.997 (0.992, 1.001) 0.1 Insulin Folate40.2 / Folate39.2 STOP 0.998 (0.995, 1.001) 0.2 HOMA.IR Folate40.2 / Folate39.2 SCOPE 0.997 (0.995, 0.999) 0.02 HOMA.IR Folate40.2 / Folate39.2 STOP 0.999 (0.997, 1.000) 0.1 HOMA.IR Folate40.2 / Folate39.2 SCOPE 0.996 (0.991, 1.001) 0.08 HOMA.IR Folate40.2 / Folate39.2 STOP 0.997 (0.994, 1.001) 0.1 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE 1.000 (0.999, 1.000) 0.2 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP 1.000 (1.000, 1.001) 0.4 GLUC3_mmol.L Folate40.2 / Folate39.2 SCOPE 0.999 (0.997, 1.000) 0.03 GLUC3_mmol.L Folate40.2 / Folate39.2 STOP 0.999 (0.998, 1.000) 0.02 31.2.4.2 Between Groups Below are comparisons of the differences in the change in Serum folate concentration (nM) between groups. I.e. whether the change in Serum folate concentration (nM) are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.2.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.2.6 Plots "],["b12-3.html", "31.3 B12", " 31.3 B12 31.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.3.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.3.4 Comparisons 31.3.4.1 Within Groups Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin B12366 / B12266 SCOPE 1.010 (0.956, 1.067) 0.7 Prolactin B12366 / B12266 STOP 1.017 (0.978, 1.058) 0.4 Prolactin B12366 / B12266 SCOPE 1.045 (0.958, 1.140) 0.3 Prolactin B12366 / B12266 STOP 1.052 (0.986, 1.123) 0.1 HPL B12366 / B12266 SCOPE 1.027 (0.998, 1.058) 0.07 HPL B12366 / B12266 STOP 1.013 (0.992, 1.035) 0.2 HPL B12366 / B12266 SCOPE 1.008 (0.962, 1.055) 0.7 HPL B12366 / B12266 STOP 0.994 (0.960, 1.030) 0.7 GH2 B12366 / B12266 SCOPE 1.060 (1.018, 1.103) 0.004 GH2 B12366 / B12266 STOP 1.016 (0.987, 1.045) 0.3 GH2 B12366 / B12266 SCOPE 1.077 (1.011, 1.148) 0.02 GH2 B12366 / B12266 STOP 1.032 (0.984, 1.083) 0.2 Insulin B12366 / B12266 SCOPE 0.916 (0.833, 1.008) 0.07 Insulin B12366 / B12266 STOP 0.973 (0.921, 1.027) 0.3 Insulin B12366 / B12266 SCOPE 0.798 (0.598, 1.063) 0.1 Insulin B12366 / B12266 STOP 0.927 (0.840, 1.024) 0.1 HOMA.IR B12366 / B12266 SCOPE 0.914 (0.825, 1.013) 0.09 HOMA.IR B12366 / B12266 STOP 0.973 (0.917, 1.032) 0.4 HOMA.IR B12366 / B12266 SCOPE 0.814 (0.593, 1.117) 0.2 HOMA.IR B12366 / B12266 STOP 0.923 (0.829, 1.027) 0.1 GLUC3_mmol.L B12366 / B12266 SCOPE 0.989 (0.973, 1.005) 0.2 GLUC3_mmol.L B12366 / B12266 STOP 0.996 (0.986, 1.005) 0.4 GLUC3_mmol.L B12366 / B12266 SCOPE 0.992 (0.960, 1.026) 0.7 GLUC3_mmol.L B12366 / B12266 STOP 0.999 (0.978, 1.020) 0.9 31.3.4.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.3.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.3.6 Comparisons (50 unit increase) 31.3.6.1 Within Groups Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin B12316 / B12266 SCOPE 1.005 (0.978, 1.033) 0.7 Prolactin B12316 / B12266 STOP 1.008 (0.989, 1.028) 0.4 Prolactin B12316 / B12266 SCOPE 1.022 (0.979, 1.068) 0.3 Prolactin B12316 / B12266 STOP 1.026 (0.993, 1.060) 0.1 HPL B12316 / B12266 SCOPE 1.013 (0.999, 1.028) 0.07 HPL B12316 / B12266 STOP 1.007 (0.996, 1.017) 0.2 HPL B12316 / B12266 SCOPE 1.004 (0.981, 1.027) 0.7 HPL B12316 / B12266 STOP 0.997 (0.980, 1.015) 0.7 GH2 B12316 / B12266 SCOPE 1.029 (1.009, 1.050) 0.004 GH2 B12316 / B12266 STOP 1.008 (0.994, 1.022) 0.3 GH2 B12316 / B12266 SCOPE 1.038 (1.005, 1.071) 0.02 GH2 B12316 / B12266 STOP 1.016 (0.992, 1.041) 0.2 Insulin B12316 / B12266 SCOPE 0.957 (0.912, 1.004) 0.07 Insulin B12316 / B12266 STOP 0.986 (0.960, 1.013) 0.3 Insulin B12316 / B12266 SCOPE 0.893 (0.774, 1.031) 0.1 Insulin B12316 / B12266 STOP 0.963 (0.916, 1.012) 0.1 HOMA.IR B12316 / B12266 SCOPE 0.956 (0.908, 1.006) 0.09 HOMA.IR B12316 / B12266 STOP 0.987 (0.958, 1.016) 0.4 HOMA.IR B12316 / B12266 SCOPE 0.902 (0.770, 1.057) 0.2 HOMA.IR B12316 / B12266 STOP 0.961 (0.911, 1.013) 0.1 GLUC3_mmol.L B12316 / B12266 SCOPE 0.995 (0.986, 1.003) 0.2 GLUC3_mmol.L B12316 / B12266 STOP 0.998 (0.993, 1.003) 0.4 GLUC3_mmol.L B12316 / B12266 SCOPE 0.996 (0.980, 1.013) 0.7 GLUC3_mmol.L B12316 / B12266 STOP 0.999 (0.989, 1.010) 0.9 31.3.6.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.3.7 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.3.8 Plots "],["folateb12-3.html", "31.4 Folate:B12", " 31.4 Folate:B12 31.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.4.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.4.4 Comparisons 31.4.4.1 Within Groups Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin folate_B12245.96 / folate_B12145.96 SCOPE 0.961 (0.924, 0.999) 0.04 Prolactin folate_B12245.96 / folate_B12145.96 STOP 1.023 (0.991, 1.055) 0.2 Prolactin folate_B12245.96 / folate_B12145.96 SCOPE 0.959 (0.906, 1.016) 0.2 Prolactin folate_B12245.96 / folate_B12145.96 STOP 1.021 (0.980, 1.064) 0.3 HPL folate_B12245.96 / folate_B12145.96 SCOPE 0.988 (0.968, 1.008) 0.2 HPL folate_B12245.96 / folate_B12145.96 STOP 1.001 (0.984, 1.018) 1.0 HPL folate_B12245.96 / folate_B12145.96 SCOPE 0.982 (0.953, 1.012) 0.2 HPL folate_B12245.96 / folate_B12145.96 STOP 0.994 (0.972, 1.017) 0.6 GH2 folate_B12245.96 / folate_B12145.96 SCOPE 0.977 (0.950, 1.005) 0.1 GH2 folate_B12245.96 / folate_B12145.96 STOP 0.993 (0.970, 1.016) 0.5 GH2 folate_B12245.96 / folate_B12145.96 SCOPE 0.974 (0.934, 1.016) 0.2 GH2 folate_B12245.96 / folate_B12145.96 STOP 0.990 (0.960, 1.020) 0.5 Insulin folate_B12245.96 / folate_B12145.96 SCOPE 0.986 (0.937, 1.037) 0.6 Insulin folate_B12245.96 / folate_B12145.96 STOP 0.996 (0.961, 1.033) 0.8 Insulin folate_B12245.96 / folate_B12145.96 SCOPE 1.002 (0.913, 1.100) 1.0 Insulin folate_B12245.96 / folate_B12145.96 STOP 0.979 (0.927, 1.034) 0.4 HOMA.IR folate_B12245.96 / folate_B12145.96 SCOPE 0.982 (0.931, 1.035) 0.5 HOMA.IR folate_B12245.96 / folate_B12145.96 STOP 0.997 (0.959, 1.037) 0.9 HOMA.IR folate_B12245.96 / folate_B12145.96 SCOPE 0.988 (0.879, 1.111) 0.8 HOMA.IR folate_B12245.96 / folate_B12145.96 STOP 0.973 (0.918, 1.033) 0.4 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 SCOPE 0.998 (0.988, 1.007) 0.6 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 STOP 1.007 (0.995, 1.018) 0.2 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 SCOPE 0.982 (0.956, 1.009) 0.2 GLUC3_mmol.L folate_B12245.96 / folate_B12145.96 STOP 0.991 (0.976, 1.006) 0.2 31.4.4.2 Between Groups Below are comparisons of the differences in the change in Folate:B12 ratio between groups. I.e. whether the change in Folate:B12 ratio are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.4.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.4.6 Plots "],["active-b12-3.html", "31.5 Active B12", " 31.5 Active B12 31.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.5.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.5.4 Comparisons 31.5.4.1 Within Groups Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin Active.B1271 / Active.B1261 SCOPE 1.011 (0.978, 1.046) 0.5 Prolactin Active.B1271 / Active.B1261 STOP 0.997 (0.970, 1.025) 0.8 Prolactin Active.B1271 / Active.B1261 SCOPE 1.021 (0.966, 1.078) 0.5 Prolactin Active.B1271 / Active.B1261 STOP 1.006 (0.962, 1.053) 0.8 HPL Active.B1271 / Active.B1261 SCOPE 1.007 (0.989, 1.025) 0.4 HPL Active.B1271 / Active.B1261 STOP 0.999 (0.984, 1.014) 0.9 HPL Active.B1271 / Active.B1261 SCOPE 1.029 (1.000, 1.059) 0.05 HPL Active.B1271 / Active.B1261 STOP 1.021 (0.997, 1.047) 0.09 GH2 Active.B1271 / Active.B1261 SCOPE 1.019 (0.996, 1.043) 0.1 GH2 Active.B1271 / Active.B1261 STOP 0.990 (0.970, 1.009) 0.3 GH2 Active.B1271 / Active.B1261 SCOPE 1.035 (0.996, 1.076) 0.08 GH2 Active.B1271 / Active.B1261 STOP 1.005 (0.973, 1.038) 0.8 Insulin Active.B1271 / Active.B1261 SCOPE 0.993 (0.946, 1.043) 0.8 Insulin Active.B1271 / Active.B1261 STOP 0.996 (0.956, 1.038) 0.9 Insulin Active.B1271 / Active.B1261 SCOPE 0.914 (0.796, 1.049) 0.2 Insulin Active.B1271 / Active.B1261 STOP 0.972 (0.900, 1.050) 0.5 HOMA.IR Active.B1271 / Active.B1261 SCOPE 0.991 (0.940, 1.045) 0.7 HOMA.IR Active.B1271 / Active.B1261 STOP 0.996 (0.954, 1.041) 0.9 HOMA.IR Active.B1271 / Active.B1261 SCOPE 0.900 (0.770, 1.052) 0.2 HOMA.IR Active.B1271 / Active.B1261 STOP 0.971 (0.892, 1.056) 0.5 GLUC3_mmol.L Active.B1271 / Active.B1261 SCOPE 1.001 (0.991, 1.011) 0.9 GLUC3_mmol.L Active.B1271 / Active.B1261 STOP 1.008 (0.998, 1.019) 0.1 GLUC3_mmol.L Active.B1271 / Active.B1261 SCOPE 0.980 (0.955, 1.004) 0.1 GLUC3_mmol.L Active.B1271 / Active.B1261 STOP 0.987 (0.970, 1.004) 0.1 31.5.4.2 Between Groups Below are comparisons of the differences in the change in Active B12 concentration (pM) between groups. I.e. whether the change in Active B12 concentration (pM) are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.5.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.5.6 Plots "],["folateactive-b12-3.html", "31.6 Folate:Active B12", " 31.6 Folate:Active B12 31.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.6.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.6.4 Comparisons 31.6.4.1 Within Groups Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.958 (0.913, 1.005) 0.08 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 STOP 1.057 (1.006, 1.110) 0.03 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.955 (0.874, 1.045) 0.3 Prolactin folate_Active.B121123.57 / folate_Active.B12623.57 STOP 1.054 (0.980, 1.133) 0.2 HPL folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 1.001 (0.976, 1.027) 0.9 HPL folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.972 (0.947, 0.998) 0.04 HPL folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 1.019 (0.970, 1.070) 0.4 HPL folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.990 (0.951, 1.030) 0.6 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.978 (0.947, 1.011) 0.2 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 STOP 1.021 (0.986, 1.057) 0.2 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.958 (0.899, 1.022) 0.2 GH2 folate_Active.B121123.57 / folate_Active.B12623.57 STOP 1.000 (0.949, 1.055) 1.0 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.950 (0.902, 1.002) 0.06 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.999 (0.939, 1.062) 1.0 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.966 (0.889, 1.049) 0.4 Insulin folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.931 (0.850, 1.019) 0.1 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.946 (0.896, 0.999) 0.05 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.996 (0.932, 1.064) 0.9 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.958 (0.870, 1.055) 0.4 HOMA.IR folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.912 (0.832, 1.000) 0.05 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.991 (0.986, 0.996) 0.0006 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.996 (0.984, 1.008) 0.5 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 SCOPE 0.971 (0.945, 0.998) 0.04 GLUC3_mmol.L folate_Active.B121123.57 / folate_Active.B12623.57 STOP 0.976 (0.957, 0.995) 0.02 31.6.4.2 Between Groups Below are comparisons of the differences in the change in Folate:Active B12 ratio between groups. I.e. whether the change in Folate:Active B12 ratio are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.6.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.6.6 Plots "],["homocysteine-3.html", "31.7 Homocysteine", " 31.7 Homocysteine 31.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.7.2 Model summary Ratio of Geometric means (95% CI) Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.7.4 Comparisons 31.7.4.1 Within Groups Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study Ratio of Geometric means (95% CI) P-value Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE 0.978 (0.930, 1.027) 0.4 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP 0.967 (0.927, 1.009) 0.1 Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE 0.952 (0.860, 1.053) 0.3 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP 0.941 (0.865, 1.024) 0.2 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE 0.990 (0.964, 1.017) 0.5 HPL Homocysteine5.5 / Homocysteine4.5 STOP 0.983 (0.961, 1.006) 0.1 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE 0.927 (0.878, 0.979) 0.006 HPL Homocysteine5.5 / Homocysteine4.5 STOP 0.921 (0.879, 0.964) 0.0004 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE 0.980 (0.946, 1.016) 0.3 GH2 Homocysteine5.5 / Homocysteine4.5 STOP 1.003 (0.973, 1.035) 0.8 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE 0.934 (0.868, 1.006) 0.07 GH2 Homocysteine5.5 / Homocysteine4.5 STOP 0.956 (0.899, 1.017) 0.2 Insulin Homocysteine5.5 / Homocysteine4.5 SCOPE 0.979 (0.905, 1.059) 0.6 Insulin Homocysteine5.5 / Homocysteine4.5 STOP 0.980 (0.926, 1.038) 0.5 Insulin Homocysteine5.5 / Homocysteine4.5 SCOPE 0.576 (0.442, 0.750) &lt;0.0001 Insulin Homocysteine5.5 / Homocysteine4.5 STOP 0.870 (0.747, 1.014) 0.07 HOMA.IR Homocysteine5.5 / Homocysteine4.5 SCOPE 0.980 (0.901, 1.067) 0.6 HOMA.IR Homocysteine5.5 / Homocysteine4.5 STOP 0.982 (0.924, 1.044) 0.6 HOMA.IR Homocysteine5.5 / Homocysteine4.5 SCOPE 0.518 (0.387, 0.695) &lt;0.0001 HOMA.IR Homocysteine5.5 / Homocysteine4.5 STOP 0.865 (0.736, 1.017) 0.08 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 SCOPE 0.992 (0.978, 1.008) 0.3 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 STOP 1.001 (0.986, 1.017) 0.9 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 SCOPE 0.952 (0.913, 0.993) 0.02 GLUC3_mmol.L Homocysteine5.5 / Homocysteine4.5 STOP 0.960 (0.931, 0.991) 0.01 31.7.4.2 Between Groups Below are comparisons of the differences in the change in Homocysteine concentration (μM) between groups. I.e. whether the change in Homocysteine concentration (μM) are different between groups. Prolactin HPL GH2 Insulin HOMA.IR GLUC3_mmol.L 31.7.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 Diagnositcs for Insulin Diagnositcs for HOMA.IR Diagnositcs for GLUC3_mmol.L 31.7.6 Plots "],["part-gdm-vs-non-gdm.html", "(PART*) GDM vs non-GDM", " (PART*) GDM vs non-GDM "],["descriptives-3.html", "32 Descriptives", " 32 Descriptives Results in this section are from univariate analyses. Characteristic non-GDM (n=2121) GDM (n=256) Total (n=2377) P-value PRL (ng/ml): Mean (SD) 144.1 (163.6) 109.8 (109.4) 140.3 (158.8) &lt;0.0001 hPL (μg/ml): Mean (SD) 123.9 (75.4) 81.8 (56.3) 119.2 (74.7) &lt;0.0001 GH2 (ng/ml): Mean (SD) 3.2 (2.7) 2.2 (1.8) 3.1 (2.6) &lt;0.0001 "],["within-scope-1.html", "32.1 Within SCOPE", " 32.1 Within SCOPE 32.1.1 Demographics Characteristic non-GDM (n=1073) GDM (n=58) Total (n=1131) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 28.0 (25.0-32.0) 23.0 (20.0-27.0) &lt;0.0001 Maternal age (yrs): N(%) 0.29 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1054 (98.2) 56 (96.6) 1110 (98.1) &gt;=35 19 (1.8) 2 (3.4) 21 (1.9) Maternal BMI: Median (IQ range) 25.4 (22.1-30.4) 30.6 (25.4-36.3) 25.5 (22.2-30.8) &lt;0.0001 : N(%) 0.0010 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 115 (10.7) 1 (1.7) 116 (10.3) &gt;=20 to &lt;25 377 (35.1) 13 (22.4) 390 (34.5) &gt;=25 to &lt;30 301 (28.1) 13 (22.4) 314 (27.8) &gt;=30 to &lt;40 234 (21.8) 24 (41.4) 258 (22.8) &gt;=40 46 (4.3) 7 (12.1) 53 (4.7) SEI: Median (IQ range) 25.0 (20.0-30.0) 27.0 (20.2-34.0) 26.0 (20.0-30.0) 0.14 : N(%) 0.39 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 987 (92.0) 51 (87.9) 1038 (91.8) Maori 5 (0.5) 0 (0.0) 5 (0.4) Pacific Islander 1 (0.1) 0 (0.0) 1 (0.1) South East and Far East 36 (3.4) 4 (6.9) 40 (3.5) Indian 3 (0.3) 1 (1.7) 4 (0.4) African 4 (0.4) 0 (0.0) 4 (0.4) Middle-eastern 5 (0.5) 0 (0.0) 5 (0.4) Hispanic 0 (0.0) 0 (0.0) 0 (0.0) Aboriginal 21 (2.0) 1 (1.7) 22 (1.9) China and Japan 0 (0.0) 0 (0.0) 0 (0.0) Other 11 (1.0) 1 (1.7) 12 (1.1) : N(%) 0.10 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 813 (75.8) 50 (86.2) 863 (76.3) Yes 260 (24.2) 8 (13.8) 268 (23.7) : N(%) 0.09 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 230 (21.4) 9 (15.5) 239 (21.1) &lt;800 571 (53.2) 27 (46.6) 598 (52.9) &gt;=800 272 (25.3) 22 (37.9) 294 (26.0) : N(%) 0.18 Missing 0 (0.0) 0 (0.0) 0 (0.0) None 230 (21.4) 9 (15.5) 239 (21.1) &lt;=400 105 (9.8) 6 (10.3) 111 (9.8) &gt;400 to &lt;800 466 (43.4) 21 (36.2) 487 (43.1) &gt;=800 272 (25.3) 22 (37.9) 294 (26.0) : N(%) 0.008 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 110 (10.3) 3 (5.2) 113 (10.0) 1-6x/week 417 (38.9) 19 (32.8) 436 (38.5) &gt;=1-&lt;3x/day 367 (34.2) 32 (55.2) 399 (35.3) &gt;=3x/day 179 (16.7) 4 (6.9) 183 (16.2) : N(%) 0.20 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1-3x/month 103 (9.6) 3 (5.2) 106 (9.4) 1-2x/week 249 (23.2) 13 (22.4) 262 (23.2) 3-6x/week 430 (40.1) 31 (53.4) 461 (40.8) &gt;=1x/day 291 (27.1) 11 (19.0) 302 (26.7) : N(%) 0.97 Missing 216 (20.1) 9 (15.5) 225 (19.9) Never 15 (1.4) 1 (1.7) 16 (1.4) &gt;0-&lt;2x/week 102 (9.5) 6 (10.3) 108 (9.5) &gt;=2-&lt;4x/week 436 (40.6) 25 (43.1) 461 (40.8) &gt;=4x/week 304 (28.3) 17 (29.3) 321 (28.4) : N(%) 0.35 Missing 3 (0.3) 0 (0.0) 3 (0.3) Never 694 (64.7) 38 (65.5) 732 (64.7) Once a week 264 (24.6) 19 (32.8) 283 (25.0) 2-3/wk 84 (7.8) 1 (1.7) 85 (7.5) 4-6/wk 14 (1.3) 0 (0.0) 14 (1.2) Daily 12 (1.1) 0 (0.0) 12 (1.1) More than once a day 2 (0.2) 0 (0.0) 2 (0.2) : N(%) 0.65 Missing 3 (0.3) 0 (0.0) 3 (0.3) Never 453 (42.2) 30 (51.7) 483 (42.7) Once a week 278 (25.9) 16 (27.6) 294 (26.0) 2-3/wk 219 (20.4) 8 (13.8) 227 (20.1) 4-6/wk 51 (4.8) 1 (1.7) 52 (4.6) Daily 62 (5.8) 3 (5.2) 65 (5.7) More than once a day 7 (0.7) 0 (0.0) 7 (0.6) : N(%) 0.61 Missing 3 (0.3) 0 (0.0) 3 (0.3) Never 250 (23.3) 9 (15.5) 259 (22.9) Once a week 334 (31.1) 21 (36.2) 355 (31.4) 2-3/wk 283 (26.4) 17 (29.3) 300 (26.5) 4-6/wk 75 (7.0) 5 (8.6) 80 (7.1) Daily 102 (9.5) 6 (10.3) 108 (9.5) More than once a day 26 (2.4) 0 (0.0) 26 (2.3) Serum folate concentration (nM): Median (IQ range) 35.9 (28.1-42.6) 40.1 (32.0-43.8) 36.0 (28.3-42.8) 0.04 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 4.1 (0.9) 4.6 (1.1) 0.001 B12 concentration (pM): Median (IQ range) 245.0 (195.0-308.5) 253.5 (194.2-333.0) 245.0 (195.0-309.0) 0.60 Folate:B12 ratio: Median (IQ range) 142.7 (102.3-207.5) 158.9 (116.5-210.2) 143.0 (103.3-208.4) 0.28 Active B12 concentration (pM): Mean (SD) 60.1 (24.0) 72.7 (26.4) 60.7 (24.3) 0.02 Folate:Active B12 ratio: Median (IQ range) 615.4 (432.4-902.3) 553.8 (424.7-660.3) 602.8 (431.6-901.5) 0.32 Vitamin D: Median (IQ range) 58.0 (42.0-76.4) 55.8 (44.6-72.0) 57.7 (42.1-76.1) 0.74 UIC (ug/L): Median (IQ range) 105.0 (66.3-163.6) 132.7 (68.3-167.0) 105.7 (66.3-164.1) 0.57 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.6) 1.0 (0.7-1.6) 0.83 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.5-1.4) 1.0 (0.7-1.4) 0.23 Haemoglobin (g/L): Mean (SD) 129.1 (9.3) 130.9 (9.4) 129.2 (9.3) 0.15 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.14 32.1.2 MetS Characteristic non-GDM (n=1073) GDM (n=58) Total (n=1131) P-value MetS: N(%) &lt;0.0001 Missing 9 (0.8) 1 (1.7) 10 (0.9) No 898 (83.7) 29 (50.0) 927 (82.0) Yes 166 (15.5) 28 (48.3) 194 (17.2) : Median (IQ range) 1.0 (0.0-1.0) 2.0 (1.0-2.0) 1.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-97.0) 97.0 (87.0-109.0) 87.0 (79.0-98.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 5.5 (0.9) 5.5 (0.9) 0.66 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.7) 1.8 (1.6-2.4) 1.4 (1.1-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) 0.01 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 6.0 (1.1) 5.5 (0.8) 0.0004 LDL (mmol/L): Mean (SD) 3.1 (0.8) 3.0 (0.8) 3.1 (0.8) 0.33 : Mean (SD) 109.1 (10.1) 112.9 (12.0) 109.3 (10.2) 0.02 : Mean (SD) 64.2 (7.9) 68.6 (8.9) 64.4 (8.0) 0.0005 : Mean (SD) 79.2 (7.7) 83.4 (8.9) 79.4 (7.8) 0.0009 : N(%) 0.04 Missing 1 (0.1) 1 (1.7) 2 (0.2) &lt;80 cm 290 (27.0) 8 (13.8) 298 (26.3) &gt;=80 cm 782 (72.9) 49 (84.5) 831 (73.5) : N(%) &lt;0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;1.7 mmol/L 782 (72.9) 23 (39.7) 805 (71.2) &gt;=1.7 mmol/L 291 (27.1) 35 (60.3) 326 (28.8) : N(%) 0.18 Missing 0 (0.0) 0 (0.0) 0 (0.0) &gt;=1.3 mmol/L 958 (89.3) 48 (82.8) 1006 (88.9) &lt;1.3 mmol/L 115 (10.7) 10 (17.2) 125 (11.1) : N(%) 0.0001 Missing 8 (0.7) 1 (1.7) 9 (0.8) &lt;5.6 mmol/L 624 (58.2) 18 (31.0) 642 (56.8) &gt;=5.6 mmol/L 441 (41.1) 39 (67.2) 480 (42.4) : N(%) 0.09 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;130 mmHg 1043 (97.2) 54 (93.1) 1097 (97.0) &gt;=130 mmHg 30 (2.8) 4 (6.9) 34 (3.0) : N(%) 0.05 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;85 mmHg 1068 (99.5) 56 (96.6) 1124 (99.4) &gt;=85 mmHg 5 (0.5) 2 (3.4) 7 (0.6) : Mean (SD) 0.0 (0.2) 0.1 (0.3) 0.0 (0.2) 0.14 CRP (mg/L): Median (IQ range) 4.7 (2.4-8.9) 7.8 (4.4-12.5) 4.9 (2.4-9.0) 0.0007 32.1.3 Outcomes Characteristic non-GDM (n=1073) GDM (n=58) Total (n=1131) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (38.9-40.9) 38.9 (38.1-40.0) 39.9 (38.9-40.9) &lt;0.0001 Birthweight (g): Median (IQ range) 3410.0 (3070.0-3735.0) 3260.0 (2825.0-3728.8) 3400.0 (3070.0-3737.5) 0.18 : Mean (SD) 46.7 (29.4) 47.6 (31.9) 46.7 (29.5) 0.83 : N(%) 0.83 Missing 0 (0.0) 0 (0.0) 0 (0.0) Male 525 (48.9) 27 (46.6) 552 (48.8) Female 548 (51.1) 31 (53.4) 579 (51.2) : N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Unassisted vaginal 581 (54.1) 19 (32.8) 600 (53.1) Operative vaginal 177 (16.5) 7 (12.1) 184 (16.3) Pre-labour LSCS 66 (6.2) 10 (17.2) 76 (6.7) LSCS in labour 249 (23.2) 22 (37.9) 271 (24.0) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["within-stop-1.html", "32.2 Within STOP", " 32.2 Within STOP 32.2.1 Demographics Characteristic non-GDM (n=1048) GDM (n=198) Total (n=1246) P-value Maternal age (yrs): Median (IQ range) 26.0 (22.0-29.0) 28.0 (24.0-31.0) 26.0 (22.0-29.0) &lt;0.0001 Maternal age (yrs): N(%) 0.0001 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1020 (97.3) 181 (91.4) 1201 (96.4) &gt;=35 28 (2.7) 17 (8.6) 45 (3.6) Maternal BMI: Median (IQ range) 25.8 (22.6-30.6) 30.9 (24.6-37.6) 26.3 (22.7-31.8) &lt;0.0001 : N(%) &lt;0.0001 Missing 1 (0.1) 0 (0.0) 1 (0.1) &lt;20 81 (7.7) 8 (4.0) 89 (7.1) &gt;=20 to &lt;25 377 (36.0) 47 (23.7) 424 (34.0) &gt;=25 to &lt;30 304 (29.0) 40 (20.2) 344 (27.6) &gt;=30 to &lt;40 236 (22.5) 68 (34.3) 304 (24.4) &gt;=40 49 (4.7) 35 (17.7) 84 (6.7) SEI: Median (IQ range) 29.0 (22.0-45.0) 28.5 (20.0-45.0) 29.0 (21.0-45.0) 0.91 : N(%) 0.001 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 889 (84.8) 141 (71.2) 1030 (82.7) Maori 1 (0.1) 1 (0.5) 2 (0.2) Pacific Islander 4 (0.4) 0 (0.0) 4 (0.3) South East and Far East 41 (3.9) 24 (12.1) 65 (5.2) Indian 40 (3.8) 17 (8.6) 57 (4.6) African 16 (1.5) 5 (2.5) 21 (1.7) Middle-eastern 19 (1.8) 4 (2.0) 23 (1.8) Hispanic 4 (0.4) 1 (0.5) 5 (0.4) Aboriginal 18 (1.7) 3 (1.5) 21 (1.7) China and Japan 14 (1.3) 2 (1.0) 16 (1.3) Other 2 (0.2) 0 (0.0) 2 (0.2) : N(%) 0.76 Missing 6 (0.6) 0 (0.0) 6 (0.5) No 870 (83.0) 163 (82.3) 1033 (82.9) Yes 172 (16.4) 35 (17.7) 207 (16.6) : N(%) 0.85 Missing 126 (12.0) 21 (10.6) 147 (11.8) None 76 (7.3) 13 (6.6) 89 (7.1) &lt;800 214 (20.4) 44 (22.2) 258 (20.7) &gt;=800 632 (60.3) 120 (60.6) 752 (60.4) : N(%) 0.90 Missing 126 (12.0) 21 (10.6) 147 (11.8) None 76 (7.3) 13 (6.6) 89 (7.1) &lt;=400 12 (1.1) 3 (1.5) 15 (1.2) &gt;400 to &lt;800 202 (19.3) 41 (20.7) 243 (19.5) &gt;=800 632 (60.3) 120 (60.6) 752 (60.4) : N(%) 0.28 Missing 13 (1.2) 3 (1.5) 16 (1.3) &lt;1-3x/month 73 (7.0) 16 (8.1) 89 (7.1) 1-6x/week 309 (29.5) 66 (33.3) 375 (30.1) &gt;=1-&lt;3x/day 516 (49.2) 96 (48.5) 612 (49.1) &gt;=3x/day 137 (13.1) 17 (8.6) 154 (12.4) : N(%) 0.83 Missing 13 (1.2) 4 (2.0) 17 (1.4) &lt;1-3x/month 108 (10.3) 21 (10.6) 129 (10.4) 1-2x/week 239 (22.8) 42 (21.2) 281 (22.6) 3-6x/week 351 (33.5) 72 (36.4) 423 (33.9) &gt;=1x/day 337 (32.2) 59 (29.8) 396 (31.8) : N(%) 0.37 Missing 147 (14.0) 24 (12.1) 171 (13.7) Never 42 (4.0) 11 (5.6) 53 (4.3) &gt;0-&lt;2x/week 174 (16.6) 34 (17.2) 208 (16.7) &gt;=2-&lt;4x/week 397 (37.9) 84 (42.4) 481 (38.6) &gt;=4x/week 288 (27.5) 45 (22.7) 333 (26.7) : N(%) 0.96 Missing 9 (0.9) 3 (1.5) 12 (1.0) Never 652 (62.2) 124 (62.6) 776 (62.3) Once a week 255 (24.3) 48 (24.2) 303 (24.3) 2-3/wk 99 (9.4) 16 (8.1) 115 (9.2) 4-6/wk 18 (1.7) 4 (2.0) 22 (1.8) Daily 14 (1.3) 3 (1.5) 17 (1.4) More than once a day 1 (0.1) 0 (0.0) 1 (0.1) : N(%) 0.05 Missing 10 (1.0) 4 (2.0) 14 (1.1) Never 405 (38.6) 87 (43.9) 492 (39.5) Once a week 263 (25.1) 54 (27.3) 317 (25.4) 2-3/wk 233 (22.2) 42 (21.2) 275 (22.1) 4-6/wk 60 (5.7) 3 (1.5) 63 (5.1) Daily 64 (6.1) 6 (3.0) 70 (5.6) More than once a day 13 (1.2) 2 (1.0) 15 (1.2) : N(%) 0.44 Missing 11 (1.0) 3 (1.5) 14 (1.1) Never 225 (21.5) 33 (16.7) 258 (20.7) Once a week 364 (34.7) 81 (40.9) 445 (35.7) 2-3/wk 249 (23.8) 49 (24.7) 298 (23.9) 4-6/wk 81 (7.7) 12 (6.1) 93 (7.5) Daily 105 (10.0) 17 (8.6) 122 (9.8) More than once a day 13 (1.2) 3 (1.5) 16 (1.3) Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.3) 40.1 (35.5-45.2) 40.5 (36.3-45.3) 0.38 Homocysteine concentration (μM): Mean (SD) 5.0 (1.2) 4.8 (1.0) 5.0 (1.1) 0.01 B12 concentration (pM): Median (IQ range) 280.0 (218.0-357.0) 273.0 (217.5-348.5) 277.5 (218.0-356.0) 0.43 Folate:B12 ratio: Median (IQ range) 153.5 (115.1-221.2) 148.0 (112.4-225.9) 152.6 (114.8-221.7) 0.53 Active B12 concentration (pM): Mean (SD) 67.8 (25.2) 76.6 (26.1) 69.3 (25.6) 0.002 Folate:Active B12 ratio: Median (IQ range) 663.1 (475.7-951.1) 531.9 (417.3-788.4) 633.8 (460.9-923.1) 0.002 Vitamin D: Median (IQ range) 61.0 (46.0-77.0) 60.0 (44.5-77.5) 61.0 (46.0-77.0) 0.35 UIC (ug/L): Median (IQ range) 197.8 (120.4-327.6) 220.6 (139.0-344.1) 203.2 (124.5-330.8) 0.09 HCG (MoM): Median (IQ range) 1.0 (0.7-1.4) 1.1 (0.7-1.6) 1.0 (0.7-1.5) 0.41 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.81 Haemoglobin (g/L): Mean (SD) 131.3 (9.6) 132.2 (10.0) 131.5 (9.6) 0.28 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.06 Red cell folate (nmol/L): Mean (SD) 1427.4 (322.8) 1492.9 (307.2) 1437.8 (321.1) 0.010 32.2.2 MetS Characteristic non-GDM (n=1048) GDM (n=198) Total (n=1246) P-value MetS: N(%) &lt;0.0001 Missing 74 (7.1) 14 (7.1) 88 (7.1) No 907 (86.5) 144 (72.7) 1051 (84.3) Yes 67 (6.4) 40 (20.2) 107 (8.6) : Median (IQ range) 0.0 (0.0-1.0) 0.0 (0.0-1.5) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 81.5 (74.0-92.0) 91.0 (78.0-107.5) 82.9 (75.0-94.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 4.6 (0.8) 4.7 (0.9) 4.6 (0.8) 0.37 Triglyceride (mmol/L): Median (IQ range) 1.1 (0.9-1.4) 1.2 (0.9-1.6) 1.1 (0.9-1.4) 0.003 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) &lt;0.0001 Glucose (mmol/L): Mean (SD) 4.8 (0.6) 4.9 (0.8) 4.8 (0.7) 0.004 LDL (mmol/L): Mean (SD) 2.4 (0.7) 2.6 (0.7) 2.5 (0.7) 0.004 : Mean (SD) 115.3 (10.4) 118.8 (11.6) 115.9 (10.7) 0.0002 : Mean (SD) 70.2 (8.4) 73.5 (9.9) 70.7 (8.7) &lt;0.0001 : Mean (SD) 85.2 (8.1) 88.6 (9.6) 85.8 (8.4) &lt;0.0001 : N(%) &lt;0.0001 Missing 23 (2.2) 3 (1.5) 26 (2.1) &lt;80 cm 447 (42.7) 54 (27.3) 501 (40.2) &gt;=80 cm 578 (55.2) 141 (71.2) 719 (57.7) : N(%) 0.003 Missing 12 (1.1) 1 (0.5) 13 (1.0) &lt;1.7 mmol/L 907 (86.5) 156 (78.8) 1063 (85.3) &gt;=1.7 mmol/L 129 (12.3) 41 (20.7) 170 (13.6) : N(%) 0.04 Missing 12 (1.1) 1 (0.5) 13 (1.0) &gt;=1.3 mmol/L 885 (84.4) 156 (78.8) 1041 (83.5) &lt;1.3 mmol/L 151 (14.4) 41 (20.7) 192 (15.4) : N(%) 0.04 Missing 12 (1.1) 1 (0.5) 13 (1.0) &lt;5.6 mmol/L 963 (91.9) 174 (87.9) 1137 (91.3) &gt;=5.6 mmol/L 73 (7.0) 23 (11.6) 96 (7.7) : N(%) 0.003 Missing 44 (4.2) 11 (5.6) 55 (4.4) &lt;130 mmHg 909 (86.7) 155 (78.3) 1064 (85.4) &gt;=130 mmHg 95 (9.1) 32 (16.2) 127 (10.2) : N(%) &lt;0.0001 Missing 44 (4.2) 11 (5.6) 55 (4.4) &lt;85 mmHg 955 (91.1) 162 (81.8) 1117 (89.6) &gt;=85 mmHg 49 (4.7) 25 (12.6) 74 (5.9) : Mean (SD) 0.1 (0.3) 0.2 (0.4) 0.1 (0.3) 0.0009 CRP (mg/L): Median (IQ range) 3.3 (1.4-6.2) 3.9 (2.1-8.1) 3.4 (1.4-6.6) 0.005 32.2.3 Outcomes Characteristic non-GDM (n=1048) GDM (n=198) Total (n=1246) P-value Gestational age at birth (weeks): Median (IQ range) 39.7 (38.7-40.7) 38.9 (38.1-39.7) 39.6 (38.6-40.4) &lt;0.0001 Birthweight (g): Median (IQ range) 3402.0 (3040.0-3715.0) 3350.0 (3020.0-3645.0) 3390.0 (3040.0-3710.0) 0.19 : Mean (SD) 47.6 (29.5) 52.5 (30.3) 48.4 (29.6) 0.04 : N(%) 0.57 Missing 3 (0.3) 1 (0.5) 4 (0.3) Male 546 (52.1) 98 (49.5) 644 (51.7) Female 499 (47.6) 99 (50.0) 598 (48.0) : N(%) 0.10 Missing 3 (0.3) 1 (0.5) 4 (0.3) Unassisted vaginal 522 (49.8) 91 (46.0) 613 (49.2) Operative vaginal 229 (21.9) 34 (17.2) 263 (21.1) Pre-labour LSCS 70 (6.7) 19 (9.6) 89 (7.1) LSCS in labour 224 (21.4) 53 (26.8) 277 (22.2) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-gdm-1.html", "32.3 SCOPE vs STOP (GDM)", " 32.3 SCOPE vs STOP (GDM) 32.3.1 Demographics Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Maternal age (yrs): Median (IQ range) 28.0 (25.0-32.0) 28.0 (24.0-31.0) 28.0 (24.0-32.0) 0.95 Maternal age (yrs): N(%) 0.26 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 56 (96.6) 181 (91.4) 237 (92.6) &gt;=35 2 (3.4) 17 (8.6) 19 (7.4) Maternal BMI: Median (IQ range) 30.6 (25.4-36.3) 30.9 (24.6-37.6) 30.6 (24.6-37.3) 0.85 : N(%) 0.75 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;20 1 (1.7) 8 (4.0) 9 (3.5) &gt;=20 to &lt;25 13 (22.4) 47 (23.7) 60 (23.4) &gt;=25 to &lt;30 13 (22.4) 40 (20.2) 53 (20.7) &gt;=30 to &lt;40 24 (41.4) 68 (34.3) 92 (35.9) &gt;=40 7 (12.1) 35 (17.7) 42 (16.4) SEI: Median (IQ range) 27.0 (20.2-34.0) 28.5 (20.0-45.0) 28.0 (20.0-45.0) 0.19 : N(%) 0.21 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 51 (87.9) 141 (71.2) 192 (75.0) Maori 0 (0.0) 1 (0.5) 1 (0.4) Pacific Islander 0 (0.0) 0 (0.0) 0 (0.0) South East and Far East 4 (6.9) 24 (12.1) 28 (10.9) Indian 1 (1.7) 17 (8.6) 18 (7.0) African 0 (0.0) 5 (2.5) 5 (2.0) Middle-eastern 0 (0.0) 4 (2.0) 4 (1.6) Hispanic 0 (0.0) 1 (0.5) 1 (0.4) Aboriginal 1 (1.7) 3 (1.5) 4 (1.6) China and Japan 0 (0.0) 2 (1.0) 2 (0.8) Other 1 (1.7) 0 (0.0) 1 (0.4) : N(%) 0.62 Missing 0 (0.0) 0 (0.0) 0 (0.0) No 50 (86.2) 163 (82.3) 213 (83.2) Yes 8 (13.8) 35 (17.7) 43 (16.8) : N(%) 0.0003 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;800 27 (46.6) 44 (22.2) 71 (27.7) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) : N(%) 0.0005 Missing 0 (0.0) 21 (10.6) 21 (8.2) None 9 (15.5) 13 (6.6) 22 (8.6) &lt;=400 6 (10.3) 3 (1.5) 9 (3.5) &gt;400 to &lt;800 21 (36.2) 41 (20.7) 62 (24.2) &gt;=800 22 (37.9) 120 (60.6) 142 (55.5) : N(%) 0.87 Missing 0 (0.0) 3 (1.5) 3 (1.2) &lt;1-3x/month 3 (5.2) 16 (8.1) 19 (7.4) 1-6x/week 19 (32.8) 66 (33.3) 85 (33.2) &gt;=1-&lt;3x/day 32 (55.2) 96 (48.5) 128 (50.0) &gt;=3x/day 4 (6.9) 17 (8.6) 21 (8.2) : N(%) 0.12 Missing 0 (0.0) 4 (2.0) 4 (1.6) &lt;1-3x/month 3 (5.2) 21 (10.6) 24 (9.4) 1-2x/week 13 (22.4) 42 (21.2) 55 (21.5) 3-6x/week 31 (53.4) 72 (36.4) 103 (40.2) &gt;=1x/day 11 (19.0) 59 (29.8) 70 (27.3) : N(%) 0.36 Missing 9 (15.5) 24 (12.1) 33 (12.9) Never 1 (1.7) 11 (5.6) 12 (4.7) &gt;0-&lt;2x/week 6 (10.3) 34 (17.2) 40 (15.6) &gt;=2-&lt;4x/week 25 (43.1) 84 (42.4) 109 (42.6) &gt;=4x/week 17 (29.3) 45 (22.7) 62 (24.2) : N(%) 0.24 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 38 (65.5) 124 (62.6) 162 (63.3) Once a week 19 (32.8) 48 (24.2) 67 (26.2) 2-3/wk 1 (1.7) 16 (8.1) 17 (6.6) 4-6/wk 0 (0.0) 4 (2.0) 4 (1.6) Daily 0 (0.0) 3 (1.5) 3 (1.2) More than once a day 0 (0.0) 0 (0.0) 0 (0.0) : N(%) 0.68 Missing 0 (0.0) 4 (2.0) 4 (1.6) Never 30 (51.7) 87 (43.9) 117 (45.7) Once a week 16 (27.6) 54 (27.3) 70 (27.3) 2-3/wk 8 (13.8) 42 (21.2) 50 (19.5) 4-6/wk 1 (1.7) 3 (1.5) 4 (1.6) Daily 3 (5.2) 6 (3.0) 9 (3.5) More than once a day 0 (0.0) 2 (1.0) 2 (0.8) : N(%) 0.89 Missing 0 (0.0) 3 (1.5) 3 (1.2) Never 9 (15.5) 33 (16.7) 42 (16.4) Once a week 21 (36.2) 81 (40.9) 102 (39.8) 2-3/wk 17 (29.3) 49 (24.7) 66 (25.8) 4-6/wk 5 (8.6) 12 (6.1) 17 (6.6) Daily 6 (10.3) 17 (8.6) 23 (9.0) More than once a day 0 (0.0) 3 (1.5) 3 (1.2) Serum folate concentration (nM): Median (IQ range) 40.1 (32.0-43.8) 40.1 (35.5-45.2) 40.1 (35.0-44.8) 0.26 Homocysteine concentration (μM): Mean (SD) 4.1 (0.9) 4.8 (1.0) 4.7 (1.0) &lt;0.0001 B12 concentration (pM): Median (IQ range) 253.5 (194.2-333.0) 273.0 (217.5-348.5) 270.0 (215.0-345.5) 0.16 Folate:B12 ratio: Median (IQ range) 158.9 (116.5-210.2) 148.0 (112.4-225.9) 149.3 (113.3-220.0) 0.79 Active B12 concentration (pM): Mean (SD) 72.7 (26.4) 76.6 (26.1) 75.7 (26.1) 0.48 Folate:Active B12 ratio: Median (IQ range) 553.8 (424.7-660.3) 531.9 (417.3-788.4) 536.7 (418.1-784.2) 0.97 Vitamin D: Median (IQ range) 55.8 (44.6-72.0) 60.0 (44.5-77.5) 59.0 (44.3-75.1) 0.52 UIC (ug/L): Median (IQ range) 132.7 (68.3-167.0) 220.6 (139.0-344.1) 206.4 (124.8-323.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.1 (0.7-1.6) 1.0 (0.7-1.6) 0.92 PAPP-A (MoM): Median (IQ range) 0.9 (0.5-1.4) 0.9 (0.7-1.3) 0.9 (0.7-1.4) 0.53 Haemoglobin (g/L): Mean (SD) 130.9 (9.4) 132.2 (10.0) 131.9 (9.8) 0.38 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) 0.07 32.3.2 MetS Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value MetS: N(%) 0.0001 Missing 1 (1.7) 14 (7.1) 15 (5.9) No 29 (50.0) 144 (72.7) 173 (67.6) Yes 28 (48.3) 40 (20.2) 68 (26.6) : Median (IQ range) 2.0 (1.0-2.0) 0.0 (0.0-1.5) 1.0 (0.0-2.0) &lt;0.0001 Waist (cm): Median (IQ range) 97.0 (87.0-109.0) 91.0 (78.0-107.5) 93.0 (80.0-108.0) 0.03 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.7 (0.9) 4.9 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.8 (1.6-2.4) 1.2 (0.9-1.6) 1.3 (1.0-1.8) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.6 (0.3) 1.5 (0.3) 1.6 (0.3) 0.09 Glucose (mmol/L): Mean (SD) 6.0 (1.1) 4.9 (0.8) 5.2 (1.0) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.0 (0.8) 2.6 (0.7) 2.7 (0.7) 0.004 : Mean (SD) 112.9 (12.0) 118.8 (11.6) 117.4 (11.9) 0.001 : Mean (SD) 68.6 (8.9) 73.5 (9.9) 72.3 (9.9) 0.0005 : Mean (SD) 83.4 (8.9) 88.6 (9.6) 87.4 (9.7) 0.0002 : N(%) 0.05 Missing 1 (1.7) 3 (1.5) 4 (1.6) &lt;80 cm 8 (13.8) 54 (27.3) 62 (24.2) &gt;=80 cm 49 (84.5) 141 (71.2) 190 (74.2) : N(%) &lt;0.0001 Missing 0 (0.0) 1 (0.5) 1 (0.4) &lt;1.7 mmol/L 23 (39.7) 156 (78.8) 179 (69.9) &gt;=1.7 mmol/L 35 (60.3) 41 (20.7) 76 (29.7) : N(%) 0.68 Missing 0 (0.0) 1 (0.5) 1 (0.4) &gt;=1.3 mmol/L 48 (82.8) 156 (78.8) 204 (79.7) &lt;1.3 mmol/L 10 (17.2) 41 (20.7) 51 (19.9) : N(%) &lt;0.0001 Missing 1 (1.7) 1 (0.5) 2 (0.8) &lt;5.6 mmol/L 18 (31.0) 174 (87.9) 192 (75.0) &gt;=5.6 mmol/L 39 (67.2) 23 (11.6) 62 (24.2) : N(%) 0.06 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;130 mmHg 54 (93.1) 155 (78.3) 209 (81.6) &gt;=130 mmHg 4 (6.9) 32 (16.2) 36 (14.1) : N(%) 0.03 Missing 0 (0.0) 11 (5.6) 11 (4.3) &lt;85 mmHg 56 (96.6) 162 (81.8) 218 (85.2) &gt;=85 mmHg 2 (3.4) 25 (12.6) 27 (10.5) : Mean (SD) 0.1 (0.3) 0.2 (0.4) 0.2 (0.4) 0.005 CRP (mg/L): Median (IQ range) 7.8 (4.4-12.5) 3.9 (2.1-8.1) 4.5 (2.4-9.1) &lt;0.0001 32.3.3 Outcomes Characteristic SCOPE (n=58) STOP (n=198) Total (n=256) P-value Gestational age at birth (weeks): Median (IQ range) 38.9 (38.1-40.0) 38.9 (38.1-39.7) 38.9 (38.1-39.9) 0.91 Birthweight (g): Median (IQ range) 3260.0 (2825.0-3728.8) 3350.0 (3020.0-3645.0) 3330.0 (2990.5-3650.0) 0.61 : Mean (SD) 47.6 (31.9) 52.5 (30.3) 51.4 (30.7) 0.30 : N(%) 0.78 Missing 0 (0.0) 1 (0.5) 1 (0.4) Male 27 (46.6) 98 (49.5) 125 (48.8) Female 31 (53.4) 99 (50.0) 130 (50.8) : N(%) 0.08 Missing 0 (0.0) 1 (0.5) 1 (0.4) Unassisted vaginal 19 (32.8) 91 (46.0) 110 (43.0) Operative vaginal 7 (12.1) 34 (17.2) 41 (16.0) Pre-labour LSCS 10 (17.2) 19 (9.6) 29 (11.3) LSCS in labour 22 (37.9) 53 (26.8) 75 (29.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["scope-vs-stop-non-gdm.html", "32.4 SCOPE vs STOP (non-GDM)", " 32.4 SCOPE vs STOP (non-GDM) 32.4.1 Demographics Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value Maternal age (yrs): Median (IQ range) 23.0 (20.0-27.0) 26.0 (22.0-29.0) 24.0 (21.0-28.0) &lt;0.0001 Maternal age (yrs): N(%) 0.21 Missing 0 (0.0) 0 (0.0) 0 (0.0) &lt;35 1054 (98.2) 1020 (97.3) 2074 (97.8) &gt;=35 19 (1.8) 28 (2.7) 47 (2.2) Maternal BMI: Median (IQ range) 25.4 (22.1-30.4) 25.8 (22.6-30.6) 25.6 (22.4-30.5) 0.15 : N(%) 0.22 Missing 0 (0.0) 1 (0.1) 1 (0.0) &lt;20 115 (10.7) 81 (7.7) 196 (9.2) &gt;=20 to &lt;25 377 (35.1) 377 (36.0) 754 (35.5) &gt;=25 to &lt;30 301 (28.1) 304 (29.0) 605 (28.5) &gt;=30 to &lt;40 234 (21.8) 236 (22.5) 470 (22.2) &gt;=40 46 (4.3) 49 (4.7) 95 (4.5) SEI: Median (IQ range) 25.0 (20.0-30.0) 29.0 (22.0-45.0) 27.0 (20.0-34.0) &lt;0.0001 : N(%) 0.0005 Missing 0 (0.0) 0 (0.0) 0 (0.0) Caucasian 987 (92.0) 889 (84.8) 1876 (88.4) Maori 5 (0.5) 1 (0.1) 6 (0.3) Pacific Islander 1 (0.1) 4 (0.4) 5 (0.2) South East and Far East 36 (3.4) 41 (3.9) 77 (3.6) Indian 3 (0.3) 40 (3.8) 43 (2.0) African 4 (0.4) 16 (1.5) 20 (0.9) Middle-eastern 5 (0.5) 19 (1.8) 24 (1.1) Hispanic 0 (0.0) 4 (0.4) 4 (0.2) Aboriginal 21 (2.0) 18 (1.7) 39 (1.8) China and Japan 0 (0.0) 14 (1.3) 14 (0.7) Other 11 (1.0) 2 (0.2) 13 (0.6) : N(%) &lt;0.0001 Missing 0 (0.0) 6 (0.6) 6 (0.3) No 813 (75.8) 870 (83.0) 1683 (79.3) Yes 260 (24.2) 172 (16.4) 432 (20.4) : N(%) &lt;0.0001 Missing 0 (0.0) 126 (12.0) 126 (5.9) None 230 (21.4) 76 (7.3) 306 (14.4) &lt;800 571 (53.2) 214 (20.4) 785 (37.0) &gt;=800 272 (25.3) 632 (60.3) 904 (42.6) : N(%) &lt;0.0001 Missing 0 (0.0) 126 (12.0) 126 (5.9) None 230 (21.4) 76 (7.3) 306 (14.4) &lt;=400 105 (9.8) 12 (1.1) 117 (5.5) &gt;400 to &lt;800 466 (43.4) 202 (19.3) 668 (31.5) &gt;=800 272 (25.3) 632 (60.3) 904 (42.6) : N(%) &lt;0.0001 Missing 0 (0.0) 13 (1.2) 13 (0.6) &lt;1-3x/month 110 (10.3) 73 (7.0) 183 (8.6) 1-6x/week 417 (38.9) 309 (29.5) 726 (34.2) &gt;=1-&lt;3x/day 367 (34.2) 516 (49.2) 883 (41.6) &gt;=3x/day 179 (16.7) 137 (13.1) 316 (14.9) : N(%) 0.01 Missing 0 (0.0) 13 (1.2) 13 (0.6) &lt;1-3x/month 103 (9.6) 108 (10.3) 211 (9.9) 1-2x/week 249 (23.2) 239 (22.8) 488 (23.0) 3-6x/week 430 (40.1) 351 (33.5) 781 (36.8) &gt;=1x/day 291 (27.1) 337 (32.2) 628 (29.6) : N(%) &lt;0.0001 Missing 216 (20.1) 147 (14.0) 363 (17.1) Never 15 (1.4) 42 (4.0) 57 (2.7) &gt;0-&lt;2x/week 102 (9.5) 174 (16.6) 276 (13.0) &gt;=2-&lt;4x/week 436 (40.6) 397 (37.9) 833 (39.3) &gt;=4x/week 304 (28.3) 288 (27.5) 592 (27.9) : N(%) 0.66 Missing 3 (0.3) 9 (0.9) 12 (0.6) Never 694 (64.7) 652 (62.2) 1346 (63.5) Once a week 264 (24.6) 255 (24.3) 519 (24.5) 2-3/wk 84 (7.8) 99 (9.4) 183 (8.6) 4-6/wk 14 (1.3) 18 (1.7) 32 (1.5) Daily 12 (1.1) 14 (1.3) 26 (1.2) More than once a day 2 (0.2) 1 (0.1) 3 (0.1) : N(%) 0.35 Missing 3 (0.3) 10 (1.0) 13 (0.6) Never 453 (42.2) 405 (38.6) 858 (40.5) Once a week 278 (25.9) 263 (25.1) 541 (25.5) 2-3/wk 219 (20.4) 233 (22.2) 452 (21.3) 4-6/wk 51 (4.8) 60 (5.7) 111 (5.2) Daily 62 (5.8) 64 (6.1) 126 (5.9) More than once a day 7 (0.7) 13 (1.2) 20 (0.9) : N(%) 0.11 Missing 3 (0.3) 11 (1.0) 14 (0.7) Never 250 (23.3) 225 (21.5) 475 (22.4) Once a week 334 (31.1) 364 (34.7) 698 (32.9) 2-3/wk 283 (26.4) 249 (23.8) 532 (25.1) 4-6/wk 75 (7.0) 81 (7.7) 156 (7.4) Daily 102 (9.5) 105 (10.0) 207 (9.8) More than once a day 26 (2.4) 13 (1.2) 39 (1.8) Serum folate concentration (nM): Median (IQ range) 35.9 (28.1-42.6) 40.5 (36.4-45.3) 39.0 (32.9-43.9) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 4.6 (1.1) 5.0 (1.2) 4.8 (1.2) &lt;0.0001 B12 concentration (pM): Median (IQ range) 245.0 (195.0-308.5) 280.0 (218.0-357.0) 261.0 (205.0-334.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 142.7 (102.3-207.5) 153.5 (115.1-221.2) 148.7 (108.4-216.5) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.1 (24.0) 67.8 (25.2) 63.6 (24.9) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 615.4 (432.4-902.3) 663.1 (475.7-951.1) 628.7 (453.0-925.0) 0.008 Vitamin D: Median (IQ range) 58.0 (42.0-76.4) 61.0 (46.0-77.0) 59.8 (43.7-76.6) 0.01 UIC (ug/L): Median (IQ range) 105.0 (66.3-163.6) 197.8 (120.4-327.6) 152.5 (89.2-259.4) &lt;0.0001 HCG (MoM): Median (IQ range) 1.0 (0.7-1.6) 1.0 (0.7-1.4) 1.0 (0.7-1.5) 0.06 PAPP-A (MoM): Median (IQ range) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 1.0 (0.7-1.4) 0.05 Haemoglobin (g/L): Mean (SD) 129.1 (9.3) 131.3 (9.6) 130.2 (9.5) &lt;0.0001 Haematocrit (PCV): Mean (SD) 0.4 (0.0) 0.4 (0.0) 0.4 (0.0) &lt;0.0001 32.4.2 MetS Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value MetS: N(%) &lt;0.0001 Missing 9 (0.8) 74 (7.1) 83 (3.9) No 898 (83.7) 907 (86.5) 1805 (85.1) Yes 166 (15.5) 67 (6.4) 233 (11.0) : Median (IQ range) 1.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) &lt;0.0001 Waist (cm): Median (IQ range) 87.0 (79.0-97.0) 81.5 (74.0-92.0) 84.0 (76.0-95.0) &lt;0.0001 Cholesterol (mmol/L): Mean (SD) 5.5 (0.9) 4.6 (0.8) 5.1 (1.0) &lt;0.0001 Triglyceride (mmol/L): Median (IQ range) 1.4 (1.1-1.7) 1.1 (0.9-1.4) 1.2 (1.0-1.6) &lt;0.0001 HDL (mmol/L): Mean (SD) 1.7 (0.4) 1.6 (0.3) 1.7 (0.4) &lt;0.0001 Glucose (mmol/L): Mean (SD) 5.4 (0.7) 4.8 (0.6) 5.1 (0.8) &lt;0.0001 LDL (mmol/L): Mean (SD) 3.1 (0.8) 2.4 (0.7) 2.8 (0.8) &lt;0.0001 : Mean (SD) 109.1 (10.1) 115.3 (10.4) 112.1 (10.7) &lt;0.0001 : Mean (SD) 64.2 (7.9) 70.2 (8.4) 67.1 (8.7) &lt;0.0001 : Mean (SD) 79.2 (7.7) 85.2 (8.1) 82.1 (8.4) &lt;0.0001 : N(%) &lt;0.0001 Missing 1 (0.1) 23 (2.2) 24 (1.1) &lt;80 cm 290 (27.0) 447 (42.7) 737 (34.7) &gt;=80 cm 782 (72.9) 578 (55.2) 1360 (64.1) : N(%) &lt;0.0001 Missing 0 (0.0) 12 (1.1) 12 (0.6) &lt;1.7 mmol/L 782 (72.9) 907 (86.5) 1689 (79.6) &gt;=1.7 mmol/L 291 (27.1) 129 (12.3) 420 (19.8) : N(%) 0.009 Missing 0 (0.0) 12 (1.1) 12 (0.6) &gt;=1.3 mmol/L 958 (89.3) 885 (84.4) 1843 (86.9) &lt;1.3 mmol/L 115 (10.7) 151 (14.4) 266 (12.5) : N(%) &lt;0.0001 Missing 8 (0.7) 12 (1.1) 20 (0.9) &lt;5.6 mmol/L 624 (58.2) 963 (91.9) 1587 (74.8) &gt;=5.6 mmol/L 441 (41.1) 73 (7.0) 514 (24.2) : N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;130 mmHg 1043 (97.2) 909 (86.7) 1952 (92.0) &gt;=130 mmHg 30 (2.8) 95 (9.1) 125 (5.9) : N(%) &lt;0.0001 Missing 0 (0.0) 44 (4.2) 44 (2.1) &lt;85 mmHg 1068 (99.5) 955 (91.1) 2023 (95.4) &gt;=85 mmHg 5 (0.5) 49 (4.7) 54 (2.5) : Mean (SD) 0.0 (0.2) 0.1 (0.3) 0.1 (0.3) &lt;0.0001 CRP (mg/L): Median (IQ range) 4.7 (2.4-8.9) 3.3 (1.4-6.2) 3.9 (1.9-7.5) &lt;0.0001 32.4.3 Outcomes Characteristic SCOPE (n=1073) STOP (n=1048) Total (n=2121) P-value Gestational age at birth (weeks): Median (IQ range) 40.0 (38.9-40.9) 39.7 (38.7-40.7) 39.9 (38.9-40.7) 0.003 Birthweight (g): Median (IQ range) 3410.0 (3070.0-3735.0) 3402.0 (3040.0-3715.0) 3405.0 (3060.0-3730.0) 0.46 : Mean (SD) 46.7 (29.4) 47.6 (29.5) 47.1 (29.4) 0.47 : N(%) 0.14 Missing 0 (0.0) 3 (0.3) 3 (0.1) Male 525 (48.9) 546 (52.1) 1071 (50.5) Female 548 (51.1) 499 (47.6) 1047 (49.4) : N(%) 0.01 Missing 0 (0.0) 3 (0.3) 3 (0.1) Unassisted vaginal 581 (54.1) 522 (49.8) 1103 (52.0) Operative vaginal 177 (16.5) 229 (21.9) 406 (19.1) Pre-labour LSCS 66 (6.2) 70 (6.7) 136 (6.4) LSCS in labour 249 (23.2) 224 (21.4) 473 (22.3) Unknown 0 (0.0) 0 (0.0) 0 (0.0) Maternal death antepartum 0 (0.0) 0 (0.0) 0 (0.0) "],["folate-vs-fa-supplement-3.html", "33 Folate vs FA supplement", " 33 Folate vs FA supplement Within non-GDM Characteristic None (n=306) &lt;=400 (n=117) &gt;400 to &lt;800 (n=668) &gt;=800 (n=904) Total (n=1995) P-value Serum folate concentration (nM): Median (IQ range) 28.8 (19.6-35.7) 36.5 (28.3-42.6) 38.7 (32.7-43.9) 41.2 (36.7-56.4) 39.1 (32.9-44.1) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.2 (1.5) 4.5 (1.0) 4.7 (1.2) 4.7 (1.0) 4.8 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 243.0 (192.0-303.0) 265.0 (200.2-350.5) 252.0 (200.0-322.0) 273.5 (215.0-353.8) 261.0 (205.0-334.0) &lt;0.0001 Active B12 concentration (pM): Mean (SD) 60.4 (24.6) 60.6 (26.3) 61.2 (24.6) 67.5 (24.9) 63.9 (25.0) 0.0005 Folate:B12 ratio: Median (IQ range) 115.3 (78.1-161.3) 135.0 (106.1-186.1) 154.0 (113.6-224.4) 160.1 (118.3-236.4) 149.5 (108.7-217.1) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 465.8 (331.8-693.3) 540.9 (429.0-894.7) 654.6 (481.7-956.3) 670.5 (485.2-1036.5) 626.2 (450.3-937.0) &lt;0.0001 Vitamin D: Median (IQ range) 53.0 (39.9-69.1) 49.0 (37.0-68.0) 59.0 (43.3-77.1) 64.0 (47.0-79.0) 60.0 (43.8-77.0) &lt;0.0001 Within GDM Characteristic None (n=22) &lt;=400 (n=9) &gt;400 to &lt;800 (n=62) &gt;=800 (n=142) Total (n=235) P-value Serum folate concentration (nM): Median (IQ range) 30.4 (26.5-40.2) 41.3 (36.3-54.4) 39.8 (33.8-44.0) 41.2 (37.9-58.0) 40.7 (35.9-45.2) 0.0002 Homocysteine concentration (μM): Mean (SD) 4.6 (1.0) 4.1 (0.9) 4.6 (1.0) 4.6 (0.9) 4.6 (1.0) 0.43 B12 concentration (pM): Median (IQ range) 260.5 (175.2-314.0) 268.0 (222.0-292.0) 268.5 (218.0-303.5) 278.0 (220.0-353.0) 271.5 (216.8-345.8) 0.55 Active B12 concentration (pM): Mean (SD) 65.2 (22.4) 80.3 (35.3) 84.4 (26.1) 74.1 (24.1) 76.4 (25.5) 0.09 Folate:B12 ratio: Median (IQ range) 123.5 (80.3-170.6) 162.4 (135.4-220.6) 153.1 (112.8-215.4) 160.1 (117.5-256.9) 150.7 (116.1-227.3) 0.10 Folate:Active B12 ratio: Median (IQ range) 510.1 (409.2-591.5) 715.7 (399.3-826.4) 524.9 (427.0-593.3) 565.1 (429.3-895.6) 539.5 (424.7-784.2) 0.30 Vitamin D: Median (IQ range) 45.4 (29.4-69.3) 68.6 (44.3-74.0) 57.6 (45.2-72.7) 61.0 (46.8-76.5) 59.0 (44.5-75.2) 0.23 Click here for table within SCOPE Within non-GDM Characteristic None (n=230) &lt;=400 (n=105) &gt;400 to &lt;800 (n=466) &gt;=800 (n=272) Total (n=1073) P-value Serum folate concentration (nM): Median (IQ range) 25.7 (17.5-33.3) 35.5 (27.4-41.7) 37.5 (30.7-43.5) 39.8 (34.4-47.2) 35.9 (28.1-42.6) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.1 (1.4) 4.5 (1.0) 4.5 (1.1) 4.3 (0.9) 4.6 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 233.0 (186.0-297.0) 250.5 (196.8-345.0) 247.5 (196.2-309.8) 248.5 (199.0-303.8) 245.0 (195.0-308.5) 0.01 Active B12 concentration (pM): Mean (SD) 56.0 (22.4) 60.0 (26.7) 59.3 (23.5) 64.9 (24.7) 60.1 (24.0) 0.02 Folate:B12 ratio: Median (IQ range) 108.4 (74.3-153.1) 132.0 (100.9-184.7) 146.0 (111.9-220.1) 165.1 (118.8-247.7) 142.7 (102.3-207.5) &lt;0.0001 Folate:Active B12 ratio: Median (IQ range) 461.7 (343.8-710.6) 540.9 (415.3-911.7) 643.6 (484.0-967.9) 653.3 (483.0-1082.9) 615.4 (432.4-902.3) &lt;0.0001 Vitamin D: Median (IQ range) 51.9 (39.1-68.5) 48.1 (35.7-63.5) 56.7 (41.2-75.8) 68.0 (50.9-83.9) 58.0 (42.0-76.4) &lt;0.0001 Within GDM Characteristic None (n=9) &lt;=400 (n=6) &gt;400 to &lt;800 (n=21) &gt;=800 (n=22) Total (n=58) P-value Serum folate concentration (nM): Median (IQ range) 26.7 (21.7-29.6) 36.8 (32.7-40.3) 41.5 (32.6-43.7) 42.5 (38.4-65.4) 40.1 (32.0-43.8) 0.002 Homocysteine concentration (μM): Mean (SD) 4.3 (1.1) 3.7 (0.7) 4.2 (0.9) 4.1 (0.8) 4.1 (0.9) 0.52 B12 concentration (pM): Median (IQ range) 200.5 (171.8-265.5) 280.0 (259.8-348.2) 271.5 (228.5-333.0) 237.5 (192.0-342.8) 253.5 (194.2-333.0) 0.25 Active B12 concentration (pM): Mean (SD) 66.6 (22.5) 102.7 (39.7) 68.4 (21.1) 71.7 (27.1) 72.7 (26.4) 0.22 Folate:B12 ratio: Median (IQ range) 125.3 (68.1-178.3) 138.4 (125.8-157.2) 144.0 (111.7-170.7) 210.6 (147.3-391.7) 158.9 (116.5-210.2) 0.03 Folate:Active B12 ratio: Median (IQ range) 447.5 (321.0-553.6) 320.2 (289.2-478.5) 558.4 (516.5-660.3) 674.9 (540.9-1118.7) 553.8 (424.7-660.3) 0.12 Vitamin D: Median (IQ range) 45.4 (29.8-79.0) 56.5 (33.3-70.7) 51.7 (45.9-68.3) 65.5 (51.4-75.2) 55.8 (44.6-72.0) 0.27 Click here for table within STOP Within non-GDM Characteristic None (n=76) &lt;=400 (n=12) &gt;400 to &lt;800 (n=202) &gt;=800 (n=632) Total (n=922) P-value Serum folate concentration (nM): Median (IQ range) 36.4 (30.7-40.5) 42.2 (37.2-49.7) 40.2 (35.9-48.2) 41.6 (37.6-58.0) 40.9 (36.8-54.0) &lt;0.0001 Homocysteine concentration (μM): Mean (SD) 5.4 (1.5) 5.0 (0.9) 5.2 (1.3) 4.8 (1.0) 5.0 (1.1) &lt;0.0001 B12 concentration (pM): Median (IQ range) 278.0 (215.0-331.0) 314.5 (247.5-367.8) 263.5 (208.2-347.0) 281.0 (225.8-370.5) 280.0 (220.0-363.0) 0.08 Active B12 concentration (pM): Mean (SD) 75.8 (26.0) 68.0 (23.3) 66.6 (26.9) 68.8 (25.0) 69.0 (25.5) 0.32 Folate:B12 ratio: Median (IQ range) 132.7 (100.7-188.3) 165.0 (135.9-197.8) 166.4 (119.0-229.8) 157.0 (117.9-227.6) 155.4 (116.2-223.0) 0.02 Folate:Active B12 ratio: Median (IQ range) 501.3 (325.8-682.9) 550.8 (476.6-682.4) 693.8 (476.6-951.1) 684.1 (491.4-1022.0) 665.1 (470.7-974.0) 0.003 Vitamin D: Median (IQ range) 58.0 (44.0-70.5) 63.5 (46.8-81.8) 64.0 (49.0-79.2) 62.0 (46.0-77.0) 62.0 (46.0-77.0) 0.28 Within GDM Characteristic None (n=13) &lt;=400 (n=3) &gt;400 to &lt;800 (n=41) &gt;=800 (n=120) Total (n=177) P-value Serum folate concentration (nM): Median (IQ range) 35.6 (30.1-42.0) 54.4 (49.5-57.2) 39.4 (34.6-44.5) 41.1 (37.5-56.3) 40.7 (36.1-53.6) 0.02 Homocysteine concentration (μM): Mean (SD) 4.7 (0.9) 4.9 (0.8) 4.8 (1.1) 4.7 (0.9) 4.7 (1.0) 0.96 B12 concentration (pM): Median (IQ range) 279.0 (243.8-381.5) 182.0 (181.0-227.0) 268.5 (218.0-284.2) 285.0 (224.0-358.5) 275.5 (221.2-348.8) 0.20 Active B12 concentration (pM): Mean (SD) 63.4 (24.8) 58.0 (6.2) 90.2 (25.6) 74.5 (23.8) 77.6 (25.2) 0.01 Folate:B12 ratio: Median (IQ range) 123.5 (102.6-144.2) 244.5 (232.5-273.4) 162.0 (116.1-254.6) 150.2 (116.3-228.4) 150.6 (116.1-231.2) 0.09 Folate:Active B12 ratio: Median (IQ range) 633.8 (487.5-645.7) 836.9 (815.8-984.5) 512.7 (419.6-590.5) 542.1 (424.7-838.0) 534.2 (427.0-788.4) 0.13 Vitamin D: Median (IQ range) 45.0 (29.0-54.8) 89.0 (77.0-107.5) 59.0 (45.0-79.0) 60.5 (46.0-77.5) 60.0 (44.8-78.0) 0.07 "],["folate-4.html", "33.1 Folate", " 33.1 Folate 33.1.1 FA supp (4 categories) 33.1.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.0528919 0.0668606 45.6605578 &lt;0.0001 *** folate_cat3&lt;=400 0.3518275 0.0587560 5.9879380 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 0.4649705 0.0407018 11.4238245 &lt;0.0001 *** folate_cat3&gt;=800 0.5650408 0.0451551 12.5133278 &lt;0.0001 *** f39_gdm_newGDM 0.0034892 0.1718463 0.0203042 0.98 ns StudySTOP 0.4244351 0.0645591 6.5743687 &lt;0.0001 *** f1_age 0.0129201 0.0021827 5.9194029 &lt;0.0001 *** BMI -0.0056095 0.0015641 -3.5862901 0.0003 *** folate_cat3&lt;=400:StudySTOP -0.1754408 0.1592787 -1.1014703 0.27 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.3263096 0.0764343 -4.2691494 &lt;0.0001 *** folate_cat3&gt;=800:StudySTOP -0.3215653 0.0733970 -4.3811771 &lt;0.0001 *** f39_gdm_newGDM:StudySTOP -0.0989743 0.2267777 -0.4364372 0.66 ns folate_cat3&lt;=400:f39_gdm_newGDM 0.0119271 0.2640464 0.0451703 0.96 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.0362343 0.2102623 0.1723289 0.86 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.1130757 0.2074434 0.5450921 0.59 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.1723689 0.4315894 0.3993815 0.69 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP 0.0254739 0.2702429 0.0942630 0.92 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.0343081 0.2593700 -0.1322749 0.89 ns 33.1.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 25.05059 0.8525770 2095 23.43318 26.77963 &lt;=400 non-GDM SCOPE 35.61350 1.7165847 2095 32.40132 39.14413 &gt;400 to &lt;800 non-GDM SCOPE 39.87971 0.9370133 2095 38.08383 41.76028 &gt;=800 non-GDM SCOPE 44.07700 1.3077944 2095 41.58548 46.71780 None GDM SCOPE 25.13815 4.2374781 2095 18.06198 34.98656 &lt;=400 GDM SCOPE 36.16678 7.0459233 2095 24.68226 52.99498 &gt;400 to &lt;800 GDM SCOPE 41.49576 4.9479757 2095 32.84334 52.42761 &gt;=800 GDM SCOPE 49.52626 5.5930515 2095 39.68742 61.80423 None non-GDM STOP 38.29550 2.1076182 2095 34.37749 42.66004 &lt;=400 non-GDM STOP 45.68268 6.2877261 2095 34.87588 59.83812 &gt;400 to &lt;800 non-GDM STOP 43.99136 1.5068199 2095 41.13340 47.04789 &gt;=800 non-GDM STOP 48.85262 0.9369488 2095 47.04930 50.72506 None GDM STOP 34.80800 4.7914096 2095 26.57305 45.59496 &lt;=400 GDM STOP 49.92540 13.7610924 2095 29.07814 85.71888 &gt;400 to &lt;800 GDM STOP 42.53028 3.2335819 2095 36.63902 49.36880 &gt;=800 GDM STOP 48.04271 2.1441766 2095 44.01654 52.43716 33.1.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.04 (0.90, 1.22) 0.6 GDM / (non-GDM) STOP 0.99 (0.83, 1.17) 0.9 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.24 (1.15, 1.35) &lt;0.0001 STOP / SCOPE GDM 1.17 (0.95, 1.46) 0.1 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.30 (1.06, 1.60) 0.005 &gt;400 to &lt;800 / None non-GDM 1.35 (1.23, 1.49) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.04 (0.85, 1.26) 1.0 &gt;=800 / None non-GDM 1.50 (1.36, 1.65) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 1.15 (0.95, 1.40) 0.2 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.11 (1.03, 1.19) 0.001 &lt;=400 / None GDM 1.44 (0.86, 2.41) 0.3 &gt;400 to &lt;800 / None GDM 1.42 (1.02, 1.98) 0.03 &gt;400 to &lt;800 / &lt;=400 GDM 0.99 (0.62, 1.58) 1.0 &gt;=800 / None GDM 1.65 (1.20, 2.27) 0.0004 &gt;=800 / &lt;=400 GDM 1.15 (0.72, 1.82) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.16 (0.91, 1.47) 0.4 "],["b12-4.html", "33.2 B12", " 33.2 B12 33.2.1 FA supp (4 categories) 33.2.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 5.4377715 0.0532476 102.1224372 &lt;0.0001 *** folate_cat3&lt;=400 0.1122903 0.0468046 2.3991278 0.02 * folate_cat3&gt;400 to &lt;800 0.0843004 0.0324228 2.6000367 0.009 ** folate_cat3&gt;=800 0.0915894 0.0359702 2.5462590 0.01 * f39_gdm_newGDM -0.0122623 0.1368915 -0.0895766 0.93 ns StudySTOP 0.1676752 0.0514273 3.2604325 0.001 ** f1_age 0.0090210 0.0017386 5.1886518 &lt;0.0001 *** BMI -0.0085213 0.0012456 -6.8409060 &lt;0.0001 *** folate_cat3&lt;=400:StudySTOP -0.0060563 0.1268803 -0.0477322 0.96 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.1125006 0.0608871 -1.8476921 0.06 ns folate_cat3&gt;=800:StudySTOP -0.0387190 0.0584675 -0.6622314 0.51 ns f39_gdm_newGDM:StudySTOP 0.0472084 0.1806496 0.2613257 0.79 ns folate_cat3&lt;=400:f39_gdm_newGDM 0.1192740 0.2103376 0.5670598 0.57 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.1372106 0.1674935 0.8191994 0.41 ns folate_cat3&gt;=800:f39_gdm_newGDM -0.1590593 0.1652480 -0.9625493 0.34 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP -0.5257651 0.3438012 -1.5292709 0.13 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP -0.1976340 0.2152736 -0.9180594 0.36 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP 0.1217768 0.2065885 0.5894656 0.56 ns 33.2.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 227.7876 6.175602 2096 215.9930 240.2263 &lt;=400 non-GDM SCOPE 254.8573 9.785493 2096 236.3717 274.7886 &gt;400 to &lt;800 non-GDM SCOPE 247.8228 4.638413 2096 238.8913 257.0882 &gt;=800 non-GDM SCOPE 249.6358 5.900239 2096 238.3289 261.4791 None GDM SCOPE 225.0114 30.214515 2096 172.9176 292.7992 &lt;=400 GDM SCOPE 283.6428 44.018596 2096 209.2171 384.5442 &gt;400 to &lt;800 GDM SCOPE 280.8055 26.672654 2096 233.0808 338.3021 &gt;=800 GDM SCOPE 210.3308 18.921345 2096 176.3131 250.9118 None non-GDM STOP 269.3708 11.809480 2096 247.1789 293.5550 &lt;=400 non-GDM STOP 299.5624 32.844728 2096 241.6048 371.4232 &gt;400 to &lt;800 non-GDM STOP 261.8806 7.145504 2096 248.2358 276.2753 &gt;=800 non-GDM STOP 283.9957 4.338844 2096 275.6130 292.6333 None GDM STOP 278.9506 30.587795 2096 224.9762 345.8742 &lt;=400 GDM STOP 206.5986 45.362281 2096 134.3146 317.7835 &gt;400 to &lt;800 GDM STOP 255.2928 15.461794 2096 226.7023 287.4891 &gt;=800 GDM STOP 283.3329 10.028021 2096 264.3340 303.6974 33.2.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.01 (0.89, 1.14) 0.8 GDM / (non-GDM) STOP 0.91 (0.79, 1.05) 0.2 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.14 (1.06, 1.21) 0.0001 STOP / SCOPE GDM 1.03 (0.86, 1.22) 0.8 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.12 (0.95, 1.31) 0.3 &gt;400 to &lt;800 / None non-GDM 1.03 (0.95, 1.11) 0.8 &gt;400 to &lt;800 / &lt;=400 non-GDM 0.92 (0.79, 1.08) 0.5 &gt;=800 / None non-GDM 1.07 (1.00, 1.16) 0.07 &gt;=800 / &lt;=400 non-GDM 0.96 (0.83, 1.12) 0.9 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.05 (0.99, 1.11) 0.2 &lt;=400 / None GDM 0.97 (0.64, 1.46) 1.0 &gt;400 to &lt;800 / None GDM 1.07 (0.82, 1.39) 0.9 &gt;400 to &lt;800 / &lt;=400 GDM 1.11 (0.76, 1.61) 0.9 &gt;=800 / None GDM 0.97 (0.75, 1.26) 1.0 &gt;=800 / &lt;=400 GDM 1.01 (0.70, 1.45) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.91 (0.75, 1.10) 0.6 "],["homocysteine-4.html", "33.3 Homocysteine", " 33.3 Homocysteine 33.3.1 FA supp (4 categories) 33.3.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 1.5889477 0.0310049 51.2482479 &lt;0.0001 *** folate_cat3&lt;=400 -0.1162933 0.0272515 -4.2674041 &lt;0.0001 *** folate_cat3&gt;400 to &lt;800 -0.1147800 0.0188778 -6.0801583 &lt;0.0001 *** folate_cat3&gt;=800 -0.1527889 0.0209433 -7.2953462 &lt;0.0001 *** f39_gdm_newGDM -0.1555582 0.0797035 -1.9517110 0.05 ns StudySTOP 0.0523273 0.0299430 1.7475655 0.08 ns f1_age 0.0001087 0.0010126 0.1073105 0.91 ns BMI 0.0001147 0.0007257 0.1580232 0.87 ns folate_cat3&lt;=400:StudySTOP 0.0567108 0.0738746 0.7676637 0.44 ns folate_cat3&gt;400 to &lt;800:StudySTOP 0.0846171 0.0354508 2.3868885 0.02 * folate_cat3&gt;=800:StudySTOP 0.0605118 0.0340452 1.7773955 0.08 ns f39_gdm_newGDM:StudySTOP 0.0403690 0.1051811 0.3838049 0.70 ns folate_cat3&lt;=400:f39_gdm_newGDM -0.0350023 0.1224666 -0.2858109 0.78 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.0991240 0.0975211 1.0164364 0.31 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.0984017 0.0962137 1.0227411 0.31 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.1349603 0.2001742 0.6742140 0.50 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP -0.0567051 0.1253406 -0.4524079 0.65 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.0083027 0.1202852 -0.0690255 0.94 ns 33.3.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 4.927409 0.0777824 2094 4.777207 5.082333 &lt;=400 non-GDM SCOPE 4.386449 0.0980616 2094 4.198295 4.583035 &gt;400 to &lt;800 non-GDM SCOPE 4.393092 0.0478753 2094 4.300200 4.487990 &gt;=800 non-GDM SCOPE 4.229249 0.0582002 2094 4.116639 4.344939 None GDM SCOPE 4.217553 0.3297413 2094 3.618032 4.916415 &lt;=400 GDM SCOPE 3.625381 0.3275809 2094 3.036663 4.328234 &gt;400 to &lt;800 GDM SCOPE 4.152037 0.2296274 2094 3.725276 4.627686 &gt;=800 GDM SCOPE 3.994298 0.2092136 2094 3.604379 4.426399 None non-GDM STOP 5.192112 0.1325333 2094 4.938599 5.458638 &lt;=400 non-GDM STOP 4.891789 0.3122816 2094 4.316158 5.544189 &gt;400 to &lt;800 non-GDM STOP 5.037841 0.0800334 2094 4.883307 5.197265 &gt;=800 non-GDM STOP 4.734440 0.0421866 2094 4.652427 4.817899 None GDM STOP 4.627197 0.2954199 2094 4.082651 5.244375 &lt;=400 GDM STOP 4.817845 0.6159155 2094 3.749488 6.190615 &gt;400 to &lt;800 GDM STOP 4.684257 0.1651837 2094 4.371263 5.019662 &gt;=800 GDM STOP 4.617129 0.0951462 2094 4.434259 4.807542 33.3.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 0.89 (0.83, 0.96) 0.002 GDM / (non-GDM) STOP 0.94 (0.87, 1.02) 0.2 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.11 (1.07, 1.15) &lt;0.0001 STOP / SCOPE GDM 1.17 (1.06, 1.30) 0.002 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 0.92 (0.83, 1.01) 0.08 &gt;400 to &lt;800 / None non-GDM 0.93 (0.89, 0.97) 0.0003 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.02 (0.93, 1.11) 1.0 &gt;=800 / None non-GDM 0.88 (0.85, 0.92) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 0.97 (0.88, 1.06) 0.8 &gt;=800 / &gt;400 to &lt;800 non-GDM 0.95 (0.92, 0.98) 0.0005 &lt;=400 / None GDM 0.95 (0.74, 1.20) 0.9 &gt;400 to &lt;800 / None GDM 1.00 (0.86, 1.17) 1.0 &gt;400 to &lt;800 / &lt;=400 GDM 1.06 (0.85, 1.31) 0.9 &gt;=800 / None GDM 0.97 (0.84, 1.13) 1.0 &gt;=800 / &lt;=400 GDM 1.03 (0.83, 1.27) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.97 (0.87, 1.09) 0.9 "],["active-b12-4.html", "33.4 Active B12", " 33.4 Active B12 33.4.1 FA supp (4 categories) 33.4.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 3.7064034 0.0723742 51.2116899 &lt;0.0001 *** folate_cat3&lt;=400 0.0408019 0.0650813 0.6269372 0.53 ns folate_cat3&gt;400 to &lt;800 0.0486532 0.0422632 1.1511966 0.25 ns folate_cat3&gt;=800 0.1302236 0.0468160 2.7816063 0.005 ** f39_gdm_newGDM 0.1846099 0.1512249 1.2207637 0.22 ns StudySTOP 0.3095086 0.0727115 4.2566651 &lt;0.0001 *** f1_age 0.0062833 0.0024611 2.5529962 0.01 * BMI 0.0039079 0.0016674 2.3437692 0.02 * folate_cat3&lt;=400:StudySTOP -0.1476278 0.2149912 -0.6866690 0.49 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2267694 0.0871117 -2.6032013 0.009 ** folate_cat3&gt;=800:StudySTOP -0.2561995 0.0821579 -3.1183806 0.002 ** f39_gdm_newGDM:StudySTOP -0.4209300 0.2394739 -1.7577278 0.08 ns folate_cat3&lt;=400:f39_gdm_newGDM 0.3478960 0.2764791 1.2583085 0.21 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM -0.0711430 0.2007666 -0.3543567 0.72 ns folate_cat3&gt;=800:f39_gdm_newGDM -0.1547553 0.1981000 -0.7811977 0.43 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP -0.3001328 0.4464490 -0.6722666 0.50 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP 0.6348743 0.2875216 2.2080926 0.03 * folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP 0.4544318 0.2775590 1.6372439 0.10 ns 33.4.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 53.04455 1.851862 1123 49.53270 56.80539 &lt;=400 non-GDM SCOPE 55.25363 3.047929 1123 49.58562 61.56954 &gt;400 to &lt;800 non-GDM SCOPE 55.68915 1.386598 1123 53.03393 58.47732 &gt;=800 non-GDM SCOPE 60.42215 1.891606 1123 56.82236 64.24999 None GDM SCOPE 63.79929 9.396205 1123 47.78787 85.17536 &lt;=400 GDM SCOPE 94.10770 21.167215 1123 60.52875 146.31492 &gt;400 to &lt;800 GDM SCOPE 62.38047 8.115285 1123 48.32741 80.52000 &gt;=800 GDM SCOPE 62.25322 7.764789 1123 48.73912 79.51444 None non-GDM STOP 72.28675 4.631759 1123 63.74693 81.97060 &lt;=400 non-GDM STOP 64.96281 12.653702 1123 44.32877 95.20153 &gt;400 to &lt;800 non-GDM STOP 60.49282 2.501760 1123 55.77804 65.60612 &gt;=800 non-GDM STOP 63.73060 1.439091 1123 60.96863 66.61770 None GDM STOP 57.07240 9.961485 1123 40.52249 80.38151 &lt;=400 GDM STOP 53.79917 12.138897 1123 34.55483 83.76110 &gt;400 to &lt;800 GDM STOP 83.92603 6.571717 1123 71.97349 97.86351 &gt;=800 GDM STOP 67.89900 3.476383 1123 61.40948 75.07431 33.4.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.24 (1.05, 1.46) 0.01 GDM / (non-GDM) STOP 0.99 (0.83, 1.19) 0.9 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.16 (1.04, 1.30) 0.007 STOP / SCOPE GDM 0.93 (0.75, 1.16) 0.5 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 0.97 (0.73, 1.28) 1.0 &gt;400 to &lt;800 / None non-GDM 0.94 (0.84, 1.05) 0.4 &gt;400 to &lt;800 / &lt;=400 non-GDM 0.97 (0.74, 1.27) 1.0 &gt;=800 / None non-GDM 1.00 (0.90, 1.12) 1.0 &gt;=800 / &lt;=400 non-GDM 1.04 (0.79, 1.35) 1.0 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.07 (0.99, 1.16) 0.1 &lt;=400 / None GDM 1.18 (0.71, 1.95) 0.8 &gt;400 to &lt;800 / None GDM 1.20 (0.84, 1.71) 0.5 &gt;400 to &lt;800 / &lt;=400 GDM 1.02 (0.65, 1.60) 1.0 &gt;=800 / None GDM 1.08 (0.77, 1.51) 0.9 &gt;=800 / &lt;=400 GDM 0.91 (0.59, 1.42) 1.0 &gt;=800 / &gt;400 to &lt;800 GDM 0.90 (0.69, 1.17) 0.7 "],["folateb12-4.html", "33.5 Folate:B12", " 33.5 Folate:B12 33.5.1 FA supp (4 categories) 33.5.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 4.5213369 0.0819238 55.1895486 &lt;0.0001 *** folate_cat3&lt;=400 0.2394912 0.0719933 3.3265742 0.0009 *** folate_cat3&gt;400 to &lt;800 0.3806140 0.0498716 7.6318720 &lt;0.0001 *** folate_cat3&gt;=800 0.4733487 0.0553282 8.5552816 &lt;0.0001 *** f39_gdm_newGDM 0.0155494 0.2105621 0.0738473 0.94 ns StudySTOP 0.2566793 0.0791037 3.2448433 0.001 ** f1_age 0.0039230 0.0026744 1.4668514 0.14 ns BMI 0.0029504 0.0019165 1.5394510 0.12 ns folate_cat3&lt;=400:StudySTOP -0.1693382 0.1951630 -0.8676756 0.39 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.2137956 0.0936544 -2.2828135 0.02 * folate_cat3&gt;=800:StudySTOP -0.2828074 0.0899328 -3.1446529 0.002 ** f39_gdm_newGDM:StudySTOP -0.1461777 0.2778691 -0.5260667 0.60 ns folate_cat3&lt;=400:f39_gdm_newGDM -0.1074162 0.3235341 -0.3320089 0.74 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM -0.1009938 0.2576329 -0.3920067 0.70 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.2720636 0.2541788 1.0703630 0.28 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.6979206 0.5288233 1.3197614 0.19 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP 0.2230307 0.3311266 0.6735509 0.50 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.1601713 0.3178042 -0.5039936 0.61 ns 33.5.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 109.9886 4.586729 2095 101.35153 119.3616 &lt;=400 non-GDM SCOPE 139.7517 8.253679 2095 124.46766 156.9126 &gt;400 to &lt;800 non-GDM SCOPE 160.9333 4.633184 2095 152.09896 170.2809 &gt;=800 non-GDM SCOPE 176.5713 6.419297 2095 164.42077 189.6198 None GDM SCOPE 111.7122 23.073558 2095 74.50540 167.4994 &lt;=400 GDM SCOPE 127.4853 30.431814 2095 79.82767 203.5947 &gt;400 to &lt;800 GDM SCOPE 147.7536 21.587468 2095 110.94347 196.7770 &gt;=800 GDM SCOPE 235.4122 32.574822 2095 179.46389 308.8025 None non-GDM STOP 142.1746 9.587512 2095 124.56273 162.2765 &lt;=400 non-GDM STOP 152.5067 25.719993 2095 109.56007 212.2881 &gt;400 to &lt;800 non-GDM STOP 167.9849 7.050241 2095 154.71237 182.3960 &gt;=800 non-GDM STOP 172.0176 4.042413 2095 164.26994 180.1307 None GDM STOP 124.7644 21.043345 2095 89.62727 173.6766 &lt;=400 GDM STOP 241.5520 81.579634 2095 124.55672 468.4401 &gt;400 to &lt;800 GDM STOP 166.5478 15.515451 2095 138.73817 199.9319 &gt;=800 GDM STOP 168.8247 9.232277 2095 151.65635 187.9366 33.5.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 1.03 (0.85, 1.25) 0.7 GDM / (non-GDM) STOP 1.08 (0.87, 1.34) 0.5 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.09 (0.99, 1.21) 0.08 STOP / SCOPE GDM 1.14 (0.88, 1.49) 0.3 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.17 (0.91, 1.50) 0.4 &gt;400 to &lt;800 / None non-GDM 1.31 (1.17, 1.48) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.13 (0.89, 1.43) 0.6 &gt;=800 / None non-GDM 1.39 (1.24, 1.57) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 1.19 (0.94, 1.51) 0.2 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.06 (0.97, 1.15) 0.3 &lt;=400 / None GDM 1.49 (0.79, 2.80) 0.4 &gt;400 to &lt;800 / None GDM 1.33 (0.88, 2.00) 0.3 &gt;400 to &lt;800 / &lt;=400 GDM 0.89 (0.50, 1.59) 1.0 &gt;=800 / None GDM 1.69 (1.14, 2.50) 0.003 &gt;=800 / &lt;=400 GDM 1.14 (0.65, 2.00) 0.9 &gt;=800 / &gt;400 to &lt;800 GDM 1.27 (0.95, 1.70) 0.2 "],["folateactive-b12-4.html", "33.6 Folate:Active B12", " 33.6 Folate:Active B12 33.6.1 FA supp (4 categories) 33.6.2 Model summary Estimate Std. Error t value Pr(&gt;|t|) (Intercept) 6.2715785 0.1089142 57.5827273 &lt;0.0001 *** folate_cat3&lt;=400 0.2645272 0.0978920 2.7022359 0.007 ** folate_cat3&gt;400 to &lt;800 0.3952297 0.0635701 6.2172232 &lt;0.0001 *** folate_cat3&gt;=800 0.3871869 0.0704183 5.4983870 &lt;0.0001 *** f39_gdm_newGDM -0.1804659 0.2274650 -0.7933788 0.43 ns StudySTOP 0.0850330 0.1093690 0.7774870 0.44 ns f1_age 0.0058488 0.0037021 1.5798784 0.11 ns BMI -0.0092678 0.0025099 -3.6925390 0.0002 *** folate_cat3&lt;=400:StudySTOP -0.1601929 0.3233788 -0.4953722 0.62 ns folate_cat3&gt;400 to &lt;800:StudySTOP -0.0676212 0.1310291 -0.5160776 0.61 ns folate_cat3&gt;=800:StudySTOP -0.0306936 0.1235777 -0.2483749 0.80 ns f39_gdm_newGDM:StudySTOP 0.2400103 0.3602046 0.6663166 0.51 ns folate_cat3&lt;=400:f39_gdm_newGDM -0.3173972 0.4158657 -0.7632205 0.45 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM 0.1612432 0.3019829 0.5339481 0.59 ns folate_cat3&gt;=800:f39_gdm_newGDM 0.3197122 0.2979724 1.0729593 0.28 ns folate_cat3&lt;=400:f39_gdm_newGDM:StudySTOP 0.7432475 0.6715259 1.1068039 0.27 ns folate_cat3&gt;400 to &lt;800:f39_gdm_newGDM:StudySTOP -0.5749122 0.4324757 -1.3293515 0.18 ns folate_cat3&gt;=800:f39_gdm_newGDM:StudySTOP -0.4436389 0.4175883 -1.0623837 0.29 ns 33.6.3 Estimated Marginal Means folate_cat3 f39_gdm_new Study response SE df lower.CL upper.CL None non-GDM SCOPE 470.8393 24.72491 1122 424.7426 521.9389 &lt;=400 non-GDM SCOPE 613.4164 50.89726 1122 521.2572 721.8696 &gt;400 to &lt;800 non-GDM SCOPE 699.0670 26.18145 1122 649.5389 752.3716 &gt;=800 non-GDM SCOPE 693.4671 32.65549 1122 632.2653 760.5931 None GDM SCOPE 393.0949 87.08116 1122 254.5245 607.1069 &lt;=400 GDM SCOPE 372.8517 126.14372 1122 191.9754 724.1472 &gt;400 to &lt;800 GDM SCOPE 685.7574 134.18886 1122 467.1191 1006.7306 &gt;=800 GDM SCOPE 797.0760 149.54154 1122 551.6087 1151.7769 None non-GDM STOP 512.6277 49.40609 1122 424.3032 619.3382 &lt;=400 non-GDM STOP 569.0021 166.70872 1122 320.2254 1011.0484 &gt;400 to &lt;800 non-GDM STOP 711.3456 44.25005 1122 629.6128 803.6886 &gt;=800 non-GDM STOP 732.1923 24.86924 1122 684.9873 782.6504 None GDM STOP 544.0789 142.84048 1122 325.0493 910.6983 &lt;=400 GDM STOP 924.5238 313.77161 1122 475.0279 1799.3557 &gt;400 to &lt;800 GDM STOP 499.2135 58.79765 1122 396.2078 628.9984 &gt;=800 GDM STOP 686.5375 53.35135 1122 589.4478 799.6192 33.6.4 Comparisons Results from comparisons below may be misleading when interaction term is involved. Contrast Study Ratio of Geometric means (95% CI) P-value GDM / (non-GDM) SCOPE 0.87 (0.68, 1.11) 0.3 GDM / (non-GDM) STOP 1.03 (0.79, 1.36) 0.8 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value STOP / SCOPE non-GDM 1.02 (0.87, 1.20) 0.8 STOP / SCOPE GDM 1.21 (0.88, 1.68) 0.2 Contrast f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;=400 / None non-GDM 1.20 (0.79, 1.82) 0.7 &gt;400 to &lt;800 / None non-GDM 1.44 (1.21, 1.70) &lt;0.0001 &gt;400 to &lt;800 / &lt;=400 non-GDM 1.19 (0.80, 1.79) 0.7 &gt;=800 / None non-GDM 1.45 (1.24, 1.70) &lt;0.0001 &gt;=800 / &lt;=400 non-GDM 1.21 (0.81, 1.80) 0.6 &gt;=800 / &gt;400 to &lt;800 non-GDM 1.01 (0.90, 1.14) 1.0 &lt;=400 / None GDM 1.27 (0.59, 2.71) 0.8 &gt;400 to &lt;800 / None GDM 1.27 (0.74, 2.15) 0.7 &gt;400 to &lt;800 / &lt;=400 GDM 1.00 (0.50, 1.97) 1.0 &gt;=800 / None GDM 1.60 (0.96, 2.67) 0.09 &gt;=800 / &lt;=400 GDM 1.26 (0.65, 2.45) 0.8 &gt;=800 / &gt;400 to &lt;800 GDM 1.26 (0.85, 1.87) 0.4 "],["age-groups-3.html", "34 Age groups", " 34 Age groups Descriptives with univariate P-values. Within non-GDM Characteristic &lt;35 yrs (n=2054) &gt;=35 yrs (n=67) Total (n=2121) P-value PRL (ng/ml): Median (IQ range) 103.1 (60.3-169.5) 89.9 (50.4-166.9) 102.2 (59.7-169.5) 0.25 hPL (μg/ml): Median (IQ range) 120.2 (56.6-180.9) 90.1 (52.2-158.4) 117.3 (56.5-180.7) 0.13 GH2 (ng/ml): Median (IQ range) 2.7 (1.3-4.3) 2.2 (1.2-3.8) 2.7 (1.3-4.3) 0.32 Within GDM Characteristic &lt;35 yrs (n=229) &gt;=35 yrs (n=27) Total (n=256) P-value PRL (ng/ml): Median (IQ range) 81.3 (46.4-133.7) 65.6 (43.9-131.4) 79.9 (45.7-132.7) 0.63 hPL (μg/ml): Median (IQ range) 66.6 (43.0-107.5) 41.6 (24.6-69.0) 65.0 (40.5-106.7) 0.01 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.7) 1.6 (1.0-2.9) 1.5 (1.0-2.8) 0.80 Click here for table within SCOPE Within non-GDM Characteristic &lt;35 yrs (n=1047) &gt;=35 yrs (n=26) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 139.7 (92.6-220.5) 177.6 (100.6-292.1) 140.0 (92.7-221.7) 0.24 hPL (μg/ml): Median (IQ range) 180.1 (148.7-215.9) 163.8 (132.1-208.7) 180.0 (148.6-215.7) 0.30 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.7) 4.1 (3.4-6.3) 4.2 (3.2-5.7) 0.66 Serum folate concentration (nM): Median (IQ range) 35.8 (27.9-42.5) 40.3 (34.6-46.5) 35.9 (28.1-42.6) 0.02 B12 concentration (pM): Median (IQ range) 243.0 (194.0-307.0) 265.0 (227.5-365.0) 245.0 (195.0-308.5) 0.08 Folate:B12 ratio: Median (IQ range) 142.6 (101.7-208.7) 162.5 (120.6-200.7) 142.7 (102.3-207.5) 0.31 Active B12 concentration (pM): Median (IQ range) 56.0 (43.0-72.2) 59.0 (46.0-94.0) 56.0 (43.0-73.0) 0.40 Folate:Active B12 ratio: Median (IQ range) 612.1 (436.5-902.1) 685.4 (420.3-904.2) 615.4 (432.4-902.3) 0.64 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.5 (3.9-4.7) 4.4 (3.8-5.0) 0.83 Within GDM Characteristic &lt;35 yrs (n=56) &gt;=35 yrs (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 120.5 (80.3-181.6) 113.5 (100.0-126.9) 120.5 (81.8-180.0) 0.83 hPL (μg/ml): Median (IQ range) 133.7 (105.7-192.1) 179.7 (176.0-183.4) 163.3 (105.8-191.6) 0.53 GH2 (ng/ml): Median (IQ range) 3.5 (2.1-5.4) 2.4 (2.0-2.7) 3.4 (2.0-5.3) 0.39 Serum folate concentration (nM): Median (IQ range) 38.8 (31.7-43.8) 86.0 (63.5-108.6) 40.1 (32.0-43.8) 0.23 B12 concentration (pM): Median (IQ range) 254.5 (194.8-335.0) 205.0 (200.0-210.0) 253.5 (194.2-333.0) 0.31 Folate:B12 ratio: Median (IQ range) 152.8 (114.2-196.8) 410.0 (309.9-510.1) 158.9 (116.5-210.2) 0.11 Active B12 concentration (pM): Median (IQ range) 68.0 (55.0-85.5) 67.5 (50.8-84.2) 68.0 (55.0-86.0) 0.83 Folate:Active B12 ratio: Median (IQ range) 553.8 (431.4-648.6) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) 0.65 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 4.1 (3.5-4.7) 3.9 (3.6-4.6) 0.94 Click here for table within STOP Within non-GDM Characteristic &lt;35 yrs (n=1007) &gt;=35 yrs (n=41) Total (n=1048) P-value PRL (ng/ml): Median (IQ range) 75.1 (49.2-119.7) 60.0 (44.1-99.7) 74.7 (48.6-119.1) 0.20 hPL (μg/ml): Median (IQ range) 60.3 (40.2-92.6) 60.6 (40.9-88.5) 60.3 (40.2-92.6) 0.95 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.5 (1.0-2.3) 1.4 (0.9-2.4) 0.73 Serum folate concentration (nM): Median (IQ range) 40.4 (36.3-45.2) 43.4 (40.1-93.9) 40.5 (36.4-45.3) 0.002 B12 concentration (pM): Median (IQ range) 280.0 (218.0-356.5) 272.5 (205.8-363.0) 280.0 (218.0-357.0) 0.71 Folate:B12 ratio: Median (IQ range) 152.6 (114.8-219.0) 185.4 (141.9-297.7) 153.5 (115.1-221.2) 0.007 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-83.5) 62.0 (54.0-96.0) 63.0 (49.0-84.0) 0.82 Folate:Active B12 ratio: Median (IQ range) 663.0 (474.1-946.7) 742.2 (493.6-959.1) 663.1 (475.7-951.1) 0.70 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.9 (4.3-5.8) 4.8 (4.2-5.6) 0.37 Within GDM Characteristic &lt;35 yrs (n=173) &gt;=35 yrs (n=25) Total (n=198) P-value PRL (ng/ml): Median (IQ range) 72.5 (42.0-112.7) 59.5 (43.1-128.5) 68.6 (42.3-114.0) 0.85 hPL (μg/ml): Median (IQ range) 57.8 (39.2-84.6) 38.4 (24.5-65.8) 55.6 (36.6-83.8) 0.01 GH2 (ng/ml): Median (IQ range) 1.3 (0.9-2.2) 1.5 (1.0-2.9) 1.3 (0.9-2.3) 0.42 Serum folate concentration (nM): Median (IQ range) 39.7 (35.1-44.7) 41.3 (38.5-64.4) 40.1 (35.5-45.2) 0.08 B12 concentration (pM): Median (IQ range) 272.5 (221.2-345.8) 282.0 (187.0-376.0) 273.0 (217.5-348.5) 0.87 Folate:B12 ratio: Median (IQ range) 148.0 (114.1-217.6) 169.4 (102.0-285.2) 148.0 (112.4-225.9) 0.46 Active B12 concentration (pM): Median (IQ range) 75.0 (56.5-92.5) 75.0 (62.8-96.8) 75.0 (57.0-93.0) 1.00 Folate:Active B12 ratio: Median (IQ range) 521.2 (418.5-762.9) 809.3 (456.7-1008.0) 531.9 (417.3-788.4) 0.14 Homocysteine concentration (μM): Median (IQ range) 4.7 (4.0-5.4) 4.9 (4.5-5.2) 4.8 (4.0-5.3) 0.64 mod_ls &lt;- lapply(hormone_var,function(x){ #mod_eq &lt;- as.formula(paste0(x,&quot;~BMI_gp2 + GA_samp + Study + (1|Study.ID)&quot;)) #mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID)&quot;)) #log mod_eq &lt;- as.formula(paste0(&quot;log(&quot;,x,&quot;)~&quot;,fvarc,&quot;+&quot;,preg_out,&quot;+&quot;,fvarc,&quot;*Study +&quot;,preg_out,&quot;*Study +&quot;,preg_out,&quot;*&quot;,fvarc,&quot;*Study + GA_samp + Study + (1|Study.ID) + (1|Assay.&quot;,x,&quot;)&quot;)) #log mod &lt;- eval(bquote(lmer(.(mod_eq),data=dat_run))) return(mod)}) em2_eq &lt;- as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study*&quot;,preg_out)) em2_eq_o &lt;- as.formula(paste0(&quot;revpairwise~Study*&quot;,preg_out)) em2_eq_c &lt;- as.formula(paste0(&quot;~&quot;,fvarc,&quot;*Study*&quot;,preg_out)) ##mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~&quot;,fvarc,&quot;|Study*&quot;,preg_out)),type=&quot;response&quot;)}) ##mod_em2 &lt;- lapply(mod_ls,function(x){emmeans(x,as.formula(paste0(&quot;revpairwise~Study|&quot;,fvarc)),type=&quot;response&quot;)}) ##names(mod_ls) &lt;- names(mod_em) &lt;- names(mod_em2) &lt;- hormone_var #mod_em &lt;- lapply(mod_ls,function(x){emmeans(x,em2_eq,type=&quot;response&quot;)}) #mod_em_o &lt;- lapply(mod_ls,function(x){emmeans(x,em2_eq_o,type=&quot;response&quot;)}) #mod_em_c &lt;- lapply(mod_ls,function(x){emmeans(x,em2_eq_c,type=&quot;response&quot;)}) mod_em &lt;- foreach(ind1=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind1]],em2_eq,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} ## Warning: executing %dopar% sequentially: no parallel backend registered mod_em_o &lt;- foreach(ind2=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind2]],em2_eq_o,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} mod_em_c &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;emmeans&quot;,&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { emmeans(mod_ls[[ind3]],em2_eq_c,type=&quot;response&quot;,lmer.df=&quot;satterthwaite&quot;)} names(mod_em) &lt;- names(mod_em_o) &lt;- names(mod_em_c) &lt;- hormone_var #mod_sum &lt;- lapply(mod_ls,extract.ci.lme,rc=2,eff.exp=T) #model summary mod_sum &lt;- foreach(ind3=1:length(mod_ls),.packages=c(&quot;lme4&quot;,&quot;lmerTest&quot;)) %dopar% { extract.ci.lme(mod_ls[[ind3]],rc=2,eff.exp=T)} #model summary names(mod_sum) &lt;- hormone_var mod_em_est &lt;- lapply(mod_em,function(x) round_df(data.frame(x$emmeans),2)) #estimated means mod_em2 &lt;- lapply(mod_em,function(x) return(emmeans.sum(x))) #Post-hoc: within gps names(mod_em) &lt;- names(mod_em_o) &lt;- names(mod_em_c) &lt;- names(mod_sum) &lt;- names(mod_em_est) &lt;- names(mod_em2) &lt;- hormone_var fit_em_contrasts &lt;- lapply(mod_em_c,function(x){ contrast_dat &lt;- data.frame(x) contrast_dat$Group &lt;- with(contrast_dat,paste(Study,get(preg_out),sep=&quot;.&quot;)) contrast_dat$Group &lt;- paste(contrast_dat$Group,1:2,sep=&quot;.&quot;) contrast_mat &lt;- diag(nrow(contrast_dat)) rownames(contrast_mat) &lt;- colnames(contrast_mat) &lt;- contrast_dat$Group contrast_ls &lt;- list( &quot;STOP/SCOPE (Overall)&quot;= ((contrast_mat[4,]-contrast_mat[3,])+(contrast_mat[8,]-contrast_mat[7,]))- ((contrast_mat[2,]-contrast_mat[1,])+(contrast_mat[6,]-contrast_mat[5,])), &quot;STOP/SCOPE (Control)&quot;= (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.1&quot;),]), &quot;STOP/SCOPE (Cases)&quot;= (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.1&quot;),]), &quot;Cases/Control (SCOPE)&quot;= (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1],&quot;.1&quot;),]), &quot;Cases/Control (STOP)&quot;= (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2],&quot;.1&quot;),])- (contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.2&quot;),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1],&quot;.1&quot;),])) names(contrast_ls) &lt;- c(&quot;SCOPE/SCOPE (Overall)&quot;,paste0(&quot;STOP/SCOPE (&quot;,preg_out_label,&quot;)&quot;), paste0(preg_out_label[2],&quot;/&quot;,preg_out_label[1],&quot; (&quot;,c(&quot;SCOPE&quot;,&quot;STOP&quot;),&quot;)&quot;)) contrast_out &lt;- contrast(x,method=contrast_ls) return(contrast_out)}) mod_em2_c &lt;- lapply(fit_em_contrasts,function(x){ #tmp1 &lt;- data.frame(confint(x)$contrasts) tmp1 &lt;- data.frame(confint(x)) #tmp2 &lt;- cbind(tmp1,&quot;p.value&quot;=data.frame(x$contrasts)$p.value) tmp2 &lt;- cbind(tmp1,&quot;p.value&quot;=data.frame(x)$p.value) tmp2$&quot;&quot; &lt;- p_val_ast(tmp2$p.value) tmp2$p.value &lt;- round_p_vec(tmp2$p.value,rc=3) return(tmp2)}) names(mod_em2_c) &lt;- hormone_var #mod_em_sum1 &lt;- lapply(mod_em,emmeans.sum) #post-hoc contrasts #mod_em_sum2 &lt;- lapply(mod_em2,emmeans.sum) #post-hoc contrasts #mod_em_sum &lt;- mapply(function(x,y){ # x[,2] &lt;- paste(dat_labels[names(x)[2]],x[,2],sep=&quot;: &quot;) # y[,2] &lt;- paste(dat_labels[names(y)[2]],y[,2],sep=&quot;: &quot;) # names(x)[2] &lt;- names(y)[2] &lt;- &quot;Subgroup&quot; # return(rbind(x,y))}, # mod_em_sum1,mod_em_sum2,SIMPLIFY=F) "],["prolactin-21.html", "34.1 Prolactin", " 34.1 Prolactin LME for repeated measures. 34.1.1 Model summary Var Effect P (Intercept) 12.23 (8.80, 16.99) &lt;0.0001 Age_gp&gt;=35 yrs 1.12 (0.87, 1.46) 0.38 f39_gdm_newGDM 1.35 (1.12, 1.63) 0.001 StudySTOP 1.06 (0.97, 1.17) 0.20 GA_samp 1.17 (1.14, 1.19) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.72 (0.52, 1.00) 0.05 f39_gdm_newGDM:StudySTOP 0.80 (0.65, 0.98) 0.03 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.34 (0.14, 0.84) 0.02 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 3.24 (1.26, 8.39) 0.02 34.1.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 93.80 6.97 80.76 80.91 108.74 &gt;=35 yrs SCOPE non-GDM 105.37 15.77 1002.86 78.56 141.34 &lt;35 yrs STOP non-GDM 99.88 7.20 71.89 86.51 115.33 &gt;=35 yrs STOP non-GDM 80.91 9.68 493.70 63.96 102.34 &lt;35 yrs SCOPE GDM 127.04 14.61 423.80 101.34 159.26 &gt;=35 yrs SCOPE GDM 49.05 21.23 1405.54 20.99 114.64 &lt;35 yrs STOP GDM 108.42 9.33 143.13 91.46 128.53 &gt;=35 yrs STOP GDM 97.92 14.11 889.19 73.80 129.93 ## Warning: Using `size` aesthetic for lines was deprecated in ggplot2 3.4.0. ## ℹ Please use `linewidth` instead. ## This warning is displayed once every 8 hours. ## Call `lifecycle::last_lifecycle_warnings()` to see where this warning was generated. 34.1.3 Post-hoc comparisons 34.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.12 (0.87, 1.46) 0.4 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.81 (0.67, 0.99) 0.04 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.39 (0.16, 0.91) 0.03 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.90 (0.70, 1.17) 0.4 34.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.6866527 0.8168377 1655.225 0.6523659 4.3607390 0.281 ns STOP/SCOPE (non-GDM) 0.7210373 0.1204855 2646.394 0.5195850 1.0005960 0.050 ns STOP/SCOPE (GDM) 2.3392032 1.0642786 1496.589 0.9582508 5.7102708 0.062 ns GDM/non-GDM (SCOPE) 0.3436914 0.1568368 1527.334 0.1404208 0.8412129 0.019 * GDM/non-GDM (STOP) 1.1150104 0.1845881 2605.010 0.8059320 1.5426217 0.511 ns "],["hpl-21.html", "34.2 HPL", " 34.2 HPL LME for repeated measures. 34.2.1 Model summary Var Effect P (Intercept) 1.78 (1.49, 2.13) &lt;0.0001 Age_gp&gt;=35 yrs 0.95 (0.82, 1.11) 0.52 f39_gdm_newGDM 1.00 (0.90, 1.10) 0.94 StudySTOP 1.11 (1.05, 1.17) 0.0003 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 1.01 (0.84, 1.22) 0.89 f39_gdm_newGDM:StudySTOP 1.03 (0.92, 1.15) 0.60 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.88 (0.56, 1.39) 0.58 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 0.87 (0.53, 1.41) 0.57 34.2.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 90.51 2.53 129.12 85.63 95.67 &gt;=35 yrs SCOPE non-GDM 86.09 6.94 2179.89 73.51 100.83 &lt;35 yrs STOP non-GDM 100.32 2.63 100.85 95.23 105.69 &gt;=35 yrs STOP non-GDM 96.72 5.84 1468.25 85.91 108.88 &lt;35 yrs SCOPE GDM 90.19 4.93 961.61 81.01 100.41 &gt;=35 yrs SCOPE GDM 75.37 16.23 1016.83 49.40 115.00 &lt;35 yrs STOP GDM 102.97 3.85 359.81 95.68 110.83 &gt;=35 yrs STOP GDM 75.53 5.66 1840.34 65.21 87.49 34.2.3 Post-hoc comparisons 34.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 0.95 (0.82, 1.11) 0.5 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.96 (0.86, 1.08) 0.5 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.84 (0.54, 1.28) 0.4 &gt;=35 yrs / &lt;35 yrs STOP GDM 0.73 (0.63, 0.85) &lt;0.0001 34.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8895816 0.2225875 1271.169 0.5445009 1.4533592 0.640 ns STOP/SCOPE (non-GDM) 1.0135201 0.0975569 2480.926 0.8391885 1.2240671 0.889 ns STOP/SCOPE (GDM) 0.8777148 0.2028371 1110.769 0.5577362 1.3812681 0.573 ns GDM/non-GDM (SCOPE) 0.8785873 0.2043135 1147.869 0.5567126 1.3865606 0.578 ns GDM/non-GDM (STOP) 0.7608622 0.0714794 2330.890 0.6328461 0.9147742 0.004 ** "],["gh2-21.html", "34.3 GH2", " 34.3 GH2 LME for repeated measures. 34.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 Age_gp&gt;=35 yrs 1.07 (0.87, 1.32) 0.51 f39_gdm_newGDM 1.03 (0.89, 1.18) 0.70 StudySTOP 0.95 (0.88, 1.02) 0.16 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Age_gp&gt;=35 yrs:StudySTOP 0.84 (0.65, 1.09) 0.19 f39_gdm_newGDM:StudySTOP 0.97 (0.83, 1.13) 0.70 Age_gp&gt;=35 yrs:f39_gdm_newGDM 0.69 (0.35, 1.34) 0.27 Age_gp&gt;=35 yrs:f39_gdm_newGDM:StudySTOP 1.84 (0.91, 3.74) 0.09 34.3.2 Estimated marginal means Age_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs SCOPE non-GDM 2.40 0.07 315.90 2.27 2.54 &gt;=35 yrs SCOPE non-GDM 2.58 0.27 2592.14 2.09 3.18 &lt;35 yrs STOP non-GDM 2.28 0.06 212.53 2.17 2.40 &gt;=35 yrs STOP non-GDM 2.06 0.16 2379.11 1.77 2.39 &lt;35 yrs SCOPE GDM 2.47 0.18 1941.16 2.14 2.85 &gt;=35 yrs SCOPE GDM 1.82 0.58 1305.33 0.98 3.39 &lt;35 yrs STOP GDM 2.27 0.10 870.54 2.09 2.47 &gt;=35 yrs STOP GDM 2.60 0.25 2445.21 2.14 3.15 34.3.3 Post-hoc comparisons 34.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;=35 yrs / &lt;35 yrs SCOPE non-GDM 1.07 (0.87, 1.32) 0.5 &gt;=35 yrs / &lt;35 yrs STOP non-GDM 0.90 (0.78, 1.05) 0.2 &gt;=35 yrs / &lt;35 yrs SCOPE GDM 0.74 (0.39, 1.39) 0.3 &gt;=35 yrs / &lt;35 yrs STOP GDM 1.14 (0.94, 1.39) 0.2 34.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.3047431 0.4717250 1602.195 0.6420127 2.651590 0.462 ns STOP/SCOPE (non-GDM) 0.8419760 0.1097623 2600.797 0.6520533 1.087217 0.187 ns STOP/SCOPE (GDM) 1.5496202 0.5230118 1434.525 0.7992707 3.004392 0.195 ns GDM/non-GDM (SCOPE) 0.6877727 0.2335279 1472.833 0.3533364 1.338756 0.270 ns GDM/non-GDM (STOP) 1.2658157 0.1597019 2542.741 0.9883876 1.621114 0.062 ns "],["bmi-groups-3.html", "35 BMI groups", " 35 BMI groups Descriptives with univariate P-values. Within non-GDM Characteristic Underweight (n=55) Normal (n=895) Overweight (n=605) Obese (n=565) Total (n=2120) P-value PRL (ng/ml): Median (IQ range) 112.4 (72.9-216.6) 106.1 (62.9-170.5) 104.8 (62.8-183.9) 92.8 (51.9-148.7) 102.2 (59.7-169.5) 0.002 hPL (μg/ml): Median (IQ range) 164.7 (90.3-220.8) 132.4 (62.5-199.0) 120.9 (56.4-172.8) 92.9 (45.6-153.3) 117.3 (56.5-180.7) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.3 (2.8-6.2) 3.2 (1.3-4.9) 2.6 (1.3-4.0) 2.4 (1.1-3.6) 2.7 (1.3-4.3) &lt;0.0001 Within GDM Characteristic Underweight (n=3) Normal (n=66) Overweight (n=53) Obese (n=134) Total (n=256) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 92.5 (50.1-180.3) 82.0 (49.9-156.1) 71.9 (45.6-113.0) 79.9 (45.7-132.7) 0.06 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 87.5 (53.8-129.8) 79.6 (42.5-120.5) 55.5 (36.0-81.1) 65.0 (40.5-106.7) 0.003 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.8 (1.1-3.7) 1.5 (0.8-3.0) 1.4 (1.0-2.5) 1.5 (1.0-2.8) 0.19 Click here for table within SCOPE Within non-GDM Characteristic Underweight (n=34) Normal (n=458) Overweight (n=301) Obese (n=280) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 168.8 (90.4-271.0) 138.4 (96.6-219.2) 153.7 (99.6-237.7) 131.1 (82.1-207.2) 140.0 (92.7-221.7) 0.03 hPL (μg/ml): Median (IQ range) 213.7 (167.4-258.0) 198.9 (169.3-228.4) 171.0 (148.4-206.1) 155.5 (129.9-187.1) 180.0 (148.6-215.7) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 5.1 (4.3-6.5) 4.8 (3.6-6.4) 4.0 (3.1-5.4) 3.4 (2.7-4.4) 4.2 (3.2-5.7) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 29.3 (22.4-38.1) 36.0 (29.0-43.0) 35.8 (28.9-41.1) 35.8 (25.6-43.0) 35.9 (28.1-42.6) 0.13 B12 concentration (pM): Median (IQ range) 269.0 (207.5-330.5) 253.0 (197.8-319.0) 240.0 (199.0-309.0) 230.0 (185.0-290.5) 245.0 (195.0-308.5) 0.005 Folate:B12 ratio: Median (IQ range) 115.9 (74.5-201.5) 141.6 (102.3-205.7) 143.2 (106.1-198.6) 145.9 (102.5-219.1) 142.7 (102.3-207.5) 0.35 Active B12 concentration (pM): Median (IQ range) 52.5 (39.5-71.5) 54.0 (42.0-71.0) 56.0 (43.2-72.0) 61.0 (45.2-75.0) 56.0 (43.0-73.0) 0.13 Folate:Active B12 ratio: Median (IQ range) 613.6 (414.7-845.3) 649.1 (457.9-983.6) 618.7 (466.7-891.8) 537.6 (392.3-819.3) 615.4 (432.4-902.3) 0.02 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.2-5.3) 4.4 (3.9-5.2) 4.3 (3.7-4.8) 4.4 (3.8-5.1) 4.4 (3.8-5.0) 0.01 Within GDM Characteristic Underweight (n=0) Normal (n=14) Overweight (n=13) Obese (n=31) Total (n=58) P-value PRL (ng/ml): Median (IQ range) NA (NA-NA) 147.9 (123.6-190.2) 176.9 (90.8-295.3) 94.1 (65.6-146.5) 120.5 (81.8-180.0) hPL (μg/ml): Median (IQ range) NA (NA-NA) 177.3 (105.8-199.8) 143.3 (102.7-192.4) 132.6 (104.9-176.5) 163.3 (105.8-191.6) GH2 (ng/ml): Median (IQ range) NA (NA-NA) 5.1 (4.0-6.5) 5.4 (4.0-7.7) 2.7 (1.8-3.5) 3.4 (2.0-5.3) Serum folate concentration (nM): Median (IQ range) NA (NA-NA) 43.6 (39.0-44.6) 36.9 (31.7-45.9) 39.6 (31.5-43.0) 40.1 (32.0-43.8) B12 concentration (pM): Median (IQ range) NA (NA-NA) 289.0 (170.5-372.5) 263.5 (224.2-309.8) 240.0 (192.0-301.0) 253.5 (194.2-333.0) Folate:B12 ratio: Median (IQ range) NA (NA-NA) 155.4 (114.2-232.5) 145.1 (121.9-190.5) 169.4 (118.7-199.0) 158.9 (116.5-210.2) Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 83.5 (66.2-99.2) 58.5 (54.5-77.0) 77.0 (53.0-85.0) 68.0 (55.0-86.0) Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 553.9 (377.4-674.3) 535.8 (321.6-763.8) 553.8 (516.5-577.4) 553.8 (424.7-660.3) Homocysteine concentration (μM): Median (IQ range) NA (NA-NA) 4.3 (3.9-5.1) 4.0 (3.5-4.6) 3.7 (3.5-4.3) 3.9 (3.6-4.6) Click here for table within STOP Within non-GDM Characteristic Underweight (n=21) Normal (n=437) Overweight (n=304) Obese (n=285) Total (n=1047) P-value PRL (ng/ml): Median (IQ range) 91.8 (50.0-112.4) 76.5 (50.9-122.9) 76.5 (52.3-118.5) 67.4 (43.2-112.3) 74.7 (48.6-119.1) 0.06 hPL (μg/ml): Median (IQ range) 87.7 (64.9-139.2) 66.3 (44.7-103.1) 60.2 (42.0-96.2) 49.4 (32.5-71.7) 60.3 (40.2-92.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 2.5 (1.5-4.0) 1.5 (0.9-2.5) 1.4 (0.9-2.3) 1.2 (0.8-2.3) 1.4 (0.9-2.4) 0.0005 Serum folate concentration (nM): Median (IQ range) 34.2 (29.1-40.0) 40.8 (36.9-54.0) 40.5 (36.3-45.7) 40.3 (36.0-45.3) 40.5 (36.4-45.3) 0.001 B12 concentration (pM): Median (IQ range) 340.0 (207.0-412.0) 293.0 (227.0-375.5) 282.0 (218.8-352.8) 258.0 (205.0-324.2) 280.0 (218.0-357.0) &lt;0.0001 Folate:B12 ratio: Median (IQ range) 106.3 (69.0-161.8) 152.6 (109.4-222.4) 147.6 (116.3-215.1) 169.8 (123.0-233.2) 153.5 (115.1-221.4) 0.003 Active B12 concentration (pM): Median (IQ range) 48.0 (40.0-50.0) 65.5 (47.2-84.0) 62.0 (47.0-82.8) 64.0 (52.0-86.5) 63.0 (49.0-84.0) 0.31 Folate:Active B12 ratio: Median (IQ range) 711.3 (619.0-840.3) 674.7 (493.3-990.3) 670.7 (457.2-973.9) 628.6 (471.3-867.2) 663.6 (476.4-952.0) 0.56 Homocysteine concentration (μM): Median (IQ range) 5.4 (4.7-6.0) 4.8 (4.2-5.6) 4.8 (4.2-5.5) 4.8 (4.3-5.7) 4.8 (4.2-5.6) 0.07 Within GDM Characteristic Underweight (n=3) Normal (n=52) Overweight (n=40) Obese (n=103) Total (n=198) P-value PRL (ng/ml): Median (IQ range) 40.9 (39.0-41.7) 85.4 (49.3-169.3) 72.9 (34.2-120.1) 66.0 (43.4-105.9) 68.6 (42.3-114.0) 0.14 hPL (μg/ml): Median (IQ range) 82.9 (57.5-95.5) 69.0 (51.5-110.6) 67.4 (36.1-90.8) 47.8 (33.9-66.4) 55.6 (36.6-83.8) 0.0004 GH2 (ng/ml): Median (IQ range) 1.5 (1.2-1.7) 1.7 (1.0-2.9) 1.2 (0.8-2.6) 1.3 (0.9-2.1) 1.3 (0.9-2.3) 0.15 Serum folate concentration (nM): Median (IQ range) 42.7 (41.5-42.9) 41.6 (36.9-59.7) 40.7 (37.0-55.6) 39.2 (34.4-43.8) 40.1 (35.5-45.2) 0.24 B12 concentration (pM): Median (IQ range) 345.0 (307.0-492.5) 293.0 (240.0-348.5) 258.0 (197.5-358.5) 269.5 (215.1-335.0) 273.0 (217.5-348.5) 0.19 Folate:B12 ratio: Median (IQ range) 117.1 (91.9-138.7) 138.1 (110.9-219.8) 153.1 (114.8-261.1) 150.2 (113.0-220.0) 148.0 (112.4-225.9) 0.60 Active B12 concentration (pM): Median (IQ range) NA (NA-NA) 68.0 (55.0-79.0) 71.0 (54.0-104.5) 78.0 (61.5-92.5) 75.0 (57.0-93.0) Folate:Active B12 ratio: Median (IQ range) NA (NA-NA) 521.2 (457.3-770.2) 774.9 (426.9-879.1) 513.8 (411.6-650.2) 531.9 (417.3-788.4) Homocysteine concentration (μM): Median (IQ range) 4.5 (4.0-4.5) 4.7 (4.0-5.4) 4.8 (4.0-5.7) 4.8 (4.0-5.2) 4.8 (4.0-5.3) 0.68 "],["prolactin-22.html", "35.1 Prolactin", " 35.1 Prolactin LME for duplicated or repeated measures. 35.1.1 Model summary Var Effect P (Intercept) 14.73 (9.85, 22.03) &lt;0.0001 BMI_gp3Normal 0.87 (0.69, 1.11) 0.27 BMI_gp3Overweight 0.93 (0.73, 1.18) 0.54 BMI_gp3Obese 0.78 (0.61, 1.00) 0.05 f39_gdm_newGDM 0.90 (0.43, 1.90) 0.78 StudySTOP 1.04 (0.73, 1.49) 0.82 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 BMI_gp3Normal:StudySTOP 1.03 (0.72, 1.47) 0.87 BMI_gp3Overweight:StudySTOP 0.98 (0.68, 1.40) 0.90 BMI_gp3Obese:StudySTOP 0.97 (0.68, 1.40) 0.89 f39_gdm_newGDM:StudySTOP 1.07 (0.80, 1.45) 0.64 BMI_gp3Normal:f39_gdm_newGDM 1.21 (0.53, 2.76) 0.66 BMI_gp3Overweight:f39_gdm_newGDM 1.92 (0.87, 4.27) 0.11 BMI_gp3Obese:f39_gdm_newGDM 1.17 (0.58, 2.35) 0.66 BMI_gp3Normal:f39_gdm_newGDM:StudySTOP 1.02 (0.62, 1.68) 0.94 BMI_gp3Overweight:f39_gdm_newGDM:StudySTOP 0.53 (0.34, 0.83) 0.006 35.1.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 109.94 15.26 816.58 83.72 144.38 Normal SCOPE non-GDM 95.90 7.42 97.22 82.24 111.83 Overweight SCOPE non-GDM 101.84 8.23 114.84 86.79 119.51 Obese SCOPE non-GDM 86.01 7.03 120.49 73.16 101.13 Underweight STOP non-GDM 114.52 16.85 969.27 85.80 152.86 Normal STOP non-GDM 102.88 7.70 85.31 88.65 119.40 Overweight STOP non-GDM 103.72 8.06 98.73 88.90 121.01 Obese STOP non-GDM 87.24 6.86 103.40 74.64 101.96 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 104.10 20.56 1673.79 70.67 153.34 Overweight SCOPE GDM 176.18 28.05 1137.02 128.91 240.79 Obese SCOPE GDM 90.71 13.40 886.24 67.88 121.22 Underweight STOP GDM 110.69 36.85 2451.94 57.62 212.62 Normal STOP GDM 122.28 13.63 387.15 98.21 152.24 Overweight STOP GDM 101.91 12.18 498.09 80.58 128.88 Obese STOP GDM 98.80 9.30 206.78 82.07 118.95 35.1.3 Post-hoc comparisons 35.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 0.87 (0.64, 1.20) 0.7 Overweight / Underweight SCOPE non-GDM 0.93 (0.67, 1.28) 0.9 Overweight / Normal SCOPE non-GDM 1.06 (0.94, 1.20) 0.6 Obese / Underweight SCOPE non-GDM 0.78 (0.57, 1.08) 0.2 Obese / Normal SCOPE non-GDM 0.90 (0.79, 1.02) 0.1 Obese / Overweight SCOPE non-GDM 0.84 (0.73, 0.98) 0.01 Normal / Underweight STOP non-GDM 0.90 (0.64, 1.26) 0.9 Overweight / Underweight STOP non-GDM 0.91 (0.64, 1.28) 0.9 Overweight / Normal STOP non-GDM 1.01 (0.90, 1.14) 1.0 Obese / Underweight STOP non-GDM 0.76 (0.54, 1.08) 0.2 Obese / Normal STOP non-GDM 0.85 (0.75, 0.96) 0.004 Obese / Overweight STOP non-GDM 0.84 (0.74, 0.96) 0.004 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 1.69 (0.94, 3.05) 0.10 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.87 (0.49, 1.55) 0.9 Obese / Overweight SCOPE GDM 0.51 (0.32, 0.83) 0.002 Normal / Underweight STOP GDM 1.10 (0.47, 2.62) 1.0 Overweight / Underweight STOP GDM 0.92 (0.39, 2.20) 1.0 Overweight / Normal STOP GDM 0.83 (0.60, 1.16) 0.5 Obese / Underweight STOP GDM 0.89 (0.38, 2.08) 1.0 Obese / Normal STOP GDM 0.81 (0.62, 1.06) 0.2 Obese / Overweight STOP GDM 0.97 (0.73, 1.29) 1.0 35.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9065555 0.1776179 2627.908 0.6173692 1.331202 0.617 ns STOP/SCOPE (non-GDM) 1.0299235 0.1878342 2615.115 0.7202672 1.472707 0.872 ns STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/non-GDM (SCOPE) NA NA NA NA NA NA GDM/non-GDM (STOP) 1.2296857 0.4443740 2522.366 0.6054051 2.497711 0.567 ns "],["hpl-22.html", "35.2 HPL", " 35.2 HPL LME for duplicated or repeated measures. 35.2.1 Model summary Var Effect P (Intercept) 1.98 (1.60, 2.45) &lt;0.0001 BMI_gp3Normal 1.04 (0.91, 1.18) 0.58 BMI_gp3Overweight 0.97 (0.85, 1.11) 0.69 BMI_gp3Obese 0.81 (0.71, 0.93) 0.003 f39_gdm_newGDM 0.95 (0.62, 1.45) 0.81 StudySTOP 1.49 (1.23, 1.82) &lt;0.0001 GA_samp 1.34 (1.33, 1.35) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.74 (0.61, 0.90) 0.003 BMI_gp3Overweight:StudySTOP 0.72 (0.59, 0.87) 0.0009 BMI_gp3Obese:StudySTOP 0.70 (0.57, 0.85) 0.0004 f39_gdm_newGDM:StudySTOP 0.99 (0.85, 1.16) 0.94 BMI_gp3Normal:f39_gdm_newGDM 0.99 (0.63, 1.57) 0.98 BMI_gp3Overweight:f39_gdm_newGDM 1.08 (0.69, 1.68) 0.75 BMI_gp3Obese:f39_gdm_newGDM 1.06 (0.71, 1.57) 0.79 BMI_gp3Normal:f39_gdm_newGDM:StudySTOP 1.16 (0.89, 1.50) 0.27 BMI_gp3Overweight:f39_gdm_newGDM:StudySTOP 1.01 (0.79, 1.29) 0.94 35.2.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 96.33 6.76 1914.39 83.94 110.55 Normal SCOPE non-GDM 100.03 3.04 183.70 94.21 106.21 Overweight SCOPE non-GDM 93.75 3.06 242.21 87.90 99.98 Obese SCOPE non-GDM 78.43 2.60 256.11 73.47 83.72 Underweight STOP non-GDM 143.98 10.82 2030.46 124.25 166.85 Normal STOP non-GDM 110.60 3.14 142.33 104.56 116.99 Overweight STOP non-GDM 100.27 3.05 184.18 94.44 106.47 Obese STOP non-GDM 81.91 2.55 200.84 77.03 87.09 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 94.41 9.24 1421.47 77.92 114.39 Overweight SCOPE GDM 95.74 7.90 2040.83 81.44 112.55 Obese SCOPE GDM 78.52 5.45 1129.70 68.51 89.98 Underweight STOP GDM 135.86 25.68 2665.30 93.78 196.80 Normal STOP GDM 120.28 6.30 1026.61 108.54 133.29 Overweight STOP GDM 102.85 6.02 1378.34 91.69 115.36 Obese STOP GDM 81.55 3.43 562.44 75.08 88.58 35.2.3 Post-hoc comparisons 35.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.04 (0.87, 1.24) 0.9 Overweight / Underweight SCOPE non-GDM 0.97 (0.82, 1.16) 1.0 Overweight / Normal SCOPE non-GDM 0.94 (0.87, 1.00) 0.08 Obese / Underweight SCOPE non-GDM 0.81 (0.68, 0.97) 0.02 Obese / Normal SCOPE non-GDM 0.78 (0.73, 0.84) &lt;0.0001 Obese / Overweight SCOPE non-GDM 0.84 (0.77, 0.90) &lt;0.0001 Normal / Underweight STOP non-GDM 0.77 (0.64, 0.93) 0.002 Overweight / Underweight STOP non-GDM 0.70 (0.58, 0.84) &lt;0.0001 Overweight / Normal STOP non-GDM 0.91 (0.85, 0.97) 0.0006 Obese / Underweight STOP non-GDM 0.57 (0.47, 0.69) &lt;0.0001 Obese / Normal STOP non-GDM 0.74 (0.69, 0.79) &lt;0.0001 Obese / Overweight STOP non-GDM 0.82 (0.76, 0.88) &lt;0.0001 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 1.01 (0.74, 1.39) 1.0 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.83 (0.62, 1.11) 0.4 Obese / Overweight SCOPE GDM 0.82 (0.63, 1.06) 0.2 Normal / Underweight STOP GDM 0.89 (0.54, 1.45) 0.9 Overweight / Underweight STOP GDM 0.76 (0.46, 1.25) 0.5 Overweight / Normal STOP GDM 0.86 (0.72, 1.02) 0.1 Obese / Underweight STOP GDM 0.60 (0.37, 0.98) 0.04 Obese / Normal STOP GDM 0.68 (0.59, 0.78) &lt;0.0001 Obese / Overweight STOP GDM 0.79 (0.68, 0.93) 0.0010 35.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8566265 0.0923116 2489.344 0.6934575 1.0581888 0.151 ns STOP/SCOPE (non-GDM) 0.7397032 0.0739842 2467.900 0.6079664 0.8999853 0.003 ** STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/non-GDM (SCOPE) NA NA NA NA NA NA GDM/non-GDM (STOP) 1.1525754 0.2376437 2625.702 0.7692783 1.7268525 0.491 ns "],["gh2-22.html", "35.3 GH2", " 35.3 GH2 LME for duplicated or repeated measures. 35.3.1 Model summary Var Effect P (Intercept) 0.10 (0.07, 0.13) &lt;0.0001 BMI_gp3Normal 1.00 (0.84, 1.20) 0.97 BMI_gp3Overweight 0.83 (0.69, 1.00) 0.05 BMI_gp3Obese 0.71 (0.59, 0.85) 0.0003 f39_gdm_newGDM 0.43 (0.25, 0.75) 0.003 StudySTOP 1.58 (1.22, 2.06) 0.0007 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 BMI_gp3Normal:StudySTOP 0.54 (0.41, 0.70) &lt;0.0001 BMI_gp3Overweight:StudySTOP 0.60 (0.46, 0.79) 0.0002 BMI_gp3Obese:StudySTOP 0.65 (0.50, 0.85) 0.002 f39_gdm_newGDM:StudySTOP 1.18 (0.95, 1.47) 0.15 BMI_gp3Normal:f39_gdm_newGDM 2.67 (1.43, 4.95) 0.002 BMI_gp3Overweight:f39_gdm_newGDM 2.90 (1.59, 5.28) 0.0005 BMI_gp3Obese:f39_gdm_newGDM 2.14 (1.27, 3.61) 0.004 BMI_gp3Normal:f39_gdm_newGDM:StudySTOP 0.82 (0.56, 1.19) 0.30 BMI_gp3Overweight:f39_gdm_newGDM:StudySTOP 0.62 (0.44, 0.87) 0.006 35.3.2 Estimated marginal means BMI_gp3 Study f39_gdm_new response SE df lower.CL upper.CL Underweight SCOPE non-GDM 2.79 0.26 2502.08 2.33 3.34 Normal SCOPE non-GDM 2.80 0.09 495.37 2.62 2.99 Overweight SCOPE non-GDM 2.32 0.09 715.53 2.16 2.50 Obese SCOPE non-GDM 1.98 0.08 785.72 1.84 2.14 Underweight STOP non-GDM 4.42 0.44 2552.21 3.64 5.36 Normal STOP non-GDM 2.39 0.07 363.16 2.26 2.54 Overweight STOP non-GDM 2.21 0.07 526.86 2.07 2.36 Obese STOP non-GDM 2.04 0.07 571.56 1.91 2.18 Underweight SCOPE GDM NA NA NA NA NA Normal SCOPE GDM 3.22 0.45 2142.44 2.44 4.25 Overweight SCOPE GDM 2.90 0.33 2292.47 2.32 3.64 Obese SCOPE GDM 1.83 0.18 1767.50 1.52 2.22 Underweight STOP GDM 2.24 0.55 2426.60 1.39 3.62 Normal STOP GDM 2.66 0.18 1928.13 2.33 3.04 Overweight STOP GDM 2.01 0.15 2217.91 1.74 2.33 Obese STOP GDM 2.22 0.11 1284.98 2.01 2.46 35.3.3 Post-hoc comparisons 35.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Normal / Underweight SCOPE non-GDM 1.00 (0.79, 1.27) 1.0 Overweight / Underweight SCOPE non-GDM 0.83 (0.66, 1.06) 0.2 Overweight / Normal SCOPE non-GDM 0.83 (0.75, 0.91) &lt;0.0001 Obese / Underweight SCOPE non-GDM 0.71 (0.56, 0.90) 0.002 Obese / Normal SCOPE non-GDM 0.71 (0.64, 0.78) &lt;0.0001 Obese / Overweight SCOPE non-GDM 0.85 (0.77, 0.95) 0.0010 Normal / Underweight STOP non-GDM 0.54 (0.42, 0.70) &lt;0.0001 Overweight / Underweight STOP non-GDM 0.50 (0.39, 0.65) &lt;0.0001 Overweight / Normal STOP non-GDM 0.92 (0.85, 1.01) 0.10 Obese / Underweight STOP non-GDM 0.46 (0.36, 0.60) &lt;0.0001 Obese / Normal STOP non-GDM 0.85 (0.78, 0.93) &lt;0.0001 Obese / Overweight STOP non-GDM 0.92 (0.84, 1.02) 0.1 Normal / Underweight SCOPE GDM NA (NA, NA) Overweight / Underweight SCOPE GDM NA (NA, NA) Overweight / Normal SCOPE GDM 0.90 (0.57, 1.42) 0.9 Obese / Underweight SCOPE GDM NA (NA, NA) Obese / Normal SCOPE GDM 0.57 (0.37, 0.87) 0.004 Obese / Overweight SCOPE GDM 0.63 (0.44, 0.92) 0.008 Normal / Underweight STOP GDM 1.19 (0.62, 2.26) 0.9 Overweight / Underweight STOP GDM 0.90 (0.47, 1.72) 1.0 Overweight / Normal STOP GDM 0.76 (0.59, 0.96) 0.02 Obese / Underweight STOP GDM 0.99 (0.53, 1.87) 1.0 Obese / Normal STOP GDM 0.84 (0.68, 1.02) 0.09 Obese / Overweight STOP GDM 1.11 (0.89, 1.37) 0.6 35.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.4496797 0.2107976 2585.059 1.0900365 1.9279825 0.011 * STOP/SCOPE (non-GDM) 0.5399778 0.0729986 2574.667 0.4142375 0.7038861 &lt;0.0001 *** STOP/SCOPE (GDM) NA NA NA NA NA NA GDM/non-GDM (SCOPE) NA NA NA NA NA NA GDM/non-GDM (STOP) 2.1864264 0.5901008 2485.963 1.2879226 3.7117608 0.004 ** "],["age-bmi-groups-3.html", "36 Age &amp; BMI groups", " 36 Age &amp; BMI groups Descriptives with univariate P-values. Within non-GDM Characteristic &lt;35 yrs, non-obese (n=1511) &lt;35 yrs, obese (n=542) &gt;=35 yrs, non-obese (n=44) &gt;=35 yrs, obese (n=23) Total (n=2120) P-value PRL (ng/ml): Median (IQ range) 106.1 (62.9-177.6) 93.5 (53.3-148.1) 90.7 (61.5-179.1) 55.8 (40.0-154.3) 102.2 (59.7-169.5) 0.002 hPL (μg/ml): Median (IQ range) 131.0 (60.4-191.8) 93.4 (46.6-153.5) 95.1 (59.8-167.8) 83.1 (34.7-121.2) 117.3 (56.5-180.7) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 3.0 (1.4-4.7) 2.4 (1.1-3.6) 2.3 (1.2-4.5) 1.7 (1.2-3.0) 2.7 (1.3-4.3) &lt;0.0001 Within GDM Characteristic &lt;35 yrs, non-obese (n=112) &lt;35 yrs, obese (n=117) &gt;=35 yrs, non-obese (n=10) &gt;=35 yrs, obese (n=17) Total (n=256) P-value PRL (ng/ml): Median (IQ range) 84.5 (46.6-162.9) 76.4 (47.1-114.0) 131.4 (68.4-182.2) 58.7 (43.5-71.2) 79.9 (45.7-132.7) 0.20 hPL (μg/ml): Median (IQ range) 83.7 (53.3-123.1) 56.6 (39.0-83.1) 67.2 (41.6-100.1) 30.2 (21.4-51.6) 65.0 (40.5-106.7) 0.0004 GH2 (ng/ml): Median (IQ range) 1.7 (0.9-3.2) 1.3 (1.0-2.4) 1.5 (1.2-3.8) 1.6 (1.0-2.6) 1.5 (1.0-2.8) 0.43 Click here for table within SCOPE Within non-GDM Characteristic &lt;35 yrs, non-obese (n=773) &lt;35 yrs, obese (n=274) &gt;=35 yrs, non-obese (n=20) &gt;=35 yrs, obese (n=6) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 145.5 (97.2-223.7) 131.0 (82.0-208.2) 202.7 (98.1-334.1) 154.3 (110.3-166.9) 140.0 (92.7-221.7) 0.03 hPL (μg/ml): Median (IQ range) 189.9 (158.0-222.9) 155.4 (130.0-186.1) 171.8 (138.4-213.0) 158.4 (121.2-200.3) 180.0 (148.6-215.7) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 4.5 (3.5-6.1) 3.4 (2.7-4.4) 4.4 (3.5-6.4) 3.8 (3.2-6.1) 4.2 (3.2-5.7) &lt;0.0001 Serum folate concentration (nM): Median (IQ range) 35.8 (28.4-42.2) 35.8 (25.4-43.1) 41.4 (35.3-49.6) 34.9 (32.3-37.6) 35.9 (28.1-42.6) 0.08 B12 concentration (pM): Median (IQ range) 248.0 (198.0-316.0) 230.0 (185.0-291.0) 297.0 (248.0-367.0) 227.5 (208.2-249.0) 245.0 (195.0-308.5) 0.003 Folate:B12 ratio: Median (IQ range) 141.6 (101.8-203.6) 145.2 (100.7-220.7) 152.3 (116.9-202.9) 174.2 (146.0-195.2) 142.7 (102.3-207.5) 0.52 Active B12 concentration (pM): Median (IQ range) 54.0 (42.0-71.0) 61.0 (46.0-75.0) 53.5 (47.5-98.5) 74.0 (39.0-93.0) 56.0 (43.0-73.0) 0.13 Folate:Active B12 ratio: Median (IQ range) 630.2 (456.0-932.6) 537.9 (392.2-819.8) 791.6 (567.9-977.4) 420.3 (400.0-817.9) 615.4 (432.4-902.3) 0.03 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.0) 4.4 (3.8-5.1) 4.5 (3.9-4.7) 4.3 (3.9-4.6) 4.4 (3.8-5.0) 0.96 Within GDM Characteristic &lt;35 yrs, non-obese (n=27) &lt;35 yrs, obese (n=29) &gt;=35 yrs, non-obese (n=0) &gt;=35 yrs, obese (n=2) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 173.1 (92.0-193.1) 93.9 (64.8-153.6) NA (NA-NA) 113.5 (100.0-126.9) 120.5 (81.8-180.0) hPL (μg/ml): Median (IQ range) 170.8 (105.8-196.2) 128.0 (101.5-172.6) NA (NA-NA) 179.7 (176.0-183.4) 163.3 (105.8-191.6) GH2 (ng/ml): Median (IQ range) 5.4 (3.8-6.6) 2.7 (1.9-3.6) NA (NA-NA) 2.4 (2.0-2.7) 3.4 (2.0-5.3) Serum folate concentration (nM): Median (IQ range) 41.3 (34.2-44.6) 38.0 (31.1-42.9) NA (NA-NA) 86.0 (63.5-108.6) 40.1 (32.0-43.8) B12 concentration (pM): Median (IQ range) 268.0 (212.5-350.0) 245.0 (192.0-314.0) NA (NA-NA) 205.0 (200.0-210.0) 253.5 (194.2-333.0) Folate:B12 ratio: Median (IQ range) 150.3 (114.2-232.5) 167.7 (115.9-185.4) NA (NA-NA) 410.0 (309.9-510.1) 158.9 (116.5-210.2) Active B12 concentration (pM): Median (IQ range) 63.0 (56.5-99.2) 77.0 (54.0-82.5) NA (NA-NA) 67.5 (50.8-84.2) 68.0 (55.0-86.0) Folate:Active B12 ratio: Median (IQ range) 540.4 (321.6-674.3) 553.8 (524.6-575.9) NA (NA-NA) 2131.9 (1268.4-2995.4) 553.8 (424.7-660.3) Homocysteine concentration (μM): Median (IQ range) 4.2 (3.8-4.8) 3.7 (3.5-4.2) NA (NA-NA) 4.1 (3.5-4.7) 3.9 (3.6-4.6) Click here for table within STOP Within non-GDM Characteristic &lt;35 yrs, non-obese (n=738) &lt;35 yrs, obese (n=268) &gt;=35 yrs, non-obese (n=24) &gt;=35 yrs, obese (n=17) Total (n=1047) P-value PRL (ng/ml): Median (IQ range) 77.4 (51.4-121.6) 68.5 (44.3-112.3) 72.9 (49.1-91.1) 54.6 (39.9-113.3) 74.7 (48.6-119.1) 0.03 hPL (μg/ml): Median (IQ range) 64.5 (43.1-100.6) 49.8 (33.3-71.1) 62.5 (53.4-83.5) 44.4 (31.5-92.3) 60.3 (40.2-92.6) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.5) 1.2 (0.8-2.3) 1.6 (1.0-2.2) 1.4 (1.0-2.4) 1.4 (0.9-2.4) 0.06 Serum folate concentration (nM): Median (IQ range) 40.5 (36.4-45.3) 40.0 (35.9-45.1) 43.2 (40.2-71.3) 43.6 (39.8-99.6) 40.5 (36.4-45.3) 0.01 B12 concentration (pM): Median (IQ range) 288.0 (224.0-369.0) 258.0 (207.0-322.0) 309.0 (232.0-348.5) 246.0 (200.0-363.0) 280.0 (218.0-357.0) 0.0003 Folate:B12 ratio: Median (IQ range) 149.8 (110.8-218.2) 166.0 (121.6-224.9) 168.2 (127.4-284.3) 203.6 (145.8-292.3) 153.5 (115.1-221.4) 0.006 Active B12 concentration (pM): Median (IQ range) 63.0 (47.0-83.0) 64.0 (52.0-87.0) 68.0 (54.0-99.0) 57.0 (54.0-70.0) 63.0 (49.0-84.0) 0.61 Folate:Active B12 ratio: Median (IQ range) 670.9 (481.8-978.8) 616.7 (465.4-866.7) 527.9 (427.3-960.5) 747.4 (613.4-954.8) 663.6 (476.4-952.0) 0.32 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.5) 4.8 (4.2-5.7) 4.9 (4.2-6.0) 4.9 (4.3-5.5) 4.8 (4.2-5.6) 0.82 Within GDM Characteristic &lt;35 yrs, non-obese (n=85) &lt;35 yrs, obese (n=88) &gt;=35 yrs, non-obese (n=10) &gt;=35 yrs, obese (n=15) Total (n=198) P-value PRL (ng/ml): Median (IQ range) 70.4 (40.9-127.9) 73.0 (44.0-108.6) 131.4 (68.4-182.2) 55.3 (42.7-64.1) 68.6 (42.3-114.0) 0.31 hPL (μg/ml): Median (IQ range) 68.5 (45.3-105.0) 50.3 (36.7-69.3) 67.2 (41.6-100.1) 25.8 (19.4-40.6) 55.6 (36.6-83.8) &lt;0.0001 GH2 (ng/ml): Median (IQ range) 1.5 (0.9-2.3) 1.3 (0.9-2.1) 1.5 (1.2-3.8) 1.3 (1.0-2.4) 1.3 (0.9-2.3) 0.39 Serum folate concentration (nM): Median (IQ range) 40.7 (36.4-51.8) 39.0 (34.3-43.5) 44.0 (40.2-61.9) 40.8 (36.5-63.3) 40.1 (35.5-45.2) 0.05 B12 concentration (pM): Median (IQ range) 285.0 (232.5-358.5) 268.0 (217.2-306.0) 226.0 (156.0-309.8) 305.0 (215.0-388.0) 273.0 (217.5-348.5) 0.09 Folate:B12 ratio: Median (IQ range) 144.2 (107.9-222.2) 150.6 (116.9-211.0) 183.4 (136.7-411.0) 135.4 (92.2-278.5) 148.0 (112.4-225.9) 0.43 Active B12 concentration (pM): Median (IQ range) 69.0 (55.0-92.0) 78.0 (58.8-92.5) 63.5 (52.2-98.0) 77.0 (75.5-84.2) 75.0 (57.0-93.0) 0.71 Folate:Active B12 ratio: Median (IQ range) 569.2 (444.4-830.6) 509.1 (409.1-642.7) 809.3 (493.4-988.3) 755.0 (548.3-1065.0) 531.9 (417.3-788.4) 0.28 Homocysteine concentration (μM): Median (IQ range) 4.6 (4.0-5.5) 4.8 (4.0-5.3) 5.0 (4.2-5.4) 4.8 (4.5-5.1) 4.8 (4.0-5.3) 0.94 "],["prolactin-23.html", "36.1 Prolactin", " 36.1 Prolactin LME for duplicated or repeated measures. 36.1.1 Model summary Var Effect P (Intercept) 13.15 (9.46, 18.27) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.87 (0.79, 0.95) 0.003 Age_BMI_gp&gt;=35 yrs, non-obese 1.13 (0.83, 1.54) 0.45 Age_BMI_gp&gt;=35 yrs, obese 0.96 (0.60, 1.53) 0.87 f39_gdm_newGDM 1.47 (1.17, 1.86) 0.001 StudySTOP 1.06 (0.96, 1.17) 0.25 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.97 (0.85, 1.10) 0.60 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.66 (0.44, 0.98) 0.04 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.84 (0.48, 1.46) 0.53 f39_gdm_newGDM:StudySTOP 0.71 (0.55, 0.92) 0.01 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM 0.76 (0.54, 1.08) 0.13 Age_BMI_gp&gt;=35 yrs, non-obese:f39_gdm_newGDM 1.74 (1.09, 2.78) 0.02 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM 0.35 (0.13, 0.92) 0.03 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.48 (0.99, 2.22) 0.05 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM:StudySTOP 2.39 (0.81, 7.04) 0.11 36.1.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 98.46 7.38 85.62 84.83 114.29 &lt;35 yrs, obese SCOPE non-GDM 85.48 7.00 121.46 72.69 100.53 &gt;=35 yrs, non-obese SCOPE non-GDM 111.00 19.14 1439.29 79.14 155.69 &gt;=35 yrs, obese SCOPE non-GDM 94.69 23.44 2326.30 58.27 153.86 &lt;35 yrs, non-obese STOP non-GDM 104.48 7.59 75.54 90.41 120.74 &lt;35 yrs, obese STOP non-GDM 87.68 6.94 106.33 74.94 102.59 &gt;=35 yrs, non-obese STOP non-GDM 77.59 11.12 901.79 58.56 102.80 &gt;=35 yrs, obese STOP non-GDM 83.91 14.11 1336.74 60.33 116.71 &lt;35 yrs, non-obese SCOPE GDM 145.06 19.55 738.44 111.33 189.00 &lt;35 yrs, obese SCOPE GDM 95.89 14.70 977.14 70.98 129.56 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 48.23 20.75 1375.40 20.74 112.14 &lt;35 yrs, non-obese STOP GDM 109.29 10.66 236.78 90.19 132.44 &lt;35 yrs, obese STOP GDM 103.67 10.04 230.44 85.66 125.46 &gt;=35 yrs, non-obese STOP GDM 141.52 28.88 1908.31 94.85 211.17 &gt;=35 yrs, obese STOP GDM 72.50 12.89 1509.82 51.16 102.75 36.1.3 Post-hoc comparisons 36.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.87 (0.77, 0.98) 0.02 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.13 (0.75, 1.70) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.30 (0.85, 1.97) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.96 (0.52, 1.77) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.11 (0.60, 2.05) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 0.85 (0.41, 1.77) 0.9 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.84 (0.75, 0.94) 0.0006 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 0.74 (0.53, 1.03) 0.09 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 0.88 (0.63, 1.24) 0.8 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.80 (0.54, 1.20) 0.5 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.96 (0.64, 1.44) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 1.08 (0.65, 1.80) 1.0 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.66 (0.42, 1.03) 0.08 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.33 (0.11, 1.03) 0.06 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.50 (0.16, 1.58) 0.4 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.95 (0.75, 1.20) 0.9 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.29 (0.77, 2.17) 0.6 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.37 (0.81, 2.29) 0.4 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.66 (0.42, 1.04) 0.09 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.70 (0.45, 1.09) 0.2 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.51 (0.27, 0.97) 0.04 36.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.2661796 0.4452633 2639.417 0.6353681 2.523279 0.502 ns STOP/SCOPE (non-GDM) 0.9666996 0.0628221 2608.210 0.8510392 1.098079 0.602 ns STOP/SCOPE (GDM) 1.4348909 0.2775819 2487.396 0.9819117 2.096840 0.062 ns GDM/non-GDM (SCOPE) 0.7614189 0.1368008 2414.462 0.5353222 1.083009 0.129 ns GDM/non-GDM (STOP) 1.1301887 0.1152213 2606.895 0.9254048 1.380290 0.230 ns "],["hpl-23.html", "36.2 HPL", " 36.2 HPL LME for duplicated or repeated measures. 36.2.1 Model summary Var Effect P (Intercept) 2.00 (1.68, 2.37) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.80 (0.76, 0.85) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 0.95 (0.79, 1.12) 0.52 Age_BMI_gp&gt;=35 yrs, obese 0.79 (0.61, 1.03) 0.08 f39_gdm_newGDM 0.97 (0.86, 1.10) 0.64 StudySTOP 1.10 (1.04, 1.16) 0.0009 GA_samp 1.34 (1.33, 1.35) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 0.96 (0.89, 1.02) 0.21 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 1.07 (0.86, 1.34) 0.54 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.93 (0.68, 1.26) 0.63 f39_gdm_newGDM:StudySTOP 1.11 (0.96, 1.28) 0.14 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM 1.04 (0.87, 1.25) 0.66 Age_BMI_gp&gt;=35 yrs, non-obese:f39_gdm_newGDM 0.86 (0.66, 1.10) 0.23 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM 0.98 (0.60, 1.61) 0.95 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM:StudySTOP 0.93 (0.75, 1.15) 0.52 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM:StudySTOP 0.70 (0.40, 1.20) 0.20 36.2.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 97.41 2.74 143.03 92.13 102.98 &lt;35 yrs, obese SCOPE non-GDM 78.37 2.60 268.91 73.41 83.68 &gt;=35 yrs, non-obese SCOPE non-GDM 92.05 8.39 2368.39 76.99 110.06 &gt;=35 yrs, obese SCOPE non-GDM 77.14 10.44 2528.80 59.15 100.59 &lt;35 yrs, non-obese STOP non-GDM 107.07 2.82 110.20 101.63 112.80 &lt;35 yrs, obese STOP non-GDM 82.38 2.59 216.74 77.43 87.65 &gt;=35 yrs, non-obese STOP non-GDM 108.52 7.91 1962.91 94.06 125.21 &gt;=35 yrs, obese STOP non-GDM 78.54 6.79 2188.29 66.28 93.06 &lt;35 yrs, non-obese SCOPE GDM 94.58 6.25 1444.77 83.08 107.67 &lt;35 yrs, obese SCOPE GDM 79.28 5.75 1163.57 68.76 91.40 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 73.62 15.12 1017.59 49.21 110.16 &lt;35 yrs, non-obese STOP GDM 115.60 5.11 677.92 105.99 126.08 &lt;35 yrs, obese STOP GDM 86.42 3.80 668.91 79.28 94.21 &gt;=35 yrs, non-obese STOP GDM 100.24 10.62 1970.41 81.44 123.39 &gt;=35 yrs, obese STOP GDM 57.94 5.36 2278.00 48.33 69.47 36.2.3 Post-hoc comparisons 36.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.80 (0.75, 0.86) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.95 (0.75, 1.19) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.17 (0.93, 1.48) 0.3 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.79 (0.56, 1.12) 0.3 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 0.98 (0.70, 1.39) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 0.84 (0.56, 1.26) 0.7 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.77 (0.72, 0.82) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 1.01 (0.85, 1.21) 1.0 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 1.32 (1.09, 1.59) 0.0008 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.73 (0.59, 0.91) 0.001 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.95 (0.76, 1.19) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 0.72 (0.55, 0.96) 0.02 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.84 (0.67, 1.06) 0.2 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.78 (0.45, 1.35) 0.6 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.93 (0.53, 1.61) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.75 (0.66, 0.85) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 0.87 (0.66, 1.15) 0.6 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.16 (0.88, 1.53) 0.5 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.50 (0.39, 0.64) &lt;0.0001 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 0.67 (0.52, 0.86) 0.0002 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.58 (0.41, 0.82) 0.0003 36.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9795682 0.1913606 2475.348 0.6678354 1.436812 0.916 ns STOP/SCOPE (non-GDM) 0.9562646 0.0339775 2380.016 0.8919043 1.025269 0.208 ns STOP/SCOPE (GDM) 0.8918342 0.0914328 1722.425 0.7293832 1.090467 0.264 ns GDM/non-GDM (SCOPE) 1.0417782 0.0978059 1530.868 0.8665590 1.252427 0.663 ns GDM/non-GDM (STOP) 0.9715862 0.0543367 2398.224 0.8706693 1.084200 0.606 ns "],["gh2-23.html", "36.3 GH2", " 36.3 GH2 LME for duplicated or repeated measures. 36.3.1 Model summary Var Effect P (Intercept) 0.09 (0.07, 0.11) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese 0.76 (0.71, 0.82) &lt;0.0001 Age_BMI_gp&gt;=35 yrs, non-obese 1.10 (0.86, 1.40) 0.46 Age_BMI_gp&gt;=35 yrs, obese 0.81 (0.56, 1.17) 0.26 f39_gdm_newGDM 1.15 (0.96, 1.38) 0.13 StudySTOP 0.91 (0.85, 0.98) 0.02 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Age_BMI_gp&lt;35 yrs, obese:StudySTOP 1.15 (1.04, 1.26) 0.006 Age_BMI_gp&gt;=35 yrs, non-obese:StudySTOP 0.84 (0.62, 1.14) 0.26 Age_BMI_gp&gt;=35 yrs, obese:StudySTOP 0.98 (0.64, 1.52) 0.94 f39_gdm_newGDM:StudySTOP 0.85 (0.69, 1.04) 0.12 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM 0.81 (0.62, 1.06) 0.12 Age_BMI_gp&gt;=35 yrs, non-obese:f39_gdm_newGDM 1.32 (0.93, 1.88) 0.12 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM 0.75 (0.36, 1.56) 0.44 Age_BMI_gp&lt;35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.34 (0.98, 1.81) 0.06 Age_BMI_gp&gt;=35 yrs, obese:f39_gdm_newGDM:StudySTOP 1.74 (0.78, 3.91) 0.18 36.3.2 Estimated marginal means Age_BMI_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;35 yrs, non-obese SCOPE non-GDM 2.59 0.08 367.78 2.45 2.75 &lt;35 yrs, obese SCOPE non-GDM 1.98 0.08 864.22 1.83 2.13 &gt;=35 yrs, non-obese SCOPE non-GDM 2.84 0.35 2606.82 2.23 3.63 &gt;=35 yrs, obese SCOPE non-GDM 2.09 0.40 2600.38 1.44 3.04 &lt;35 yrs, non-obese STOP non-GDM 2.37 0.06 251.77 2.25 2.49 &lt;35 yrs, obese STOP non-GDM 2.06 0.07 658.56 1.93 2.21 &gt;=35 yrs, non-obese STOP non-GDM 2.17 0.21 2523.88 1.80 2.63 &gt;=35 yrs, obese STOP non-GDM 1.88 0.22 2477.54 1.50 2.36 &lt;35 yrs, non-obese SCOPE GDM 2.99 0.28 2405.39 2.49 3.58 &lt;35 yrs, obese SCOPE GDM 1.84 0.19 1805.90 1.50 2.25 &gt;=35 yrs, non-obese SCOPE GDM NA NA NA NA NA &gt;=35 yrs, obese SCOPE GDM 1.80 0.56 1299.37 0.98 3.32 &lt;35 yrs, non-obese STOP GDM 2.32 0.13 1556.67 2.08 2.58 &lt;35 yrs, obese STOP GDM 2.18 0.12 1511.54 1.96 2.43 &gt;=35 yrs, non-obese STOP GDM 2.82 0.41 2531.55 2.12 3.75 &gt;=35 yrs, obese STOP GDM 2.40 0.30 2540.32 1.88 3.06 36.3.3 Post-hoc comparisons 36.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.76 (0.69, 0.84) &lt;0.0001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE non-GDM 1.10 (0.80, 1.51) 0.9 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE non-GDM 1.44 (1.04, 1.99) 0.02 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE non-GDM 0.81 (0.50, 1.31) 0.7 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE non-GDM 1.06 (0.65, 1.73) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE non-GDM 0.74 (0.41, 1.31) 0.5 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.87 (0.80, 0.95) 0.0003 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP non-GDM 0.92 (0.72, 1.18) 0.8 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP non-GDM 1.05 (0.81, 1.36) 1.0 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP non-GDM 0.79 (0.59, 1.07) 0.2 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP non-GDM 0.91 (0.67, 1.23) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP non-GDM 0.87 (0.59, 1.27) 0.8 &lt;35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.62 (0.44, 0.86) 0.001 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) SCOPE GDM NA (NA, NA) (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese SCOPE GDM NA (NA, NA) &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) SCOPE GDM 0.60 (0.26, 1.39) 0.4 &gt;=35 yrs, obese / &lt;35 yrs, obese SCOPE GDM 0.98 (0.42, 2.27) 1.0 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) SCOPE GDM NA (NA, NA) &lt;35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 0.94 (0.79, 1.12) 0.8 (&gt;=35 yrs, non-obese) / (&lt;35 yrs, non-obese) STOP GDM 1.22 (0.82, 1.79) 0.6 (&gt;=35 yrs, non-obese) / &lt;35 yrs, obese STOP GDM 1.29 (0.88, 1.90) 0.3 &gt;=35 yrs, obese / (&lt;35 yrs, non-obese) STOP GDM 1.03 (0.74, 1.45) 1.0 &gt;=35 yrs, obese / &lt;35 yrs, obese STOP GDM 1.10 (0.78, 1.54) 0.9 &gt;=35 yrs, obese / (&gt;=35 yrs, non-obese) STOP GDM 0.85 (0.52, 1.38) 0.8 36.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9589407 0.2620954 2590.922 0.5610926 1.638887 0.878 ns STOP/SCOPE (non-GDM) 1.1454504 0.0560892 2553.966 1.0405807 1.260889 0.006 ** STOP/SCOPE (GDM) 1.5310485 0.2266932 2403.244 1.1452311 2.046844 0.004 ** GDM/non-GDM (SCOPE) 0.8074421 0.1108722 2328.598 0.6168360 1.056947 0.119 ns GDM/non-GDM (STOP) 1.0792551 0.0827929 2551.560 0.9285276 1.254450 0.320 ns "],["mets-13.html", "37 MetS", " 37 MetS Descriptives with univariate P-values. Within non-GDM Characteristic No MetS (n=1805) MetS (n=233) Total (n=2038) P-value PRL (ng/ml): Median (IQ range) 98.5 (58.6-162.7) 124.5 (70.6-196.2) 101.1 (59.4-168.7) 0.0003 hPL (μg/ml): Median (IQ range) 111.4 (55.4-180.2) 145.3 (70.6-186.2) 116.0 (56.2-180.9) 0.02 GH2 (ng/ml): Median (IQ range) 2.6 (1.2-4.3) 3.1 (1.9-4.7) 2.7 (1.3-4.3) 0.007 Within GDM Characteristic No MetS (n=173) MetS (n=68) Total (n=241) P-value PRL (ng/ml): Median (IQ range) 78.0 (46.8-131.4) 74.0 (44.5-113.0) 77.8 (45.5-123.6) 0.60 hPL (μg/ml): Median (IQ range) 65.0 (40.8-105.8) 59.5 (39.0-97.7) 61.5 (40.2-104.1) 0.67 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.7) 1.5 (1.0-2.5) 1.5 (1.0-2.7) 0.79 Click here for table within SCOPE Within non-GDM Characteristic No MetS (n=898) MetS (n=166) Total (n=1064) P-value PRL (ng/ml): Median (IQ range) 137.1 (90.4-221.8) 161.2 (108.5-222.6) 139.7 (92.6-221.8) 0.07 hPL (μg/ml): Median (IQ range) 181.4 (150.9-217.7) 168.6 (135.2-203.5) 180.0 (148.3-215.7) 0.02 GH2 (ng/ml): Median (IQ range) 4.2 (3.3-5.8) 3.8 (2.9-5.4) 4.2 (3.2-5.7) 0.03 Serum folate concentration (nM): Median (IQ range) 35.9 (28.2-42.7) 35.6 (26.2-42.5) 35.9 (28.2-42.6) 0.49 B12 concentration (pM): Median (IQ range) 248.5 (196.0-316.0) 229.0 (186.0-286.8) 245.0 (195.0-308.8) 0.001 Folate:B12 ratio: Median (IQ range) 141.3 (101.5-205.2) 152.7 (114.0-214.9) 142.8 (102.5-207.8) 0.26 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.0) 58.0 (45.0-78.0) 56.0 (43.0-73.0) 0.24 Folate:Active B12 ratio: Median (IQ range) 618.5 (450.0-925.0) 546.7 (392.3-771.2) 615.6 (438.4-903.3) 0.05 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.9) 4.4 (3.8-5.0) 0.07 Within GDM Characteristic No MetS (n=29) MetS (n=28) Total (n=57) P-value PRL (ng/ml): Median (IQ range) 173.1 (104.5-188.6) 86.6 (66.0-120.5) 120.5 (81.1-177.7) 0.006 hPL (μg/ml): Median (IQ range) 167.0 (119.6-199.8) 163.3 (93.6-187.1) 165.1 (105.8-191.8) 0.28 GH2 (ng/ml): Median (IQ range) 4.7 (3.2-6.4) 2.4 (1.7-3.2) 3.3 (2.0-5.3) 0.007 Serum folate concentration (nM): Median (IQ range) 39.7 (31.7-44.0) 39.6 (31.9-42.3) 39.6 (31.9-43.8) 0.90 B12 concentration (pM): Median (IQ range) 274.0 (196.2-341.5) 240.0 (193.5-296.5) 254.0 (193.5-334.0) 0.39 Folate:B12 ratio: Median (IQ range) 152.8 (112.5-184.8) 167.7 (121.8-210.6) 155.4 (115.4-210.6) 0.59 Active B12 concentration (pM): Median (IQ range) 85.0 (58.0-99.5) 60.0 (53.0-79.0) 66.5 (54.5-89.2) 0.28 Folate:Active B12 ratio: Median (IQ range) 516.5 (418.5-688.3) 560.9 (424.7-636.8) 546.6 (419.7-674.3) 0.61 Homocysteine concentration (μM): Median (IQ range) 4.1 (3.8-4.7) 3.7 (3.5-4.1) 3.9 (3.6-4.6) 0.10 Click here for table within STOP Within non-GDM Characteristic No MetS (n=907) MetS (n=67) Total (n=974) P-value PRL (ng/ml): Median (IQ range) 74.0 (48.4-116.2) 70.9 (50.4-108.9) 74.0 (48.5-115.4) 0.82 hPL (μg/ml): Median (IQ range) 60.0 (40.8-90.1) 46.9 (31.2-74.3) 59.1 (40.1-89.4) 0.01 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.5 (0.9-2.4) 1.4 (0.9-2.4) 0.92 Serum folate concentration (nM): Median (IQ range) 40.6 (36.4-45.3) 39.8 (35.4-44.8) 40.5 (36.3-45.3) 0.36 B12 concentration (pM): Median (IQ range) 280.0 (219.0-363.0) 258.0 (200.5-330.5) 280.0 (218.0-356.5) 0.02 Folate:B12 ratio: Median (IQ range) 152.2 (114.8-220.7) 164.8 (128.2-206.1) 152.8 (115.3-220.5) 0.37 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-84.0) 63.0 (53.0-76.0) 63.0 (49.0-84.0) 0.97 Folate:Active B12 ratio: Median (IQ range) 666.1 (471.1-946.7) 550.7 (493.4-726.8) 652.4 (472.0-937.6) 0.10 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.8 (4.3-5.9) 4.8 (4.3-5.6) 0.90 Within GDM Characteristic No MetS (n=144) MetS (n=40) Total (n=184) P-value PRL (ng/ml): Median (IQ range) 68.6 (42.4-110.5) 61.9 (39.7-111.5) 68.0 (41.7-110.9) 0.58 hPL (μg/ml): Median (IQ range) 58.4 (35.7-84.8) 49.8 (36.6-62.3) 55.5 (36.0-82.6) 0.06 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.1) 1.1 (0.8-2.0) 1.3 (0.9-2.1) 0.29 Serum folate concentration (nM): Median (IQ range) 40.7 (36.0-54.3) 37.2 (33.8-41.7) 40.0 (35.1-45.2) 0.02 B12 concentration (pM): Median (IQ range) 278.0 (218.0-358.5) 264.0 (207.0-306.0) 273.5 (216.8-352.0) 0.24 Folate:B12 ratio: Median (IQ range) 147.7 (110.8-230.6) 149.8 (114.6-211.8) 148.0 (111.9-227.3) 0.94 Active B12 concentration (pM): Median (IQ range) 75.5 (56.0-90.2) 73.0 (57.5-92.2) 75.5 (56.0-91.8) 0.92 Folate:Active B12 ratio: Median (IQ range) 531.9 (420.0-836.9) 551.8 (417.2-693.7) 536.4 (420.0-811.7) 0.73 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.8 (4.1-5.2) 4.8 (4.0-5.3) 0.92 "],["prolactin-24.html", "37.1 Prolactin", " 37.1 Prolactin LME for duplicated or repeated measures. 37.1.1 Model summary Var Effect P (Intercept) 13.20 (9.34, 18.66) &lt;0.0001 metab.C1MetS 0.95 (0.85, 1.06) 0.34 f39_gdm_newGDM 1.52 (1.21, 1.90) 0.0003 StudySTOP 1.02 (0.92, 1.13) 0.73 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 metab.C1MetS:StudySTOP 1.08 (0.89, 1.30) 0.42 f39_gdm_newGDM:StudySTOP 0.71 (0.56, 0.91) 0.006 metab.C1MetS:f39_gdm_newGDM 0.65 (0.45, 0.93) 0.02 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.58 (1.01, 2.46) 0.05 37.1.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 96.09 7.24 85.15 82.73 111.61 MetS SCOPE non-GDM 91.05 7.99 155.73 76.55 108.28 No MetS STOP non-GDM 97.86 7.12 74.51 84.66 113.13 MetS STOP non-GDM 100.12 10.15 270.52 82.01 122.24 No MetS SCOPE GDM 145.89 19.20 669.32 112.67 188.90 MetS SCOPE GDM 89.33 14.23 1023.01 65.36 122.10 No MetS STOP GDM 105.49 9.38 161.87 88.51 125.73 MetS STOP GDM 109.99 13.49 531.60 86.44 139.96 37.1.3 Post-hoc comparisons 37.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 0.95 (0.85, 1.06) 0.3 MetS / No MetS STOP non-GDM 1.02 (0.88, 1.19) 0.8 MetS / No MetS SCOPE GDM 0.61 (0.43, 0.86) 0.005 MetS / No MetS STOP GDM 1.04 (0.84, 1.29) 0.7 37.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.838521 0.4151847 2391.677 1.1807237 2.8627855 0.007 ** STOP/SCOPE (non-GDM) 1.079762 0.1036309 2516.596 0.8945282 1.3033528 0.424 ns STOP/SCOPE (GDM) 1.702709 0.3501276 2327.225 1.1376722 2.5483785 0.010 ** GDM/non-GDM (SCOPE) 0.646241 0.1188326 2243.428 0.4505974 0.9268305 0.018 * GDM/non-GDM (STOP) 1.019077 0.1360482 2519.737 0.7843607 1.3240311 0.887 ns "],["hpl-24.html", "37.2 HPL", " 37.2 HPL LME for duplicated or repeated measures. 37.2.1 Model summary Var Effect P (Intercept) 1.96 (1.64, 2.36) &lt;0.0001 metab.C1MetS 0.88 (0.83, 0.94) &lt;0.0001 f39_gdm_newGDM 1.04 (0.92, 1.18) 0.49 StudySTOP 1.09 (1.03, 1.15) 0.004 GA_samp 1.34 (1.32, 1.35) &lt;0.0001 metab.C1MetS:StudySTOP 0.92 (0.83, 1.02) 0.13 f39_gdm_newGDM:StudySTOP 0.97 (0.85, 1.11) 0.66 metab.C1MetS:f39_gdm_newGDM 1.01 (0.84, 1.22) 0.90 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.07 (0.84, 1.36) 0.59 37.2.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 93.14 2.65 135.62 88.05 98.53 MetS SCOPE non-GDM 81.99 3.12 407.51 76.07 88.37 No MetS STOP non-GDM 101.38 2.70 105.14 96.17 106.87 MetS STOP non-GDM 82.43 3.88 811.07 75.15 90.42 No MetS SCOPE GDM 97.20 6.28 1421.45 85.63 110.33 MetS SCOPE GDM 86.66 6.60 1158.75 74.64 100.61 No MetS STOP GDM 102.72 3.95 394.08 95.23 110.79 MetS STOP GDM 90.39 5.44 1403.32 80.31 101.72 37.2.3 Post-hoc comparisons 37.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 0.88 (0.83, 0.94) &lt;0.0001 MetS / No MetS STOP non-GDM 0.81 (0.75, 0.88) &lt;0.0001 MetS / No MetS SCOPE GDM 0.89 (0.75, 1.07) 0.2 MetS / No MetS STOP GDM 0.88 (0.78, 0.99) 0.03 37.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.9117282 0.1101027 1929.515 0.7194614 1.155376 0.444 ns STOP/SCOPE (non-GDM) 0.9237098 0.0486511 2391.729 0.8330685 1.024213 0.132 ns STOP/SCOPE (GDM) 0.9870289 0.1077827 1784.543 0.7967394 1.222766 0.905 ns GDM/non-GDM (SCOPE) 1.0128236 0.0978875 1588.357 0.8379228 1.224232 0.895 ns GDM/non-GDM (STOP) 1.0822513 0.0794072 2397.656 0.9372210 1.249724 0.281 ns "],["gh2-24.html", "37.3 GH2", " 37.3 GH2 LME for duplicated or repeated measures. 37.3.1 Model summary Var Effect P (Intercept) 0.09 (0.07, 0.11) &lt;0.0001 metab.C1MetS 0.90 (0.82, 0.98) 0.01 f39_gdm_newGDM 1.20 (1.01, 1.43) 0.04 StudySTOP 0.92 (0.85, 0.99) 0.03 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 metab.C1MetS:StudySTOP 1.10 (0.95, 1.27) 0.21 f39_gdm_newGDM:StudySTOP 0.86 (0.71, 1.04) 0.12 metab.C1MetS:f39_gdm_newGDM 0.67 (0.51, 0.89) 0.006 metab.C1MetS:f39_gdm_newGDM:StudySTOP 1.43 (1.02, 2.02) 0.04 37.3.2 Estimated marginal means metab.C1 Study f39_gdm_new response SE df lower.CL upper.CL No MetS SCOPE non-GDM 2.47 0.07 348.71 2.33 2.62 MetS SCOPE non-GDM 2.21 0.10 1285.22 2.02 2.43 No MetS STOP non-GDM 2.26 0.06 234.08 2.15 2.38 MetS STOP non-GDM 2.22 0.13 1940.00 1.98 2.50 No MetS SCOPE GDM 2.95 0.26 2278.58 2.48 3.52 MetS SCOPE GDM 1.79 0.20 1661.21 1.44 2.22 No MetS STOP GDM 2.33 0.11 956.14 2.13 2.55 MetS STOP GDM 2.22 0.17 2180.03 1.90 2.59 37.3.3 Post-hoc comparisons 37.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value MetS / No MetS SCOPE non-GDM 0.90 (0.82, 0.98) 0.01 MetS / No MetS STOP non-GDM 0.98 (0.88, 1.10) 0.8 MetS / No MetS SCOPE GDM 0.61 (0.46, 0.79) 0.0002 MetS / No MetS STOP GDM 0.95 (0.81, 1.12) 0.5 37.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.7218554 0.2986793 2297.260 1.2253675 2.4195076 0.002 ** STOP/SCOPE (non-GDM) 1.0963443 0.0801202 2463.340 0.9499725 1.2652690 0.208 ns STOP/SCOPE (GDM) 1.5705426 0.2483287 2225.985 1.1518277 2.1414697 0.004 ** GDM/non-GDM (SCOPE) 0.6749940 0.0957961 2129.876 0.5110078 0.8916047 0.006 ** GDM/non-GDM (STOP) 0.9669471 0.0978558 2468.618 0.7928997 1.1791993 0.740 ns "],["birthweight-centile-3.html", "38 Birthweight centile", " 38 Birthweight centile Descriptives with univariate P-values. Within non-GDM Characteristic &lt;=90th centile (n=1910) &gt;90th centile (n=203) Total (n=2113) P-value PRL (ng/ml): Median (IQ range) 101.7 (59.7-168.2) 106.5 (59.6-190.3) 102.2 (59.7-169.4) 0.50 hPL (μg/ml): Median (IQ range) 120.9 (56.9-180.0) 100.4 (56.6-199.6) 117.9 (56.7-180.8) 0.50 GH2 (ng/ml): Median (IQ range) 2.8 (1.3-4.3) 2.5 (1.2-4.4) 2.7 (1.3-4.3) 0.42 Within GDM Characteristic &lt;=90th centile (n=223) &gt;90th centile (n=31) Total (n=254) P-value PRL (ng/ml): Median (IQ range) 73.3 (45.6-123.3) 127.3 (82.6-179.6) 80.6 (47.3-132.8) 0.007 hPL (μg/ml): Median (IQ range) 63.0 (40.8-106.2) 68.3 (36.0-116.7) 65.0 (40.3-106.4) 0.87 GH2 (ng/ml): Median (IQ range) 1.5 (1.0-2.7) 1.6 (0.9-3.4) 1.5 (1.0-2.8) 0.85 Click here for table within SCOPE Within non-GDM Characteristic &lt;=90th centile (n=977) &gt;90th centile (n=96) Total (n=1073) P-value PRL (ng/ml): Median (IQ range) 137.8 (91.3-220.7) 179.8 (121.5-230.6) 140.0 (92.7-221.7) 0.01 hPL (μg/ml): Median (IQ range) 177.6 (148.1-212.8) 207.5 (156.7-239.4) 180.0 (148.6-215.7) 0.002 GH2 (ng/ml): Median (IQ range) 4.2 (3.2-5.7) 4.6 (3.2-5.6) 4.2 (3.2-5.7) 0.71 Serum folate concentration (nM): Median (IQ range) 35.8 (28.1-42.6) 37.7 (29.4-42.6) 35.9 (28.1-42.6) 0.50 B12 concentration (pM): Median (IQ range) 243.0 (193.0-305.0) 250.5 (202.2-329.8) 245.0 (195.0-308.5) 0.15 Folate:B12 ratio: Median (IQ range) 142.6 (103.5-206.7) 151.4 (96.8-213.0) 142.7 (102.3-207.5) 0.85 Active B12 concentration (pM): Median (IQ range) 56.0 (42.0-72.0) 59.0 (44.8-79.2) 56.0 (43.0-73.0) 0.38 Folate:Active B12 ratio: Median (IQ range) 615.4 (429.8-904.2) 608.7 (467.2-871.9) 615.4 (432.4-902.3) 0.63 Homocysteine concentration (μM): Median (IQ range) 4.4 (3.8-5.1) 4.3 (3.7-4.8) 4.4 (3.8-5.0) 0.16 Within GDM Characteristic &lt;=90th centile (n=50) &gt;90th centile (n=8) Total (n=58) P-value PRL (ng/ml): Median (IQ range) 104.5 (79.9-176.9) 177.5 (171.7-185.4) 120.5 (81.8-180.0) 0.07 hPL (μg/ml): Median (IQ range) 133.7 (102.8-190.1) 203.3 (165.9-233.4) 163.3 (105.8-191.6) 0.06 GH2 (ng/ml): Median (IQ range) 3.1 (1.9-5.3) 4.2 (4.0-4.6) 3.4 (2.0-5.3) 0.39 Serum folate concentration (nM): Median (IQ range) 39.6 (32.2-43.8) 41.4 (32.1-43.7) 40.1 (32.0-43.8) 0.93 B12 concentration (pM): Median (IQ range) 245.0 (192.0-332.0) 257.0 (245.0-324.5) 253.5 (194.2-333.0) 0.29 Folate:B12 ratio: Median (IQ range) 167.7 (118.7-211.5) 122.6 (114.2-155.7) 158.9 (116.5-210.2) 0.34 Active B12 concentration (pM): Median (IQ range) 63.0 (53.0-81.5) 85.0 (77.0-104.0) 68.0 (55.0-86.0) 0.14 Folate:Active B12 ratio: Median (IQ range) 559.7 (436.8-674.3) 438.2 (424.7-516.5) 553.8 (424.7-660.3) 0.32 Homocysteine concentration (μM): Median (IQ range) 3.9 (3.6-4.6) 3.8 (3.7-4.2) 3.9 (3.6-4.6) 0.66 Click here for table within STOP Within non-GDM Characteristic &lt;=90th centile (n=933) &gt;90th centile (n=107) Total (n=1040) P-value PRL (ng/ml): Median (IQ range) 74.8 (49.1-119.4) 71.6 (45.9-113.8) 74.6 (48.6-118.9) 0.45 hPL (μg/ml): Median (IQ range) 60.3 (39.3-94.8) 60.3 (47.2-87.5) 60.3 (40.3-92.8) 0.35 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.4) 1.4 (1.0-2.3) 1.4 (0.9-2.4) 0.97 Serum folate concentration (nM): Median (IQ range) 40.5 (36.3-49.6) 40.8 (36.5-44.8) 40.5 (36.4-45.6) 0.89 B12 concentration (pM): Median (IQ range) 280.0 (217.0-356.0) 277.0 (231.0-380.2) 279.0 (218.0-356.5) 0.54 Folate:B12 ratio: Median (IQ range) 153.8 (115.6-222.8) 153.2 (114.4-212.1) 153.8 (115.3-221.7) 0.40 Active B12 concentration (pM): Median (IQ range) 63.0 (49.0-84.0) 67.5 (49.2-77.5) 63.0 (49.0-84.0) 0.68 Folate:Active B12 ratio: Median (IQ range) 663.0 (477.8-955.4) 646.1 (462.7-869.2) 663.0 (475.7-948.9) 0.67 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.2-5.6) 4.7 (4.3-5.4) 4.8 (4.2-5.6) 0.32 Within GDM Characteristic &lt;=90th centile (n=173) &gt;90th centile (n=23) Total (n=196) P-value PRL (ng/ml): Median (IQ range) 64.1 (42.3-111.5) 92.9 (81.1-162.2) 68.8 (42.7-114.3) 0.02 hPL (μg/ml): Median (IQ range) 55.6 (36.8-83.7) 56.7 (34.1-84.3) 55.6 (36.3-83.7) 0.94 GH2 (ng/ml): Median (IQ range) 1.4 (0.9-2.3) 1.3 (0.8-2.0) 1.3 (0.9-2.3) 0.83 Serum folate concentration (nM): Median (IQ range) 39.8 (35.2-44.7) 43.8 (38.4-65.7) 40.1 (35.6-45.2) 0.05 B12 concentration (pM): Median (IQ range) 275.5 (216.8-354.5) 270.0 (207.0-293.5) 273.0 (216.0-349.0) 0.35 Folate:B12 ratio: Median (IQ range) 145.9 (108.9-220.0) 163.2 (132.0-288.2) 148.0 (113.6-227.7) 0.08 Active B12 concentration (pM): Median (IQ range) 75.0 (56.0-90.2) 82.0 (69.0-103.0) 75.0 (56.5-92.5) 0.31 Folate:Active B12 ratio: Median (IQ range) 529.7 (418.5-783.6) 531.9 (439.6-840.5) 531.9 (418.5-792.6) 0.72 Homocysteine concentration (μM): Median (IQ range) 4.8 (4.0-5.4) 4.6 (3.8-4.8) 4.8 (4.0-5.3) 0.06 "],["prolactin-25.html", "38.1 Prolactin", " 38.1 Prolactin LME for duplicated or repeated measures. 38.1.1 Model summary Var Effect P (Intercept) 12.15 (8.75, 16.88) &lt;0.0001 BW_gp&gt;90th centile 1.30 (1.12, 1.50) 0.0004 f39_gdm_newGDM 1.35 (1.12, 1.64) 0.002 StudySTOP 1.07 (0.97, 1.18) 0.16 GA_samp 1.17 (1.14, 1.19) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.77 (0.64, 0.93) 0.008 f39_gdm_newGDM:StudySTOP 0.76 (0.62, 0.94) 0.010 BW_gp&gt;90th centile:f39_gdm_newGDM 0.75 (0.40, 1.43) 0.38 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 2.07 (1.02, 4.19) 0.04 38.1.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 92.22 6.86 81.33 79.53 106.93 &gt;90th centile SCOPE non-GDM 119.85 12.06 262.98 98.32 146.11 &lt;=90th centile STOP non-GDM 98.87 7.14 72.42 85.61 114.18 &gt;90th centile STOP non-GDM 98.96 9.04 182.30 82.64 118.50 &lt;=90th centile SCOPE GDM 124.73 14.48 439.11 99.28 156.70 &gt;90th centile SCOPE GDM 121.88 38.39 1488.05 65.71 226.07 &lt;=90th centile STOP GDM 101.67 8.79 145.68 85.71 120.61 &gt;90th centile STOP GDM 158.36 22.20 825.35 120.26 208.52 38.1.3 Post-hoc comparisons 38.1.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.30 (1.12, 1.50) 0.0004 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.00 (0.89, 1.13) 1.0 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.98 (0.52, 1.82) 0.9 &gt;90th centile / &lt;=90th centile STOP GDM 1.56 (1.21, 2.00) 0.0006 38.1.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.2274086 0.4404909 1771.369 0.6071586 2.4812824 0.568 ns STOP/SCOPE (non-GDM) 0.7700875 0.0753333 2569.224 0.6356713 0.9329266 0.008 ** STOP/SCOPE (GDM) 1.5938561 0.5503880 1702.126 0.8096630 3.1375735 0.177 ns GDM/non-GDM (SCOPE) 0.7518520 0.2456954 1570.919 0.3960557 1.4272774 0.383 ns GDM/non-GDM (STOP) 1.5561139 0.2223375 2628.786 1.1758874 2.0592878 0.002 ** "],["hpl-25.html", "38.2 HPL", " 38.2 HPL LME for duplicated or repeated measures. 38.2.1 Model summary Var Effect P (Intercept) 1.74 (1.46, 2.08) &lt;0.0001 BW_gp&gt;90th centile 1.10 (1.02, 1.20) 0.02 f39_gdm_newGDM 0.98 (0.88, 1.08) 0.66 StudySTOP 1.10 (1.04, 1.17) 0.0005 GA_samp 1.35 (1.33, 1.36) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 1.06 (0.95, 1.18) 0.28 f39_gdm_newGDM:StudySTOP 1.02 (0.91, 1.15) 0.71 BW_gp&gt;90th centile:f39_gdm_newGDM 1.18 (0.85, 1.63) 0.33 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 0.77 (0.53, 1.11) 0.16 38.2.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 89.64 2.53 130.98 84.78 94.78 &gt;90th centile SCOPE non-GDM 98.86 4.70 809.79 90.06 108.52 &lt;=90th centile STOP non-GDM 98.87 2.61 102.21 93.83 104.19 &gt;90th centile STOP non-GDM 115.77 4.82 549.21 106.68 125.64 &lt;=90th centile SCOPE GDM 87.58 4.87 991.57 78.53 97.67 &gt;90th centile SCOPE GDM 113.79 17.85 1077.06 83.64 154.81 &lt;=90th centile STOP GDM 98.75 3.71 360.40 91.73 106.31 &gt;90th centile STOP GDM 104.36 7.83 2004.38 90.07 120.91 38.2.3 Post-hoc comparisons 38.2.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.10 (1.02, 1.20) 0.02 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.17 (1.09, 1.26) &lt;0.0001 &gt;90th centile / &lt;=90th centile SCOPE GDM 1.30 (0.95, 1.78) 0.1 &gt;90th centile / &lt;=90th centile STOP GDM 1.06 (0.91, 1.22) 0.5 38.2.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8634839 0.1616940 1327.876 0.5980188 1.246791 0.433 ns STOP/SCOPE (non-GDM) 1.0616596 0.0588016 2296.964 0.9523912 1.183464 0.280 ns STOP/SCOPE (GDM) 0.8133341 0.1455383 1254.214 0.5725422 1.155395 0.248 ns GDM/non-GDM (SCOPE) 1.1781075 0.1970540 1138.725 0.8485135 1.635728 0.327 ns GDM/non-GDM (STOP) 0.9025444 0.0749859 2484.156 0.7668561 1.062242 0.217 ns "],["gh2-25.html", "38.3 GH2", " 38.3 GH2 LME for duplicated or repeated measures. 38.3.1 Model summary Var Effect P (Intercept) 0.08 (0.06, 0.10) &lt;0.0001 BW_gp&gt;90th centile 1.04 (0.93, 1.17) 0.46 f39_gdm_newGDM 1.02 (0.88, 1.17) 0.84 StudySTOP 0.94 (0.88, 1.01) 0.11 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 BW_gp&gt;90th centile:StudySTOP 0.97 (0.84, 1.13) 0.69 f39_gdm_newGDM:StudySTOP 1.02 (0.87, 1.20) 0.80 BW_gp&gt;90th centile:f39_gdm_newGDM 0.93 (0.58, 1.50) 0.76 BW_gp&gt;90th centile:f39_gdm_newGDM:StudySTOP 0.93 (0.55, 1.57) 0.78 38.3.2 Estimated marginal means BW_gp Study f39_gdm_new response SE df lower.CL upper.CL &lt;=90th centile SCOPE non-GDM 2.41 0.07 325.30 2.27 2.55 &gt;90th centile SCOPE non-GDM 2.51 0.15 1931.67 2.23 2.82 &lt;=90th centile STOP non-GDM 2.27 0.06 219.62 2.16 2.38 &gt;90th centile STOP non-GDM 2.29 0.11 1606.97 2.08 2.53 &lt;=90th centile SCOPE GDM 2.44 0.18 1979.08 2.11 2.83 &gt;90th centile SCOPE GDM 2.37 0.54 1384.39 1.51 3.70 &lt;=90th centile STOP GDM 2.35 0.10 867.95 2.16 2.56 &gt;90th centile STOP GDM 2.05 0.20 2503.06 1.70 2.47 38.3.3 Post-hoc comparisons 38.3.3.1 Within Groups Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value &gt;90th centile / &lt;=90th centile SCOPE non-GDM 1.04 (0.93, 1.17) 0.5 &gt;90th centile / &lt;=90th centile STOP non-GDM 1.01 (0.92, 1.11) 0.8 &gt;90th centile / &lt;=90th centile SCOPE GDM 0.97 (0.61, 1.54) 0.9 &gt;90th centile / &lt;=90th centile STOP GDM 0.87 (0.72, 1.06) 0.2 38.3.3.2 Between Groups contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.8736499 0.2346088 1703.686 0.5159343 1.479382 0.615 ns STOP/SCOPE (non-GDM) 0.9705561 0.0730759 2525.599 0.8373375 1.124970 0.691 ns STOP/SCOPE (GDM) 0.9001539 0.2320581 1629.998 0.5428945 1.492513 0.683 ns GDM/non-GDM (SCOPE) 0.9290565 0.2262405 1505.305 0.5762273 1.497926 0.763 ns GDM/non-GDM (STOP) 0.8616645 0.0949346 2597.313 0.6942449 1.069458 0.177 ns "],["hormone-models-3.html", "39 Hormone Models ", " 39 Hormone Models "],["scope-vs-stop-3.html", "39.1 SCOPE vs STOP", " 39.1 SCOPE vs STOP - Outcomes: Prolactin, hPL, GH2 (all outcomes log-transformed) - Independent variables: Study, f39_gdm_new, BMI, Ethnicity (Caucasian/non-Caucasian), smoking (yes/no), GA at sampling - Model fitted: LME model       log(hormones) ~ Study + f39_gdm_new + BMI + Ethnicity + Smoking + GA at sampling + Study:GDM       Random intercepts for Study ID and Plate #outc_ls &lt;- c(&quot;Prolactin&quot;,&quot;HPL&quot;,&quot;GH2&quot;) outc_ls &lt;- hormone_var outc2 &lt;- preg_out # fit LME fit_ls &lt;- lapply(outc_ls,function(outc){ fit_eq &lt;- as.formula(paste0(&quot;log(&quot;,outc,&quot;)~ Study + &quot;,outc2,&quot; + BMI + Ethnicity_cauc + f10c_any_cig_1st_vst + GA_samp + Study*&quot;,outc2,&quot; + (1|Study.ID) + (1|Assay.&quot;,outc,&quot;)&quot;)) fit &lt;- eval(bquote(lmer(.(fit_eq),data=dat_run))) return(fit)}) names(fit_ls) &lt;- outc_ls # Type III SS anova_ls &lt;- lapply(fit_ls,Anova,type=&quot;III&quot;) 39.1.1 Model Summary Model summaries. Prolactin Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 2.9024839 0.1741115 1368.074 16.670262 &lt;0.0001 *** StudySTOP -0.0794015 0.0475829 2655.087 -1.668700 0.10 ns f39_gdm_newGDM 0.1931262 0.0885866 2568.513 2.180084 0.03 * BMI -0.0040572 0.0019591 2583.596 -2.070904 0.04 * Ethnicity_caucNo 0.4774880 0.0393604 2545.560 12.131175 &lt;0.0001 *** f10c_any_cig_1st_vstYes -0.2617962 0.0313040 2641.151 -8.363038 &lt;0.0001 *** GA_samp 0.1367618 0.0094725 2647.038 14.437746 &lt;0.0001 *** StudySTOP:f39_gdm_newGDM -0.0943752 0.0966392 2584.216 -0.976573 0.3 ns HPL Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) 1.1485576 0.0935605 2252.701 12.2760942 &lt;0.0001 *** StudySTOP 0.0734657 0.0269634 2520.842 2.7246454 0.006 ** f39_gdm_newGDM 0.0024517 0.0475411 1621.494 0.0515703 1.0 ns BMI -0.0175460 0.0010983 2337.785 -15.9749328 &lt;0.0001 *** Ethnicity_caucNo 0.0619723 0.0220399 2311.740 2.8118297 0.005 ** f10c_any_cig_1st_vstYes 0.0200900 0.0179144 2464.757 1.1214394 0.3 ns GA_samp 0.2895993 0.0054262 2498.843 53.3707683 &lt;0.0001 *** StudySTOP:f39_gdm_newGDM 0.0268452 0.0526417 1830.056 0.5099607 0.6 ns GH2 Estimate Std. Error df t value Pr(&gt;|t|) (Intercept) -2.0166842 0.1266481 2455.177 -15.9235192 &lt;0.0001 *** StudySTOP -0.0805537 0.0368403 2561.817 -2.1865628 0.03 * f39_gdm_newGDM 0.0291292 0.0690201 2318.523 0.4220399 0.7 ns BMI -0.0151010 0.0015140 2518.719 -9.9740970 &lt;0.0001 *** Ethnicity_caucNo 0.0551653 0.0306744 2478.124 1.7984155 0.07 ns f10c_any_cig_1st_vstYes 0.0415616 0.0245582 2589.207 1.6923715 0.09 ns GA_samp 0.2499428 0.0074744 2568.953 33.4399169 &lt;0.0001 *** StudySTOP:f39_gdm_newGDM 0.0285314 0.0762810 2447.236 0.3740307 0.7 ns 39.1.2 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 277.8976418 1 &lt;0.0001 *** Study 2.7845604 1 0.10 ns f39_gdm_new 4.7527648 1 0.03 * BMI 4.2886443 1 0.04 * Ethnicity_cauc 147.1654082 1 &lt;0.0001 *** f10c_any_cig_1st_vst 69.9404082 1 &lt;0.0001 *** GA_samp 208.4485184 1 &lt;0.0001 *** Study:f39_gdm_new 0.9536949 1 0.3 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 150.7024880 1 &lt;0.0001 *** Study 7.4236925 1 0.006 ** f39_gdm_new 0.0026595 1 1.0 ns BMI 255.1984795 1 &lt;0.0001 *** Ethnicity_cauc 7.9063860 1 0.005 ** f10c_any_cig_1st_vst 1.2576264 1 0.3 ns GA_samp 2848.4389042 1 &lt;0.0001 *** Study:f39_gdm_new 0.2600599 1 0.6 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 253.5584630 1 &lt;0.0001 *** Study 4.7810569 1 0.03 * f39_gdm_new 0.1781177 1 0.7 ns BMI 99.4826102 1 &lt;0.0001 *** Ethnicity_cauc 3.2342983 1 0.07 ns f10c_any_cig_1st_vst 2.8641214 1 0.09 ns GA_samp 1118.2280409 1 &lt;0.0001 *** Study:f39_gdm_new 0.1398990 1 0.7 ns 39.1.3 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.1.4 Results 39.1.4.1 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling and BMI. em_eq &lt;- as.formula(paste0(&quot;pairwise~Study*&quot;,outc2)) fit_em &lt;- lapply(fit_ls,function(x){emmeans(x,em_eq,type=&quot;response&quot;)}) fit_em_contrasts &lt;- lapply(fit_em,function(x){ contrast_dat &lt;- data.frame(x$emmeans) contrast_dat$Group &lt;- with(contrast_dat,paste(Study,get(outc2),sep=&quot;.&quot;)) contrast_mat &lt;- diag(nrow(contrast_dat)) rownames(contrast_mat) &lt;- colnames(contrast_mat) &lt;- contrast_dat$Group contrast_ls &lt;- list( &quot;STOP/SCOPE (non-cases)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1]),], &quot;STOP/SCOPE (Cases)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2]),], &quot;Cases/non-cases (SCOPE)&quot;=contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;SCOPE.&quot;,preg_out_label[1]),], &quot;Cases/non-cases (STOP)&quot;=contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[2]),]-contrast_mat[paste0(&quot;STOP.&quot;,preg_out_label[1]),]) names(contrast_ls) &lt;- c(&quot;STOP/SCOPE (non-cases)&quot;,paste0(&quot;STOP/SCOPE (&quot;,outc2,&quot;)&quot;), paste0(outc2,&quot;/non-cases (SCOPE)&quot;),paste0(outc2,&quot;/non-cases (STOP)&quot;)) contrast_out &lt;- contrast(x$emmeans,method=contrast_ls) return(contrast_out)}) Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 111.0033 8.640692 88.39873 95.09490 129.5730 STOP non-GDM 102.5303 7.684554 76.11669 88.31305 119.0363 SCOPE GDM 134.6510 15.223960 366.29795 107.80814 168.1773 STOP GDM 113.1721 9.676396 127.08483 95.55653 134.0349 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 93.7796 2.779980 169.9545 88.44934 99.43108 STOP non-GDM 100.9286 2.761284 124.3761 95.60871 106.54443 SCOPE GDM 94.0098 4.950773 943.6817 84.77920 104.24541 STOP GDM 103.9292 3.712455 322.4835 96.87624 111.49565 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.500552 0.0813888 527.0090 2.345670 2.665660 STOP non-GDM 2.307022 0.0647037 329.8672 2.183186 2.437883 SCOPE GDM 2.574462 0.1846933 1958.7616 2.236573 2.963398 STOP GDM 2.443957 0.1020076 834.8843 2.251717 2.652608 39.1.4.2 Comparisons Prolactin contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases) 0.924 0.044 2654.351 0.841 1.014 0.096 ns STOP/SCOPE (f39_gdm_new) 0.840 0.085 2603.060 0.689 1.026 0.087 ns f39_gdm_new/non-cases (SCOPE) 1.213 0.108 2570.391 1.019 1.443 0.030 * f39_gdm_new/non-cases (STOP) 1.104 0.055 2614.938 1.002 1.216 0.046 * HPL contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases) 1.076 0.029 2516.182 1.021 1.135 0.007 ** STOP/SCOPE (f39_gdm_new) 1.106 0.061 1944.384 0.992 1.232 0.069 ns f39_gdm_new/non-cases (SCOPE) 1.002 0.048 1614.451 0.913 1.101 0.959 ns f39_gdm_new/non-cases (STOP) 1.030 0.029 2386.025 0.975 1.087 0.290 ns GH2 contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases) 0.923 0.034 2567.452 0.858 0.992 0.029 * STOP/SCOPE (f39_gdm_new) 0.949 0.076 2478.372 0.812 1.110 0.513 ns f39_gdm_new/non-cases (SCOPE) 1.030 0.071 2340.973 0.899 1.179 0.674 ns f39_gdm_new/non-cases (STOP) 1.059 0.040 2444.830 0.984 1.141 0.127 ns 39.1.4.3 Barplots 39.1.5 Comparisons by Timepoint Prolactin contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases)|10wks 0.924 0.044 2654.351 0.841 1.014 0.096 ns STOP/SCOPE (f39_gdm_new)|10wks 0.840 0.085 2603.060 0.689 1.026 0.087 ns f39_gdm_new/non-cases (SCOPE)|10wks 1.213 0.108 2570.391 1.019 1.443 0.030 * f39_gdm_new/non-cases (STOP)|10wks 1.104 0.055 2614.938 1.002 1.216 0.046 * STOP/SCOPE (non-cases)|16wks 0.924 0.044 2654.351 0.841 1.014 0.096 ns STOP/SCOPE (f39_gdm_new)|16wks 0.840 0.085 2603.060 0.689 1.026 0.087 ns f39_gdm_new/non-cases (SCOPE)|16wks 1.213 0.108 2570.391 1.019 1.443 0.030 * f39_gdm_new/non-cases (STOP)|16wks 1.104 0.055 2614.938 1.002 1.216 0.046 * 16wks/10wks (non-cases)|SCOPE 2.272 0.129 2646.160 2.032 2.540 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|SCOPE 2.272 0.129 2646.160 2.032 2.540 &lt;0.0001 *** 16wks/10wks (non-cases)|STOP 2.272 0.129 2646.160 2.032 2.540 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|STOP 2.272 0.129 2646.160 2.032 2.540 &lt;0.0001 *** HPL contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases)|10wks 1.076 0.029 2516.182 1.021 1.135 0.007 ** STOP/SCOPE (f39_gdm_new)|10wks 1.106 0.061 1944.384 0.992 1.232 0.069 ns f39_gdm_new/non-cases (SCOPE)|10wks 1.002 0.048 1614.451 0.913 1.101 0.959 ns f39_gdm_new/non-cases (STOP)|10wks 1.030 0.029 2386.025 0.975 1.087 0.290 ns STOP/SCOPE (non-cases)|16wks 1.076 0.029 2516.182 1.021 1.135 0.007 ** STOP/SCOPE (f39_gdm_new)|16wks 1.106 0.061 1944.384 0.992 1.232 0.069 ns f39_gdm_new/non-cases (SCOPE)|16wks 1.002 0.048 1614.451 0.913 1.101 0.959 ns f39_gdm_new/non-cases (STOP)|16wks 1.030 0.029 2386.025 0.975 1.087 0.290 ns 16wks/10wks (non-cases)|SCOPE 5.684 0.185 2492.286 5.332 6.059 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|SCOPE 5.684 0.185 2492.286 5.332 6.059 &lt;0.0001 *** 16wks/10wks (non-cases)|STOP 5.684 0.185 2492.286 5.332 6.059 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|STOP 5.684 0.185 2492.286 5.332 6.059 &lt;0.0001 *** GH2 contrast ratio SE df lower.CL upper.CL p.value STOP/SCOPE (non-cases)|10wks 0.923 0.034 2567.452 0.858 0.992 0.029 * STOP/SCOPE (f39_gdm_new)|10wks 0.949 0.076 2478.372 0.812 1.110 0.513 ns f39_gdm_new/non-cases (SCOPE)|10wks 1.030 0.071 2340.973 0.899 1.179 0.674 ns f39_gdm_new/non-cases (STOP)|10wks 1.059 0.040 2444.830 0.984 1.141 0.127 ns STOP/SCOPE (non-cases)|16wks 0.923 0.034 2567.452 0.858 0.992 0.029 * STOP/SCOPE (f39_gdm_new)|16wks 0.949 0.076 2478.372 0.812 1.110 0.513 ns f39_gdm_new/non-cases (SCOPE)|16wks 1.030 0.071 2340.973 0.899 1.179 0.674 ns f39_gdm_new/non-cases (STOP)|16wks 1.059 0.040 2444.830 0.984 1.141 0.127 ns 16wks/10wks (non-cases)|SCOPE 4.480 0.201 2573.535 4.102 4.893 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|SCOPE 4.480 0.201 2573.535 4.102 4.893 &lt;0.0001 *** 16wks/10wks (non-cases)|STOP 4.480 0.201 2573.535 4.102 4.893 &lt;0.0001 *** 16wks/10wks (f39_gdm_new)|STOP 4.480 0.201 2573.535 4.102 4.893 &lt;0.0001 *** 39.1.5.1 Barplots by Timepoint 39.1.5.2 Plots for GA "],["folate-5.html", "39.2 Folate", " 39.2 Folate 39.2.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 219.2092026 1 &lt;0.0001 *** Folate 1.2176379 1 0.3 ns f39_gdm_new 2.9054539 1 0.09 ns Study 0.0007704 1 1.0 ns GA_samp 241.0093485 1 &lt;0.0001 *** Folate:f39_gdm_new 1.0149630 1 0.3 ns f39_gdm_new:Study 1.2840916 1 0.3 ns Folate:Study 2.2356814 1 0.1 ns Folate:f39_gdm_new:Study 0.7837867 1 0.4 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 42.5362508 1 &lt;0.0001 *** Folate 0.3045421 1 0.6 ns f39_gdm_new 0.4164175 1 0.5 ns Study 12.2529520 1 0.0005 *** GA_samp 2664.0274408 1 &lt;0.0001 *** Folate:f39_gdm_new 0.9235740 1 0.3 ns f39_gdm_new:Study 2.2772799 1 0.1 ns Folate:Study 0.8091110 1 0.4 ns Folate:f39_gdm_new:Study 2.8387545 1 0.09 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 410.6597393 1 &lt;0.0001 *** Folate 1.4061496 1 0.2 ns f39_gdm_new 0.6588281 1 0.4 ns Study 1.6789578 1 0.2 ns GA_samp 1126.9432431 1 &lt;0.0001 *** Folate:f39_gdm_new 1.4688838 1 0.2 ns f39_gdm_new:Study 0.8100837 1 0.4 ns Folate:Study 0.0122662 1 0.9 ns Folate:f39_gdm_new:Study 1.8116481 1 0.2 ns 39.2.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 12.63 (9.03, 17.65) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.21 f39_gdm_newGDM 1.20 (0.97, 1.49) 0.10 StudySTOP 0.99 (0.88, 1.12) 0.89 GA_samp 1.17 (1.14, 1.19) &lt;0.0001 Folate:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.61 f39_gdm_newGDM:StudySTOP 0.93 (0.75, 1.14) 0.47 Folate:StudySTOP 1.00 (1.00, 1.00) 0.08 HPL Var Effect P (Intercept) 1.84 (1.53, 2.21) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.38 f39_gdm_newGDM 0.94 (0.83, 1.05) 0.26 StudySTOP 1.12 (1.05, 1.20) 0.0010 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 Folate:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.11 f39_gdm_newGDM:StudySTOP 0.99 (0.89, 1.11) 0.88 Folate:StudySTOP 1.00 (1.00, 1.00) 0.61 GH2 Var Effect P (Intercept) 0.08 (0.07, 0.11) &lt;0.0001 Folate 1.00 (1.00, 1.00) 0.15 f39_gdm_newGDM 0.96 (0.82, 1.14) 0.66 StudySTOP 0.93 (0.85, 1.02) 0.14 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Folate:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.89 f39_gdm_newGDM:StudySTOP 1.04 (0.89, 1.21) 0.66 Folate:StudySTOP 1.00 (1.00, 1.00) 0.67 39.2.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Serum folate concentration (nM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 94.01117 6.982933 79.74327 81.09238 108.9880 STOP non-GDM 98.28859 7.089628 71.09864 85.12211 113.4916 SCOPE GDM 110.11206 12.827978 436.63191 87.57797 138.4442 STOP GDM 106.76073 9.182390 140.94763 90.06716 126.5484 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 90.37545 2.551865 129.6073 85.46518 95.56784 STOP non-GDM 100.39757 2.661253 101.7518 95.25520 105.81754 SCOPE GDM 88.18814 4.889314 978.9128 79.09692 98.32428 STOP GDM 97.10631 3.628770 350.0417 90.22533 104.51206 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.410291 0.0694896 318.8801 2.277380 2.550959 STOP non-GDM 2.273520 0.0577913 220.0025 2.162431 2.390317 SCOPE GDM 2.336262 0.1719865 1876.4802 2.022177 2.699132 STOP GDM 2.283636 0.0974471 846.0725 2.100161 2.483141 39.2.4 Comparisons 39.2.4.1 Within Groups Effect for every 1 unit increase in Serum folate concentration (nM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin Folate40.2 / Folate39.2 SCOPE non-GDM 1.00 (1.00, 1.00) 0.2 Prolactin Folate40.2 / Folate39.2 STOP non-GDM 1.00 (1.00, 1.00) 0.3 Prolactin Folate40.2 / Folate39.2 SCOPE GDM 1.00 (1.00, 1.00) 0.3 Prolactin Folate40.2 / Folate39.2 STOP GDM 1.00 (1.00, 1.00) 1.0 HPL Folate40.2 / Folate39.2 SCOPE non-GDM 1.00 (1.00, 1.00) 0.4 HPL Folate40.2 / Folate39.2 STOP non-GDM 1.00 (1.00, 1.00) 0.07 HPL Folate40.2 / Folate39.2 SCOPE GDM 1.00 (1.00, 1.00) 0.3 HPL Folate40.2 / Folate39.2 STOP GDM 1.00 (1.00, 1.00) 0.4 GH2 Folate40.2 / Folate39.2 SCOPE non-GDM 1.00 (1.00, 1.00) 0.2 GH2 Folate40.2 / Folate39.2 STOP non-GDM 1.00 (1.00, 1.00) 0.3 GH2 Folate40.2 / Folate39.2 SCOPE GDM 1.00 (1.00, 1.00) 0.6 GH2 Folate40.2 / Folate39.2 STOP GDM 1.00 (1.00, 1.00) 0.7 39.2.4.2 Between Groups Below are comparisons of the differences in the change in Serum folate concentration (nM) between groups. I.e. whether the change in Serum folate concentration (nM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.003 0.002 2593.676 1.000 1.006 0.085 ns STOP/SCOPE (non-GDM) 1.001 0.001 2593.676 1.000 1.003 0.085 ns STOP/SCOPE (GDM) 1.001 0.001 2593.676 1.000 1.003 0.085 ns GDM/non-GDM (SCOPE) 0.999 0.001 2512.768 0.997 1.002 0.609 ns GDM/non-GDM (STOP) 0.999 0.001 2512.768 0.997 1.002 0.609 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.000 0.001 2354.068 0.998 1.001 0.607 ns STOP/SCOPE (non-GDM) 1.000 0.000 2354.068 0.999 1.001 0.607 ns STOP/SCOPE (GDM) 1.000 0.000 2354.068 0.999 1.001 0.607 ns GDM/non-GDM (SCOPE) 1.001 0.001 2210.644 1.000 1.002 0.107 ns GDM/non-GDM (STOP) 1.001 0.001 2210.644 1.000 1.002 0.107 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.001 0.001 2527.340 0.998 1.003 0.673 ns STOP/SCOPE (non-GDM) 1.000 0.001 2527.340 0.999 1.001 0.673 ns STOP/SCOPE (GDM) 1.000 0.001 2527.340 0.999 1.001 0.673 ns GDM/non-GDM (SCOPE) 1.000 0.001 2450.399 0.998 1.002 0.886 ns GDM/non-GDM (STOP) 1.000 0.001 2450.399 0.998 1.002 0.886 ns 39.2.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.2.6 Plots "],["b12-5.html", "39.3 B12", " 39.3 B12 39.3.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 181.6524869 1 &lt;0.0001 *** B12 8.7035060 1 0.003 ** f39_gdm_new 0.2223768 1 0.6 ns Study 0.0882528 1 0.8 ns GA_samp 240.0485339 1 &lt;0.0001 *** B12:f39_gdm_new 1.2565907 1 0.3 ns f39_gdm_new:Study 0.4355744 1 0.5 ns B12:Study 0.0063594 1 0.9 ns B12:f39_gdm_new:Study 1.0043491 1 0.3 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 29.7752155 1 &lt;0.0001 *** B12 2.2213715 1 0.1 ns f39_gdm_new 1.1859538 1 0.3 ns Study 1.6645102 1 0.2 ns GA_samp 2723.0713238 1 &lt;0.0001 *** B12:f39_gdm_new 0.7284528 1 0.4 ns f39_gdm_new:Study 2.9732046 1 0.08 ns B12:Study 0.4672938 1 0.5 ns B12:f39_gdm_new:Study 2.5439862 1 0.1 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 462.9328421 1 &lt;0.0001 *** B12 21.0324465 1 &lt;0.0001 *** f39_gdm_new 0.0013894 1 1.0 ns Study 0.9116095 1 0.3 ns GA_samp 1156.6070227 1 &lt;0.0001 *** B12:f39_gdm_new 0.0836876 1 0.8 ns f39_gdm_new:Study 0.0532859 1 0.8 ns B12:Study 6.3336938 1 0.01 * B12:f39_gdm_new:Study 0.0231708 1 0.9 ns 39.3.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 10.57 (7.50, 14.91) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.001 f39_gdm_newGDM 1.12 (0.86, 1.45) 0.40 StudySTOP 1.05 (0.88, 1.24) 0.60 GA_samp 1.16 (1.14, 1.19) &lt;0.0001 B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.61 f39_gdm_newGDM:StudySTOP 0.92 (0.75, 1.12) 0.41 B12:StudySTOP 1.00 (1.00, 1.00) 0.72 HPL Var Effect P (Intercept) 1.68 (1.39, 2.03) &lt;0.0001 B12 1.00 (1.00, 1.00) 0.06 f39_gdm_newGDM 1.04 (0.90, 1.20) 0.56 StudySTOP 1.09 (0.99, 1.20) 0.09 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.11 f39_gdm_newGDM:StudySTOP 1.04 (0.93, 1.16) 0.51 B12:StudySTOP 1.00 (1.00, 1.00) 0.81 GH2 Var Effect P (Intercept) 0.07 (0.05, 0.09) &lt;0.0001 B12 1.00 (1.00, 1.00) &lt;0.0001 f39_gdm_newGDM 0.96 (0.79, 1.18) 0.72 StudySTOP 1.06 (0.94, 1.21) 0.34 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.69 f39_gdm_newGDM:StudySTOP 1.09 (0.93, 1.27) 0.28 B12:StudySTOP 1.00 (1.00, 1.00) 0.01 39.3.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 97.72449 7.344445 83.59665 84.15737 113.4788 STOP non-GDM 99.31734 7.139408 70.17056 86.05242 114.6270 SCOPE GDM 115.52013 13.414910 432.99861 91.94621 145.1381 STOP GDM 107.86672 9.174767 135.04318 91.16594 127.6270 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 91.22504 2.627104 144.29641 86.17748 96.56824 STOP non-GDM 100.24159 2.621043 99.41307 95.17373 105.57930 SCOPE GDM 86.38851 4.777275 986.56514 77.50448 96.29088 STOP GDM 98.48869 3.608101 335.20406 91.64101 105.84804 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.500915 0.0750338 380.9051 2.357650 2.652886 STOP non-GDM 2.268880 0.0563643 210.1482 2.160445 2.382757 SCOPE GDM 2.333791 0.1707784 1916.5859 2.021784 2.693947 STOP GDM 2.306098 0.0959038 795.2930 2.125323 2.502250 39.3.4 Comparisons 39.3.4.1 Within Groups Effect for every 100 unit increase in B12 concentration (pM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin B12366 / B12266 SCOPE non-GDM 1.07 (1.03, 1.11) 0.001 Prolactin B12366 / B12266 STOP non-GDM 1.06 (1.03, 1.09) 0.0002 Prolactin B12366 / B12266 SCOPE GDM 1.09 (1.01, 1.18) 0.03 Prolactin B12366 / B12266 STOP GDM 1.08 (1.01, 1.15) 0.02 HPL B12366 / B12266 SCOPE non-GDM 1.02 (1.00, 1.05) 0.06 HPL B12366 / B12266 STOP non-GDM 1.03 (1.01, 1.04) 0.003 HPL B12366 / B12266 SCOPE GDM 0.99 (0.95, 1.04) 0.7 HPL B12366 / B12266 STOP GDM 1.00 (0.96, 1.03) 0.8 GH2 B12366 / B12266 SCOPE non-GDM 1.08 (1.04, 1.11) &lt;0.0001 GH2 B12366 / B12266 STOP non-GDM 1.02 (1.00, 1.05) 0.05 GH2 B12366 / B12266 SCOPE GDM 1.07 (1.00, 1.13) 0.03 GH2 B12366 / B12266 STOP GDM 1.01 (0.97, 1.06) 0.6 39.3.4.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.982 0.051 2513.706 0.887 1.087 0.725 ns STOP/SCOPE (non-GDM) 0.991 0.026 2513.706 0.942 1.042 0.725 ns STOP/SCOPE (GDM) 0.991 0.026 2513.706 0.942 1.042 0.725 ns GDM/non-GDM (SCOPE) 1.018 0.035 2392.435 0.951 1.090 0.608 ns GDM/non-GDM (STOP) 1.018 0.035 2392.435 0.951 1.090 0.608 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.007 0.029 2235.207 0.951 1.066 0.808 ns STOP/SCOPE (non-GDM) 1.004 0.015 2235.207 0.975 1.033 0.808 ns STOP/SCOPE (GDM) 1.004 0.015 2235.207 0.975 1.033 0.808 ns GDM/non-GDM (SCOPE) 0.970 0.019 2126.409 0.934 1.007 0.114 ns GDM/non-GDM (STOP) 0.970 0.019 2126.409 0.934 1.007 0.114 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.904 0.035 2442.544 0.837 0.977 0.010 * STOP/SCOPE (non-GDM) 0.951 0.019 2442.544 0.915 0.988 0.010 * STOP/SCOPE (GDM) 0.951 0.019 2442.544 0.915 0.988 0.010 * GDM/non-GDM (SCOPE) 0.989 0.026 2321.552 0.940 1.042 0.689 ns GDM/non-GDM (STOP) 0.989 0.026 2321.552 0.940 1.042 0.689 ns 39.3.5 Estimated means (50 unit increase) Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 96.09942 7.159399 80.74242 82.85935 111.4551 STOP non-GDM 97.88782 7.035388 70.12279 84.81585 112.9745 SCOPE GDM 113.09274 13.014232 419.50931 90.19836 141.7982 STOP GDM 105.84023 8.963068 132.74954 89.51662 125.1405 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 90.71154 2.563640 134.12996 85.78025 95.92631 STOP non-GDM 99.58920 2.602447 99.19445 94.55709 104.88911 SCOPE GDM 86.56408 4.733011 969.77793 77.75690 96.36881 STOP GDM 98.60158 3.588114 327.18475 91.78963 105.91906 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.455346 0.0712892 339.5039 2.319050 2.599651 STOP non-GDM 2.255695 0.0559525 209.2659 2.148046 2.368740 SCOPE GDM 2.297329 0.1661259 1903.7375 1.993570 2.647372 STOP GDM 2.298764 0.0945712 779.3936 2.120418 2.492111 39.3.6 Comparisons (50 unit increase) 39.3.6.1 Within Groups Effect for every 50 unit increase in B12 concentration (pM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin B12316 / B12266 SCOPE non-GDM 1.03 (1.01, 1.06) 0.001 Prolactin B12316 / B12266 STOP non-GDM 1.03 (1.01, 1.05) 0.0002 Prolactin B12316 / B12266 SCOPE GDM 1.04 (1.00, 1.08) 0.03 Prolactin B12316 / B12266 STOP GDM 1.04 (1.01, 1.07) 0.02 HPL B12316 / B12266 SCOPE non-GDM 1.01 (1.00, 1.02) 0.06 HPL B12316 / B12266 STOP non-GDM 1.01 (1.00, 1.02) 0.003 HPL B12316 / B12266 SCOPE GDM 1.00 (0.97, 1.02) 0.7 HPL B12316 / B12266 STOP GDM 1.00 (0.98, 1.02) 0.8 GH2 B12316 / B12266 SCOPE non-GDM 1.04 (1.02, 1.05) &lt;0.0001 GH2 B12316 / B12266 STOP non-GDM 1.01 (1.00, 1.02) 0.05 GH2 B12316 / B12266 SCOPE GDM 1.03 (1.00, 1.06) 0.03 GH2 B12316 / B12266 STOP GDM 1.01 (0.98, 1.03) 0.6 39.3.6.2 Between Groups Below are comparisons of the differences in the change in B12 concentration (pM) between groups. I.e. whether the change in B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.991 0.026 2513.706 0.942 1.042 0.725 ns STOP/SCOPE (non-GDM) 0.995 0.013 2513.706 0.971 1.021 0.725 ns STOP/SCOPE (GDM) 0.995 0.013 2513.706 0.971 1.021 0.725 ns GDM/non-GDM (SCOPE) 1.009 0.018 2392.435 0.975 1.044 0.608 ns GDM/non-GDM (STOP) 1.009 0.018 2392.435 0.975 1.044 0.608 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.004 0.015 2235.207 0.975 1.033 0.808 ns STOP/SCOPE (non-GDM) 1.002 0.007 2235.207 0.988 1.016 0.808 ns STOP/SCOPE (GDM) 1.002 0.007 2235.207 0.988 1.016 0.808 ns GDM/non-GDM (SCOPE) 0.985 0.010 2126.409 0.966 1.004 0.114 ns GDM/non-GDM (STOP) 0.985 0.010 2126.409 0.966 1.004 0.114 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.951 0.019 2442.544 0.915 0.988 0.010 * STOP/SCOPE (non-GDM) 0.975 0.010 2442.544 0.957 0.994 0.010 * STOP/SCOPE (GDM) 0.975 0.010 2442.544 0.957 0.994 0.010 * GDM/non-GDM (SCOPE) 0.995 0.013 2321.552 0.969 1.021 0.689 ns GDM/non-GDM (STOP) 0.995 0.013 2321.552 0.969 1.021 0.689 ns 39.3.7 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.3.8 Plots "],["folateb12-5.html", "39.4 Folate:B12", " 39.4 Folate:B12 39.4.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 222.1721895 1 &lt;0.0001 *** folate_B12 1.9565883 1 0.2 ns f39_gdm_new 4.3519939 1 0.04 * Study 0.0159568 1 0.9 ns GA_samp 240.7988788 1 &lt;0.0001 *** folate_B12:f39_gdm_new 1.7290670 1 0.2 ns f39_gdm_new:Study 2.0345857 1 0.2 ns folate_B12:Study 2.1217438 1 0.1 ns folate_B12:f39_gdm_new:Study 1.4301325 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 41.5148152 1 &lt;0.0001 *** folate_B12 0.0100768 1 0.9 ns f39_gdm_new 2.2544351 1 0.1 ns Study 17.5762181 1 &lt;0.0001 *** GA_samp 2681.6709146 1 &lt;0.0001 *** folate_B12:f39_gdm_new 5.6138005 1 0.02 * f39_gdm_new:Study 4.6010377 1 0.03 * folate_B12:Study 4.5171710 1 0.03 * folate_B12:f39_gdm_new:Study 8.4002634 1 0.004 ** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 412.7048220 1 &lt;0.0001 *** folate_B12 6.5317298 1 0.01 * f39_gdm_new 0.5055467 1 0.5 ns Study 2.3815628 1 0.1 ns GA_samp 1135.9022359 1 &lt;0.0001 *** folate_B12:f39_gdm_new 1.7655948 1 0.2 ns f39_gdm_new:Study 0.8746763 1 0.3 ns folate_B12:Study 0.1634244 1 0.7 ns folate_B12:f39_gdm_new:Study 2.7571483 1 0.10 ns 39.4.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 12.71 (9.11, 17.74) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.10 f39_gdm_newGDM 1.20 (0.97, 1.48) 0.08 StudySTOP 1.00 (0.89, 1.12) 0.97 GA_samp 1.17 (1.14, 1.19) &lt;0.0001 folate_B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.59 f39_gdm_newGDM:StudySTOP 0.92 (0.75, 1.13) 0.43 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.07 HPL Var Effect P (Intercept) 1.82 (1.51, 2.18) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.92 f39_gdm_newGDM 1.12 (0.97, 1.30) 0.13 StudySTOP 1.15 (1.08, 1.23) &lt;0.0001 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 folate_B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.02 f39_gdm_newGDM:StudySTOP 0.83 (0.71, 0.98) 0.03 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.03 folate_B12:f39_gdm_newGDM:StudySTOP 1.00 (1.00, 1.00) 0.004 GH2 Var Effect P (Intercept) 0.09 (0.07, 0.11) &lt;0.0001 folate_B12 1.00 (1.00, 1.00) 0.003 f39_gdm_newGDM 0.96 (0.82, 1.12) 0.59 StudySTOP 0.92 (0.85, 1.01) 0.07 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 folate_B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.68 f39_gdm_newGDM:StudySTOP 1.04 (0.89, 1.21) 0.66 folate_B12:StudySTOP 1.00 (1.00, 1.00) 0.37 39.4.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:B12 ratio and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 93.61358 6.955415 79.56256 80.74555 108.5323 STOP non-GDM 98.95769 7.119285 70.11810 85.73074 114.2254 SCOPE GDM 109.82229 12.777198 433.03468 87.37365 138.0386 STOP GDM 106.81198 9.090548 134.83101 90.26509 126.3921 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 90.28783 2.542769 128.66386 85.39438 95.4617 STOP non-GDM 99.76458 2.620084 98.32287 94.69848 105.1017 SCOPE GDM 88.99351 4.907332 962.15259 79.86597 99.1642 STOP GDM 97.75546 3.581697 327.25539 90.95734 105.0617 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.398553 0.0688689 318.4272 2.266814 2.537949 STOP non-GDM 2.263566 0.0564233 206.6909 2.155016 2.377584 SCOPE GDM 2.327736 0.1705617 1861.5489 2.016149 2.687479 STOP GDM 2.276020 0.0946342 788.5729 2.097634 2.469576 39.4.4 Comparisons 39.4.4.1 Within Groups Effect for every 100 unit increase in Folate:B12 ratio. Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin folate_B12245.89 / folate_B12145.89 SCOPE non-GDM 0.98 (0.96, 1.00) 0.10 Prolactin folate_B12245.89 / folate_B12145.89 STOP non-GDM 1.01 (0.99, 1.03) 0.4 Prolactin folate_B12245.89 / folate_B12145.89 SCOPE GDM 0.97 (0.92, 1.02) 0.2 Prolactin folate_B12245.89 / folate_B12145.89 STOP GDM 1.00 (0.96, 1.04) 0.9 HPL folate_B12245.89 / folate_B12145.89 SCOPE non-GDM 1.00 (0.99, 1.01) 0.9 HPL folate_B12245.89 / folate_B12145.89 STOP non-GDM 0.98 (0.97, 0.99) 0.005 HPL folate_B12245.89 / folate_B12145.89 SCOPE GDM 0.94 (0.89, 0.99) 0.02 HPL folate_B12245.89 / folate_B12145.89 STOP GDM 1.00 (0.98, 1.03) 0.7 GH2 folate_B12245.89 / folate_B12145.89 SCOPE non-GDM 0.98 (0.96, 0.99) 0.003 GH2 folate_B12245.89 / folate_B12145.89 STOP non-GDM 0.99 (0.97, 1.00) 0.1 GH2 folate_B12245.89 / folate_B12145.89 SCOPE GDM 0.98 (0.95, 1.02) 0.3 GH2 folate_B12245.89 / folate_B12145.89 STOP GDM 0.99 (0.96, 1.02) 0.6 39.4.4.2 Between Groups Below are comparisons of the differences in the change in Folate:B12 ratio between groups. I.e. whether the change in Folate:B12 ratio are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.061 0.034 2505.302 0.996 1.130 0.066 ns STOP/SCOPE (non-GDM) 1.030 0.017 2505.302 0.998 1.063 0.066 ns STOP/SCOPE (GDM) 1.030 0.017 2505.302 0.998 1.063 0.066 ns GDM/non-GDM (SCOPE) 0.988 0.023 2276.992 0.944 1.033 0.586 ns GDM/non-GDM (STOP) 0.988 0.023 2276.992 0.944 1.033 0.586 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.051 0.033 1150.154 0.989 1.118 0.111 ns STOP/SCOPE (non-GDM) 0.980 0.009 2360.173 0.962 0.998 0.034 * STOP/SCOPE (GDM) 1.072 0.032 1070.313 1.012 1.137 0.019 * GDM/non-GDM (SCOPE) 0.936 0.026 972.487 0.886 0.989 0.018 * GDM/non-GDM (STOP) 1.024 0.014 2265.025 0.997 1.053 0.087 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.022 0.025 2430.808 0.974 1.073 0.366 ns STOP/SCOPE (non-GDM) 1.011 0.012 2430.808 0.987 1.036 0.366 ns STOP/SCOPE (GDM) 1.011 0.012 2430.808 0.987 1.036 0.366 ns GDM/non-GDM (SCOPE) 1.007 0.017 2206.704 0.974 1.042 0.685 ns GDM/non-GDM (STOP) 1.007 0.017 2206.704 0.974 1.042 0.685 ns 39.4.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.4.6 Plots "],["active-b12-5.html", "39.5 Active B12", " 39.5 Active B12 39.5.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 153.6886819 1 &lt;0.0001 *** Active.B12 3.0752426 1 0.08 ns f39_gdm_new 6.5862139 1 0.01 * Study 0.5158613 1 0.5 ns GA_samp 74.7962909 1 &lt;0.0001 *** Active.B12:f39_gdm_new 9.0809087 1 0.003 ** f39_gdm_new:Study 8.3364701 1 0.004 ** Active.B12:Study 0.3948108 1 0.5 ns Active.B12:f39_gdm_new:Study 11.7457017 1 0.0006 *** HPL Chisq Df Pr(&gt;Chisq) (Intercept) 29.5258247 1 &lt;0.0001 *** Active.B12 0.2332697 1 0.6 ns f39_gdm_new 13.0144308 1 0.0003 *** Study 1.7352098 1 0.2 ns GA_samp 1378.2539166 1 &lt;0.0001 *** Active.B12:f39_gdm_new 11.4345749 1 0.0007 *** f39_gdm_new:Study 7.6905423 1 0.006 ** Active.B12:Study 0.2532038 1 0.6 ns Active.B12:f39_gdm_new:Study 6.7609778 1 0.009 ** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 219.6360432 1 &lt;0.0001 *** Active.B12 0.9848774 1 0.3 ns f39_gdm_new 6.1491515 1 0.01 * Study 0.0991955 1 0.8 ns GA_samp 599.2197608 1 &lt;0.0001 *** Active.B12:f39_gdm_new 4.8418225 1 0.03 * f39_gdm_new:Study 3.7615820 1 0.05 ns Active.B12:Study 2.8210995 1 0.09 ns Active.B12:f39_gdm_new:Study 2.7276422 1 0.10 ns 39.5.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 18.77 (11.80, 29.82) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.08 f39_gdm_newGDM 0.41 (0.21, 0.81) 0.01 StudySTOP 0.92 (0.73, 1.16) 0.47 GA_samp 1.13 (1.10, 1.16) &lt;0.0001 Active.B12:f39_gdm_newGDM 1.01 (1.00, 1.02) 0.003 f39_gdm_newGDM:StudySTOP 3.14 (1.45, 6.84) 0.004 Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.53 Active.B12:f39_gdm_newGDM:StudySTOP 0.98 (0.98, 0.99) 0.0006 HPL Var Effect P (Intercept) 2.01 (1.56, 2.58) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.63 f39_gdm_newGDM 0.51 (0.35, 0.73) 0.0003 StudySTOP 1.09 (0.96, 1.24) 0.19 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 Active.B12:f39_gdm_newGDM 1.01 (1.00, 1.01) 0.0007 f39_gdm_newGDM:StudySTOP 1.83 (1.19, 2.80) 0.006 Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.61 Active.B12:f39_gdm_newGDM:StudySTOP 0.99 (0.99, 1.00) 0.009 GH2 Var Effect P (Intercept) 0.08 (0.05, 0.11) &lt;0.0001 Active.B12 1.00 (1.00, 1.00) 0.16 f39_gdm_newGDM 0.73 (0.53, 1.01) 0.06 StudySTOP 1.07 (0.90, 1.27) 0.46 GA_samp 1.29 (1.26, 1.32) &lt;0.0001 Active.B12:f39_gdm_newGDM 1.00 (1.00, 1.01) 0.14 f39_gdm_newGDM:StudySTOP 1.13 (0.91, 1.40) 0.27 Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.03 39.5.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Active B12 concentration (pM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 106.07565 8.867501 87.54089 89.83826 125.2478 STOP non-GDM 91.33502 7.507674 82.16467 77.55742 107.5601 SCOPE GDM 95.27499 15.308649 671.50412 69.49636 130.6158 STOP GDM 89.61522 9.325686 197.74535 72.98897 110.0288 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 94.91126 2.883224 184.5970 89.39005 100.77348 STOP non-GDM 106.73089 3.123666 162.4897 100.73753 113.08082 SCOPE GDM 79.32904 6.139892 845.1562 68.14855 92.34381 STOP GDM 103.56623 4.755476 567.8573 94.63457 113.34085 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.557416 0.0910123 317.2739 2.384477 2.742898 STOP non-GDM 2.303047 0.0769766 279.9333 2.156397 2.459669 SCOPE GDM 2.212096 0.2225587 1057.0500 1.815794 2.694892 STOP GDM 2.249046 0.1282192 746.6258 2.010908 2.515385 39.5.4 Comparisons 39.5.4.1 Within Groups Effect for every 10 unit increase in Active B12 concentration (pM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin Active.B1271 / Active.B1261 SCOPE non-GDM 1.02 (1.00, 1.04) 0.08 Prolactin Active.B1271 / Active.B1261 STOP non-GDM 1.01 (0.99, 1.03) 0.4 Prolactin Active.B1271 / Active.B1261 SCOPE GDM 1.15 (1.07, 1.24) 0.0002 Prolactin Active.B1271 / Active.B1261 STOP GDM 0.97 (0.92, 1.02) 0.2 HPL Active.B1271 / Active.B1261 SCOPE non-GDM 1.00 (0.98, 1.01) 0.6 HPL Active.B1271 / Active.B1261 STOP non-GDM 1.00 (0.99, 1.01) 0.8 HPL Active.B1271 / Active.B1261 SCOPE GDM 1.08 (1.03, 1.12) 0.0008 HPL Active.B1271 / Active.B1261 STOP GDM 1.01 (0.98, 1.04) 0.6 GH2 Active.B1271 / Active.B1261 SCOPE non-GDM 1.01 (1.00, 1.03) 0.2 GH2 Active.B1271 / Active.B1261 STOP non-GDM 0.99 (0.97, 1.00) 0.10 GH2 Active.B1271 / Active.B1261 SCOPE GDM 1.04 (1.00, 1.08) 0.04 GH2 Active.B1271 / Active.B1261 STOP GDM 1.01 (0.98, 1.04) 0.5 39.5.4.2 Between Groups Below are comparisons of the differences in the change in Active B12 concentration (pM) between groups. I.e. whether the change in Active B12 concentration (pM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.835 0.040 1294.116 0.760 0.919 0.0002 *** STOP/SCOPE (non-GDM) 0.990 0.015 1287.196 0.960 1.021 0.530 ns STOP/SCOPE (GDM) 0.844 0.038 1300.468 0.772 0.921 0.0002 *** GDM/non-GDM (SCOPE) 1.125 0.044 1296.861 1.042 1.215 0.003 ** GDM/non-GDM (STOP) 0.958 0.026 1175.814 0.909 1.011 0.117 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.942 0.026 1197.916 0.893 0.993 0.028 * STOP/SCOPE (non-GDM) 1.004 0.009 1225.747 0.987 1.022 0.615 ns STOP/SCOPE (GDM) 0.937 0.024 1223.049 0.892 0.985 0.011 * GDM/non-GDM (SCOPE) 1.078 0.024 1256.331 1.032 1.127 0.0008 *** GDM/non-GDM (STOP) 1.007 0.015 1129.391 0.978 1.036 0.662 ns GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.950 0.022 1259.117 0.908 0.994 0.026 * STOP/SCOPE (non-GDM) 0.975 0.011 1259.117 0.953 0.997 0.026 * STOP/SCOPE (GDM) 0.975 0.011 1259.117 0.953 0.997 0.026 * GDM/non-GDM (SCOPE) 1.026 0.018 1218.356 0.992 1.061 0.138 ns GDM/non-GDM (STOP) 1.026 0.018 1218.356 0.992 1.061 0.138 ns 39.5.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.5.6 Plots "],["folateactive-b12-5.html", "39.6 Folate:Active B12", " 39.6 Folate:Active B12 39.6.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 178.368871 1 &lt;0.0001 *** folate_Active.B12 3.305218 1 0.07 ns f39_gdm_new 3.329806 1 0.07 ns Study 9.230636 1 0.002 ** GA_samp 77.423996 1 &lt;0.0001 *** folate_Active.B12:f39_gdm_new 1.991686 1 0.2 ns f39_gdm_new:Study 3.645324 1 0.06 ns folate_Active.B12:Study 6.255489 1 0.01 * folate_Active.B12:f39_gdm_new:Study 1.968232 1 0.2 ns HPL Chisq Df Pr(&gt;Chisq) (Intercept) 31.2425883 1 &lt;0.0001 *** folate_Active.B12 0.4218343 1 0.5 ns f39_gdm_new 0.0298128 1 0.9 ns Study 18.4871565 1 &lt;0.0001 *** GA_samp 1360.6715412 1 &lt;0.0001 *** folate_Active.B12:f39_gdm_new 2.8256494 1 0.09 ns f39_gdm_new:Study 1.6967610 1 0.2 ns folate_Active.B12:Study 10.6095401 1 0.001 ** folate_Active.B12:f39_gdm_new:Study 7.0368344 1 0.008 ** GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 221.4393872 1 &lt;0.0001 *** folate_Active.B12 2.1105268 1 0.1 ns f39_gdm_new 0.0440423 1 0.8 ns Study 3.5947847 1 0.06 ns GA_samp 598.6994877 1 &lt;0.0001 *** folate_Active.B12:f39_gdm_new 1.8896277 1 0.2 ns f39_gdm_new:Study 0.2940806 1 0.6 ns folate_Active.B12:Study 0.2425480 1 0.6 ns folate_Active.B12:f39_gdm_new:Study 2.4083005 1 0.1 ns 39.6.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 21.41 (13.64, 33.57) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.04 f39_gdm_newGDM 1.19 (0.89, 1.59) 0.22 StudySTOP 0.78 (0.67, 0.91) 0.001 GA_samp 1.13 (1.10, 1.16) &lt;0.0001 folate_Active.B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.72 f39_gdm_newGDM:StudySTOP 0.83 (0.63, 1.11) 0.20 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.004 HPL Var Effect P (Intercept) 2.00 (1.57, 2.55) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.52 f39_gdm_newGDM 1.02 (0.84, 1.23) 0.86 StudySTOP 1.21 (1.11, 1.32) &lt;0.0001 GA_samp 1.33 (1.31, 1.35) &lt;0.0001 folate_Active.B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.09 f39_gdm_newGDM:StudySTOP 0.87 (0.70, 1.07) 0.19 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.001 folate_Active.B12:f39_gdm_newGDM:StudySTOP 1.00 (1.00, 1.00) 0.008 GH2 Var Effect P (Intercept) 0.09 (0.06, 0.12) &lt;0.0001 folate_Active.B12 1.00 (1.00, 1.00) 0.08 f39_gdm_newGDM 0.91 (0.73, 1.12) 0.37 StudySTOP 0.88 (0.78, 0.99) 0.03 GA_samp 1.29 (1.26, 1.32) &lt;0.0001 folate_Active.B12:f39_gdm_newGDM 1.00 (1.00, 1.00) 0.99 f39_gdm_newGDM:StudySTOP 1.09 (0.88, 1.34) 0.45 folate_Active.B12:StudySTOP 1.00 (1.00, 1.00) 0.36 39.6.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Folate:Active B12 ratio and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 103.61318 8.610064 87.18251 87.83875 122.2204 STOP non-GDM 91.78958 7.522085 82.77716 77.98360 108.0397 SCOPE GDM 120.45415 17.897564 610.83227 89.96958 161.2679 STOP GDM 88.73513 9.109336 191.23139 72.46975 108.6512 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 95.27863 2.879040 177.8359 89.76322 101.13292 STOP non-GDM 106.10827 3.117087 161.7390 100.12798 112.44575 SCOPE GDM 84.69219 6.206321 906.6047 73.34714 97.79206 STOP GDM 103.92517 4.663512 525.0877 95.15594 113.50254 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.528484 0.0894550 304.3522 2.358443 2.710784 STOP non-GDM 2.297206 0.0771573 278.4987 2.150233 2.454225 SCOPE GDM 2.291207 0.2259435 1095.5208 1.888129 2.780334 STOP GDM 2.258963 0.1265221 709.6919 2.023731 2.521537 39.6.4 Comparisons 39.6.4.1 Within Groups Effect for every 500 unit increase in Folate:Active B12 ratio. Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin folate_Active.B121124.49 / folate_Active.B12624.49 SCOPE non-GDM 0.96 (0.93, 1.00) 0.04 Prolactin folate_Active.B121124.49 / folate_Active.B12624.49 STOP non-GDM 1.04 (1.00, 1.08) 0.05 Prolactin folate_Active.B121124.49 / folate_Active.B12624.49 SCOPE GDM 0.95 (0.87, 1.03) 0.2 Prolactin folate_Active.B121124.49 / folate_Active.B12624.49 STOP GDM 1.02 (0.95, 1.10) 0.5 HPL folate_Active.B121124.49 / folate_Active.B12624.49 SCOPE non-GDM 1.01 (0.99, 1.03) 0.5 HPL folate_Active.B121124.49 / folate_Active.B12624.49 STOP non-GDM 0.96 (0.94, 0.98) 0.0002 HPL folate_Active.B121124.49 / folate_Active.B12624.49 SCOPE GDM 0.93 (0.85, 1.02) 0.1 HPL folate_Active.B121124.49 / folate_Active.B12624.49 STOP GDM 1.02 (0.98, 1.06) 0.4 GH2 folate_Active.B121124.49 / folate_Active.B12624.49 SCOPE non-GDM 0.98 (0.95, 1.00) 0.08 GH2 folate_Active.B121124.49 / folate_Active.B12624.49 STOP non-GDM 1.00 (0.97, 1.03) 0.7 GH2 folate_Active.B121124.49 / folate_Active.B12624.49 SCOPE GDM 0.98 (0.92, 1.04) 0.5 GH2 folate_Active.B121124.49 / folate_Active.B12624.49 STOP GDM 0.99 (0.94, 1.05) 0.8 39.6.4.2 Between Groups Below are comparisons of the differences in the change in Folate:Active B12 ratio between groups. I.e. whether the change in Folate:Active B12 ratio are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.161 0.060 1267.990 1.049 1.285 0.004 ** STOP/SCOPE (non-GDM) 1.077 0.028 1267.990 1.024 1.133 0.004 ** STOP/SCOPE (GDM) 1.077 0.028 1267.990 1.024 1.133 0.004 ** GDM/non-GDM (SCOPE) 0.986 0.040 1115.033 0.910 1.067 0.720 ns GDM/non-GDM (STOP) 0.986 0.040 1115.033 0.910 1.067 0.720 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.041 0.055 841.850 0.939 1.154 0.447 ns STOP/SCOPE (non-GDM) 0.953 0.014 1241.716 0.925 0.981 0.001 ** STOP/SCOPE (GDM) 1.092 0.054 827.386 0.990 1.204 0.077 ns GDM/non-GDM (SCOPE) 0.926 0.042 785.224 0.846 1.013 0.093 ns GDM/non-GDM (STOP) 1.061 0.026 1151.096 1.011 1.114 0.016 * GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.037 0.042 1272.315 0.959 1.122 0.363 ns STOP/SCOPE (non-GDM) 1.018 0.020 1272.315 0.979 1.059 0.363 ns STOP/SCOPE (GDM) 1.018 0.020 1272.315 0.979 1.059 0.363 ns GDM/non-GDM (SCOPE) 1.000 0.030 1109.634 0.942 1.061 0.990 ns GDM/non-GDM (STOP) 1.000 0.030 1109.634 0.942 1.061 0.990 ns 39.6.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.6.6 Plots "],["homocysteine-5.html", "39.7 Homocysteine", " 39.7 Homocysteine 39.7.1 Global tests Type III ANOVA on main and interaction effects, and LM model summaries. Prolactin Chisq Df Pr(&gt;Chisq) (Intercept) 267.2926600 1 &lt;0.0001 *** Homocysteine 24.5361460 1 &lt;0.0001 *** f39_gdm_new 3.2864956 1 0.07 ns Study 0.0320502 1 0.9 ns GA_samp 203.0324248 1 &lt;0.0001 *** Homocysteine:f39_gdm_new 4.6440385 1 0.03 * f39_gdm_new:Study 4.8697289 1 0.03 * Homocysteine:Study 0.2573399 1 0.6 ns Homocysteine:f39_gdm_new:Study 5.7766965 1 0.02 * HPL Chisq Df Pr(&gt;Chisq) (Intercept) 40.3854976 1 &lt;0.0001 *** Homocysteine 0.8615600 1 0.4 ns f39_gdm_new 1.3202733 1 0.3 ns Study 3.0272455 1 0.08 ns GA_samp 2566.7201207 1 &lt;0.0001 *** Homocysteine:f39_gdm_new 1.7720726 1 0.2 ns f39_gdm_new:Study 0.1463471 1 0.7 ns Homocysteine:Study 0.1346403 1 0.7 ns Homocysteine:f39_gdm_new:Study 0.0069783 1 0.9 ns GH2 Chisq Df Pr(&gt;Chisq) (Intercept) 326.8864613 1 &lt;0.0001 *** Homocysteine 0.3838227 1 0.5 ns f39_gdm_new 0.1669448 1 0.7 ns Study 1.1578267 1 0.3 ns GA_samp 1103.3428481 1 &lt;0.0001 *** Homocysteine:f39_gdm_new 0.3220907 1 0.6 ns f39_gdm_new:Study 0.0498829 1 0.8 ns Homocysteine:Study 0.2341337 1 0.6 ns Homocysteine:f39_gdm_new:Study 0.0010763 1 1.0 ns 39.7.2 Model summary Ratio of Geometric means (95% CI) Prolactin Var Effect P (Intercept) 22.04 (15.22, 31.91) &lt;0.0001 Homocysteine 0.92 (0.89, 0.95) &lt;0.0001 f39_gdm_newGDM 0.43 (0.17, 1.07) 0.07 StudySTOP 0.98 (0.77, 1.24) 0.86 GA_samp 1.15 (1.13, 1.17) &lt;0.0001 Homocysteine:f39_gdm_newGDM 1.28 (1.02, 1.59) 0.03 f39_gdm_newGDM:StudySTOP 3.18 (1.14, 8.87) 0.03 Homocysteine:StudySTOP 1.01 (0.97, 1.06) 0.61 Homocysteine:f39_gdm_newGDM:StudySTOP 0.74 (0.58, 0.95) 0.02 HPL Var Effect P (Intercept) 1.94 (1.58, 2.38) &lt;0.0001 Homocysteine 0.99 (0.97, 1.01) 0.35 f39_gdm_newGDM 1.37 (1.10, 1.70) 0.005 StudySTOP 1.13 (0.99, 1.29) 0.07 GA_samp 1.34 (1.33, 1.36) &lt;0.0001 Homocysteine:f39_gdm_newGDM 0.92 (0.87, 0.96) 0.0003 f39_gdm_newGDM:StudySTOP 1.09 (0.97, 1.23) 0.14 Homocysteine:StudySTOP 0.99 (0.97, 1.02) 0.69 GH2 Var Effect P (Intercept) 0.08 (0.06, 0.11) &lt;0.0001 Homocysteine 0.99 (0.97, 1.02) 0.53 f39_gdm_newGDM 1.15 (0.85, 1.54) 0.36 StudySTOP 0.90 (0.76, 1.08) 0.27 GA_samp 1.29 (1.27, 1.31) &lt;0.0001 Homocysteine:f39_gdm_newGDM 0.95 (0.90, 1.02) 0.15 f39_gdm_newGDM:StudySTOP 1.11 (0.94, 1.30) 0.21 Homocysteine:StudySTOP 1.01 (0.97, 1.05) 0.62 39.7.3 Estimated means Estimated marginal means (or adjusted means) adjusted for GA at sampling. Results are averaged over the levels of Homocysteine concentration (μM) and may be misleading when interaction term is involved. Prolactin Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 93.09559 6.945846 80.92717 80.25223 107.9944 STOP non-GDM 96.87831 6.971666 70.22919 83.92621 111.8293 SCOPE GDM 135.00850 21.196392 1073.96708 99.21362 183.7177 STOP GDM 101.49612 8.648393 135.57414 85.75630 120.1248 HPL Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 90.30770 2.576003 135.94815 85.35450 95.54834 STOP non-GDM 99.42147 2.616538 99.69027 94.36334 104.75073 SCOPE GDM 79.94497 4.778980 1195.98532 71.09780 89.89306 STOP GDM 96.03370 3.547302 339.09155 89.30366 103.27092 GH2 Study f39_gdm_new response SE df lower.CL upper.CL SCOPE non-GDM 2.391248 0.0702937 346.4898 2.256913 2.533579 STOP non-GDM 2.263479 0.0567173 212.3408 2.154395 2.378088 SCOPE GDM 2.168632 0.1715118 2084.9951 1.857066 2.532471 STOP GDM 2.276529 0.0957335 817.8792 2.096163 2.472415 39.7.4 Comparisons 39.7.4.1 Within Groups Effect for every 1 unit increase in Homocysteine concentration (μM). Hormone Contrast Study f39_gdm_new Ratio of Geometric means (95% CI) P-value Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.92 (0.89, 0.95) &lt;0.0001 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 0.93 (0.90, 0.96) &lt;0.0001 Prolactin Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 1.17 (0.94, 1.46) 0.2 Prolactin Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.88 (0.81, 0.96) 0.003 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.99 (0.97, 1.01) 0.4 HPL Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 0.99 (0.97, 1.00) 0.1 HPL Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.91 (0.86, 0.96) 0.0002 HPL Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.90 (0.86, 0.95) &lt;0.0001 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE non-GDM 0.99 (0.97, 1.02) 0.5 GH2 Homocysteine5.5 / Homocysteine4.5 STOP non-GDM 1.00 (0.98, 1.03) 1.0 GH2 Homocysteine5.5 / Homocysteine4.5 SCOPE GDM 0.95 (0.88, 1.01) 0.1 GH2 Homocysteine5.5 / Homocysteine4.5 STOP GDM 0.95 (0.90, 1.01) 0.1 39.7.4.2 Between Groups Below are comparisons of the differences in the change in Homocysteine concentration (μM) between groups. I.e. whether the change in Homocysteine concentration (μM) are different between groups. Prolactin contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.762 0.093 2412.313 0.599 0.969 0.027 * STOP/SCOPE (non-GDM) 1.012 0.025 2596.867 0.965 1.062 0.612 ns STOP/SCOPE (GDM) 0.753 0.091 2378.732 0.594 0.954 0.019 * GDM/non-GDM (SCOPE) 1.276 0.144 2357.217 1.022 1.593 0.031 * GDM/non-GDM (STOP) 0.949 0.043 2611.604 0.867 1.038 0.249 ns HPL contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 0.989 0.027 2427.605 0.937 1.044 0.694 ns STOP/SCOPE (non-GDM) 0.995 0.014 2427.605 0.968 1.022 0.694 ns STOP/SCOPE (GDM) 0.995 0.014 2427.605 0.968 1.022 0.694 ns GDM/non-GDM (SCOPE) 0.916 0.022 2427.330 0.874 0.961 0.0003 *** GDM/non-GDM (STOP) 0.916 0.022 2427.330 0.874 0.961 0.0003 *** GH2 contrast ratio SE df lower.CL upper.CL p.value SCOPE/SCOPE (Overall) 1.019 0.037 2540.027 0.948 1.094 0.616 ns STOP/SCOPE (non-GDM) 1.009 0.018 2540.027 0.974 1.046 0.616 ns STOP/SCOPE (GDM) 1.009 0.018 2540.027 0.974 1.046 0.616 ns GDM/non-GDM (SCOPE) 0.954 0.031 2558.644 0.895 1.017 0.146 ns GDM/non-GDM (STOP) 0.954 0.031 2558.644 0.895 1.017 0.146 ns 39.7.5 Diagnostics Model diagnositcs. Diagnositcs for Prolactin Diagnositcs for HPL Diagnositcs for GH2 39.7.6 Plots "],["404.html", "Page not found", " Page not found The page you requested cannot be found (perhaps it was moved or renamed). You may want to try searching to find the page's new location, or use the table of contents to find the page you are looking for. "]]
